0001099800-21-000007.txt : 20210212 0001099800-21-000007.hdr.sgml : 20210212 20210212165856 ACCESSION NUMBER: 0001099800-21-000007 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 165 CONFORMED PERIOD OF REPORT: 20201231 FILED AS OF DATE: 20210212 DATE AS OF CHANGE: 20210212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Edwards Lifesciences Corp CENTRAL INDEX KEY: 0001099800 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 364316614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-15525 FILM NUMBER: 21629022 BUSINESS ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9492502500 MAIL ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP. DATE OF NAME CHANGE: 20090225 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP DATE OF NAME CHANGE: 20000203 FORMER COMPANY: FORMER CONFORMED NAME: CVG CONTROLLED INC DATE OF NAME CHANGE: 19991126 10-K 1 ew-20201231.htm 10-K ew-20201231
0001099800false2020FYP3YP3Y00010998002020-01-012020-12-31iso4217:USD00010998002020-06-30xbrli:shares00010998002021-01-3100010998002020-12-3100010998002019-12-31iso4217:USDxbrli:shares00010998002019-01-012019-12-3100010998002018-01-012018-12-3100010998002018-12-3100010998002017-12-310001099800us-gaap:CommonStockMember2017-12-310001099800us-gaap:TreasuryStockMember2017-12-310001099800us-gaap:AdditionalPaidInCapitalMember2017-12-310001099800us-gaap:RetainedEarningsMember2017-12-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2017-12-310001099800srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:RetainedEarningsMember2017-12-310001099800srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2017-12-310001099800srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2017-12-310001099800us-gaap:CommonStockMembersrt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember2017-12-310001099800us-gaap:TreasuryStockMembersrt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember2017-12-310001099800us-gaap:AdditionalPaidInCapitalMembersrt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember2017-12-310001099800us-gaap:RetainedEarningsMembersrt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember2017-12-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMembersrt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember2017-12-310001099800srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember2017-12-310001099800us-gaap:RetainedEarningsMember2018-01-012018-12-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-01-012018-12-310001099800us-gaap:CommonStockMember2018-01-012018-12-310001099800us-gaap:AdditionalPaidInCapitalMember2018-01-012018-12-310001099800us-gaap:TreasuryStockMember2018-01-012018-12-310001099800us-gaap:CommonStockMember2018-12-310001099800us-gaap:TreasuryStockMember2018-12-310001099800us-gaap:AdditionalPaidInCapitalMember2018-12-310001099800us-gaap:RetainedEarningsMember2018-12-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-310001099800us-gaap:RetainedEarningsMember2019-01-012019-12-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-01-012019-12-310001099800us-gaap:CommonStockMember2019-01-012019-12-310001099800us-gaap:AdditionalPaidInCapitalMember2019-01-012019-12-310001099800us-gaap:TreasuryStockMember2019-01-012019-12-310001099800us-gaap:CommonStockMember2019-12-310001099800us-gaap:TreasuryStockMember2019-12-310001099800us-gaap:AdditionalPaidInCapitalMember2019-12-310001099800us-gaap:RetainedEarningsMember2019-12-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001099800us-gaap:RetainedEarningsMember2020-01-012020-12-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-12-310001099800us-gaap:CommonStockMember2020-01-012020-12-310001099800us-gaap:AdditionalPaidInCapitalMember2020-01-012020-12-310001099800us-gaap:TreasuryStockMember2020-01-012020-12-310001099800us-gaap:CommonStockMember2020-12-310001099800us-gaap:TreasuryStockMember2020-12-310001099800us-gaap:AdditionalPaidInCapitalMember2020-12-310001099800us-gaap:RetainedEarningsMember2020-12-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-31utr:Rate00010998002020-05-072020-05-070001099800ew:HemodynamicMonitorsMember2020-01-012020-12-310001099800us-gaap:ShippingAndHandlingMember2020-01-012020-12-310001099800us-gaap:ShippingAndHandlingMember2019-01-012019-12-310001099800us-gaap:ShippingAndHandlingMember2018-01-012018-12-31xbrli:pure0001099800srt:MinimumMember2020-12-310001099800srt:MinimumMember2020-01-012020-12-310001099800srt:MaximumMember2020-01-012020-12-310001099800srt:MinimumMemberus-gaap:BuildingAndBuildingImprovementsMember2020-01-012020-12-310001099800srt:MaximumMemberus-gaap:BuildingAndBuildingImprovementsMember2020-01-012020-12-310001099800srt:MinimumMemberus-gaap:MachineryAndEquipmentMember2020-01-012020-12-310001099800srt:MaximumMemberus-gaap:MachineryAndEquipmentMember2020-01-012020-12-310001099800srt:MinimumMemberus-gaap:SoftwareAndSoftwareDevelopmentCostsMember2020-01-012020-12-310001099800srt:MaximumMemberus-gaap:SoftwareAndSoftwareDevelopmentCostsMember2020-01-012020-12-310001099800us-gaap:InProcessResearchAndDevelopmentMember2020-01-012020-12-310001099800us-gaap:InProcessResearchAndDevelopmentMember2019-01-012019-12-310001099800ew:DevelopedTechnologyAndInProcessResearchAndDevelopmentMemberew:ValtechCardioLtdMember2018-01-012018-12-310001099800us-gaap:StockCompensationPlanMember2020-01-012020-12-310001099800us-gaap:StockCompensationPlanMember2019-01-012019-12-310001099800us-gaap:StockCompensationPlanMember2018-01-012018-12-310001099800us-gaap:CostOfSalesMember2020-01-012020-12-310001099800us-gaap:CostOfSalesMember2019-01-012019-12-310001099800us-gaap:CostOfSalesMember2018-01-012018-12-310001099800us-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-12-310001099800us-gaap:SellingGeneralAndAdministrativeExpensesMember2019-01-012019-12-310001099800us-gaap:SellingGeneralAndAdministrativeExpensesMember2018-01-012018-12-310001099800us-gaap:ResearchAndDevelopmentExpenseMember2020-01-012020-12-310001099800us-gaap:ResearchAndDevelopmentExpenseMember2019-01-012019-12-310001099800us-gaap:ResearchAndDevelopmentExpenseMember2018-01-012018-12-310001099800us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-12-310001099800ew:AbbottLaboratoriesMember2020-06-012020-06-300001099800ew:AbbottLaboratoriesMemberus-gaap:SubsequentEventMembersrt:ScenarioForecastMember2021-01-012024-05-310001099800ew:AbbottLaboratoriesMember2020-07-012020-07-310001099800ew:TranscatheterMitralValveReplacementMember2018-01-012018-12-310001099800us-gaap:DevelopedTechnologyRightsMemberew:ValtechCardioLtdMemberew:RestOfWorldSegmentMember2019-12-012019-12-310001099800ew:DevelopedTechnologyAndInProcessResearchAndDevelopmentMemberew:ValtechCardioLtdMemberew:RestOfWorldSegmentMember2018-12-012018-12-310001099800ew:EarlystageTranscatheterIntellectualPropertyMember2019-03-310001099800us-gaap:PensionPlansDefinedBenefitMember2018-03-012018-03-310001099800srt:MaximumMember2020-12-310001099800us-gaap:BankTimeDepositsMember2020-12-310001099800us-gaap:BankTimeDepositsMember2019-12-310001099800us-gaap:CommercialPaperMember2020-12-310001099800us-gaap:CommercialPaperMember2019-12-310001099800us-gaap:USTreasuryAndGovernmentMember2020-12-310001099800us-gaap:USTreasuryAndGovernmentMember2019-12-310001099800us-gaap:ForeignGovernmentDebtSecuritiesMember2020-12-310001099800us-gaap:ForeignGovernmentDebtSecuritiesMember2019-12-310001099800us-gaap:AssetBackedSecuritiesMember2020-12-310001099800us-gaap:AssetBackedSecuritiesMember2019-12-310001099800us-gaap:CorporateDebtSecuritiesMember2020-12-310001099800us-gaap:CorporateDebtSecuritiesMember2019-12-310001099800us-gaap:MunicipalBondsMember2020-12-310001099800us-gaap:MunicipalBondsMember2019-12-31ew:investment0001099800us-gaap:OtherNonoperatingIncomeExpenseMember2020-12-310001099800us-gaap:OtherNonoperatingIncomeExpenseMember2019-12-310001099800ew:CASMedicalSystemsInc.Member2019-02-110001099800ew:CASMedicalSystemsInc.Member2019-02-112019-02-110001099800ew:CASMedicalSystemsInc.Member2019-04-182019-04-180001099800ew:CASMedicalSystemsInc.Member2019-01-012019-12-310001099800ew:CASMedicalSystemsInc.Member2019-04-180001099800ew:CASMedicalSystemsInc.Memberus-gaap:DevelopedTechnologyRightsMember2019-04-180001099800ew:CASMedicalSystemsInc.Memberus-gaap:CustomerRelationshipsMember2019-04-180001099800ew:CASMedicalSystemsInc.Memberus-gaap:DevelopedTechnologyRightsMember2019-04-182019-04-180001099800ew:CASMedicalSystemsInc.Memberus-gaap:CustomerRelationshipsMember2019-04-182019-04-180001099800ew:HarpoonMedicalInc.Member2017-12-012017-12-010001099800ew:HarpoonMedicalInc.Member2015-12-012017-11-300001099800ew:HarpoonMedicalInc.Member2017-12-010001099800ew:ValtechCardioLtdMember2016-11-262016-11-260001099800ew:ValtechCardioLtdMember2016-11-260001099800ew:ValtechCardioLtdMember2017-01-232017-01-230001099800ew:ValtechCardioLtdMember2017-01-230001099800ew:ValtechSpinoffMember2017-01-232017-01-230001099800ew:DevelopedTechnologyAndInProcessResearchAndDevelopmentMemberew:ValtechCardioLtdMember2018-12-012018-12-310001099800ew:CardiAQValveTechnologiesInc.Member2015-07-032015-07-030001099800ew:CardiAQValveTechnologiesInc.Member2015-08-262015-08-260001099800ew:CardiAQValveTechnologiesInc.Member2015-08-260001099800ew:CasmedMember2019-04-012019-04-300001099800ew:CasmedMember2019-04-300001099800ew:UnitedStatesSegmentMember2018-12-310001099800ew:EuropeSegmentMember2018-12-310001099800ew:RestOfWorldSegmentMember2018-12-310001099800ew:UnitedStatesSegmentMember2019-01-012019-12-310001099800ew:EuropeSegmentMember2019-01-012019-12-310001099800ew:RestOfWorldSegmentMember2019-01-012019-12-310001099800ew:UnitedStatesSegmentMember2019-12-310001099800ew:EuropeSegmentMember2019-12-310001099800ew:RestOfWorldSegmentMember2019-12-310001099800ew:UnitedStatesSegmentMember2020-01-012020-12-310001099800ew:EuropeSegmentMember2020-01-012020-12-310001099800ew:RestOfWorldSegmentMember2020-01-012020-12-310001099800ew:UnitedStatesSegmentMember2020-12-310001099800ew:EuropeSegmentMember2020-12-310001099800ew:RestOfWorldSegmentMember2020-12-310001099800us-gaap:PatentsMember2020-01-012020-12-310001099800us-gaap:PatentsMember2020-12-310001099800us-gaap:PatentsMember2019-12-310001099800us-gaap:DevelopedTechnologyRightsMember2020-01-012020-12-310001099800us-gaap:DevelopedTechnologyRightsMember2020-12-310001099800us-gaap:DevelopedTechnologyRightsMember2019-12-310001099800us-gaap:OtherIntangibleAssetsMember2020-01-012020-12-310001099800us-gaap:OtherIntangibleAssetsMember2020-12-310001099800us-gaap:OtherIntangibleAssetsMember2019-12-310001099800us-gaap:InProcessResearchAndDevelopmentMember2020-12-310001099800us-gaap:InProcessResearchAndDevelopmentMember2019-12-310001099800ew:FixedRate4.3002018NotesMemberus-gaap:SeniorNotesMember2018-06-300001099800ew:SeniorNotesDue2018Member2018-06-012018-06-300001099800ew:FixedRate4.3002018NotesMemberus-gaap:SeniorNotesMember2020-12-310001099800ew:FixedRate4.3002018NotesMemberus-gaap:SeniorNotesMember2019-12-310001099800us-gaap:SeniorNotesMember2020-12-310001099800us-gaap:SeniorNotesMember2019-12-310001099800ew:SeniorNotesDue2018Memberus-gaap:FairValueInputsLevel2Member2020-12-310001099800ew:SeniorNotesDue2018Memberus-gaap:FairValueInputsLevel2Member2019-12-310001099800ew:CreditAgreementMaturityJuly2019Memberus-gaap:LineOfCreditMember2018-04-012018-04-300001099800ew:CreditAgreementMaturityApril2023Memberus-gaap:LineOfCreditMember2018-04-300001099800srt:MaximumMemberus-gaap:LineOfCreditMemberew:CreditAgreementMaturityApril2023Member2018-04-300001099800srt:MinimumMemberus-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:LineOfCreditMemberew:CreditAgreementMaturityApril2023Member2018-04-012018-04-300001099800srt:MaximumMemberus-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:LineOfCreditMemberew:CreditAgreementMaturityApril2023Member2018-04-012018-04-300001099800srt:MinimumMemberus-gaap:LineOfCreditMemberew:CreditAgreementMaturityApril2023Member2018-04-012018-04-300001099800srt:MaximumMemberus-gaap:LineOfCreditMemberew:CreditAgreementMaturityApril2023Member2018-04-012018-04-300001099800us-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:LineOfCreditMemberew:CreditAgreementMaturityApril2023Member2020-01-012020-12-310001099800ew:CreditAgreementMaturityApril2023Memberus-gaap:LineOfCreditMember2020-01-012020-12-310001099800ew:CreditAgreementMaturityApril2023Memberus-gaap:LineOfCreditMember2020-12-310001099800ew:CreditAgreementMaturityApril2023Memberus-gaap:LineOfCreditMember2019-12-310001099800us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-12-310001099800us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:BankTimeDepositsMember2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:BankTimeDepositsMemberus-gaap:FairValueInputsLevel2Member2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Memberus-gaap:BankTimeDepositsMember2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:BankTimeDepositsMember2020-12-310001099800us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CorporateDebtSecuritiesMember2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CorporateDebtSecuritiesMember2020-12-310001099800us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:AssetBackedSecuritiesMember2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Member2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Member2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:AssetBackedSecuritiesMember2020-12-310001099800us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:USTreasuryAndGovernmentMember2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:USTreasuryAndGovernmentMember2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Memberus-gaap:USTreasuryAndGovernmentMember2020-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:USTreasuryAndGovernmentMember2020-12-310001099800us-gaap:MunicipalBondsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-12-310001099800us-gaap:MunicipalBondsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2020-12-310001099800us-gaap:MunicipalBondsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2020-12-310001099800us-gaap:MunicipalBondsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-12-310001099800us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2019-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2019-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2019-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2019-12-310001099800us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:BankTimeDepositsMember2019-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:BankTimeDepositsMemberus-gaap:FairValueInputsLevel2Member2019-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Memberus-gaap:BankTimeDepositsMember2019-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:BankTimeDepositsMember2019-12-310001099800us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CorporateDebtSecuritiesMember2019-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2019-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2019-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CorporateDebtSecuritiesMember2019-12-310001099800us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:AssetBackedSecuritiesMember2019-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Member2019-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Member2019-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:AssetBackedSecuritiesMember2019-12-310001099800us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:USTreasuryAndGovernmentMember2019-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:USTreasuryAndGovernmentMember2019-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Memberus-gaap:USTreasuryAndGovernmentMember2019-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:USTreasuryAndGovernmentMember2019-12-310001099800us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2019-12-310001099800us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2019-12-310001099800us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2019-12-310001099800us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2019-12-310001099800us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CommercialPaperMember2019-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CommercialPaperMember2019-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Memberus-gaap:CommercialPaperMember2019-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CommercialPaperMember2019-12-310001099800ew:TwoPreviousAcquisitionsMember2020-01-012020-12-310001099800ew:TwoPreviousAcquisitionsMember2019-01-012019-12-310001099800srt:MinimumMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ObligationsMember2020-12-310001099800us-gaap:MeasurementInputDiscountRateMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ObligationsMember2020-12-310001099800us-gaap:MeasurementInputDiscountRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ObligationsMember2020-12-310001099800srt:MinimumMemberus-gaap:FairValueInputsLevel3Memberew:MeasurementInputProbabilityOfMilestoneAchievementMemberus-gaap:ObligationsMember2020-12-310001099800srt:MaximumMemberus-gaap:FairValueInputsLevel3Memberew:MeasurementInputProbabilityOfMilestoneAchievementMemberus-gaap:ObligationsMember2020-12-310001099800srt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberew:MeasurementInputProbabilityOfMilestoneAchievementMemberus-gaap:ObligationsMember2020-12-310001099800srt:MinimumMemberus-gaap:FairValueInputsLevel3Memberew:MeasurementInputVolatilityOfFutureRevenueMemberus-gaap:ObligationsMember2020-12-310001099800srt:MaximumMemberus-gaap:FairValueInputsLevel3Memberew:MeasurementInputVolatilityOfFutureRevenueMemberus-gaap:ObligationsMember2020-12-310001099800srt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberew:MeasurementInputVolatilityOfFutureRevenueMemberus-gaap:ObligationsMember2020-12-310001099800us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001099800us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-12-310001099800us-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001099800us-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-12-310001099800us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001099800us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-12-310001099800us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001099800us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-12-310001099800us-gaap:OtherNoncurrentAssetsMemberus-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001099800us-gaap:OtherNoncurrentAssetsMemberus-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-12-310001099800us-gaap:ForeignExchangeContractMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001099800us-gaap:ForeignExchangeContractMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-12-310001099800us-gaap:ForeignExchangeContractMember2020-12-310001099800us-gaap:CurrencySwapMember2020-12-310001099800us-gaap:ForeignExchangeContractMember2019-12-310001099800us-gaap:CurrencySwapMember2019-12-310001099800us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-12-310001099800us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-01-012019-12-310001099800us-gaap:CostOfSalesMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-12-310001099800us-gaap:CostOfSalesMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-01-012019-12-310001099800us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-12-310001099800us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-01-012019-12-310001099800us-gaap:NetInvestmentHedgingMemberus-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-12-310001099800us-gaap:NetInvestmentHedgingMemberus-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-01-012019-12-310001099800us-gaap:NetInvestmentHedgingMemberus-gaap:InterestIncomeMemberus-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-12-310001099800us-gaap:NetInvestmentHedgingMemberus-gaap:InterestIncomeMemberus-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-01-012019-12-31iso4217:EUR0001099800us-gaap:NetInvestmentHedgingMemberus-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001099800us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:FairValueHedgingMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-12-310001099800us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:FairValueHedgingMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-01-012019-12-310001099800us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:FairValueHedgingMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2018-01-012018-12-310001099800us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2020-01-012020-12-310001099800us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2019-01-012019-12-310001099800us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2018-01-012018-12-310001099800us-gaap:CostOfSalesMemberus-gaap:ForeignExchangeContractMember2020-01-012020-12-310001099800us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:ForeignExchangeContractMember2020-01-012020-12-310001099800us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ForeignExchangeContractMember2020-01-012020-12-310001099800us-gaap:CostOfSalesMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-12-310001099800us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-12-310001099800us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-12-310001099800us-gaap:CostOfSalesMemberus-gaap:ForeignExchangeContractMember2019-01-012019-12-310001099800us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:ForeignExchangeContractMember2019-01-012019-12-310001099800us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ForeignExchangeContractMember2019-01-012019-12-310001099800us-gaap:CostOfSalesMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-01-012019-12-310001099800us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-01-012019-12-310001099800us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-01-012019-12-310001099800us-gaap:PensionPlansDefinedBenefitMember2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMember2018-12-310001099800us-gaap:PensionPlansDefinedBenefitMember2020-01-012020-12-310001099800us-gaap:PensionPlansDefinedBenefitMember2019-01-012019-12-310001099800us-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001099800us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:PensionPlansDefinedBenefitMember2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMember2018-01-012018-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanEquitySecuritiesMember2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanDebtSecurityMember2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanRealEstateMember2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:OtherInvestmentsMember2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Memberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel2Member2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel3Member2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel12And3Memberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember2020-12-310001099800us-gaap:DefinedBenefitPlanEquitySecuritiesUsMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2020-12-310001099800us-gaap:DefinedBenefitPlanEquitySecuritiesUsMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Member2020-12-310001099800us-gaap:DefinedBenefitPlanEquitySecuritiesUsMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel3Member2020-12-310001099800us-gaap:DefinedBenefitPlanEquitySecuritiesUsMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel12And3Member2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Memberus-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:FairValueInputsLevel2Member2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:FairValueInputsLevel3Member2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel12And3Memberus-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Memberus-gaap:USGovernmentDebtSecuritiesMember2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:USGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:USGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel12And3Memberus-gaap:USGovernmentDebtSecuritiesMember2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Memberus-gaap:ForeignGovernmentDebtSecuritiesMember2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Memberus-gaap:ForeignGovernmentDebtSecuritiesMember2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ForeignGovernmentDebtSecuritiesMember2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel12And3Memberus-gaap:ForeignGovernmentDebtSecuritiesMember2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Memberus-gaap:DefinedBenefitPlanRealEstateMember2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanRealEstateMemberus-gaap:FairValueInputsLevel2Member2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanRealEstateMemberus-gaap:FairValueInputsLevel3Member2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel12And3Memberus-gaap:DefinedBenefitPlanRealEstateMember2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Memberus-gaap:MortgagesMember2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:MortgagesMemberus-gaap:FairValueInputsLevel2Member2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:MortgagesMemberus-gaap:FairValueInputsLevel3Member2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel12And3Memberus-gaap:MortgagesMember2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Memberew:InsuranceContractsMember2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberew:InsuranceContractsMemberus-gaap:FairValueInputsLevel2Member2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberew:InsuranceContractsMemberus-gaap:FairValueInputsLevel3Member2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberew:InsuranceContractsMemberus-gaap:FairValueInputsLevel12And3Member2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Member2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel3Member2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel12And3Member2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2020-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Memberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel2Member2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel3Member2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel12And3Memberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember2019-12-310001099800us-gaap:DefinedBenefitPlanEquitySecuritiesUsMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2019-12-310001099800us-gaap:DefinedBenefitPlanEquitySecuritiesUsMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Member2019-12-310001099800us-gaap:DefinedBenefitPlanEquitySecuritiesUsMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel3Member2019-12-310001099800us-gaap:DefinedBenefitPlanEquitySecuritiesUsMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel12And3Member2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Memberus-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:FairValueInputsLevel2Member2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:FairValueInputsLevel3Member2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel12And3Memberus-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Memberus-gaap:USGovernmentDebtSecuritiesMember2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:USGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:USGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel12And3Memberus-gaap:USGovernmentDebtSecuritiesMember2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Memberus-gaap:ForeignGovernmentDebtSecuritiesMember2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Memberus-gaap:ForeignGovernmentDebtSecuritiesMember2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ForeignGovernmentDebtSecuritiesMember2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel12And3Memberus-gaap:ForeignGovernmentDebtSecuritiesMember2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Memberus-gaap:DefinedBenefitPlanRealEstateMember2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanRealEstateMemberus-gaap:FairValueInputsLevel2Member2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanRealEstateMemberus-gaap:FairValueInputsLevel3Member2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel12And3Memberus-gaap:DefinedBenefitPlanRealEstateMember2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Memberus-gaap:MortgagesMember2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:MortgagesMemberus-gaap:FairValueInputsLevel2Member2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:MortgagesMemberus-gaap:FairValueInputsLevel3Member2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel12And3Memberus-gaap:MortgagesMember2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Memberew:InsuranceContractsMember2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberew:InsuranceContractsMemberus-gaap:FairValueInputsLevel2Member2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberew:InsuranceContractsMemberus-gaap:FairValueInputsLevel3Member2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberew:InsuranceContractsMemberus-gaap:FairValueInputsLevel12And3Member2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Member2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel3Member2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel12And3Member2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberew:InsuranceContractsMemberus-gaap:FairValueInputsLevel3Member2018-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberew:InsuranceContractsMemberus-gaap:FairValueInputsLevel3Member2019-01-012019-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberew:InsuranceContractsMemberus-gaap:FairValueInputsLevel3Member2020-01-012020-12-310001099800country:US2020-01-012020-12-310001099800country:PR2020-01-012020-12-310001099800ew:NonqualifiedDeferredCompensationPlanSelectEmployeeGroupMember2020-12-310001099800ew:NonqualifiedDeferredCompensationPlanSelectEmployeeGroupMember2019-12-310001099800ew:May2019StockRepurchaseProgramMember2019-05-310001099800ew:April2018StockRepurchaseProgramMember2018-04-300001099800ew:April2018StockRepurchaseProgramMember2018-04-012018-04-300001099800ew:July2018StockRepurchaseProgramMember2018-07-012018-07-310001099800ew:AcceleratedShareRepurchaseAgreementsEnteredIntoOctober2018Member2018-10-310001099800ew:AcceleratedShareRepurchaseAgreementsEnteredIntoOctober2018Member2018-10-012018-10-310001099800ew:AcceleratedShareRepurchaseAgreementsEnteredIntoNovember2018Member2018-11-012018-11-300001099800ew:InitialDeliveryofSharesSettledMay2019Member2019-05-310001099800ew:InitialDeliveryofSharesSettledMay2019Member2019-05-012019-05-310001099800ew:May2019StockRepurchaseProgramSharesPurchasedAndSoldInMay2019Member2019-05-012019-05-310001099800ew:InitialDeliveryOfSharesSettledJune2019Member2019-05-310001099800ew:InitialDeliveryOfSharesSettledJune2019Member2019-05-012019-05-310001099800ew:May2019StockRepurchaseProgramSharesSoldInJune2019Member2019-06-012019-06-3000010998002020-05-292020-05-290001099800srt:MinimumMemberew:EmployeeAndNonemployeeStockOptionsMemberew:LongTermStockIncentiveCompensationProgramMember2020-01-012020-12-310001099800srt:MaximumMemberew:EmployeeAndNonemployeeStockOptionsMemberew:LongTermStockIncentiveCompensationProgramMember2020-01-012020-12-310001099800ew:EmployeeAndNonemployeeStockOptionsMemberew:LongTermStockIncentiveCompensationProgramMember2020-01-012020-12-310001099800srt:MinimumMemberus-gaap:RestrictedStockUnitsRSUMemberew:LongTermStockIncentiveCompensationProgramMember2020-01-012020-12-310001099800us-gaap:RestrictedStockUnitsRSUMembersrt:MaximumMemberew:LongTermStockIncentiveCompensationProgramMember2020-01-012020-12-310001099800ew:MarketBasedRestrictedStockUnitsMemberew:LongTermStockIncentiveCompensationProgramMember2020-01-012020-12-310001099800ew:LongTermStockIncentiveCompensationProgramMember2020-12-310001099800srt:MaximumMemberew:LongTermStockIncentiveCompensationProgramMemberew:RestrictedStockAndRestrictedStockUnitAwardsMember2020-12-310001099800ew:NonemployeeDirectorsStockIncentiveCompensationProgramMemberew:ShareBasedCompensationArrangementsAwardGrantedAnnuallyToNonemployeeDirectorMembersrt:MaximumMemberew:EmployeeAndNonemployeeStockOptionsMember2020-12-310001099800us-gaap:RestrictedStockUnitsRSUMemberew:NonemployeeDirectorsStockIncentiveCompensationProgramMemberew:ShareBasedCompensationArrangementsAwardGrantedAnnuallyToNonemployeeDirectorMembersrt:MaximumMember2020-12-310001099800ew:NonemployeeDirectorsStockIncentiveCompensationProgramMemberew:ShareBasedCompensationArrangementsAwardGrantedAnnuallyToNonemployeeDirectorMember2020-01-012020-12-310001099800ew:ShareBasedCompensationArrangementsAwardsGranted2012AndAfterMemberew:NonemployeeDirectorsStockIncentiveCompensationProgramMemberew:EmployeeAndNonemployeeStockOptionsMember2020-01-012020-12-310001099800ew:NonemployeeDirectorsStockIncentiveCompensationProgramMember2020-12-310001099800us-gaap:EmployeeStockMemberew:EmployeeStockPurchasePlanMember2020-01-012020-12-310001099800us-gaap:EmployeeStockMemberew:EmployeeStockPurchasePlanMember2020-12-310001099800us-gaap:EmployeeStockMemberus-gaap:SubsequentEventMemberew:EmployeeStockPurchasePlanMember2021-01-010001099800ew:EmployeeAndNonemployeeStockOptionsMember2020-01-012020-12-310001099800ew:EmployeeAndNonemployeeStockOptionsMember2019-01-012019-12-310001099800ew:EmployeeAndNonemployeeStockOptionsMember2018-01-012018-12-310001099800us-gaap:EmployeeStockMember2020-01-012020-12-310001099800us-gaap:EmployeeStockMember2019-01-012019-12-310001099800us-gaap:EmployeeStockMember2018-01-012018-12-310001099800ew:MarketBasedRestrictedStockUnitsMember2020-01-012020-12-310001099800ew:MarketBasedRestrictedStockUnitsMember2019-01-012019-12-310001099800ew:MarketBasedRestrictedStockUnitsMember2018-01-012018-12-310001099800ew:EmployeeAndNonemployeeStockOptionsMember2019-12-310001099800ew:EmployeeAndNonemployeeStockOptionsMember2020-12-310001099800us-gaap:RestrictedStockUnitsRSUMember2019-12-310001099800us-gaap:RestrictedStockUnitsRSUMember2020-12-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2017-12-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2017-12-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2017-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2017-12-310001099800srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccumulatedTranslationAdjustmentMember2017-12-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2017-12-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2017-12-310001099800srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2017-12-310001099800us-gaap:AccumulatedTranslationAdjustmentMembersrt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember2017-12-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMembersrt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember2017-12-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMembersrt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember2017-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMembersrt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember2017-12-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2018-01-012018-12-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2018-01-012018-12-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2018-01-012018-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2018-01-012018-12-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2018-12-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2018-12-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2018-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2018-12-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2019-01-012019-12-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2019-01-012019-12-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-01-012019-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-01-012019-12-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2019-12-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2019-12-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-12-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2020-01-012020-12-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-01-012020-12-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-01-012020-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-01-012020-12-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2020-12-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-12-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2020-01-012020-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2020-01-012020-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2019-01-012019-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2019-01-012019-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2018-01-012018-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2018-01-012018-12-310001099800us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedTranslationAdjustmentMember2020-01-012020-12-310001099800us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedTranslationAdjustmentMember2019-01-012019-12-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-01-012020-12-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2019-01-012019-12-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-01-012020-12-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2019-01-012019-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-01-012020-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2019-01-012019-12-310001099800ew:CarryforwardPeriodEnds20302037Membercountry:USus-gaap:DomesticCountryMember2020-12-310001099800country:USus-gaap:DomesticCountryMemberew:TaxCarryforwardsNoExpirationMember2020-12-310001099800country:USus-gaap:StateAndLocalJurisdictionMemberew:TaxCarryforwardsExpirationPeriodYears20262039Member2020-12-310001099800country:USus-gaap:StateAndLocalJurisdictionMemberew:TaxCarryforwardsNoExpirationMember2020-12-310001099800ew:TaxCarryforwardsExpirationPeriodYears20202027Memberus-gaap:ForeignCountryMemberus-gaap:NonUsMember2020-12-310001099800ew:TaxCarryforwardsNoExpirationMemberus-gaap:ForeignCountryMemberus-gaap:NonUsMember2020-12-310001099800country:USew:CapitalLossCarryforwardPeriodEnds2022Memberus-gaap:DomesticCountryMember2020-12-310001099800us-gaap:ResearchMemberus-gaap:StateAndLocalJurisdictionMemberew:TaxCarryforwardsNoExpirationMemberstpr:CA2020-12-310001099800us-gaap:ResearchMembercountry:USus-gaap:DomesticCountryMemberew:TaxCarryforwardsNoExpirationMember2020-12-310001099800country:PRew:PurchaseCreditMemberew:TaxCarryforwardsNoExpirationMemberus-gaap:ForeignCountryMember2020-12-310001099800country:PRew:PuertoRicoPurchasesCreditMemberew:TaxCarryforwardsNoExpirationMemberus-gaap:ForeignCountryMember2020-12-3100010998002017-01-012017-12-310001099800us-gaap:ForeignCountryMember2020-01-012020-12-310001099800us-gaap:ForeignCountryMember2019-01-012019-12-310001099800us-gaap:ForeignCountryMember2018-01-012018-12-31ew:lawsuit0001099800us-gaap:OperatingSegmentsMemberew:UnitedStatesSegmentMember2020-01-012020-12-310001099800us-gaap:OperatingSegmentsMemberew:UnitedStatesSegmentMember2019-01-012019-12-310001099800us-gaap:OperatingSegmentsMemberew:UnitedStatesSegmentMember2018-01-012018-12-310001099800ew:EuropeSegmentMemberus-gaap:OperatingSegmentsMember2020-01-012020-12-310001099800ew:EuropeSegmentMemberus-gaap:OperatingSegmentsMember2019-01-012019-12-310001099800ew:EuropeSegmentMemberus-gaap:OperatingSegmentsMember2018-01-012018-12-310001099800ew:JapanSegmentMemberus-gaap:OperatingSegmentsMember2020-01-012020-12-310001099800ew:JapanSegmentMemberus-gaap:OperatingSegmentsMember2019-01-012019-12-310001099800ew:JapanSegmentMemberus-gaap:OperatingSegmentsMember2018-01-012018-12-310001099800us-gaap:OperatingSegmentsMemberew:RestOfWorldSegmentMember2020-01-012020-12-310001099800us-gaap:OperatingSegmentsMemberew:RestOfWorldSegmentMember2019-01-012019-12-310001099800us-gaap:OperatingSegmentsMemberew:RestOfWorldSegmentMember2018-01-012018-12-310001099800us-gaap:OperatingSegmentsMember2020-01-012020-12-310001099800us-gaap:OperatingSegmentsMember2019-01-012019-12-310001099800us-gaap:OperatingSegmentsMember2018-01-012018-12-310001099800us-gaap:MaterialReconcilingItemsMember2020-01-012020-12-310001099800us-gaap:MaterialReconcilingItemsMember2019-01-012019-12-310001099800us-gaap:MaterialReconcilingItemsMember2018-01-012018-12-310001099800us-gaap:CorporateNonSegmentMember2020-01-012020-12-310001099800us-gaap:CorporateNonSegmentMember2019-01-012019-12-310001099800us-gaap:CorporateNonSegmentMember2018-01-012018-12-310001099800country:US2020-01-012020-12-310001099800country:US2019-01-012019-12-310001099800country:US2018-01-012018-12-310001099800srt:EuropeMember2020-01-012020-12-310001099800srt:EuropeMember2019-01-012019-12-310001099800srt:EuropeMember2018-01-012018-12-310001099800country:JP2020-01-012020-12-310001099800country:JP2019-01-012019-12-310001099800country:JP2018-01-012018-12-310001099800ew:RestOfWorldMember2020-01-012020-12-310001099800ew:RestOfWorldMember2019-01-012019-12-310001099800ew:RestOfWorldMember2018-01-012018-12-310001099800ew:TranscatheterAorticValveReplacementMember2020-01-012020-12-310001099800ew:TranscatheterAorticValveReplacementMember2019-01-012019-12-310001099800ew:TranscatheterAorticValveReplacementMember2018-01-012018-12-310001099800ew:TranscatheterMitralAndTricuspidTherapiesMember2020-01-012020-12-310001099800ew:TranscatheterMitralAndTricuspidTherapiesMember2019-01-012019-12-310001099800ew:TranscatheterMitralAndTricuspidTherapiesMember2018-01-012018-12-310001099800ew:SurgicalHeartValveTherapyMember2020-01-012020-12-310001099800ew:SurgicalHeartValveTherapyMember2019-01-012019-12-310001099800ew:SurgicalHeartValveTherapyMember2018-01-012018-12-310001099800ew:CriticalCareMember2020-01-012020-12-310001099800ew:CriticalCareMember2019-01-012019-12-310001099800ew:CriticalCareMember2018-01-012018-12-310001099800country:US2020-12-310001099800country:US2019-12-310001099800country:US2018-12-310001099800srt:EuropeMember2020-12-310001099800srt:EuropeMember2019-12-310001099800srt:EuropeMember2018-12-310001099800country:JP2020-12-310001099800country:JP2019-12-310001099800country:JP2018-12-310001099800ew:RestOfWorldMember2020-12-310001099800ew:RestOfWorldMember2019-12-310001099800ew:RestOfWorldMember2018-12-3100010998002020-01-012020-03-3100010998002020-04-012020-06-3000010998002020-07-012020-09-3000010998002020-10-012020-12-310001099800srt:MaximumMember2020-01-012020-03-310001099800srt:MaximumMember2020-04-012020-06-300001099800srt:MaximumMember2020-07-012020-09-300001099800srt:MaximumMember2020-10-012020-12-310001099800srt:MinimumMember2020-01-012020-03-310001099800srt:MinimumMember2020-04-012020-06-300001099800srt:MinimumMember2020-07-012020-09-300001099800srt:MinimumMember2020-10-012020-12-3100010998002019-01-012019-03-3100010998002019-04-012019-06-3000010998002019-07-012019-09-3000010998002019-10-012019-12-310001099800srt:MaximumMember2019-01-012019-03-310001099800srt:MaximumMember2019-04-012019-06-300001099800srt:MaximumMember2019-07-012019-09-300001099800srt:MaximumMember2019-10-012019-12-310001099800srt:MaximumMember2019-01-012019-12-310001099800srt:MinimumMember2019-01-012019-03-310001099800srt:MinimumMember2019-04-012019-06-300001099800srt:MinimumMember2019-07-012019-09-300001099800srt:MinimumMember2019-10-012019-12-310001099800srt:MinimumMember2019-01-012019-12-310001099800us-gaap:DevelopedTechnologyRightsMemberew:ValtechCardioLtdMember2020-10-012020-12-310001099800us-gaap:AllowanceForCreditLossMember2019-12-310001099800us-gaap:AllowanceForCreditLossMember2020-01-012020-12-310001099800us-gaap:AllowanceForCreditLossMember2020-12-310001099800us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2019-12-310001099800us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2020-01-012020-12-310001099800us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2020-12-310001099800us-gaap:AllowanceForCreditLossMember2018-12-310001099800us-gaap:AllowanceForCreditLossMember2019-01-012019-12-310001099800us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2018-12-310001099800us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2019-01-012019-12-310001099800us-gaap:AllowanceForCreditLossMember2017-12-310001099800us-gaap:AllowanceForCreditLossMember2018-01-012018-12-310001099800us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2017-12-310001099800us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2018-01-012018-12-310001099800us-gaap:SubsequentEventMemberew:February2021StockRepurchaseProgramMember2021-02-120001099800us-gaap:SubsequentEventMemberew:February2021StockRepurchaseProgramMember2021-02-012021-02-12
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
(Mark One)
☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Fiscal Year Ended December 31, 2020
OR
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Transition Period From            to
Commission File Number 1-15525
EDWARDS LIFESCIENCES CORPORATION
(Exact name of registrant as specified in its charter)
Delaware36-4316614
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
One Edwards WayIrvineCalifornia92614
(Address of Principal Executive Offices)(Zip Code)
(949) 250-2500
Registrant's telephone number, including area code
Securities registered pursuant to Section 12(b) of the Act: 
Title of each classTrading Symbols(s)Name of each exchange on which registered:
Common Stock, par value $1.00 per shareEWNew York Stock Exchange
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined by Rule 405 of the Securities Act.    Yes ☒ No ☐
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Exchange Act.    Yes ☐ No ☒
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes ý No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☒
Accelerated filer
☐
Non-accelerated filer
☐
Smaller reporting company
☐
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report ☒. 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes ☐ No ý
The aggregate market value of the registrant's common stock held by non-affiliates as of June 30, 2020 (the last trading day of the registrant's most recently completed second quarter): $42,640,586,293 based on the closing price of the registrant's common stock on the New York Stock Exchange. This calculation does not reflect a determination that persons are affiliates for any other purpose.
The number of shares outstanding of the registrant's common stock, $1.00 par value, as of January 31, 2021, was 624,518,873.
Documents Incorporated by Reference
Portions of the registrant's proxy statement for the 2021 Annual Meeting of Stockholders (to be filed within 120 days of December 31, 2020) are incorporated by reference into Part III, as indicated herein.

EDWARDS LIFESCIENCES CORPORATION
Form 10-K Annual Report—2020
Table of Contents

  
  
  
  


PART I

NOTE REGARDING FORWARD-LOOKING STATEMENTS
This report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. We intend the forward-looking statements contained in this report to be covered by the safe harbor provisions of such Acts. Some statements other than statements of historical fact in this report or referred to or incorporated by reference into this report are "forward-looking statements" for purposes of these sections. These statements include, among other things, the expected impact of COVID-19 on our business, any predictions, opinions, expectations, plans, strategies, objectives and any statements of assumptions underlying any of the foregoing relating to the company's current and future business and operations, including, but not limited to, financial matters, development activities, clinical trials and regulatory matters, manufacturing and supply operations, and product sales and demand. These statements can sometimes be identified by the use of the forward-looking words such as "may," "believe," "will," "expect," "project," "estimate," "should," "anticipate," "plan," "goal," "continue," "seek," "pro forma," "forecast," "intend," "guidance," "optimistic," "aspire," "confident," other forms of these words or similar words or expressions or the negative thereof. Statements of past performance, efforts, or results about which inferences or assumptions may be made can also be forward-looking statements and are not indicative of future performance or results; these statements can be identified by the use of words such as "preliminary," "initial," diligence," "industry-leading," "compliant," "indications," or "early feedback" or other forms of these words or similar words or expressions or the negative thereof. These forward-looking statements are subject to substantial risks and uncertainties that could cause our results or future business, financial condition, results of operations or performance to differ materially from our historical results or experiences or those expressed or implied in any forward-looking statements contained in this report. These risks and uncertainties include, but are not limited to: uncertainties regarding the severity and duration of the COVID-19 pandemic and its impact on our business and the economy generally, clinical trial or commercial results or new product approvals and therapy adoption; inability or failure to comply with regulations; unpredictability of product launches; competitive dynamics; changes to reimbursement for the company's products; the company’s success in developing new products and avoiding manufacturing and quality issues; the impact of currency exchange rates; the timing or results of research and development and clinical trials; unanticipated actions by the U.S. Food and Drug Administration and other regulatory agencies; unexpected litigation impacts or expenses; and other risks detailed under "Risk Factors" in Part I, Item 1A below, as such risks and uncertainties may be amended, supplemented or superseded from time to time by our subsequent reports on Forms 10-Q and 8-K we file with the Securities and Exchange Commission. These forward-looking statements speak only as of the date on which they are made and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of the statement. If we do update or correct one or more of these statements, investors and others should not conclude that we will make additional updates or corrections.

Unless otherwise indicated or otherwise required by the context, the terms "we," "our," "it," "its," "Company," "Edwards," and "Edwards Lifesciences" refer to Edwards Lifesciences Corporation and its subsidiaries.

1
Item 1.    Business
       
Overview

Edwards Lifesciences Corporation is the global leader in patient-focused medical innovations for structural heart disease and critical care monitoring. Driven by a passion to help patients, we partner with the world’s leading clinicians and researchers and invest in research and development to transform care for those impacted by structural heart disease or who require hemodynamic monitoring during surgery or in intensive care. Edwards Lifesciences has been a leader in these areas for over six decades. Since our founder, Lowell Edwards, first dreamed of using engineering to address diseases of the human heart, we have steadily built a company on the premise of imagining, building, and realizing a better future for patients.

A pioneer in the development of heart valve therapies, we are the world's leading manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. Our innovative work in heart valves encompasses both surgical and transcatheter therapies for heart valve replacement and repair. In addition, our robust pipeline of future technologies is focused on the less invasive repair or replacement of the mitral and tricuspid valves of the heart, which are more complex and more challenging to treat than the aortic valve that is currently the focus of many of our commercially approved valve technologies. We are also a global leader in hemodynamic and noninvasive brain and tissue oxygenation monitoring systems used to measure a patient's cardiovascular function in the hospital setting.

Cardiovascular disease is the number-one cause of death in the world, and is the top disease in terms of health care spending in nearly every country. Cardiovascular disease is progressive in that it tends to worsen over time and often affects the structure of an individual's heart.

Patients undergoing treatment for cardiovascular disease can be treated with a number of our medical technologies, which are designed to address individual patient needs with respect to disease process, comorbidities, and health status. For example, an individual with a heart valve disorder may have a faulty valve that is affecting the function of his or her heart or blood flow throughout his or her body. A clinician may elect to remove the valve and replace it with one of our bioprosthetic surgical tissue heart valves or surgically re-shape and repair the faulty valve with an Edwards Lifesciences annuloplasty ring. Alternatively, a clinician may implant an Edwards Lifesciences transcatheter valve or repair system via a catheter-based approach that does not require traditional open-heart surgery and can be done while the heart continues to beat. Patients in the hospital setting, including high-risk patients in the operating room or intensive care unit, are candidates for having their cardiac function or fluid levels monitored by our Critical Care products through multiple monitoring options, including noninvasive and minimally invasive technologies. These technologies enable proactive clinical decisions while also providing the opportunity for improving diagnoses and developing individualized therapeutic management plans for patients.

Corporate Background

Edwards Lifesciences Corporation was incorporated in Delaware on September 10, 1999.

Our principal executive offices are located at One Edwards Way, Irvine, California 92614. The telephone number at that address is (949) 250-2500. We make available, free of charge on our website located at www.edwards.com, our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and any amendments to those reports, as soon as reasonably practicable after filing such reports with the Securities and Exchange Commission ("SEC"). The contents of our website are not incorporated by reference into this report.

Edwards Lifesciences' Product and Technology Offerings

The following discussion summarizes the main areas of products and technologies we offer to treat advanced cardiovascular disease. Our products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. For more information on net sales from these four main areas, see "Net Sales by Product Group" in Part II, Item 7 "Management's Discussion and Analysis of Financial Condition and Results of Operations."

Transcatheter Aortic Valve Replacement

We are the global leader in transcatheter heart valve replacement technologies designed for the minimally invasive replacement of heart valves. The Edwards SAPIEN family of valves, including Edwards SAPIEN XT, the Edwards SAPIEN 3, and the Edwards SAPIEN 3 Ultra transcatheter aortic heart valves, and their respective delivery systems, are used to treat heart valve disease using catheter-based approaches for patients who have severe symptomatic aortic stenosis and certain patients
2
with congenital heart disease. Delivered while the heart is beating, these valves can enable patients to experience a better quality of life sooner than patients receiving traditional surgical therapies. We began offering our transcatheter heart valves to patients commercially in Europe in 2007, in the United States in 2011, and in Japan in 2013. Supported by extensive customer training and service, and a growing body of compelling clinical evidence, our SAPIEN family of transcatheter aortic heart valves are the most widely prescribed transcatheter heart valves in the world.

Sales of our transcatheter aortic valve replacement products represented 65%, 63%, and 61% of our net sales in 2020, 2019, and 2018, respectively.

Transcatheter Mitral and Tricuspid Therapies

We are making significant investments in the development of transcatheter heart valve repair and replacement technologies designed to treat mitral and tricuspid valve diseases. While many of these technologies are in early development and clinical phases, the PASCAL transcatheter valve repair system and the Cardioband systems for mitral and tricuspid valve repair are commercially available in Europe. The PASCAL system provides a differentiated, minimally-invasive therapy to address the needs of patients with mitral or tricuspid regurgitation through leaflet approximation, while the Cardioband system enables clinicians to restore a patient’s mitral or tricuspid valve to a more functional state by reducing the annulus and lowering regurgitation. In addition to transcatheter repair, we believe transcatheter replacement is key to unlocking the full mitral and tricuspid opportunity, given the complex and diverse patient population. Our two-platform strategy positions us for leadership in the mid-to-long term. SAPIEN M3 is based on the proven SAPIEN valve, paired with a novel docking system. We are also continuing to advance our EVOQUE platform for both mitral and tricuspid replacement. Both SAPIEN M3 and EVOQUE transfemoral delivery systems are sub 30-French, which has benefits for femoral puncture and septal crossing, contributing to ease of use, and patient safety.

Surgical Structural Heart

The core of our surgical tissue heart valve product line is the Carpentier-Edwards PERIMOUNT pericardial valve platform, including the line of PERIMOUNT Magna Ease pericardial valves for aortic and mitral surgical valve replacement. With more long-term clinical publications on durability and performance than any other surgical valve, PERIMOUNT valves are the most widely implanted surgical tissue heart valves in the world.  Our latest innovation, the INSPIRIS RESILIA aortic valve, is built on our PERIMOUNT platform and offers RESILIA tissue and VFit technology. INSPIRIS is now the leading aortic surgical valve in the world. In addition to our replacement valves, we are the worldwide leader in surgical heart valve repair therapies. In 2020, we launched the HARPOON Beating Heart Mitral Valve Repair System, which can help transform care for many patients with degenerative mitral regurgitation. We are also a global leader in cardiac cannula devices and offer a variety of procedure-enabling innovations that advance minimally invasive surgery. We believe the demand for surgical structural heart therapies is growing worldwide and that our innovation strategy will continue to extend our leadership and patient impact.

Sales of our surgical tissue heart valve products represented 16%, 17%, and 18% of our net sales in 2020, 2019, and 2018, respectively.

Critical Care

We are a world leader in hemodynamic monitoring systems used to measure a patient's heart function and fluid status in surgical and intensive care settings. Hemodynamic monitoring plays an important role in enhancing surgical recovery. Edwards’ complete hemodynamic portfolio helps clinicians make proactive clinical decisions that can improve patient outcomes, and includes the minimally invasive FloTrac system, the noninvasive ClearSight system, and ForeSight, the noninvasive tissue oximetry system. We also support clinical needs with our well-established Swan-Ganz line of pulmonary artery catheters, arterial pressure monitoring products, and Edwards Oximetry Central Venous Catheters. In conjunction with our sensors, our HemoSphere monitoring platforms display valuable physiological information in an easy to understand and actionable manner. Amplifying our sensor and monitoring platform portfolio is the addition of our first predictive algorithm, Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure.

Sales of our core hemodynamic products represented 9%, 9%, and 10% of our net sales in 2020, 2019, and 2018, respectively.

Competition

The medical technology industry is highly competitive. We compete with many companies, including divisions of companies much larger than us and smaller companies that compete in specific product lines or certain geographies.
3
Furthermore, new product development and technological change characterize the areas in which we compete. Our present or future products could be rendered obsolete or uneconomical as a result of technological advances by one or more of our present or future competitors or by other therapies, including drug therapies. We must continue to develop and commercialize new products and technologies to remain competitive in the cardiovascular medical technology industry. We believe that we are competitive primarily because we deliver superior clinical outcomes that are supported by extensive data, and innovative features that enhance patient benefit, product performance, and reliability; these superior clinical outcomes are in part due to the level of customer and clinical support we provide.

The cardiovascular segment of the medical technology industry is dynamic and subject to significant change due to cost-of-care considerations, regulatory reform, industry and customer consolidation, and evolving patient needs. The ability to provide products and technologies that demonstrate value and improve clinical outcomes is becoming increasingly important for medical technology manufacturers.
    
We believe that we are a leading global competitor in each of our product lines. In Transcatheter Aortic Valve Replacement, our primary competitors include Medtronic PLC and Abbott Laboratories ("Abbott"). In Transcatheter Mitral and Tricuspid Therapies, our primary competitor is Abbott, and there are a considerable number of large and small companies with development efforts in these fields. In Surgical Structural Heart, our primary competitors include Medtronic PLC, Abbott, and CryoLife. In Critical Care, we compete primarily with a variety of companies in specific product lines including ICU Medical, Inc., PULSION Medical Systems SE, a subsidiary of Getinge AB, Cheetah Medical, Inc., a subsidiary of Baxter International, and LiDCO Group PLC, now part of Masimo.

Sales and Marketing

Our portfolio includes some of the most recognizable cardiovascular device product brands in treating structural heart disease today. We have a number of product lines that require sales and marketing strategies tailored to deliver high-quality, cost-effective products and technologies to customers worldwide. Because of the diverse global needs of the population that we serve, our distribution system consists of several direct sales forces as well as independent distributors. We are not dependent on any single customer and no single customer accounted for 10% or more of our net sales in 2020.

To ensure optimal outcomes for patients, we conduct educational symposia and best practices training for our physician, hospital executive, service line leadership, nursing, and clinical-based customers. We rely extensively on our sales and field clinical specialist personnel who work closely with our customers in hospitals. Field clinical specialists routinely attend procedures where Edwards' products are being used in order to provide guidance on the use of our devices, thereby enabling physicians and staff to reach expert proficiency and deliver positive patient outcomes. Our customers include physicians, nurses, and other clinical personnel, but can also include decision makers such as service line leaders, material managers, biomedical staff, hospital administrators and executives, purchasing managers, and ministries of health. Also, for certain of our product lines and where appropriate, our corporate sales team actively pursues approval of Edwards Lifesciences as a qualified supplier for hospital group purchasing organizations ("GPOs") that negotiate contracts with suppliers of medical products. Additionally, we have contracts with a number of United States and European national and regional buying groups, including healthcare systems and Integrated Delivery Networks. Where we choose to market our products is also influenced by the existence of, or potential for, adequate reimbursement to hospitals and other providers by national healthcare systems.

United States.    In the United States, we sell substantially all of our products through our direct sales forces. In 2020, 57% of our net sales were derived from sales to customers in the United States.

International.    In 2020, 43% of our net sales were derived internationally through our direct sales forces and independent distributors. Of the total international sales, 52% were in Europe, 25% were in Japan, and 23% were in Rest of World. We sell our products in approximately 100 countries, and our major international markets include Canada, China, France, Germany, Italy, Japan, and the United Kingdom. A majority of the sales and marketing approach outside the United States is direct sales, although it varies depending on each country's size and state of development.

Raw Materials and Manufacturing

We operate manufacturing facilities in various geographies around the world. We manufacture our Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid technologies, and Structural Surgical Heart products primarily in the United States (California and Utah), Singapore, Costa Rica, and Ireland. We manufacture our Critical Care products primarily in our facilities located in Puerto Rico and the Dominican Republic.

4
We use a diverse and broad range of raw and organic materials in the design, development, and manufacture of our products. We manufacture our non-implantable products from fabricated raw materials including resins, chemicals, electronics, and metals. Most of our replacement heart valves are manufactured from natural tissues harvested from animal tissue, as well as fabricated materials. We purchase certain materials and components used in manufacturing our products from external suppliers. In addition, we purchase certain supplies from single sources for reasons of sole source availability or constraints resulting from regulatory requirements.

We work with our suppliers to mitigate risk and seek continuity of supply while maintaining quality and reliability. Alternative supplier options are generally considered, identified, and approved for materials deemed critical to our products, although we do not typically pursue immediate regulatory qualification of alternative sources due to the strength of our existing supplier relationships and the time and expense associated with the regulatory validation process.

We comply with all current global guidelines regarding risks for products incorporating animal tissue intended to be implanted in humans. We follow rigorous sourcing and manufacturing procedures intended to safeguard humans from potential risks associated with diseases such as bovine spongiform encephalopathy ("BSE"). We obtain bovine tissue used in our pericardial tissue valve products only from sources within the United States and Australia, where strong control measures and surveillance programs exist. In addition, bovine tissue used in our pericardial tissue valve products is from tissue types considered by global health and regulatory organizations to have shown no risk of infectibility. Our manufacturing and sterilization processes are designed to render tissue biologically safe from all known infectious agents and viruses.

Quality Assurance

We are committed to providing to our patients quality products and have implemented modern quality systems and concepts throughout the organization. The quality system starts with the initial design concept, risk management, and product specification, and continues through the design of the product, packaging and labeling, and the manufacturing, sales, support, and servicing of the product. The quality system is intended to design quality into the products and utilizes continuous improvement concepts, including Lean/Six Sigma principles, throughout the product lifecycle.

Our operations are frequently inspected by the many regulators that oversee medical device manufacturing, including the United States Food and Drug Administration ("FDA"), European Notified Bodies, and other regulatory entities. The medical technology industry is highly regulated and our facilities and operations are designed to comply with all applicable quality systems standards, including the International Organization for Standardization ("ISO") 13485. These standards require, among other items, quality system controls that are applied to product design, component material, suppliers, and manufacturing operations. These regulatory approvals and ISO certifications can be obtained only after a successful audit of a company's quality system has been conducted by regulatory or independent outside auditors. Periodic reexamination by an independent outside auditor is required to maintain these certifications.

Environmental, Health, and Safety

We are committed to providing a safe and healthy workplace and complying with all relevant regulations and medical technology industry standards. Through our corporate and site level Environmental, Health, and Safety functions, we establish and monitor programs to reduce pollution, prevent injuries, and maintain compliance with applicable regulations. In order to measure performance, we monitor and report on a number of metrics, including regulated and non-regulated waste disposal, energy usage, water consumption, air toxic emissions, and injuries from our production activities. Each of our manufacturing sites is evaluated regularly with respect to a broad range of Environmental, Health, and Safety criteria.

Research and Development

In 2020, we made significant investments in research and development as we worked to develop therapies that we believe have the potential to change the practice of medicine. Research and development spending increased 1% year over year to 17% of 2020 sales. This increase was primarily the result of significant investments in our transcatheter structural heart programs, including an increase in clinical research for our mitral and tricuspid therapies business. We are engaged in ongoing research and development to deliver clinically advanced new products, to enhance the effectiveness, ease of use, safety, and reliability of our current leading products, and to expand the applications of our products as appropriate. We focus on opportunities within specific areas of structural heart disease and critical care monitoring.

A considerable portion of our research and development investment includes clinical trials and the collection of evidence that provide data for use in regulatory submissions, and required post-market approval studies involving applications of our
5
products. Our investment in clinical studies also includes outcomes and cost-effectiveness data for payers, clinicians, and healthcare systems.

In Transcatheter Aortic Valve Replacement, we are developing new products to further improve and streamline transcatheter aortic heart valve replacement procedures, and developing pulmonic platforms to expand therapies for congenital heart disease patients.

In Transcatheter Mitral and Tricuspid Therapies, we are making significant investments in innovation and clinical evidence to develop technologies designed to treat mitral and tricuspid valve diseases. In addition to our internally developed programs, we have made investments in several companies that are independently developing minimally-invasive technologies to treat structural heart diseases.

Our Surgical Structural Heart development programs include innovative platforms for patients who are best treated surgically, specifically active patients and patients with more complex combined procedures.

In our Critical Care product line, we are pursuing the development of a variety of decision support solutions for our clinicians.  This includes next-generation noninvasive and minimally-invasive hemodynamic monitoring systems, and a next-generation monitor platform.  We are also developing a decision support software suite with advanced algorithms for proactive hemodynamic management, including a semi-closed loop system for standardized management of patient fluid levels. Lastly, we are developing a connectivity platform that will offer clinicians additional clinical support, remote monitoring capability, analytics, and insights for their patients’ hemodynamic status.

Our research and development activities are conducted primarily in facilities located in the United States and Israel. Our experienced research and development staff are focused on product design and development, quality, clinical research, and regulatory compliance. To pursue primary research efforts, we have developed alliances with several leading research institutions and universities, and also work with leading clinicians around the world in conducting scientific studies on our existing and developing products.

Proprietary Technology

Patents, trademarks, and other proprietary rights are important to the success of our business. We also rely upon trade secrets, know-how, continuing innovations, licensing opportunities, and non-disclosure agreements to develop and maintain our competitive position.

We own or have rights to a substantial number of patents and have patent applications pending both in the U.S. and in foreign countries. We continue to innovate and file new patent applications to protect the full range of our products and technologies.

Additionally, we are a party to numerous license agreements with various third parties pursuant to which we have obtained, for varying terms, the exclusive or non-exclusive rights to certain patents held by such third parties in consideration for cross-licensing rights and/or royalty payments. We have also licensed certain patent rights to others.

We undertake reasonable measures to protect our patent rights, including monitoring the products of our competitors for possible infringement of our owned and licensed patents. Litigation has been necessary to enforce certain patent rights held by us, and we plan to continue to defend and prosecute our rights with respect to such patents.

Moreover, we own certain U.S. registered trademarks used in our business. Many of our trademarks have also been registered for use in certain foreign countries where registration is available and where we have determined it is commercially advantageous to do so.

Government Regulation and Other Matters

Our products and facilities are subject to regulation by numerous government agencies, including the U.S. FDA, European Union Member States competent authorities, and the Japanese Pharmaceuticals and Medical Devices Agency, to confirm compliance with the various laws and regulations governing the development, testing, manufacturing, labeling, marketing, and distribution of our products. We are also governed by federal, state, local, and international laws of general applicability, such as those regulating employee health and safety, and the protection of the environment. Overall, the amount and scope of domestic and foreign laws and regulations applicable to our business has increased over time. Compliance with these regulations has not had a material effect on our capital expenditures, earnings, or competitive position to date, but new
6
regulations or amendments to existing regulations to make them more stringent could have such an effect in the future. We cannot estimate the expenses we may incur to comply with potential new laws or changes to existing laws, or the other potential effects these laws may have on our business.

United States Regulation.    In the United States, the FDA has responsibility for regulating medical devices. The FDA regulates design, development, testing, clinical studies, manufacturing, labeling, promotion, and record keeping for medical devices, and reporting of adverse events, recalls, or other field actions by manufacturers and users to identify potential problems with marketed medical devices. Many of the devices that we develop and market are in a category for which the FDA has implemented stringent clinical investigation and pre-market clearance or approval requirements. The process of obtaining FDA clearance or approval to market a product is resource intensive, lengthy, and costly. FDA review may involve substantial delays that adversely affect the marketing and sale of our products. A number of our products are pending regulatory clearance or approval to begin commercial sales in various markets. Ultimately, the FDA may not authorize the commercial release of a medical device if it determines the device is not safe and effective or does not meet other regulatory standards. Additionally, even if a product is cleared or approved, the FDA may impose restrictions or require testing and surveillance programs to monitor the effects of these products once commercialized.

The FDA has the authority to halt the distribution of certain medical devices, detain or seize adulterated or misbranded medical devices, order the repair, replacement, or refund of the costs of such devices, or preclude the importation of devices that are or appear violative. The FDA also conducts inspections to determine compliance with the quality system regulations concerning the manufacturing and design of devices and current medical device reporting regulations, recall regulations, clinical testing regulations, and other requirements. The FDA may withdraw product clearances or approvals due to failure to comply with regulatory standards, or the occurrence of unforeseen problems following initial approval, and require notification of health professionals and others with regard to medical devices that present unreasonable risks of substantial harm to the public health. Additionally, the failure to comply with FDA or comparable regulatory standards or the discovery of previously unknown product problems could result in fines, delays, suspensions or withdrawals of regulatory clearances or approvals, seizures, injunctions, recalls, refunds, civil money penalties, or criminal prosecution. Our compliance with applicable regulatory requirements is subject to continual review. Moreover, the FDA and several other United States agencies administer controls over the export of medical devices from the United States and the import of medical devices into the United States, which could also subject us to sanctions for noncompliance.

We are also subject to additional laws and regulations that govern our business operations, products, and technologies, including:

•federal, state, and foreign anti-kickback laws and regulations, which generally prohibit payments to anyone, including physicians as an inducement to purchase or recommend a product;

•the Stark law, which prohibits physicians from referring Medicare or Medicaid patients to a provider that bills these programs for the provision of certain designated health services if the physician (or a member of the physician's immediate family) has a financial relationship with that provider;

•federal and state laws and regulations that protect the confidentiality of certain patient health information, including patient records, and restrict the use and disclosure of such information, in particular, the Health Insurance Portability and Accountability Act of 1996;

•the Physician Payments Sunshine Act, which requires public disclosure of the financial relationships of United States physicians and teaching hospitals with applicable manufacturers, including medical device, pharmaceutical, and biologics companies;

•the False Claims Act, which prohibits the submission of false or otherwise improper claims for payment to a federally funded health care program, and health care fraud statutes that prohibit false statements and improper claims to any third-party payor; and

•the United States Foreign Corrupt Practices Act, which can be used to prosecute United States companies for arrangements with foreign government officials or other parties, or for not keeping accurate financial records or maintaining adequate internal controls to prevent and detect arrangements with foreign government officials or other parties.

Failure to comply with these laws and regulations could result in criminal liability, significant fines or penalties, negative publicity, and substantial costs and expenses associated with investigation and enforcement activities. To assist in our
7
compliance efforts, we work to adhere to many codes of ethics and conduct regarding our business activities in the United States and other countries in which we operate. In addition, we have in place a dedicated team to improve our internal business compliance programs and policies.

International Regulation.    Internationally, the regulation of medical devices is complex. In Europe, our products are subject to extensive regulatory requirements. The regulatory regime in the European Union for medical devices became mandatory in June 1998. It requires that medical devices may only be placed on the market if they do not compromise safety and health when properly installed, maintained, and used in accordance with their intended purpose. National laws conforming to the European Union's legislation regulate our products under the medical devices regulatory system. Although the more variable national requirements under which medical devices were formerly regulated have been substantially replaced by the European Union Medical Devices Directive, individual nations can still impose unique requirements that may require supplemental submissions. The European Union medical device laws require manufacturers to declare that their products conform to the essential regulatory requirements after which the products may be placed on the market bearing the CE Mark. Manufacturers' quality systems for products in all but the lowest risk classification are also subject to certification and audit by an independent notified body. In Europe, particular emphasis is being placed on more sophisticated and faster procedures for the reporting of adverse events to the competent authorities.

In May 2017, the European Union (the "EU") implemented a new regulatory scheme for medical devices under the Medical Device Regulation ("MDR"). The MDR becomes fully effective in 2021 and will bring significant new requirements for many medical devices, including enhanced requirements for clinical evidence and documentation, increased focus on device identification and traceability, new definitions and registration of economic operators throughout the distribution chain, and additional post-market surveillance and vigilance. Compliance with the MDR requires re-certification of many of our products to the enhanced standards, and has resulted in and will continue to result in substantial additional expense. In addition, in the EU, we import some of our devices through our offices in Switzerland. Switzerland is not a member state of the EU, but is linked to the EU through bilateral treaties; therefore, the free movement of goods, including medical devices, between the EU and Switzerland after implementation of the MDR requires a revised Mutual Recognition Agreement ("MRA"), which continues to be under negotiation for the MDR. If an MRA covering the MDR is not put in place, then non-EU manufacturers may be required to make significant changes, including replacement of Swiss economic operators with operators based in EU Member States, and changes will need to be made to our device labeling and/or packaging to satisfy MDR requirements. If these measures are unable to be taken, it may no longer be possible to place such devices on the EU market.

In Japan, pre-market approval and clinical studies are required as is governmental pricing approval for medical devices. Clinical studies are subject to a stringent Japanese "Good Clinical Practices" standard. Approval time frames from the Japanese Ministry of Health, Labour and Welfare vary from simple notifications to review periods of one or more years, depending on the complexity and risk level of the device. In addition, importation of medical devices into Japan is subject to the "Good Import Practices" regulations. As with any highly regulated market, significant changes in the regulatory environment could adversely affect future sales.

In many of the other foreign countries in which we market our products, we may be subject to regulations affecting, among other things:

•product standards and specifications;

•packaging requirements;

•labeling requirements;

•product collection and disposal requirements;

•quality system requirements;

•import restrictions;

•tariffs;

•duties; and

•tax requirements.

8
Many of the regulations applicable to our devices and products in these countries are similar to those of the FDA. In some regions, the level of government regulation of medical devices is increasing, which can lengthen time to market and increase registration and approval costs. In many countries, the national health or social security organizations require our products to be qualified before they can be marketed and considered eligible for reimbursement.

Health Care Initiatives.    Government and private sector initiatives to limit the growth of health care costs, including price regulation and competitive pricing, coverage and payment policies, comparative effectiveness reviews, technology assessments, increasing evidentiary demands, and managed-care arrangements, are continuing in many countries where we do business, including the United States, Europe, and Japan. As a result of these changes, the marketplace has placed increased emphasis on the delivery of more cost-effective medical therapies. For example, government programs, private health care insurance, and managed-care plans have attempted to control costs by restricting coverage and limiting the level of reimbursement for procedures or treatments, and some third-party payors require their pre-approval before new or innovative devices or therapies are utilized by patients. These various initiatives have created increased price sensitivity over medical products generally and may impact demand for our products and technologies.

The delivery of our products is subject to regulation by the United States Department of Health and Human Services ("HHS") and comparable state and foreign agencies responsible for reimbursement and regulation of health care items and services. Foreign governments also impose regulations in connection with their health care reimbursement programs and the delivery of health care items and services. Reimbursement schedules regulate the amount the United States government will reimburse hospitals and doctors for the inpatient care of persons covered by Medicare. HHS' Centers for Medicare & Medicaid Services ("CMS") may also review whether and/or under what circumstances a procedure or technology is reimbursable for Medicare beneficiaries. Changes in current coverage and reimbursement levels could have an adverse effect on market demand and our pricing flexibility. The CMS National Coverage Determination for Transcatheter Aortic Valve Replacement was issued in June 2019.  The modernized requirements and more streamlined patient evaluation process are meaningful enhancements that may help ensure equitable access for more patients suffering from severe aortic stenosis.

Health care cost containment efforts have also prompted domestic hospitals and other customers of medical device manufacturers to consolidate into larger purchasing groups to enhance purchasing power. The medical technology industry has also experienced some consolidation, partly in order to offer a broader range of products to large purchasers. As a result, transactions with customers are larger, more complex, and tend to involve more long-term contracts than in the past. These larger customers, due to their enhanced purchasing power, may have a material impact on product pricing.

These laws or any future legislation, including deficit reduction legislation, could impact medical procedure volumes, reimbursement for our products, and demand for our products or the prices at which we sell our products.

Seasonality

Our quarterly net sales are influenced by many factors, including new product introductions, acquisitions, regulatory approvals, patient and physician holiday schedules, and other factors. Net sales in the third quarter are typically lower than other quarters of the year due to the seasonality of the United States and European markets, where summer vacation schedules normally result in fewer medical procedures.

Human Capital Management Strategy

Human Capital Management ("HCM") Governance

Attracting, developing, and retaining talent is fundamental to our success. The primary goals of our talent management strategy are to attract and maintain a motivated, professional workforce and to ensure alignment on our patient-focused innovation strategy.

Our Board of Directors has oversight over human capital management with time dedicated at each regularly scheduled meeting to discuss talent management, including, among other things, talent strategy, diversity, succession planning, employee development, employee health, safety, and welfare, results of employee surveys, and compensation. The Board of Directors also approves Key Operating Drivers, which are strategic milestones that include financial objectives and are tracked using a point system across our entire organization, that focus the Company and management toward short, medium, and long-term goals that align with our talent management strategy. In addition, the Chief Executive Officer ("CEO") has talent management related performance goals tied to his compensation; these Performance Management Objectives are tracked and, then, reported to and evaluated by our Board of Directors.
9
Our HCM governance includes a global talent development review ("TDR") process as well as an HCM dashboard. The purpose of our TDR process is to align our business strategy with talent strategies, assess talent against future organizational needs, evaluate critical talent populations, and enhance the strength of our succession planning. Our HCM dashboard is generated quarterly and provides insights on key metrics related to areas such as attraction and growth rates, retention trends, diversity, and employee sentiment.

Culture

Investing in our workforce means our employees can stay focused on our patient-focused innovation strategy and the development of life-saving therapies for the patients we serve. We are committed to maintaining a culture where we celebrate diversity, ensure that employees' voices are heard, and promote good health and safety. We strive to offer competitive employee benefits packages and are committed to fair and equitable pay practices. We track compensation patterns in all geographies where we operate, and we regularly look for ways to ensure fair and equitable pay.

We are committed to fostering an environment where all employees can grow and thrive. A diverse workforce results in a broader range of perspectives, helping drive our commitment to innovation.

We believe in empowering our employees and providing avenues that enable their voices to be heard. We conduct a multilingual global employee survey, called myVoice, to pulse our employees and gain their feedback in a confidential manner. We gain insights on various topics including patient focus, diversity, inclusion and belonging, quality, innovation, and engagement. Speak-Up is a resource available to all employees to bring forth compliance related concerns. In addition, during each quarterly townhall meeting, our CEO has an "Ask Mike" section in which he answers questions that have been submitted to him by employees. Answers to questions that are not covered in the townhall meeting are posted online internally.

We understand that good health leads to better performance. Edwards offers a competitive employee benefits package that includes, among other things, health and welfare insurance, health savings accounts, family support services, and a variety of site-specific programs. We regularly evaluate our benefits package to make modifications that are aligned with the competitive landscape, legislative changes, and the unique needs of our population. We also provide robust wellness programs that address prevention, nutrition, mental health, physical activity, education, financial fitness, and community service.

Talent Development

In addition to our robust TDR process and tuition reimbursement programs, we provide a variety of leadership, technical, and professional development programs around the globe.

Headcount and Labor Representation

As of December 31, 2020, we had approximately 14,900 employees worldwide, the majority of whom were located in the United States, Singapore, and the Dominican Republic. None of our North American employees are represented by a labor union. In various countries outside of North America, we interact with trade unions and work councils that represent employees.

Additional details regarding diversity, talent development, compensation, and employee health and safety can be found in our Sustainability Report posted on our website at www.edwards.com under "About Us — Corporate Responsibility."

References to our website in this Annual Report on Form 10-K are provided for convenience only and the content on our website does not constitute a part of this Report.

10
Item 1A.    Risk Factors

Our business and assets are subject to varying degrees of risk and uncertainty. An investor should carefully consider the risks described below, as well as other information contained in this Annual Report on Form 10-K and in our other filings with the SEC. Additional risks not presently known to us or that we currently deem immaterial may also adversely affect our business. If any of these events or circumstances occurs, our business, financial condition, results of operations, or prospects could be materially harmed. In that case, the value of our securities could decline and an investor could lose part or all of his or her investment. In addition, forward-looking statements within the meaning of the federal securities laws that are contained in this Annual Report on Form 10-K or in our other filings or statements may be subject to the risks described below as well as other risks and uncertainties. Please read the cautionary notice regarding forward-looking statements in Part I above.

Business and Operating Risks

We are subject to risks associated with public health threats and epidemics, including the novel coronavirus ("COVID-19").

We are subject to risks associated with public health threats and epidemics, including the global health concerns relating to the COVID-19 pandemic. The global pandemic has adversely impacted and is likely to further adversely impact nearly all aspects of our business and markets, including our workforce and operations and the operations of our customers, suppliers, and business partners. In particular, we may experience material financial or operational impacts, including:

•Significant volatility or reductions in demand for our products;

•Impacts and delays to clinical trials, our pipeline milestones, or regulatory clearances and approvals; or

•The inability to meet our customers’ needs or other obligations due to disruptions to our operations or the operations of our third-party partners, suppliers, contractors, logistics partners, or customers including disruptions to production, development, manufacturing, administrative, and supply operations and arrangements.

The extent to which the COVID-19 global pandemic and measures taken in response thereto impact our business, results
of operations, and financial condition will depend on future developments, which are highly uncertain and are difficult to
predict. These developments include, but are not limited to, the duration and spread of the outbreak (including new variants of COVID-19), its severity, the actions to contain the virus or address its impact, the timing, distribution, and efficacy of vaccines and other treatments, U.S. and foreign government actions to respond to the reduction in global economic activity, and how quickly and to what extent normal economic and operating conditions can resume.

Failure to successfully innovate and develop new and differentiated products in a timely manner and effectively market these products could have a material effect on our prospects.

Our continued growth and success depend on our ability to innovate and develop new and differentiated products in a timely manner and effectively market these products. Without the timely innovation and development of products, our products could be rendered obsolete or less competitive by changing customer preferences or because of the introduction of a competitor’s newer technologies. Innovating products requires the devotion of significant financial and other resources to research and development activities; however, there is no certainty that the products we are currently developing will complete the development process, or that we will obtain the regulatory or other approvals required to market such products in a timely manner or at all. Even if we timely innovate and develop products, our ability to market them could be constrained by a number of different factors, including barriers in patients' treatment pathway (including disease awareness, detection, and diagnosis), the need for regulatory clearance, restrictions imposed on approved indications, and uncertainty over third-party reimbursement. Failure in any of these areas could have a material effect on our prospects.

Unsuccessful clinical trials or procedures relating to products could have a material adverse effect on our prospects.

The regulatory approval process for new products and new indications for existing products requires extensive clinical trials and procedures, including early clinical feasibility and regulatory studies. Unfavorable or inconsistent clinical data from current or future clinical trials or procedures conducted by us, our competitors, or third parties, or perceptions regarding this clinical data, could adversely affect our ability to obtain necessary approvals and the market's view of our future prospects. Such clinical trials and procedures are inherently uncertain and there can be no assurance that these trials or procedures will be enrolled or completed in a timely or cost-effective manner or result in a commercially viable product or indication; failure to do so could have a material adverse effect on our prospects. Clinical trials or procedures may experience significant setbacks even after earlier trials have shown promising results. Further, preliminary results from clinical trials or procedures may be contradicted by subsequent analyses. In addition, results from our clinical trials or procedures may not be supported by actual long-term studies or clinical experience. If preliminary clinical results are later contradicted, or if initial results cannot be
11
supported by actual long-term studies or clinical experience, our business could be adversely affected. Clinical trials or procedures may be delayed, suspended, or terminated by us, the FDA, or other regulatory authorities at any time if it is believed that the trial participants face unacceptable health risks or any other reasons.

We operate in highly competitive markets, and if we do not compete effectively, our business will be harmed.

We face substantial competition and compete with companies of all sizes on the basis of cost-effectiveness, technological innovations, product performance, brand name recognition, breadth of product offerings, real or perceived product advantages, pricing and availability and rate of reimbursement. In addition, given the trend toward value-based healthcare, if we are not able to continue to demonstrate the full value of our differentiated products to healthcare providers and payors, our competitive position could be adversely affected. See "Competition" under "Business" in Part I, Item 1 included herein.

If we identify underperforming operations or products or if there are unforeseen operating difficulties and expenditures in connection with business acquisitions or strategic alliances, we may be required, from time to time, to recognize charges, which could be substantial and which could adversely affect our results of operations.

We actively manage a portfolio of research and development products, and we regularly explore potential acquisitions of complementary businesses, technologies, services, or products, as well as potential strategic alliances. From time to time, we identify operations and products that are underperforming, do not fit with our longer-term business strategy or there may be unforeseen operating difficulties and significant expenditures during the integration of an acquired business, technology, service, or product into our existing operations. We may seek to dispose of these underperforming operations or products, and we may also seek to dispose of other operations or products for strategic or other business reasons. If we cannot dispose of an operation or product on acceptable terms, we may voluntarily cease operations related to that product. In addition, we may be required to take charges or write-downs in connection with acquisitions and divestitures. In particular, acquisitions of businesses engaged in the development of new products may give rise to developed technology and/or in-process research and development assets. To the extent that the value of these assets decline, we may be required to write down the value of the assets. Also, in connection with certain asset acquisitions, we may be required to take an immediate charge related to acquired in-process research and development assets. Any of these events could result in charges, which could be substantial and which could adversely affect our results of operations.

The success of many of our products depends upon certain key physicians.

We maintain working relationships with physicians upon whom we rely to provide considerable knowledge and experience. These physicians may assist us as researchers, marketing consultants, product trainers and consultants, inventors, and as public speakers. If new laws, regulations, or other developments limit our ability to appropriately engage these professionals or to continue to receive their advice and input, the development, marketing, and successful use of our products could suffer, which could have a material adverse effect on our business, financial condition, and results of operations.


If we or one of our suppliers or logistics partners encounters manufacturing, logistics, or quality problems, our business could be materially adversely affected.

The manufacture and sterilization of many of our products is highly complex due in part to rigorous regulatory requirements. Quality is extremely important due to the serious and costly consequences of a product failure. Problems can arise for a number of reasons, including disruption of facility utilities, equipment malfunction, failure to follow protocols and procedures, raw material problems, software problems, or human error. Disruptions can occur at any time, including during production line transfers and expansions. Disruptions can also occur if our manufacturing and warehousing facilities are damaged by earthquakes, hurricanes, volcanoes, fires, and other natural disasters or catastrophic circumstances. As we expand into new markets and scale new products for commercial production, we may face unanticipated delays or surges in demand which could strain our production capacity and lead to other types of disruption. If any of these manufacturing, logistics, or quality problems arise or if we or one of our suppliers or logistics partner otherwise fail to meet internal quality standards or those of the FDA or other applicable regulatory body, our reputation could be damaged, we could become subject to a safety alert or a recall, we could incur product liability and other costs, product approvals and production could be delayed, and our business could otherwise be materially adversely affected.

We rely on third parties in the design, manufacture, and sterilization of our products. Any failure by or loss of a vendor could result in delays and increased costs, which may adversely affect our business.

We rely on third parties for a broad range of raw and organic materials and other items in the design, manufacture, and sterilization of our products, and we purchase certain supplies and services from single sources for reasons of quality assurance, cost-effectiveness, availability, constraints resulting from regulatory requirements, and other reasons. We may experience supply interruptions due to a variety of factors, including:
12

•General economic conditions that could adversely affect the financial viability of our vendors;

•Vendors' election to no longer service medical technology companies due to the burdens of applicable quality requirements and regulations;

•The limitation or ban of certain materials used in the manufacture of our products; and

•Delays or shortages due to trade or regulatory embargoes.

A change or addition to our vendors could require significant effort due to the rigorous regulations and requirements of the FDA and other regulatory authorities; it could be difficult to establish additional or replacement sources on a timely basis, which could have a material adverse effect on our business.

Failure to protect our information technology infrastructure against cyber-based attacks, network security breaches, service interruptions, or data corruption could materially disrupt our operations and adversely affect our business and operating results.

The operation of our business depends on our information technology systems. We rely on our information technology systems to, among other things, effectively manage sales and marketing data, accounting and financial functions, inventory management, product development tasks, clinical data, customer service and technical support functions. Our information technology systems are vulnerable to damage or interruption from earthquakes, fires, floods and other natural disasters, terrorist attacks, power losses, computer system or data network failures, security breaches, data corruption, and cyber-based attacks.  Cyber-based attacks can include, but are not limited to, computer viruses, computer denial-of-service attacks, phishing attacks, ransomware attacks, worms, and other malicious software programs or other attacks, covert introduction of malware to computers and networks, impersonation of authorized users, and efforts to discover and exploit any design flaws, bugs, security vulnerabilities, or security weaknesses, as well as intentional or unintentional acts by employees or other insiders with access privileges, intentional acts of vandalism by third parties and sabotage. In addition, federal, state, and international laws and regulations, such as the General Data Protection Regulation adopted by the European Union and the California Consumer Privacy Act, can expose us to enforcement actions and investigations by regulatory authorities, and potentially result in regulatory penalties and significant legal liability, if our information technology security efforts fail. In addition, a variety of our software systems are cloud‑based data management applications, hosted by third‑party service providers whose security and information technology systems are subject to similar risks.

The failure of either our or our service providers’ information technology could disrupt our operations or result in decreased sales, result in liability claims or regulatory penalties, or lead to increased overhead costs, product shortages, loss or misuse of proprietary or confidential information, intellectual property, or sensitive or personal information, all of which could have a material adverse effect on our reputation, business, financial condition, and operating results.

Our business and results of operations may be adversely affected if we are unable to recruit and retain qualified management and other personnel.

Our continued success depends, in large part, on our ability to hire and retain qualified people or otherwise have access to such qualified people globally and if we are unable to do so, our business and operations may be impaired or disrupted. See "Human Capital Management Strategy" under "Business" in Part I, Item 1 included herein. Competition for highly qualified people is intense, and there is no assurance that we will be successful in attracting or retaining replacements to fill vacant positions, successors to fill retirements or employees moving to new positions, or other highly qualified personnel.

Market and Other External Risks

Because we operate globally, our business is subject to a variety of risks associated with international sales and operations.

Our extensive global operations and business activity as well as the fact that many of our manufacturing facilities and suppliers are outside of the United States are accompanied by certain financial, economic, political, and other risks, including those listed below.

Domestic and Global Economic Conditions.  We cannot predict to what extent general domestic and global economic conditions may negatively impact our business. These include, but are not limited to, credit and capital markets, interest rates, tax law, including tax rate and policy changes, factors affecting global economic stability, the political environment relating to health care, and the potential implications of the U.K. “Brexit” or the withdrawal from the European Union of other member
13
countries. These and other conditions could also adversely affect our customers, payers, vendors and other stakeholders and may impact their ability or decision to purchase our products or make payments on a timely basis.

Health Care Legislation and Other Regulations. We are subject to various federal and foreign laws that govern our domestic and international business practices. For example, in the U.S., the Affordable Care Act, the Medicare Access and CHIP Reauthorization Act of 2015, and the 21st Century Cures Act, or any future legislation, including deficit reduction legislation, could impact medical procedure volumes, reimbursement for our products, and demand for our products or the prices at which we sell our products. In addition, a Mutual Recognition Agreement still under negotiation for the Medical Device Regulation can result in a lack of free movement of medical devices between the European Union and Switzerland, can impact our access in the European Union and can, ultimately, have a material effect on our business, financial condition, and results of operations. For more information about these laws as they relate to our business, see the section entitled “Health Care Legislation” and “Government Regulation and Other Matters” in Part I, Item 1, “Business.”

In addition, the United States Foreign Corrupt Practices Act, the United Kingdom Bribery Act, and similar laws in other jurisdictions contain prohibitions against bribery and other illegal payments, and make it an offense to fail to have procedures in place that prevent such payments. Penalties resulting from any violation of these laws could adversely affect us and our business.

Taxes. We are subject to income taxes in the United States as well as other jurisdictions.

•Provision for Income Taxes. Our provision for income taxes and our underlying effective tax rate could fluctuate due to changes in the mix of earnings and losses in countries with differing statutory tax rates. Our income tax provision could also be impacted by changes in excess tax benefits of stock-based compensation, federal and state tax credits, non-deductible expenses, changes in the valuation of deferred tax assets and liabilities and our ability to utilize them, the applicability and creditability of withholding taxes, and effects from acquisitions.

•Tax Reform. Our provision for income taxes could be materially impacted by changes in accounting principles or evolving tax laws, including, but not limited to, global corporate tax reform and base-erosion and tax transparency efforts. For example, many countries are aligning their international tax rules with the Organisation for Economic Co-operation and Development’s Base Erosion and Profit Shifting recommendations and action plans that aim to standardize and modernize international corporate tax policy, including changes to cross-border taxes, transfer pricing documentation rules, nexus-based tax practices, and taxation of digital activities.

•Tax Audits. We are subject to ongoing tax audits in the various jurisdictions in which we operate. Tax authorities may disagree with certain positions we have taken and assess additional taxes. Although we regularly assess the likely outcomes of the audits and record reserves for potential tax payments, the calculation of tax liabilities involves the application of complex tax laws, and our estimates could be different than the amounts for which we are ultimately liable.

•Tax Incentives. We benefit from various global tax incentives extended to encourage investment or employment. Several foreign jurisdictions have granted us tax incentives which require renewal at various times in the future. If our incentives are not renewed or we cannot or do not wish to satisfy all or part of the tax incentive conditions, we may lose the tax incentives and could be required to refund tax incentives previously realized. As a result, our provision for income taxes could be higher than it would have been had we maintained the benefits of the tax incentives.

Other economic, political, and social risks. Our future results could be harmed by a variety of other factors associated with doing business internationally such as those enumerated in these risk factors as well as the following:

•trade protection measures, quotas, embargoes, import or export requirements, and duties, tariffs, or surcharges;

•cultural or other local factors affecting financial terms with customers;

•differing labor regulations; and

•currency exchange rate fluctuations; that is, decreases in the value of the United States dollar to the Euro or the Japanese yen, as well as other currencies, have the effect of increasing our reported revenues even when the volume of international sales has remained constant. Increases in the value of the United States dollar relative to the Euro or the Japanese yen, as well as other currencies, have the opposite effect. Significant increases or decreases in the value of the United States dollar could have a material adverse effect on our revenues, cost of sales, or results of operations.

14
If government and other third-party payors decline to reimburse our customers for our products or impose other cost containment measures to reduce reimbursement levels, our ability to profitably sell our products will be harmed.

We sell our products and technologies to hospitals and other health care providers, nearly all of which receive reimbursement for the health care services provided to patients from third-party payors, such as government programs (both domestic and international), private insurance plans, and managed care programs. The ability of customers to obtain appropriate reimbursement for their products from private and governmental third-party payors is critical to our success. The availability of reimbursement affects which products customers purchase and the prices they are willing to pay. Reimbursement varies from country to country and can significantly impact acceptance of new products.

Government and other third-party payors are increasingly attempting to contain health care costs by limiting both coverage and the level of reimbursement for medical products and services. Reimbursement levels may be decreased in the future. Additionally, future legislation, regulation, or reimbursement policies of third-party payors may otherwise adversely affect the demand for and price levels of our products. The introduction of cost containment incentives, combined with closer scrutiny of health care expenditures by both private health insurers and employers, has resulted in increased discounts and contractual adjustments to hospital charges for services performed. Hospitals or physicians may respond to such cost-containment pressures by substituting lower cost products or other therapies.

Third-party payors may deny reimbursement if they determine that a device used in a procedure was not used in accordance with cost-effective treatment methods as determined by such third-party payors or was used for an unapproved indication. Third-party payors may also deny reimbursement for experimental procedures and devices. We believe that many of our existing products are cost-effective, even though the one-time cost may be significant, because they are intended to improve quality of life and reduce overall health care costs over a long period of time. We cannot be certain that these third-party payors will recognize these cost savings and quality of life benefits instead of merely focusing on the lower initial costs associated with competing therapies. If our products are not considered cost-effective by third-party payors, our customers may not be reimbursed for them, resulting in lower sales of our products.

Continued consolidation in the health care industry could have an adverse effect on our sales and results of operations.

The health care industry has been consolidating, and organizations such as GPOs, independent delivery networks, and large single accounts, such as the United States Veterans Administration, continue to consolidate purchasing decisions for many of our health care provider customers. As a result, transactions with customers are larger and more complex, and tend to involve more long-term contracts. The purchasing power of these larger customers has increased, and may continue to increase, causing downward pressure on product pricing. If we are not one of the providers selected by one of these organizations, we may be precluded from making sales to its members or participants. Even if we are one of the selected providers, we may be at a disadvantage relative to other selected providers that are able to offer volume discounts based on purchases of a broader range of medical equipment and supplies. Further, we may be required to commit to pricing that has a material adverse effect on our revenues, profit margins, business, financial condition, and results of operations. We expect that market demand, governmental regulation, third-party reimbursement policies, and societal pressures will continue to drive consolidation and increase pricing pressure.

Legal, Compliance, and Regulatory Risks

Our inability to protect our intellectual property or failure to maintain the confidentiality and integrity of data or other sensitive company information, by cyber-attack or other event, could have a material adverse effect on our business.

Our success and competitive position are dependent in part upon our ability to protect our proprietary intellectual property through a combination of patents and trade secrets. We cannot guarantee that the protective steps we take are adequate to protect these rights:

•Patents issued to or licensed by us in the past or in the future may be challenged and held invalid.

•As our patents expire, we may be unsuccessful in extending their protection through patent term extensions.

•Confidentiality agreements with certain employees, consultants, and other third parties intended to protect, in part, trade secrets and other proprietary information could be breached, and we may not have adequate remedies.

•Others could independently develop substantially equivalent proprietary information or gain access to our trade secrets or proprietary information, design around our technology, or develop competing technologies.
15
•Our intellectual property, other proprietary technology, and other sensitive company information is dependent on sophisticated information technology systems and is potentially vulnerable to cyber-attacks, loss, theft, damage, destruction from system malfunction, computer viruses, loss of data privacy, or misappropriation or misuse of it by those with permitted access, and other events.

•We may not detect infringement.

•Intellectual property protection may also be unavailable or limited in some foreign countries.

We spend significant resources to protect and enforce our intellectual property rights, sometimes resulting in expensive and time-consuming litigation that is complex and may ultimately be unsuccessful. Our inability to protect our intellectual property could have a material adverse effect on our business or prospects.

Third parties may claim we are infringing their intellectual property, and we could suffer significant litigation or licensing expenses or be prevented from selling products.

During recent years, we and our competitors have been involved in substantial litigation regarding patent and other intellectual property rights which is typically costly and time-consuming. We may be forced to defend against claims and legal actions alleging infringement of the intellectual property rights of others, and, if our defense is unsuccessful, Edwards could have significant liabilities to third parties or face injunctions that bar the sale of our products, or could require us to seek licenses from third parties. Such licenses may not be available on commercially reasonable terms, may prevent us from manufacturing, selling, or using certain products, or may be non-exclusive, which could provide our competitors access to the same technologies.

In addition, third parties could also obtain patents that may require us to either redesign products, negotiate licenses from such third parties, which may be costly, unavailable or require us to exit a particular product offering.

We and our customers are subject to rigorous governmental regulations and we may incur significant expenses to comply with these regulations and develop products that are compatible with these regulations. In addition, failure to comply with these regulations could subject us to substantial sanctions which could adversely affect our business, results of operations, and financial condition.

The medical technologies we create, study, manufacture and market globally are subject to rigorous regulation and scrutiny by the FDA and various other federal, state, and foreign governmental authorities. Government regulation applies to nearly all aspects of our products’ lifecycles, including testing, clinical study, manufacturing, transporting, sourcing, safety, labeling, storing, packaging, recordkeeping, reporting, advertising, promoting, distributing, marketing, and importing or exporting of medical devices and products. In general, unless an exemption applies, a medical device or product must receive regulatory approval or clearance before it can be marketed or sold. Modifications to existing products or the marketing of new uses for existing products also may require regulatory approvals, approval supplements, or clearances. If we are unable to obtain these required approvals, we may be required to cease manufacturing and sale, or recall or restrict the use of such modified device, pay fines, or take other action until such time as appropriate clearance or approval is obtained.

Regulatory agencies may refuse to grant approval or clearance, or review and disagree with our interpretation of approvals or clearances, or with our decision that regulatory approval is not required or has been maintained. Regulatory submissions may require the provision of additional data and may be time consuming and costly, and their outcome is uncertain. Regulatory agencies may also change policies, adopt additional regulations, or revise existing regulations, each of which could prevent or delay approval or clearance of devices, or could impact our ability to market a previously cleared, approved, or unregulated device. Our failure to comply with these regulatory requirements of the FDA or other applicable regulatory requirements in the United States or elsewhere might subject us to administratively or judicially imposed sanctions. These sanctions include, among others, warning letters, fines, civil penalties, criminal penalties, injunctions, debarment, product seizure or detention, product recalls and total or partial suspension of production, sale and/or promotion. Any of the foregoing actions could result in decreased sales including as a result of negative publicity and product liability claims, and could have a material adverse effect on our financial condition, results of operations, and prospects. In addition to the sanctions for noncompliance described above, commencement of an enforcement proceeding, inspection, or investigation could divert substantial management attention from the operation of our business and have an adverse effect on our business, results of operations, and financial condition.

Also, we are subject to various United States and international laws pertaining to health care pricing, anti-corruption, and fraud and abuse, including prohibitions on kickbacks and the submission of false claims laws and restrictions on relationships with physicians and other referral sources. These laws are broad in scope and are subject to evolving interpretation, which could require us to incur substantial costs to monitor compliance. If we are found not to be in compliance, we may be required to alter our practices or have sanctions imposed against us and our officers and employees, including substantial fines, imprisonment, and exclusion from participation in governmental health care programs.
16

We may incur losses from product liability or other claims that could adversely affect our operating results.

Our business exposes us to potential product liability risks that are inherent in the design, manufacture, and marketing of medical technologies. Our products are often used in surgical and intensive care settings with seriously ill patients. In addition, many of the devices we manufacture and sell are designed to be implanted in the human body for long periods of time. Component failures, manufacturing and assembly flaws, design defects, software defects, medical procedure errors, or inadequate disclosure of product-related risks or information could result in an unsafe condition, injury to, or death of, patients. Such problems could result in product liability, medical malpractice or other lawsuits and claims, safety alerts, or product recalls in the future. We establish reserves and may incur charges in excess of those reserves. Although we maintain product liability and other insurance with coverages we believe are adequate, product liability or other claims may exceed insurance coverage limits, fines, and penalties. In addition, regulatory sanctions may not be covered by insurance, or insurance may not continue to be available or available on commercially reasonable terms. These litigation matters and regulatory actions, recalls or other actions, regardless of outcome, could have a material adverse effect on our business, reputation, and ability to attract and retain customers.

Use of our products in unapproved circumstances could expose us to liabilities.

The marketing approval from the FDA and other regulators of certain of our products are, or are expected to be, limited to specific indications. We are prohibited from marketing or promoting any unapproved use of our products. Physicians, however, can use these products in ways or circumstances other than those strictly within the scope of the regulatory approval. Although the product training we provide to physicians and other health care professionals is conducted in compliance with applicable laws, and therefore, is mainly limited to approved uses or for clinical trials, no assurance can be given that claims might not be asserted against us if our products are used in ways or for procedures that are not approved.

Our operations are subject to environmental, health, and safety regulations that could result in substantial costs.

Our operations are subject to environmental, health, and safety laws, and regulations concerning, among other things, the generation, handling, transportation, and disposal of hazardous substances or wastes, the cleanup of hazardous substance releases, and emissions or discharges into the air or water. We have incurred and may incur in the future expenditures in connection with environmental, health and safety laws, and regulations. New laws and regulations, violations of these laws or regulations, stricter enforcement of existing requirements, or the discovery of previously unknown contamination could require us to incur costs or could become the basis for new or increased liabilities that could be material.

We are subject to risks arising from concerns and/or regulatory actions relating to animal borne illnesses, including “mad cow disease.”

Certain of our products, including pericardial tissue valves, are manufactured using bovine tissue. Concerns relating to the potential transmission of animal borne illnesses, including BSE, commonly known as "mad cow disease," from cows to humans may result in reduced acceptance of products containing bovine materials. Certain medical device regulatory agencies have considered whether to continue to permit the sale of medical devices that incorporate bovine material. We obtain bovine tissue only from closely controlled sources within the United States and Australia. The bovine tissue used in our pericardial tissue valves is from tissue types considered by global health and regulatory organizations to have shown no risk of infectibility for the suspected BSE infectious agent. We have not experienced any significant adverse impact on our sales as a result of concerns regarding BSE, but no assurance can be given that such an impact may not occur in the future.

Item 1B.    Unresolved Staff Comments

None.

17
Item 2.    Properties

The locations and uses of our major properties are as follows:
North America  
Irvine, California(1)Corporate Headquarters, Research and Development, Regulatory and Clinical Affairs, Manufacturing, Marketing, Administration
Draper, Utah(1),(2)Manufacturing, Administration
Haina, Dominican Republic(1),(2)Manufacturing
Añasco, Puerto Rico(2)Manufacturing
Central America  
Cartago, Costa Rica(1),(2)Manufacturing
Europe  
Nyon, Switzerland(1)Administration, Marketing
Prague, Czech Republic(2)Administration
Shannon, Limerick, Ireland(1),(2)Manufacturing (under construction)
Asia  
Singapore(1),(2)Manufacturing, Distribution, Administration
Tokyo, Japan(2)Administration, Marketing, Distribution
Shanghai, China(2)Administration, Marketing
Caesarea, Israel(2)Research and Development
Or Yehuda, Israel(2)Research and Development
_______________________________________________________________________________
(1)     Owned property.

(2)    Leased property.

The Dominican Republic lease expires in 2022; the Puerto Rico property has two leases that expire in 2023; the Costa Rica lease expires in 2021; the Prague, Czech Republic lease expires in 2026; the Shannon, Ireland lease expires in 2024; the Tokyo, Japan lease expires in 2021; the Shanghai, China lease expires in 2021; Singapore has one land lease that expires in 2036 and one that expires in 2041; Caesarea, Israel has one lease that expires in 2021 and one that expires in 2030; and the Or Yehuda, Israel lease expires in 2023. We believe our properties have been well maintained, are in good operating condition, and are adequate for current needs. We do not anticipate difficulty in renewing existing leases as they expire or in finding alternative facilities.

Item 3.    Legal Proceedings

For a description of our material pending legal proceedings, please see Note 18 to the "Consolidated Financial Statements" of this Annual Report on Form 10-K, which is incorporated by reference.

Item 4.    Mine Safety Disclosures

Not applicable.
18
PART II

Item 5.    Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Market Information

Our common stock is traded on the New York Stock Exchange (the "NYSE") under the symbol "EW."

Number of Stockholders

On January 31, 2021, there were 8,876 stockholders of record of our common stock.

Dividends

We have never paid any cash dividends on our capital stock and have no current plans to pay any cash dividends. Our current policy is to retain any future earnings for use in our business.

Issuer Purchases of Equity Securities
On May 8, 2019, the Board of Directors approved a stock repurchase program authorizing us to purchase on the open market, including pursuant to a Rule 10b5-1 plan and in privately negotiated transactions, up to $1.0 billion of our common stock. The repurchase program does not have an expiration date. We did not purchase any of our common stock during the fourth quarter of 2020 and, as of December 31, 2020, we had remaining authority to purchase $625.0 million of common stock.


19
Performance Graph

The following graph compares the performance of our common stock with that of the S&P 500 Index and the S&P 500 Health Care Equipment Index. The cumulative total return listed below assumes an initial investment of $100 at the market close on December 31, 2015 and reinvestment of dividends. Stockholder returns over the indicated period should not be considered indicative of future stockholder returns.

ew-20201231_g1.jpg
Total Cumulative Return
20162017201820192020
Edwards Lifesciences$118.64 $142.71 $193.94 $295.38 $346.53 
S&P 500111.96 136.40 130.42 171.49 203.04 
S&P 500 Health Care Equipment106.48 139.38 162.02 209.52 246.47 

20
Item 6.    Selected Financial Data

  As of or for the Years Ended December 31,
  20202019201820172016
  (in millions, except per share data)
OPERATING RESULTSNet sales$4,386.3 $4,348.0 $3,722.8 $3,435.3 $2,963.7 
Gross profit3,305.7 3,233.6 2,783.4 2,560.0 2,166.3 
Operating income (a)897.6 1,146.8 748.2 1,089.4 751.2 
Net income (a)823.4 1,046.9 722.2 583.6 569.5 
COMMON STOCK INFORMATIONNet income per common share (a) (c):     
Basic$1.32 $1.68 $1.15 $0.92 $0.89 
Diluted1.30 1.64 1.13 0.90 0.87 
Cash dividends declared per common share— — — — — 
BALANCE SHEET DATATotal assets$7,237.1 $6,488.1 $5,323.7 $5,666.4 $4,518.5 
Long-term debt (b)595.0 594.4 593.8 438.4 822.3 
_______________________________________________________________________________
(a)    The above results for 2020 include a $367.9 million pre-tax charge ($305.1 million, net of tax) related to a litigation settlement. The above results for 2019 include special charges of $64.6 million ($58.7 million, net of tax), primarily the impairment of certain assets and the acquisition of early-stage intellectual property. The above results for 2018 include special charges of $109.1 million ($103.0 million, net of tax), primarily the impairment of intangible assets and a $180.0 million ($137.5 million, net of tax) charge related to a litigation settlement. The above results for 2017 include a $112.5 million ($70.3 million, net of tax) gain for a litigation payment received in 2017 and a $262.0 million tax expense related to the implementation of U.S. tax law changes. See Part II, Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations" and Note 3, Note 4, and Note 17 to the "Consolidated Financial Statements" for additional information.

(b)    In October 2013, we issued $600.0 million of 2.875% fixed-rate unsecured senior notes due October 15, 2018 (the "2013 Notes"). At December 31, 2017, the 2013 Notes were classified as short-term obligations as these obligations were due within one year. These 2013 Notes were paid in October 2018. In June 2018, we issued $600.0 million of 4.3% fixed-rate unsecured senior notes due June 15, 2028, which were classified as long-term obligations as of December 31, 2020, 2019 and 2018. Amounts outstanding under our Five-Year Credit Agreement ("Credit Agreement") have been classified as long-term obligations in accordance with the terms of the Credit Agreement.

(c)    The per share amounts for the prior periods presented have been retroactively adjusted to reflect the three-for-one stock split effected in the second quarter of 2020.

Item 7.    Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis presents the factors that had a material effect on our results of operations during the two years ended December 31, 2020. Also discussed is our financial position as of December 31, 2020. You should read this discussion in conjunction with the historical consolidated financial statements and related notes included elsewhere in this Form 10-K. For a discussion related to the results of operations for 2019 compared to 2018 and a discussion related to our consolidated cash flows for 2019 compared to 2018, refer to Part II, Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our 2019 Annual Report on Form 10–K filed with the Securities and Exchange Commission on February 14, 2020.

Overview

We are the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. Driven by a passion to help patients, we partner with the world's leading clinicians and researchers and invest in research and development to transform care for those impacted by structural heart disease or who require
21
hemodynamic monitoring during surgery or in intensive care. We conduct operations worldwide and are managed in the following geographical regions: United States, Europe, Japan, and Rest of World. Our products are categorized into the following main areas: Transcatheter Aortic Valve Replacement ("TAVR"), Transcatheter Mitral and Tricuspid Therapies ("TMTT"), Surgical Structural Heart ("Surgical"), and Critical Care.

On May 7, 2020, our Board of Directors declared a three-for-one stock split of our outstanding shares of common stock effected in the form of a stock dividend, distributed on May 29, 2020 to stockholders of record on May 18, 2020. We distributed two newly issued shares of common stock to holders of record of each share of common stock to effect the stock split. All applicable share and per-share amounts in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” have been retroactively adjusted to give effect to this stock split.

Financial Highlights and COVID-19
ew-20201231_g2.jpgew-20201231_g3.jpg
In March 2020, the World Health Organization categorized the Coronavirus disease 2019 ("COVID-19") as a pandemic. COVID-19 continues to spread throughout the United States and other countries across the world, and the duration and severity of its effects are currently unknown. The global pandemic has adversely impacted and is likely to further adversely impact nearly all aspects of our business and markets, including our workforce and the operations of our customers, suppliers, and business partners. Our priority has been to support our clinician partners, protect the well-being of our employees, and maintain continuous access to our life-saving technologies while offering front-line in-hospital support. Our manufacturing operations have continued to respond to impacts related to COVID-19, and we have been able to supply our technologies around the world. Across the organization, we are proactively managing inventory, assessing alternative logistics options, and closely monitoring the supply of components.

TAVR and Surgical procedure volumes varied greatly since the middle of March 2020 by geography, and even by hospital, as patients and their physicians analyzed the trade-off between aortic stenosis and their concern for COVID-19. In the last few weeks of the first quarter of 2020, procedure volumes related to our TAVR and Surgical products dropped significantly. Beginning in the second quarter of 2020, procedure volumes improved. In the second quarter of 2020, we also started to progressively resume patient enrollment in all clinical trials that were voluntarily paused or slowed at the end of the first quarter of 2020. While we saw improvements to pre-COVID levels when we resumed enrollment, procedure volumes and enrollment in our clinical trials have since been negatively impacted due to a resurgence of COVID-19 in late 2020. Even though health systems adapted to the challenge, the resurgence of COVID-19 late in 2020 continued to impact these patients who need care. In Critical Care, there was greater demand in Europe and the United States for our pressure monitoring products, but demand for other Critical Care products began to decrease at the end of the first quarter of 2020 due to COVID-19, and that trend continued through the fourth quarter of 2020.

Despite the challenges associated with COVID-19, our net sales for 2020 were $4.4 billion, representing an increase of $38.3 million over 2019, driven by sales growth of our TAVR products.
22

Our gross profit increase in 2020 was driven by a charge of $73.1 million recorded in 2019, primarily comprised of the write off of inventory related to strategic decisions regarding our TAVR portfolio, including the decision to discontinue our CENTERA program.

The decrease in our diluted earnings per share in 2020 was driven by an after-tax charge of $305.1 million to settle certain patent litigation related to transcatheter mitral and tricuspid repair products.

Healthcare Environment, Opportunities, and Challenges

The medical technology industry is highly competitive and continues to evolve. Our success is measured both by the development of innovative products and the value we bring to our stakeholders. We are committed to developing new technologies and providing innovative patient care, and we are committed to defending our intellectual property in support of those developments. While some evidence collection was slowed due to the COVID-19 pandemic, we and the clinical community are committed to continuing our trials and generating robust evidence. In 2020, we invested 17.3% of our net sales in research and development. The following is a summary of important developments during 2020:

•in response to the urgent COVID-19 response around the globe, we temporarily paused new enrollments in our active pivotal clinical trials of transcatheter mitral and tricuspid therapies, which began resuming in the second quarter of 2020;
•we received CE Mark for the Edwards PASCAL transcatheter valve repair system for the treatment of European patients with tricuspid regurgitation;
•we received Chinese regulatory approval for the Edwards SAPIEN 3 transcatheter heart valve for the treatment of severe, symptomatic aortic stenosis patients at high risk for or unable to undergo open-heart surgery;
•we reached an agreement with Abbott to settle all outstanding patent disputes between the companies in cases related to transcatheter mitral and tricuspid repair products;
•we received FDA approval for the KONECT RESILIA aortic valved conduit, the first ready-to-implant solution for bio-Bentall procedures, a complex surgery that involves replacement of a patient's aortic valve, aortic root, and the ascending aorta.
•we treated our first patient in the RESTORE clinical trial, which will evaluate the safety and effectiveness of the investigational HARPOON Beating Heart Mitral Valve Repair System in the United States and Canada.
We are dedicated to generating robust clinical, economic, and quality of life evidence increasingly expected by patients, clinicians, and payors in the current healthcare environment, with the goal of encouraging the adoption of innovative new medical therapies that demonstrate superior outcomes.

Results of Operations

Net Sales by Major Regions
(dollars in millions)
 Years Ended December 31,Change
 20202019$%
United States$2,516.8 $2,532.7 $(15.9)(0.6)%
Europe973.6 941.2 32.4 3.4 %
Japan460.1 444.7 15.4 3.5 %
Rest of World435.8 429.4 6.4 1.5 %
International1,869.5 1,815.3 54.2 3.0 %
Total net sales$4,386.3 $4,348.0 $38.3 0.9 %

International net sales include the impact of foreign currency exchange rate fluctuations. The impact of foreign currency exchange rate fluctuations on net sales is not necessarily indicative of the impact on net income due to the corresponding effect of foreign currency exchange rate fluctuations on international manufacturing and operating costs, and our hedging activities. For more information, see "Quantitative and Qualitative Disclosures About Market Risk."
23

Net Sales by Product Group
(dollars in millions)
 Years Ended December 31,Change
 2020 2019$%
Transcatheter Aortic Valve Replacement$2,857.3  $2,737.9  $119.4 4.4 %
Transcatheter Mitral and Tricuspid Therapies41.8 28.2 13.6 48.5 %
Surgical Heart Valve Therapy761.8  841.7  (79.9)(9.5)%
Critical Care725.4  740.2  (14.8)(2.0)%
Total net sales$4,386.3  $4,348.0  $38.3 0.9 %


Transcatheter Aortic Valve Replacement
ew-20201231_g4.jpg
The increase in net sales of TAVR products was due primarily to higher sales of the Edwards SAPIEN 3 Ultra System following its regulatory approval in the United States (December 2018) and in Europe (November 2018). The adoption of the Edwards SAPIEN 3 Ultra System continued to be very positive in 2020. However, our sales in 2020 were negatively impacted by the COVID-19 pandemic, and these challenges have continued in early 2021. Our procedure volumes dropped significantly beginning in March 2020 due to COVID-19, and began to steadily improve beginning in May 2020. In the first quarter of 2020, to ensure the safety of our employees and clinician partners from the threat of COVID-19, we decided to pause proctoring at centers that were not already trained on the Edwards SAPIEN 3 Ultra System. In the second quarter of 2020, we resumed proctoring.

24
Transcatheter Mitral and Tricuspid Therapies
ew-20201231_g5.jpg
The increase in net sales of TMTT products was due primarily to sales in Europe of the Edwards PASCAL transcatheter valve repair system, which received CE Mark in February 2019. Our sales in 2020 were negatively impacted by the COVID-19 pandemic. Our procedure volumes for PASCAL dropped significantly in March 2020 due to COVID-19, and began to improve beginning in May 2020.

At the end of March 2020, we temporarily paused new enrollments in our active pivotal clinical trials of transcatheter
mitral and tricuspid therapies in response to the COVID-19 response around the globe. In the second quarter of 2020, we began
resuming enrollments. However, due to a resurgence of COVID-19 in late 2020, we are experiencing a negative impact to clinical trial enrollment. In May 2020, we received CE Mark for the PASCAL Ace implant system for mitral and tricuspid repair.

Surgical Structural Heart
ew-20201231_g6.jpg
The decrease in net sales of Surgical products was due primarily to decreased sales of aortic tissue valves, primarily in the United States and Europe, due to the impact of COVID-19. The ongoing adoption of TAVR also contributed to the decrease in United States surgical aortic valve sales. These decreases were partially offset by increased sales of the INSPIRIS RESILIA
25
aortic valve and the KONECT aortic valved conduit, primarily in the United States. Increased and improved management of intensive care unit capacity, as well as prioritization of heart surgery in many hospitals, contributed to rebounding procedure volumes late in the second quarter of 2020. In the fourth quarter of 2020, hospitals experienced an influx of COVID-19 patients, limiting surgical valve procedures.

In Europe, our HARPOON Beating Heart Mitral Valve Repair System became available commercially at the end of 2019, and the first commercial case was successfully completed in Europe in the second quarter of 2020. In addition, we received FDA approval in April 2020 to begin our U.S. pivotal investigational device exemption study. HARPOON offers the potential for earlier treatment of degenerative mitral valve disease, with faster recovery and more consistent outcomes for surgical patients.
Critical Care
ew-20201231_g7.jpg
The decrease in net sales of Critical Care products was driven by a decline in sales of our enhanced surgical recovery products, primarily in the United States, as many surgical procedures were delayed due to COVID-19 beginning in March 2020. We also experienced a decline in orders of our HemoSphere advanced monitoring platform in the United States as hospitals limited their capital spending due to COVID-19.

These decreases in net sales were partially offset by increased demand for our pressure monitoring products, primarily in Europe and the United States, as COVID-19 hospitalizations increased. In addition, our sales in 2020 and 2019 included $22.6 million and $16.8 million, respectively, related to CAS Medical Systems, Inc. ("CASMED"), which we acquired on April 18, 2019. CASMED is a medical technology company dedicated to non-invasive monitoring of tissue oxygenation in the brain.


26
Gross Profit

ew-20201231_g8.jpg
Our gross profit was higher as a percentage of net sales in 2020 compared to 2019. In 2019, our gross profit was reduced by $73.1 million due to the decision to discontinue our CENTERA program, resulting in a 1.7 percentage point increase in 2020 compared to 2019. This increase was partially offset by a) a 1.0 percentage point decrease in 2020 due to the impact of foreign currency exchange rate fluctuations, net of hedging, and b) incremental costs associated with COVID-19.

Selling, General, and Administrative ("SG&A") Expenses
ew-20201231_g9.jpg
The decrease in SG&A expenses in 2020 compared to 2019 was due primarily to a) decreased sales, marketing and travel-related expense associated with COVID-19 and b) lower performance-based compensation, partially offset by increased sales and marketing expenses related to transcatheter structural heart field personnel, primarily in the United States.

27
Research and Development ("R&D") Expenses
ew-20201231_g10.jpg
The increase in R&D expenses in 2020 compared to 2019 was due primarily to a) investments in our transcatheter mitral and tricuspid therapies and our aortic valve replacement programs and b) costs associated with discontinuing our SUTRAFIX program. These increases were partially offset by a) decreased spending on transcatheter aortic valve clinical trials and b) decreased performance-based compensation.

Intellectual Property Litigation Expenses, net

We incurred intellectual property litigation expenses, including settlements and external legal costs, of $405.4 million and $33.4 million during 2020 and 2019, respectively. On July 12, 2020, we reached an agreement with Abbott Laboratories and its direct and indirect subsidiaries ("Abbott") to, among other things, settle all outstanding patent disputes between the companies (the “Settlement Agreement”) in cases related to transcatheter mitral and tricuspid repair products. See Note 18 to the "Consolidated Financial Statements" for additional information. The Settlement Agreement resulted in us recording an estimated $367.9 million pre-tax charge and related liability in June 2020 related to past damages. In addition, we will incur royalty expenses through May 2024 totaling an estimated $100 million. We made a one-time $100.0 million payment to Abbott in July 2020, and will make quarterly payments in future years.

Change in Fair Value of Contingent Consideration Liabilities, net

The change in fair value of contingent consideration liabilities resulted in expense of $13.6 million in 2020 and income of $6.1 million in 2019. The expense in 2020 was primarily driven by the accretion of interest due to the passage of time and adjustments to discount rates, partially offset by changes in the projected probability and timing of milestone achievements, and the projected timing of cash inflows. The income in 2019 was due primarily to longer product development timelines, which reduced the probability of milestone achievements, partially offset by the accretion of interest due to the passage of time and discount rate adjustments.

Special Charges (Gain), net

For information on special charges and gains, see Note 4 to the "Consolidated Financial Statements."

Interest Expense

Interest expense was $15.8 million and $20.7 million in 2020 and 2019, respectively. The decrease in interest expense resulted primarily from higher capitalized interest due to facilities construction.

28
Interest Income

Interest income was $23.4 million and $32.2 million in 2020 and 2019, respectively. The decrease in interest income resulted primarily from lower average interest rates, partially offset by a higher average investment balance.

Other Income, net
(in millions)
 Years Ended December 31,
 20202019
Foreign exchange gains, net$(12.3)$(5.9)
Gain on investments(0.6)(0.5)
Non-service cost components of net periodic pension benefit cost0.4 0.2 
Other1.0 (2.0)
Total other income, net$(11.5)$(8.2)

The net foreign exchange gains relate to the foreign currency fluctuations in our global trade and intercompany receivable and payable balances, offset by the gains and losses on derivative instruments intended as an economic hedge of those exposures.

The gain on investments represents our net share of gains and losses in investments accounted for under the equity method, and realized gains and losses on investments in equity securities.

The non-service cost components of net periodic pension benefit cost includes the costs of our defined benefit plans that are not attributed to services rendered by eligible employees during the year, such as interest costs, expected return on plan assets, and amortization of actuarial gains or losses.

Provision for Income Taxes
 Years Ended December 31,Change
 2020 2019$%
Provision for income taxes93.3 119.6 (26.3)(22.0)%
Effective tax rate10.2 %10.3 %
Our effective income tax rate in 2020 and 2019 was 10.2% and 10.3%, respectively. Our effective tax rate for 2020 decreased slightly in comparison to 2019 primarily due to the tax benefit from the Settlement Agreement with Abbott (see Notes 3 and 18 to the "Consolidated Financial Statements"), partially offset by the increase in the U.S. tax on global intangible low-taxed income and the decrease in the tax benefit from employee share-based compensation.

In 2020, the difference between our 10.2% effective tax rate and the Federal statutory rate of 21% was primarily due to a) foreign earnings taxed at lower rates, b) Federal and California research and development credits, and c) the tax benefit from employee share-based compensation.

As of December 31, 2020, we have $145.1 million of California research expenditure tax credits that we expect to use in future periods. The credits may be carried forward indefinitely. Based upon anticipated future taxable income, we expect that it is more likely than not that all California research expenditure tax credits will be utilized, although the utilization of the full benefit is expected to occur over a number of years and into the distant future.

As of December 31, 2020, gross uncertain tax positions were $281.8 million. We estimate that these liabilities would be reduced by $95.1 million from offsetting tax benefits associated with the correlative effects of potential transfer pricing adjustments, state income taxes, and timing adjustments. The net amount of $186.7 million, if not required, would favorably affect our effective tax rate.

We strive to resolve open matters with each tax authority at the examination level and could reach agreement with a tax authority at any time. While we have accrued for matters we believe are more likely than not to require settlement, the final outcome with a tax authority may result in a tax liability that is more or less than that reflected in the consolidated financial statements. Furthermore, we may later decide to challenge any assessments, if made, and may exercise our right to appeal. The
29
uncertain tax positions are reviewed quarterly and adjusted as events occur that affect potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new legislation, regulations, or case law. We believe that adequate amounts of tax and related penalty and interest have been provided in income tax expense for any adjustments that may result from our uncertain tax positions.

At December 31, 2020, all material state, local, and foreign income tax matters have been concluded for years through 2015. While not material, we continue to address matters in Wisconsin and India for years from 2010.

During 2018, we executed an Advance Pricing Agreement (“APA”) between the United States and Switzerland governments for tax years 2009 through 2020 covering various, but not all, transfer pricing matters. The unagreed transfer pricing matters, namely Surgical Structural Heart and Transcatheter Aortic Valve Replacement intercompany royalty transactions, then reverted to Internal Revenue Service ("IRS") Examination for further consideration as part of the respective years' regular tax audit. In addition, we signed agreements during 2018 with the IRS to settle open tax years 2009 through 2014, including all transfer pricing matters for those years and the tax treatment of a portion of a litigation settlement payment received in 2014.

The IRS began its examination of the 2015 and 2016 tax years during the fourth quarter of 2018 and later added the 2017 tax year to this audit cycle during the first quarter of 2019. The IRS audit field work for the 2015 through 2017 tax years was substantially completed during the fourth quarter of 2020, except for transfer pricing matters.

As a result, certain intercompany transactions covering tax years 2015 through 2020 that were not resolved under the APA program remain subject to IRS examination, and those transactions and related tax positions remain uncertain as of December 31, 2020. The IRS has signaled that it may be preparing proposed audit adjustments related to these intercompany transactions for the 2015 through 2017 tax years which, if issued, could be provided to us during 2021. We have considered this information in our evaluation of our reserves for uncertain tax positions.

These unresolved transfer pricing matters, net of any correlative repatriation tax adjustment, may be significant to our consolidated financial statements. Based on the information currently available and numerous possible outcomes, we cannot reasonably estimate what, if any, changes to our existing uncertain tax positions may occur in the next 12 months and, therefore, have continued to record the gross uncertain tax positions as a long-term liability.

We intend to file to renew the APA between the United States and Switzerland for the years 2021 and forward. In addition, we executed other APAs as follows: during 2017, an APA between the United States and Japan covering tax years 2015 through 2019; and during 2018, APAs between Japan and Singapore and between Switzerland and Japan covering tax years 2015 through 2019. We have filed to renew these APAs related to Japan for the years 2020 and forward. The execution of some or all of these APAs depends on a number of variables outside of our control.

We have received tax incentives in certain non-U.S. tax jurisdictions, the primary benefit for which will expire in 2029. The tax reductions as compared to the local statutory rates were $189.2 million ($0.30 per diluted share) and $157.6 million ($0.25 per diluted share) for the years ended December 31, 2020 and 2019, respectively.

Liquidity and Capital Resources

Our sources of cash liquidity include cash and cash equivalents, short-term investments, amounts available under credit facilities, and cash from operations. We believe that these sources are sufficient to fund the current requirements of working capital, capital expenditures, and other financial commitments for the next twelve months from the financial statement issuance date. However, we periodically consider various financing alternatives and may, from time to time, seek to take advantage of favorable interest rate environments or other market conditions.

The Tax Cuts and Jobs Act of 2017 (the "2017 Act"), which was signed into law on December 22, 2017, included extensive changes to the international tax regime. The 2017 Act required a deemed repatriation of post-1986 undistributed foreign earnings and profits. The one-time transition tax liability, as adjusted, is payable in five remaining annual installments, as outlined in the contractual obligations table below. As of December 31, 2020, we had a remaining tax obligation of $238.7 million related to the deemed repatriation. See Note 17 to the "Consolidated Financial Statements" for additional information about the one-time transition tax.

As of December 31, 2020, cash and cash equivalents and short-term investments held in the United States and outside the United States were $618.8 million and $783.8 million, respectively. During 2020, we repatriated cash of $600.0 million. We
30
assert that $1.1 billion of our foreign earnings continue to be permanently reinvested and our intent is to repatriate $599.8 million of our foreign earnings as of December 31, 2020.

On July 12, 2020, we reached the Settlement Agreement with Abbott to settle all outstanding patent disputes between the companies in cases related to transcatheter mitral and tricuspid repair products. The Settlement Agreement resulted in us recording an estimated $367.9 million pretax charge in June 2020 related to past damages. In addition, we will incur royalty expenses through May 2024 totaling an estimated $100 million. We made a one-time $100.0 million payment to Abbott in July 2020, and will make quarterly payments in future years. For further information, see Notes 3 and 18 to the "Consolidated Financial Statements."

On April 18, 2019, we acquired CASMED for an aggregate cash purchase price of $2.45 per share of common stock, or $100.8 million. For more information, see Note 8 to the "Consolidated Financial Statements."

Certain of our business acquisitions involve contingent consideration arrangements. Payment of additional consideration in the future may be required, contingent upon the acquired company reaching certain performance milestones, such as attaining specified revenue levels or obtaining regulatory approvals. For further information, see Note 8 to the "Consolidated Financial Statements."

We have a Five-Year Credit Agreement ("the Credit Agreement") which matures on April 28, 2023. The Credit Agreement provides up to an aggregate of $750.0 million in borrowings in multiple currencies. Subject to certain terms and conditions, we may increase the amount available under the Credit Agreement by up to an additional $250.0 million in the aggregate. As of December 31, 2020, there were no borrowings outstanding under the Credit Agreement. The Credit Agreement is unsecured and contains various financial and other covenants, including a maximum leverage ratio, as defined in the Credit Agreement. The Company was in compliance with all covenants at December 31, 2020.

In June 2018, we issued $600.0 million of 4.3% fixed-rate unsecured senior notes (the "2018 Notes") due June 15, 2028. We may redeem the 2018 Notes, in whole or in part, at any time and from time to time at specified redemption prices. As of December 31, 2020, we have not elected to redeem any of the 2018 Notes. As of December 31, 2020, the total carrying value of our 2018 Notes was $595.0 million. For further information on our debt, see Note 10 to the "Consolidated Financial Statements."

From time to time, we repurchase shares of our common stock under share repurchase programs authorized by the Board of Directors. We consider several factors in determining when to execute share repurchases, including, among other things, expected dilution from stock plans, cash capacity, and the market price of our common stock. During 2020, under the Board authorized repurchase programs, we repurchased a total of 3.0 million shares at an aggregate cost of $614.7 million, and as of December 31, 2020, we had remaining authority to purchase $625.0 million of our common stock. For further information, see Note 14 to the "Consolidated Financial Statements." In February 2021, we entered into an accelerated share repurchase agreement to repurchase $250.0 million of our common stock. For further information, see Note 22 to the "Consolidated Financial Statements."
Consolidated Cash Flows - For the twelve months ended December 31, 2020 and 2019
ew-20201231_g11.jpg ew-20201231_g12.jpg ew-20201231_g13.jpg
Net cash flows provided by operating activities of $1.1 billion for 2020 decreased $128.6 million from 2019 due primarily to lower operating profits in 2020 and a payment of $100.0 million for a litigation settlement, partially offset by a payment of $180.0 million in 2019 for a litigation settlement.
31

Net cash used in investing activities of $531.1 million in 2020 consisted primarily of capital expenditures of $407.0 million and net purchases of investments of $87.6 million.

Net cash used in investing activities of $595.8 million in 2019 consisted primarily of a) capital expenditures of $254.4 million, b) net purchases of investments of $174.9 million, c) a $100.2 million net cash payment associated with the acquisition of CASMED, d) a $35.0 million payment for an option to acquire a company, and e) a $24.0 million payment to acquire certain early-stage transcatheter intellectual property and associated clinical and regulatory experience.

We currently anticipate making capital expenditures of approximately $350 million in 2021 as we continue to invest in our operations.
Net cash used in financing activities of $486.9 million in 2020 consisted primarily of purchases of treasury stock of $625.4 million, partially offset by proceeds from stock plans of $140.5 million.

Net cash used in financing activities of $115.6 million in 2019 consisted primarily of purchases of treasury stock of $263.3 million, partially offset by proceeds from stock plans of $160.5 million.

Contractual Obligations

A summary of all of our contractual obligations and commercial commitments as of December 31, 2020 is as follows (in millions):
 Payments Due by Period
Contractual ObligationsTotalYear 1
Years 2-3
Years 4-5		After 5
Years
Debt$600.0 $— $— $— $600.0 
Operating leases108.1 30.0 35.1 14.9 28.1 
Interest on debt148.9 20.5 40.5 39.4 48.5 
Transition tax on unremitted foreign earnings and profits (a)238.7 25.1 72.2 141.4 — 
Litigation settlement obligation (minimum payments)250.0 50.0 100.0 100.0 — 
Pension obligations (b)2.5 2.5 — — — 
Purchase and other commitments (c)26.7 13.7 9.7 1.5 1.8 
Total contractual cash obligations (d), (e)$1,374.9 $141.8 $257.5 $297.2 $678.4 
_______________________________________________________________________________
(a)     As of December 31, 2020, we had recorded $238.7 million of income tax liabilities related to the one-time transition tax that resulted from the enactment of the 2017 Act. The transition tax is due in eight annual installments, with the first annual installment paid in 2018, the second annual installment paid in 2019 and the third annual installment paid in 2020. The remaining installment amounts will be equal to 8% of the total liability, payable in fiscal years 2021 through 2022, 15% in fiscal year 2023, 20% in fiscal year 2024, and 25% in fiscal year 2025. See Note 17 to the "Consolidated Financial Statements" for additional information about the one-time transition tax.

(b)    The amount included in "Less Than 1 Year" reflects anticipated contributions to our various pension plans. Anticipated contributions beyond one year are not determinable. The total accrued benefit liability for our pension plans recognized as of December 31, 2020 was $52.9 million. This amount is impacted by, among other items, pension expense funding levels, changes in plan demographics and assumptions, and investment returns on plan assets. Therefore, we are unable to make a reasonably reliable estimate of the amount and period in which the liability might be paid, and did not include this amount in the contractual obligations table. See Note 13 to the "Consolidated Financial Statements" for further information.

(c)    Purchase and other commitments consists primarily of open purchase orders for the acquisition of goods and services in the normal course of business. We have excluded open purchase orders with a remaining term of less than one year. For certain purchase and other commitments, such as commitments to fund equity method or other investments, the timing of the payment is not certain. In these cases, the maturity dates in the table reflect our best estimates.

(d)    As of December 31, 2020, the gross liability for uncertain tax positions, including interest, was $301.2 million and relates primarily to transfer pricing matters. During 2018, we executed an APA between the United States and Switzerland governments for tax years 2009 through 2020 covering various but not all transfer pricing matters. As a result, certain
32
intercompany transactions covering tax years 2015 through 2020 that were not resolved under the APA program remain subject to IRS examination, and those transactions and related tax positions remain uncertain as of the balance sheet date. These unresolved transfer pricing matters may be significant to our consolidated financial statements, and the final outcome of the negotiations is uncertain. Management believes that adequate amounts of tax and related penalty and interest have been provided in income tax expense for any adjustments that may result for our uncertain tax positions. We are unable to make a reasonably reliable estimate of the amount and period in which the liability might be paid, and did not include this amount in the contractual obligations table.

(e)    We acquire assets still in development, enter into research and development arrangements, acquire businesses, and sponsor certain clinical trials that often require milestone, royalty, or other future payments to third-parties, contingent upon the occurrence of certain future events. In situations where we have no ability to influence the achievement of the milestone or otherwise avoid the payment, we have included those payments in the table above. However, we have excluded from the table contingent milestone payments and other contingent liabilities for which we cannot reasonably predict future payments or for which we can avoid making payment by unilaterally deciding to stop development of a product or cease progress of a clinical trial. We estimate that these contingent payments could be up to $810.0 million if all milestones or other contingent obligations are met. This amount includes certain milestone-based contingent obligations that may be paid through a combination of cash and issuance of common stock, and certain sales-based royalties in excess of minimum payment thresholds related to litigation settlements.

Critical Accounting Policies and Estimates

Our results of operations and financial position are determined based upon the application of our accounting policies, as discussed in the notes to the "Consolidated Financial Statements." Certain of our accounting policies represent a selection among acceptable alternatives under GAAP. In evaluating our transactions, management assesses all relevant GAAP and chooses the accounting policy that most accurately reflects the nature of the transactions.

The application of accounting policies requires the use of judgment and estimates. These matters that are subject to judgments and estimation are inherently uncertain, and different amounts could be reported using different assumptions and estimates. Management uses its best estimates and judgments in determining the appropriate amount to reflect in the consolidated financial statements, using historical experience and all available information. We also use outside experts where appropriate. We apply estimation methodologies consistently from year to year.

We believe the following are the critical accounting policies which could have the most significant effect on our reported results and require subjective or complex judgments by management.

Revenue Recognition

When we recognize revenue from the sale of our products, the amount of consideration we ultimately receive varies depending upon the return terms, sales rebates, discounts, and other incentives that we may offer, which are accounted for as variable consideration when estimating the amount of revenue to recognize. The estimate of variable consideration requires significant judgment. We include estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely upon an assessment of historical payment experience, historical relationship to revenues, estimated customer inventory levels, and current contract sales terms with direct and indirect customers. Product returns are typically not significant because returns are generally not allowed unless the product is damaged at time of receipt. If the historical data and inventory estimates used to calculate the variable consideration do not approximate future activity, our financial position, results of operations, and cash flows could be impacted.

In addition, in limited circumstances, we may allow customers to return previously purchased products, such as for next-generation product offerings. For these transactions, we defer recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer. Uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls, and variation in product utilization all affect the estimates related to sales returns and could cause actual returns to differ from these estimates.

Our sales adjustment related to distributor rebates given to our United States distributors represents the difference between our sales price to the distributor and the negotiated price to be paid by the end-customer. We validate the distributor rebate accrual quarterly through either a review of the inventory reports obtained from our distributors or an estimate of the
33
distributor's inventory. This distributor inventory information is used to verify the estimated liability for future distributor rebate claims based on historical rebates and contract rates. We periodically monitor current pricing trends and distributor inventory levels to ensure the credit for future distributor rebates is fairly stated.

Excess and Obsolete Inventory

The valuation of our inventory requires us to estimate excess, obsolete, and expired inventory. We base our provisions for excess, obsolete, and expired inventory on our estimates of forecasted net sales. A significant change in the timing or level of demand for our products as compared to forecasted amounts may result in recording additional allowances for excess, obsolete, and expired inventory in the future. In addition, our industry is characterized by rapid product development and frequent new product introductions. Uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls, increasing levels of consigned inventory, and variation in product utilization all affect our estimates related to excess, obsolete, and expired inventory.

Intangible Assets and Long-lived Assets

We acquire intangible assets in connection with business combinations and asset purchases. The acquired intangible assets are recorded at fair value, which is determined based on a discounted cash flow analysis. The determination of fair value requires significant estimates, including, but not limited to, the amount and timing of projected future cash flows, the discount rate used to discount those cash flows, the assessment of the asset's life cycle, including the timing and expected costs to complete in-process projects, and the consideration of legal, technical, regulatory, economic, and competitive risks.

In-process research and development assets acquired in business combinations is reviewed for impairment annually, or whenever an event occurs or circumstances change that would indicate the carrying amount may be impaired. Additionally, management reviews the carrying amounts of other intangible and long-lived assets whenever events or circumstances indicate that the carrying amounts of an asset may not be recoverable. The impairment reviews require significant estimates about fair value, including estimation of future cash flows, selection of an appropriate discount rate, and estimates of long-term growth rates.

Contingent Consideration

We record contingent consideration resulting from a business combination at its fair value on the acquisition date. We determine the fair value of the contingent consideration based primarily on the following factors:

•discount rates used to present value the projected cash flows;

•the probability of success of clinical events and regulatory approvals, and/or meeting commercial milestones;

•projected payment dates; and

•volatility of future revenue.

On a quarterly basis, we revalue these obligations and record changes in their fair value as an adjustment to earnings. Changes to contingent consideration obligations can result from adjustments to discount rates, accretion of the discount rates due to the passage of time, changes in our estimates of the likelihood or timing of achieving development or commercial milestones, changes in the probability of certain clinical events, or changes in the assumed probability associated with regulatory approval.

The assumptions related to determining the value of contingent consideration include a significant amount of judgment, and any changes in the underlying estimates could have a material impact on the amount of contingent consideration expense recorded in any given period.

34
Income Taxes

The determination of our provision for income taxes requires significant judgment, the use of estimates, and the interpretation and application of complex tax laws. Realization of certain deferred tax assets, primarily tax credits, net operating loss and other carryforwards, is dependent upon generating sufficient taxable income in the appropriate jurisdiction prior to the expiration of the carryforward periods. Failure to achieve forecasted taxable income in the applicable taxing jurisdictions could affect the ultimate realization of deferred tax assets and could result in an increase in our effective tax rate on future earnings.

We have made an accounting policy election to recognize the U.S. tax effects of global intangible low-taxed income as a component of income tax expense in the period the tax arises.

We are subject to income taxes in the United States and numerous foreign jurisdictions. Our income tax returns are periodically audited by domestic and foreign tax authorities. These audits include questions regarding our tax filing positions, including the timing and amount of deductions and the allocation of income amongst various tax jurisdictions. We evaluate our tax positions and establish liabilities in accordance with the applicable accounting guidance on uncertainty in income taxes. Significant judgment is required in evaluating our uncertain tax positions, including estimating the ultimate resolution to intercompany pricing controversies between countries when there are numerous possible outcomes. We review these tax uncertainties quarterly and adjust the liability as events occur that affect potential liabilities for additional taxes, such as the progress of tax audits, lapsing of applicable statutes of limitations, negotiations between tax authorities, identification of new issues, and issuance of new legislation, regulations, or case law.

For additional details on our income taxes, see Note 2 and Note 17 to the "Consolidated Financial Statements."

Stock-based Compensation

We measure and recognize compensation expense for all stock-based awards based on estimated fair values. Stock-based awards consist of stock options, service-based restricted stock units, market-based restricted stock units, performance-based restricted stock units, and employee stock purchase subscriptions. The fair value of each option award and employee stock purchase subscription is estimated on the date of grant using the Black-Scholes option valuation model. The fair value of market-based restricted stock units is determined using a Monte Carlo simulation model, which uses multiple input variables to determine the probability of satisfying the market condition requirements. The Black-Scholes and Monte Carlo models require various highly judgmental assumptions, including stock price volatility, risk-free interest rate, and expected option term. For performance-based restricted stock units, expense is recognized if and when we conclude that it is probable that the performance condition will be achieved, which requires judgment. Stock-based compensation expense is recorded net of estimated forfeitures. Judgment is required in estimating the stock awards that will ultimately be forfeited. If actual results differ significantly from these estimates, stock-based compensation expense and our results of operations would be impacted.

Legal Contingencies

We are or may be a party to, or may otherwise be responsible for, pending or threatened lawsuits including those related to products and services currently or formerly manufactured or performed, as applicable, by us, workplace and employment matters, matters involving real estate, our operations or health care regulations, or governmental investigations. We accrue for loss contingencies to the extent that we conclude that it is probable that a loss will be incurred and the amount of the loss can be reasonably estimated. These matters raise difficult and complex factual and legal issues and are subject to many uncertainties, including, but not limited to, the facts and circumstances of each particular case or claim, the jurisdiction in which each suit is brought, and differences in applicable law. As such, significant judgment is required in determining our legal accruals. We describe our legal proceedings in Note 18 to the "Consolidated Financial Statements."

New Accounting Standards

Information regarding new accounting standards is included in Note 2 to the "Consolidated Financial Statements."

Item 7A.    Quantitative and Qualitative Disclosures About Market Risk

Our business and financial results are affected by fluctuations in world financial markets, including changes in currency exchange rates and interest rates. We manage these risks through a combination of normal operating and financing activities and derivative financial instruments. We do not use derivative financial instruments for trading or speculative purposes.

35
Interest Rate Risk

Our exposure to market risk for changes in interest rates relates primarily to our investment portfolio and our long-term debt. Our investment strategy is focused on preserving capital and supporting our liquidity requirements, while earning a reasonable market return. We invest in a variety of debt securities, primarily time deposits, commercial paper, U.S. and foreign government and agency securities, asset-backed securities, corporate debt securities, and municipal debt securities. The market value of our investments may decline if current market interest rates rise. As of December 31, 2020, we had $985.9 million of investments in debt securities which had an average remaining term to maturity of approximately 1.56 years. Taking into consideration the average maturity of our debt securities, a hypothetical 0.5% to 1.0% absolute increase in interest rates at December 31, 2020 would have resulted in a $7.8 million to $15.6 million decrease in the fair value of these investments. Such a decrease would only result in a realized loss if we choose or are forced to sell the investments before the scheduled maturity, which we currently do not anticipate.

For more information related to investments, see Note 7 to the "Consolidated Financial Statements."

We are also exposed to interest rate risk on our debt obligations. As of December 31, 2020, we had $600.0 million of Notes outstanding that carry a fixed rate, and also had available a $750.0 million Credit Agreement that carries a variable interest rate based on the London interbank offered rate ("LIBOR"). As of December 31, 2020, there were no borrowings outstanding under the Credit Agreement. Based on our December 31, 2020 variable debt levels, a hypothetical 1.0% absolute increase in floating market interest rates would not have impacted our interest expense since we had no variable debt outstanding during the year. As of December 31, 2020, a hypothetical 1.0% absolute increase in market interest rates would decrease the fair value of the fixed-rate debt by approximately $43.2 million. This hypothetical change in interest rates would not impact the interest expense on the fixed-rate debt.

For more information related to outstanding debt obligations, see Note 10 to the "Consolidated Financial Statements."

Currency Risk

We are exposed to foreign currency risks that arise from normal business operations. These risks include the translation of local currency balances and results of our non-United States subsidiaries into United States dollars, currency gains and losses related to intercompany and third-party transactions denominated in currencies other than a subsidiary's functional currency, and currency gains and losses associated with intercompany loans. Our principal currency exposures relate to the Euro and the Japanese yen. Our objective is to minimize the volatility of our exposure to these risks through a combination of normal operating and financing activities and the use of derivative financial instruments in the form of foreign currency forward exchange contracts and cross currency swap contracts. The total notional amount of our derivative financial instruments entered into for foreign currency management purposes at December 31, 2020 was $1.8 billion. A hypothetical 10% increase/decrease in the value of the United States dollar against all hedged currencies would increase/decrease the fair value of these derivative contracts by $141.5 million. Any gains or losses on the fair value of derivative contracts would generally be offset by gains and losses on the underlying transactions, so the net impact would not be significant to our financial condition or results of operations.

For more information related to outstanding foreign exchange contracts, see Note 2 and Note 12 to the "Consolidated Financial Statements."

Credit Risk

Derivative financial instruments involve credit risk in the event the financial institution counterparty should default. It is our policy to execute such instruments with major financial institutions that we believe to be creditworthy. At December 31, 2020, all derivative financial instruments were with bank counterparties assigned investment grade ratings by national rating agencies. We further diversify our derivative financial instruments among counterparties to minimize exposure to any one of these entities. We have not experienced a counterparty default and do not anticipate any non-performance by our current derivative counterparties.

Concentrations of Risk

We invest excess cash in a variety of debt securities, and diversify the investments between financial institutions. Our investment policy limits the amount of credit exposure to any one issuer.

36
In the normal course of business, we provide credit to customers in the health care industry, perform credit evaluations of these customers, and maintain allowances for potential credit losses, which have historically been adequate compared to actual losses. In 2020, we had no customers that represented 10% or more of our total net sales or accounts receivable, net.

Investment Risk

We are exposed to investment risks related to changes in the underlying financial condition and credit capacity of certain of our investments. As of December 31, 2020, we had $985.9 million of investments in debt securities of various companies, of which $766.5 million were long-term. In addition, we had $35.1 million of investments in equity instruments of public and private companies. Should these companies experience a decline in financial performance, financial condition or credit capacity, or fail to meet certain development milestones, including as a result of the impact from COVID-19 on their business or operations or otherwise, a decline in the investments' value may occur, resulting in unrealized or realized losses.

37
Item 8.    Financial Statements and Supplementary Data


INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2020

Financial Statements: 
For the Years Ended December 31, 2020, 2019, and 2018:
 
All other schedules are omitted as they are not applicable or the required information is furnished in the Consolidated Financial Statements or notes thereto. 

38
Report of Independent Registered Public Accounting Firm

To the Board of Directors and Stockholders of Edwards Lifesciences Corporation

Opinions on the Financial Statements and Internal Control over Financial Reporting

We have audited the accompanying consolidated balance sheets of Edwards Lifesciences Corporation and its subsidiaries (the “Company”) as of December 31, 2020 and 2019, and the related consolidated statements of operations, of comprehensive income, of stockholders’ equity and of cash flows for each of the three years in the period ended December 31, 2020, including the related notes (collectively referred to as the “consolidated financial statements”). We also have audited the Company's internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2020 and 2019, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2020 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.

Change in Accounting Principle

As discussed in Note 2 to the consolidated financial statements, the Company changed the manner in which it accounts for leases in 2019.

Basis for Opinions

The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management's Report on Internal Control Over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the
39
company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Critical Audit Matters
The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that (i) relate to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

Uncertain Tax Positions Related to Intercompany Transfer Pricing

As described in Notes 2 and 17 to the consolidated financial statements, the Company had a gross uncertain tax position liability balance of $281.8 million as of December 31, 2020, primarily related to transfer pricing. The Company is subject to income taxes in the United States and numerous foreign jurisdictions. As disclosed by management, the Company’s income tax returns in these jurisdictions are periodically audited by domestic and foreign tax authorities. These audits include questions regarding the Company’s tax filing positions, including the timing and amount of deductions and the allocation of income amongst various tax jurisdictions. Significant judgment is required by management in evaluating uncertain tax positions, including estimating the ultimate resolution to intercompany pricing controversies between countries when there are numerous possible outcomes.

The principal considerations for our determination that performing procedures relating to uncertain tax positions related to intercompany transfer pricing is a critical audit matter are the significant judgment by management when determining uncertain tax positions related to intercompany transfer pricing, including a high degree of estimation uncertainty in evaluating whether certain tax filing positions taken by management will be upheld by the related local tax authority. This in turn led to a high degree of auditor judgment, effort, and subjectivity in performing procedures to evaluate the accurate measurement of uncertain tax positions related to intercompany transfer pricing. Also, the evaluation of audit evidence available to support the tax liabilities for uncertain tax positions related to intercompany transfer pricing is complex and required significant auditor judgment as the nature of the evidence is highly subjective and the audit effort involved the use of professionals with specialized skill and knowledge.

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to recognition of the liability for uncertain tax positions related to intercompany transfer pricing and controls over measurement of the liability. These procedures also included, among others, (i) testing the information used in the calculation of the liability for uncertain tax positions, including U.S. federal filing positions and the related final tax returns; (ii) testing the calculation of the liability for uncertain tax positions related to intercompany transfer pricing, by jurisdiction, including management’s assessment of the technical merits of tax positions and estimates of the amount of tax benefit expected to be sustained; (iii) testing of management’s assessment of possible outcomes of uncertain tax positions related to intercompany transfer pricing; and (iv) evaluating the status and results of income tax audits with the relevant tax authorities. Professionals with specialized skill and knowledge were used to assist in the evaluation of the completeness and measurement of the Company’s uncertain tax positions related to intercompany transfer pricing, including evaluating the reasonableness of management’s assessment of whether tax positions are more-likely-than-not to be sustained and the amount of potential benefit to be realized, and the application of relevant tax laws.

Fair Value of Contingent Consideration Liabilities
As described in Note 11 to the consolidated financial statements, certain of the Company’s acquisitions involve contingent consideration arrangements. As of December 31, 2020, the Company had a contingent consideration liability of $186.1 million. As disclosed by management, payment of additional consideration is contingent upon the acquired company reaching certain performance milestones, such as attaining specified revenue levels or obtaining regulatory approvals. These contingent consideration liabilities are measured by management at estimated fair value using either a probability weighted discounted cash flow analysis or a Monte Carlo simulation model, both of which consider significant unobservable inputs. These inputs
40
include (1) the discount rate used to present value the projected cash flows, (2) the probability of milestone achievement, (3) the projected payment dates, and (4) the volatility of future revenue.
The principal considerations for our determination that performing procedures relating to the fair value of contingent consideration liabilities is a critical audit matter are the significant judgment by management when estimating the fair value of these contingent consideration liabilities, including a high degree of estimation uncertainty in evaluating the discount rate, the probability of milestone achievement, the projected payment dates, and the volatility of future revenue. This in turn led to a high degree of auditor judgment, effort, and subjectivity in performing procedures to evaluate the fair value of contingent consideration liabilities. Also, the evaluation of audit evidence available to support the fair value of the contingent consideration liabilities is complex and resulted in significant auditor judgment as the nature of the evidence is highly subjective and the audit effort involved the use of professionals with specialized skill and knowledge.

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to management’s process for estimating the fair value of contingent consideration liabilities, including controls over the determination of the significant unobservable inputs selected by management. These procedures also included, among others, (i) testing management’s process for estimating the fair value of contingent consideration liabilities and (ii) testing management’s probability weighted discounted cash flow analysis or a Monte Carlo simulation used to estimate the fair value of the contingent consideration liabilities. Testing management’s process included evaluating the appropriateness of the valuation methods used and the reasonableness of the significant assumptions related to the discount rate, the probability of milestone achievement, the projected payment dates, and the volatility of future revenue. Evaluating the reasonableness of the probability of milestone achievement and projected payment date of each milestone involved consideration of information obtained from the Company’s product engineers, clinical trial data, and third-party industry data. The discount rate was evaluated by considering the cost of capital of comparable businesses and other industry factors. Professionals with specialized skill and knowledge were used to assist in the evaluation of certain significant assumptions, including the discount rate and volatility of future revenue. 



/s/ PricewaterhouseCoopers LLP
Irvine, California
February 12, 2021

We have served as the Company’s auditor since 1999
41
EDWARDS LIFESCIENCES CORPORATION

CONSOLIDATED BALANCE SHEETS

(in millions, except par value)

December 31,
20202019
ASSETS
Current assets  
Cash and cash equivalents$1,183.2 $1,179.1 
Short-term investments (Note 7)219.4 337.8 
Accounts receivable, net of allowances of $9.6 and $8.7, respectively
514.6 543.6 
Other receivables88.2 55.5 
Inventories (Note 5)802.3 640.9 
Prepaid expenses75.1 59.1 
Other current assets208.2 168.0 
Total current assets3,091.0 2,984.0 
Long-term investments (Note 7)801.6 585.5 
Property, plant, and equipment, net (Note 5)1,395.2 1,060.3 
Operating lease right-of-use assets (Note 6)94.2 80.1 
Goodwill (Note 9)1,173.2 1,167.7 
Other intangible assets, net (Note 9)331.4 336.5 
Deferred income taxes230.9 172.2 
Other assets119.6 101.8 
Total assets$7,237.1 $6,488.1 
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities  
Accounts payable$196.5 $180.4 
Accrued and other liabilities (Note 5)670.2 696.5 
Operating lease liabilities (Note 6)27.2 25.5 
Total current liabilities893.9 902.4 
Long-term debt (Note 10)595.0 594.4 
Contingent consideration liabilities (Notes 8 and 11)186.1 172.5 
Taxes payable (Note 17)215.3 236.6 
Operating lease liabilities (Note 6)72.7 58.9 
Uncertain tax positions (Note 17)214.4 171.7 
Litigation settlement accrual (Notes 3 and 18)233.0 — 
Other long-term liabilities252.4 203.3 
Commitments and contingencies (Notes 6, 10 and 18)
Stockholders' equity (Note 14)
  
Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding
— — 
Common stock, $1.00 par value, 1,050.0 shares authorized, 636.4 and 218.1 shares issued, and 624.3 and 209.1 shares outstanding, respectively
636.4 218.1 
Additional paid-in capital1,438.1 1,623.3 
Retained earnings4,565.0 3,741.6 
Accumulated other comprehensive loss(161.1)(156.0)
Treasury stock, at cost, 12.1 and 9.0 shares, respectively
(1,904.1)(1,278.7)
Total stockholders' equity4,574.3 4,148.3 
Total liabilities and stockholders' equity$7,237.1 $6,488.1 
   
The accompanying notes are an integral part of these consolidated financial statements.
42
EDWARDS LIFESCIENCES CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS

(in millions, except per share information)

Years Ended December 31,
 202020192018
Net sales$4,386.3 $4,348.0 $3,722.8 
Cost of sales1,080.6 1,114.4 939.4 
Gross profit3,305.7 3,233.6 2,783.4 
Selling, general, and administrative expenses1,228.4 1,242.2 1,088.5 
Research and development expenses760.7 752.7 622.2 
Intellectual property litigation expenses, net (Note 3)405.4 33.4 214.0 
Change in fair value of contingent consideration liabilities13.6 (6.1)(5.7)
Special charges (Note 4)— 64.6 116.2 
Operating income897.6 1,146.8 748.2 
Interest expense15.8 20.7 29.9 
Interest income(23.4)(32.2)(32.0)
Special gain (Note 4)— — (7.1)
Other income, net (Note 16)(11.5)(8.2)(4.0)
Income before provision for income taxes916.7 1,166.5 761.4 
Provision for income taxes (Note 17)93.3 119.6 39.2 
Net income$823.4 $1,046.9 $722.2 
Share information (Note 2):
   
Earnings per share:   
Basic$1.32 $1.68 $1.15 
Diluted$1.30 $1.64 $1.13 
Weighted-average number of common shares outstanding:  
Basic622.6 624.8 627.6 
Diluted631.9 636.7 640.9 

   The accompanying notes are an integral part of these consolidated financial statements.

43
EDWARDS LIFESCIENCES CORPORATION

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(in millions)

 Years Ended December 31,
 202020192018
Net income$823.4 $1,046.9 $722.2 
Other comprehensive (loss) income, net of tax (Note 15):   
Foreign currency translation adjustments32.4 (11.2)(38.6)
Unrealized (loss) gain on hedges(40.2)(11.1)40.4 
Unrealized pension costs(4.2)(1.9)0.6 
Unrealized gain (loss) on available-for-sale investments6.6 6.3 (3.3)
Reclassification of net realized investment loss to earnings0.3 0.4 2.9 
Other comprehensive (loss) income, net of tax(5.1)(17.5)2.0 
Comprehensive income$818.3 $1,029.4 $724.2 
   
The accompanying notes are an integral part of these consolidated financial statements.

44
EDWARDS LIFESCIENCES CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in millions)

 Years Ended December 31,
 202020192018
Cash flows from operating activities   
Net income$823.4 $1,046.9 $722.2 
Adjustments to reconcile net income to cash provided by operating activities:  
Depreciation and amortization107.2 89.3 77.4 
Non-cash operating lease cost28.2 25.3 — 
Stock-based compensation (Notes 2 and 14)92.6 81.3 71.0 
Inventory write off— 73.1 — 
Impairment charges (Note 4)— 40.6 118.8 
Change in fair value of contingent consideration liabilities, net (Note 11)13.6 (6.1)(5.7)
Deferred income taxes(49.4)12.1 (27.3)
Purchased in-process research and development— 24.0 — 
Other(3.5)(2.8)13.0 
Changes in operating assets and liabilities:  
Accounts and other receivables, net41.9 (88.0)(28.7)
Inventories(120.6)(105.4)(65.7)
Prepaid expenses and other current assets(28.5)(6.8)15.6 
Accounts payable and accrued liabilities(84.5)116.5 12.5 
Litigation settlement accrual270.5 (180.0)180.0 
Income taxes(52.9)43.2 (157.8)
Other16.3 19.7 1.4 
Net cash provided by operating activities1,054.3 1,182.9 926.7 
Cash flows from investing activities  
Capital expenditures(407.0)(254.4)(238.7)
Purchases of held-to-maturity investments (Note 7)(162.0)(130.2)(210.0)
Proceeds from sales and maturities of held-to-maturity investments (Note 7)212.2 50.0 578.1 
Purchases of available-for-sale investments (Note 7)(689.7)(437.9)(249.3)
Proceeds from sales and maturities of available-for-sale investments (Note 7)564.8 359.9 223.2 
Acquisition (Notes 8 and 9)— (100.2)— 
Payment for acquisition option(10.0)(35.0)— 
Issuances of notes receivable(27.0)(12.9)(0.6)
Investments in intangible assets and in-process research and development(0.3)(24.0)(3.0)
Other(12.1)(11.1)(23.0)
Net cash (used in) provided by investing activities(531.1)(595.8)76.7 
Cash flows from financing activities   
Proceeds from issuance of debt16.2 18.9 688.0 
Payments on debt and finance lease obligations(17.0)(28.9)(1,125.3)
Purchases of treasury stock(625.4)(263.3)(795.5)
Proceeds from stock plans140.5 160.5 147.0 
Payment of contingent consideration— — (15.1)
Other(1.2)(2.8)(0.3)
Net cash used in financing activities(486.9)(115.6)(1,101.2)
Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash(20.5)(3.0)(6.5)
Net increase (decrease) in cash, cash equivalents, and restricted cash15.8 468.5 (104.3)
Cash, cash equivalents, and restricted cash at beginning of year1,184.4 715.9 820.2 
Cash, cash equivalents, and restricted cash at end of year$1,200.2 $1,184.4 $715.9 

The accompanying notes are an integral part of these consolidated financial statements.
45
EDWARDS LIFESCIENCES CORPORATION

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

(in millions)

 Common StockTreasury Stock
 SharesPar ValueSharesAmountAdditional Paid-in CapitalRetained EarningsAccumulated Other Comprehensive LossTotal Stockholders' Equity
BALANCE AT DECEMBER 31, 2017212.0 $212.0 2.3 $(252.1)$1,166.9 $1,962.1 $(132.7)$2,956.2 
Impact to retained earnings from adoption of ASU 2016-16 and ASU 2018-0210.4 (7.8)2.6 
BALANCE AT JANUARY 1, 2018212.0 212.0 2.3 (252.1)1,166.9 1,972.5 (140.5)2,958.8 
Net income     722.2  722.2 
Other comprehensive income, net of tax      2.0 2.0 
Common stock issued under equity plans
3.2 3.2   143.8   147.0 
Stock-based compensation expense    71.0   71.0 
Shares issued in payment for contingent consideration liabilities(0.3)32.2 2.7 34.9 
Purchases of treasury stock  5.5 (795.5)  (795.5)
BALANCE AT DECEMBER 31, 2018215.2 215.2 7.5 (1,015.4)1,384.4 2,694.7 (138.5)3,140.4 
Net income     1,046.9  1,046.9 
Other comprehensive loss, net of tax      (17.5)(17.5)
Common stock issued under equity plans
2.9 2.9   157.6   160.5 
Stock-based compensation expense    81.3   81.3 
Purchases of treasury stock  1.5 (263.3)—   (263.3)
BALANCE AT DECEMBER 31, 2019218.1 218.1 9.0 (1,278.7)1,623.3 3,741.6 (156.0)4,148.3 
Net income     823.4  823.4 
Other comprehensive loss, net of tax      (5.1)(5.1)
Common stock issued under equity plans
4.5 4.5   136.0   140.5 
Stock-based compensation expense    92.6   92.6 
Purchases of treasury stock  3.1 (625.4)   (625.4)
Stock issued to effect stock split413.8 413.8   (413.8)— 
BALANCE AT DECEMBER 31, 2020636.4 $636.4 12.1 $(1,904.1)$1,438.1 $4,565.0 $(161.1)$4,574.3 
   
The accompanying notes are an integral part of these consolidated financial statements.
46
EDWARDS LIFESCIENCES CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1.    DESCRIPTION OF BUSINESS

Edwards Lifesciences Corporation ("Edwards Lifesciences" or the "Company") conducts operations worldwide and is managed in the following geographical regions: United States, Europe, Japan, and Rest of World. Edwards Lifesciences is focused on technologies that treat structural heart disease and critically ill patients. The products and technologies provided by Edwards Lifesciences are categorized into the following main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care.

2.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of Edwards Lifesciences and its majority-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The Company reviews its investments in other entities to determine whether the Company is the primary beneficiary of a variable interest entity ("VIE"). The Company would be the primary beneficiary of the VIE, and would be required to consolidate the VIE, if it has the power to direct the significant activities of the entity and the obligation to absorb losses or receive benefits from the entity that may be significant to the VIE. Based on the Company's analysis, it determined it is not the primary beneficiary of any VIEs; however, future events may require VIEs to be consolidated if the Company becomes the primary beneficiary.

Certain reclassifications of previously reported amounts have been made to conform to classifications used in the current year.

Stock Split

On May 7, 2020, the Company’s Board of Directors declared a three-for-one stock split of its outstanding shares of common stock effected in the form of a stock dividend, distributed on May 29, 2020 to stockholders of record on May 18, 2020. The Company distributed two newly issued shares of common stock to holders of record of each share of common stock to effect the stock split. All applicable share and per-share amounts in the consolidated financial statements and the notes to consolidated financial statements have been retroactively adjusted to reflect this stock split. The consolidated balance sheet as of December 31, 2019 and the consolidated statements of stockholders’ equity for the twelve months ended December 31, 2019 have not been retroactively adjusted to reflect the stock split.

Use of Estimates

The consolidated financial statements of Edwards Lifesciences have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") which have been applied consistently in all material respects. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. In particular, the novel Coronavirus ("COVID-19") pandemic has adversely impacted and is likely to further adversely impact nearly all aspects of our business and markets, including our workforce and the operations of our customers, suppliers, and business partners. The full extent to which the pandemic will directly or indirectly impact the Company's business, results of operations and financial condition, including sales, expenses, manufacturing, clinical trials, research and development costs, reserves and allowances, fair value measurements, asset impairment charges, contingent consideration obligations, and the effectiveness of the Company's hedging instruments, will depend on future developments that are highly uncertain and difficult to predict. These developments include, but are not limited to, the duration and spread of the outbreak (including new variants of COVID-19), its severity, the actions to contain the virus or address its impact, the timing, distribution, and efficacy of vaccines and other treatments, U.S. and foreign government actions to respond to the reduction in global economic activity, and how quickly and to what extent normal economic and operating conditions can resume.

47
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
2.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)


Foreign Currency Translation

When the local currency of the Company's foreign entities is the functional currency, all assets and liabilities are translated into United States dollars at the rate of exchange in effect at the balance sheet date. Income and expense items are translated at the weighted-average exchange rate prevailing during the period. The effects of foreign currency translation adjustments for these entities are deferred and reported in stockholders' equity as a component of "Accumulated Other Comprehensive Loss." The effects of foreign currency transactions denominated in a currency other than an entity's functional currency are included in "Other Income, net."

Revenue Recognition

Revenue is recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those products or services.

The Company generates nearly all of its revenue from direct product sales and sales of products under consignment arrangements. Revenue from direct product sales is recognized at a point in time when the performance obligation is satisfied upon delivery of the product. Revenue from sales of consigned inventory is recognized at a point in time when the performance obligation is satisfied once the product has been implanted or used by the customer. The Company periodically reviews consignment inventories to confirm the accuracy of customer reporting. The Company also generates a small portion of its revenue from service contracts, and recognizes revenue from service contracts ratably over the term of the contracts. Sales taxes and other similar taxes that the Company collects concurrent with revenue-producing activities are excluded from revenue. The Company does not typically have any significant unusual payment terms beyond 90 days in its contracts with customers. In addition, the Company receives royalty payments for the licensing of certain intellectual property and recognizes the royalty when the subsequent sale of product using the intellectual property occurs.

The amount of consideration the Company ultimately receives varies depending upon the return terms, sales rebates, discounts, and other incentives that the Company may offer, which are accounted for as variable consideration when estimating the amount of revenue to recognize. The Company includes estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely upon an assessment of historical payment experience, historical relationship to revenues, estimated customer inventory levels, and current contract sales terms with direct and indirect customers.

The Company's sales adjustment related to distributor rebates given to the Company's United States distributors represents the difference between the Company's sales price to the distributor and the negotiated price to be paid by the end-customer. This distributor rebate is recorded as a reduction to sales and a reduction to the distributor's accounts receivable at the time of sale to a distributor. The Company periodically monitors current pricing trends and distributor inventory levels to ensure the credit for future distributor rebates is fairly stated.

The Company offers volume rebates to certain group purchasing organizations ("GPOs") and customers based upon targeted sales levels. Volume rebates offered to GPOs are recorded as a reduction to sales and an obligation to the GPOs, as the Company expects to pay in cash. Volume rebates offered to customers are recorded as a reduction to sales and either accounts receivable if the Company expects a net payment from the customer, or as an obligation to the customer if the Company expects to pay in cash. The provision for volume rebates is estimated based upon customers' contracted rebate programs, projected sales levels, and historical experience of rebates paid. The Company periodically monitors its customer rebate programs to ensure that the allowance and liability for accrued rebates is fairly stated.

Product returns are typically not significant because returns are generally not allowed unless the product is damaged at time of receipt. In limited circumstances, the Company may allow customers to return previously purchased products, such as for next-generation product offerings. For these transactions, the Company defers recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer.

48
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
2.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)


The Company sells separately priced service contracts, which range from 12 to 36 months, to owners of its hemodynamic monitors. The Company invoices the customer the total amount of consideration at the inception of the contract and recognizes revenue ratably over the term of the contract. As of December 31, 2020 and December 31, 2019, $6.3 million and $8.4 million, respectively, of deferred revenue associated with outstanding service contracts was recorded in “Accrued and Other Liabilities” and "Other Long-term Liabilities." During 2020, the Company recognized as revenue $6.3 million that was included in the balance of deferred revenue as of December 31, 2019, and during 2019, the Company recognized as revenue $5.5 million that was included in the balance of deferred revenue as of December 31, 2018.

A limited number of the Company’s contracts with customers contain multiple performance obligations. For these contracts, the transaction price is allocated to each performance obligation based on its relative standalone selling price charged to other customers.

The Company applies the optional exemption of not disclosing the amount of the transaction price allocated to unsatisfied performance obligations for contracts with an original expected duration of one year or less.

Shipping and Handling Costs

Shipping costs, which are costs incurred to physically move product from the Company's premises or third party distribution centers, including storage, to the customer's premises, are included in "Selling, General, and Administrative Expenses." Handling costs, which are costs incurred to store at the Company's premises, move, and prepare products for shipment, are included in "Cost of Sales." For the years ended December 31, 2020, 2019, and 2018, shipping costs of $74.0 million, $71.5 million, and $70.6 million, respectively, were included in "Selling, General, and Administrative Expenses."

Cash Equivalents

The Company considers highly liquid investments with original maturities of three months or less to be cash equivalents. These investments are valued at cost, which approximates fair value.

Investments

The Company invests its excess cash in debt securities, including time deposits, commercial paper, U.S. government and agency securities, asset-backed securities, corporate debt securities, and municipal debt securities. Investments with maturities of one year or less are classified as short-term, and investments with maturities greater than one year are classified as long-term. Investments that the Company has the ability and intent to hold until maturity are classified as held-to-maturity and carried at amortized cost. Investments in debt securities that are classified as available-for-sale are carried at fair value with unrealized gains and losses included in "Accumulated Other Comprehensive Loss." The Company determines the appropriate classification of its investments in debt securities at the time of purchase and reevaluates such designation at each balance sheet date.

The Company also has long-term equity investments in companies that are in various stages of development. These investments are reported at fair value or under the equity method of accounting, as appropriate. Equity investments that do not have readily determinable fair values are recorded at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. The Company accounts for investments in limited partnerships and limited liability corporations, whereby the Company owns a minimum of 5% of the investee's outstanding voting stock, under the equity method of accounting. These investments are recorded at the amount of the Company's investment and adjusted each period for the Company's share of the investee's income or loss, and dividends paid.

Realized gains and losses on investments that are sold are determined using the specific identification method, or the first-in, first-out method, depending on the investment type, and recorded to "Other Income, net." Income relating to investments in debt securities is recorded to "Interest Income."

49
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
2.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)


Equity investments without readily determinable fair value are considered impaired when there is an indication that the fair value of the Company's interest is less than the carrying amount. Equity method investments are considered impaired when there is an indication of an other-than-temporary decline in value below the carrying amount. Impairments of equity investments are recorded in "Other Income, net."

Debt securities in an unrealized loss position are written down to fair value through “Other Income, net” if the Company intends to sell the security or it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. For debt securities in an unrealized loss position that do not meet the aforementioned criteria, the Company assesses whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost, changes to the rating of the security by a rating agency, and any adverse conditions specifically related to the security, among other factors. When a credit loss exists, the Company compares the present value of cash flows expected to be collected from the debt security to the amortized cost basis of the security to determine the allowance amount that should be recorded, if any. For available-to-sale debt securities, any additional impairment not recorded through an allowance for credit losses is recognized in “Accumulated Other Comprehensive Loss.”

Accounts Receivable

The majority of the Company’s accounts receivable arise from direct product sales and sales of products under consignment arrangements, and have payment terms that generally require payment within 30 to 90 days. The Company does not adjust its receivables for the effects of a significant financing component at contract exception if collection of the receivable is expected within one year or less from the time of sale. In countries where the Company has experienced a pattern of payments extending beyond the stated terms and collection of the receivable is expected beyond one year from the time of sale, the Company assesses whether the customer has a significant financing component and discounts the receivable and reduces the related revenues over the period of time that the Company estimates those amounts will be paid using the country’s market-based borrowing rate for such period.

The Company provides reserves against accounts receivable for estimated losses that may result from a customer’s inability to pay based on customer-specific analysis and general matters such as current assessments of past due balances, economic conditions and forecasts, and historical credit loss activity. Amounts determined to be uncollectible are charged or written-off against the reserve.

Inventories

Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value. Market value for raw materials is based on replacement costs, and for other inventory classifications is based on net realizable value.

A write-down for excess or slow moving inventory is recorded for inventory which is obsolete, damaged, nearing its expiration date (generally triggered at six months prior to expiration), or slow moving (generally defined as quantities in excess of a two-year supply).

The Company allocates to inventory general and administrative costs that are related to the production process. These costs include insurance, manufacturing accounting personnel, human resources personnel, and information technology. During the years ended December 31, 2020, 2019, and 2018, the Company allocated $63.1 million, $56.6 million, and $45.0 million, respectively, of general and administrative costs to inventory. General and administrative costs included in inventory at December 31, 2020 and 2019 were $30.7 million and $22.8 million, respectively.

At December 31, 2020 and 2019, $130.0 million and $117.8 million, respectively, of the Company's finished goods inventories were held on consignment.

50
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
2.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)


Property, Plant, and Equipment

Property, plant, and equipment are recorded at cost. Depreciation is principally calculated for financial reporting purposes on the straight-line method over the estimated useful lives of the related assets, which range from 10 to 40 years for buildings and improvements, from 3 to 15 years for machinery and equipment, and from 3 to 5 years for software. Leasehold improvements are amortized over the life of the related facility leases or the asset, whichever is shorter. Straight-line and accelerated methods of depreciation are used for income tax purposes. Construction in progress is not depreciated until the asset is ready for its intended use.

Depreciation expense for property, plant, and equipment was $101.8 million, $84.7 million, and $74.9 million for the years ended December 31, 2020, 2019, and 2018, respectively.

Leases

On January 1, 2019, the Company adopted an amendment to the guidance on leases using a modified retrospective transition approach. The Company determines whether a contract is, or contains, a lease at inception. Right-of-use assets represent the Company’s right to use an underlying asset during the lease term, and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at lease commencement based upon the estimated present value of unpaid lease payments over the lease term. The Company uses its incremental borrowing rate based on the information available at lease commencement in determining the present value of unpaid lease payments. The Company's incremental borrowing rate is determined based on the estimated rate of interest for collateralized borrowing over a similar term as the associated lease. Right-of-use assets also include any lease payments made at or before lease commencement and any initial direct costs incurred, and exclude any lease incentives received.

The Company determines the lease term as the noncancellable period of the lease, and may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Leases with a term of 12 months or less are not recognized on the balance sheet. Certain of the Company’s leases include variable lease payments that are based on costs incurred or actual usage, or adjusted periodically based on an index or a rate. The Company’s leases do not contain any residual value guarantees.

The Company accounts for the lease and non-lease components as a single lease component for all of its leases except vehicle leases, for which the lease and non-lease components are accounted for separately.

Operating leases are included in “Operating Lease Right-of-Use Assets” and “Operating Lease Liabilities” on the Company’s consolidated balance sheets. See Note 6 for further information.

Impairment of Goodwill and Long-lived Assets

Goodwill is reviewed for impairment annually in the fourth quarter of each fiscal year, or whenever an event occurs or circumstances change that would indicate that the carrying amount may be impaired. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the Company performs a quantitative impairment test. The Company determined, after performing a qualitative review of each reporting unit, that it is more likely than not that the fair value of each of its reporting units substantially exceeds the respective carrying amounts. Accordingly, in 2020, 2019, and 2018, the Company did not record any impairment loss.

Indefinite-lived intangible assets relate to in-process research and development acquired in business combinations. The estimated fair values of in-process research and development projects acquired in a business combination which have not reached technological feasibility are capitalized and accounted for as indefinite-lived intangible assets subject to impairment testing until completion or abandonment of the projects. Upon successful completion of the project, the capitalized amount is amortized over its estimated useful life. If the project is abandoned, all remaining capitalized amounts are written off immediately. Indefinite-lived intangible assets are reviewed for impairment annually in the fourth quarter of each fiscal year, or whenever an event occurs or circumstances change that would indicate the carrying amount may be impaired. An impairment
51
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
2.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)


loss is recognized when the asset's carrying value exceeds its fair value. In-process research and development projects acquired in an asset acquisition are expensed unless the project has an alternative future use.

Management reviews the carrying amounts of other finite-lived intangible assets and long-lived tangible assets whenever events or circumstances indicate that the carrying amounts of an asset may not be recoverable. Impairment indicators include, among other conditions, cash flow deficits, historic or anticipated declines in revenue or operating profit, and adverse legal or regulatory developments. If it is determined that such indicators are present and the review indicates that the assets will not be fully recoverable, based on undiscounted estimated cash flows over the remaining amortization periods, their carrying values are reduced to estimated fair market value. Estimated fair market value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved. For the purposes of identifying and measuring impairment, long-lived assets are grouped with other assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities.

In 2020, the Company did not record any impairment loss related to its in-process research and development assets. In 2019, the Company recorded a $40.6 million charge related to the impairment of certain in-process research and development assets. In 2018, the Company recorded a $116.2 million charge related to the impairment of certain developed technology and in-process research and development assets. See Note 4 for further information.

Income Taxes

The Company is subject to income taxes in the United States and numerous foreign jurisdictions. Significant judgment is required in evaluating the Company's uncertain tax positions and determining its provision for income taxes. The Company recognizes the financial statement benefit of a tax position only after determining that a position would more likely than not be sustained based upon its technical merit if challenged by the relevant taxing authority and taken by management to the court of last resort. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon settlement with the relevant tax authority. The Company recognizes interest and penalties related to income tax matters in income tax expense. The Company has made an accounting policy election to recognize the U.S. tax effects of global intangible low-taxed income as a component of income tax expense in the period the tax arises.

Deferred tax assets and liabilities are recognized for the expected future tax consequences of events that have been recognized in the Company's financial statements or tax returns. The Company evaluates quarterly the realizability of its deferred tax assets by assessing its valuation allowance and adjusting the amount, if necessary. The factors used to assess the likelihood of realization are both historical experience and the Company's forecast of future taxable income and available tax planning strategies that could be implemented to realize the net deferred tax assets. Failure to achieve forecasted taxable income in the applicable taxing jurisdictions could affect the ultimate realization of deferred tax assets and could result in an increase in the Company's effective tax rate on future earnings.

Research and Development Costs

Research and development costs are charged to expense when incurred.

Earnings per Share

Basic earnings per share is computed by dividing net income by the weighted-average common shares outstanding during a period. Diluted earnings per share is computed based on the weighted-average common shares outstanding plus the effect of dilutive potential common shares outstanding during the period calculated using the treasury stock method. Dilutive potential common shares include employee equity share options, nonvested shares, and similar equity instruments granted by the Company. Potential common share equivalents have been excluded where their inclusion would be anti-dilutive.

52
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
2.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)


The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):
 Years Ended December 31,
 202020192018
Basic:   
Net income$823.4 $1,046.9 $722.2 
Weighted-average shares outstanding622.6 624.8 627.6 
Basic earnings per share$1.32 $1.68 $1.15 
Diluted:   
Net income$823.4 $1,046.9 $722.2 
Weighted-average shares outstanding622.6 624.8 627.6 
Dilutive effect of stock plans9.3 11.9 13.3 
Dilutive weighted-average shares outstanding631.9 636.7 640.9 
Diluted earnings per share$1.30 $1.64 $1.13 

Stock options, restricted stock units, and market-based restricted stock units to purchase approximately 2.0 million, 1.5 million, and 3.2 million shares were outstanding for the years ended December 31, 2020, 2019, and 2018, respectively, but were not included in the computation of diluted earnings per share because the effect would have been anti-dilutive.

Stock-based Compensation

The Company measures and recognizes compensation expense for all stock-based awards based on estimated fair values. Stock-based awards consist of stock options, restricted stock units (service-based, market-based, and performance-based), and employee stock purchase subscriptions. Stock-based compensation expense is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period (vesting period) on a straight-line basis. For performance-based restricted stock units, the Company recognizes stock-based compensation expense if and when the Company concludes that it is probable that the performance condition will be achieved, net of estimated forfeitures. The Company reassesses the probability of vesting at each quarter end and adjusts the stock-based compensation expense based on its probability assessment. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Upon exercise of stock options or vesting of restricted stock units, the Company issues common stock.

Total stock-based compensation expense was as follows (in millions):
 Years Ended December 31,
 202020192018
Cost of sales$17.2 $14.7 $11.4 
Selling, general, and administrative expenses56.6 51.2 46.3 
Research and development expenses18.8 15.4 13.3 
Total stock-based compensation expense92.6 81.3 71.0 
Income tax benefit(15.4)(14.8)(13.4)
Total stock-based compensation expense, net of tax$77.2 $66.5 $57.6 

Upon a participant's retirement, all unvested stock options and performance-based restricted stock units are immediately forfeited. In addition, upon retirement, a participant will immediately vest in 25% of service-based restricted stock units for each full year of employment with the Company measured from the grant date. All remaining unvested service-based restricted stock units are immediately forfeited. For market-based restricted stock units, upon retirement and in certain other specified cases, a participant will receive a pro-rated portion of the shares that would ultimately be issued based on attainment of the
53
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
2.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)


performance goals as determined on the vesting date. The pro-rated portion is based on the participant's whole months of service with the Company during the performance period prior to the date of termination.

Derivatives

The Company uses derivative financial instruments to manage interest rate and foreign currency risks. It is the Company's policy not to enter into derivative financial instruments for speculative purposes.

Derivative financial instruments involve credit risk in the event the counterparty should default. It is the Company's policy to execute such instruments with global financial institutions that the Company believes to be creditworthy. The Company diversifies its derivative financial instruments among counterparties to minimize exposure to any one of these entities. The Company also uses International Swap Dealers Association master-netting agreements. The master-netting agreements provide for the net settlement of all contracts through a single payment in a single currency in the event of default, as defined by the agreements.

The Company uses foreign currency forward exchange contracts, cross currency swap contracts, and foreign currency denominated debt to manage its exposure to changes in currency exchange rates from (1) future cash flows associated with intercompany transactions and certain local currency expenses expected to occur within the next 13 months (designated as cash flow hedges), (2) its net investment in certain foreign subsidiaries (designated as net investment hedges) and (3) foreign currency denominated assets or liabilities (designated as fair value hedges). The Company also uses foreign currency forward exchange contracts that are not designated as hedging instruments to offset the transaction gains and losses associated with certain assets and liabilities denominated in currencies other than their functional currencies resulting principally from intercompany and local currency transactions.

All derivative financial instruments are recognized at fair value in the consolidated balance sheets. For each derivative instrument that is designated as a fair value hedge, the gain or loss on the derivative included in the assessment of hedge effectiveness is recognized immediately to earnings, and offsets the loss or gain on the underlying hedged item. The Company reports in "Accumulated Other Comprehensive Loss" the gain or loss on derivative financial instruments that are designated, and that qualify, as cash flow hedges. The Company reclassifies these gains and losses into earnings in the same line item and in the same period in which the underlying hedged transactions affect earnings. Changes in the fair value of net investment hedges are reported in "Accumulated Other Comprehensive Loss" as a part of the cumulative translation adjustment and would be reclassified into earnings if the underlying net investment is sold or substantially liquidated. The portion of the change in fair value related to components excluded from the hedge effectiveness assessment are amortized into earnings over the life of the derivative. The gains and losses on derivative financial instruments for which the Company does not elect hedge accounting treatment are recognized in the consolidated statements of operations in each period based upon the change in the fair value of the derivative financial instrument. Cash flows from net investment hedges are reported as investing activities in the consolidated statements of cash flows, and cash flows from all other derivative financial instruments are reported as operating activities.

Recently Adopted Accounting Standards

In August 2018, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on cloud computing service arrangements. The guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The guidance also requires an entity to expense the capitalized implementation costs of a hosting arrangement that is a service contract over the term of the hosting arrangement. The guidance was effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. The adoption of this guidance on January 1, 2020 did not have a material impact on the Company's consolidated financial statements.

In August 2018, the FASB issued an amendment to the accounting guidance on fair value measurements. The guidance modifies the disclosure requirements on fair value measurements, including the removal of disclosures of the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation processes for Level 3 fair value measurements. The guidance also adds certain disclosure requirements related to Level 3 fair value measurements. The guidance was effective for fiscal years, and interim periods within those fiscal years,
54
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
2.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)


beginning after December 15, 2019. The adoption of this guidance on January 1, 2020 did not have a material impact on the Company's consolidated financial statements.

In June 2016, the FASB issued an amendment to the guidance on the measurement of credit losses on financial instruments. The amendment updates the guidance for measuring and recording credit losses on financial assets measured at amortized cost by replacing the “incurred loss” model with an “expected loss” model. Accordingly, these financial assets will be presented at the net amount expected to be collected. The amendment also requires that credit losses related to available-for-sale debt securities be recorded as an allowance through net income rather than reducing the carrying amount under the current, other-than-temporary-impairment model. The guidance was effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The adoption of this guidance on January 1, 2020 did not have a material impact on the Company's consolidated financial statements.

3.    INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET

The Company incurred intellectual property litigation expenses, including settlements and external legal costs, of $405.4 million, $33.4 million and $214.0 million during 2020, 2019 and 2018, respectively.

On July 12, 2020, the Company reached an agreement with Abbott Laboratories and its direct and indirect subsidiaries ("Abbott") to, among other things, settle all outstanding patent disputes between the companies (the “Settlement Agreement”) in cases related to transcatheter mitral and tricuspid repair products. See Note 18 for additional information. The Settlement Agreement resulted in the Company recording an estimated $367.9 million pre-tax charge and related liability in June 2020 related to past damages. In addition, the Company will incur royalty expenses through May 2024 totaling an estimated $100 million. The Company made a one-time $100.0 million payment to Abbott in July 2020, and will make quarterly payments in future years.

In January 2019, the Company reached an agreement with Boston Scientific Corporation ("Boston Scientific") to settle all outstanding patent disputes for a one-time payment to Boston Scientific of $180.0 million, which was included as an expense in 2018. The settlement covered alleged past damages and no further royalties will be owed by either party.

4. SPECIAL CHARGES (GAIN)

Impairment of Long-lived Assets

In December 2019, the Company recorded a charge of $40.6 million related to the impairment of certain in-process research and development assets, and in December 2018, the Company recorded a charge of $116.2 million related to the impairment of certain developed technology and in-process research and development assets. These assets were acquired as part of the acquisition of Valtech Cardio Ltd. ("Valtech"). The Company measured the amount of the impairments by calculating the amount by which the carrying values exceeded the estimated fair values, which were based on projected discounted future net cash flows. Based on market and clinical trial developments at the time of the impairments, the Company re-evaluated the clinical development plans for the technologies acquired from Valtech, which resulted in a reduction to the projected near-term discounted future net cash flows related to the acquired mitral technology for the 2018 charge, and related to the acquired mitral and tricuspid technology for the 2019 charge. The impairments were recorded to the Company’s Rest of World segment.

Acquisition of Intellectual Property

In March 2019, the Company recorded a $24.0 million charge related to the acquisition of early-stage transcatheter intellectual property and associated clinical and regulatory experience.

Pension Gain

In March 2018, the Company recorded a $7.1 million gain related to the curtailment of its defined benefit plan in Switzerland resulting from the closure of its manufacturing plant.

55
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

5. OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS

Composition of Certain Financial Statement Captions

Components of selected captions in the consolidated balance sheets are as follows:
 As of December 31,
 20202019
 (in millions)
Inventories  
Raw materials$136.7 $118.0 
Work in process140.0 121.7 
Finished products525.6 401.2 
$802.3 $640.9 
Property, plant, and equipment, net  
Land$97.6 $98.0 
Buildings and leasehold improvements881.5 619.8 
Machinery and equipment564.9 466.3 
Equipment with customers42.2 35.6 
Software94.2 87.9 
Construction in progress313.3 265.0 
1,993.7 1,572.6 
Accumulated depreciation(598.5)(512.3)
$1,395.2 $1,060.3 
Accrued and other liabilities  
Employee compensation and withholdings$236.7 $295.8 
Accrued rebates67.2 67.1 
Property, payroll, and other taxes49.7 51.4 
Research and development accruals52.3 51.4 
Litigation settlement (Notes 3 and 18)37.5 — 
Litigation and insurance reserves (Note 18)23.3 20.0 
Taxes payable18.6 52.9 
Fair value of derivatives39.3 6.4 
Accrued marketing expenses14.3 17.5 
Accrued professional services7.6 10.1 
Accrued realignment reserves14.5 16.7 
Accrued relocation related costs21.0 17.4 
Other accrued liabilities88.2 89.8 
$670.2 $696.5 

In 2019, the Company recorded a $73.1 million charge to "Cost of Sales," primarily comprised of the write off of inventory related to strategic decisions regarding its transcatheter aortic valve portfolio, including the decision to discontinue its CENTERA program.

56
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
5. OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Continued)
Supplemental Cash Flow Information
(in millions)
Years Ended December 31,
202020192018
Cash paid during the year for:   
Interest$19.9 $19.9 $30.1 
Income taxes$197.9 $61.5 $223.7 
Amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases
$29.7 $28.6 $— 
Non-cash investing and financing transactions:   
Fair value of shares issued in payment for contingent consideration liabilities $— $— $34.3 
Right-of-use assets obtained in exchange for new lease liabilities$39.7 $49.6 $— 
Capital expenditures accruals$80.4 $50.8 $18.7 

Cash, Cash Equivalents, and Restricted Cash
(in millions)
Years Ended December 31,
202020192018
Cash and cash equivalents$1,183.2 $1,179.1 $714.1 
Restricted cash included in other current assets16.6 1.6 1.5 
Restricted cash included in other assets0.4 3.7 0.3 
Total cash, cash equivalents, and restricted cash$1,200.2 $1,184.4 $715.9 

Amounts included in restricted cash primarily represent funds placed in escrow related to litigation and real estate purchases, and funds restricted for construction.

6. LEASES

The Company leases certain office space, manufacturing facilities, land, apartments, warehouses, vehicles, and equipment with remaining lease terms ranging from less than 1 year to 20 years, some of which include options to extend or terminate the leases.

Operating lease costs for the years ended December 31, 2020, 2019, and 2018 were $30.5 million, $27.9 million, and $27.0 million, respectively. Short-term and variable lease costs were not material for the years ended December 31, 2020 and 2019.

Supplemental balance sheet information related to operating leases was as follows (in millions, except lease term and discount rate):
As of December 31,
20202019
Operating lease right-of-use assets$94.2 $80.1 
Operating lease liabilities, current portion$27.2 $25.5 
Operating lease liabilities, long-term portion72.7 58.9 
Total operating lease liabilities
$99.9 $84.4 

57
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
6. LEASES (Continued)

Maturities of operating lease liabilities at December 31, 2020 were as follows (in millions):
2021$30.0 
202220.7 
202314.4 
20248.8 
20256.1 
Thereafter28.1 
Total lease payments
108.1 
Less: imputed interest
(8.2)
Total lease liabilities
$99.9 

The following table provides information on the lease terms and discount rates:
Years Ended December 31,
20202019
Weighted-average remaining lease term (in years)6.65.3
Weighted-average discount rate2.7 %2.8 %

As of December 31, 2020, the Company had no additional operating lease commitments for office space that have not yet commenced.

7. INVESTMENTS

Debt Securities

Investments in debt securities at the end of each period were as follows (in millions):

 December 31, 2020December 31, 2019
Held-to-maturityAmortized CostGross Unrealized GainsGross Unrealized LossesFair ValueAmortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Bank time deposits$50.0 $— $— $50.0 $100.2 $— $— $100.2 
Available-for-sale
Bank time deposits$24.1 $— $— $24.1 $13.1 $— $— $13.1 
Commercial paper— — — — 34.3 — — 34.3 
U.S. government and agency securities
147.0 2.2 — 149.2 113.2 0.6 — 113.8 
Foreign government bonds— — — — 1.7 — — 1.7 
Asset-backed securities149.6 1.9 — 151.5 141.2 0.6 (0.1)141.7 
Corporate debt securities600.8 7.5 — 608.3 487.0 2.3 (0.1)489.2 
Municipal securities2.8 — — 2.8 — — — — 
$924.3 $11.6 $— $935.9 $790.5 $3.5 $(0.2)$793.8 

58
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
7. INVESTMENTS (Continued)

The cost and fair value of investments in debt securities, by contractual maturity, as of December 31, 2020 were as follows:

 Held-to-MaturityAvailable-for-Sale
 Amortized CostFair ValueAmortized CostFair Value
 (in millions)
Due in 1 year or less$50.0 $50.0 $168.4 $169.4 
Due after 1 year through 5 years— — 578.2 586.5 
Instruments not due at a single maturity date— — 177.7 180.0 
$50.0 $50.0 $924.3 $935.9 

Actual maturities may differ from the contractual maturities due to call or prepayment rights.

There were no investments that were in an unrealized loss position as of December 31, 2020. The following table presents gross unrealized losses and fair values for those investments that were in an unrealized loss position as of December 31, 2019, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):
December 31, 2019
Less than 12 Months12 Months or GreaterTotal
Fair ValueGross Unrealized LossesFair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
Asset-backed securities$73.4 $(0.1)$— $— $73.4 $(0.1)
Corporate debt securities81.4 (0.1)— — 81.4 (0.1)
$154.8 $(0.2)$— $— $154.8 $(0.2)

Investments in Unconsolidated Affiliates

The Company has a number of equity investments in privately and publicly held companies. Investments in these unconsolidated affiliates are recorded in "Long-term Investments" on the consolidated balance sheets, and are as follows:

 December 31,
 20202019
 (in millions)
Equity method investments  
Carrying value of equity method investments$5.7 $6.2 
Equity securities  
Carrying value of non-marketable equity securities29.4 23.1 
Total investments in unconsolidated affiliates$35.1 $29.3 

Non-marketable equity securities consist of investments in privately held companies without readily determinable fair values, and are reported at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. The Company recorded an upward adjustment of $1.8 million based on observable price changes and a downward adjustment of $0.7 million due to an impairment during 2020, and an upward adjustment of $0.3 million based on observable price changes during 2019. As of December 31, 2020 and 2019, the Company had recorded accumulated upward adjustments of $3.8 million and $2.0 million, respectively, based on observable price changes, and accumulated downward adjustments of $2.6 million and $1.9 million, respectively, due to impairment and observable price changes.
59
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
7. INVESTMENTS (Continued)


During 2020, 2019, and 2018, the gross realized gains or losses from sales of available-for-sale investments were not material.

8.    ACQUISITIONS

CAS Medical Systems, Inc.

On February 11, 2019, the Company entered into an agreement and plan of merger to acquire all the outstanding shares of CAS Medical Systems, Inc. ("CASMED") for an aggregate cash purchase price of $2.45 per share of common stock, or an equity value of approximately $100 million. The transaction closed on April 18, 2019, and the cash purchase price was $100.8 million. Acquisition-related costs of $2.0 million were recorded in “Selling, General, and Administrative Expenses” during the year ended December 31, 2019.

CASMED is a medical technology company dedicated to noninvasive monitoring of tissue oxygenation in the brain. The Company integrated the acquired technology platform into its hemodynamic monitoring platform. The acquisition was accounted for as a business combination. Tangible and intangible assets acquired were recorded based on their estimated fair values at the acquisition date. The excess of the purchase price over the fair value of net assets acquired was recorded to goodwill. The following table summarizes the fair values of the assets acquired and liabilities assumed (in millions):

Current assets$6.1 
Property and equipment, net1.3 
Goodwill64.4 
Developed technology35.9 
Customer relationships8.8 
Deferred tax assets2.2 
Liabilities assumed(17.9)
Total purchase price
100.8 
Less: cash acquired(0.6)
Total purchase price, net of cash acquired
$100.2 

Goodwill includes expected synergies and other benefits the Company believes will result from the acquisition. Goodwill was assigned to the Company’s United States segment and is not deductible for tax purposes. Developed technology assets are being amortized over a weighted-average useful life of 14 years. Customer relationships assets are being amortized over a weighted-average useful life of 10 years.

The results of operations for CASMED have been included in the accompanying consolidated financial statements from the date of acquisition. Pro forma results have not been presented as the results of CASMED are not material in relation to the consolidated financial statements of Edwards Lifesciences.

Harpoon Medical, Inc.

On December 1, 2017, the Company acquired all the outstanding shares of Harpoon Medical, Inc. for an aggregate cash purchase price of $119.5 million, which includes $16.0 million paid previously for a cost method investment and an exclusive option to acquire Harpoon Medical, Inc., and is net of $8.0 million received from the sale of the Company's previous ownership interest. In addition, the Company agreed to pay up to an additional $150.0 million in pre-specified milestone-driven payments over the next 10 years. The Company recognized in "Contingent Consideration Liabilities" a $59.7 million liability for the estimated fair value of the contingent milestone payments. The fair value of the contingent milestone payments are remeasured each quarter, with changes in the fair value recognized within operating expenses on the consolidated statements of operations. For further information on the fair value of the contingent milestone payments, see Note 11.

60
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
8.    ACQUISITIONS (Continued)
In-process research and development assets acquired as part of this transaction were capitalized at fair value, which was determined using the income approach. This approach determines fair value based on cash flow projections which are discounted to present value using a risk-adjusted rate of return. Completion of successful design developments, bench testing, pre-clinical studies and human clinical studies are required prior to selling any product. The risks and uncertainties associated with completing development within a reasonable period of time include those related to the design, development, and manufacturability of the product, the success of pre-clinical and clinical studies, and the timing of regulatory approvals. The valuation assumed $41.4 million of additional research and development expenditures would be incurred prior to the date of product introduction. In the valuation, net cash inflows were modeled to commence in Europe in 2018, and in the United States and Japan in 2022. The Company does not currently anticipate significant changes to forecasted research and development expenditures, and net cash inflows commenced in Europe in 2020 and are now expected to commence in the United States and Japan in 2023. Upon completion of development, the underlying in-process research and development asset will be amortized over its estimated useful life.

Valtech Cardio Ltd.

On November 26, 2016, the Company entered into an agreement and plan of merger to acquire Valtech Cardio Ltd. ("Valtech") for approximately $340.0 million, subject to certain adjustments, with the potential for up to an additional $350.0 million in pre-specified milestone-driven payments over the next 10.0 years. The transaction closed on January 23, 2017, and the consideration paid included the issuance of approximately 2.8 million shares of the Company's common stock (fair value of $266.5 million) and cash of $86.2 million. The Company recognized in "Contingent Consideration Liabilities" a $162.9 million liability for the estimated fair value of the contingent milestone payments. For further information on the fair value of the contingent milestone payments, see Note 11.

Prior to the close of the transaction, Valtech spun off its early-stage transseptal mitral valve replacement technology program. Concurrent with the closing, the Company entered into an agreement for an exclusive option to acquire that program and its associated intellectual property for approximately $200.0 million, subject to certain adjustments, plus an additional $50.0 million if a certain European regulatory approval is obtained within 10 years of the acquisition closing date. The option expired in January 2020.

In-process research and development assets acquired as part of this transaction were capitalized at fair value, which was determined using the income approach. This approach determines fair value based on cash flow projections which are discounted to present value using a risk-adjusted rate of return. The valuation assumed $87.3 million of additional research and development expenditures would be incurred prior to the date of product introduction and that net cash inflows would commence in 2019. In December 2018, the Company recorded a $116.2 million impairment charge related to Valtech's intangible assets, and in December 2019, the Company recorded a $40.6 million impairment charge to write off the remaining in-process research and development assets. For further information, see Note 4.

CardiAQ Valve Technologies, Inc.

On July 3, 2015, the Company entered into an agreement and plan of merger to acquire CardiAQ Valve Technologies, Inc. ("CardiAQ") for an aggregate cash purchase price of $350.0 million, subject to certain adjustments. The transaction closed on August 26, 2015, and the cash purchase price after the adjustments was $348.0 million. In addition, the Company agreed to pay an additional $50.0 million if a certain European regulatory approval is obtained within 48 months of the acquisition closing date. The Company recognized in "Contingent Consideration Liabilities" a $30.3 million liability for the estimated fair value of this contingent milestone payment. The Company estimated this milestone would not be achieved and reversed the liability in 2018. For further information on the fair value of the contingent milestone payment, see Note 11.

In-process research and development assets acquired as part of this acquisition were capitalized at fair value, which was determined using the income approach. This approach determines fair value based on cash flow projections which are discounted to present value using a risk-adjusted rate of return. Completion of successful design developments, bench testing, pre-clinical studies and human clinical studies are required prior to selling any product. The risks and uncertainties associated with completing development within a reasonable period of time include those related to the design, development, and manufacturability of the product, the success of pre-clinical and clinical studies, and the timing of regulatory approvals. The valuation assumed $97.7 million of additional research and development expenditures would be incurred prior to the date of
61
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
8.    ACQUISITIONS (Continued)
product introduction and that net cash inflows would commence in late 2018. As a result of certain design enhancements to increase the product's commercial life and applicability to a broader group of patients, the Company has incurred incremental research and development expenditures; however, the Company expects an increase in the net cash inflows, commencing in 2023. Upon completion of development, the underlying research and development intangible asset will be amortized over its estimated useful life.

9.    GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill and in-process research and development assets resulting from purchase business combinations are not subject to amortization. Other acquired intangible assets with finite lives are amortized over their expected useful lives on a straight-line basis, or if reliably determinable, based on the pattern in which the economic benefit of the asset is expected to be used. The Company expenses costs incurred to renew or extend the term of acquired intangible assets.

In April 2019, the Company acquired CASMED. This transaction resulted in an increase to goodwill of $64.4 million and developed technology of $35.9 million. For further information, see Note 8.

The changes in the carrying amount of goodwill, by segment, during the years ended December 31, 2020 and 2019 were as follows:
 United
States		EuropeRest of WorldTotal
 (in millions)
Goodwill at December 31, 2018$709.3 $64.2 $338.7 $1,112.2 
Goodwill acquired during the year64.4 — — 64.4 
Currency translation adjustment— (1.4)(7.5)(8.9)
Goodwill at December 31, 2019773.7 62.8 331.2 1,167.7 
Currency translation adjustment— 5.5 — 5.5 
Goodwill at December 31, 2020$773.7 $68.3 $331.2 $1,173.2 

Other intangible assets consist of the following (in millions):

 December 31,
 Weighted-Average Useful Life (in years)20202019
 CostAccumulated
Amortization		Net
Carrying
Value		CostAccumulated
Amortization		Net
Carrying
Value
Finite-lived intangible assets      
Patents7.4$186.1 $(183.6)$2.5 $185.7 $(182.1)$3.6 
Developed technology13.1155.2 (51.0)104.2 153.5 (46.6)106.9 
Other10.012.6 (6.0)6.6 12.3 (4.4)7.9 
12.6353.9 (240.6)113.3 351.5 (233.1)118.4 
Indefinite-lived intangible assets      
In-process research and development218.1 — 218.1 218.1 — 218.1 
$572.0 $(240.6)$331.4 $569.6 $(233.1)$336.5 

62
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
9.    GOODWILL AND OTHER INTANGIBLE ASSETS (Continued)

Amortization expense related to other intangible assets for the years ended December 31, 2020, 2019, and 2018 was $5.4 million, $4.6 million, and $2.5 million, respectively. Estimated amortization expense for each of the years ending December 31 is as follows (in millions):
2021$5.2 
20227.6 
202310.1 
202412.2 
202514.8 

10.    DEBT AND CREDIT FACILITIES

In June 2018, the Company issued $600.0 million of fixed-rate unsecured senior notes (the "Notes") due June 15, 2028. Interest is payable semi-annually in arrears, with payments due in June and December of each year. The Company may redeem the Notes, in whole or in part, at any time and from time to time at specified redemption prices. In addition, upon the occurrence of certain change of control triggering events, the Company may be required to repurchase all or a portion of the Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest. The Notes also include covenants that limit the Company's ability to incur secured indebtedness, enter into sale and leaseback transactions, and consolidate, merge, or transfer all or substantially all of its assets.

The following is a summary of the Notes as of December 31, 2020 and 2019:
 December 31,
 2020 2019
 AmountEffective
Interest Rate		 AmountEffective
Interest Rate
(in millions)(in millions)
Fixed-rate 4.300% 2018 Notes
$600.0 4.329 %$600.0 4.329 %
Unamortized discount(1.1)  (1.2) 
Unamortized debt issuance costs(3.9)(4.4)
Total carrying amount$595.0   $594.4  

As of December 31, 2020 and 2019, the fair value of the Notes was $711.2 million and $667.6 million, respectively, based on observable market prices in less active markets and categorized as Level 2 (Note 11). The debt issuance costs, as well as the discount, are being amortized to interest expense over the term of the notes.

The Company has a Five-Year Credit Agreement ("the Credit Agreement") which matures on April 28, 2023. The Credit Agreement provides up to an aggregate of $750.0 million in borrowings in multiple currencies. The Company may increase the amount available under the Credit Agreement, subject to agreement of the lenders, by up to an additional $250.0 million in the aggregate. Borrowings generally bear interest at the London interbank offered rate ("LIBOR"), or a comparable or successor rate, plus a spread ranging from 0.9% to 1.3%, depending on the leverage ratio, as defined in the Credit Agreement. The Company also pays a facility fee ranging from 0.1% to 0.2%, depending on the leverage ratio, on the entire credit commitment available, whether drawn or not. The facility fee is expensed as incurred. During 2020, the spread over LIBOR was 0.9% and the facility fee was 0.1%. Issuance costs of $2.4 million are being amortized to interest expense over the term of the Credit Agreement. As of December 31, 2020 and 2019, there were no borrowings outstanding under the Credit Agreement. Amounts outstanding under the Credit Agreement, if any from time to time, are classified as long-term obligations in accordance with the terms of the Credit Agreement. The Credit Agreement is unsecured and contains various financial and other covenants, including a maximum leverage ratio, as defined in the Credit Agreement. The Company was in compliance with all covenants at December 31, 2020.

63
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
10.    DEBT AND CREDIT FACILITIES (Continued)

The weighted-average interest rate under all debt obligations was 3.5% and 3.4% at December 31, 2020 and 2019, respectively.
11.    FAIR VALUE MEASUREMENTS

The consolidated financial statements include financial instruments for which the fair market value of such instruments may differ from amounts reflected on a historical cost basis. Financial instruments of the Company consist of cash deposits, accounts and other receivables, investments, accounts payable, certain accrued liabilities, and borrowings under a revolving credit agreement. The carrying value of these financial instruments generally approximates fair value due to their short-term nature. Financial instruments also include notes payable. See Note 10 for further information on the fair value of the notes payable.

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The Company prioritizes the inputs used to determine fair values in one of the following three categories:

Level 1—Quoted market prices in active markets for identical assets or liabilities.

Level 2—Inputs, other than quoted prices in active markets, that are observable, either directly or indirectly.

Level 3—Unobservable inputs that are not corroborated by market data.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety.

64
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
11.    FAIR VALUE MEASUREMENTS (Continued)
Assets and Liabilities Measured at Fair Value on a Recurring Basis

The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis as of December 31, 2020 and 2019 (in millions):

December 31, 2020Level 1Level 2Level 3Total
Assets    
Cash equivalents$16.2 $— $— $16.2 
Available-for-sale investments: 
Bank time deposits— 24.1 — 24.1 
Corporate debt securities— 608.3 — 608.3 
Asset-backed securities— 151.5 — 151.5 
U.S. government and agency securities56.9 92.2 — 149.1 
Municipal securities— 2.8 — 2.8 
Investments held for deferred compensation plans111.2 — — 111.2 
Derivatives— 8.1 — 8.1 
$184.3 $887.0 $— $1,071.3 
Liabilities    
Derivatives$— $39.3 $— $39.3 
Deferred compensation plans111.6 — — 111.6 
Contingent consideration liabilities— — 186.1 186.1 
$111.6 $39.3 $186.1 $337.0 
December 31, 2019
Assets
Cash equivalents$0.7 $31.7 $— $32.4 
Available-for-sale investments: 
Bank time deposits— 13.1 — 13.1 
Corporate debt securities— 489.2 — 489.2 
Asset-backed securities— 141.7 — 141.7 
U.S. government and agency securities76.1 37.7 — 113.8 
Foreign government bonds— 1.7 — 1.7 
Commercial paper— 34.3 — 34.3 
Investments held for deferred compensation plans88.9 — — 88.9 
Derivatives— 30.7 — 30.7 
$165.7 $780.1 $— $945.8 
Liabilities    
Derivatives$— $6.4 $— $6.4 
Deferred compensation plans88.7 — — 88.7 
Contingent consideration liabilities— — 172.5 172.5 
$88.7 $6.4 $172.5 $267.6 

65
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
11.    FAIR VALUE MEASUREMENTS (Continued)
The following table summarizes the changes in fair value of the contingent consideration obligation for the years ended December 31, 2020 and 2019 (in millions):

December 31,
20202019
Fair value, beginning of year$172.5 $178.6 
Changes in fair value13.6 (6.1)
Fair value, end of year$186.1 $172.5 

The changes in 2020 in fair value of the contingent consideration obligation were primarily driven by the accretion of interest due to the passage of time and adjustments to discount rates, partially offset by a $12.7 million reduction to the liability due to changes in the projected probability and timing of milestone achievements, and the projected timing of cash inflows. During 2019, the contingent consideration liability was reduced by $24.1 million due to delays in product development, which reduced the probability of milestone achievement. This reduction was partially offset by changes in the fair value of the liabilities associated primarily with adjustments to discount rates and accretion of interest due to the passage of time.

Cash Equivalents and Available-for-sale Investments

The Company estimates the fair values of its money market funds based on quoted prices in active markets for identical assets. The Company estimates the fair values of its time deposits, commercial paper, U.S. and foreign government and agency securities, municipal securities, asset-backed securities, and corporate debt securities by taking into consideration valuations obtained from third-party pricing services. The pricing services use industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include reported trades and broker-dealer quotes on the same or similar securities, benchmark yields, credit spreads, prepayment and default projections based on historical data, and other observable inputs. The Company independently reviews and validates the pricing received from the third-party pricing service by comparing the prices to prices reported by a secondary pricing source. The Company’s validation procedures have not resulted in an adjustment to the pricing received from the pricing service.

Deferred Compensation Plans

The Company holds investments in trading securities related to its deferred compensation plans. The investments are in a variety of stock, bond, and money market mutual funds. The fair values of these investments and the corresponding liabilities are based on quoted market prices.

Derivative Instruments

The Company uses derivative financial instruments in the form of foreign currency forward exchange contracts and cross currency swap contracts to manage foreign currency exposures. All derivatives contracts are recognized on the balance sheet at their fair value. The fair value of foreign currency derivative financial instruments and the cross currency swap contracts was estimated based on quoted market foreign exchange rates, cross currency swap basis rates, and market discount rates. Judgment was employed in interpreting market data to develop estimates of fair value; accordingly, the estimates presented herein are not necessarily indicative of the amounts that the Company could realize in a current market exchange. The use of different market assumptions or valuation methodologies could have a material effect on the estimated fair value amounts.

Contingent Consideration Liabilities

Certain of the Company's acquisitions involve contingent consideration arrangements. Payment of additional consideration is contingent upon the acquired company reaching certain performance milestones, such as attaining specified revenue levels or obtaining regulatory approvals. These contingent consideration liabilities are measured at estimated fair value using either a probability weighted discounted cash flow analysis or a Monte Carlo simulation model, both of which consider significant unobservable inputs. These inputs include (1) the discount rate used to present value the projected cash flows
66
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
11.    FAIR VALUE MEASUREMENTS (Continued)
(ranging from 0.08% to 8.53%; weighted average of 3.1%), (2) the probability of milestone achievement (ranging from 0.4% to 99.7%; weighted average of 70.7%), (3) the projected payment dates (ranging from 2023 to 2027; weighted average of 2026), and (4) the volatility of future revenue (ranging from 37.0% to 40.0%; weighted average of 38.8%). The weighted average of each of the above inputs was determined based on the relative fair value of each obligation. The use of different assumptions could have a material effect on the estimated fair value amounts.

12.    DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.
 Notional Amount
 December 31, 2020December 31, 2019
 (in millions)
Foreign currency forward exchange contracts$1,525.5 $1,336.5 
Cross currency swap contracts300.0 300.0 

The following table presents the location and fair value amounts of derivative instruments reported in the consolidated balance sheets (in millions):

  Fair Value
 Balance Sheet LocationDecember 31, 2020December 31, 2019
Derivatives designated as hedging instruments   
Assets   
Foreign currency contractsOther current assets$7.3 $14.2 
Foreign currency contractsOther assets$— $3.2 
Cross currency swap contractsOther assets$0.8 $13.3 
Liabilities   
Foreign currency contractsAccrued and other liabilities$39.3 $6.4 

67
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
12.    DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Continued)
The following table presents the effect of master-netting agreements and rights of offset on the consolidated balance sheets (in millions):

    Gross Amounts Not Offset in the Consolidated Balance Sheet 
  Gross Amounts
Offset in the
Consolidated
Balance Sheet		Net Amounts
Presented in the
Consolidated
Balance Sheet
December 31, 2020Gross
Amounts		Financial
Instruments		Cash
Collateral
Received		Net
Amount
Derivative Assets      
Foreign currency contracts$7.3 $— $7.3 $(6.1)$— $1.2 
Cross currency swap contracts$0.8 $— $0.8 $— $— $0.8 
Derivative Liabilities      
Foreign currency contracts$39.3 $— $39.3 $(6.1)$— $33.2 
December 31, 2019      
Derivative Assets      
Foreign currency contracts$17.4 $— $17.4 $(5.7)$— $11.7 
Cross currency swap contracts$13.3 $— $13.3 $— $— $13.3 
Derivative Liabilities      
Foreign currency contracts$6.4 $— $6.4 $(5.7)$— $0.7 
 
The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated statements of operations and consolidated statements of comprehensive income:

 Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)Location of Gain or (Loss) Reclassified from Accumulated OCI into IncomeAmount of Gain or (Loss) Reclassified from Accumulated OCI into Income
 
 2020201920202019
(in millions)(in millions)
Cash flow hedges
Foreign currency contracts$(33.7)$23.5 Cost of sales$18.4 $40.9 
Selling, general, and administrative expenses$2.2 $1.9 
 Amount of Gain or (Loss)
Recognized in OCI
on Derivative
(Effective Portion)		Location of Gain or (Loss) Reclassified from Accumulated OCI into IncomeAmount of Gain or (Loss)
Recognized in Income on Derivative (Amount Excluded from
Effectiveness Testing)
2020201920202019
(in millions) (in millions)
Net investment hedges
Cross currency swap contracts$(12.6)$12.5 Interest expense$6.4 $6.6 

The cross currency swaps have an expiration date of June 15, 2028. At maturity of the cross currency swap contracts, the Company will deliver the notional amount of €257.2 million and will receive $300.0 million from the counterparties. The Company will receive semi-annual interest payments from the counterparties based on a fixed interest rate until maturity of the agreements.
68
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
12.    DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Continued)
  Amount of Gain or
(Loss) Recognized in
Income on Derivative
 Location of Gain or
(Loss) Recognized in
Income on Derivative
 202020192018
 (in millions)
Fair value hedges
Foreign currency contractsOther income, net$(1.4)$1.4 $0.5 

  Amount of Gain or
(Loss) Recognized in
Income on Derivative
 Location of Gain or
(Loss) Recognized in
Income on Derivative
 202020192018
 (in millions)
Derivatives not designated as hedging instruments
Foreign currency contractsOther income, net$(15.1)$0.3 $9.7 

The following table presents the effect of fair value and cash flow hedge accounting on the consolidated statements of operations:

Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships
 Twelve Months Ended December 31, 2020
 Cost of salesSelling, general, and administrative expensesOther Income, net
Total amounts of income and expense line items shown in the consolidated statements of operations in which the effects of fair value or cash flow hedges are recorded$(1,080.6)$(1,228.4)$11.5 
The effects of fair value and cash flow hedging:
Gain (loss) on fair value hedging relationships:
Foreign currency contracts:
Hedged items
— — 4.8 
Derivatives designated as hedging instruments
— — (4.8)
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach
— — 3.4 
Gain (loss) on cash flow hedging relationships:
Foreign currency contracts:
Amount of gain (loss) reclassified from accumulated OCI into income
18.4 2.2 — 
69
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
12.    DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Continued)
Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships
 Twelve Months Ended December 31, 2019
 Cost of salesSelling, general, and administrative expensesOther Income, net
Total amounts of income and expense line items shown in the consolidated statements of operations in which the effects of fair value or cash flow hedges are recorded$(1,114.4)$(1,242.2)$8.2 
The effects of fair value and cash flow hedging:
Gain (loss) on fair value hedging relationships:
Foreign currency contracts:
Hedged items
— — 2.9 
Derivatives designated as hedging instruments
— — (2.9)
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach
— — 4.3 
Gain (loss) on cash flow hedging relationships:
Foreign currency contracts:
Amount of gain (loss) reclassified from accumulated OCI into income
40.9 1.9 — 
The Company expects that during 2021 it will reclassify to earnings a $7.0 million loss currently recorded in "Accumulated Other Comprehensive Loss." For the years ended December 31, 2020, 2019, and 2018, the Company did not record any gains or losses due to hedge ineffectiveness.

70
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

13.    EMPLOYEE BENEFIT PLANS

Defined Benefit Plans

Edwards Lifesciences maintains defined benefit pension plans in Japan and certain European countries. In 2018, the Company curtailed its defined benefit plan in Horw, Switzerland (see Note 4).
 Years Ended December 31,
 20202019
(in millions)
Change in projected benefit obligation:  
Beginning of year$105.2 $97.4 
Service cost6.3 5.2 
Interest cost0.5 0.9 
Participant contributions1.5 1.3 
Actuarial loss2.9 8.2 
Benefits paid(0.6)(4.2)
Plan amendment— (4.6)
Currency exchange rate changes and other10.4 1.0 
End of year$126.2 $105.2 
Change in fair value of plan assets:  
Beginning of year$63.2 $60.4 
Actual return on plan assets0.4 2.0 
Employer contributions2.8 2.6 
Participant contributions1.5 1.3 
Benefits paid(0.6)(4.2)
Currency exchange rate changes and other6.0 1.1 
End of year$73.3 $63.2 
Funded Status  
Projected benefit obligation$(126.2)$(105.2)
Plan assets at fair value73.3 63.2 
Underfunded status$(52.9)$(42.0)
Net amounts recognized on the consolidated balance sheet:  
Other long-term liabilities$52.9 $42.0 
Accumulated other comprehensive loss, net of tax:  
Net actuarial loss$(30.8)$(26.3)
Net prior service cost6.6 6.7 
Deferred income tax benefit4.6 4.2 
Total$(19.6)$(15.4)

The accumulated benefit obligation ("ABO") for all defined benefit pension plans was $120.9 million and $101.1 million as of December 31, 2020 and 2019, respectively. The projected benefit obligation and ABO were in excess of plan assets for all pension plans as of December 31, 2020 and 2019.

71
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
13.    EMPLOYEE BENEFIT PLANS (Continued)
The components of net periodic pension benefit cost (credit) are as follows (in millions):

 Years Ended December 31,
 202020192018
Service cost, net$6.3 $5.2 $6.0 
Interest cost0.5 0.9 0.8 
Expected return on plan assets(1.0)(1.4)(1.3)
Settlements and curtailment gain— — (7.4)
Amortization of actuarial loss1.6 0.9 0.8 
Amortization of prior service credit (0.7)(0.2)(0.1)
Net periodic pension benefit cost (credit)$6.7 $5.4 $(1.2)

Expected long-term returns for each of the plans' strategic asset classes were developed through consultation with investment advisors. Several factors were considered, including a survey of investment managers' expectations, current market data, minimum guaranteed returns in certain insurance contracts, and historical market returns over long periods. Using policy target allocation percentages and the asset class expected returns, a weighted-average expected return was calculated.

To select the discount rates for the defined benefit pension plans, the Company uses a modeling process that involves matching the expected duration of its benefit plans to a yield curve constructed from a portfolio of AA-rated fixed-income debt instruments, or their equivalent. For each country, the Company uses the implied yield of this hypothetical portfolio at the appropriate duration as a discount rate benchmark.

The weighted-average assumptions used to determine the benefit obligations are as follows:
 December 31,
 20202019
Discount rate0.3 %0.5 %
Rate of compensation increase2.6 %2.7 %
Cash balance interest crediting rate2.5 %2.6 %
Social securities increase1.6 %1.6 %
Pension increase1.8 %1.8 %

The weighted-average assumptions used to determine the net periodic pension benefit cost are as follows:
 Years ended December 31,
 202020192018
Discount rate0.5 %0.9 %0.9 %
Expected return on plan assets1.5 %2.3 %2.3 %
Rate of compensation increase2.7 %2.8 %2.6 %
Cash balance interest crediting rate1.5 %1.5 %1.5 %
Social securities increase1.6 %1.8 %1.5 %
Pension increase1.8 %1.8 %1.8 %

72
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
13.    EMPLOYEE BENEFIT PLANS (Continued)
Plan Assets

The Company's investment strategy for plan assets is to seek a competitive rate of return relative to an appropriate level of risk and to earn performance rates of return in accordance with the benchmarks adopted for each asset class. Risk management practices include diversification across asset classes and investment styles, and periodic rebalancing toward asset allocation targets.

The Administrative and Investment Committee decides on the defined benefit plan provider in each location and that provider decides the target allocation for the Company's defined benefit plan at that location. The target asset allocation selected reflects a risk/return profile the Company feels is appropriate relative to the plans' liability structure and return goals. In certain plans, asset allocations may be governed by local requirements. Target weighted-average asset allocations at December 31, 2020, by asset category, are as follows:
Equity securities25.3 %
Debt securities47.5 %
Real estate7.7 %
Other19.5 %
Total100.0 %

The fair values of the Company's defined benefit plan assets at December 31, 2020 and 2019, by asset category, are as follows (in millions):
December 31, 2020Level 1Level 2Level 3Total
Asset Category    
Cash$3.0 $— $— $3.0 
Equity securities:    
United States equities3.3 — — 3.3 
International equities16.1 — — 16.1 
Debt securities:    
United States government bonds7.4 — — 7.4 
International government bonds26.0 — — 26.0 
Real estate— 5.6 — 5.6 
Mortgages— 3.1 — 3.1 
Insurance contracts— — 1.0 1.0 
Total plan assets measured at fair value
$55.8 $8.7 $1.0 $65.5 
Alternative investments measured at net asset value (a)7.8 
Total plan assets
$73.3 
73
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
13.    EMPLOYEE BENEFIT PLANS (Continued)
 
December 31, 2019Level 1Level 2Level 3Total
Asset Category
Cash$3.8 $— $— $3.8 
Equity securities:
United States equities3.0 — — 3.0 
International equities11.2 — — 11.2 
Debt securities:
United States government bonds8.2 — — 8.2 
International government bonds22.3 — — 22.3 
Real estate— 4.4 — 4.4 
Mortgages— 2.3 — 2.3 
Insurance contracts— — 0.9 0.9 
Total plan assets $48.5 $6.7 $0.9 $56.1 
Alternative investments measured at net asset value (a)7.1 
Total plan assets $63.2 
_______________________________________
(a)     Certain investments that were measured at net asset value per share have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the total plan assets.

The following table summarizes the changes in fair value of the Company's defined benefit plan assets that have been classified as Level 3 for the years ended December 31, 2020 and 2019 (in millions):

 Insurance
Contracts
Balance at December 31, 2018$1.0 
Purchases, sales and settlements(0.1)
Balance at December 31, 20190.9 
Currency exchange rate impact0.1 
Balance at December 31, 2020$1.0 

Equity and debt securities are valued at fair value based on quoted market prices reported on the active markets on which the individual securities are traded. Real estate investments are valued by discounting to present value the cash flows expected to be generated by the specific properties. Investments in mortgages are valued at cost, which is deemed to approximate its fair value. The insurance contracts are valued at the cash surrender value of the contracts, which is deemed to approximate its fair value. Alternative investments include hedge funds, private equity funds and other miscellaneous investments, and are valued using the net asset value provided by the fund administrator as a practical expedient. The net asset value is based on the fair value of the underlying assets owned by the fund divided by the number of shares outstanding.

74
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
13.    EMPLOYEE BENEFIT PLANS (Continued)
The following benefit payments, which reflect expected future service, as appropriate, at December 31, 2020, are expected to be paid (in millions):

2021$4.6 
20224.9 
20236.7 
20245.6 
20255.3 
2024-202636.7 

As of December 31, 2020, expected employer contributions for 2021 are $2.5 million.

Defined Contribution Plans

The Company's employees in the United States and Puerto Rico are eligible to participate in a qualified defined contribution plan. In the United States, participants may contribute up to 25% of their eligible compensation (subject to tax code limitation) to the plan. Edwards Lifesciences matches the first 4% of the participant's annual eligible compensation contributed to the plan on a dollar-for-dollar basis. Edwards Lifesciences matches the next 2% of the participant's annual eligible compensation to the plan on a 50% basis. In Puerto Rico, participants may contribute up to 25% of their annual compensation (subject to tax code limitation) to the plan. Edwards Lifesciences matches the first 4% of participant's annual eligible compensation contributed to the plan on a 50% basis. The Company also provides a 2% profit sharing contribution calculated on eligible earnings for each employee. Matching contributions relating to Edwards Lifesciences employees were $36.6 million, $31.4 million, and $26.6 million in 2020, 2019, and 2018, respectively.

The Company also has nonqualified deferred compensation plans for a select group of employees. The plans provide eligible participants the opportunity to defer eligible compensation to future dates specified by the participant with a return based on investment alternatives selected by the participant. The amount accrued under these nonqualified plans was $111.6 million and $88.7 million at December 31, 2020 and 2019, respectively.

14.    COMMON STOCK

Treasury Stock

In May 2019, the Board of Directors approved a stock repurchase program authorizing the Company to purchase up to $1.0 billion of the Company's common stock. The repurchase program does not have an expiration date. Stock repurchased under the program may be used to offset obligations under the Company's employee stock-based benefit programs and stock-based business acquisitions, and will reduce the total shares outstanding.

During 2020, 2019, and 2018, the Company repurchased 3.1 million, 1.5 million, and 5.5 million shares, respectively, at an aggregate cost of $625.4 million, $263.3 million, and $795.5 million, respectively, including shares purchased under the accelerated share repurchase ("ASR") agreements described below and shares acquired to satisfy tax withholding obligations in connection with the vesting of restricted stock units issued to employees. The timing and size of any future stock repurchases are subject to a variety of factors, including expected dilution from stock plans, cash capacity, and the market price of the Company's common stock.

75
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
14.    COMMON STOCK (Continued)
Accelerated Share Repurchase

During 2019 and 2018, the Company entered into ASR agreements providing for the repurchase of the Company's common stock based on the volume-weighted average price ("VWAP") of the Company's common stock during the term of the agreements, less a discount. The following table summarizes the terms of the ASR agreements (dollars and shares in millions, except per share data):
  Initial DeliveryFinal Settlement
Agreement DateAmount
Paid		Shares
Received		Price per
Share (a)		Value of
Shares as %
of Contract
Value		Settlement
Date		Total Shares
Received		Average Price
per Share (a)
April 2018$400.0 2.5 $127.36 80 %July 20182.8 $142.37 
October 2018$250.0 1.4 $139.22 80 %November 20181.7 $150.54 
May 2019$150.0 0.7 $178.66 80 %May 20190.8 $178.42 
May 2019$100.0 0.5 $170.02 80 %June 20190.6 $178.46 
_______________________________________________________________________________
(a)    The three-for-one stock split distributed on May 29, 2020 excluded treasury shares. The shares and per share prices in the table are reflected at the pre-split amounts and prices at the time of the transaction.

The ASR agreements were accounted for as two separate transactions: (1) the value of the initial delivery of shares was recorded as shares of common stock acquired in a treasury stock transaction on the acquisition date and (2) the remaining amount of the purchase price paid was recorded as a forward contract indexed to the Company's own common stock and was recorded in "Additional Paid-in Capital" on the consolidated balance sheets. The initial delivery of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted-average common shares outstanding for basic and diluted earnings per share. The Company determined that the forward contract indexed to the Company's common stock met all the applicable criteria for equity classification and, therefore, was not accounted for as a derivative instrument.

Employee and Director Stock Plans

The Edwards Lifesciences Corporation Long-term Stock Incentive Compensation Program (the "Program") provides for the grant of incentive and non-qualified stock options, restricted stock, and restricted stock units for eligible employees of the Company. Under the Program, these grants are awarded at a price equal to the fair market value at the date of grant based upon the closing price on that date. Options to purchase shares of the Company's common stock granted under the Program generally vest over predetermined periods of between three to four years and expire seven years after the date of grant. Service-based restricted stock units of the Company's common stock granted under the Program generally vest over predetermined periods ranging from three to four years after the date of grant. Market-based restricted stock units of the Company's common stock granted under the Program vest over three years based on a combination of certain service and market conditions. The actual number of shares issued will be determined based on the Company's total stockholder return relative to a selected industry peer group. Performance-based restricted stock units vest based on a combination of certain service conditions and upon achievement of specified milestones. Under the Program, the number of shares of common stock available for issuance under the Program was 327.6 million shares. No more than 33.6 million shares reserved for issuance may be granted in the form of restricted stock or restricted stock units.

The Company also maintains the Nonemployee Directors Stock Incentive Compensation Program (the "Nonemployee Directors Program"). Under the Nonemployee Directors Program, annually each nonemployee director may receive up to 120,000 stock options or 48,000 restricted stock units of the Company's common stock, or a combination thereof, provided that in no event may the total value of the combined annual award exceed $0.2 million. These grants generally vest over one year from the date of grant. Under the Nonemployee Directors Program, an aggregate of 8.4 million shares of the Company's common stock has been authorized for issuance.

The Company has an employee stock purchase plan for United States employees and a plan for international employees (collectively "ESPP"). Under the ESPP, eligible employees may purchase shares of the Company's common stock at 85% of the lower of the fair market value of Edwards Lifesciences common stock on the effective date of subscription or the date of
76
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
14.    COMMON STOCK (Continued)
purchase. Under the ESPP, employees can authorize the Company to withhold up to 12% (15% effective January 1, 2021) of their compensation for common stock purchases, subject to certain limitations. The ESPP is available to all active employees of the Company paid from the United States payroll and to eligible employees of the Company outside the United States, to the extent permitted by local law. The ESPP for United States employees is qualified under Section 423 of the Internal Revenue Code. The number of shares of common stock authorized for issuance under the ESPP was 45.9 million shares.

The fair value of each option award and employee stock purchase subscription is estimated on the date of grant using the Black-Scholes option valuation model that uses the assumptions noted in the following tables. The risk-free interest rate is estimated using the U.S. Treasury yield curve and is based on the expected term of the award. Expected volatility is estimated based on a blend of the weighted-average of the historical volatility of Edwards Lifesciences' stock and the implied volatility from traded options on Edwards Lifesciences' stock. The expected term of awards granted is estimated from the vesting period of the award, as well as historical exercise behavior, and represents the period of time that awards granted are expected to be outstanding. The Company uses historical data to estimate forfeitures and has estimated an annual forfeiture rate of 6.4%.

The Black-Scholes option pricing model was used with the following weighted-average assumptions for options granted during the following periods:

Option Awards
202020192018
Average risk-free interest rate0.3 %2.3 %2.9 %
Expected dividend yieldNoneNoneNone
Expected volatility33 %30 %29 %
Expected life (years)5.05.15.0
Fair value, per share$21.70 $18.17 $14.17 

The Black-Scholes option pricing model was used with the following weighted-average assumptions for ESPP subscriptions granted during the following periods:

ESPP
202020192018
Average risk-free interest rate1.3 %2.4 %1.7 %
Expected dividend yieldNoneNoneNone
Expected volatility33 %27 %31 %
Expected life (years)0.60.60.6
Fair value, per share$16.61 $16.43 $12.18 

The fair value of market-based restricted stock units was determined using a Monte Carlo simulation model, which uses multiple input variables to determine the probability of satisfying the market condition requirements. The weighted-average assumptions used to determine the fair value of the market-based restricted stock units during the years ended December 31, 2020, 2019, and 2018 included a risk-free interest rate of 0.2%, 2.2%, and 2.7%, respectively, and an expected volatility rate of 32.7%, 29.4%, and 29.7%, respectively.

77
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
14.    COMMON STOCK (Continued)
Stock option activity during the year ended December 31, 2020 under the Program and the Nonemployee Directors Program was as follows (in millions, except years and per-share amounts):

 SharesWeighted-
Average
Exercise
Price		Weighted-
Average
Remaining
Contractual
Term		Aggregate
Intrinsic Value
Outstanding as of December 31, 201917.1 $32.19   
Options granted1.8 73.02   
Options exercised(4.3)18.16   
Options forfeited(0.3)49.74   
Outstanding as of December 31, 202014.3 41.27 3.4 years$712.5 
Exercisable as of December 31, 20209.5 32.32 2.5 years558.1 
Vested and expected to vest as of December 31, 202013.6 40.37 3.3 years690.4 

The following table summarizes nonvested restricted stock unit activity during the year ended December 31, 2020 under the Program and the Nonemployee Directors Program (in millions, except per-share amounts):

 SharesWeighted-
Average
Grant-Date
Fair Value
Nonvested as of December 31, 20192.7 $46.89 
Granted (a)0.9 71.31 
Vested(0.9)40.03 
Forfeited(0.1)49.90 
Nonvested as of December 31, 20202.6 57.59 
_______________________________________________________________________________
(a)    The shares granted includes 0.1 million shares of market-based restricted stock units granted during 2020, which represents the target number of shares to be issued, and 0.1 million shares related to a previous year's grant of market-based restricted stock units since the payout percentage achieved at the end of the performance period was in excess of target. As described above, the actual number of shares ultimately issued is determined based on the Company's total stockholder return relative to a selected industry peer group.

The intrinsic value of stock options exercised and restricted stock units vested during the years ended December 31, 2020, 2019, and 2018 were $323.5 million, $382.1 million, and $281.1 million, respectively. The intrinsic value of stock options is calculated as the amount by which the market price of the Company's common stock exceeds the exercise price of the option. During the years ended December 31, 2020, 2019, and 2018, the Company received cash from exercises of stock options of $79.2 million, $110.4 million, and $103.7 million, respectively, and tax benefits from exercises of stock options and vesting of restricted stock units of $72.1 million, $85.1 million, and $62.5 million, respectively. The total grant-date fair value of stock options vested during the years ended December 31, 2020, 2019, and 2018 were $34.0 million, $31.2 million, and $29.0 million, respectively.

As of December 31, 2020, the total remaining unrecognized compensation expense related to nonvested stock options, restricted stock units, and employee stock purchase subscriptions amounted to $140.9 million, which will be amortized over the weighted-average remaining requisite service period of 30 months.

78
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

15.    ACCUMULATED OTHER COMPREHENSIVE LOSS

Presented below is a summary of activity for each component of "Accumulated Other Comprehensive Loss" for the years ended December 31, 2020, 2019, and 2018.

 Foreign
Currency
Translation
Adjustments		Unrealized (Loss) Gain on HedgesUnrealized (Loss) Gain on
Available-for-sale
Investments		Unrealized
Pension
Costs (a)		Total
Accumulated
Other
Comprehensive
Loss
 (in millions)
December 31, 2017$(100.1)$(13.9)$(4.6)$(14.1)$(132.7)
Impact from adoption of ASU 2016-16 and ASU 2018-02(4.9)(2.9)— — (7.8)
January 1, 2018(105.0)(16.8)(4.6)(14.1)(140.5)
Other comprehensive (loss) income before reclassifications          (36.7)35.1 (3.1)7.6 2.9 
Amounts reclassified from accumulated other comprehensive loss— 19.1 2.9 (6.7)15.3 
Deferred income tax expense(1.9)(13.8)(0.2)(0.3)(16.2)
December 31, 2018(143.6)23.6 (5.0)(13.5)(138.5)
Other comprehensive (loss) income before reclassifications          (1.5)27.9 7.9 (3.2)31.1 
Amounts reclassified from accumulated other comprehensive loss(6.6)(44.2)0.4 0.7 (49.7)
Deferred income tax (expense) benefit(3.1)5.2 (1.6)0.6 1.1 
December 31, 2019(154.8)12.5 1.7 (15.4)(156.0)
Other comprehensive income (loss) before reclassifications          35.7 (34.8)8.0 (5.5)3.4 
Amounts reclassified from accumulated other comprehensive loss(6.4)(19.2)0.3 0.9 (24.4)
Deferred income tax benefit (expense)3.1 13.8 (1.4)0.4 15.9 
December 31, 2020$(122.4)$(27.7)$8.6 $(19.6)$(161.1)
_______________________________________________________________________________

79
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
15.    ACCUMULATED OTHER COMPREHENSIVE LOSS (Continued)

(a)For the years ended December 31, 2020, 2019, and 2018, the change in unrealized pension costs consisted of the following (in millions):
 Pre-Tax
Amount		Tax (Expense) BenefitNet of Tax
Amount
2020   
Prior service credit arising during period$0.6 $(0.2)$0.4 
Amortization of prior service credit(0.7)0.1 (0.6)
Net prior service cost arising during period(0.1)(0.1)(0.2)
Net actuarial loss arising during period(4.5)0.5 (4.0)
Unrealized pension costs, net$(4.6)$0.4 $(4.2)
2019   
Prior service credit arising during period$4.6 $(0.6)$4.0 
Amortization of prior service credit(0.2)0.1 (0.1)
Net prior service credit arising during period4.4 (0.5)3.9 
Net actuarial loss arising during period(6.9)1.1 (5.8)
Unrealized pension costs, net$(2.5)$0.6 $(1.9)
2018   
Prior service credit arising during period$3.3 $(0.9)$2.4 
Amortization of prior service credit(0.1)— (0.1)
Net prior service credit arising during period3.2 (0.9)2.3 
Net actuarial loss arising during period(2.3)0.6 (1.7)
Unrealized pension credits, net$0.9 $(0.3)$0.6 

The following table provides information about amounts reclassified from "Accumulated Other Comprehensive Loss" (in millions):
 Years Ended December 31, 
Details about Accumulated Other Comprehensive Loss
Components		20202019Affected Line on Consolidated
Statements of Operations
Foreign currency translation adjustments$6.4 $6.6 Other income, net
(1.6)(1.6)Provision for income taxes
$4.8 $5.0 Net of tax
(Loss) gain on hedges$18.4 $40.9 Cost of sales
2.2 1.9 Selling, general, and administrative expenses
(1.4)1.4 Other income, net
19.2 44.2 Total before tax
(5.0)(11.0)Provision for income taxes
$14.2 $33.2 Net of tax
(Loss) gain on available-for-sale investments$(0.3)$(0.4)Other income, net
(0.6)(0.3)Provision for income taxes
$(0.9)$(0.7)Net of tax
Amortization of pension adjustments$(0.9)$(0.7)Other income, net
0.2 0.1 Provision for income taxes
$(0.7)$(0.6)Net of tax

80
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

16.    OTHER INCOME, NET
 Years Ended December 31,
 202020192018
(in millions)
Foreign exchange gains, net$(12.3)$(5.9)$(6.7)
Gain on investments(0.6)(0.5)1.7 
Non-service cost components of net periodic pension benefit cost (credit)0.4 0.2 (0.1)
Other1.0 (2.0)1.1 
Total other income, net$(11.5)$(8.2)$(4.0)

17.    INCOME TAXES

The Company's income before provision for income taxes was generated from United States and international operations as follows (in millions):
 Years Ended December 31,
 202020192018
United States$151.3 $383.4 $266.1 
International, including Puerto Rico765.4 783.1 495.3 
$916.7 $1,166.5 $761.4 

The provision for income taxes consists of the following (in millions):
 Years Ended December 31,
 202020192018
Current   
United States:   
Federal$23.4 $31.3 $10.9 
State and local48.2 48.7 13.6 
International, including Puerto Rico73.9 29.1 35.9 
Current income tax expense$145.5 $109.1 $60.4 
Deferred   
United States:   
Federal$11.0 $28.3 $(16.1)
State and local(32.9)(18.3)(22.4)
International, including Puerto Rico(30.3)0.5 17.3 
Deferred income tax (benefit) expense(52.2)10.5 (21.2)
Total income tax provision$93.3 $119.6 $39.2 

81
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
17.    INCOME TAXES (Continued)
The components of deferred tax assets and liabilities are as follows (in millions):
 December 31,
 20202019
Deferred tax assets  
Compensation and benefits$88.6 $90.1 
Benefits from uncertain tax positions27.0 22.5 
Net tax credit carryforwards125.5 108.4 
Net operating loss carryforwards64.1 57.6 
Accrued liabilities105.0 41.3 
Inventories16.3 12.9 
Cash flow and net investment hedges3.3 — 
State income taxes0.5 0.5 
Investments1.8 1.5 
Lease liability obligations7.7 18.4 
Other3.6 3.4 
Total deferred tax assets443.4 356.6 
Deferred tax liabilities  
Property, plant, and equipment(53.4)(22.6)
Cash flow and net investment hedges— (6.8)
Deferred tax on foreign earnings(29.2)(35.3)
Right-of-use assets (7.0)(17.5)
Other intangible assets(76.3)(71.0)
Other(3.1)(2.2)
Total deferred tax liabilities(169.0)(155.4)
Valuation allowance(71.6)(65.8)
Net deferred tax assets$202.8 $135.4 

During 2020, net deferred tax assets increased $67.4 million, including items that were recorded to stockholders' equity and which did not impact the Company's income tax provision.

The valuation allowance of $71.6 million as of December 31, 2020 reduces certain deferred tax assets to amounts that are more likely than not to be realized. This allowance primarily relates to the net operating loss carryforwards of certain non-United States subsidiaries and certain non-United States credit carryforwards.

82
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
17.    INCOME TAXES (Continued)
Net operating loss and capital loss carryforwards and the related carryforward periods at December 31, 2020 are summarized as follows (in millions):
 Carryforward
Amount		Tax Benefit
Amount		Valuation
Allowance		Net Tax
Benefit		Carryforward
Period Ends
United States federal net operating losses$26.6 $5.6 $— $5.6 2030-2037
United States federal net operating losses11.3 2.4 — 2.4 Indefinite
United States state net operating losses33.5 2.1 (2.1)— 2026-2039
United States state net operating losses1.0 0.1 (0.1)— Indefinite
Non-United States net operating losses18.2 4.7 (3.6)1.1 2020-2027
Non-United States net operating losses295.1 49.2 (39.9)9.3 Indefinite
United States capital losses34.1 0.2 (0.2)— 2024
Total$419.8 $64.3 $(45.9)$18.4  

Certain tax attributes are subject to an annual limitation as a result of the acquisitions of Harpoon Medical, Inc. and CASMED (see Note 8), which constitute a change of ownership as defined under Internal Revenue Code Section 382.

The gross tax credit carryforwards and the related carryforward periods at December 31, 2020 are summarized as follows (in millions):
 Carryforward
Amount		Valuation
Allowance		Net Tax
Benefit		Carryforward
Period Ends
California research expenditure tax credits$145.1 $— $145.1 Indefinite
Federal research expenditure tax credits1.5 — 1.5 2026-2039
Puerto Rico purchases credit23.4 (23.4)— Indefinite
Total$170.0 $(23.4)$146.6  

The Company has $145.1 million of California research expenditure tax credits it expects to use in future periods. The credits may be carried forward indefinitely. Based upon anticipated future taxable income, the Company expects that it is more likely than not that all California research expenditure tax credits will be utilized, although the utilization of the full benefit is expected to occur over a number of years and into the distant future. Accordingly, no valuation allowance has been provided. The Company has $23.4 million of Puerto Rico purchases credit. Throughout its history and into the future, the Puerto Rico operations generate, or are expected to generate, credits each year in excess of its ability to utilize credits in those years. As a result, even though the credits have an indefinite life, the Company continues to record a valuation allowance on the credit carryforwards.

On December 22, 2017, Public Law 115-97, commonly referred to as the Tax Cuts and Jobs Act (the "2017 Act"), was signed into law. The 2017 Act a) reduced the U.S. federal corporate tax rate from 35 percent to 21 percent for tax years beginning after December 31, 2017, b) required companies to pay a one-time mandatory deemed repatriation tax on the cumulative earnings of certain foreign subsidiaries that were previously tax deferred, and c) created new taxes on certain foreign earnings in future years.

On December 22, 2017, Staff Accounting Bulletin No. 118 ("SAB 118") was issued to address the application of generally accepted accounting principles in the United States of America in situations when a registrant does not have the necessary information available, prepared, or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of the 2017 Act. In accordance with SAB 118, as of December 31, 2017, the Company had estimated provisional amounts for a) $3.3 million of tax benefits in connection with the remeasurement of certain tax assets and liabilities, b) $297.4 million of net tax expense in connection with the one-time mandatory deemed repatriation tax on cumulative earnings of certain foreign subsidiaries, and c) $32.3 million of tax benefits associated with a tax reform related restructuring. In accordance with SAB 118, during 2018 the Company adjusted the provisional amounts as described below.

83
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
17.    INCOME TAXES (Continued)
As a result of Internal Revenue Service ("IRS") guidance issued subsequent to the 2017 Act, the $32.3 million of tax benefits associated with the tax reform related restructuring mentioned above were reversed in 2018. In addition, during 2018, the Company recorded a $12.8 million reduction in the repatriation tax and an additional benefit of $3.7 million in connection with the remeasurement of deferred tax assets. In accordance with SAB 118, the Company completed its accounting for the 2017 Act during the fourth quarter of 2018. In addition, the Company elected to pay the repatriation tax in installments over eight years.

The Company asserts that $1.1 billion of its foreign earnings continue to be indefinitely reinvested and it intends to repatriate $599.8 million of its foreign earnings as of December 31, 2020. The estimated net tax liability on the indefinitely reinvested earnings if repatriated is $21.1 million.

The Company has received tax incentives in certain non-U.S. tax jurisdictions, the primary benefit for which will expire in 2029. The tax reductions as compared to the local statutory rates were $189.2 million ($0.30 per diluted share), $157.6 million ($0.25 per diluted share), and $144.9 million ($0.23 per diluted share) for the years ended December 31, 2020, 2019, and 2018, respectively.

A reconciliation of the United States federal statutory income tax rate to the Company's effective income tax rate is as follows (in millions):
 Years Ended December 31,
 202020192018
Income tax expense at U.S. federal statutory rate$192.5 $245.0 $159.9 
Foreign income taxed at different rates(80.5)(75.0)(16.2)
State and local taxes, net of federal tax benefit5.0 11.9 6.8 
Tax credits, federal and state(43.1)(42.9)(36.7)
Build (release) of reserve for prior years' uncertain tax positions4.2 5.0 (35.5)
U.S. tax on foreign earnings, net of credits1.5 (2.9)(12.2)
Tax on global intangible low-taxed income49.2 32.0 — 
Foreign-derived intangible income deduction(2.6)(7.2)(6.6)
U.S. federal deductible employee share-based compensation(48.3)(57.6)(41.8)
Nondeductible employee share-based compensation4.2 3.2 2.8 
Impact related to 2017 U.S. Tax Reform— 2.8 15.8 
Other11.2 5.3 2.9 
Income tax provision$93.3 $119.6 $39.2 

The Company's effective tax rate for 2020 decreased slightly in comparison to 2019 primarily due to the tax benefit from the Settlement Agreement with Abbott (see Notes 3 and 18), partially offset by the increase in the U.S. tax on global intangible low-taxed income and the decrease in the tax benefit from employee share-based compensation. The Company's effective tax rate for 2019 increased in comparison to 2018 primarily because of the increase in the U.S. tax on global intangible low-taxed income and the tax benefit in 2018 from audit settlements.
Uncertain Tax Positions

As of December 31, 2020 and 2019, the gross uncertain tax positions were $281.8 million and $203.1 million, respectively. The Company estimates that these liabilities would be reduced by $95.1 million and $50.1 million, respectively, from offsetting tax benefits associated with the correlative effects of potential transfer pricing adjustments, state income taxes, and timing adjustments. The net amounts of $186.7 million and $153.0 million, respectively, if not required, would favorably affect the Company's effective tax rate.

84
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
17.    INCOME TAXES (Continued)
A reconciliation of the beginning and ending amount of uncertain tax positions, excluding interest, penalties, and foreign exchange, is as follows (in millions):
 December 31,
 202020192018
Uncertain gross tax positions, January 1$203.1 $150.7 $225.6 
Current year tax positions
86.4 55.4 37.8 
Increase in prior year tax positions
6.0 0.8 13.9 
Decrease in prior year tax positions
(10.0)(3.8)(78.8)
Settlements
(3.7)— (46.5)
Lapse of statutes of limitations
— — (1.3)
Uncertain gross tax positions, December 31$281.8 $203.1 $150.7 

The table above summarizes the gross amounts of uncertain tax positions without regard to reduction in tax liabilities or additions to deferred tax assets and liabilities if such uncertain tax positions were settled.

The Company recognizes interest and penalties, if any, related to uncertain tax positions in the provision for income taxes. As of December 31, 2020, the Company had accrued $14.3 million (net of $5.1 million tax benefit) of interest related to uncertain tax positions, and as of December 31, 2019, the Company had accrued $9.3 million (net of $3.5 million tax benefit) of interest related to uncertain tax positions. During 2020, 2019, and 2018, the Company recognized interest expense (benefit), net of tax benefit, of $5.0 million, $4.7 million, and $(2.8) million, respectively, in "Provision for Income Taxes" on the consolidated statements of operations.

The Company strives to resolve open matters with each tax authority at the examination level and could reach agreement with a tax authority at any time. While the Company has accrued for matters it believes are more likely than not to require settlement, the final outcome with a tax authority may result in a tax liability that is more or less than that reflected in the consolidated financial statements. Furthermore, the Company may later decide to challenge any assessments, if made, and may exercise its right to appeal. The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new legislation, regulations, or case law. Management believes that adequate amounts of tax and related penalty and interest have been provided in income tax expense for any adjustments that may result from these uncertain tax positions.

At December 31, 2020, all material state, local, and foreign income tax matters have been concluded for years through 2015. While not material, the Company continues to address matters in Wisconsin and India for years from 2010.

During 2018, the Company executed an Advance Pricing Agreement (“APA”) between the United States and Switzerland governments for tax years 2009 through 2020 covering various, but not all, transfer pricing matters. The unagreed transfer pricing matters, namely Surgical Structural Heart and Transcatheter Aortic Valve Replacement intercompany royalty transactions, then reverted to IRS Examination for further consideration as part of the respective years' regular tax audit. In addition, the Company signed agreements during 2018 with the IRS to settle open tax years 2009 through 2014, including all transfer pricing matters for those years and the tax treatment of a portion of a litigation settlement payment received in 2014.

The IRS began its examination of the 2015 and 2016 tax years during the fourth quarter of 2018 and later added the 2017 tax year to this audit cycle during the first quarter of 2019. The IRS audit field work for the 2015-2017 tax years was substantially completed during the fourth quarter of 2020, except for transfer pricing matters.

As a result, certain intercompany transactions covering tax years 2015 through 2020 that were not resolved under the APA program remain subject to IRS examination, and those transactions and related tax positions remain uncertain as of December 31, 2020. The IRS has signaled that it may be preparing proposed audit adjustments related to these intercompany transactions for the 2015-2017 tax years which, if issued, could be provided to the Company during 2021. The Company has considered this information in its evaluation of its uncertain tax positions.

85
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
17.    INCOME TAXES (Continued)
These unresolved transfer pricing matters, net of any correlative repatriation tax adjustment, may be significant to the Company’s consolidated financial statements. Based on the information currently available and numerous possible outcomes, the Company cannot reasonably estimate what, if any, changes to its existing uncertain tax positions may occur in the next 12 months and, therefore, has continued to record the gross uncertain tax positions as a long-term liability.

The Company intends to file to renew the APA between the United States and Switzerland for the years 2021 and forward. In addition, the Company executed other APAs as follows: during 2017, an APA between the United States and Japan covering tax years 2015 through 2019; and during 2018, APAs between Japan and Singapore and between Switzerland and Japan covering tax years 2015 through 2019. The Company has filed to renew these APAs related to Japan for the years 2020 and forward. The execution of some or all of these APAs depends on a number of variables outside of the Company's control.

18.    LEGAL PROCEEDINGS

In January 2019, Abbott filed lawsuits against Edwards Lifesciences and its direct and indirect subsidiaries (“Edwards”) in the Federal District Court in the District of Delaware, in the United Kingdom, Germany, Switzerland and Italy, and, in February 2020, in Ireland, alleging patent infringement involving Edwards’ PASCAL heart valve repair system (collectively, the “PASCAL litigation”). In February 2019, Edwards filed a lawsuit against Abbott in the Federal District Court in the Central District of California alleging patent infringement involving Abbott's MITRACLIP device (with the PASCAL litigation, the “Abbott Matters”). On July 12, 2020, Edwards entered into the Settlement Agreement with Abbott to, among other things, settle all patent litigation between the parties related to alleged patent infringement involving Edwards’ PASCAL heart valve repair system and Abbott’s MITRACLIP device. Pursuant to the Settlement Agreement, all of the Abbott Matters and related appeals in courts worldwide were dismissed. The Settlement Agreement resulted in the Company recording an estimated $367.9 million pre-tax net charge in June 2020 related to past damages. See Note 3 for additional information.

In addition, the Company is or may be a party to, or may otherwise be responsible for, pending or threatened lawsuits including those related to products and services currently or formerly manufactured or performed, as applicable, by the Company, workplace and employment matters, matters involving real estate, Company operations or health care regulations, or governmental investigations (the "Other Lawsuits"). The Other Lawsuits raise difficult and complex factual and legal issues and are subject to many uncertainties, including, but not limited to, the facts and circumstances of each particular case or claim, the jurisdiction in which each suit is brought, and differences in applicable law. Management does not believe that any loss relating to the Other Lawsuits would have a material adverse effect on the Company's overall financial condition, results of operations or cash flows. However, the resolution of one or more of the Other Lawsuits in any reporting period, could have a material adverse impact on the Company's financial results for that period. The Company is not able to estimate the amount or range of any loss for legal contingencies related to the Other Lawsuits for which there is no reserve or additional loss for matters already reserved.

The Company is subject to various environmental laws and regulations both within and outside of the United States. The Company's operations, like those of other medical device companies, involve the use of substances regulated under environmental laws, primarily in manufacturing and sterilization processes. While it is difficult to quantify the potential impact of continuing compliance with environmental protection laws, management believes that such compliance will not have a material impact on the Company's financial results. The Company's threshold of disclosing material environmental legal proceedings involving a governmental authority where potential monetary exposure is involved is $1 million.

19.    SEGMENT INFORMATION

The Company conducts operations worldwide and is managed in the following geographical regions: United States, Europe, Japan, and Rest of World. All regions sell products that are used to treat advanced cardiovascular disease.

The Company's geographic segments are reported based on the financial information provided to the Chief Operating Decision Maker (the Chief Executive Officer). The Company evaluates the performance of its geographic segments based on net sales and operating income. The accounting policies of the segments are substantially the same as those described in Note 2. Segment net sales and segment operating income are based on internally derived standard foreign exchange rates, which may differ from year to year, and do not include inter-segment profits. Because of the interdependence of the reportable segments,
86
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
19.    SEGMENT INFORMATION (Continued)
the operating profit as presented may not be representative of the geographical distribution that would occur if the segments were not interdependent. Net sales by geographic area are based on the location of the customer.

Certain items are maintained at the corporate level and are not allocated to the segments. The non-allocated items include net interest expense, global marketing expenses, corporate research and development expenses, manufacturing variances, corporate headquarters costs, special gains and charges, stock-based compensation, foreign currency hedging activities, certain litigation costs, changes in the fair value of contingent consideration liabilities, and most of the Company's amortization expense. Although most of the Company's depreciation expense is included in segment operating income, due to the Company's methodology for cost build-up, it is impractical to determine the amount of depreciation expense included in each segment, and, therefore, a portion is maintained at the corporate level. The Company neither discretely allocates assets to its operating segments, nor evaluates the operating segments using discrete asset information.

The table below presents information about Edwards Lifesciences' reportable segments (in millions):
 Years Ended December 31,
 202020192018
Segment Net Sales   
United States$2,516.8 $2,532.7 $2,055.2 
Europe945.2 926.1 826.4 
Japan448.6 441.4 398.4 
Rest of World451.5 433.3 396.0 
Total segment net sales$4,362.1 $4,333.5 $3,676.0 
Segment Operating Income  
United States$1,727.3 $1,742.3 $1,368.1 
Europe479.3 472.0 394.8 
Japan286.4 272.3 237.0 
Rest of World150.1 127.9 115.6 
Total segment operating income$2,643.1 $2,614.5 $2,115.5 

87
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
19.    SEGMENT INFORMATION (Continued)
The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated income before provision for income taxes ("pre-tax income") (in millions):
 Years Ended December 31,
 202020192018
Net Sales Reconciliation   
Segment net sales$4,362.1 $4,333.5 $3,676.0 
Foreign currency24.2 14.5 46.8 
Consolidated net sales$4,386.3 $4,348.0 $3,722.8 
Pre-tax Income Reconciliation  
Segment operating income$2,643.1 $2,614.5 $2,115.5 
Unallocated amounts:
Corporate items(1,358.0)(1,439.7)(1,058.1)
Special charges— (64.6)(116.2)
Intellectual property litigation expenses, net(405.4)(33.4)(214.0)
Change in fair value of contingent consideration liabilities, net(13.6)6.1 5.7 
Foreign currency31.5 63.9 15.3 
Consolidated operating income897.6 1,146.8 748.2 
Non-operating income19.1 19.7 13.2 
Consolidated pre-tax income$916.7 $1,166.5 $761.4 

88
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
19.    SEGMENT INFORMATION (Continued)
Enterprise-Wide Information

Enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated financial statements.

 As of or for the Years Ended December 31,
 202020192018
(in millions)
Net Sales by Geographic Area   
United States$2,516.8 $2,532.7 $2,055.3 
Europe973.6 941.2 885.1 
Japan460.1 444.7 396.8 
Rest of World435.8 429.4 385.6 
$4,386.3 $4,348.0 $3,722.8 
Net Sales by Major Product Area  
Transcatheter Aortic Valve Replacement$2,857.3 $2,737.9 $2,283.8 
Transcatheter Mitral and Tricuspid Therapies41.8 28.2 2.9 
Surgical Structural Heart761.8 841.7 761.6 
Critical Care725.4 740.2 674.5 
$4,386.3 $4,348.0 $3,722.8 
Long-lived Tangible Assets by Geographic Area   
United States$1,084.3 $849.1 $642.1 
Europe192.7 101.5 36.6 
Japan20.4 21.7 6.7 
Rest of World311.0 269.4 214.4 
$1,608.4 $1,241.7 $899.8 

89
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
20.    QUARTERLY FINANCIAL RESULTS AND MARKET FOR THE COMPANY'S STOCK (UNAUDITED)

Years Ended December 31,First
Quarter		Second
Quarter		Third
Quarter		Fourth
Quarter		Total
Year
 (in millions, except per share data)
2020     
Net sales$1,128.7 $925.0 $1,140.9 $1,191.7 $4,386.3 
Gross profit863.6 686.8 859.9 895.4 3,305.7 
Net income (loss) (a)310.6 (121.9)325.2 309.5 823.4 
Earnings (loss) per common share (a):     
Basic0.50 (0.20)0.52 0.50 1.32 
Diluted0.49 (0.20)0.52 0.49 1.30 
Market price:     
High$81.90 $78.43 $87.79 $92.08 $92.08 
Low51.51 56.44 66.87 70.92 51.51 
2019     
Net sales$993.0 $1,086.9 $1,094.0 $1,174.1 $4,348.0 
Gross profit761.2 782.9 801.6 887.9 3,233.6 
Net income (b)249.7 242.3 274.7 280.2 1,046.9 
Earnings per common share (b):     
Basic0.40 0.39 0.44 0.45 1.68 
Diluted0.39 0.38 0.43 0.44 1.64 
Market price:     
High$65.95 $65.00 $76.06 $82.55 $82.55 
Low46.95 55.23 61.00 71.08 46.95 
_______________________________________________________________________________
(a)    The second quarter of 2020 includes a $367.9 million charge related to a litigation settlement.
(b) The first quarter of 2019 includes a $24.0 million charge related to the acquisition of early-stage transcatheter intellectual property and associated clinical and regulatory experience. The second and third quarters of 2019 include a $46.2 million and $26.9 million charge, respectively, related to the write off of inventory. The fourth quarter of 2019 includes a $40.6 million charge related to the impairment of certain in-process research and development assets.

90
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)


21.    VALUATION AND QUALIFYING ACCOUNTS

  Additions  
 Balance at
Beginning
of Period		Charged to
Costs and
Expenses		Charged to
Other
Accounts		DeductionsBalance at
End of
Period
 (in millions)
Year ended December 31, 2020     
Allowance for doubtful accounts (a)$14.7 $3.1 $— $(1.4)$16.4 
Tax valuation allowance (b)64.0 6.3 0.6 (1.1)69.8 
Year ended December 31, 2019     
Allowance for doubtful accounts (a)$13.6 $4.7 $0.2 $(3.8)$14.7 
Tax valuation allowance (b)44.9 18.9 0.2 — 64.0 
Year ended December 31, 2018     
Allowance for doubtful accounts (a)$13.7 $2.2 $1.0 $(3.3)$13.6 
Tax valuation allowance (b)41.6 7.1 (1.8)(2.0)44.9 
_______________________________________________________________________________
(a)    The deductions related to allowances for doubtful accounts represent accounts receivable which are written off.

(b)     The tax valuation allowances are provided for other-than-temporary impairments and unrealized losses related to certain investments that may not be recognized due to the uncertainty of the ready marketability of certain impaired investments, and net operating loss and credit carryforwards that may not be recognized due to insufficient taxable income.

22.    SUBSEQUENT EVENT

In February 2021, Edwards entered into an ASR agreement to repurchase $250.0 million of the Company's common stock based on the volume-weighted average price ("VWAP") of the Company's common stock during the term of the agreements, less a discount. Upon entering into the agreement, Edwards received an initial delivery of 2.4 million shares, representing approximately 80% of the shares to be repurchased. At the termination of the ASR, Edwards may receive additional shares or may be required to pay additional cash or shares (at the Company's election). The final settlement is based on the VWAP over the term of the agreement, less a discount. The ASR agreement has a scheduled termination date of March 18, 2021.


91
Item 9.    Changes in and Disagreements With Accountants on Accounting and Financial Disclosure

None.

Item 9A.    Controls and Procedures

Evaluation of Disclosure Controls and Procedures.    The Company's management, including the Chief Executive Officer and Chief Financial Officer, performed an evaluation of the effectiveness of the design and operation of the Company's disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of December 31, 2020.

Based on their evaluation, the Chief Executive Officer and Chief Financial Officer have concluded as of December 31, 2020 that the Company's disclosure controls and procedures are designed at a reasonable assurance level and are effective in providing reasonable assurance that the information required to be disclosed by the Company in the reports it files or submits under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized, and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to the Company's management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Management's Report on Internal Control Over Financial Reporting.    The Company's management, including the Chief Executive Officer and Chief Financial Officer, is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended. Under the supervision and with the participation of the Company's management, including the Chief Executive Officer and Chief Financial Officer, the Company conducted an evaluation of the effectiveness of its internal control over financial reporting based on the framework in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on that evaluation, the Company's management concluded that its internal control over financial reporting was effective as of December 31, 2020. The effectiveness of the Company's internal control over financial reporting as of December 31, 2020 has been audited by PricewaterhouseCoopers LLP, the independent registered public accounting firm that audited the financial statements included in this Annual Report on Form 10-K, as stated in their report which appears herein.

Changes in Internal Control Over Financial Reporting.    There have been no changes in the Company's internal control over financial reporting that occurred during the Company's fourth fiscal quarter of 2020 that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting. We have not experienced any material impact to our internal control over financial reporting despite the fact that many of our employees are working remotely due to the COVID-19 pandemic. We are continually monitoring and assessing the potential impact of COVID-19 on our internal controls to minimize the impact on their design and operating effectiveness.

Item 9B.    Other Information

None.

92
PART III

Item 10.    Directors, Executive Officers and Corporate Governance

Certain information required by this Item will be set forth under the headings "Board of Directors Matters—Proposal 1 - Election of Directors—Board of Director Nominees," "Board of Directors Matters—Corporate Governance Policies and Practices," and "Executive Compensation and Other Information—Executive Officers" in the definitive proxy statement to be filed in connection with the Company's 2021 Annual Meeting of Stockholders (the "Proxy Statement") (which Proxy Statement will be filed with the SEC within 120 days of December 31, 2020). The information required by this Item to be contained in the Proxy Statement is incorporated herein by reference. The Company has adopted a code of ethics that applies to all directors and employees, including the Company's principal executive officer, principal financial officer, and principal accounting officer, or persons performing similar functions. The code of ethics (business practice standards) is posted on the Company's website, which is found at www.edwards.com under "Investors—Corporate governance—Corporate responsibility—Global Integrity Program." To the extent required by applicable rules of the SEC and the New York Stock Exchange, the Company intends to disclose on its website any amendments to, or waivers from, any provision of its code of ethics that apply to the Company's directors and executive officers, including the principal executive officer, principal financial officer or controller or persons performing similar functions.

Item 11.    Executive Compensation

The information contained under the heading "Executive Compensation and Other Information" in the Proxy Statement is incorporated herein by reference.

Item 12.    Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The information contained under the headings "Security Ownership of Certain Beneficial Owners and Management" and "Equity Compensation Plan Information" in the Proxy Statement is incorporated herein by reference.

Item 13.    Certain Relationships and Related Transactions, and Director Independence

The information contained under the heading "Other Matters and Business—Related Persons Transactions" and under the heading "Corporate Governance Policies and Practices—Director Independence" in the Proxy Statement is incorporated herein by reference.

Item 14.    Principal Accounting Fees and Services

The information contained under the headings "Audit Matters—Fees Paid to Principal Accountants" and "Audit Matters—Pre-Approval of Services" in the Proxy Statement is incorporated herein by reference.

93
PART IV

Item 15.    Exhibits and Financial Statement Schedules

(a)  The following documents are filed as part of this report:

1.  Consolidated Financial Statements.  See “Index to Consolidated Financial Statements” in Part II, Item 8 herein.

2.  Financial Statement Schedules.  Other schedules are not applicable and have not been included herein.

3.  Exhibits. 
Exhibit No.Description
3.1 
3.2 
3.3 
4.1 
+4.2
4.3 
4.4 
4.5 
4.6 
10.1 
#10.2
*10.3
*10.4
*10.5
*10.6
*10.7
*10.8
94
Exhibit No.Description
*10.9
*10.10
*10.11
*10.12
*10.13
*10.14
*10.15
+*10.16
+*10.17
+*10.18
*10.19
*10.20
*10.21
21.1
23 
31.1 
31.2 
+32
101.INSXBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCHXBRL Taxonomy Extension Schema Document
101.CALXBRL Taxonomy Extension Calculation Linkbase Document
101.DEFXBRL Taxonomy Extension Definition Linkbase Document
101.LABXBRL Taxonomy Extension Label Linkbase Document
101.PREXBRL Taxonomy Extension Presentation Linkbase Document
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
______________________________________________________________________________
# Pursuant to a request for confidential treatment, confidential portions of this exhibit have been redacted and have been filed separately with the Securities and Exchange Commission
* Represents management contract or compensatory plan
+ Furnished herewith
95

Item 16.    Form 10-K Summary

None.
96
SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 EDWARDS LIFESCIENCES CORPORATION
February 12, 2021By: /s/ MICHAEL A. MUSSALLEM
Michael A. Mussallem
 Chairman of the Board and
Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

SignatureTitleDate
   
/s/ MICHAEL A. MUSSALLEMChairman of the Board and Chief Executive OfficerFebruary 12, 2021
Michael A. Mussallem(Principal Executive Officer)
/s/ SCOTT B. ULLEMCorporate Vice President, Chief Financial OfficerFebruary 12, 2021
Scott B. Ullem(Principal Financial Officer)
/s/ ROBERT W.A. SELLERSVice President, Corporate ControllerFebruary 12, 2021
Robert W.A. Sellers(Principal Accounting Officer)
/s/ KIERAN T. GALLAHUEDirectorFebruary 12, 2021
Kieran T. Gallahue
/s/ LESLIE S. HEISZDirectorFebruary 12, 2021
Leslie S. Heisz
/s/ PAUL A. LAVIOLETTEDirectorFebruary 12, 2021
Paul A. LaViolette
/s/ WILLIAM J. LINK, PH.D.DirectorFebruary 12, 2021
William J. Link, Ph.D.
/s/ STEVEN R. LORANGERDirectorFebruary 12, 2021
Steven R. Loranger
/s/ MARTHA H. MARSHDirectorFebruary 12, 2021
Martha H. Marsh
/s/ RAMONA SEQUEIRADirectorFebruary 12, 2021
Ramona Sequeira
/s/ NICHOLAS J. VALERIANIDirectorFebruary 12, 2021
Nicholas J. Valeriani

97
 EX-4.2 2 ex-4210xkq42020.htm EX-4.2 Document

Exhibit 4.2

DESCRIPTION OF CAPITAL STOCK

References to “we,” “us” and “our” refer to Edwards Lifesciences Corporation.

General

This section summarizes the rights of our capital stock, certain provisions of our amended and restated certificate of incorporation, as amended (our “certificate of incorporation”), and our bylaws, as amended and restated (our “bylaws”), and certain provisions of applicable law. The following description is only a summary and is qualified by reference to our certificate of incorporation and our bylaws, each of which is incorporated by reference as an exhibit to our Annual Report on Form 10-K for the year ended December 31, 2020 filed with the Securities and Exchange Commission.

Authorized Capitalization

Our authorized capital stock consists of:

◦1,050,000,000 shares of common stock, with a par value of $1.00 per share; and

◦50,000,000 shares of preferred stock, with a par value of $0.01 per share, of which 3,500,000 shares have been designated as “Series A Junior Participating Preferred Stock.”

As of December 31, 2020, 636.4 million shares of our common stock were issued and 624.3 million shares of our common stock were outstanding, and no shares of our preferred stock were issued and outstanding. As of December 31, 2020, we also had approximately 336 million shares of our common stock reserved to be issued upon exercise of outstanding stock options and restricted stock units granted to employees and directors.

Common Stock

The holders of our common stock are entitled to one vote for each share on all matters submitted to a vote of stockholders and do not have cumulative voting rights with respect to the election of directors. Holders of our common stock are entitled to receive ratably such dividends as may be declared from time to time by our board of directors out of legally available assets. In the event of our liquidation, dissolution or winding up, holders of common stock are entitled to share ratably in all assets remaining after payment of all debts and other liabilities and any amounts due to any holders of preferred stock. Holders of our common stock have no preemptive or conversion rights. No redemption or sinking fund provisions apply to our common stock. The rights, preferences and privileges of holders of our common stock are subject to the rights of the holders of shares of any series of preferred stock which we may issue. All of our outstanding shares of common stock are fully paid and non-assessable.

Preferred Stock

Our board of directors has the authority, without stockholder approval, to issue up to 50,000,000 shares of our preferred stock in one or more series and to determine, with respect to any such series, the powers, preferences and rights of the shares of such series, and the qualifications, limitations and restrictions thereof, including, without limitation, voting rights, dividend rights, conversion rights, terms of redemption, liquidation preference, sinking fund terms and the number of shares constituting any series and the designation thereof.

Our board of directors can issue, without stockholder approval, preferred stock with voting and conversion rights that could adversely affect the voting power of the holders of common stock and reduce the likelihood that such holders will receive dividend payments or payments upon liquidation. Such issuance could have the effect of decreasing the market price of the common stock. The issuance of preferred stock or even the ability to issue preferred stock could also have the effect of delaying, deterring or preventing a change of control or other corporate action.



Anti-Takeover Effects of Delaware Law and Our Certificate of Incorporation and Bylaw Provisions

Our certificate of incorporation and bylaws contain certain provisions that may make it more difficult to acquire control of us by means of a tender offer, open market purchase, proxy fight or otherwise. These provisions and certain provisions of Delaware law are expected to discourage coercive takeover practices and inadequate takeover bids.

These provisions are intended to enhance the likelihood of continued stability in the composition of our board of directors and its policies and to discourage certain types of transactions that may involve an actual or threatened acquisition of us. The provisions also are intended to discourage certain tactics that may be used in proxy fights. However, such provisions could have the effect of discouraging others from making tender offers for our shares and, as a consequence, could deprive stockholders of opportunities to realize takeover premiums for their shares.

Set forth below is a summary of the relevant provisions of our certificate of incorporation and bylaws and certain applicable sections of the General Corporation Law of the State of Delaware. For additional information we refer you to the provisions of our certificate of incorporation, our bylaws and those sections of the General Corporation Law of the State of Delaware.

Delaware Anti-Takeover Statute

We are subject to the provisions of Section 203 of the General Corporation Law of the State of Delaware regulating corporate takeovers. In general, Section 203, subject to certain exceptions, prohibits a publicly-held Delaware corporation from engaging in any business combination with any interested stockholder for a period of three years following the date that such person or entity became an interested stockholder, unless:

◦prior to that date, the board of directors of the corporation approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder;

◦upon consummation of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding specified shares; or

◦at or subsequent to that date of the transaction that resulted in a person or entity becoming an interested stockholder, the business combination is approved by the board of directors and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 662⁄3% of the outstanding voting stock that is not owned by the interested stockholder.

The application of Section 203 may limit the ability of stockholders to approve a transaction that they may deem to be in their best interests. In addition, Section 203 makes it more difficult for an interested stockholder to effect various business combinations with a corporation for a three-year period, although the stockholders may, by adopting an amendment to our certificate of incorporation or bylaws, elect not to be governed by this section, effective 12 months after adoption.

In general, Section 203 defines “business combination” as:

◦any merger or consolidation involving the corporation and the interested stockholder;

◦any sale, lease, exchange, mortgage, pledge, transfer or other disposition of 10% or more of the assets of the corporation to or with the interested stockholder;

◦subject to certain exceptions, any transaction which results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder;

◦any transaction involving the corporation that has the effect of increasing the proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder; or



◦the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation.

In general, Section 203 defines an “interested stockholder” as any person that is:

◦the owner of 15% or more of the outstanding voting stock of the corporation;

◦an affiliate or associate of the corporation and was the owner of 15% or more of the outstanding voting stock of the corporation at any time within three years immediately prior to the relevant date; or

◦an affiliate or associate of the above.

Our certificate of incorporation and bylaws do not exclude us from the restrictions imposed under Section 203. We anticipate that the provisions of Section 203 may encourage companies interested in acquiring us to negotiate in advance with our board of directors because the stockholder approval requirement would be avoided if a majority of the directors then in office approve either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder.

Our Board of Directors

Our certificate of incorporation provides that the number of directors may be fixed from time to time by the board of directors, subject to the rights of holders of shares of any series of preferred stock to elect additional directors under specific circumstances. The size of our board of directors is currently fixed at eight directors. Each elected director holds office until his or her successor is duly elected and qualified, or until his or her earlier death, resignation, disqualification or removal.

Our certificate of incorporation and bylaws do not authorize cumulative voting with regard to the election of directors.

Board Vacancies

Our certificate of incorporation and bylaws provide that any vacancy in our board of directors may be filled only by a majority of the directors then in office, though less than a quorum, or by our sole remaining director. Each director so elected shall hold office until his or her successor is duly elected and qualified, or until his or her earlier death, resignation, disqualification or removal.

Advance Notice Requirements for Stockholder Proposals and Director Nominees

Our bylaws provide that stockholders seeking to make nominations of candidates for election as directors, or to bring other business before an annual or special meeting of the stockholders, must provide timely notice of their intent in writing. To be timely, a stockholder’s notice must be delivered to and received at our principal executive offices not less than 90 days nor more than 120 days prior to the meeting. However, in the event that the date of the annual meeting is more than 25 days before or more than 25 days after the first anniversary date of the preceding year’s annual meeting, or in the event of a special meeting of stockholders called for the purpose of electing directors, a stockholder’s notice must be delivered to our principal executive offices not later than the close of business on the 10th day following the earlier of the date on which such notice of the date of the meeting was mailed or such public disclosure of the date of the meeting was made. Our bylaws also specify certain requirements as to the form and content of a stockholder’s notice. These provisions may restrict the ability of our stockholders to bring business before our annual meeting of stockholders or to make nominations for directors at our annual meeting or any special meeting of stockholders.

Proxy Access

Our bylaws permit an eligible stockholder or group of stockholders to include up to a specified number of director nominees in our proxy materials for an annual meeting of stockholders. To qualify, the stockholders (or group of up to thirty stockholders) must have continuously owned for at least three years 3% or more of our


outstanding shares of capital stock. The maximum number of stockholder nominees permitted under the proxy access provisions of our bylaws is generally the greater of (i) two or (ii) 20% of the total number of our directors in office as of the last day on which notice of a nomination may be delivered.

Notice of a nomination under our proxy access bylaw provisions must generally be submitted to our principal executive offices not less than 120 days nor more than 150 days prior to the first anniversary of the date that we first mailed our proxy statement to stockholders for the immediately preceding annual meeting of stockholders. The notice must contain certain information specified in our bylaws.

Blank Check Preferred Stock

Our certificate of incorporation provides that our board of directors can issue, without stockholder approval, up to 50,000,000 shares of our preferred stock in one or more series and to determine, with respect to any such series, the powers, preferences and rights of the shares of such series, and the qualifications, limitations and restrictions thereof, including, without limitation, voting rights, dividend rights, conversion rights, terms of redemption, liquidation preference, sinking fund terms and the number of shares constituting any series and the designation thereof.

Stockholder Action by Written Consent

Our certificate of incorporation provides that all actions requiring the vote or consent of stockholders must be taken at a regular or special meeting of stockholders and cannot be taken by written consent without a meeting.

Choice of Forum

Our bylaws provide that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware will be, to the fullest extent permitted by law, the sole and exclusive forum for any derivative action or proceeding brought on our behalf; any action asserting a claim of breach of fiduciary duty; any action asserting a claim against us arising pursuant to the Delaware General Corporation Law; or any action asserting a claim against us that is governed by the internal affairs doctrine. This exclusive forum provision is intended to apply to claims arising under Delaware state law and would not apply to claims brought pursuant to the Securities Exchange Act of 1934 or Securities Act of 1933, or any other claim for which the federal courts have exclusive jurisdiction.

Transfer Agent and Registrar

Computershare is the transfer agent and registrar for our common stock.

Listing

Our common stock is listed on the NYSE under the symbol “EW.”


 EX-10.16 3 ex-101610xkq42020.htm EX-10.16 Document

Exhibit 10.16

Participant Stock Option Statement



Name:
Date of Grant:Option Price:
Date of Expiration:Number of Shares Covered:
Vesting Schedule
This certifies that on __________, Edwards Lifesciences Corporation granted to the Participant shown above a Nonqualified Stock Option to purchase shares of its common stock as indicated above upon the terms and conditions of the Nonemployee Directors Stock Incentive Program and the attached Nonqualified Stock Option Award Agreement (the “Award Agreement”). The Award Agreement imposes additional limitations on the Participant’s rights under the Option and provides for early termination of the Option (before the Expiration Date set forth above) in the event of termination of the Participant’s Directorship.
Edwards Lifesciences Corporation

By
exhibit10-161.jpg

Michael A. Mussallem
Chairman and Chief Executive Officer





Edwards Lifesciences Corporation
Nonemployee Directors Stock Incentive Program
Nonqualified Stock Option Award Agreement

THIS AGREEMENT, in conjunction with the Participant Stock Option Statement attached to the front of this agreement (the “Statement”) effective as of the Date of Grant set forth on the Statement, represents the grant of a nonqualified stock option (the “Option”) by Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), to the Participant named on the Statement, pursuant to the provisions of the Nonemployee Directors Stock Incentive Program (the “Program”). This agreement and the Statement shall be considered one agreement and are referred to herein as the “Agreement.”

The Program provides additional terms and conditions governing the Option. If there is any inconsistency between the terms of this Agreement and the terms of the Program, the Program’s terms shall completely supersede and replace the conflicting terms of this Agreement. All capitalized terms shall have the meanings ascribed to them in the Program, unless specifically set forth otherwise herein. The parties hereto agree as follows:

1. Grant of Stock Option. The Company hereby grants to the Participant an Option to purchase the number of Shares set forth on the Statement, at the stated Option Price set forth on the Statement, which is one hundred percent (100%) of the Fair Market Value of a Share on the Date of Grant, in the manner and subject to the terms and conditions of the Program and this Agreement.

The grant of this Option to the Participant shall not confer any right to such Participant (or any other Participant) to be granted any Option or other Awards in the future under the Program.

2. Exercise of Stock Option. Except as may otherwise be provided in Sections 3 and 4 below, the Participant may only exercise this Option according to the vesting schedule set forth on the Statement, provided that no exercise may occur subsequent to the close of business on the Date of Expiration (as set forth on the Statement).

The number of Shares for which this Option becomes vested and exercisable pursuant to this Section 2 shall be rounded up to the next whole number in the event that the use of the percentages set forth on the Statement results in the Option being exercisable with respect to a fractional Share. In addition, the Option may be exercised in whole or in part, but not for less than fifty (50) Shares at any one time, unless fewer than fifty (50) Shares then remain subject to the Option, and the Option is then being exercised as to all such remaining Shares.

3. Termination of Directorship:

(a) By Death or Disability: All unvested Shares under this Option shall immediately vest and become exercisable as of the Participant’s date of termination of service by death or Disability. Shares under this Option that vest and become exercisable in accordance with this Section 3(a) or that are already vested and exercisable as of the Participant’s date of termination by reason of death or Disability, may be purchased only until the earlier of: (i) the Date of Expiration of this Option; or (ii) the third (3rd) anniversary of the Participant’s date of termination by reason of death or Disability.

(b) For Other Reasons: Unless determined otherwise by the Committee or its designee in their sole discretion, all unvested Shares under this Option shall immediately terminate and be forfeited to the Company as of the date of the Participant’s termination of service for any reason other than the reasons set forth in Section 3(a) above. Shares under this Option that are vested and exercisable as of the date of a termination of service for any reason other than those reasons set forth in Section 3(a) above may be purchased until the earlier of: (i) the Date of Expiration of this Option; or (ii) the third (3rd) anniversary of the Participant’s date termination of service.

4. Change in Control. Notwithstanding anything to the contrary in this Agreement, in the event of a Change in Control of the Company prior to the Participant’s termination of service for any reason, all Shares under this Option shall immediately vest and become exercisable in full.


5. Restrictions on Transfer. This Option may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent and distribution. Further, this Option shall be exercisable during the Participant’s lifetime only by the Participant or the Participant’s legal representative.

6. Recapitalization. In the event there is any change in the Company’s Shares through the declaration of stock dividends or through recapitalization resulting in stock split-ups or through merger, consolidation, exchange of Shares, or otherwise, the number and class of Shares subject to this Option, as well as the Option Price, shall be equitably adjusted by the Committee, in the manner determined in its sole discretion, to prevent dilution or enlargement of rights.

7. Procedure for Exercise of Option. This Option may be exercised by delivery of written notice (or such other form of notice as the Company may specify) to the Company at its executive offices, addressed to the attention of its Secretary or the Company’s designee. Such notice: (a) shall be signed by the Participant or his or her legal representative (or assented to in a form other than written signature if and to the extent that the Company specifies); (b) shall specify the number of full Shares then elected to be purchased with respect to the Option; (c) if a Registration Statement under the Securities Act of 1933 is not in effect with respect to the Shares to be purchased, shall contain a representation of the Participant that the Shares are being acquired by him or her for investment and with no present intention of selling or transferring them, and that he or she will not sell or otherwise transfer the Shares except in compliance with all applicable securities laws and requirements of any stock exchange upon which the Shares may then be listed; and (d) shall be accompanied by payment in full of the Option Price of the Shares to be purchased (or a satisfactory “cashless exercise” notice).

The Option Price upon exercise of this Option shall be payable to the Company in full either: (a) in cash or its equivalent (acceptable cash equivalents shall be determined at the sole discretion of the Committee); (b) by tendering previously acquired Shares (by either actual delivery or attestation) having an aggregate Fair Market Value at the time of exercise equal to the total Option Price; (c) by a “cashless exercise” to the extent permitted under Federal Reserve Board’s Regulation T and other applicable law, and subject to such procedures and limitations as the Company may specify from time to time; (d) by any other means which the Committee determines to be consistent with the Program’s purpose and applicable law; or (e) by a combination of two or more of (a) through (d).

As promptly as practicable after receipt of notice and payment upon exercise (or satisfactory “cashless exercise” notice) and subject to any Company “cashless exercise” procedures, the Company shall cause to be issued and delivered to the Participant in certificate form or otherwise, evidence of the Shares so purchased, which may, if appropriate, be endorsed with or otherwise include appropriate restrictive legends. The Company shall maintain a record of all information pertaining to the Participant’s rights under this Agreement, including the number of Shares for which the Option is exercisable. If the Option shall have been exercised in full, this Agreement shall be returned to the Company and canceled.

8. Beneficiary Designation. The Participant may, from time to time, name any beneficiary or beneficiaries (who may be named contingently or successively) to whom any benefit under this Agreement is to be paid in case of his or her death before he or she receives any or all of such benefit. Each such designation shall revoke all prior designations by the Participant, shall be in a form prescribed by the Company, and will be effective only when filed by the Participant in writing with the Secretary of the Company during the Participant’s lifetime. In the absence of any such designation, benefits remaining unpaid at the Participant’s death shall be paid to the Participant’s estate.

9. Rights as a Stockholder. The Participant shall have no rights as a stockholder of the Company with respect to the Shares subject to this Agreement until such time as the purchase price has been paid, and the Shares have been issued and delivered to him or her.

10. Continuation of Service. This Agreement shall not confer upon the Participant any right to continue providing services to the Company or to be nominated to the Board, nor shall this Agreement interfere in any way with the Company’s right to terminate the Participant’s service at any time.




11. Miscellaneous.
(a) This Agreement and the rights of the Participant hereunder are subject to all the terms and conditions of the Program, as the same may be amended from time to time, as well as to such rules and regulations as the Committee may adopt for administration of the Program. The Committee shall have the right to impose such restrictions on any Shares acquired pursuant to the exercise of this Option, as it may deem advisable for regulatory compliance, including, without limitation, restrictions under applicable federal securities laws, under the requirements of any stock exchange or market upon which such Shares are then listed and/or traded, and under any blue sky or state securities laws applicable to such Shares. It is expressly understood that the Committee is authorized to administer, construe, and make all determinations necessary or appropriate to the administration of the Program and this Agreement, all of which shall be binding upon the Participant.

(b) The Board may terminate, amend, or modify the Program and the Committee may amend or modify this Option at any time; provided, however, that except for the Company’s right to cash out this Option under certain circumstances pursuant to Section 6.10 of the Program, no such termination, amendment, or modification of the Program or amendment of this Option may in any material way adversely affect the Participant’s rights under this Agreement, without the express consent of the Participant.

(c) The Company shall have the power and the right to deduct or withhold, or require the Participant to remit to the Company, an amount sufficient to satisfy all federal, state, local and foreign taxes required by law or regulations to be withheld with respect to any exercise of the Participant’s rights under this Agreement.

The Participant may elect, subject to any procedural rules adopted by the Committee, to satisfy the minimum withholding requirement, in whole or in part, by having the Company withhold Shares having an aggregate Fair Market Value on the date the tax is to be determined, equal to or less than the minimum amount required to be withheld.

(d) The Participant agrees to take all steps necessary to comply with all applicable provisions of federal, state and foreign securities law in exercising his or her rights under this Agreement.

(e) This Agreement shall be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required.

(f) All obligations of the Company under the Program and this Agreement, with respect to this Option, shall, to the extent legally permissible, be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of the Company.

(g) To the extent not preempted by federal law, this Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware.

Accepted and agreed:

Company: Director:
Edwards Lifesciences Corporation



By: ________________________ __________________________

 EX-10.17 4 ex-101710xkq42020.htm EX-10.17 Document

Exhibit 10.17

Edwards Lifesciences Corporation
Nonemployee Directors Stock Incentive Program
Restricted Stock Units Agreement

You have been selected to be a Participant in the Edwards Lifesciences Corporation Nonemployee Directors Stock Incentive Program (the “Program”), as specified below:

Participant:

Date of Grant:

Number of Restricted Stock Units Granted:

Vesting Date: The Restricted Stock Units shall vest on the date and in the amount listed below:
Vesting DateNumber of Units Which Vest

THIS AGREEMENT, effective as of the Date of Grant set forth above, represents the grant of Restricted Stock Units by Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), to the Participant named above, pursuant to the provisions of the Program.

The Program provides additional terms and conditions governing the Restricted Stock Units. If there is any inconsistency between the terms of this Agreement and the terms of the Program, the Program’s terms shall completely supersede and replace the conflicting terms of this Agreement. All capitalized terms shall have the meanings ascribed to them in the Program, unless specifically set forth otherwise herein. The parties hereto agree as follows:

1. Restricted Stock Units. The Participant is entitled to receive one Share for each Restricted Stock Unit, provided the Restricted Stock Units have not terminated.

2. Service to the Company. Except as may otherwise be provided in Sections 5 or 6, the Restricted Stock Units granted hereunder shall vest in full on the Vesting Date (as set forth above) provided the Participant remains a Nonemployee Director of the Company from the Date of Grant through (and including) such date.

This grant of Restricted Stock Units shall not confer any right to the Participant (or any other Participant) to be granted Restricted Stock Units or other Awards in the future under the Program.

3. Issuance of Shares. Except as may otherwise be provided herein and in the Program, the Shares issuable with respect to any Restricted Stock Units that have vested shall be issued as soon as administratively feasible following the Vesting Date applicable to such units. Any such issuance of Shares shall be subject to applicable Federal and state securities laws.

4. Shareholder Rights. The Participant shall not have any shareholder rights hereunder with respect to any Shares issuable until the Shares have been issued.




5. Termination of Directorship.

a) By Death or Disability: In the event the service of the Participant is terminated due to death or Disability, then the Restricted Stock Units held by the Participant at the time of his or her death or Disability shall immediately become fully vested.

b) Termination for Other Reasons: In the event of the Participant’s termination of service with the Company for any reason other than death or Disability, all Restricted Stock Units held by the Participant at the time of service termination and still subject to vesting shall be forfeited by the Participant to the Company.

6. Change in Control. Notwithstanding anything to the contrary in this Agreement, in the event of a Change in Control of the Company prior to the Participant’s termination of service, the Restricted Stock Units shall immediately become fully vested.

7. Nontransferability. Restricted Stock Units granted pursuant to this Agreement may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent and distribution, except as provided in the Program.

8. Restriction on Sale of Shares. Notwithstanding any other provision of the Program or this Agreement to the contrary, the Shares acquired upon vesting of the Restricted Stock Units (net of any Shares sold to cover applicable taxes due in connection with the settlement of the Restricted Stock Units) may not be sold, transferred or otherwise disposed of prior to the Participant's cessation of service as a Nonemployee Director of the Company.

9. Recapitalization. In the event there is any change in the Company’s Shares through the declaration of stock dividends or through recapitalization resulting in stock split-ups or through merger, consolidation, exchange of Shares, or otherwise, the number and class of Restricted Stock Units subject to this Agreement shall be equitably adjusted by the Committee, in the manner determined in its sole discretion, to prevent dilution or enlargement of rights.

10. Tax Withholding. The Company shall have the power and the right to deduct or withhold, or require the Participant or beneficiary to remit to the Company, an amount sufficient to satisfy federal, state, and local taxes (including the Participant’s FICA obligation), domestic or foreign, required by law or regulation to be withheld with respect to any taxable event arising as a result of this Agreement. The Participant may elect, subject to any procedural rules adopted by the Committee, to satisfy the minimum withholding tax requirement, in whole or in part, by having the Company withhold Shares having an aggregate Fair Market Value on the date the tax is to be determined, equal to or less than such minimum withholding tax.

11. Beneficiary Designation. The Participant may, from time to time, name any beneficiary or beneficiaries (who may be named contingently or successively) to whom any benefit under this Agreement is to be paid in case of his or her death before he or she receives any or all of such benefit. Each such designation shall revoke all prior designations by the Participant, shall be in a form prescribed by the Company, and will be effective only when filed by the Participant in writing with the Secretary of the Company during the Participant’s lifetime. In the absence of any such designation, benefits remaining unpaid at the Participant’s death shall be paid to the Participant’s estate.
12. Continuation of Service. This Agreement shall not confer upon the Participant any right to continue providing services to the Company or to be nominated to the Board, nor shall this Agreement interfere in any way with the Company’s right to terminate the Participant’s service at any time.

13. Miscellaneous.

a) This Agreement and the rights of the Participant hereunder are subject to all the terms and conditions of the Program, as the same may be amended from time to time, as well as to such rules and regulations as the Committee may adopt for administration of the Program. The Committee shall have the right to impose such restrictions on any Shares acquired pursuant to this Agreement, as it may deem advisable for regulatory compliance, including, without limitation, restrictions under applicable Federal securities laws, under the requirements of any stock exchange or market upon which such Shares are then listed and/or


traded, and under any blue sky or state securities laws applicable to such Shares. It is expressly understood that the Committee is authorized to administer, construe, and make all determinations necessary or appropriate to the administration of the Program and this Agreement, all of which shall be binding upon the Participant.

b) The Board may terminate, amend or modify the Program and, the Committee may amend this Agreement; provided, however, that no such termination, amendment, or modification of the Program may in any material way adversely affect the Participant’s rights under this Agreement, without the express consent of the Participant.

c) The Participant agrees to take all steps necessary to comply with all applicable provisions of federal, state and foreign securities law in exercising his or her rights under this Agreement.

d) This Agreement shall be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required.

e) All obligations of the Company under the Program and this Agreement, with respect to the Restricted Stock Units, shall to the extent legally permissible, be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of the Company.

f) To the extent not preempted by federal law, this Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware.

Accepted and agreed:

Company: Director:
Edwards Lifesciences Corporation



By: ________________________ __________________________

EX-10.18 5 ex-101810xkq42020.htm EX-10.18 Document

Exhibit 10.18


Edwards Lifesciences Corporation
Nonemployee Directors Stock Incentive Program
Restricted Stock Agreement

You have been selected to be a Participant in the Edwards Lifesciences Corporation Nonemployee Directors Stock Incentive Program (the “Program”), as specified below:

Participant:

Date of Grant:

Number of Shares of Restricted Stock Granted:

Lapse of Restrictions Dates: Restrictions placed on the Shares of Restricted Stock shall lapse on the date and in the amount listed below:
Date on Which Restrictions LapseNumber of Shares for Which Restrictions LapseCumulative Number of Shares for Which Restrictions Lapse

THIS AGREEMENT, effective as of the Date of Grant set forth above, represents the grant of Shares of Restricted Stock by Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), to the Participant named above, pursuant to the provisions of the Program.

The Program provides additional terms and conditions governing the Restricted Stock. If there is any inconsistency between the terms of this Agreement and the terms of the Program, the Program’s terms shall completely supersede and replace the conflicting terms of this Agreement. All capitalized terms shall have the meanings ascribed to them in the Program, unless specifically set forth otherwise herein. The parties hereto agree as follows:

1. Service to the Company. Except as may otherwise be provided in Sections 5 or 6, the Restricted Stock granted hereunder is granted on the condition that the Participant remains a Nonemployee Director of the Company from the Date of Grant through (and including) each of the separate Lapse of Restrictions Dates, as set forth above (each such time period is referred to herein as a “Period of Restriction”).

This grant of Restricted Stock shall not confer any right to the Participant (or any other Participant) to be granted Restricted Stock or other Awards in the future under the Program.

2. Certificate Legend. Shares of Restricted Stock granted hereunder shall be registered in the name of the Participant and the Company shall cause to be issued and delivered to the Participant, in certificate form or otherwise, evidence of the purchased Shares of Restricted Stock. If such Shares are certificated, in the sole discretion of the Committee, such certificate may be deposited in a bank or with the Company. Each certificate representing Shares of Restricted Stock granted pursuant to the Program shall bear the following legend:

“The sale or other transfer of the shares of stock represented by this certificate, whether voluntary, involuntary, or by operation of law is subject to certain restrictions on transfer set forth in the Edwards Lifesciences Corporation Nonemployee Directors Stock Incentive Program, rules of administration adopted pursuant to such Program, and a Restricted Stock Agreement dated May 8, 2020. A copy of the Edwards Lifesciences Corporation Nonemployee Directors Stock Incentive Program, such rules, and


such Restricted Stock Agreement may be obtained from the Secretary of Edwards Lifesciences Corporation.”

3. Removal of Restrictions. Except as may otherwise be provided herein and in the Program, the Shares of Restricted Stock granted pursuant to this Agreement shall become freely transferable by the Participant on the day following the date and in the amount set forth under the Lapse of Restrictions Dates above, subject to applicable Federal and state securities laws. Once Shares of Restricted Stock are no longer subject to any Period of Restriction, the Participant shall be entitled to have the legend required by Section 2 of this Agreement removed from the applicable stock certificates; provided, however, one or more other legends may continue to apply, such as a legend pertaining to transfer restrictions imposed pursuant to Rule 144 of the Securities Act of 1933, as amended.
4. Voting Rights and Dividends. During the Period of Restriction, the Participant may exercise full voting rights and shall accrue all dividends and other distributions paid with respect to the Shares of Restricted Stock while they are held. If any such dividends or distributions are paid in Shares, such Shares shall be subject to the same restrictions on transferability as are the Shares of Restricted Stock with respect to which they were paid.

5. Termination of Directorship.

a) By Death or Disability: In the event the service of the Participant is terminated due to death or Disability during the Periods of Restriction, the Periods of Restriction and the restrictions imposed on the Shares of Restricted Stock held by the Participant at the time of his or her death or Disability shall immediately lapse with all such Shares becoming immediately transferable by the Participant or his or her estate, subject to applicable Federal and state securities laws.


b) Termination for Other Reasons: In the event of the Participant’s termination of service with the Company for any reason other than death or Disability during the Periods of Restriction, all Shares of Restricted Stock held by the Participant at the time of service termination and still subject to a Period of Restriction and other restrictions shall be forfeited by the Participant to the Company.

6. Change in Control. Notwithstanding anything to the contrary in this Agreement, in the event of a Change in Control of the Company during the Periods of Restriction and prior to the Participant’s termination of service, the Periods of Restriction and restrictions imposed on the Shares shall immediately lapse with all such Shares of Restricted Stock vesting and becoming freely transferable by the Participant, subject to applicable Federal and state securities laws.

7. Nontransferability. During the Periods of Restriction, Shares of Restricted Stock granted pursuant to this Agreement may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated (a “Transfer”), other than by will or by the laws of descent and distribution, except as provided in the Program. If any Transfer, whether voluntary or involuntary, of unvested Shares of Restricted Stock is made, or if any attachment, execution, garnishment, or lien shall be issued against or placed upon the Shares of Restricted Stock, the Participant’s right to such Shares of Restricted Stock shall be immediately forfeited by the Participant to the Company, and this Agreement shall lapse.

8. Recapitalization. In the event there is any change in the Company’s Shares through the declaration of stock dividends or through recapitalization resulting in stock split-ups or through merger, consolidation, exchange of Shares, or otherwise, the number and class of Shares of Restricted Stock subject to this Agreement shall be equitably adjusted by the Committee, in the manner determined in its sole discretion, to prevent dilution or enlargement of rights.

9. Tax Withholding. The Company shall have the power and the right to deduct or withhold, or require the Participant or beneficiary to remit to the Company, an amount sufficient to satisfy federal, state, and local taxes (including the Participant’s FICA obligation), domestic or foreign, required by law or regulation to be withheld with respect to any taxable event arising as a result of this Agreement. The Participant may elect, subject to any procedural rules adopted by the Committee, to satisfy the minimum withholding tax requirement, in whole or in part,


by having the Company withhold Shares having an aggregate Fair Market Value on the date the tax is to be determined, equal to such minimum withholding tax.

10. Beneficiary Designation. The Participant may, from time to time, name any beneficiary or beneficiaries (who may be named contingently or successively) to whom any benefit under this Agreement is to be paid in case of his or her death before he or she receives any or all of such benefit. Each such designation shall revoke all prior designations by the Participant, shall be in a form prescribed by the Company, and will be effective only when filed by the Participant in writing with the Secretary of the Company during the Participant’s lifetime. In the absence of any such designation, benefits remaining unpaid at the Participant’s death shall be paid to the Participant’s estate.
11. Continuation of Service. This Agreement shall not confer upon the Participant any right to continue providing services to the Company or to be nominated to the Board, nor shall this Agreement interfere in any way with the Company’s right to terminate the Participant’s service at any time.

12. Special Tax Election.

a) Section 83(b) Election. Under Code Section 83, the excess of the Fair Market Value of the Shares of Restricted Stock on the date any forfeiture restrictions applicable to such Shares lapse over the price paid for those shares, if any, will be reportable as ordinary income on the lapse date. Participant may elect under Code Section 83(b) to be taxed at the time the Shares of Restricted Stock are acquired, rather than on the Lapse of Restrictions Dates. If Participant chooses to make an election under Code Section 83(b), such election must be filed with the Internal Revenue Service within thirty (30) days after the date of this Agreement.

b) Filing Responsibility. Participant acknowledges that, if Participant, chooses to file an election under Section 83(b), it is the Participant’s sole responsibility, and not the Company’s to file a timely election under Code Section 83(b), even if Participant requests the Company or its representatives to make this filing on his or her behalf.

13. Miscellaneous.

a) This Agreement and the rights of the Participant hereunder are subject to all the terms and conditions of the Program, as the same may be amended from time to time, as well as to such rules and regulations as the Committee may adopt for administration of the Program. The Committee shall have the right to impose such restrictions on any Shares acquired pursuant to this Agreement, as it may deem advisable for regulatory compliance, including, without limitation, restrictions under applicable Federal securities laws, under the requirements of any stock exchange or market upon which such Shares are then listed and/or traded, and under any blue sky or state securities laws applicable to such Shares. It is expressly understood that the Committee is authorized to administer, construe, and make all determinations necessary or appropriate to the administration of the Program and this Agreement, all of which shall be binding upon the Participant.

b) The Board may terminate, amend or modify the Program and, the Committee may amend this Agreement; provided, however, that no such termination, amendment, or modification of the Program may in any material way adversely affect the Participant’s rights under this Agreement, without the express consent of the Participant.

c) The Participant agrees to take all steps necessary to comply with all applicable provisions of federal, state and foreign securities law in exercising his or her rights under this Agreement.

d) This Agreement shall be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required.

e) All obligations of the Company under the Program and this Agreement, with respect to the Restricted Stock, shall to the extent legally permissible, be binding on any successor to the Company, whether the


existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of the Company.

f) To the extent not preempted by federal law, this Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware.


Accepted and agreed:

Company: Director:
Edwards Lifesciences Corporation



By: ________________________ __________________________

 EX-21.1 6 ex-21110xkq42020.htm EX-21.1 Document

Exhibit 21.1

The following is a list of subsidiaries of Edwards Lifesciences Corporation, omitting subsidiaries which, considered in the aggregate as a single subsidiary, would not constitute a significant subsidiary as of December 31, 2020:


Legal Entity  State of
Incorporation/
Formation		 Country of
Incorporation/
Formation
Edwards Lifesciences LLC Delaware U.S.
Edwards Lifesciences SASFrance
Edwards Lifesciences Services GmbH   Germany
Edwards Lifesciences (Japan) Limited   Japan
Edwards Lifesciences Holding B.V.   The Netherlands
Edwards Lifesciences (Singapore) Pte LtdSingapore
Edwards Lifesciences AG   Switzerland


 EX-23 7 ex-2310xkq42020.htm EX-23 Document

Exhibit 23

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-33054, 333-33056, 333-40434, 333-52334, 333-52346, 333-60670, 333-98219, 333-105961, 333-127260, 333-150810, 333-154242, 333-168462, 333-183106, 333-192229, 333-195853, 333-204180, 333-211333, and 333-217909) and Form S-3 (No. 333-232866) of Edwards Lifesciences Corporation of our report dated February 12, 2021 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.


/s/ PricewaterhouseCoopers LLP
Irvine, California
February 12, 2021


EX-31.1 8 ex-31110xkq42020.htm EX-31.1 Document

Exhibit 31.1

EDWARDS LIFESCIENCES CORPORATION
CERTIFICATIONS PURSUANT TO
SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
CERTIFICATION
I, Michael A. Mussallem, certify that:
1.I have reviewed this annual report on Form 10-K of Edwards Lifesciences Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
By:/s/ MICHAEL A. MUSSALLEM
Michael A. Mussallem
Chairman of the Board and Chief Executive Officer
February 12, 2021


 EX-31.2 9 ex-31210xkq42020.htm EX-31.2 Document

Exhibit 31.2

EDWARDS LIFESCIENCES CORPORATION
CERTIFICATIONS PURSUANT TO
SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
CERTIFICATION
I, Scott B. Ullem, certify that:
1.I have reviewed this annual report on Form 10-K of Edwards Lifesciences Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
By:/s/ SCOTT B. ULLEM
Scott B. Ullem
 Corporate Vice President,
Chief Financial Officer
February 12, 2021

EX-32 10 ex-3210xkq42020.htm EX-32 Document

Exhibit 32

EDWARDS LIFESCIENCES CORPORATION
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Edwards Lifesciences Corporation (the "Company") on Form 10-K for the year ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), we, Michael A. Mussallem, Chairman of the Board and Chief Executive Officer of the Company, and Scott B. Ullem, Corporate Vice President, Chief Financial Officer, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ MICHAEL A. MUSSALLEM
February 12, 2021
Michael A. Mussallem
 Chairman of the Board and Chief Executive Officer
/s/ SCOTT B. ULLEM
February 12, 2021
Scott B. Ullem
 Corporate Vice President,
 Chief Financial Officer


 EX-101.SCH 11 ew-20201231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 000010001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 100010002 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 100020003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 100030004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 100040005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 100050006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 100060007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 210011001 - Disclosure - DESCRIPTION OF BUSINESS link:presentationLink link:calculationLink link:definitionLink 210021002 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 220032001 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 230043001 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 240054001 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240064002 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Shipping and Handling Costs (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240074003 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investments (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240084004 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounts Receivable (Details) link:presentationLink link:calculationLink link:definitionLink 240094005 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Inventories (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240104006 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property, Plant, and Equipment (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240114007 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Goodwill and Intangible Assets (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240124008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 240134009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per Share (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240144010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Stock-Based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 240154011 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Stock-based Compensation (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240164012 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Derivatives (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 210171003 - Disclosure - INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET link:presentationLink link:calculationLink link:definitionLink 240184013 - Disclosure - INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET (Details) link:presentationLink link:calculationLink link:definitionLink 210191004 - Disclosure - SPECIAL CHARGES (GAIN) link:presentationLink link:calculationLink link:definitionLink 240204014 - Disclosure - SPECIAL CHARGES (GAIN) - Impairment of Long-lived Assets (Details) link:presentationLink link:calculationLink link:definitionLink 240214015 - Disclosure - SPECIAL CHARGES (GAIN) - Acquisition of Intellectual Property (Details) link:presentationLink link:calculationLink link:definitionLink 240224016 - Disclosure - SPECIAL CHARGES (GAIN) - Realignment Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 210231005 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS link:presentationLink link:calculationLink link:definitionLink 230243002 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables) link:presentationLink link:calculationLink link:definitionLink 240254017 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Components of Selected Captions (Details) link:presentationLink link:calculationLink link:definitionLink 240264018 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240274019 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Supplemental Cash Flow Information (Details) link:presentationLink link:calculationLink link:definitionLink 240284020 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Cash, Cash Equivalents, and Restricted Cash (Details) link:presentationLink link:calculationLink link:definitionLink 210291006 - Disclosure - LEASES link:presentationLink link:calculationLink link:definitionLink 230303003 - Disclosure - LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 240314021 - Disclosure - LEASES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240324022 - Disclosure - LEASES - Assets and Liabilities of Operating Leases (Details) link:presentationLink link:calculationLink link:definitionLink 240334023 - Disclosure - LEASES - Maturities Of Operating Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 240334023 - Disclosure - LEASES - Maturities Of Operating Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 210341007 - Disclosure - INVESTMENTS link:presentationLink link:calculationLink link:definitionLink 230353004 - Disclosure - INVESTMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 240364024 - Disclosure - INVESTMENTS - Schedule of Investments in Debt Securities (Details) link:presentationLink link:calculationLink link:definitionLink 240374025 - Disclosure - INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details) link:presentationLink link:calculationLink link:definitionLink 240384026 - Disclosure - INVESTMENTS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240394027 - Disclosure - INVESTMENTS - Schedule of Unrealized Losses on Debt Securities (Details) link:presentationLink link:calculationLink link:definitionLink 240404028 - Disclosure - INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details) link:presentationLink link:calculationLink link:definitionLink 210411008 - Disclosure - ACQUISITIONS link:presentationLink link:calculationLink link:definitionLink 230423005 - Disclosure - ACQUISITIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 240434029 - Disclosure - ACQUISITIONS - CAS Medical Systems, Inc. (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240444030 - Disclosure - ACQUISITIONS - Summary of Fair Values of Assets Acquired and Liabilities Assumed (Details) link:presentationLink link:calculationLink link:definitionLink 240454031 - Disclosure - ACQUISITIONS - Harpoon Medical, Inc. (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240464032 - Disclosure - ACQUISITIONS - Valtech Cardio, Ltd. (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240474033 - Disclosure - ACQUISITIONS - CardiAQ Valve Technologies, Inc. (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 210481009 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 230493006 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 240504034 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240514035 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in the Carrying Amount of Goodwill, by Segment (Details) link:presentationLink link:calculationLink link:definitionLink 240524036 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 240534037 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Estimated Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 210541010 - Disclosure - DEBT AND CREDIT FACILITIES link:presentationLink link:calculationLink link:definitionLink 230553007 - Disclosure - DEBT AND CREDIT FACILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 240564038 - Disclosure - DEBT AND CREDIT FACILITIES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240574039 - Disclosure - DEBT AND CREDIT FACILITIES - Summary of the Notes (Details) link:presentationLink link:calculationLink link:definitionLink 210581011 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 230593008 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 240604040 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on a Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 240614041 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of Changes in Fair Value of Contingent Consideration Obligation (Details) link:presentationLink link:calculationLink link:definitionLink 240624042 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 210631012 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES link:presentationLink link:calculationLink link:definitionLink 230643009 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 240654043 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Summary of Derivative Financial Instruments Used to Manage Currency Exchange and Interest Rate Risk (Details) link:presentationLink link:calculationLink link:definitionLink 240664044 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 240674045 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset (Details) link:presentationLink link:calculationLink link:definitionLink 240684046 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 240694047 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location of Gain or Loss on Derivative Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 240704048 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 210711013 - Disclosure - EMPLOYEE BENEFIT PLANS link:presentationLink link:calculationLink link:definitionLink 230723010 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables) link:presentationLink link:calculationLink link:definitionLink 240734049 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Information Regarding Defined Benefit Pension Plans (Details) link:presentationLink link:calculationLink link:definitionLink 240744050 - Disclosure - EMPLOYEE BENEFIT PLANS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240754051 - Disclosure - EMPLOYEE BENEFIT PLANS - Components of Net Periodic Benefit Cost (Details) link:presentationLink link:calculationLink link:definitionLink 240764052 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Weighted-Average Assumptions Used to Determine Benefit Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 240774053 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Target Weighted-Average Asset Allocations and Fair Value (Details) link:presentationLink link:calculationLink link:definitionLink 240784054 - Disclosure - EMPLOYEE BENEFIT PLANS - Summary of Changes in Fair Value of Defined Benefit Plan Assets Classified as Level 3 (Details) link:presentationLink link:calculationLink link:definitionLink 240794055 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Benefit Payments Which Reflect Expected Future Service (Details) link:presentationLink link:calculationLink link:definitionLink 210801014 - Disclosure - COMMON STOCK link:presentationLink link:calculationLink link:definitionLink 230813011 - Disclosure - COMMON STOCK (Tables) link:presentationLink link:calculationLink link:definitionLink 240824056 - Disclosure - COMMON STOCK - Treasury Stock (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240834057 - Disclosure - COMMON STOCK - Accelerated Share Repurchases (Details) link:presentationLink link:calculationLink link:definitionLink 240844058 - Disclosure - COMMON STOCK - Employee and Director Stock Plans (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240854059 - Disclosure - COMMON STOCK - Schedule of Weighted-Average Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 240864060 - Disclosure - COMMON STOCK - Schedule of Stock Option (Details) link:presentationLink link:calculationLink link:definitionLink 240874061 - Disclosure - COMMON STOCK - Schedule of Restricted Stock Unit Activity (Details) link:presentationLink link:calculationLink link:definitionLink 240884062 - Disclosure - COMMON STOCK - Schedule of Restricted Stock Unit Activity (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240894063 - Disclosure - COMMON STOCK - Additional Information (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 210901015 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS link:presentationLink link:calculationLink link:definitionLink 230913012 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables) link:presentationLink link:calculationLink link:definitionLink 240924064 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Summary of Activity for Each Component of Accumulated Other Comprehensive Loss (Details) link:presentationLink link:calculationLink link:definitionLink 240934065 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Change in Unrealized Pension Costs (Details) link:presentationLink link:calculationLink link:definitionLink 240934065 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Change in Unrealized Pension Costs (Details) link:presentationLink link:calculationLink link:definitionLink 240944066 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Information About Amounts Reclassified from Accumulated Other Comprehensive Loss (Details) link:presentationLink link:calculationLink link:definitionLink 210951016 - Disclosure - OTHER INCOME, NET link:presentationLink link:calculationLink link:definitionLink 230963013 - Disclosure - OTHER INCOME, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 240974067 - Disclosure - OTHER INCOME, NET (Details) link:presentationLink link:calculationLink link:definitionLink 210981017 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 230993014 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 241004068 - Disclosure - INCOME TAXES - Schedule of Income Before Provisions for Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 241014069 - Disclosure - INCOME TAXES - Provision for Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 241024070 - Disclosure - INCOME TAXES - Components of Deferred Tax Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 241034071 - Disclosure - INCOME TAXES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 241044072 - Disclosure - INCOME TAXES - Summary of Net Operating Loss Carryforwards (Details) link:presentationLink link:calculationLink link:definitionLink 241054073 - Disclosure - INCOME TAXES - Summary of Tax Credit Carryforwards (Details) link:presentationLink link:calculationLink link:definitionLink 241064074 - Disclosure - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details) link:presentationLink link:calculationLink link:definitionLink 241074075 - Disclosure - INCOME TAXES - Reconciliation of Beginning and Ending Amount of Uncertain Tax Positions (Details) link:presentationLink link:calculationLink link:definitionLink 211081018 - Disclosure - LEGAL PROCEEDINGS link:presentationLink link:calculationLink link:definitionLink 241094076 - Disclosure - LEGAL PROCEEDINGS (Details) link:presentationLink link:calculationLink link:definitionLink 211101019 - Disclosure - SEGMENT INFORMATION link:presentationLink link:calculationLink link:definitionLink 231113015 - Disclosure - SEGMENT INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 241124077 - Disclosure - SEGMENT INFORMATION - Schedule of Information About Reportable Segments (Details) link:presentationLink link:calculationLink link:definitionLink 241134078 - Disclosure - SEGMENT INFORMATION - Reconciliation of Segment Net Sales and Pre-Tax Income to Consolidated Net Sales and Pre-Tax Income (Details) link:presentationLink link:calculationLink link:definitionLink 241144079 - Disclosure - SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details) link:presentationLink link:calculationLink link:definitionLink 211151020 - Disclosure - QUARTERLY FINANCIAL RESULTS AND MARKET FOR THE COMPANY'S STOCK (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 231163016 - Disclosure - QUARTERLY FINANCIAL RESULTS AND MARKET FOR THE COMPANY'S STOCK (UNAUDITED) (Tables) link:presentationLink link:calculationLink link:definitionLink 241174080 - Disclosure - QUARTERLY FINANCIAL RESULTS AND MARKET FOR THE COMPANY'S STOCK (UNAUDITED) (Details) link:presentationLink link:calculationLink link:definitionLink 241184081 - Disclosure - QUARTERLY FINANCIAL RESTULTS AND MARKET FOR THE COMPANY'S STOCK (UNAUDITED) - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 211191021 - Disclosure - VALUATION AND QUALIFYING ACCOUNTS link:presentationLink link:calculationLink link:definitionLink 241204082 - Disclosure - VALUATION AND QUALIFYING ACCOUNTS (Details) link:presentationLink link:calculationLink link:definitionLink 211211022 - Disclosure - SUBSEQUENT EVENT link:presentationLink link:calculationLink link:definitionLink 241224083 - Disclosure - SUBSEQUENT EVENT (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 12 ew-20201231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 13 ew-20201231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 14 ew-20201231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Target asset allocations (as a percent) Defined Benefit Plan, Plan Assets, Target Allocation, Percentage Outstanding as of period end Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Expected employer contributions Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year Change in projected benefit obligation: Defined Benefit Plan, Change in Benefit Obligation [Roll Forward] LEGAL PROCEEDINGS Commitments and Contingencies Disclosure [Text Block] Change in fair value of plan assets: Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward] INVESTMENTS Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Accrued relocation related costs Accrued Relocation Costs, Current Accrued Relocation Costs, Current Net actuarial loss Accumulated Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Tax Future option to acquire business, period to obtain regulatory approval Business Combination, Future Option To Acquire Business, Period To Obtain Regulatory Approval Business Combination, Future Option To Acquire Business, Period To Obtain Regulatory Approval Indefinite-lived intangible assets Indefinite-lived Intangible Assets (Excluding Goodwill) [Abstract] Net Tax Benefit Deferred Tax Assets, Capital Loss Carryforwards, Net Of Valuation Allowance Deferred Tax Assets, Capital Loss Carryforwards, Net Of Valuation Allowance Intrinsic value of stock options exercised and restricted stock units vested Share Based Compensation Arrangement by Share Based Payment Award, Intrinsic Value of Stock Options Exercised and Vested Restricted Stock Units This element represents the intrinsic value of stock options exercised and restricted stock units that vested during the period. Statistical Measurement [Domain] Statistical Measurement [Domain] LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities and Equity [Abstract] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Option Awards Stock option activity Employee and Nonemployee Stock Options [Member] An arrangement whereby an employee or nonemployee (including a member of the entity's Board of Directors) is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement. Security Exchange Name Security Exchange Name Beginning of year End of year Plan assets at fair value Defined Benefit Plan, Plan Assets, Amount Aggregate Intrinsic Value Aggregate Intrinsic Value [Abstract] Proceeds from issuance of debt Proceeds from Issuance of Long-term Debt State income taxes Deferred Tax Assets, State Taxes Total current liabilities Liabilities, Current Accounts Receivable Accounts Receivable [Policy Text Block] Amount Reclassified from Accumulated Other Comprehensive Loss Reclassification out of Accumulated Other Comprehensive Income [Member] Additional amount available, subject to lender approval Line of Credit Facility, Additional Capacity Increase Option Represents the amount by which the borrowing capacity of the line of credit may be increased at the entity's option, subject to certain conditions, under the terms of the credit agreement. Amortized Cost Debt Securities, Available-for-sale, Maturity, Amortized Cost, Rolling Maturity [Abstract] Beginning balance (in dollars per share) Ending balance (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Variable Rate [Domain] Variable Rate [Domain] Accrued professional services Accrued Professional Fees, Current 2025 Defined Benefit Plan, Expected Future Benefit Payment, Year Five ASSETS Assets [Abstract] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Less: cash acquired Cash Acquired from Acquisition Accounting Policies [Abstract] Accounting Policies [Abstract] Common stock issued under equity plans Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture Proceeds from stock plans Proceeds from Stock Plans Operating cash flows from operating leases Operating Lease, Payments U.S. tax on foreign earnings, net of credits Effective Income Tax Rate Reconciliation, U.S. Tax On Foreign Earnings, Net Of Credits, Amount Effective Income Tax Rate Reconciliation, U.S. Tax On Foreign Earnings, Net Of Credits, Amount ACCUMULATED OTHER COMPREHENSIVE LOSS Comprehensive Income (Loss) Note [Text Block] Litigation settlement (Notes 3 and 18) Estimated Litigation Liability, Noncurrent Equity method investments Equity Method Investment, Financial Statement, Reported Amounts [Abstract] Other intangible assets Deferred Tax Liabilities, Goodwill and Intangible Assets Weighted average useful life Acquired Finite-lived Intangible Assets, Weighted Average Useful Life 2021 Lessee, Operating Lease, Liability, to be Paid, Year One Purchases of treasury stock (in shares) Shares repurchased (in shares) Treasury Stock, Shares, Acquired Beginning balance (in shares) Ending balance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 2024 Lessee, Operating Lease, Liability, to be Paid, Year Four Summary of Financial Instruments Measured at Fair Value on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Purchases credit Purchase Credit [Member] Represents information pertaining to purchase credit carryforward. Employee stock purchase subscriptions Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET Legal Matters and Contingencies [Text Block] Accumulated Other Comprehensive Income (Loss), Net of Tax AOCI Attributable to Parent, Net of Tax [Roll Forward] State and local Current State and Local Tax Expense (Benefit) Carryforward Amount Tax Credit Carryforward, Amount Purchased and sold in May 2019 May 2019 Stock Repurchase Program, Shares Purchased And Sold In May 2019 [Member] May 2019 Stock Repurchase Program, Shares Purchased And Sold In May 2019 [Member] Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding Preferred Stock, Value, Issued Future option to acquire business, amount Business Combination, Future Option To Acquire Business, Amount Business Combination, Future Option To Acquire Business, Amount Net of Tax Amount Other Comprehensive Income (Loss), Net of Tax [Abstract] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share 2023 Defined Benefit Plan, Expected Future Benefit Payment, Year Three Other comprehensive (loss) income, net of tax (Note 15): Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Other long-term liabilities Other Liabilities, Noncurrent Deferred income taxes Deferred Income Tax Assets, Net Work in process Inventory, Work in Process, Net of Reserves Tax valuation allowance SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member] Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Measurement Input, Probability of Milestone Achievement Measurement Input, Probability Of Milestone Achievement [Member] Measurement Input, Probability Of Milestone Achievement [Member] Segment reconciling items Segment Reconciling Items [Member] Inventories (Note 5) Total inventories Inventory, Net Measurement Frequency [Domain] Measurement Frequency [Domain] Accelerated Share Repurchases, Date [Domain] Accelerated Share Repurchases, Date [Domain] CardiAQ CardiAQ Valve Technologies, Inc. [Member] CardiAQ Valve Technologies, Inc. [Member] Valuation Allowance Capital Loss Carryforwards, Valuation Allowance Capital Loss Carryforwards, Valuation Allowance Expiration date Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Valuation and Qualifying Accounts Disclosure SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] Statement Statement [Line Items] Amount of Gain or (Loss) Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing) Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred Weighted-average interest rate under all debt obligations (as a percent) Long-term Debt, Weighted Average Interest Rate, at Point in Time Tax Period [Axis] Tax Period [Axis] Term of the credit agreement Debt Instrument, Term Measurement Input Type [Domain] Measurement Input Type [Domain] Statement [Table] Statement [Table] Compensation and benefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits Other comprehensive income (loss) Other Comprehensive Income, Other, Net of Tax Interest cost Interest cost Defined Benefit Plan, Interest Cost Statistical Measurement [Axis] Statistical Measurement [Axis] Deferred tax on foreign earnings Deferred Tax Liabilities, Undistributed Foreign Earnings Cash previously paid for cost method investment Payments to Acquire Additional Interest in Subsidiaries Weighted Average Weighted Average [Member] Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax Entity Small Business Entity Small Business Principles of Consolidation Consolidation, Policy [Policy Text Block] Gross Amounts Not Offset in the Consolidated Balance Sheet Derivative Fair Value of Derivative Liability Gross Amounts Not Offset [Abstract] Rest of World Rest of World Segment [Member] Represents the reportable segment of the entity comprised of regions other than the United States, Europe and Japan (Rest of World). Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] DEBT AND CREDIT FACILITIES Debt Disclosure [Text Block] Harpoon Medical Harpoon Medical, Inc. [Member] Harpoon Medical, Inc. [Member] Purchases of held-to-maturity investments (Note 7) Payments to Acquire Held-to-maturity Securities Prepaid expenses Prepaid Expense, Current Share Repurchase Program [Domain] Share Repurchase Program [Domain] Amendment Flag Amendment Flag Transcatheter Mitral and Tricuspid Therapies Transcatheter Mitral And Tricuspid Therapies [Member] Transcatheter Mitral And Tricuspid Therapies [Member] Weighted-average number of common shares outstanding: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Fair value, beginning of year Fair value, end of year Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Fair value of shares issued in connection with business combinations (Note 8) Business Acquisition, Equity Interest Issued or Issuable, Value Assigned Common stock available for issuance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Corporate items Corporate, Non-Segment [Member] Other accrued liabilities Other Accrued Liabilities, Current Amount of gain (loss) reclassified from accumulated OCI into income Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax Measurement Frequency [Axis] Measurement Frequency [Axis] Stock-based Compensation Compensation Related Costs, Policy [Policy Text Block] Insurance contracts Insurance Contracts Insurance Contracts [Member] This element represents the information about insurance contracts. Financial Instruments [Domain] Financial Instruments [Domain] Liability for estimated fair value of contingent milestone payment Business Combination, Liabilities Arising from Contingencies, Amount Recognized Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Amount of Gain or (Loss) Recognized in Income on Derivative Derivative, Gain (Loss) on Derivative, Net Schedule of Effect of Master-Netting Agreements and Rights of Offset, Assets Offsetting Assets [Table Text Block] Fair Value Measurement [Domain] Fair Value Measurement [Domain] Fair value, 12 months or greater Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer Capital expenditures accruals Capital Expenditures Incurred but Not yet Paid Derivatives Derivatives, Policy [Policy Text Block] SUBSEQUENT EVENT Subsequent Events [Text Block] Liabilities Derivative Liability [Abstract] Adjustment to transition tax Tax Cuts And Jobs Act, Measurement Period Adjustment, Transition Tax For Accumulated Foreign Earnings, Income Tax Expense (Benefits) Tax Cuts And Jobs Act, Measurement Period Adjustment, Transition Tax For Accumulated Foreign Earnings, Income Tax Expense (Benefits) Cash flow and net investment hedges Deferred Tax Assets, Hedging Transactions Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] ESPP Employee Stock [Member] July 2018 July 2018 Stock Repurchase Program [Member] July 2018 Stock Repurchase Program Balance at Beginning of Period Balance at End of Period SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount Allowance for doubtful accounts Accounts Receivable, Allowance for Credit Loss, Current Shares issued in payment for contingent consideration liabilities Stock Issued During Period, Value, Acquisitions Income Statement Location [Domain] Income Statement Location [Domain] 2022 Lessee, Operating Lease, Liability, to be Paid, Year Two State and local jurisdiction United States state net operating losses California research expenditure tax credits State and Local Jurisdiction [Member] Selling, general, and administrative expenses Selling, general, and administrative expenses Selling, General and Administrative Expense Foreign currency contracts Foreign Exchange Contract [Member] 2023 Lessee, Operating Lease, Liability, to be Paid, Year Three Other assets Other Assets, Noncurrent Plan Name [Axis] Plan Name [Axis] Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Total assets Assets Impairment of intangible assets Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) Foreign government bonds Debt Security, Government, Non-US [Member] Beginning balance (in shares) Ending balance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Retirement Plan Sponsor Location [Axis] Retirement Plan Sponsor Location [Axis] Value of Shares as % of Contract Value Percentage of shares repurchased Accelerated Share Repurchases, Value of Shares Repurchased as Percentage of Contract Amount Represents the value of the initial shares repurchased as a percentage of the contract amount under accelerated share repurchase agreement. Amortization of prior service credit Defined Benefit Plan, Amortization of Prior Service Cost (Credit) 2013 Notes Senior Notes Due 2018 [Member] Represents information pertaining to senior notes which are due in 2018. Subsequent Event Type [Axis] Subsequent Event Type [Axis] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Investments, Debt and Equity Securities [Abstract] Investments, Debt and Equity Securities [Abstract] Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Axis] Cost of sales Cost of sales Cost of Sales [Member] Number of lawsuits that if settled could have a material adverse impact on net income or cash flows Loss Contingency, Claims That If Settled Could Have A Material Adverse Impact, Number Loss Contingency, Claims That If Settled Could Have A Material Adverse Impact, Number Nondeductible employee share-based compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount Revenue, Initial Application Period Cumulative Effect Transition [Line Items] Revenue, Initial Application Period Cumulative Effect Transition [Line Items] Other Other Intangible Assets [Member] Cash balance interest crediting rate Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Weighted-Average Interest Crediting Rate Uncertain tax positions (Note 17) Liability for Uncertainty in Income Taxes, Noncurrent Final settlement per share price (in dollars per share) Accelerated Share Repurchases, Final Price Paid Per Share Change in Unrealized Pension Costs Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block] Expected volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate October 2018 Accelerated Share Repurchase Agreements Entered Into October 2018 [Member] Accelerated Share Repurchase Agreements Entered Into October 2018 [Member] Retirement Plan Type [Axis] Retirement Plan Type [Axis] Accumulated benefit obligation Defined Benefit Plan, Accumulated Benefit Obligation Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Vested and expected to vest as of period end Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Participant contributions Defined Benefit Plan, Plan Assets, Contributions by Plan Participant Total fair value Debt Securities, Available-for-sale, Unrealized Loss Position Annual award to nonemployee director Share-based Compensation Arrangements Award Granted Annually to Nonemployee Director [Member] This element represents details pertaining to an award granted annually to a nonemployee director. Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Level 1 Fair Value, Inputs, Level 1 [Member] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Inventories Increase (Decrease) in Inventories Gross Amounts Offset in the Consolidated Balance Sheet Derivative Liability, Fair Value, Gross Asset Fair value, less than 12 months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months Shares Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Other Increase (Decrease) in Other Operating Assets and Liabilities, Net Additional Paid-in Capital Additional Paid-in Capital [Member] Schedule of Other Expense, Net Schedule of Other Nonoperating Income (Expense) [Table Text Block] Japan JAPAN Stock split, conversion ratio Stockholders' Equity Note, Stock Split, Conversion Ratio Due after 1 year through 5 years Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost Beginning balance (in shares) Ending balance (in shares) Shares, Issued Accrued and other liabilities Accounts Payable and Accrued Liabilities [Member] Schedule of Investments in Unconsolidated Affiliates Schedule of Investments in and Advances to Affiliates, Schedule of Investments [Table Text Block] Machinery and equipment Machinery and Equipment [Member] Other receivables Other Receivables Carrying value of equity method investments Equity Method Investments Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Europe Europe Segment [Member] Represents the Europe reportable segment of the entity. Tax Benefit Amount Deferred Tax Assets, Capital Loss Carryforwards Schedule of Goodwill [Table] Schedule of Goodwill [Table] MRSUs Market Based Restricted Stock Units [Member] Market Based Restricted Stock Units [Member] Purchases, sales and settlements Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Purchase, Sale, and Settlement Net actuarial gain (loss) arising during period Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member] Beginning balance (in dollars per share) Ending balance (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Initial delivery, price per share (in dollars per share) Accelerated Share Repurchases, Initial Price Paid Per Share Total purchase price, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Common stock, shares authorized (in shares) Common Stock, Shares Authorized Puerto Rico PUERTO RICO Cash from exercises of stock options Proceeds from Stock Options Exercised Total property, plant and equipment, gross Property, Plant and Equipment, Gross Dilutive effect of stock plans (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Federal Deferred Federal Income Tax Expense (Benefit) Surgical Structural Heart Surgical Heart Valve Therapy [Member] This element represents the surgical heart valve therapy product line. 2022 Defined Benefit Plan, Expected Future Benefit Payment, Year Two Schedule of Information About Reportable Segments and Reconciliation of Segment Net Sales and Pre-Tax Income Schedule of Segment Reporting Information, by Segment [Table Text Block] Underfunded status Defined Benefit Plan, Funded (Unfunded) Status of Plan Effects of mandatory deemed repatriation Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Transition Tax For Accumulated Foreign Earnings, Provisional Income Tax Expense (Benefit) Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Transition Tax For Accumulated Foreign Earnings, Provisional Income Tax Expense (Benefit) SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] Foreign-derived intangible income deduction Effective Income Tax Rate Reconciliation, Deduction, Amount Income Statement [Abstract] Income Statement [Abstract] Accumulated Other Comprehensive Loss Total Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity Investments Classified by Contractual Maturity Date [Table Text Block] Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Period to make additional pre-specified milestone-driven payments Period to obtain certain European regulatory approval Business Combination, Contingent Consideration, Liability, Period Business Combination, Contingent Consideration, Liability, Period Abbott Laboratories Abbott Laboratories [Member] Abbott Laboratories [Member] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Use of Estimates Use of Estimates, Policy [Policy Text Block] Contingent consideration liabilities Obligations, Fair Value Disclosure Impact related to 2017 U.S. Tax Reform Effective Income Tax Rate Reconciliation, Impacts Related To 2017 U.S. Tax Reform, Amount Effective Income Tax Rate Reconciliation, Impacts Related To 2017 U.S. Tax Reform, Amount Income Tax Authority [Domain] Income Tax Authority [Domain] Schedule of Weighted-Average Assumptions Used to Determine Benefit Obligations Defined Benefit Plan, Assumptions [Table Text Block] Software Software and Software Development Costs [Member] Company match, second level (as a percent) Defined Contribution Plan, Employer Matching Contribution Percent of Match, Second Level Percentage employer matches for the second level of the employee's percentage contribution matched. Tax benefit of accrued interest Unrecognized Tax Benefits, Accrued Interest, Tax Benefit The tax benefits pertaining to the amount of interest expense accrued on unrecognized tax benefits. Scenario [Domain] Scenario [Domain] Capital expenditures Payments to Acquire Property, Plant, and Equipment Consolidation Items [Domain] Consolidation Items [Domain] Obligations Obligations [Member] Build (release) of reserve for prior years' uncertain tax positions Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount Additional payments if certain European regulatory approval is obtained Business Combination, Contingent Consideration, Liability GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill and Intangible Assets Disclosure [Text Block] Actual return on plan assets Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss) Total gross unrealized losses Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss Income before provision for income taxes Segment Operating Income Consolidated pre-tax income Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Purchased in May 2019 and sold in June 2019 May 2019 Stock Repurchase Program, Shares Sold In June 2019 [Member] May 2019 Stock Repurchase Program, Shares Sold In June 2019 [Member] Hedging Designation [Axis] Hedging Designation [Axis] Liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income [Domain] 2024-2026 Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years Prior service credit arising during period Other Comprehensive Income (Loss) before Reclassifications, Tax Carrying value of non-marketable equity securities Equity Securities, FV-NI Summary of Tax Credit Carryforwards Summary of Tax Credit Carryforwards [Table Text Block] Derivatives designated as hedging instruments Designated as Hedging Instrument [Member] Increase to goodwill Goodwill acquired during the year Goodwill, Acquired During Period General and administrative costs allocated to inventory General and Administrative Costs in Inventory, Amount Incurred QUARTERLY FINANCIAL RESULTS AND MARKET FOR THE COMPANY'S STOCK (UNAUDITED) Quarterly Financial Information [Text Block] Intellectual property litigation expenses, net Intellectual Property Litigation Expense Represents the net amount of judgment or settlement awarded to (against) the entity and legal, forensic, accounting, investigative fees and other expenses related to intellectual property litigation. Tax reductions compared to local statutory rates per diluted share (in dollars per share) Income Tax Holiday, Income Tax Benefits Per Share Decrease in non-marketable equity securities due to observable price changes Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount Debt and Equity Securities, FV-NI [Line Items] Debt and Equity Securities, FV-NI [Line Items] Estimated useful life Property, Plant and Equipment, Useful Life Carryforward Period Ends 2026-2039 Tax Carryforwards Expiration Period Years 2026-2039 [Member] Tax Carryforwards Expiration Period Years 2026-2039 [Member] Property, plant, and equipment, net Property, Plant and Equipment, Net [Abstract] Carrying amount of goodwill Goodwill [Line Items] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Net deferred tax assets increase Increase (Decrease) in Deferred Tax Assets (Liabilities), Net The increase or decrease during the year in net deferred tax assets. Includes items recorded to stockholders' equity and which did not impact the income tax provision. Net deferred tax assets Deferred Tax Assets, Net Fair Value Total Available-for-sale investments Debt Securities, Available-for-sale Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Finished products Inventory, Finished Goods, Net of Reserves Carryforward Amount Capital Loss Carryforwards Capital Loss Carryforwards Operating lease liabilities (Note 6) Operating lease liabilities, current portion Operating Lease, Liability, Current Schedule of Effect of Derivative Instruments Derivative Instruments, Gain (Loss) [Table Text Block] Forfeited (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Schedule of Weighted-Average Assumptions for Options Granted Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets Derivative Instruments, Gain (Loss) Derivative Instruments, Gain (Loss) [Line Items] FAIR VALUE MEASUREMENTS Fair Value Disclosures [Text Block] Market price (in dollars per share) Common Stock Market Price Price of a single share of a number of saleable stocks of a company during the period. Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Derivatives designated as hedging instruments Derivatives, Fair Value [Line Items] Impact to retained earnings from adoption of ASU 2016-16 and ASU 2018-02 Cumulative Effect, Period of Adoption, Adjustment [Member] Additional paid-in capital Additional Paid in Capital, Common Stock Entity Registrant Name Entity Registrant Name Subsequent Event Type [Domain] Subsequent Event Type [Domain] Business Acquisition [Line Items] Business Acquisition [Line Items] Assets Assets, Fair Value Disclosure [Abstract] Company match of eligible compensation after dollar-for-dollar basis (as a percent) Defined Contribution Plan, Employer Matching Contribution Percent, Second Level Represents the percentage of the second level of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan. Purchased in-process research and development Research and Development Asset Acquired Other than Through Business Combination, Written-off Unamortized debt issuance costs Debt Issuance Costs, Net Shipping and Handling Shipping and Handling [Member] Weighted- Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Carryforward Period Ends 2022 Capital Loss Carryforward Period Ends 2022 [Member] Capital Loss Carryforward Period Ends 2022 [Member] Increase in non-marketable equity securities due to observable price changes Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Schedule of the Effect of Fair Value and Cash Flow Hedge Disclosure Of Fair Value Hedging Instruments And Cash Flow Hedging Instruments, Statements Of Financial Performance And Financial Position, Location [Table Text Block] Disclosure Of Fair Value Hedging Instruments And Cash Flow Hedging Instruments, Statements Of Financial Performance And Financial Position, Location [Table Text Block] Accrued and other liabilities Accrued Liabilities and Other Liabilities [Abstract] Period used to evaluate slow-moving inventory levels Inventory Write Down Slow Moving Period Trigger The time period used to identify slow-moving inventory which triggers an inventory write-down. Schedule of Cash and Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Restricted cash included in other assets Restricted Cash, Noncurrent Gross Unrealized Losses Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax Tax Credit Carryforward [Table] Tax Credit Carryforward [Table] Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Line Items] Additional research and development expenditures to be incurred prior to product introduction Business Combination, In-process Research and Development, Expected Costs Business Combination, In-process Research and Development, Expected Costs Entity Address, Postal Zip Code Entity Address, Postal Zip Code Percentage of lower of fair market value of common stock on effective date of subscription or date of purchase Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent Goodwill (Note 9) Goodwill Beginning balance Ending balance Goodwill Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-sale [Line Items] Payments on debt and finance lease obligations Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security Other comprehensive (loss) income, net of tax Other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Accelerated Share Repurchases Accelerated Share Repurchases [Table Text Block] Acquisition transaction costs Business Acquisition, Transaction Costs Allocation of stock-based compensation expense Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Tax Benefit Amount Deferred Tax Assets, Operating Loss Carryforwards Instruments not due at a single maturity date Debt Securities, Held-to-maturity, Maturity, without Single Maturity Date, Fair Value Income taxes Increase (Decrease) in Income Taxes Payable Fixed-rate unsecured senior notes Debt Instrument, Face Amount Buildings and improvements Building and Building Improvements [Member] Other current assets Other Assets, Current Contingent consideration liability measurement input Business Combination, Contingent Consideration, Liability, Measurement Input Schedule of Changes in the Carrying Amount of Goodwill, by Segment Schedule of Goodwill [Table Text Block] Options forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Equity [Abstract] Equity [Abstract] Total assets Assets, Fair Value Disclosure Debt Securities, Held-to-maturity [Table] Debt Securities, Held-to-maturity [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Non-cash investing and financing transactions: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Litigation settlement (Notes 3 and 18) Estimated Litigation Liability, Current Options granted (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Derivative Contract [Domain] Derivative Contract [Domain] Schedule of Estimated Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Due after 1 year through 5 years Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value Diluted (in shares) Dilutive weighted-average shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Diluted Defined Contribution Plan [Table] Defined Contribution Plan [Table] Other Income and Expenses [Abstract] Other Income and Expenses [Abstract] Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion) Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax Debt Disclosure [Abstract] Debt Disclosure [Abstract] Net Amount Derivative Liability, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election Cash Defined Benefit Plan, Cash and Cash Equivalents [Member] Accrued liabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Enterprise-Wide Information Revenues from External Customers and Long-Lived Assets [Line Items] Unrecognized tax benefits Uncertain gross tax positions, beginning balance Uncertain gross tax positions, ending balance Unrecognized Tax Benefits Tax Credit Carryforward, Name [Domain] Tax Credit Carryforward, Name [Domain] Credit agreement, maturity July 2019 Credit Agreement, Maturity July 2019 [Member] Represents the credit agreement with a maturity of July 2019. Common stock, $1.00 par value, 1,050.0 shares authorized, 636.4 and 218.1 shares issued, and 624.3 and 209.1 shares outstanding, respectively Common Stock, Value, Issued Long-term investments (Note 7) Long-term Investments 2024 Defined Benefit Plan, Expected Future Benefit Payment, Year Four Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Document Fiscal Year Focus Document Fiscal Year Focus Deferred tax assets Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets Deferred income tax expense Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent 2022 Finite-Lived Intangible Asset, Expected Amortization, Year Two Offsetting Assets [Line Items] Offsetting Assets [Line Items] Property, payroll, and other taxes Accrual for Property Payroll and Other Taxes Other than Income Taxes Current Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes, payroll taxes and other taxes, excluding income taxes payable. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Restricted cash included in other current assets Restricted Cash, Current SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] Upward price adjustments Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount Settlements Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities Beginning of year End of year Projected benefit obligation Defined Benefit Plan, Benefit Obligation Entity Current Reporting Status Entity Current Reporting Status Changes in fair value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Assets Derivative Asset [Abstract] Cross currency swap contracts Currency Swap [Member] Purchases of available-for-sale investments (Note 7) Payments to Acquire Debt Securities, Available-for-sale Earnings per Share Earnings Per Share, Policy [Policy Text Block] Weighted- Average Remaining Contractual Term Weighted Average Remaining Contractual Term Years [Abstract] Inventory Disclosure [Abstract] Consideration per share to be transferred (in dollars per share) Business Acquisition, Share Price Percentage vesting upon retirement for each full year of employment subsequent to the grant date Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Common stock, shares issued (in shares) Common Stock, Shares, Issued Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Total operating lease liabilities Total lease liabilities Operating Lease, Liability Gain on investments Gain (Loss) on Investments, Other Income Expense, Net This item represents the portion of gain (loss) on investments categorized by the entity as other income (expense). Includes, but is not limited to, (1) the net realized and unrealized gain (loss) included in earnings for the period as a result of selling or holding marketable securities categorized as trading, available-for-sale, or held-to-maturity, including those trading securities held for investment under deferred compensation agreements net of the gain (loss) of the related deferred compensation liability; (2) the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied; (3) gains (losses) realized during the period from the sale of investments accounted for under the cost method of accounting; (4) losses recognized for other than temporary impairments (OTTI) of the subject investments; and (5) the amount of recovery of investments which had previously been fully or partially written-off. Long-term debt (Note 10) Long-term Debt, Excluding Current Maturities Segment Reporting [Abstract] Segment Reporting [Abstract] Share information (Note 2): Share Information [Abstract] Unallocated amounts: Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract] Share Repurchase Program [Axis] Share Repurchase Program [Axis] Debt Instrument [Line Items] Debt Instrument [Line Items] Total stockholders' equity Beginning balance Ending balance Stockholders' Equity Attributable to Parent DESCRIPTION OF BUSINESS Nature of Operations [Text Block] Foreign income taxed at different rates Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount Cash purchase price Purchase price subject to certain adjustments Business Combination, Consideration Transferred Issuance of shares of common stock (in shares) Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Entity Address, City or Town Entity Address, City or Town Employee compensation and withholdings Employee-related Liabilities, Current Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Accounts receivable, required payment terms Accounts Receivable, Payment Terms Accounts Receivable, Payment Terms Investments in intangible assets and in-process research and development Payments to Acquire Intangible Assets Restricted stock units Nonvested restricted stock unit activity Restricted Stock Units (RSUs) [Member] Maximum percentage of compensation employees can authorize to be withheld for common stock purchases Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate 2025 Lessee, Operating Lease, Liability, to be Paid, Year Five Issuance costs Debt Issuance Cost, Gross, Noncurrent Financial Instrument [Axis] Financial Instrument [Axis] Financial Instrument [Axis] Litigation and insurance reserves (Note 18) Accrued Litigation And Insurance Reserves Accrued Litigation And Insurance Reserves Net Tax Benefit Tax Credit Carryforward Deferred Tax Asset Net of Valuation Allowance Represents the amount after allocation of valuation allowances of deferred tax asset attributable to tax credit carryforwards. Equipment with customers Equipment with Customers The gross amount, as of the balance sheet date, of long-lived, depreciable equipment at customer locations. Pre-Tax Amount Other Comprehensive Income (Loss), before Tax [Abstract] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets [Axis] Amounts reclassified from accumulated other comprehensive loss to affected line on Consolidated Statements of Operations Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Foreign earnings to be repatriated Foreign Earnings To Be Repatriated Foreign Earnings To Be Repatriated Valuation allowance Valuation allowance that reduces certain deferred tax assets Deferred Tax Assets, Valuation Allowance Schedule of Available-for-sale Securities [Table] Schedule of Available-for-sale Securities [Table] Currency exchange rate changes and other Currency exchange rate impact Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss) 2023 Finite-Lived Intangible Asset, Expected Amortization, Year Three Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Summary of Derivative Financial Instruments Used to Manage Currency Exchange and Interest Rate Risk Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block] Transcatheter Mitral Valve Replacement Transcatheter Mitral Valve Replacement [Member] Transcatheter Mitral Valve Replacement [Member] Leases [Abstract] Leases [Abstract] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Total current assets Assets, Current Carryforward Amount Operating Loss Carryforwards Dollar-for-dollar match of employee's annual eligible compensation (as a percent) Defined Contribution Plan Employer Matching Contribution Percent, First Level Represents the percentage of the first level of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan. Earnings per share: Earnings per common share: Earnings Per Share [Abstract] Components of Deferred Tax Assets and Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Alternative investments measured at net asset value Fair Value Measured at Net Asset Value Per Share [Member] Unrealized Pension Costs Unrealized pension credits (cost), net Amortization of pension adjustments Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Stockholders' equity (Note 14) Stockholders' Equity Attributable to Parent [Abstract] November 2018 Accelerated Share Repurchase Agreements Entered Into November 2018 [Member] Accelerated Share Repurchase Agreements Entered Into November 2018 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Five Document Fiscal Period Focus Document Fiscal Period Focus SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] Gain (loss) on litigation settlement Gain (Loss) Related to Litigation Settlement Other long-term liabilities Liability, Defined Benefit Pension Plan, Noncurrent Employer contributions Defined Benefit Plan, Plan Assets, Contributions by Employer Carryforward Period Ends 2030-2037 Carryforward Period Ends 2030-2037 [Member] Carryforward Period Ends 2030-2037 [Member] Mortgages Mortgages [Member] Total plan assets measured at fair value Fair Value, Inputs, Level 1, 2 and 3 [Member] Price equal to principal amount, plus accrued and unpaid interest (as a percent) Debt Instrument, Redemption Price, Percentage Entity Filer Category Entity Filer Category Schedule of Stock-Based Compensation Expense Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Common Stock Common Stock [Member] Foreign Currency Translation Adjustments Foreign currency translation adjustments Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Product and Service [Domain] Product and Service [Domain] Weighted-average discount rate Lessee, Operating Lease, Discount Rate Schedule of Information About Amounts Reclassified from Accumulated Other Comprehensive Loss Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] Matching contributions relating to entity's employees Defined Contribution Plan, Cost Amortized Cost Debt Securities, Held-to-maturity, Maturity, Amortized Cost, Net [Abstract] Class of Treasury Stock [Table] Class of Treasury Stock [Table] Net amounts recognized on the consolidated balance sheet: Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position [Abstract] Other income, net Other Nonoperating Income (Expense) [Member] Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Fixed interest rate Debt Instrument, Interest Rate, Stated Percentage Municipal securities Municipal Bonds [Member] Stock compensation plan Share-based Payment Arrangement [Member] Diluted: Earnings Per Share, Diluted [Abstract] Amounts included in the measurement of lease liabilities: Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract] Options exercised (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Net increase (decrease) in cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Non-operating income Nonoperating Income (Expense) Schedule of Information Regarding Defined Benefit Pension Plans Defined Benefit Plan, Change in Benefit Obligation Plan Assets, Net Amount Recognized on Balance Sheet [Table Text Block] This element represents the changes in benefit obligations, plan assets and the net amount recognized in the balance sheet for defined benefit plans. ACQUISITIONS Business Combination Disclosure [Text Block] Hedged items Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge Available-for-sale Debt Securities, Available-for-sale [Abstract] Subsequent Events [Abstract] Subsequent Events [Abstract] Number of Investments Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Treasury stock, shares (in shares) Treasury Stock, Shares United States: Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract] Impairment charges (Note 4) Other than Temporary Impairment Losses, Investments State and local Deferred State and Local Income Tax Expense (Benefit) United States Income (Loss) from Continuing Operations before Income Taxes, Domestic Expected return on plan assets Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets Lease liability obligations Deferred Tax Assets, Lease Liability Obligations Deferred Tax Assets, Lease Liability Obligations Interest Interest Paid, Excluding Capitalized Interest, Operating Activities Tax Period [Domain] Tax Period [Domain] Due after 1 year through 5 years Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value 2021 Finite-Lived Intangible Asset, Expected Amortization, Year One Deferred compensation plans Deferred Compensation Cash-based Arrangements, Liability, Classified, Noncurrent Schedule of Restricted Stock Unit Activity Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Valtech Valtech Cardio, Ltd [Member] Valtech Cardio, Ltd [Member] Total liabilities Financial and Nonfinancial Liabilities, Fair Value Disclosure Diluted (in dollars per share) Diluted earnings per share (in dollars per share) Earnings Per Share, Diluted Schedule of Enterprise-Wide Information Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Measurement Input, Volatility of Future Revenue Measurement Input, Volatility Of Future Revenue [Member] Measurement Input, Volatility Of Future Revenue [Member] Deferred tax asset provisional income tax expense (benefit) Tax Cuts And Jobs Act Of 2017, Measurement Period Adjustments, Change In Tax Rate, Deferred Tax Asset, Provisional Income Tax Expense (Benefit) Tax Cuts And Jobs Act Of 2017, Measurement Period Adjustments, Change In Tax Rate, Deferred Tax Asset, Provisional Income Tax Expense (Benefit) CAS Medical Systems, Inc. CAS Medical Systems, Inc. [Member] CAS Medical Systems, Inc. [Member] Summary of the Notes Schedule of Long-term Debt Instruments [Table Text Block] Depreciation expense for property, plant and equipment Depreciation Entity Address, Address Line One Entity Address, Address Line One Tax credits, federal and state Effective Income Tax Rate Reconciliation, Tax Credit, Amount Interest expense (benefit), net of tax benefit Unrecognized Tax Benefits, Interest on Income Taxes Expense Equity securities Investments, All Other Investments [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company In-process research and development Indefinite-lived Intangible Assets (Excluding Goodwill) Deferred income tax (benefit) expense Deferred Income Tax Expense (Benefit) Gross Amounts Derivative Liability, Fair Value, Gross Liability Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Rest of World Rest of World [Member] Represents the geographic areas of the world other than the United States, Europe and Japan. Maximum High Maximum [Member] Preferred stock, authorized shares (in shares) Preferred Stock, Shares Authorized Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Estimated annual forfeiture rate Estimated Annual Forfeiture Rate Percent This element represents the estimated annual forfeiture rate of the entity's stock-based compensation plans, percentage. Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Effect of Master-Netting Agreements and Rights of Offset, Liabilities Offsetting Liabilities [Table Text Block] Trading Symbol Trading Symbol Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Company match, first level (as a percent) Defined Contribution Plan, Employer Matching Contribution Percent of Match First Level Percentage employer matches for the first level of the employee's percentage contribution matched. Due in 1 year or less Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Period prior to expiration date which triggers write-down of inventory Inventory Write Down Expiration Period Trigger The period prior to the expiration date which triggers the write down of inventory, expressed in months. Revenue, Initial Application Period Cumulative Effect Transition [Table] Revenue, Initial Application Period Cumulative Effect Transition [Table] Cash Collateral Received Derivative, Collateral, Right to Reclaim Cash Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Instruments not due at a single maturity date Debt Securities, Held-to-maturity, Maturity, without Single Maturity Date, Amortized Cost International, including Puerto Rico Income (Loss) from Continuing Operations before Income Taxes, Foreign Entity Shell Company Entity Shell Company Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Fair Value on a Recurring Basis Fair Value, Recurring [Member] Entity Public Float Entity Public Float Net proceeds from sale of previous ownership Proceeds from Divestiture of Businesses and Interests in Affiliates Document Type Document Type ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Other income, net (Note 16) Other income, net Total other income, net Other Nonoperating Income (Expense) Treasury Stock Treasury Stock [Member] Accounts payable and accrued liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Product Information [Line Items] Product Information [Line Items] Available-for-Sale Available-for-sale Securities, Debt Maturities [Abstract] Segments [Axis] Segments [Axis] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] EMPLOYEE BENEFIT PLANS Retirement Benefits [Text Block] Summary of Activity for Each Component of Accumulated Other Comprehensive Loss Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Vested (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value In-process research and development In Process Research and Development [Member] Accrual for environmental loss contingencies, component amount Accrual For Environmental Loss Contingencies, Governmental Authority, Threshold For Disclosure Accrual For Environmental Loss Contingencies, Governmental Authority, Threshold For Disclosure Level 3 Fair Value, Inputs, Level 3 [Member] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Inventory write off Inventory Write-down Credit Agreement Maturity April 2023 Credit Agreement Maturity April 2023 [Member] Credit Agreement Maturity April 2023 [Member] Leases Lessee, Leases [Policy Text Block] Other current assets Other Current Assets [Member] Benefits paid Defined Benefit Plan, Plan Assets, Benefits Paid Derivatives Fair Value Net Amounts Presented in the Consolidated Balance Sheet Derivative Asset Credit Facility Line of Credit [Member] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES Derivative Instruments and Hedging Activities Disclosure [Text Block] Other intangible assets, net (Note 9) Net Carrying Value Intangible Assets, Net (Excluding Goodwill) Instruments not due at a single maturity date Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value Accounts and other receivables, net Increase (Decrease) in Accounts and Other Receivables Operating income Operating income Operating Income (Loss) Cash Collateral Received Derivative, Collateral, Obligation to Return Cash Defined Contribution Plans Defined Contribution Plan Disclosure [Line Items] Impairment of Goodwill and Long-lived Assets Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block] Variable Rate [Axis] Variable Rate [Axis] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Commitments and contingencies (Notes 6, 10 and 18) Commitments and Contingencies Maximum contributions of a participant's eligible compensation (as a percent) Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent Purchases of treasury stock Payments for Repurchase of Common Stock Vesting period Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five Entity Address, State or Province Entity Address, State or Province Vested (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Income tax expense at U.S. federal statutory rate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount Other comprehensive income (loss) Other Comprehensive Income (Loss), before Tax Accounts payable Accounts Payable, Current Currency translation adjustment Goodwill, Foreign Currency Translation Gain (Loss) Retained earnings Retained Earnings (Accumulated Deficit) Operating lease right-of-use assets (Note 6) Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Offsetting Assets [Table] Offsetting Assets [Table] Unamortized discount Debt Instrument, Unamortized Discount Property, plant, and equipment Deferred Tax Liabilities, Property, Plant and Equipment Summary of Changes in Fair Value of Defined Benefit Plan Assets Classified as Level 3 Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets [Table Text Block] Payments for Legal Settlements Payments for Legal Settlements Income taxes Income Taxes Paid Property and equipment, net Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Instruments not due at a single maturity date Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Amortized Cost Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Income Taxes Income Tax, Policy [Policy Text Block] Hedging Designation [Domain] Hedging Designation [Domain] U.S. government and agency securities US Treasury and Government [Member] Exercisable as of period end (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Accelerated Share Repurchase Accelerated Share Repurchases [Line Items] Machinery and equipment Machinery and Equipment, Gross Other Payments for (Proceeds from) Other Investing Activities Liability Class [Axis] Liability Class [Axis] Domestic Plan Domestic Plan [Member] Stock-based compensation expense APIC, Share-based Payment Arrangement, Increase for Cost Recognition Construction in progress Construction in Progress, Gross Cumulative Effect, Period of Adoption, Adjusted Balance Cumulative Effect, Period of Adoption, Adjusted Balance [Member] Net sales Segment Net Sales Revenue from Contract with Customer, Excluding Assessed Tax Investments Investment, Policy [Policy Text Block] Business Acquisition [Axis] Business Acquisition [Axis] Geographical [Domain] Geographical [Domain] Gross Unrealized Losses Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss Litigation settlement accrual Increase (Decrease) In Legal Settlement Accrual Increase (Decrease) In Legal Settlement Accrual Settlements and curtailment gain Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Net Tax Benefit Deferred Tax Assets Operating Loss Carryforwards Net of Valuation Allowance Represents the amount after allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. Stock issued in payment for contingent consideration liabilities (in shares) Stock Issued During Period, Shares, Acquisitions Due in 1 year or less Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value International, including Puerto Rico Deferred Foreign Income Tax Expense (Benefit) Forecast Forecast [Member] Deferred income taxes Increase (Decrease) in Deferred Income Taxes Pre-tax Income Reconciliation Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract] Entity Voluntary Filers Entity Voluntary Filers Acquisition-related costs Business Combination, Acquisition Related Costs Contingent consideration liabilities (Notes 8 and 11) Business Combination, Contingent Consideration, Liability, Noncurrent Tax Credit Carryforward [Axis] Tax Credit Carryforward [Axis] Credit Facility [Axis] Credit Facility [Axis] Initial Delivery of Shares Settled June 2019 Initial Delivery Of Shares Settled June 2019 [Member] Initial Delivery Of Shares Settled June 2019 [Member] Fair value of the notes, based on Level 2 inputs Debt Instrument, Fair Value Disclosure Weighted-average assumptions used to determine the benefit obligations Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract] Land Land Lease commitments for leases not yet commenced Lessee, Operating Lease, Lease Not Yet Commenced, Amount Lessee, Operating Lease, Lease Not Yet Commenced, Amount Amount accrued under nonqualified plans Deferred Compensation Liability, Current and Noncurrent Non-U.S. Non-United States net operating losses Puerto Rico purchases credit Foreign Tax Authority [Member] Business Combinations [Abstract] Business Combinations [Abstract] Retirement Plan Name [Domain] Retirement Plan Name [Domain] Tax benefit from remeasurement of deferred taxes Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Change In Tax Rate, Deferred Tax Asset, Provisional Income Tax Expense (Benefit) Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Change In Tax Rate, Deferred Tax Asset, Provisional Income Tax Expense (Benefit) Other income, net Other Operating Income (Expense), Net Increase (Decrease) in Stockholders' Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Accelerated Share Repurchases [Table] Accelerated Share Repurchases [Table] Exercisable as of period end Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Selling, general, and administrative expenses Selling, general, and administrative expenses Selling, General and Administrative Expenses [Member] Schedule of Location and Fair Value Amounts of Derivative Instruments Schedule of Foreign Exchange Contracts, Statement of Financial Position [Table Text Block] Goodwill Goodwill [Roll Forward] Proceeds from sales and maturities of available-for-sale investments (Note 7) Proceeds from Sale and Maturity of Debt Securities, Available-for-sale Schedule of Computation of Basic and Diluted Earnings Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Research and Development Costs Research and Development Expense, Policy [Policy Text Block] Summary of Fair Values of Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Borrowings outstanding Long-term Line of Credit OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS Supplemental Balance Sheet Disclosures [Text Block] Other Other Investments [Member] Funded Status Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract] Defined Benefit Plan, Plan Assets, Category [Axis] Defined Benefit Plan, Plan Assets, Category [Axis] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Entity Central Index Key Entity Central Index Key Profit sharing contribution calculated on eligible earnings (as a percent) Defined Contribution Plan Profit Sharing Contribution Rate For a defined contribution plan, the percent of the participant's eligible compensation that the employer will contribute to the profit sharing plan. Intellectual property litigation expenses, net (Note 3) Intellectual property litigation expenses Litigation Settlement, Expense Unrealized (Loss) Gain on Hedges (Loss) gain on hedges Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] Derivative Instrument [Axis] Derivative Instrument [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Other long-term liabilities Other Noncurrent Liabilities [Member] Schedule of Finite-Lived Other Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Senior Notes Senior Notes [Member] ESPP Employee Stock Purchase Plan [Member] Employee Stock Purchase Plan [Member] Geographical [Axis] Geographical [Axis] Amortization of prior service credit Reclassification from AOCI, Current Period, Tax Charged to Other Accounts SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account Valtech spin off Valtech Spin-off [Member] Valtech Spin-off [Member] Segments [Domain] Segments [Domain] Non-service cost components of net periodic pension benefit cost (credit) Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component Amortized Cost Debt Securities, Available-for-sale, Amortized Cost Gross Unrealized Gains Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Income Statement Location [Axis] Income Statement Location [Axis] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Indefinite-lived Intangible Assets [Line Items] Indefinite-lived Intangible Assets [Line Items] Accrued marketing expenses Accrued Marketing Costs, Current Federal Current Federal Tax Expense (Benefit) Notional Amount Derivative, Notional Amount Amortization expense related to other intangible assets Amortization of Intangible Assets Realized tax benefits from exercises of stock options and vesting of restricted stock units Employee Service Share Based Compensation, Tax Benefit Realized from Exercise of Stock Options and Vesting of Restricted Stock Units Disclosure of aggregate tax benefit realized from the exercise of stock options and vesting of restricted stock units during the period. SEGMENT INFORMATION Segment Reporting Disclosure [Text Block] Pension increase Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Pension Increase This element represents the percentage of increase in pension. Scenario [Axis] Scenario [Axis] Finished goods inventories held on consignment Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross Fair value of derivatives Derivative Liability, Current Schedule of Components of Selected Captions in the Consolidated Balance Sheets Schedule of Selected Captions Balance Sheet Disclosures [Table Text Block] Schedule of the aggregate supplemental balance sheet disclosures, including descriptions and amounts, related to assets and liabilities. Title of 12(b) Security Title of 12(b) Security Net Carrying Value Finite-Lived Intangible Assets, Net Long-lived tangible assets Long-Lived Assets Fair value, per share (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Taxes payable Accrued Income Taxes, Current Unrealized gain (loss) on available-for-sale investments OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Future option to acquire business, additional amount subject to regulatory approval Business Combination, Future Option To Acquire Business, Additional Amount Subject To Regulatory Approval Business Combination, Future Option To Acquire Business, Additional Amount Subject To Regulatory Approval Puerto Rico purchases credit Puerto Rico Purchases Credit [Member] Puerto Rico Purchases Credit [Member] Interest expense Interest Expense Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] General and administrative costs included in inventory General and Administrative Costs in Inventory, Amount Remaining Research expenditure tax credits Research Tax Credit Carryforward [Member] Depreciation and amortization Depreciation, Depletion and Amortization Schedule of Provision for Income Taxes Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Schedule of Investments in Debt Securities Unrealized Gain (Loss) on Investments [Table Text Block] Product and Service [Axis] Product and Service [Axis] Derivatives designated as hedging instruments Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments Prior service credit Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member] Other assets Other Noncurrent Assets [Member] Weighted-average remaining requisite service period Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition International Non-US [Member] Deferred income tax benefit Defined Benefit Plan, Accumulated Other Comprehensive Income, Deferred Income Tax Expense (Benefit), Net of Tax Defined Benefit Plan, Accumulated Other Comprehensive Income, Deferred Income Tax Expense (Benefit), Net of Tax Accelerated Share Repurchases, Date [Axis] Accelerated Share Repurchases, Date [Axis] Revenue recognized that was previously deferred Contract with Customer, Liability, Revenue Recognized Net income Net income Net Income (Loss) Available to Common Stockholders, Basic Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion) Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Fair Value Debt Securities, Available-for-sale, Maturity, Fair Value, Rolling Maturity [Abstract] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Raw materials Inventory, Raw Materials, Net of Reserves Financial Instruments Derivative Asset, Not Offset, Policy Election Deduction Summary of Net Operating Loss Carryforwards Summary of Operating Loss Carryforwards [Table Text Block] Debt Instrument [Axis] Debt Instrument [Axis] Fair value hedges Fair Value Hedging [Member] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Schedule of Quarterly Financial Results and Market for the Company's Stock Quarterly Financial Information [Table Text Block] Operating segments Operating Segments [Member] Class of Stock [Line Items] Class of Stock [Line Items] Purchases of treasury stock Aggregate cost of stock repurchases Treasury Stock, Value, Acquired, Cost Method Valuation Allowance Tax Credit Carryforward, Valuation Allowance Derivatives Fair Value Net Amounts Presented in the Consolidated Balance Sheet Derivative Liability February 2021 Stock Repurchase Program February 2021 Stock Repurchase Program [Member] February 2021 Stock Repurchase Program Litigation Case [Axis] Litigation Case [Axis] Inventories Deferred Tax Assets, Inventory Valuation Allowance Operating Loss Carryforwards, Valuation Allowance State and local taxes, net of federal tax benefit Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount Adjustments to reconcile net income to cash provided by operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Research and development expenses Research and Development Expense U.S. federal deductible employee share-based compensation Effective Income Tax Rate Reconciliation, Deduction, Share-based Compensation Cost, Amount Effective Income Tax Rate Reconciliation, Deduction, Share-based Compensation Cost, Amount Subsequent Event Subsequent Event [Member] United States federal net operating losses Federal research expenditure tax credits Domestic Tax Authority [Member] Fair Value Debt Securities, Held-to-maturity, Maturity, Fair Value, Rolling Maturity [Abstract] United States United States Segment [Member] Represents the United States reportable segment of the entity. United States government bonds US Government Debt Securities [Member] Due in 1 year or less Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost Special gain (Note 4) Special charges (gain), net Other Nonoperating Nonrecurring (Income) Expense Other Nonoperating Nonrecurring (Income) Expense Estimate of Fair Value Measurement Estimate of Fair Value Measurement [Member] Operating lease liabilities (Note 6) Operating lease liabilities, long-term portion Operating Lease, Liability, Noncurrent Capital Loss Carryforward [Abstract] Capital Loss Carryforward [Abstract] Capital Loss Carryforward [Abstract] 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Four Finite lived intangible assets Increase to intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Unrealized pension costs Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Net prior service cost Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax Japan Japan Segment [Member] Represents the Japan reportable segment of the entity. Tax credit carryforwards and the related carryforward periods Tax Credit Carryforward [Line Items] Current assets Assets, Current [Abstract] Interest income Investment Income, Interest Cash flows from investing activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] International equities Defined Benefit Plan, Equity Securities, Non-US [Member] Comprehensive income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Expected dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Patents Patents [Member] Issuances of notes receivable Increase (Decrease) in Notes Receivables Transcatheter Aortic Valve Replacement Transcatheter Aortic Valve Replacement [Member] Transcatheter Aortic Valve Replacement [Member] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Rate of compensation increase Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase Held-to-maturity Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract] Deductions SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction City Area Code City Area Code Income Tax Authority [Axis] Income Tax Authority [Axis] Document Period End Date Document Period End Date Net investment hedges Net Investment Hedging [Member] Authorized amount for share repurchase Amount Paid Stock Repurchase Program, Authorized Amount Amortization of prior service credit Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Schedule of Held-to-maturity Securities [Line Items] Schedule of Held-to-maturity Securities [Line Items] Lease term Lessee, Operating Lease, Term of Contract Quarterly Financial Information Disclosure [Abstract] Quarterly Financial Information Disclosure [Abstract] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Stock-based compensation (Notes 2 and 14) Share-based Payment Arrangement, Noncash Expense Tax benefit from harvesting foreign tax credits Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Foreign Tax Credits, Provisional Income Tax Expense (Benefit) Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Foreign Tax Credits, Provisional Income Tax Expense (Benefit) Hemodynamic Monitors Hemodynamic Monitors [Member] Hemodynamic Monitors [Member] Other Proceeds from (Payments for) Other Financing Activities Cover [Abstract] Cover [Abstract] Measurement Input Type [Axis] Measurement Input Type [Axis] Prior service credit arising during period Other Comprehensive Income (Loss), before Reclassifications, Net of Tax United States: Current Federal, State and Local, Tax Expense (Benefit) [Abstract] Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Casmed Casmed [Member] Casmed [Member] Taxes payable (Note 17) Taxes Payable Schedule of Income Before Provisions for Income Taxes Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Total carrying amount Long-term Debt LEASES Lessee, Operating Leases [Text Block] Participant contributions Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant Retirement Plan Name [Axis] Retirement Plan Name [Axis] Service cost Service cost, net Defined Benefit Plan, Service Cost OTHER INCOME, NET Other Income and Other Expense Disclosure [Text Block] Customer Relationships Customer Relationships [Member] Cost of sales Cost of sales Cost of Goods and Services Sold California CALIFORNIA Reclassification of net realized investment loss to earnings Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax Corporate items Costs and Expenses Award Date [Domain] Award Date [Domain] Equity Components [Axis] Equity Components [Axis] Unrealized (loss) gain on hedges Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Due after 1 year through 5 years Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost Total deferred tax assets Deferred Tax Assets, Gross Minimum Low Minimum [Member] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Gain (loss) on fair value hedging relationships: Effect of Fair Value Hedges on Results of Operations [Abstract] Award Date [Axis] Award Date [Axis] Europe Europe [Member] Supplemental Cash Flow Information Schedule of Cash Flow, Supplemental Disclosures [Table Text Block] Carryforward period indefinite Carryforward Period Indefinite Tax Carryforwards, No Expiration [Member] Represents tax carryforwards with no expiration. Defined Benefit Plan, Plan Assets, Category [Domain] Defined Benefit Plan, Plan Assets, Category [Domain] Equity securities Defined Benefit Plan, Equity Securities [Member] Amortization of actuarial loss Defined Benefit Plan, Amortization of Gain (Loss) Asset-backed securities Asset-backed Securities [Member] Entity Interactive Data Current Entity Interactive Data Current Net periodic pension benefit cost (credit) Defined Benefit Plan, Net Periodic Benefit Cost (Credit) United States UNITED STATES Net Sales Reconciliation Net Sales by Geographic Area and by Major Product Area Revenues [Abstract] Options exercised (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Schedule of Target Weighted-Average Asset Allocations and Fair Value Schedule of Allocation of Plan Assets [Table Text Block] Schedule of Restricted Cash Restrictions on Cash and Cash Equivalents [Table Text Block] COMMON STOCK Stockholders' Equity Note Disclosure [Text Block] Schedule of Stock Option Activity Share-based Payment Arrangement, Option, Activity [Table Text Block] Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value [Table Text Block] Facility fee (as a percent) Line of Credit Facility, Commitment Fee Percentage Fair Value Total Debt Securities, Held-to-maturity, Fair Value Movement in Valuation Allowances and Reserves SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] International, including Puerto Rico Current Foreign Tax Expense (Benefit) Derivative [Table] Derivative [Table] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Real estate Defined Benefit Plan, Real Estate [Member] Total deferred tax liabilities Deferred Tax Liabilities, Gross 2021 Defined Benefit Plan, Expected Future Benefit Payment, Year One Initial Delivery of Shares Settled May 2019 Initial Delivery of Shares Settled May 2019 [Member] Initial Delivery of Shares Settled May 2019 [Member] Cost Intangible Assets, Gross (Excluding Goodwill) Change in fair value of contingent consideration liabilities Change in fair value of contingent consideration liabilities, net (Note 11) Change in fair value of contingent consideration liabilities, net Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Retirement Plan Type [Domain] Retirement Plan Type [Domain] Estimated decrease in unrecognized tax benefits Decrease in Unrecognized Tax Benefits is Reasonably Possible Charged to Costs and Expenses SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense Cash flow hedge loss to be reclassified Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Table] Effective Interest Rate Debt Instrument, Interest Rate, Effective Percentage Consolidation Items [Axis] Consolidation Items [Axis] Research and development expenses Research and Development Expense [Member] Derivatives not designated as hedging instruments Not Designated as Hedging Instrument [Member] Accounts receivable, net of allowances of $9.6 and $8.7, respectively Accounts Receivable, after Allowance for Credit Loss, Current Total Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax Total lease payments Lessee, Operating Lease, Liability, to be Paid Other Deferred Tax Assets, Other Stock issued to effect stock split (in shares) Stock Issued During Period, Shares, Stock Splits Foreign Plan Foreign Plan [Member] Accrued interest related to unrecognized tax benefits, net of tax benefit Unrecognized Tax Benefits, Interest on Income Taxes Accrued Non-cash operating lease cost Operating Lease, Right Of Use Asset Amortization Operating Lease, Right Of Use Asset Amortization Deferred tax liabilities Components of Deferred Tax Liabilities [Abstract] Limit on total value of the award Share Based Goods and Nonemployee Services Transaction Nonemployee Award Value Maximum This element represents the maximum total grant date fair value of stock-based awards that can be granted to nonemployee directors. Cash balance interest crediting rate Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate Foreign Currency Translation Foreign Currency Transactions and Translations Policy [Policy Text Block] Held-to-Maturity Debt Securities, Held-to-maturity, Maturity [Abstract] Derivative Liabilities Offsetting Derivative Liabilities [Abstract] Document Transition Report Document Transition Report Schedule of Weighted-Average Assumptions for ESPP Subscriptions Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block] Gross unrealized losses, 12 months or greater Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss Deferred Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] Gross Amounts Derivative Asset, Fair Value, Gross Asset Level 2 Fair Value, Inputs, Level 2 [Member] Liabilities Liabilities, Fair Value Disclosure [Abstract] Stock issued to effect stock split Adjustments to Additional Paid in Capital, Stock Split Current Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Contract length Revenue, Performance Obligation, Description of Timing Two Previous Acquisitions Two Previous Acquisitions [Member] Two Previous Acquisitions [Member] Developed Technology and In-process Research and Development Developed Technology And In-Process Research And Development [Member] Developed Technology And In-Process Research And Development [Member] Subsequent Event [Line Items] Subsequent Event [Line Items] Cumulative Effect, Period of Adoption [Axis] Cumulative Effect, Period of Adoption [Axis] Vested and expected to vest as of period end (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Credit Facility [Domain] Credit Facility [Domain] Deferred tax assets Components of Deferred Tax Assets [Abstract] Litigation Case [Domain] Litigation Case [Domain] Basic (in dollars per share) Basic earnings per share (in dollars per share) Earnings Per Share, Basic Net amounts favorably affecting tax rate Unrecognized Tax Benefits that Would Impact Effective Tax Rate Expected life (years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Schedule of Indefinite-Lived Intangible Assets [Table] Schedule of Indefinite-Lived Intangible Assets [Table] Entity File Number Entity File Number Gain due to curtailment Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment Rate of compensation increase Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase Net Amount Derivative Asset, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election Derivative Assets Offsetting Derivative Assets [Abstract] Weighted-average remaining lease term (in years) Operating Lease, Weighted Average Remaining Lease Term Nonqualified deferred compensation plans Nonqualified Deferred Compensation Plan Select Employee Group [Member] Represents a nonqualified deferred compensation plan for a select group of employees. Cash flows from operating activities Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Total stock-based compensation expense Share-based Payment Arrangement, Expense Unrealized (Loss) Gain on Available-for-sale Investments (Loss) gain on available-for-sale investments AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Proceeds from sales and maturities of held-to-maturity investments (Note 7) Proceeds from Sale and Maturity of Held-to-maturity Securities Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Document Annual Report Document Annual Report Commercial paper Commercial Paper [Member] Exercisable as of period end Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Other Other Income Expense Items Reflects all other income and expense recognized by the entity in the period not otherwise specified in the income statement. Income tax benefit Share-based Payment Arrangement, Expense, Tax Benefit Investments held for deferred compensation plans Deferred Compensation Plan Assets Retirement Benefits [Abstract] Retirement Benefits [Abstract] Subsequent Event [Table] Subsequent Event [Table] Common stock issued under equity plans, including tax benefits (in shares) Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture Carryforward Period Ends 2020-2027 Tax Carryforwards Expiration Period Years 2020-2027 [Member] Tax Carryforwards Expiration Period Years 2020-2027 [Member] Reconciliation of Beginning and Ending Amount of Uncertain Tax Positions Summary of Income Tax Contingencies [Table Text Block] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Inventories Inventory, Net [Abstract] Granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Estimated net tax liability on permanently reinvested earnings Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Undistributed Earnings of Foreign Subsidiaries Net operating loss carryforwards Deferred Tax Assets Operating Loss Carryforwards Net of Reduction Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards, net of the reduction for the benefit related to windfall to be recorded to additional paid in capital when realized as a reduction to income taxes payable. Schedule of Product Information [Table] Schedule of Product Information [Table] Foreign currency forward exchange contracts Foreign Exchange Forward [Member] Due in 1 year or less Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value Other Deferred Tax Liabilities, Other Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Debt securities Defined Benefit Plan, Debt Security [Member] Gross Amounts Offset in the Consolidated Balance Sheet Derivative Asset, Fair Value, Gross Liability Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Plan amendment Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment Total liabilities and stockholders' equity Liabilities and Equity Loss Contingencies [Line Items] Loss Contingencies [Line Items] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax INCOME TAXES Income Tax Disclosure [Text Block] Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Accrued rebates Accrued Rebates Aggregate carrying amount, as of the balance sheet date, of current obligations associated with sales rebates. Lapse of statutes of limitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations Bank time deposits Bank Time Deposits [Member] Operating lease cost Operating Lease, Cost Total purchase price Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Hedging Relationship [Axis] Hedging Relationship [Axis] Foreign earnings to be indefinitely reinvested Undistributed Earnings of Foreign Subsidiaries Anti-dilutive securities excluded from the computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Current income tax expense Current Income Tax Expense (Benefit) Other Other Noncash Income (Expense) Increase in prior year tax positions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Current year tax positions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Weighted-Average Useful Life (in years) Finite-Lived Intangible Asset, Useful Life Equity Component [Domain] Equity Component [Domain] Schedule of Benefit Payments Which Reflect Expected Future Service Schedule of Expected Benefit Payments [Table Text Block] Pension increase Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Pension Increase This element represents the percentage of increase in pension. Gross profit Gross profit Gross Profit Property, plant, and equipment, net (Note 5) Total property, plant and equipment, net Property, Plant and Equipment, Net Gain (loss) on cash flow hedging relationships: Effect of Cash Flow Hedges on Results of Operations [Abstract] Entity Tax Identification Number Entity Tax Identification Number Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Currency exchange rate changes and other Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss) Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] The Program Long Term Stock Incentive Compensation Program [Member] This element represents details pertaining to the Long-Term Stock Incentive Compensation Program of the entity. LIBOR London Interbank Offered Rate (LIBOR) [Member] Debt Securities, Trading, and Equity Securities, FV-NI [Table] Debt Securities, Trading, and Equity Securities, FV-NI [Table] Period when cash flows associated with future transactions and certain local currency expenses are expected to occur Maximum Length of Time, Foreign Currency Cash Flow Hedge Current Fiscal Year End Date Current Fiscal Year End Date Retirement Plan Sponsor Location [Domain] Retirement Plan Sponsor Location [Domain] Gross Unrealized Gains Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain Gross Amounts Not Offset in the Consolidated Balance Sheet Derivative Fair Value of Derivative Asset Gross Amounts Not Offset [Abstract] Tax on global intangible low-taxed income Effective Income Tax Rate Reconciliation, Tax On Global Intangible Low-Taxed Income, Amount Effective Income Tax Rate Reconciliation, Tax On Global Intangible Low-Taxed Income, Amount Benefits from uncertain tax positions Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves Amortized Cost Debt Securities, Held-to-maturity Amounts reclassified from accumulated other comprehensive loss Reclassification from AOCI, Current Period, before Tax, Attributable to Parent Research and development accruals Research And Development Accruals Aggregate carrying amount, as of the balance sheet date, of current obligations associated with research and development and clinical trials. Software Capitalized Computer Software, Gross Accumulated Other Comprehensive Loss Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Developed technology Developed Technology Rights [Member] Net tax credit carryforwards Deferred Tax Assets, Tax Credit Carryforwards Shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Offsetting Liabilities [Table] Offsetting Liabilities [Table] Social securities increase Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Social Securities Increase This element represents the percentage of increase in social security. Special charges (Note 4) Special charges Other Nonrecurring (Income) Expense Options granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Cash paid during the year for: Supplemental Cash Flow Information [Abstract] Total grant date fair value of stock options vested Share-based Compensation Arrangement by Share-based Payment Award, Options Vested in Period, Grant Date Fair Value Represents the total grant-date fair value of options that vested during the period. Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Social securities increase Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Social Securities Increase This element represents the percentage of increase in social security. Royalty Expense Royalty Expense United States equities Defined Benefit Plan, Equity Securities, US [Member] Acquisition price, subject uncertain adjustments Business Combination, Consideration To Be Transferred Business Combination, Consideration To Be Transferred Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Allowance for doubtful accounts SEC Schedule, 12-09, Allowance, Credit Loss [Member] Benefits paid Defined Benefit Plan, Benefit Obligation, Benefits Paid Right-of-use assets Deferred Tax Liability, Operating Lease Right Of Use Amortization Deferred Tax Liability, Operating Lease Right Of Use Amortization Cash flow and net investment hedges Deferred Tax Liabilities, Derivatives Reclassification out of Accumulated Other Comprehensive Income [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Other comprehensive income (loss) Other Comprehensive Income (Loss), Tax Cost Finite-Lived Intangible Assets, Gross Finite-lived intangible assets Finite-Lived Intangible Assets, Net [Abstract] Gross unrealized losses, less than 12 months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Vested and expected to vest as of period end Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Critical Care Critical Care [Member] This element represents the critical care product line. Assets And Liabilities Of Lessee Assets And Liabilities Of Lessee [Table Text Block] Assets And Liabilities Of Lessee [Table Text Block] Accumulated other comprehensive loss, net of tax: Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax [Abstract] Hedging Relationship [Domain] Hedging Relationship [Domain] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Lessee, Operating Lease, Liability, Maturity Lessee, Operating Lease, Liability, Maturity [Table Text Block] Other Effective Income Tax Rate Reconciliation, Other Adjustments, Amount Treasury Stock Equity, Class of Treasury Stock [Line Items] Fair value of shares issued in payment for contingent consideration liabilities Stock Issued Basic (in shares) Weighted-average shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Basis spread on variable rate (as a percent) Debt Instrument, Basis Spread on Variable Rate Average risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Total investments in unconsolidated affiliates Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures Options forfeited (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Accrued realignment reserves Restructuring Reserve, Current Cash flow hedges Cash Flow Hedging [Member] Loss Contingencies [Table] Loss Contingencies [Table] Plan Name [Domain] Plan Name [Domain] Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Equity method investment, ownership percentage Equity Method Investment, Ownership Percentage Financial Instruments Derivative Liability, Not Offset, Policy Election Deduction Offsetting Liabilities [Line Items] Offsetting Liabilities [Line Items] Interest expense Interest Income [Member] Right-of-use assets obtained in exchange for new lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Actuarial loss Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Foreign exchange gains, net Foreign currency Foreign Currency Transaction Gain (Loss), before Tax Inventories Inventory, Policy [Policy Text Block] Provision for income taxes (Note 17) Provision for income taxes Total income tax provision Income Tax Expense (Benefit) Tax reductions compared to local statutory rates Income Tax Holiday, Aggregate Dollar Amount Cash, cash equivalents, and restricted cash at beginning of year Cash, cash equivalents, and restricted cash at end of year Total cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Property, Plant and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Debt Securities, Available-for-sale [Table] Debt Securities, Available-for-sale [Table] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] Local Phone Number Local Phone Number Accrued and other liabilities (Note 5) Total accrued and other liabilities Accrued Liabilities and Other Liabilities Current Represents the combined amount of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered and the aggregate carrying amount of current liabilities not separately disclosed in the balance sheet. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Amortization of prior service credit Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax Acquisition (Notes 8 and 9) Cash paid to acquire business Cash purchase price subject to certain adjustments Payments to Acquire Businesses, Gross Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Cumulative Effect, Period of Adoption [Domain] Cumulative Effect, Period of Adoption [Domain] April 2018 April 2018 Stock Repurchase Program [Member] April 2018 Stock Repurchase Program [Member] Shares related to previous year's grant (in shares) Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Grants In Previous Period Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Grants In Previous Period Derivative [Line Items] Derivative [Line Items] Summary of Changes in Fair Value of Contingent Consideration Obligation Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Schedule of Indefinite-Lived Other Intangible Assets Schedule of Indefinite-Lived Intangible Assets [Table Text Block] Restricted stock or restricted stock units Restricted Stock and Restricted Stock Unit Awards [Member] Restricted stock and restricted stock units awarded by a company to their employees as a form of incentive compensation. Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Impairment of equity securities Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount Amount Long-term Debt, Gross Awards granted in 2012 and later Share Based Compensation Arrangements Awards Granted 2012 and after [Member] This element represents details pertaining to awards granted in 2012 and years after. Decrease in prior year tax positions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Deferred revenue Contract with Customer, Liability VALUATION AND QUALIFYING ACCOUNTS SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] Payment for acquisition option Other Payments to Acquire Businesses Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Potential milestone-driven payments Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High Total stock-based compensation expense, net of tax Share-based Payment Arrangement, Expense, after Tax Aggregate borrowings in multiple currencies Line of Credit Facility, Maximum Borrowing Capacity Weighted-average assumptions used to determine the net periodic benefit cost Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Award Type [Axis] Award Type [Axis] Weighted- Average Grant-Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] May 2019 May 2019 Stock Repurchase Program [Member] May 2019 Stock Repurchase Program Discount rate Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate Amount excluded from effectiveness testing recognized in earnings based on an amortization approach Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax Tax (Expense) Benefit Other Comprehensive Income (Loss), Tax [Abstract] SPECIAL CHARGES (GAIN) Unusual or Infrequent Items, or Both, Disclosure [Text Block] Retained Earnings Retained Earnings [Member] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Measurement Basis [Axis] Measurement Basis [Axis] Payment of contingent consideration Payment for Contingent Consideration Liability, Financing Activities Early-stage Transcatheter Intellectual Property Early-stage Transcatheter Intellectual Property [Member] Early-stage Transcatheter Intellectual Property [Member] Components of Net Periodic Benefit Cost Schedule of Net Benefit Costs [Table Text Block] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] Net cash (used in) provided by investing activities Net Cash Provided by (Used in) Investing Activities Outstanding as of period end Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Award Type [Domain] Award Type [Domain] Corporate debt securities Corporate Debt Securities [Member] Exercisable as of period end (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Other comprehensive (loss) income before reclassifications           Prior service credit arising during period OCI, before Reclassifications, before Tax, Attributable to Parent Treasury stock, at cost, 12.1 and 9.0 shares, respectively Treasury Stock, Value Fixed-rate 4.300% 2018 Notes Fixed Rate 4.300% 2018 Notes [Member] Fixed Rate 4.300% 2018 Notes [Member] Defined benefit pension plans Pension Plan [Member] Discount rate Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate Current liabilities Liabilities, Current [Abstract] Cash flows from financing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Buildings and leasehold improvements Buildings and Leasehold Improvements Gross Gross amount, as of the balance sheet date, of long-lived, depreciable assets, that includes building structures and leasehold improvements. Vested and expected to vest as of period end (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Nonemployee Directors Program Nonemployee Directors Stock Incentive Compensation Program [Member] This element represents details pertaining to the Nonemployee Directors Stock Incentive Compensation Program of the entity. Investments Deferred Tax Assets, Investments in Unconsolidated Affiliates Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from investments. Includes equity method investments; excludes investments in subsidiaries. Recently Adopted Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Measurement Input, Discount Rate Measurement Input, Discount Rate [Member] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Basic: Earnings Per Share, Basic [Abstract] Long-lived Tangible Assets by Geographic Area Geographic Areas, Long-Lived Assets [Abstract] Short-term investments (Note 7) Short-term Investments EX-101.PRE 15 ew-20201231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 16 ew-20201231_g1.jpg begin 644 ew-20201231_g1.jpg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end GRAPHIC 17 ew-20201231_g10.jpg begin 644 ew-20201231_g10.jpg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ew-20201231_g11.jpg begin 644 ew-20201231_g11.jpg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end GRAPHIC 19 ew-20201231_g12.jpg begin 644 ew-20201231_g12.jpg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

')-0DR&FF\QEBFD^](L08LTC,QL M?M#^!OC/^QM_P1^T'_@IOX-^*_BG5?V@O"/AS0?'/C?Q!K?B6[FM_%7VJ2V? M5=)N[4R>0+#R;F9(84C46_D0M%Y;*6(!^I5%&;#7-*\S&[[-=V\=Q%G'&=DBUTU !7E'[<__)H_CW_L O\ ^AK7J]>4 M?MS_ /)H_CW_ + +_P#H:T =U\+O^29^'?\ L!6G_HE*W:POA=_R3/P[_P!@ M*T_]$I6[0!^,_P#P4V_Y/G\?_P#7Y9_^D-O7@]>\?\%-O^3Y_'__ %^6?_I# M;UX/7^@W"'_))Y?_ ->*7_IN)_$?$_\ R4N-_P"OU3_TN04445]$>&%%%% ! M1110!^S'_!,G_DQCP!_UYWG_ *77%>\5X/\ \$R?^3&/ '_7G>?^EUQ7O%?Y M\\7_ /)69A_U_J_^G)']M\+_ /)-8+_KS3_](B%%%%?.GNGQ;_P7!_Y-R\*_ M]CM'_P"D=S7Y@U^GW_!<'_DW+PK_ -CM'_Z1W-?F#7]G^"G_ "0=+_'4_P#2 MC^4?%G_DLZG^"'Y!1117ZR?FH4444 %%%% 'VE_P0^_Y.-\5?]B3)_Z66U?I M]7Y@_P#!#[_DXWQ5_P!B3)_Z66U?I]7\8>-?_)>5?\%/_P!)/ZM\)?\ DC:? M^.?YA1117Y,?I84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7@? M[9/Q-_9:\,?%7X(?#3]H[X0ZIXKU+Q=\0I;?X?/;>$WU.STS51I]Q UQ=L 4 M@3[/=3H&<-C<7P!$SI[Y7S#_ ,%4?^"F'P[_ ."5GPE\#?M"?&'PQK6I^$=: M^(\/ASQ$/#MC'"5WQRH3M&'B M<=JY#X._\%:_^";W[1G[3?PK^"7PM_8E\=:+XLUWQH!X=USQ3\)?[!@TZ:*R MNYGG6YR"7\E)4$8SN\P@C;DC'M?^#GG_ ()TP>);KQO9_LJ?M#KJFH:?;V5W MJ,?PD'F3VT#S20Q,WVKYE1KF=E'8S/C[QK?^%?\ P<)_LD_MA_M-_"O]ECX6 M_L_?%6QU[Q=XS"VM_P#$'P,FGV5G';V=S). .0#]'Z* M** /G7]L[6?^"K>F>,=(C_X)^>"/@/JF@-IC'79?BSK&KVUVEYYAP(!8QLAB M\O:26(;=GM7AO[16@_\ !9GQG??!CQ%K/[*7P;\?3^%(KO7/&GA;2/B7)8[QUTN=&NK:2:YBMK8+.J.J@7.='L_B>;B#1?#9UB'S-3MYOLJ_:KA06Q:[4S M@?.,U[A_P0V\':C\"_VW/V\_V=/%\;P:S%^T&WC*TCFX:?2=;2>YLYE_O@HN M"PX#9!P>*^XM(_92^ 6@_M/ZO^V7I7@+ROB3KOA.'PSJOB3^U+IO/TN*831V M_P!G,IMUQ( V]8PYZ%B.*ROC-^Q;\$?C9\1[;XR:LGB+P]XQM]%?19/%?@CQ M5>Z+J%WI;R"1K&>:SD0S0AQO0/EHF+-$T;,Q(!^+'QM_9;^(O[4/[*G_ 5K M^.?PWTFYN[#Q)\7=,M_#[01[EU!?".H/=:B\0',J^5(X!7(+)@9((K[A_P"" MJ/QH\+^+O^#:C7/B1X:F%[!XX^#?AFU\/V]KF22[GU)]/AABC5>7?=,/E S\ MIXX-?>WP@^"7PG^ 7PNTSX*_!WP'I^@>%M'MF@T_1K*(^4BLS,Y8L2TCN[.[ MNY9Y'=F8LS$GRKP5_P $S/V0_ .O:%?:%X*U:31?">O/KG@WP-?^*;ZX\.^' MM29WD^U66F22FVA='DD:(!"EN7)@6+)H ZS]AOX1:]^S_P#L4?![X#>*EQJG M@GX6^'] U(;@<7%GIMO;RE>I444 <9\9O@9X0^.>F66D^+]4UJUCL M9VFA;1=6DM&9BNTABGWACL:^?/VK?V*?A/\ #[]G7Q=XTT3Q)XPFN].TEIH( M[[Q3/-"S!E&'1CAAST-?6U>4?MS_ /)H_CW_ + +_P#H:T =!\*_ NCI\,/# MB"ZO<#0;,#-VW_/!*W_^$'TC_GYO?_ MJB^%W_),_#O_ & K3_T2E;M 'XP_ M\%*+*+3_ -MSQY9P,Y1+NTP9&W'_ (\K<\DUX;7O'_!3;_D^?Q__ -?EG_Z0 MV]>#U_H-PA_R2>7_ /7BE_Z;B?Q'Q/\ \E+C?^OU3_TN04445]$>&%%%% !1 M110!^PO_ 37\*:;J'[$?@.\GGN@[VEWD1W+*/\ C]N!P!7N?_"#Z1_S\WO_ M (%M7C__ 3)_P"3&/ '_7G>?^EUQ7O%?Y\\7_\ )69A_P!?ZO\ ZZ?#W M_!:SP]8Z/^SQX7GM9KAF;QI&I$LY88^R7)[U^:%?I]_P7!_Y-R\*_P#8[1_^ MD=S7Y@U_9_@I_P D'2_QU/\ TH_E'Q9_Y+.I_@A^04445^LGYJ%%%% !1110 M!]D?\$4])MM8_:'\4074DJJO@N1@8I"IS]KMAVK],/\ A!](_P"?F]_\"VK\ MV?\ @A]_R<;XJ_[$F3_TLMJ_3ZOXP\:_^2\J_P""G_Z2?U;X2_\ )&T_\<_S M,NS\):;8W27<-Q=%HVRH>Y8C\16I117Y,?I84444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !69XQ\%^#OB)X8O?!'Q \)Z9KNBZG 8-1TC6;".ZM; MJ(]4DBD#)(I]&!%:=?*?_!7S]LC]K3]C/]G3P[KW[#W[,Z_%7XE^-O'4/ACP M_P"'I(YY([4OIU_?27KQ0;6F2-+!@5\R( /N+@+M8 ;XP_8QNOV/O#=]\3/V M+?VK1\'_ ]I$#7.H>!OB%<'5? 4<*\D""YFCGT9.P-E6LDK,-WQMX2_8@^/'[8WB6Q^+O_ 7#\-?M7_&:^MYUN;/X M2>#/ \>C>#M+D'\ CAO(Y+D@<>:JP.1PYDZU]_?!;]I_X:? +5/AI^RY^SC_ M ,$V/B-\*O#?B;QVN#B:3R BNZL7=QN))H M^S**** "BBB@ HHHH **** "BBB@ KRC]N?_ )-'\>_]@%__ $-:]7KRC]N? M_DT?Q[_V 7_]#6@#NOA=_P DS\._]@*T_P#1*5NUA?"[_DF?AW_L!6G_ *)2 MMV@#\9_^"FW_ "?/X_\ ^ORS_P#2&WKP>O>/^"FW_)\_C_\ Z_+/_P!(;>O! MZ_T&X0_Y)/+_ /KQ2_\ 3<3^(^)_^2EQO_7ZI_Z7(****^B/#"BBB@ HHHH M_9C_ ()D_P#)C'@#_KSO/_2ZXKWBO!_^"9/_ "8QX _Z\[S_ -+KBO>*_P ^ M>+_^2LS#_K_5_P#3DC^V^%_^2:P7_7FG_P"D1"BBBOG3W3XM_P""X/\ R;EX M5_[':/\ ]([FOS!K]I_VX/V0?^&R_AQI7P__ .%A_P#"-_V9K:ZA]K_LG[9Y MF(98]FSS8L?ZS.N>V/MM7/ M^'$'_5U'_EC_ /W=1_Q%_P ._P#H-_\ *=;_ .5A_P 0PXY_Z!/_ "I2_P#D MS\]Z*_0C_AQ!_P!74?\ EC__ '=1_P .(/\ JZC_ ,L?_P"[J/\ B+_AW_T& M_P#E.M_\K#_B&''/_0)_Y4I?_)G$_P#!#[_DXWQ5_P!B3)_Z66U?I]7S!^P_ M_P $W_\ AC3XCZK\0/\ A\/:-I7Q2^#O@>V\87OA2\EO+KP1-]GBN-6@>%XG-C< MS "VOT1W\K>Z0RK)+!(T8E6>'TFB@#XKTK_@X0_X)46VM77@CXN_M"7OPO\ M%NFMY>M>"_BCX/U/1=2TV7&?+E6:#RR<=XY'4Y&":J^)/^"_G_!)3Q!KNG^! M?AG\;9_BWXNN+I9/#O@OX;>"-1US4;VZ497R!';^4CC)^=Y$"Y.6'-?4_P 8 MOV9_V.H($*00^,?"EGJ:1J>H47,;@#D\#UI?@[^S3^S ME^SO9RZ=^S]\ /!/@6WG4+/!X.\*V>F)(!T#+;1H"![T 5/V>-9^.WC'PS<_ M$/X\>%X_"MWKR\^\DB0//\)_L5>,=(\&^(?V4_CQ\0)-8TQKV._P#A-\+[ MC7K2U42%/*GEB=1%+QN"'G:0>]?!W_!8'XIW_P#P4"^)/_!/KX;VF@?$#X>> M"?BE\;K_ %76M(\8^&DT[5[.YTEX$M5N;*[66-7;S+IHTE21'1U8JP.* /O[ M]E?7/VU_CMI&F_'?]H3^SOAAH^K*M[HGPFTG34NM4M;-QNB35[^XW*;AE(9X M+:&'R22GG2D%J\\TS]KOXX?MB_MP?%7]DK]DWQ_HW@SPU\"['3K?QSXYO_#H MU:YU/Q%?))+'IMK"\L<26]O%$3<2-ND:1UC3RMID;Q/]KGQ5^TK_ ,$R/^"C M/[-.O_#K]I?Q]XX^&'QY\?+X!\>^!?B#KYU5+*^N"GV34;"210]J07D:1$(C MQ"%"XQU+2/VF?V^-)\6*PU]?VLM9GO/,SO:UEEG>U<9_Y9LA9DX' MRGMTH ]I_9Z_X*V^"]5_8^^-/QQ_:CTJT\/>*OV:]?UKP]\8-(T0LT$U]IV= MEQIZRL7,%ZNPP*[$AY#&7?9O;@?&G[?7[;W[//[!_A/_ (*Q?'C_ (1F\\$: MM'H^M^.OA#HOAUUNO#GAK5)H8X);2_,QDN;^V2YMY9Q)&(I<3JBP85Z_-O\ M;+T'Q[XD^!__ 6'\0>"XYY='?XK>!(?]'SAGLM89M1 QW5&B9^?NJ<^A_2G M_@K1J_A>V_X-R?'FHV4L(TN;X&Z0FGLN-A65+)(-N?4LF/J* /OC0->T;Q3H M5EXG\.:E#>Z?J5I'=6%Y;ONCGAD4.DBGNK*00?0U;KQ3_@FKHWB3P[_P3G^ M/A_QE'(FL6/P4\*V^JK,3O%RFD6JRAL]]X;->UT %>4?MS_\FC^/?^P"_P#Z M&M=)\9O@9X0^.>F66D^+]4UJUCL9VFA;1=6DM&9BNTABGWACL:^?/VK?V*?A M/\/OV=?%WC31/$GC":[T[26F@COO%,\T+,&48=&.&'/0T ?3/PN_Y)GX=_[ M5I_Z)2MVN(^%?@71T^&'AQ!=7N!H-F!F[;_G@E;_ /P@^D?\_-[_ .!;4 ?C M_P#\%-O^3Y_'_P#U^6?_ *0V]>#U^T'Q#_X)S?LA?%;QE??$#Q_\,I]0UC47 M1KV\;Q!?1F0JBHIVQS*HPJJ. .E8O_#J/]A+_HC,W_A3:C_\D5_4F1>-W"F5 MY'A<'5HUW*E3A!M1IVO&*B[7J)VNM+I>A_.N<>$?$F89OB,53JT5&I4G)7E. M]I2;5[4VKV>NK/QYHK]AO^'4?["7_1&9O_"FU'_Y(H_X=1_L)?\ 1&9O_"FU M'_Y(KU?^(^<'_P#/BO\ ^ T__EIYW_$%^*?^?U'_ ,"G_P#*S\>:*_77PS_P M2U_8;U73WN+OX-2EEN9$&WQ+J(X!P/\ EXK1_P"'4?["7_1&9O\ PIM1_P#D MBC_B/G!__/BO_P" T_\ Y:'_ !!?BG_G]1_\"G_\K/QYHK]AO^'4?["7_1&9 MO_"FU'_Y(H_X=1_L)?\ 1&9O_"FU'_Y(H_XCYP?_ ,^*_P#X#3_^6A_Q!?BG M_G]1_P# I_\ RLTO^"9/_)C'@#_KSO/_ $NN*]XKC?AY\!?AO\*?!ME\/_ & MGW>GZ/IR.ME9KJ,T@C#.SL-TC,QRS,>2>M;7_"#Z1_S\WO\ X%M7\MY[CJ.9 MYWBL9234:M2MF_4_HG)L'5R[*,/A:C3E3IPB[;7C%)VO9V MNM-$;%%8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@6U>4>D;%%8__ @^D?\ M/S>_^!;4?\(/I'_/S>_^!;4 ;%%8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@ M6U !9?\ ([WO_7E%_,UL5REKX5TZ3Q3=6#3W.R.VC92+AMV23U-:?_"#Z1_S M\WO_ (%M0!L45C_\(/I'_/S>_P#@6U'_ @^D?\ /S>_^!;4 ;%%8_\ P@^D M?\_-[_X%M1_P@^D?\_-[_P"!;4 ;%%9=GX2TVQNDNX;BZ+1ME0]RQ'XBM2@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OF;_@HO\ M;:M\ W^ M''PC^'OQT\%> /$_Q#\9"TF\2^-H4N+?2-&MK2YN[R[%NTL7G.WV>*UC!< 2 M7:,>%-?3->4_M>_LTZS^TM\/=.T[P%\8]5^'7C;POK:ZWX$\>Z-807DNBZBL M$UL7>VN 8KJ&2WN;B&6"3ATF;!5@KJ ?'_\ P4J_X+A?#']CC]G'1? '[,7Q MI\)?%[X\>-[Q-%\&6EO>VPMH)Y#A]5OUB<1V]K"#G#,H9@ 6"+*ZW$;F"ZL;BT=1 M>V@N!';RK-%&RK*LJ[=K(?9OV&/^"0/B+X$?M6:W^W]^VQ^UCJ?Q_P#C=J&E M_P!DZ'XJU/PS#I%CX:TW#!H+"QADDC@9PS!G0J,22 *#+*TGM?QL_9R^.GQN M_:*^'WBW5OC9H>G?"_P)XF7Q#/X)L?"LQU+6[^*SFBM1<:@UWY:P0W$HN1&E MN"S0Q@OQF@#VVWN(+NWCN[699(I4#QR('[GQA=>$O&/@;Q;9>+/AIX[TZT6>X\/:Y9OO@N/*8JMQ">4E@9@LB- MC*L%=?=:* /G%_V,_B3\^"O"W@[0KBTL!K5 MQ#Y#ZM M&M=^*.A6.G_$OP]XP\.W&H:9JEU8JT=CJT0MKFWDBN8HI)(G3<4G0KDQ.OF- M],44 ?//[.O_ 3:^!7P2_96\:?LO^+Q+XVA^*NHZUJOQ=UW6(%BF\5ZIJV[ M[? M"[W31_9D?AB6#7_$VDZ;.DVFZ1J-T;EH!#$8;=99885>X6W7 @)_]>47\S6Q6/9?\CO>_]>47\S6Q0 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !117E_[57[5W@#]D[PEH6M>+-'U36]9\7^*K/PSX(\)Z"D37 MVO:O=;C%:PF:2.*,!(Y)7EE=(XXXG9FX (!ZA17A/AS]M=]'_:.\*_LJ_M$? M!^^\!>*_'^EZA?> 9QK%OJ6G:[]A1);RT2>+:\5U#"XF,]45Y/\ L[_MI_ 7]I/]GN[_ &E/"/B5])T'19-0 MM_%]OXD5+2Z\,7E@66_L]00L5MYK=D;S/F*;0'5F1E<^0Z'_ ,%;/A]/\/\ MPE^TIXV^!GBSPO\ _QYK=MIGA7XL:W-:) ?M4ODV-]>68D-Q8V%U)L6&XD& M1YT+2I"K[@ ?6U%%% !7E'[<_P#R:/X]_P"P"_\ Z&M>KUY1^W/_ ,FC^/?^ MP"__ *&M '=?"[_DF?AW_L!6G_HE*W:POA=_R3/P[_V K3_T2E;M !1110 4 M444 8_@?_D$2_P#7[-_Z%6Q6/X'_ .01+_U^S?\ H5;% !1110 4444 %%%% M !1110 4444 8]E_R.][_P!>47\S6Q6/9?\ ([WO_7E%_,UL4 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110!Q'Q3_:9_9O^!NJ6VB?&S]H+P1X.O;V SV=IXI\5V>GRSQ!BID1)Y$++ MN!&0",C%?)?_ 6B\ ?##]J_]A'P_P#M ?!K]J_2?#'B?X>^.]/\5?!/Q[H- MPNJVNH>)899+6UTZ..V$IO3>-BB[B6VCC))KP']O/]@7 M6K7P5^S_ *[^Q#\'=%BTK]GGXOVOB^'X/: MKI5IJ]D5N$N8[-7,=M%>(;F2 M>+S&CC9VD!=2^: /GG_@G%^UEXC_ &Y_^"D^D^'?^"H/A*3X6_M)_ +PO?0> M!/@^++R=/O/M]K'%JGB*VNC+(+Z26)3$D"-Y<%NSNC7&]Y(NF_X($ZQJGQ!_ M:S_;[^+7BN1WUJ]_:BO]#F,V?,CLM,:X@LX23SB.)M@'&-O '2O7OB[^S?K_ M .VY^WO^SU^U1I_P!U[P'#\$K[5M1UGQAXK@MK34=2BN;*2VBT6WBAFDEDC\ MV7SI9) L2JI6)I&F?91^&?[//Q:_X)U?MY?'3XX_#3X'>(_B%\,?V@9['Q(^ MG^"WLCJ'AWQ3 DD5U%)#=W, >WO1*)EG5R(Y$99!&A60@'YA?M9_%WQW\*_@ M%_P6%\ ^ [J>UT>+XL>$)HA S".*77=3:VU5N.,RQ1I&WKO&<]#^B7_!5[P! MX5T?_@VU\:> $LXFTS1?@3H<=A$5 5?LBV+6Y Z#:T49'N!4_P $/^".=YX_ M_8F_:5^'?[5\UKIWC[]K+Q7J_B;QZ3M/=S7L5H@CMV@0QM<.)C"$!8 ^P/^"=7C?Q3\3?^"?7 MP*^)'CBZEGUKQ#\&_#&I:Q-.27DNI])MI96;/.2[L3GG->R5E^!O!GASX<>" MM'^'G@[3EL](T'2[?3M*M$)(@MH(UBB09[*BJ/PK4H XSXS:)\WA5 (VG/.:\E^(/P%_;?^)_@O4?A_P",?CGX'N-+ MU6W,%[#'X:FC+H2#@,K@CIV-?1M% 'S_ &'PL_;\T6QAT?1/CWX'BL[2)8;2 M*3PT[,D2C:@)/4@ #/>IO^%??\%#_P#HX+P)_P"$N]>]44 >"_\ "OO^"A__ M $<%X$_\)=Z/^%??\%#_ /HX+P)_X2[U[U10!X+_ ,*^_P""A_\ T<%X$_\ M"7>C_A7W_!0__HX+P)_X2[U[U10!\D_L\7_[>?Q:\$7?B7P_\;O"%G!;Z]>V M3Q7OAO?\*^_P""A_\ T<%X$_\ "7>MO]BGP+XN^'WP MGU+1/&F@SZ==S>,-4NHX+@ ,T,DY9'X/0CD5Z_0!X+_PK[_@H?\ ]'!>!/\ MPEWH_P"%??\ !0__ *."\"?^$N]>]44 >"_\*^_X*'_]'!>!/_"7>C_A7W_! M0_\ Z."\"?\ A+O7O5% '@O_ K[_@H?_P!'!>!/_"7>C_A7W_!0_P#Z."\" M?^$N]>]44 >"_P#"OO\ @H?_ -'!>!/_ EWH_X5]_P4/_Z."\"?^$N]>]44 M >"_\*^_X*'_ /1P7@3_ ,)=Z/\ A7W_ 4/_P"C@O G_A+O7O5% 'R3X?O_ M -O/5?VAO$/PFM_C=X034-)T&TO;B[?PWF&2.5B%50!N##')/%=Y_P *^_X* M'_\ 1P7@3_PEWK;\&^!?%UA^VGXT^(%YH,\>BZAX/TZULM18#RY9HW8N@YZ@ M&O7Z /!?^%??\%#_ /HX+P)_X2[T?\*^_P""A_\ T<%X$_\ "7>O>J* /!?^ M%??\%#_^C@O G_A+O1_PK[_@H?\ ]'!>!/\ PEWKWJB@#QOP)X*_;>T_QAI] M[\0?C7X/U#18[@'4K*Q\/-%--%W5'/W3[U[)110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !117P;^TGXO_X+N_$NW\2?'']B"+X-^%_"FA7%T?!?P]\=:->W M>M^,;:V=E^T7$ZO'%9?:O++V\"X81RQ^;+&S,(P#[RHKX?\ @U_P6R^%?B[_ M ((OM_P5W^)_@2?1+73- NFUOPG#[$:QLP)59EW%-4\$>*M;TBQ^+'A+0_#3V9\!0:IM2"[M M+MIW>Z2TFDBBN%F4F8.9(_(VB)@#[SHKP_\ X*,?'GX\?LQ_L6_$?]HS]G?P MEX3UK6? W@G5/$3P^+M1N8K8065K) M_"^RFM-)\::1]I.G7,@>2PNHY'@NK5F X !MFX B@#UZBBB@ HH MHH ***\%_;*\7_MNZGJ&C_!+]@_2?"&G>(M5M)K_ ,0_$'X@VMQ<:5X5Y#_JT< ]ZHKX!_8"_;P_;RT#_@H/XI_P""5W_! M2_PYX,U'QC:^ AXV\ ?$?X?6LUM8:_H_VE;9TFMY23',LC.,@( 8)%(;Y)). MS^''[7'[1G[>O[1OQJ^'?[(/Q)\.>"/!7P.\0#PE)XGU;PL=8E\2^*DC,EY" MR&>)8+&U)CB=4_?3.S,LL2J-P!]ET5\>?LU?\%+OB/\ M8_L+:A\8/@]\#K. MZ^,^C^,KKX?Z[\/;C4W73]+\66UPL%P9[D(72PB1A>L^TR?9_D4-*0I\*^(W M[;/_ 5\_P"";'[3'PD_X>"7WPD^)7P?^,GC^R\&3:U\-M!O-,O?"6LWI(MA MLGD?S[?B1LMO=DA?F-@HD /TXHKY6_:I_;2^(<7[<'PZ_P"":G[,NH:58>.? M%_AF]\7>,_%>KZ>;V/PMX:MG,*RQ6P=!-=7-S^XBWMY<6UG=)/E1I/V5?VSO M'UU^VO\ $?\ X)M?M*7^FWWCOP7X=LO%GA'Q3I6GFRC\4^&KIA$9WMM[B&YM MKD_9Y=C>7)N21%CRT:@'U+1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 5Y%^V!\)I]C%GR-.MGO-3FEBM8]S,(P^&D>25]TDCN0#YY_P""\_[&'AO]AO\ MX-Q]"_99^%$UU?>&?A_XI\._\)3J4J$2:@LE\[75Y,%S@S7UPLI7/#2 \"O M?O\ @Z/U+1T_X(5?&&))8F^WS>&(]-\O!$C?\)%ID@V8_P"F:.>.U>Z^ ?\ M@GYXH\9_L=^//V5O^"@_[2FH_'F[^)] T^^6)]K&&;1X8WP>QVL<&O3_P!MO]G_ ,;?M6_LK>//V9_!7Q+T MSPD?B!X2U+PYJ>N:GX9DU7[/9WUI+;3-%"EW;?O0DI*LSE00,J:K_L,_LY>- M_P!D']DOP-^S#XL^)>E^,'\ ^%[+0=*UO3_#N:AX"^+Q^( M$.GVUYIG366M:O8WOB&XL+A2KVT.H7LUU;(RGE6^SR0LRD JS,",@UZA\8 MOV&?%'[9OC#0YOVV/'.E:K\/O#6KPZMIWP@\,V$D>F:IJ$+;H)]8N9G,FI1Q M-ATM5C@AW@&59\*%^DE544(B@ # ' % "T444 %%%% !5'Q/XG\.>"O#>H> M,?&&NVFEZ3I5E+>:GJ5_<+%!:6\:%Y)9'8A415!8L3@ $FKU?*W_ 4=_8@_ M;$_;0U'PEI_P$_;UTKX1^&O#=['J=_H5S\((/$O]MZC$Y:"2Y-U?10R00GRY M([=H6 F02LSLD0B #]DWX&ZK\7_VP/&/_!47XG>&KK2KSQ'X0M?!/PFT/4K9 MH;O3O"4%P]VUW.?#WC#PI/J=I::Y#&T/] MM62P7=N1))&5\ZWD)69XT?S(SO#@'S?_ ,&[=MJE]\6_VZ_&=GN/A[4_VR?% M(T>1?]6\BW#O*5'3_5RV_3V]*]\^-GPTL?\ @HG^UO\ #_0A;BX^%'[//CP> M*M;U7&8M?\:VD*X$_N+MY)=0O55+JU6*\GD?B<,PA0; M8T!6-X_*/!/_ 2T_P""M/A'P7I7P@M_^"YL.G^!["WAL9M!\)?LPZ)H\XTY M2!);VUU#>%[21H]RB= 71FWC+"@#D_A/8ZEI?_!V/\4)_%:E?[2_9%LYO"YF MSA[1=6TY)1'GC_7QS=/1O>E\;VVJ:]_P=I>#YO"^YH=$_8VD/B0Q5BY" )&@![Y11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 G%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9 end GRAPHIC 20 ew-20201231_g13.jpg begin 644 ew-20201231_g13.jpg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ew-20201231_g2.jpg begin 644 ew-20201231_g2.jpg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ⅅ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end GRAPHIC 22 ew-20201231_g3.jpg begin 644 ew-20201231_g3.jpg M_]C_X 02D9)1@ ! @$ 8 !@ #_[@ .061O8F4 90 !_]L 0P " 0$! M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D* M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H* M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\ $0@" MF@)B P$B (1 0,1 ?_$ !\ $% 0$! 0$! ! @,$!08'" D* M"__$ +40 (! P,"! ,%!00$ !?0$" P $$042(3%!!A-180'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H MJ:JRL[2UMK>XN;K"P\3%QL?(R;GZ.GJ\?+S]/7V M]_CY^O_$ !\! ,! 0$! 0$! 0$ ! @,$!08'" D*"__$ +41 (! M @0$ P0'!00$ $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P M%6)RT0H6)#3A)?$7&!D:)BH*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_: P# M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OR;_X M.,?^"QO[>?\ P1]\8_#&\^ C?#;7]"^)46M%;'Q5X1O)+C3I-/:QR!-!J$8E M5UO5ZQJ08SRZI:67B\>$?"NH>%];T!K@?NY5,VHW\$\)8; Q5# MYCQH>'WK[?\ '7]M+X[?M+_\$J;C]LO_ (([:#IGCGQ?XET6VO? ^GZ[&BG' MVM(KV)XGD1#=0(MROE-(%\V$C+X"OYK_ ,''E]X=L?\ @@M\8!XD>$1S:!H$ M5JDN/GN3K&G>4%'=@X#<=-I/0&ORB^$/A#QAX?\ ^#-?Q]X_\56,D,\/Q@CU M'X?:FRE9[.T?6-*LYGMY/O1AY5OHV*D;@S@Y!- 'Z+?\%4/^"GW_ 4Y_P"" M;7_!)GX/_M>^+_!WPYT[XM:SK>G:'\2O".KZ)/>V4-U<6=Y.7ADMKV,1.OV5 M0R!I$W2L%;"@G]"OV5?B=XA^-G[+_P -_C+XNM[6+5?%W@+1]:U.*PC9($N+ MJRAGD6-69BJ!Y& !8D#&2>M?@I_P56U'4-6_X-&_V5]2U6^FN;B;QEH32SW$ MI=W/V'6^2QY)^M6_^#E4R>&O^"1'[$/CGPW/+IVLOX0TNQDU2PE:&=[7^P+2 M3R6=""R!QN"DX!R1U.0#^AVOG_\ :G_X*+? W]E[]H;X1?LHZQJ,.J?$'XP^ M*X=,T7PW;7:K-96&)#-J4XP2D*^68T!P99&PO"2,GY9_\%DII_"?_!T=^Q[; M^%KB338]>M_"]QKD5A(85U"8:]?PB2=4P)7\J../']&O?&%C/<3,-3G>YU6)G=M^X?N[>% %( M6-0 * /Z YIH;:%KBXE6.-%+.[M@*!U))Z"ECDCFC66*161E!5E.00>A!K\ M3_V__C5*W_!?/]F[_@EAIOP:OO$WP1\ >#?[3L_@UIM[:1VOB+5!INHSVKW MU&XAM[B.V%O;-''/(0&BD"[FDVFWJEU_P4O_ ."1O[$/[='Q:N/AE+X ^&=W M>KK/[.NB3>(M.O)?!LNJZF;2>&""SN)X[5(A>031Q*3"CP94?.P(!]Q_\%Q/ MVVOCY_P3X_X)_P#BO]KK]FS4O"<^M^#-0TR.^T;Q5HLU]!=Q7E];V@7]Q=0/ M"R^?Y@8[@VW&!G(])_X)>_M-_$+]LS_@G[\*OVH_BM8:5:^(_&WA:/4=7M]# MMI(;1)FD=2(DDDD95PHX+L?>OPQ^)7[&GP"MO^#2%OVV;CPQ]K^+7BO58-5\ M5?$$WTIU+6GF\7+:FWO9MVZZA6-(R(92R":%9@!(-U?L3_P0(_Y0V_L]_P#9 M/X?_ $=+0!Y=_P '$/\ P4D_;#_X)1?LU>%_VG?V;K[P)J=MK?C^U\,7GA_Q M?X6N;DIYUA>W0N$G@O8>ALBI0H<^8#D;>=;X0_%W_@KQ^T)^PU\/?VFOA+^T MO^S\/&_Q'^'-EXH\/_#[7OA!J=O!<2S64=RUF+U=?9AM\Q5\WR".A*J#Q\]_ M\'JW_*++P#_VOI+719 MVYGF^W2201@+/F,#R90L,>XEP#]#?V-/BC\0/CA M^R!\*?C3\6-%M]-\5>+_ (;:%K?B73K.V>&&UU"[T^">XB2.1F>-5ED=0K,S M DD9KT2VOK*],BV=Y%*8G*2B*0-L8=0<=#[5\(?\%^-"\:_&3_ ()XWM_\ M'OV\/!OP8T+0?&\+^/?$_BB[G6QU*QMGG@N-)=K9)))7-T$4VJ1L9VA,)&&8 M'\XO!?Q5T?X7?\'0?P%O?V5?@M?_ <\&?$SX?V$>L>%K3P]!X?@\2VUC=%GP71]CJ=R*:]<_X*>_\$F?V=O^"6__ 0?_:8T;X#^+/%^L'6O%^D> M+;"_\5ZJEQ=:+>/JVG6V+6:..-D)A:2-I#F219&5W8'% '['275M#-';2W$: MR3$^5&S@,^!DX'? YKY"_P""M_Q0_P""M_PST7X:3?\ !*7X'^%_&EY?^+6A M\?1^(Y8A]FLPL?DC][/$$@(/$P^+M]XL>%?'-WXIO)KNSMU%_-%;VP:39;1QR6T3((E4AM[DL\CLWU[ M_P '(==OYXM1U73W\B>Y@>ULIQ#(\>"Z+(SLJGY5 M+O@#<<@'[P4R.ZMIII+:*XC:2$CS8U<%DR,C([9'-?AM_P '16C31?\ !3O] MBNT\*Z_J7AR[\6>*4T_6=8\.W9M+R6-=8TM(F,B_>>(32%"P;:6/&.*S/AC\ M,?"O[#__ >'>%_@1^S0E]X=\)>/? ES)XJTC^V+JZ&I,?#E]>,\\EQ+)),[ M75G#.7=F)?G_%CQXLNF_#+Q+J& MMWD%[KNAQBTDN+>V\Z7RU60"\@AG54+/(R^9M4%0#^@:"]L[D9MKN*3#E#LD M!^8=5X[CTJ6OP;_X-ZOVROV1_B]^U+\,_P!FOXI?LV6OP(_:-^%&@:EX?>UT M/0CI]CX_@BL&BG6_MOD:'5X5A$S23*[,([@!E\SRT_:7]JWPKX;\;?LR?$'P MMXNT2VU'3KOP;J2W%G=PAT?%L[*<'N& 8'J"H(P0#0!W=Q=6MF@DN[F.)68* M&D<*"3T'/M+R*[MHM^U)7E\M97P2\<2Q\+N!V? /_ 5^_;$\*_\ !J?? M^,=.^).MKXULOC*?A1I?CEKMSJ-MI364>H^:DY.X2+ [V:2YW(NTJ0ZJP /Z M,X;JUN'DCM[F.1HFVRJC@E#Z''0U)7XY_ ']D;]KS2?CS^Q9^U-_P3P_8WN/ MAWX)T;P;I^E?'+6[[Q7H4*^-M O4LW-_/':7LLFH2HLE[=AYU$QED0C+9 ^? M8?@A?_'/_@[5^,?[*^E?$KQ#X.\$:SX=G/B6Q\':F]A--9S>';">YAMWCXMF MGGDS+(@#E))L,K/O !_07!<0740FMITD0D@.C @D'!Y'N,5\._\ !0G_ (*: M^+OA!_P4"^"'_!+[X,>,/#'@SQ3\7K6XU/5_B'XRL3=VVCV""X6WM[2W\V)) M[VZGM98(_-?8C%!LE:15'LG_ 32_P""='PC_P""77[-*_LO?!7QKXGU[1%\ M0WNKK>^++R*:Y62X*YC7R8HT5 $7@*,L68\L:^6_^"Y__!%_X-_\%C-;M=)^ M'7QBM?!_QZ^&7A>UO+&YN[662TNM'O[B\%I!>;!N1&N;&],\:GX]_X*'? 3]K?X.?"#QMXB\'_$7X7?$7Q-JFG:UXTA\.2:7K>AS6^@ZG MJ$%O-#%,]O/'++9IMN$6+9L:-D8R(]?/P_X*P?M@Z!_P<76'_!)K7K7P'??# M35='N-5M]3M_#MU!K$$?]ASZA'"TQO&B8K+$%+^4-R=E)R/B;_@GE_P43_X* M]_\ !)#]OSX;_P#!,O\ X*NZ7J7BOP7X_P!>M-$\'>(-_P#@\DT'X4^/;G55T35/ (&J MP:/J\UC)=P)X7NG:V>:!ED$,H7RY$5AYD;.A.UB" ?O+;W5M>1^=:7$^LK66*WN;R*.29L0I)( 9#Z*#UZ]J_#O_@V%?MLDMMI_V+Q!<64!C61F(;[.RQL^=SB)-Q;: MN/GS]O?X?)X#_P"">/[7OA/X\?$KPM^TI\:_#7Q/T?6[OXY>$O#OF/\ #N*; M6=/MDT^XU>ZV/'-)^^A32[(SBT$DNXJF2H!_293'N((I4ADG17D)$:,P!<@9 M.!WXYK\0OVW?B9XX^-7_ 9X^$_CS\3O$=UK'C2T\/\ AMK?Q3>S,]^DJ:_! M8F;SR?,\U[<%'?.YP[[B=QSZ;_P2'_X) _#_ /:4_9V_9!_X*2_'WX^?$B_^ M(?@'PW;ZAH.G6WB%!I*V*,XL[3R'C9HU$81Y61U:>26;S"5950 _6^:[M+>2 M.*XN8XVE;;$KN 7/H,]34E?SP?L1>,/B]_P6;\-?MP>//&'[,FL_%7XH:_<' M1OA=KDVL:1!!\,X]EY)I$5I_:%Y#/8HMS%%(\EJA9S:[W+R9S^TW_!,31?VP M?#'[!_PX\)?M\0X^+.CZ/)I_BR8ZK#?-=&"XEBMKA[B%F6622U2"1VR27=]W M.: />:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OSF_X+9_\$'_' MO_!9KQ=X%U+Q#^V;IG@#1?A[#J:Z)I=G\+I-1GE:^-J9FFG;585; M(0H6)< M?-G.1C]&:* /A/\ :T_X) _&K_@HSX;\*_"#]O?]N"WU7X9^&KZWO[KP-\)_ MAN_AD:[=0H41[VZN]3U&1D 9\1Q"(#>2/G5'7MO^"AG_ 2I\-?MA_\ !.0_ M\$T_@3X[T;X1>"_+TNU@>W\'OJHL[*PN8;F*&"(7EMM8R0)ND=I"P+D@LVZO MK:B@#\S?VD?^#?;XB_M'?\$I?A5_P2SUC]MW1M,TOX8Z[#J"^,+;X2RO<:DD M$5U%;Q&!M8"PD"[E+OO?>53"QX.[H_\ @HY_P0EOO^"@?_!-KX4_L5^(?VC+ M+3?%WP@@T^+0?&]MX3>*SOTMK+[$R361NY'C$D0C8LLS%9(P0-I*5^A]% 'Y M@?%'_@@1^U'^T!^W#\&O^"B/QT_X*6V&L?$'X50Z3YNG-\'4&EW;6-Y)&)_,;<7,CF1Y'#*C)#%Z3_P4._X(K^(_P!KG_@H5\)/^"E/P*_:=@^' MGC[X8VEM82V^L^#AK5A?VT%Q<3Q,(AYZ5_P3X\>?&W]EGQU\"/^"BO[1]S\6-7^)'A MDZ'KNI:/H46B6&EV@#-'_9]G&76.99F\YKB0N\DD<60L<4<2_45% 'Y&Q?\ M!NI^V=1?QH=32^DAO':](>!7\V M5(8MC&>16,WEIY3?H+_P3J_9&U[]@_\ 8[\&?LD:U\6(O&L?@C3S8:;KZ>'O M[,>:VW%U62$3S#R[F)41DD[?FXYO\ PA_8 M;_X*5_ 3]D+PI^R'\(O^"BWPOTFU\&^$K7P]HGB\_LWW4^J0VUM"L,,F)?$K M6S3!%4%F@921G9S7V310!^:?[:?_ ;V:M^U_P#\$ROAE^P9K'[:.J1^(_AY MXKNO$-_\0-1\-M/'XDU"\FO)KRXNK/[5N65Y+V:17\YR&+@Y\PD4/%__ ;Y M?'#Q;^WU\&O^"A&N_P#!377]=\<_#K1;2P\2ZMXA^'FGO-JI@\]0]I';M%!: M!HKAT"R1W!5AYC-,S,#^G=% 'P%\8O\ @BQ\2_B?_P %C_"W_!7;2_VO]%TN M]\(6<=AI7@2?X72W,3V8M+FU=);L:M&6E9;N9A(L2A3L^0A2&]V_X*G?L.>) MO^"D/[$_BO\ 8ST#XSV?@*W\8RV*ZKXAN/"K:O)';VUY#=[(H1=VP5F>W12[ M,P"%@%R0R_0]% 'Y7_M(?\&WGC_]H_\ X)H_!C_@FSK7[=^DZ=I7P?UBYOX/ M%%M\(9'N-4WB=84:$ZR%AV+0A 3!#=S_P5/\ ^"%7Q._X*A?"3X,? M"?Q)^VIHW@^'X1V+![O3_A1+=G5[TQ00^?M?5T^SQA(%Q%F0Y9B9", ?HO10 M!^??_!3K_@BE\6/^"DW[1'P2_:+U']LK0O!NH_!66*]TZQM/A3->Q:CJ NK: MYDE*O\ @M!X<_X+#W'[8>C17_AN MU6QM? *_"V4PO9'2Y].E0W?]K;A(R7,SK)Y6%8KE&"D-]_T4 ?A3\9_$_P#P M6?\ C'_P5$_:4\<_\$Y/AY\+OVAO!>A>++'PM/)\1K*R:W\'7EC!F72+./4; MBU:.2.61S,\'F12OL6^EA[^*\MF>)+R>&6;%J)(U6958*ZN@VG=]X>,_^ M"?7['GCGXCZK\8-0^"MKIOBG7MA\0>(/"VIWFBW>K%!A&NY=/FA:Y91P&E+$ M#@&NV^#OP"^"_P"S]HEWX?\ @O\ #32?#MOJ-X;S57TZU"S:A^!Y](&M77#,T<$[I' I8(2I\PA%6OK']H4A?@%XX9B M !X/U/)/_7K)785B?$GX=^$OBWX#U7X9^/+&>ZT77+-[35;2VU">U:>!^'C, MD#I(%895@&&Y25.02" ?S[?\&WO[+/[8G[5O_!'_ ..7P7_9N_:?\,>"-#\> M^/M4\,>++3Q/X)DU*2WMKC1M/2:[L)H+J!H;AX9GA=91,A"QM'Y+HS2?IKI_ M_! /]E*S_P""1#_\$E;CQ-JDNDRL=3F\=BUC6_;7_.$W]IB+)0 ,!&(=Q_T< M>47)S)7T9^R;_P $_P#]D+]A>TU/3?V2_@Y!X(L=9D\W4],TK5[UK2XEPH\Y MK>69XO-VHJ^8%W[1MW8XKV.@#X-_X)F?\$OOV[OV-O!GAKX$?M#_ /!2%OB! M\+? ,\3>#O"6B^"4TVZD2%P]K!=W[2R3FTA<*ZVR'G:D;2M IA?/^''_ 1- M^(GP_P#^"S7B/_@K^W[7VC7EYXG5[6_\!?\ "KY8XX[$V4%F(X[S^UF(F$5M M&?-,14L6/E@$*/T"HH *^4/CI^P1^T7XH_X*$1?\%!?V=_VM;?P9J5I\*M.\ M&2>"]8\)G5-(UV=1O9#?*MS!(.;R(0R0NDD3)(271VC;ZOHH ^0?%G_!. M3XC_ +5W[7/PL_:O_;L\=>$]1A^"-S9H2=2O;NZE:2 MX,9MX6B@2.)4>,,S2=*X'6_^"+'Q)U?_ (+4V'_!8I/VO]'CN=-A-C;?#UOA M?*T9T\Z9)IQB:]_M4$S>7*S^:(0N_'[O:-I^_** /S[_ .">O_!$3QW^PS^W MW\:/VYM6_;!T[Q8_QON=7N?$?ANQ^&\NE-837VHM?[K6Z.JSE!'(Y4;XV)7' M(/-?/_PF_P"#5SX@?#?]DSXU?L6W7_!3SQ+<> ?BEJ$&HV&@VO@&R2.+4+:X MAFMKN_DDEDGN2#!$'C@DME!=(32M/\06/AI])^T6D?^J$D#75 MS^\ ."XD ;CY5[^T44 ?EWX5_P"" O[27[)/[?7C7]KS_@F9^W_:_"SP[\3+ MN6?QAX'U_P )K5O%YLS3NL*M<1I(J2O(\.0CPABF]T9@?T@^$?P\?X5?#O3 M/ MQXPU;Q#I74LC2SW$FP*B%Y7=O+C5(XP0D:(BJHZ2B@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,3 MXC_$KX>?![P-J?Q.^+'CG2?#7AS1;4W&KZ[KNH1VEI9Q @%Y99"$09(&2>I MZFO//V7_ -OS]BS]M234K;]E/]IOP?X[N=&4-JMCH&L)+$XD6,G@ M/MVD\ DUN_'?]F;X4?M+S^&;'XV>'+;Q#H/AC6CK$/A?5+9)["^OTB:.WEN8 M7!6<0^9)(D;@J)?+DQOB0CX7_:%_8Z^&WAC_ (. _P!F#XC_ +(?@#3/"GB& MS\$>+=6^-[^%[&.S@N/#PMX[33FO(H@J.\MY-+$C,"S>1G)^SKM /TIKS'XO M_MH_LH_ +Q8G@7XR?'[PSX=U8V:7ES8ZCJ2JUE:.Y1+JZQD6D#."HFF*1DJP M#$@X]*NKJ"RM9+VZDV10QEY&QG"@9)X]J_-S_@W)U-/VO_V(/BM^U_\ &S28 M=9UK]H/XO>(;_P 4?VB@E\[3%2.QMM-;.-_LH?$CXM?%_P"%\WB3Q7XET^>^M-=O=/FFBTP0JY@DV9"AC@<>N?I7IGV+ MQO\ ]!NR_P# 8_XT ;%%8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C0! ML45C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\ P&/^- &Q16/]B\;_ /0;LO\ MP&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_ M ,!C_C0!L45C_8O&_P#T&[+_ ,!C_C56_N/&.GW-K:RZO:L;J7RT*VW .,\\ MT =%16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\ ]!NR M_P# 8_XT?8O&_P#T&[+_ ,!C_C0!L45C_8O&_P#T&[+_ ,!C_C1]B\;_ /0; MLO\ P&/^- &Q16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+ MQO\ ]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C0!L45C_8O&_P#T&[+_ ,!C_C1] MB\;_ /0;LO\ P&/^- &Q16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT M ;%%8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C0!L45C_8O&_P#T&[+_ M ,!C_C1]B\;_ /0;LO\ P&/^- &Q16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR M_P# 8_XT ;%%8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C0!L45SM_<> M,=/N;6UEU>U8W4OEH5MN <9YYJU]B\;_ /0;LO\ P&/^- &Q16/]B\;_ /0; MLO\ P&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\ ]!NR_P# 8_XT?8O&_P#T M&[+_ ,!C_C0!L45C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\ P&/^- &Q16/] MB\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\ ]!NR_P# 8_XT M?8O&_P#T&[+_ ,!C_C0!L457TV/48K4)JEQ'++N.7B3:,=N*L4 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\\?\%(?^"E M_P"S1_P3&^"T'Q3_ &@/&EC:7VMW?V#PAH$UPRS:M=Y4,<1I)(EO"'5YYUC? MRT(PCR/'%)\P?L3_ /!8S_@E%J/Q+@\*?#']JM_B[\>OC-XFL+76Y=!\#:M; M/?W!/EQ6\!N[:..STNQA:5D1Y,K<K&6>:1I/TFHH \BT7]MO\ 9L\7?MDZ M_P#\$^]-\63W'Q+\/^#(O$VLZ%)H\X@3399(HPWGLGE.V9X)?"UZ5N-.O[ M!7(:\:5_.@\N+>XG3RB-Y"U^F2:+H\>KOX@CTFV6_EMU@DO1 HF>)266,OC< M5!)(7. 23WJ/4?#GA[6+^SU75]!LKJZTZ0R:?5E%M!;EU(#([,A&5-?<5%% !1110!X7_P $]_\ DB>K?]CWK/\ Z4FO=*\+ M_P"">_\ R1/5O^Q[UG_TI->Z4 %%%% !1110 4444 %%%% !6/XE_P"0OH__ M %^G_P!!-;%8_B7_ )"^C_\ 7Z?_ $$T ;%%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110!C^)?^0OH_\ U^G_ -!-;%8_B7_D M+Z/_ -?I_P#036Q0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110!X7_ ,$]_P#DB>K?]CWK/_I2:]TKPO\ X)[_ /)$]6_['O6?_2DU M[I0 4444 %%%% !1110 4444 %8_B7_D+Z/_ -?I_P#036Q6/XE_Y"^C_P#7 MZ?\ T$T ;%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110!C^)?^0OH_P#U^G_T$UL5C^)?^0OH_P#U^G_T$UL4 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110!2\1:7>ZWHEUI.G>(KW2)[B(I%J6G)"T]N3_&@GCD MC)_WD8>U? G_ 0!\4?$_6X?VMO#'Q3^,?BGQS<^$/VP?%GAS3=<\8:N]Y>& MQL8K.W@0L<*BA$'R(JHI)VJHXK]"*_/#_@@%_P C5^W#_P!GW^/?_0[:@#]# MZ_*_]F']IS]EKXW?%O\ :L\&_P#!3OXG:AX?^*?PS^)&N-%I.N>+;W2SH7@R M+8NEW>AI#-&(P8BKF>V'VB66:-V9A+ *_4=-:T>35W\/QZM;-?Q6ZSR60G4S M)$Q*K(4SN"D@@-C!(([5^2NJ_L-:9_P7PT3XE_MOS^,[OX7_ !A^&_Q9U/PM M\!/$6A(+>X\+1Z#:3_:F\3 M_P#!.WX6Z]^VC#JB?$:ZT*5]9_MVW$6H/;?:IQ8/>( -MTUB+5I@0&$K2;@& MR*^B:^7O^".?[5?QQ_;$_8*\,_%/]I?0;:S\?Z;JVK>&_%T]@BK;:A?:7?SV M,MW$%^7$C0$L$P@D\P* H KZAH **R?'7@[2_B#X1O\ P7K=Q=PVFHP&&>2Q MN6AF520.HKR'_AWO\ !/\ Z&WQW_X65S_C0 ?\$]_^2)ZM_P!CWK/_ M *4FO=*^_^!;4?\(/I'_/S>_\ @6U &Q16/_P@^D?\_-[_ .!;4?\ "#Z1 M_P _-[_X%M0!L45C_P#"#Z1_S\WO_@6U?.6M?M[? W2O^"AOA;_@F_'X!^(? M_"6^)_#^HZS%K]_I4MEI*6UFLF_RI9]KW1+QLH:)&CQAO,.1D ^I:Q_$O_(7 MT?\ Z_3_ .@FC_A!](_Y^;W_ ,"VKSS]I;XJ? O]E7XI_L M^^*O WAF\M?.TI_&VLQP:Q= D;'?3X3+]F1E);$TJ3+\H>%6+!>(_P""E_[< MO[//_!+S]F#4?VE_C6=8U)(KJ*ST/PUI5[_INL7;GB*+<=JA4#R.[?*J1D\D MJK 'TW17,^&-#T/Q/X:T_P 20-?Q)J%C# M_P#@6U &Q16/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U &Q16/\ \(/I'_/S M>_\ @6U'_"#Z1_S\WO\ X%M0!L45C_\ "#Z1_P _-[_X%M1_P@^D?\_-[_X% MM0!L45C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;4 ;%%8__ @^D?\ /S>_ M^!;4?\(/I'_/S>_^!;4 ;%%8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@6U & MQ16/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U &Q16/\ \(/I'_/S>_\ @6U' M_"#Z1_S\WO\ X%M0!L45C_\ "#Z1_P _-[_X%M1_P@^D?\_-[_X%M0 >)?\ MD+Z/_P!?I_\ 036Q7*:YX5TZUU'388Y[DB>Y*N6N&) V]O2M/_A!](_Y^;W_ M ,"VH V**Q_^$'TC_GYO?_ MJ/\ A!](_P"?F]_\"VH V**Q_P#A!](_Y^;W M_P "VH_X0?2/^?F]_P# MJ -BBL?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJ M -BBL?\ X0?2/^?F]_\ MJ/^$'TC_GYO?\ P+:@#8HK'_X0?2/^?F]_\"VH M_P"$'TC_ )^;W_P+:@#8HJOING0:5:BTMWD90Q.97+'GW-6* "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH K:QI=MKFEW&C MWLMRD-S"T2?LN_L"?LN?L9:WXJ\0_LZ>$ M->T6Y\<:]<:YXL%_X^UK5(M3U.<@SWLD5_>31_:)"!NE"AVP 3Q7LE% 'DF@ M?L/?LX^&/VSM=_;]T;P=#HO#&K:R=6N&AETZ.2*14%N7\I6S!#E MPH.(QTRQ:AJ/[ _P#_X6%XH^)?@FY\6^#+_QS=B[\<6_@;QI?Z3:Z[<^6(S= M30V\JK'] M9_\ 2DU[I7A?_!/?_DB>K?\ 8]ZS_P"E)KW2@ HHHH **** "BBB@ K\\?VH M/^5DG]E[_LA_C'_V:OT.KX+_ &A_@C^U9XH_X+@_!3]K7PE^RCXFU/X;^ ?A MWKWA_7O$\'B'0(P;F^W^5)%;S:DEP\0PNXF,,-XPIP< 'WI7Y0?\% _%'QG_ M &PO^#@?X-_L4^ ]-\/ZAX:^"'P^?XG7FC^*[V:/3KC6Y)S:VUY/'#&[7)M# M+:20Q9CR[R_O$#$G[[_;/^-'[4WP4\->#M3_ &5/V5O^%KZAK/C[3]*\3Z?_ M ,))#IG]C:/+YGVC4M\H(D\LJB[1_P ]-QX4U\_?M;?LI_%3X0?\%4?AS_P5 M/^ G@&\\80W7@B?X>_%GP=I$T":C)I37 N[74[-9Y(XYGBG5%EBWJ[1(GEAF M!4@$G[/?_!4GXI>$?VXOB-_P3X_X*+>$/!GA'Q+X/\ -X^\._$#PI>W$6@Z[ MX:0[9YWCO&,MI+"0^\%W4^1/@@1JTGRS_P %K-3T?]H/_@D+\?\ ]MCXDZW8 MQ:QXC\.Z/IOPI\(75Y']J\-^&6\0Z9+ODASNCO[\QQW5PI :*..UMV :V=G^ MK;#]A!OVR?\ @H=XL_;C_:;^#<^D>"&^!K?"OPQX&\321-=ZY9W5W/7]CKQ=^P!\0_#O_ 3W_P"" M?W@Z+XPW-M8#P9)IES%93AQJ-JUQLGN[A(4_T83YWL,C(&20" ?HY\$M9TC7 M?A%X:OM$U6VO(1H5HAFM9UD7<($R,J2,CTKJ:\Q_9 _9=^#O['_P%T7X+?!# MX6Z;X/TFVA6YN]&TH?NEO9$4SR?>;+,X))!P>U>G4 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 8_B7_D+Z/_ -?I_P#036Q6/XE_Y"^C M_P#7Z?\ T$UL4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 452\1:]9>&-$NO$ M&HV][+!:1&26+3M.FNYV [)# CR2'_952?:O#/\ @G__ ,%$/AA_P42T3XC> M(_A9X \4^'K;X_:,_;9^%/[//CKPY\%4TC6?&?Q*\8H\OA;X:^#;>*XU6\MXSB2\D\ MV2.&SLT.0UU4G&W?*(HUW]Z5X7 M_P $]_\ DB>K?]CWK/\ Z4FO=* "BBB@ HKQK]HS]KC_ (4!XPL_"G_"O_[6 M^UZ:MW]H_M;R-F9'3;M\I\_6_\ 5%?_ "X__N:@#ZFHKY9_ MX>6_]45_\N/_ .YJ^C_A_P"*O^$Z\#:/XT^P?9?[5TV&[^S>;O\ *\Q VW=@ M;L9QG SZ4 :]%%% !1110 4444 %%%% !1110 4444 %%%% &/XE_P"0OH__ M %^G_P!!-;%8_B7_ )"^C_\ 7Z?_ $$UL4 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 5^>'_! +_D:OVX?^S[_'O_ *';5^@VL7USIFEW&H66CW.H30PL\=C9 MM$LL[ 9"(971 QZ#"[;XI? MM+>)_B%X3OK_ %_1;V*33-1>$P12"POYY([@",EE*;!D8<]* /NROQK_ ."/ M/BG_ (*"_M9:/^T3_P %9?@/X<^%NJ>-/B9\0;[3?";?$>^OY7&@Z8H6RT2V M6V$:V$(9R#-YD@E=59X@4\QOTP\._&C]J;4OVY?$'P)US]E;[!\(=.\#0:GH MOQ>_X22%_P"T=6::-7T_[&!YB81I3O)X\C)XE3'S7^P!\"?CQ_P297XI?LJZ M7^SGXH^(7PWU/QYJ'BWX-:]X,FL&9+>^"O)H5\EU.&)((=Y WM$SX4, /IV@#)\=6?C&_P#"-_9_ M#_6+33]:D@(TZ]OKL_P#I2:]TH Q_L7C?_H-V7_@,?\:/ ML7C?_H-V7_@,?\:V** /BO\ X*"1:K#\6-)75[N*:3_A'8RK11[0%\^;C^=> M#U]!?\%&?^2P:/\ ]BU'_P"E$]?/M !1110 4444 %%%% !1110 4444 %%% M% !7Z$? FT\7O\%?";6NKVB1'P[9F-6MR2%\E< FOSWK]'O@!_R0WPA_V+5E M_P"B4H UOL7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !K8HH Q_L7C?_H-V7_@ M,?\ &C[%XW_Z#=E_X#'_ !K8HH Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ M !K8HH Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !K8HH Q_L7C?_H-V7_@ M,?\ &C[%XW_Z#=E_X#'_ !K8HH Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ M !K8HH Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !K8HH Y37+7Q2NHZ:MU MJEL[ML_P#I2:]TKPO_ ()[_P#)$]6_['O6?_2D MU[I0 4444 ?&O_!1G_DL&C_]BU'_ .E$]?/M?07_ 49_P"2P:/_ -BU'_Z4 M3U\^T %%%% !1110 4444 %%%% !1110 4444 %?H]\ /^2&^$/^Q:LO_1*5 M^<-?H]\ /^2&^$/^Q:LO_1*4 ==1110 4444 %%%% !1110 4444 %%%% !1 M110!C^)?^0OH_P#U^G_T$UL5C^)?^0OH_P#U^G_T$UL4 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 $A068@ #DFN0^$G[0'P0^/BZ[+\$?BQH'BV+PQK;Z/K] MQX=U2.[BLM02*.5[9Y(B5$BI+&64'*EL'!! Z/Q!X=\/^+=%N?#?BK0K/4]. MO(C'>6&H6J303H>JNC@JP]B,5^=__!N[X:\/^#)_VT?!_A+1+73=*TG]N+QQ M9Z9IUC L4%K;Q&U2.*-% "(J*%"C@ "@#]'*POB;\3/A_\ !CX>ZS\5_BMX MPL/#_AOP]ITM_K>M:I<"*WL[>-2SR.QZ ?4G &20*W:_,7_ (+DZCJ?[9?[ M"_[0[Z1J%Q'\)_@YX0U,33VTS(GBWQA;K@QY4CS++3&^]U62_P#E.#8,' /T MH\&^+_#/Q!\(:5X^\%ZS#J.C:YIL&H:3J%N28[JVFC62*52?X61E8>QK2KR# M_@GM_P F"_ __LC_ (9_]-5M7K] !16?XK\5^'/ WAR[\6^+=7AL--L(3+>7 MDYPD2=-QQVYKSC_AN?\ 9'_Z+UH/_?Y__B: ,+_@GO\ \D3U;_L>]9_]*37N ME?.W_!//QKX4F^!VISQ:Y R2>-M6DC8$_,CS[U/T*L#^->[_ /"8^&/^@U!_ MWU0!I45F_P#"8^&/^@U!_P!]4?\ "8^&/^@U!_WU0!\C_P#!1G_DL&C_ /8M M1_\ I1/7S[7O7_!0G4[#5?BUI$^G723(OAV-2R'H?/G./UKP6@ HHHH **** M "BBB@ HHHH **** "BBB@ K]'O@!_R0WPA_V+5E_P"B4K\X:_0[X#^*O#MM M\$_"5O<:M"CQ^';-74GD$0KD4 =]16;_ ,)CX8_Z#4'_ 'U1_P )CX8_Z#4' M_?5 &E16;_PF/AC_ *#4'_?5'_"8^&/^@U!_WU0!I45F_P#"8^&/^@U!_P!] M4?\ "8^&/^@U!_WU0!I45F_\)CX8_P"@U!_WU1_PF/AC_H-0?]]4 :5%9O\ MPF/AC_H-0?\ ?5'_ F/AC_H-0?]]4 :5%9O_"8^&/\ H-0?]]4?\)CX8_Z# M4'_?5 &#\:?V@?@=^SEX7B\:?'GXL^'_ AI=Q>1VEI>>(-4CMEN;F1@J01! MR#+*Q( 1 6/85V%?F3_P'?A%XC_8D\*?$.7PWHEWXETSXS>$8;#7'L(VO M;> W[!HTF*[U0B1\J#CYB<T4R76KZWK=_':VEE J$M)++(0J*/4D5RW[+W[>/[&W[:L.J2_L MI?M)^$O'C:(R#5[?P_JR2SV8 M/O\ @G-\?O\ @X#\;?'K]E+XV>$M*U7P9\%QX6\2^&]$LY+&7Q;J4E_YL]ZJ MF)([J&UACMHFE0LSR%.B0HT@!^B7QI_:2^!/[.UMIL_QI^)^EZ!)K5P\&BV5 MU*6NM1D1=\BV]O&&EG*)\[[%;8OS-@ /BYX)TWXD_"WQII?B+P] MK%L+C2M;T6^CN;6[B)(WQR1DJPR".#P00>17YW_\$^?C%#^T[_P7._;$^,7C MK5HY;7X/Z3X;^'?P\BG.186W M^%/_ 6"_;=_8"['Q'H7CWPM9AB(;"\U?3H+G5%C'15DGGBDVC #K( MV,N30!^DU%9O_"8^&/\ H-0?]]4?\)CX8_Z#4'_?5 &E16;_ ,)CX8_Z#4'_ M 'U1_P )CX8_Z#4'_?5 &E16;_PF/AC_ *#4'_?5'_"8^&/^@U!_WU0!I45F M_P#"8^&/^@U!_P!]4?\ "8^&/^@U!_WU0!I45#8W]GJ4 NK&X66,D@.O3-34 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110! M6UC6-(\/:7<:YK^J6UC96D+2W=Y>3K%%#&HRSN[$!5 Y))P*_-C_ (-W_BU\ M+/&'CK]M/2/"?Q(T'4KO4_VT?&VMZ;:6.K0RRW6F3R6XAO8T5B7MWVMME *- M@X)K],** /#];_;!^ 7Q4_:8\;?\$V/!WQ7U32?BUIWPY?7;S[#I,ZG2[*XV M01W<5PR>2TL;W$#A Q/S+UPP7\Z_^"D7_!+7]J;]E?\ X)*_%72;'_@K%\2- M>\#^#OAG=(O@&\\$:%!9W]K&@S;RRQ6XF^?DM(&\QF)8L6))_7M-%T>/5W\0 M1Z3;+?RVZP27H@43/$I++&7QN*@DD+G ))[U9H ^8?\ @CK\*/B9\)?^">?P MULOB=^T+K?Q$FUOPAHVKZ1=:YIMK;-HEA-I-D(M*B%LBB2&$HY61\R'S3N)P M*^GJ** (KZPL=4M)-/U.RBN+>5=LL$\8=''H5/!%8_\ PJ[X9_\ 1.]"_P#! M1#_\36[10!X)_P $]M-TY?@EJJKI\ \65 M48AC&BHQ9L8 4Y-?>OQ%^.GP/^%_P$U_]IWQ)XHT^;P/X:\-W>O:GKVD1B^B M^P6T3RRRQ^0',V$1L!,DD8'-=U3+JUMKZVDLKVWCFAFC*2Q2H&5U(P5(/!!' M!!H ^8?&O_!47]@#PO\ CX2_M7^./CIIOAGP#\5;^./PAK_ (@TRXM8;AY( MG<),6BQ; !'R\VQ!M/S8P3XE\5_A1\!?VU_^"OW[./[5'['FJ>'?$4GPGL/$ M=S\5_B)X,N(;JP:PN=.^RZ=I4UY 3%<7+S32.L =GB@\YV"J\>_[C\:>#?"& MJVFB>$-3\*:;_%']O7]K#_@J/>:0!X5^+?BC2O#_P ++R6#:NK:+HUFMH^JP9'SVMS)%$89 M!@.L!=OVF? 7P.^,WA2*PT#XL:I)HWP_\8V6HF57UJ.W,_P#9U[ T M:FW:54D,$J/*LA1D<1-L\P ]MHHHH **** "BBB@ HHHH **** /"_\ @GO_ M ,D3U;_L>]9_]*37NE>%_P#!/?\ Y(GJW_8]ZS_Z4FO=* "BBB@#XU_X*,_\ ME@T?_L6H_P#THGKY]KZ"_P""C/\ R6#1_P#L6H__ $HGKY]H **** "BBB@ MHHHH **** "BBB@ HHHH *_1[X ?\D-\(?\ 8M67_HE*_.&OT>^ '_)#?"'_ M &+5E_Z)2@#KJ*** "BBB@ HHHH *XSXC?M!?"'X2ZQ#H'Q!\7?V?=W%L+B& M+[!<2[HRS*&S'&P'*L,$YXKLZ^-?^"C/_)8-'_[%J/\ ]*)Z /=_^&U?V9O^ MBE_^4:]_^,T?\-J_LS?]%+_\HU[_ /&:^!J* /OG_AM7]F;_ **7_P"4:]_^ M,T?\-J_LS?\ 12__ "C7O_QFO@:B@#[Y_P"&U?V9O^BE_P#E&O?_ (S1_P - MJ_LS?]%+_P#*->__ !FO@:B@#[GUS]L7]G&\U'39[;XB[DM[DO,?[(O!M&W& M>8>?PK2_X;5_9F_Z*7_Y1KW_ .,U\#44 ??/_#:O[,W_ $4O_P HU[_\9H_X M;5_9F_Z*7_Y1KW_XS7P-10!]\_\ #:O[,W_12_\ RC7O_P 9H_X;5_9F_P"B ME_\ E&O?_C-? U% 'WS_ ,-J_LS?]%+_ /*->_\ QFC_ (;5_9F_Z*7_ .4: M]_\ C-? U% 'Z@>']>TGQ3H=GXET*[\^RO[9+BTF\ME\R-U#*V& (R"." :N M5R/P _Y(;X0_[%JR_P#1*5UU !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 ?"O[;=Q\5)_VF?%'PM_82\9?"[Q?\3-<\.^' MO$_CWX,^,/$"_V(O^ M"I'[>_[=WPQ_:R_X*9V_@'X:_#SX(ZQ)K?@'X2> =;DU2ZO]9*XCN[Z[*A"( MR$8%3T0H(T\QY&VOVR/@Q_P5ST7_ (*?7?Q^_P"";/PF_9YAL=0^$UAIWB#Q M=\5+#5TEU8I>7.-/EELY6W- 0LR&-82RSJLAE$482/P_XD_X.(Y/CC\-=!_: MH3]F*P\"77CFPE\5VWP8N]='B"YTZ.9/,*)?R%6M5D>#[1L&1&QW?(7R ?HG M1110!2\13^(;;1+J?PGIME>:DL1-G:ZC?/;02/V#RI%*R#W",?:ODC_@D!^V M[^TA^VIIWQ^3]IO1?"VG:U\+/VA=<\ V=CX/BF%G%;Z=#:H2))F,DS-*TK>8 MP7(881 H^Q*_/#_ ((!?\C5^W#_ -GW^/?_ $.VH _0^OSI_:?^,?\ P7N/ MPT\0?MK?LT:7\%]'\$Z'83ZWH'P9\4:-?7&OZSHD2&7?>70>-+>]EA4RK:Q[ M1'O6)I&=3G]%J\$_;U\>^-M6^&EU^R=\ )8I?B?\4M'N]*T.1U+Q>'M/D407 MFO7>/NP6J2Y0'!FN&@@7F0LH!L_\$_OVO-!_;U_8R^'G[7GASPU-HT'CC0%O M9M(GE\PV5RKO#<0A\#S%6:*15? W* V!G ]BKA/V7_V=OAW^R3^SQX,_9G^$ MUG)#X=\$>'K;2=,\X@RRI$@4S2$ !I)&W2.0!EW8XYKNZ "BLGQUX.TOX@^$ M;_P7K=Q=PVFHP&&>2QN6AF520.HKR'_AWO\$_^AM\=_P#A97/^- !_ MP3W_ .2)ZM_V/>L_^E)KW2OG#_@GCX"T:#X&ZE;I=7Q6+QIJL2DWC$D)-L&3 MW.%&3W.37N__ @^D?\ /S>_^!;4 ;%%8_\ P@^D?\_-[_X%M1_P@^D?\_-[ M_P"!;4 ?)O\ P49_Y+!H_P#V+4?_ *43U\^U[Q_P4$TFVTCXL:3;VLDK*WAV M-B99"QSY\PZGZ5X/0 4444 %%%% !1110 4444 %%%% !1110 5^CWP _P"2 M&^$/^Q:LO_1*5^<-?H1\"?!^EW?P5\)W,EQ=AI/#MFS!;E@,F%>@[4 >B45C M_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M0!L45C_\(/I'_/S>_P#@6U'_ @^ MD?\ /S>_^!;4 ;%%8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;4 ;%?&O_!1G M_DL&C_\ 8M1_^E$]?67_ @^D?\ /S>_^!;5\A_\%!-)MM(^+&DV]K)*RMX= MC8F60L<^?,.I^E '@]%%% !1110 4444 %%%% !1110 4444 %%%% 'Z/? # M_DAOA#_L6K+_ -$I775YW\"?!^EW?P5\)W,EQ=AI/#MFS!;E@,F%>@[5UG_" M#Z1_S\WO_@6U &Q16/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M0!L457TW3 MH-*M1:6[R,H8G,KECS[FK% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% 'YO?\%$? _P"T=^U5^UGXW^"/PN_X*FZ]\$M<\)^ K*;X6_"; MPAKEKI5_XSU&>"[G-[+-*WG3PM+#]D"Q*RQ?99'."3N\1^''P;^&O@']IG]D MOX_>+/\ @L]\;OC%HWBOXFFV\.^ O%/C&W>[L]:DTN\6*2YM%!DC2$_:+&[B M95>-[U59D =7^E?^"A_[/+.PU3XR^/_ PT&GZ8UTQ2XNFCCD,,=W,A>(3[$=I) MP6=B2K@'Z]4444 5M8BU>?2[B'0+ZVMKUH6%I<7EJT\4,NH/50ZD M^HZU\P?\$W?^">WQ3_8-\2_&+5_%G[1>@^-[3XQ?%K6/B%J5M8_#V;2)=/U/ M460S0QR-J=T'MU\M0JE XYRYZ5]444 >*Z9\%/VM+']M?Q/\I M> 8M+\.?">X\*Q&/2M:61&.I-=*ZR3*0L@,>5W"?&1Y:&OEW1?\ @EQ_P5\\ M+?$;Q=\4O"'_ 7+TG3=6\:ZH+S6)A^ROI-TRQH"MO9Q276I2RI:P*S+%#O* MIOD;EY9'?]#** /+_P!D#X(_%[X"?!B'P=\?_P!I+4?BWXVNM3NK_P 1^.]0 MT6+2UOY99#Y:0V,+O%9Q1PK#$(HSM)C9_O.U>H444 %%%% 'A?\ P3W_ .2) MZM_V/>L_^E)KW2O"_P#@GO\ \D3U;_L>]9_]*37NE !1110!\:_\%&?^2P:/ M_P!BU'_Z43U\^U]!?\%&?^2P:/\ ]BU'_P"E$]?/M !1110 4444 %%%% !1 M110 4444 %%%% !7Z/? #_DAOA#_ +%JR_\ 1*5^<-?H]\ /^2&^$/\ L6K+ M_P!$I0!UU%%% !1110 4444 %?&O_!1G_DL&C_\ 8M1_^E$]?95?&O\ P49_ MY+!H_P#V+4?_ *43T ?/M%%% !1110 4444 %%%% !1110 4444 %%%% 'Z/ M? #_ )(;X0_[%JR_]$I775R/P _Y(;X0_P"Q:LO_ $2E==0 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %?.7_!1KX\?MW_ CPKX M)N?V#/V9_#GQ0U[Q)XN_L?5=)\1:ZVG1V$+6D]PMV9LA%C!MV1MQR6EB502V M*^C:* /RSTW7/^#AGP_^TCJO[3?AC_@F'\$[#6_$OA:TT+Q;;Q_%Y3%J\-G- M-+83/SE9K.5U>\L+472.K"W+<*TRQ(T@5BBN6^7&]=3]N']O;X5?L&_' M;XL_'W]I/]J35-'A\'?#W3;CX8_!-]>BM8/&%W)'=9N[>';Y]Y(]SLM66-O* M@%N995^<,/#/V'_A3^TQ^SWI'P<_;0_;/_;L^)%W^T9^T!\0-.,WP7U7Q2?[ M#?1M0N%:XT]-'D!\AK+33+>&5/+^SRPK#]TLLH!^M-%%% !102%!9B .2:Y M#X2?M ?!#X^+KLOP1^+&@>+8O#&MOH^OW'AW5([N*RU!(HY7MGDB)42*DL99 M0!?C)\?O#/AW5C9I>7-CJ.I*K65H[E M$NKK&1:0,X*B:8I&2K ,2#@ ].HIL$\%U ES;3))'(@:.1&!5E(R"".H(IU M!1110!X7_P $]_\ DB>K?]CWK/\ Z4FO=*\+_P"">_\ R1/5O^Q[UG_TI->Z M4 %%%% 'QK_P49_Y+!H__8M1_P#I1/7S[7T%_P %&?\ DL&C_P#8M1_^E$]? M/M !1110 4444 %%%% !1110 4444 %%%% !7Z/? #_DAOA#_L6K+_T2E?G# M7Z/? #_DAOA#_L6K+_T2E '74444 %%%% !1110 5\:_\%&?^2P:/_V+4?\ MZ43U]E5\:_\ !1G_ )+!H_\ V+4?_I1/0!\^T444 %%%% !1110 4444 %%% M% !1110 4444 ?H]\ /^2&^$/^Q:LO\ T2E==7(_ #_DAOA#_L6K+_T2E==0 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% & M)XO^&?PX^(-SIU[X]^'^B:Y-H]T+G29=7TJ&Y:RG&,2PF128WX'S+@\#FJ6K M_!#X+^(/'MK\5->^$/A>^\466S[%XDO- MI;^WV9V;+AD,B;-?BS\._[-TC3;>23+YECFD!ED"F*-6VC=(#EL;6 /OVBBB@"GX@\ M.^'_ !;HMSX;\5:%9ZGIUY$8[RPU"U2:"=#U5T<%6'L1BOSO_P"#=WPUX?\ M!D_[:/@_PEHEKINE:3^W%XXL],TZQ@6*"UMXC:I'%&B@!$5%"A1P !7Z)ZQ MK&D>'M+N->R>4[9GAR@8G$@Z MX8+\0_\ !'KQS\+?^"1W[.'QA_88_:W\?:=X1O?@Y\1=8U3PRFM7J0S>)?"U MZ5N-.O[!7(:\:5_.@\N+>XG3RB-Y"T =A_P;-_&GQC\2?^"=NK?"3QGK]UJK M_!7XM:_\/-+U*]E+S3:?9&">U5F/41PW:0KZ)"@[5^A=?#O_ ;W_LC_ !1_ M9._X)Z0W/QS\,3:%XU^*7C?5O'_B;0+I"LVF2ZBT:PP2@\K*+:"W+J0&1V9" M,J:^XJ ,GQUXAU3PIX1O_$>B>%;O7+NT@,D&DV+*)KILCY$+<9^OI7D/_#6' MQL_Z,?\ '?\ X%6W_P 57NE% 'SA_P $\?%.LR_ W4I7\%WR,_C3579"RY0M M-N*GW4DJ?=37N_\ PDNK_P#0H7O_ 'TM>1_\$]_^2)ZM_P!CWK/_ *4FO=* M,?\ X275_P#H4+W_ +Z6C_A)=7_Z%"]_[Z6MBB@#XK_X*"7USJ'Q8TF:ZTV6 MU8>'8P$E(R1Y\W/'^>*\'KZ"_P""C/\ R6#1_P#L6H__ $HGKY]H **** "B MBB@ HHHH **** "BBB@ HHHH *_0CX$^(-4@^"OA.&/PM=RJGAVS"R*RX8"% M>17Y[U^CWP _Y(;X0_[%JR_]$I0!K?\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ M 'TM;%% &/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+6Q10!C_\ "2ZO_P!" MA>_]]+1_PDNK_P#0H7O_ 'TM;%% &/\ \)+J_P#T*%[_ -]+7R'_ ,%!+ZYU M#XL:3-=:;+:L/#L8"2D9(\^;GC_/%?:E?&O_ 49_P"2P:/_ -BU'_Z43T ? M/M%%% !1110 4444 %%%% !1110 4444 %%%% 'Z$? GQ!JD'P5\)PQ^%KN5 M4\.V86167# 0KR*ZS_A)=7_Z%"]_[Z6LGX ?\D-\(?\ 8M67_HE*ZZ@#'_X2 M75_^A0O?^^EH_P"$EU?_ *%"]_[Z6MBB@"OIMY/?6HGN+"2V8L1Y4I&?KQ5B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#X'_;8^)? M_!1'Q?\ MO66D_LL^//"?P^^%WPJUGP8OQ/U6^T>*[UOQF-4U6,2:5;-)%(+ M:UCMV!:0&-S),P5C@[>Z_;@_:X\0_L@_MH?L_>"M:\40>)/"GQZ\>_\ "*77 M@;5;.V:;1[R.&.6UU?3Y%C639'<"$3I,TH!FB>(Q,I$GDW_!<_XV_L!_L])I M'B?XZ?MV>,O@E\2]:L+5-)7X;6*:IJ&OV=G>&YM1>:9)!-#-!#=>8\,THB*N MTR)+AY8V\7_X([^%?^":_P"UC^VRG[4WB[_@H3\3/CY^T)X:TB5O#&C?&?2& MT.30;)@R/H]1\.>'M8O[/5=7T&RNKK3I#)I] MSL_^E)K MW2O"_P#@GO\ \D3U;_L>]9_]*37NE !1110!\:_\%&?^2P:/_P!BU'_Z43U\ M^U]!?\%&?^2P:/\ ]BU'_P"E$]?/M !1110 4444 %%%% !1110 4444 %%% M% !7Z/? #_DAOA#_ +%JR_\ 1*5^<-?H]\ /^2&^$/\ L6K+_P!$I0!UU%%% M !1110 4444 %?&O_!1G_DL&C_\ 8M1_^E$]?95?&O\ P49_Y+!H_P#V+4?_ M *43T ?/M%%% !1110 4444 %%%% !1110 4444 %%%% 'Z/? #_ )(;X0_[ M%JR_]$I775R/P _Y(;X0_P"Q:LO_ $2E==0 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% 'Y/?MJ?M3?L/\ _!/K_@O!/^T+ M^T3\/?%_BWQ'XC^"&GVVE_V9X"FU6;PMY-WE MQ(8ZO[5?_!P#_P $^/C#J7PXN_#7P+^,%QK7ACXD:5K5MXLNOA%>1R^'K2WG M66],+$>8S75JLU@43@K>,7(5>?U;'A/PVOBMO'*Z+;C6'T\6#ZB(\2O;"0R+ M$6[J'9F /0LV.ISH4 ?+O_!/C_@JW\!_^"DWQ#^(7A3X">%?%EC8_#W2="N- M0N?%_AV73)YI]1DU,"-(9?F*HE@K;\ $RD#.TU]150M_#&@6GB:\\96VEQ)J ME_86UE>7H'SRV]N\[PQGV1KFZG#J)U&&1[+6&-Y+(5O; M>6WE>2X7$D\;NDA?";0#]$Z**_*_]F']IS]EKXW?%O\ :L\&_P#!3OXG:AX? M^*?PS^)&N-%I.N>+;W2SH7@R+8NEW>AI#-&(P8BKF>V'VB66:-V9A+ * /U0 MHKYV_P""3>O?M3>)_P#@G;\+=>_;1AU1/B-=:%*^L_V[;B+4'MOM4XL'O$ & MVZ:Q%JTP(#"5I-P#9%?1- !1110!X7_P3W_Y(GJW_8]ZS_Z4FO=*\+_X)[_\ MD3U;_L>]9_\ 2DU[I0 4444 ?&O_ 49_P"2P:/_ -BU'_Z43U\^U]!?\%&? M^2P:/_V+4?\ Z43U\^T %%%% !1110 4444 %%%% !1110 4444 %?H]\ /^ M2&^$/^Q:LO\ T2E?G#7Z/? #_DAOA#_L6K+_ -$I0!UU%%% !1110 4444 % M?&O_ 49_P"2P:/_ -BU'_Z43U]E5\:_\%&?^2P:/_V+4?\ Z43T ?/M%%% M!1110 4444 %%%% !1110 4444 %%%% 'Z/? #_DAOA#_L6K+_T2E==7(_ # M_DAOA#_L6K+_ -$I774 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !7R_P#\%,/VIO$OP+T[X;?"?X>?%.^\$:]\2?'T6FR^+K+P M+<:\^E:7;6=WJ-Y)%;I;S1R3R1V7V9%=6*_:3-L*PN5^H*\T_:M_9GT3]JCX M6KX"NO'OB#PAK&FZG#JWA/QIX4NEAU+0-3A#K'=P,ZLC?))+$\;JR20S2QL, M.: /AW_@I-_P6\\/_LI_L_:1\"/V/_$WBGXE_M">.91I7@>#Q1X N[2YC#E_ M-UBXMQI]M'-' H.$AAPS*NY2JR&N-_9R^._[0G[#/B/P1\1_C?\ \%//B'\< M]*\2Z[8Z/\4O"?BSX'ZO:6]A/?.((K[1[D6*R1"&ZDA0VS K/$[E4218TKZ4 M_8;_ .".WA3]E[]I;7?VWOV@_P!I/Q?\=OC1K&F_V79>.O'$$,(T33L$&WL; M6+*6^X$AF4_=+*BH))?,]>^./[+WQ4^/'Q\\ ^-/$?[0,%A\.? GB6'Q#_PK MO3/"86?6M1@@D%JUWJ#W+$Q0W#I<)%' @+1(&+%58 'M%A>V^I6,.HVC,8KB M)9(B\;(2K#(RK %3@]" 1WJ6BB@#\V?^#A;P=J.@^-?V.OVM;J-SX:^%?[4_ MAR7QC<#[EA87EU ANY#T5$>%$R3]Z9!WX/\ @XM\%ZK\?)OV0_V3_!\#SZ]X MN_:MT35(881EXM/TZSO#?76/[D,5R)&.. M?H+\5_A1\-_CG\-]:^#_Q@\%Z M?XB\,>(M/DLM:T75(!)!=P.,%6!_ AA@J0&!! -<#\'OV'?@-\&?B#:_%C38 M?$GB+Q/INBMH^A:_XY\77^N76CZ:Q4O:6CWLLGV=7*)YCK^]F\M/->38N #U M9-:T>35W\/QZM;-?Q6ZSR60G4S)$Q*K(4SN"D@@-C!(([5^2NJ_L-:9_P7PT M3XE_MOS^,[OX7_&'X;_%G4_"WP$\1:$@M[CPM'H-SB$ZCL'F7,MQ?^C&@?L/?LX^&/VSM=_;]T;P=QENX@ORXD: E@F$$GF!0% %?4-8 M/PP^&'P]^"WP_P!)^%?PI\(6.@^'=#M%M=)TC381'#;Q#)P!W))+%CEF9BQ) M))K>H R?'7@[2_B#X1O_ 7K=Q=PVFHP&&>2QN6AF520.HKR'_ (=[ M_!/_ *&WQW_X65S_ (U[I10!\X?\$\? 6C0? W4K=+J^*Q>--5B4F\8DA)M@ MR>YPHR>YR:]W_P"$'TC_ )^;W_P+:O(_^">__)$]6_['O6?_ $I->Z4 8_\ MP@^D?\_-[_X%M1_P@^D?\_-[_P"!;5L44 ?%?_!032;;2/BQI-O:R2LK>'8V M)ED+'/GS#J?I7@]?07_!1G_DL&C_ /8M1_\ I1/7S[0 4444 %%%% !1110 M4444 %%%% !1110 5^A'P)\'Z7=_!7PG_^!;4?\(/ MI'_/S>_^!;5L44 8_P#P@^D?\_-[_P"!;5\A_P#!032;;2/BQI-O:R2LK>'8 MV)ED+'/GS#J?I7VI7QK_ ,%&?^2P:/\ ]BU'_P"E$] 'S[1110 4444 %%%% M !1110 4444 %%%% !1110!^A'P)\'Z7=_!7PG_P#@6U9/P _Y(;X0_P"Q:LO_ $2E==0!C_\ "#Z1_P _-[_X M%M1_P@^D?\_-[_X%M6Q10!7TW3H-*M1:6[R,H8G,KECS[FK%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% 'A?\ P3W_ .2)ZM_V/>L_^E)KW2O"_P#@GO\ \D3U;_L>]9_] M*37NE !1110!\:_\%&?^2P:/_P!BU'_Z43U\^U]!?\%&?^2P:/\ ]BU'_P"E M$]?/M !1110 4444 %%%% !1110 4444 %%%% !7Z/? #_DAOA#_ +%JR_\ M1*5^<-?H]\ /^2&^$/\ L6K+_P!$I0!UU%%% !1110 4444 %?&O_!1G_DL& MC_\ 8M1_^E$]?95?&O\ P49_Y+!H_P#V+4?_ *43T ?/M%%% !1110 4444 M%%%% !1110 4444 %%%% 'Z/? #_ )(;X0_[%JR_]$I775R/P _Y(;X0_P"Q M:LO_ $2E==0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 >??M2_M/_!_]CCX%Z[^T1\=-?DL/#V@0H9A:V[3 MW-W/)(L4%K;Q+\TT\LKI&B#JSC) R1Y[X&_;T5/CEX1_9Y_:1^!&O?"KQ'\1 M],NKWX=)KNJV5[!K+6R++TMI*ZV^H11.LK0-E&3<8I92CA?E'_@X3UC5- M;^.7["WP/NY'_P"$=\4_M:Z!#W ."5IW_!S#KVI M_#SX(] _;$\)_P!DSQ$[]KVVH/)'@'/@JFD:SXS^)7C%'E\+?#7P;;Q7&JWEO&<27DGFR1PV= MFAR&NKF2*+(VAF?"'V&OQK_X(\^*?^"@O[66C_M$_P#!67X#^'/A;JGC3XF? M$&^TWPFWQ'OK^5QH.F*%LM$MEMA&MA"&<@S>9()756>(%/,8 _7GX?ZOXZUW MPU%J?Q$\%VGA_497).EVFL?;O*3C;OE$4:[^N57&,\5Y# M_P (#_P4$_Z+_P"!/_"4D_\ BJ #_@GO_P D3U;_ +'O6?\ TI->Z5\X?\$\ M;'QXOP-U)9]=L6D'C351*PM3AI!-AR.> 6W$#L"*]W^Q>-_^@W9?^ Q_QH V M**Q_L7C?_H-V7_@,?\:/L7C?_H-V7_@,?\: /DW_ (*,_P#)8-'_ .Q:C_\ M2B>OGVO>/^"@D6JP_%C25U>[BFD_X1V,JT4>T!?/FX_G7@] !1110 4444 % M%%% !1110 4444 %%%% !7Z/? #_ )(;X0_[%JR_]$I7YPU^A'P)M/%[_!7P MFUKJ]HD1\.V9C5K-_^@W9?^ Q_QH^Q>-_^@W9?^ Q_ MQH V**Q_L7C?_H-V7_@,?\:/L7C?_H-V7_@,?\: -BBL?[%XW_Z#=E_X#'_& MC[%XW_Z#=E_X#'_&@#8KXU_X*,_\E@T?_L6H_P#THGKZR^Q>-_\ H-V7_@,? M\:^0_P#@H)%JL/Q8TE=7NXII/^$=C*M%'M 7SYN/YT >#T444 %%%% !1110 M 4444 %%%% !1110 4444 ?H]\ /^2&^$/\ L6K+_P!$I775YW\";3Q>_P % M?";6NKVB1'P[9F-6MR2%\E< FNL^Q>-_^@W9?^ Q_P : -BBL?[%XW_Z#=E_ MX#'_ !H^Q>-_^@W9?^ Q_P : -BBJ^FQZC%:A-4N(Y9=QR\2;1CMQ5B@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /E;_@ MKA^PUXT_;6^ /AG4?@K=6%O\3_A'\1-(^(/PRDU.8Q6]QJNFR^8+.:0 F..> M,NF[HK^4YX4UP7Q_^ 'QA_X*>_M)? +5?B3^S[XE^''PT^"?C-?'OB>W\;7% MA]KUKQ#;Q;=.T^UBL[F/^"3*_%+]E72_V<_%'Q"^&^I^/-0\6_!K7O!DU@S);WP5Y-"OD MNKF#[+-!*GR7+_N)4ER7C92E??%% 'S%_P $F/V'?$7["/[+M]X+^(5Y8R^, MO'7CK6/''CB+2IVEL[34]2F#M:P.P!>.&)((=Y WM$SX4, /IVBB@ HHHH \ M+_X)[_\ )$]6_P"Q[UG_ -*37NE>%_\ !/?_ )(GJW_8]ZS_ .E)KW2@ HHH MH ^-?^"C/_)8-'_[%J/_ -*)Z^?:^@O^"C/_ "6#1_\ L6H__2B>OGV@ HHH MH **** "BBB@ HHHH **** "BBB@ K]'O@!_R0WPA_V+5E_Z)2OSAK]'O@!_ MR0WPA_V+5E_Z)2@#KJ*** "BBB@ HHHH *^-?^"C/_)8-'_[%J/_ -*)Z^RJ M^-?^"C/_ "6#1_\ L6H__2B>@#Y]HHHH **** "BBB@ HHHH **** "BBB@ MHHHH _1[X ?\D-\(?]BU9?\ HE*ZZN1^ '_)#?"'_8M67_HE*ZZ@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **JZWK>C>&M&N_$?B/5[73]/L+:2YOK^]N%BAMH44L\DCL0J(J@DL2 "3 M7!?!+]KW]F3]H[5KK0?@?\;= \27UG8QW\MEI]YF5[*1BL=Y&C &:V=@0MP@ M:)B,*YH ]'HHK"^)OQ,^'_P8^'NL_%?XK>,+#P_X;\/:=+?ZWK6J7 BM[.WC M4L\CL>@ 'U)P!DD"@#=HK-\&^+_#/Q!\(:5X^\%ZS#J.C:YIL&H:3J%N28[J MVFC62*52?X61E8>QK2H **** /"_^">__)$]6_['O6?_ $I->Z5X7_P3W_Y( MGJW_ &/>L_\ I2:]TH **** /C7_ (*,_P#)8-'_ .Q:C_\ 2B>OGVOH+_@H MS_R6#1_^Q:C_ /2B>OGV@ HHHH **** "BBB@ HHHH **** "BBB@ K]'O@! M_P D-\(?]BU9?^B4K\X:_1[X ?\ )#?"'_8M67_HE* .NHHHH **** "BBB@ M KXU_P""C/\ R6#1_P#L6H__ $HGK[*KXU_X*,_\E@T?_L6H_P#THGH ^?:* M** "BBB@ HHHH **** "BBB@ HHHH **** /T>^ '_)#?"'_ &+5E_Z)2NNK MD?@!_P D-\(?]BU9?^B4KKJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@#\Y?^#A_P")&N:KH?[-7[#MA=O# MI'Q__:.\/>'O&Z(Q O-!CNX7NK1L?PR/) 6'\2QLI!#$4W_@OAX]O/V3?&_[ M(/[:'@ BQUCPS^T?IO@Z[%JNS[5X?UBSN1J%DP'!C=+*/"G(5U1@,J*Z7_@O M=^SUXZ\8_#3X+_ME_#'PI>Z[JG[-GQOT3QYJ^C:9:M/=7F@P7"'45AC4%G=$ M2*4J.=D,F 3BN._X*>_\*_\ ^"K'QT_95_95_9C\?:+XXT+1_BYI_P 4_B/K M7AG48[ZST;0--@E$)N98F987O&N7A@5OF=E=@I6-R #]**_,7_@N3J.I_ME_ ML+_M#OI&H7$?PG^#GA#4Q-/;3,B>+?&%NN#'E2/,LM,;[W59+_Y3@V#!_LK6 M_P!L'X!?%3]ICQM_P38\'?%?5-)^+6G?#E]=O/L.DSJ=+LKC9!'=Q7#)Y+2Q MO<0.$#$_,O7#!?SK_P""D7_!+7]J;]E?_@DK\5=)L?\ @K%\2->\#^#OAG=( MO@&\\$:%!9W]K&@S;RRQ6XF^?DM(&\QF)8L6)) /TE_X)[?\F"_ _P#[(_X9 M_P#35;5Z_7S#_P $=?A1\3/A+_P3S^&ME\3OVA=;^(DVM^$-&U?2+K7--M;9 MM$L)M)LA%I40MD420PE'*R/F0^:=Q.!7T]0!G^*_%?ASP-X5 M=LL$\8=''H5/!%8__"KOAG_T3O0O_!1#_P#$T >)_P#!//QKX4F^!VISQ:Y MR2>-M6DC8$_,CS[U/T*L#^->[_\ "8^&/^@U!_WU7BW_ 3VTW3E^"6JJNGP M #QSK $0X N" .G8 #\*]U_L[3_ /GQA_[]"@"G_P )CX8_Z#4'_?5'_"8^ M&/\ H-0?]]5<_L[3_P#GQA_[]"C^SM/_ .?&'_OT* /C/_@H3J=AJOQ:TB?3 MKI)D7P[&I9#T/GSG'ZUX+7O_ /P44AA@^+VCI!"J ^&XR0B@?\O$]> 4 %%% M% !1110 4444 %%%% !1110 4444 %?H=\!_%7AVV^"?A*WN-6A1X_#MFKJ3 MR"(5R*_/&OT8^ 5C8O\ _P@[V<1)\-V1),8R?W*T =%_P )CX8_Z#4'_?5' M_"8^&/\ H-0?]]5<_L[3_P#GQA_[]"C^SM/_ .?&'_OT* *?_"8^&/\ H-0? M]]4?\)CX8_Z#4'_?57/[.T__ )\8?^_0H_L[3_\ GQA_[]"@"G_PF/AC_H-0 M?]]4?\)CX8_Z#4'_ 'U5S^SM/_Y\8?\ OT*/[.T__GQA_P"_0H I_P#"8^&/ M^@U!_P!]5\?_ /!0G4[#5?BUI$^G723(OAV-2R'H?/G./UK[,_L[3_\ GQA_ M[]"OCC_@HI##!\7M'2"%4!\-QDA% _Y>)Z / **** "BBB@ HHHH **** "B MBB@ HHHH **** /T.^ _BKP[;?!/PE;W&K0H\?AVS5U)Y!$*Y%=9_P )CX8_ MZ#4'_?5<[\ K&Q?X'^$'>SB)/ANR))C&3^Y6NN_L[3_^?&'_ +]"@"G_ ,)C MX8_Z#4'_ 'U1_P )CX8_Z#4'_?57/[.T_P#Y\8?^_0H_L[3_ /GQA_[]"@ L M;^SU* 75C<++&20'7IFIJ;'%%"NR&-47T5<"G4 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 52T7PYX>\-QSQ>'=!LK!+F MX:XN5LK5(A+*WWI&"@;F.!ECR<5=HH K)HNCQZN_B"/2;9;^6W6"2]$"B9XE M)98R^-Q4$DAK-%% !1110 4444 >%_\$]_^2)ZM_V/>L_^E)KW2O"_ M^">__)$]6_['O6?_ $I->Z4 %%%% 'QK_P %&?\ DL&C_P#8M1_^E$]?/M?0 M7_!1G_DL&C_]BU'_ .E$]?/M !1110 4444 %%%% !1110 4444 %%%% !7Z M/? #_DAOA#_L6K+_ -$I7YPU^CWP _Y(;X0_[%JR_P#1*4 ==1110 4444 % M%%% !7QK_P %&?\ DL&C_P#8M1_^E$]?95?&O_!1G_DL&C_]BU'_ .E$] 'S M[1110 4444 %%%% !1110 4444 %%%% !1110!^CWP _Y(;X0_[%JR_]$I77 M5R/P _Y(;X0_[%JR_P#1*5UU !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 45\\?\%-?V[+?]@/]G.V^(FB> M%8/$7C7Q=XKT[P?\-/#%U'_ !OX/^.>NMX4M_$^D>%CH[^&_%;1B2TMPGGR MB>RNR)(8PY\Z*1%+22JYV 'V/117YT_M/_&/_@OL32,ZG(!^BU%>._\ M$_OVO-!_;U_8R^'G[7GASPU-HT'CC0%O9M(GE\PV5RKO#<0A\#S%6:*15? W M* V!G ]BH **** /"_\ @GO_ ,D3U;_L>]9_]*37NE>%_P#!/?\ Y(GJW_8] MZS_Z4FO=* "BBB@#XU_X*,_\E@T?_L6H_P#THGKY]KZ"_P""C/\ R6#1_P#L M6H__ $HGKY]H **** "BBB@ HHHH **** "BBB@ HHHH *_1[X ?\D-\(?\ M8M67_HE*_.&OT>^ '_)#?"'_ &+5E_Z)2@#KJ*** "BBB@ HHHH *^-?^"C/ M_)8-'_[%J/\ ]*)Z^RJ^-?\ @HS_ ,E@T?\ [%J/_P!*)Z /GVBBB@ HHHH M**** "BBB@ HHHH **** "BBB@#]'O@!_P D-\(?]BU9?^B4KKJY'X ?\D-\ M(?\ 8M67_HE*ZZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH _,O_@X+L=23]I3]@7Q%J2D>&[3]KK08=4D? M/E)=R7$#6I?MTCN",]@W;-+_ ,'.5MJFN_"3]ECP9X2W-XAU/]LGP>-%CB_U MAD%OJ* J1R,221=/45]I_MT?L8_#C]O+]GC4?@'\1-3O=*=KZUU7PUXETK;] MLT#6+2436>H6^X8WQR 94\.C.AP'-<%:_L-?%7XT_M$_#C]HG]MSXJ>&/%,_ MP>6ZN/ 7ASP=X7GTVQ?6+B)89-9O!<75PTDRQJ1! NU("[OOE8H8P#Z=KP3] MO7Q[XVU;X:77[)WP EBE^)_Q2T>[TK0Y'4O%X>T^11!>:]=X^[!:I+E <&:X M:"!>9"RZ.F?!3]K2Q_;7\3_'*Y_:RBN?A7J7@&+2_#GPGN/"L1CTK6ED1CJ3 M72NLDRD+(#'E=PGQD>6AKY=T7_@EQ_P5\\+?$;Q=\4O"'_!MM)TSSB#+*D2!3-(0 ⅅ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end GRAPHIC 23 ew-20201231_g4.jpg begin 644 ew-20201231_g4.jpg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end GRAPHIC 24 ew-20201231_g5.jpg begin 644 ew-20201231_g5.jpg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end GRAPHIC 25 ew-20201231_g6.jpg begin 644 ew-20201231_g6.jpg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end GRAPHIC 26 ew-20201231_g7.jpg begin 644 ew-20201231_g7.jpg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end GRAPHIC 27 ew-20201231_g8.jpg begin 644 ew-20201231_g8.jpg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end GRAPHIC 28 ew-20201231_g9.jpg begin 644 ew-20201231_g9.jpg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end GRAPHIC 29 exhibit10-161.jpg begin 644 exhibit10-161.jpg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end XML 30 ew-20201231_htm.xml IDEA: XBRL DOCUMENT 0001099800 2020-01-01 2020-12-31 0001099800 2020-06-30 0001099800 2021-01-31 0001099800 2020-12-31 0001099800 2019-12-31 0001099800 2019-01-01 2019-12-31 0001099800 2018-01-01 2018-12-31 0001099800 2018-12-31 0001099800 2017-12-31 0001099800 us-gaap:CommonStockMember 2017-12-31 0001099800 us-gaap:TreasuryStockMember 2017-12-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001099800 us-gaap:RetainedEarningsMember 2017-12-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001099800 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2017-12-31 0001099800 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001099800 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2017-12-31 0001099800 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:CommonStockMember 2017-12-31 0001099800 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:TreasuryStockMember 2017-12-31 0001099800 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001099800 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:RetainedEarningsMember 2017-12-31 0001099800 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001099800 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2017-12-31 0001099800 us-gaap:RetainedEarningsMember 2018-01-01 2018-12-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-12-31 0001099800 us-gaap:CommonStockMember 2018-01-01 2018-12-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-12-31 0001099800 us-gaap:TreasuryStockMember 2018-01-01 2018-12-31 0001099800 us-gaap:CommonStockMember 2018-12-31 0001099800 us-gaap:TreasuryStockMember 2018-12-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001099800 us-gaap:RetainedEarningsMember 2018-12-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001099800 us-gaap:RetainedEarningsMember 2019-01-01 2019-12-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0001099800 us-gaap:CommonStockMember 2019-01-01 2019-12-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-12-31 0001099800 us-gaap:TreasuryStockMember 2019-01-01 2019-12-31 0001099800 us-gaap:CommonStockMember 2019-12-31 0001099800 us-gaap:TreasuryStockMember 2019-12-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001099800 us-gaap:RetainedEarningsMember 2019-12-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001099800 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001099800 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001099800 us-gaap:TreasuryStockMember 2020-01-01 2020-12-31 0001099800 us-gaap:CommonStockMember 2020-12-31 0001099800 us-gaap:TreasuryStockMember 2020-12-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001099800 us-gaap:RetainedEarningsMember 2020-12-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001099800 2020-05-07 2020-05-07 0001099800 ew:HemodynamicMonitorsMember 2020-01-01 2020-12-31 0001099800 us-gaap:ShippingAndHandlingMember 2020-01-01 2020-12-31 0001099800 us-gaap:ShippingAndHandlingMember 2019-01-01 2019-12-31 0001099800 us-gaap:ShippingAndHandlingMember 2018-01-01 2018-12-31 0001099800 srt:MinimumMember 2020-12-31 0001099800 srt:MinimumMember 2020-01-01 2020-12-31 0001099800 srt:MaximumMember 2020-01-01 2020-12-31 0001099800 srt:MinimumMember us-gaap:BuildingAndBuildingImprovementsMember 2020-01-01 2020-12-31 0001099800 srt:MaximumMember us-gaap:BuildingAndBuildingImprovementsMember 2020-01-01 2020-12-31 0001099800 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2020-01-01 2020-12-31 0001099800 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2020-01-01 2020-12-31 0001099800 srt:MinimumMember us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2020-01-01 2020-12-31 0001099800 srt:MaximumMember us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2020-01-01 2020-12-31 0001099800 us-gaap:InProcessResearchAndDevelopmentMember 2020-01-01 2020-12-31 0001099800 us-gaap:InProcessResearchAndDevelopmentMember 2019-01-01 2019-12-31 0001099800 ew:ValtechCardioLtdMember ew:DevelopedTechnologyAndInProcessResearchAndDevelopmentMember 2018-01-01 2018-12-31 0001099800 us-gaap:StockCompensationPlanMember 2020-01-01 2020-12-31 0001099800 us-gaap:StockCompensationPlanMember 2019-01-01 2019-12-31 0001099800 us-gaap:StockCompensationPlanMember 2018-01-01 2018-12-31 0001099800 us-gaap:CostOfSalesMember 2020-01-01 2020-12-31 0001099800 us-gaap:CostOfSalesMember 2019-01-01 2019-12-31 0001099800 us-gaap:CostOfSalesMember 2018-01-01 2018-12-31 0001099800 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-12-31 0001099800 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-12-31 0001099800 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-01-01 2018-12-31 0001099800 us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-12-31 0001099800 us-gaap:ResearchAndDevelopmentExpenseMember 2019-01-01 2019-12-31 0001099800 us-gaap:ResearchAndDevelopmentExpenseMember 2018-01-01 2018-12-31 0001099800 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-12-31 0001099800 ew:AbbottLaboratoriesMember 2020-06-01 2020-06-30 0001099800 ew:AbbottLaboratoriesMember srt:ScenarioForecastMember us-gaap:SubsequentEventMember 2021-01-01 2024-05-31 0001099800 ew:AbbottLaboratoriesMember 2020-07-01 2020-07-31 0001099800 ew:TranscatheterMitralValveReplacementMember 2018-01-01 2018-12-31 0001099800 ew:ValtechCardioLtdMember us-gaap:DevelopedTechnologyRightsMember ew:RestOfWorldSegmentMember 2019-12-01 2019-12-31 0001099800 ew:ValtechCardioLtdMember ew:DevelopedTechnologyAndInProcessResearchAndDevelopmentMember ew:RestOfWorldSegmentMember 2018-12-01 2018-12-31 0001099800 ew:EarlystageTranscatheterIntellectualPropertyMember 2019-03-31 0001099800 us-gaap:PensionPlansDefinedBenefitMember 2018-03-01 2018-03-31 0001099800 srt:MaximumMember 2020-12-31 0001099800 us-gaap:BankTimeDepositsMember 2020-12-31 0001099800 us-gaap:BankTimeDepositsMember 2019-12-31 0001099800 us-gaap:CommercialPaperMember 2020-12-31 0001099800 us-gaap:CommercialPaperMember 2019-12-31 0001099800 us-gaap:USTreasuryAndGovernmentMember 2020-12-31 0001099800 us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0001099800 us-gaap:ForeignGovernmentDebtSecuritiesMember 2020-12-31 0001099800 us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-12-31 0001099800 us-gaap:AssetBackedSecuritiesMember 2020-12-31 0001099800 us-gaap:AssetBackedSecuritiesMember 2019-12-31 0001099800 us-gaap:CorporateDebtSecuritiesMember 2020-12-31 0001099800 us-gaap:CorporateDebtSecuritiesMember 2019-12-31 0001099800 us-gaap:MunicipalBondsMember 2020-12-31 0001099800 us-gaap:MunicipalBondsMember 2019-12-31 0001099800 us-gaap:OtherNonoperatingIncomeExpenseMember 2020-12-31 0001099800 us-gaap:OtherNonoperatingIncomeExpenseMember 2019-12-31 0001099800 ew:CASMedicalSystemsInc.Member 2019-02-11 0001099800 ew:CASMedicalSystemsInc.Member 2019-02-11 2019-02-11 0001099800 ew:CASMedicalSystemsInc.Member 2019-04-18 2019-04-18 0001099800 ew:CASMedicalSystemsInc.Member 2019-01-01 2019-12-31 0001099800 ew:CASMedicalSystemsInc.Member 2019-04-18 0001099800 ew:CASMedicalSystemsInc.Member us-gaap:DevelopedTechnologyRightsMember 2019-04-18 0001099800 ew:CASMedicalSystemsInc.Member us-gaap:CustomerRelationshipsMember 2019-04-18 0001099800 ew:CASMedicalSystemsInc.Member us-gaap:DevelopedTechnologyRightsMember 2019-04-18 2019-04-18 0001099800 ew:CASMedicalSystemsInc.Member us-gaap:CustomerRelationshipsMember 2019-04-18 2019-04-18 0001099800 ew:HarpoonMedicalInc.Member 2017-12-01 2017-12-01 0001099800 ew:HarpoonMedicalInc.Member 2015-12-01 2017-11-30 0001099800 ew:HarpoonMedicalInc.Member 2017-12-01 0001099800 ew:ValtechCardioLtdMember 2016-11-26 2016-11-26 0001099800 ew:ValtechCardioLtdMember 2016-11-26 0001099800 ew:ValtechCardioLtdMember 2017-01-23 2017-01-23 0001099800 ew:ValtechCardioLtdMember 2017-01-23 0001099800 ew:ValtechSpinoffMember 2017-01-23 2017-01-23 0001099800 ew:ValtechCardioLtdMember ew:DevelopedTechnologyAndInProcessResearchAndDevelopmentMember 2018-12-01 2018-12-31 0001099800 ew:CardiAQValveTechnologiesInc.Member 2015-07-03 2015-07-03 0001099800 ew:CardiAQValveTechnologiesInc.Member 2015-08-26 2015-08-26 0001099800 ew:CardiAQValveTechnologiesInc.Member 2015-08-26 0001099800 ew:CasmedMember 2019-04-01 2019-04-30 0001099800 ew:CasmedMember 2019-04-30 0001099800 ew:UnitedStatesSegmentMember 2018-12-31 0001099800 ew:EuropeSegmentMember 2018-12-31 0001099800 ew:RestOfWorldSegmentMember 2018-12-31 0001099800 ew:UnitedStatesSegmentMember 2019-01-01 2019-12-31 0001099800 ew:EuropeSegmentMember 2019-01-01 2019-12-31 0001099800 ew:RestOfWorldSegmentMember 2019-01-01 2019-12-31 0001099800 ew:UnitedStatesSegmentMember 2019-12-31 0001099800 ew:EuropeSegmentMember 2019-12-31 0001099800 ew:RestOfWorldSegmentMember 2019-12-31 0001099800 ew:UnitedStatesSegmentMember 2020-01-01 2020-12-31 0001099800 ew:EuropeSegmentMember 2020-01-01 2020-12-31 0001099800 ew:RestOfWorldSegmentMember 2020-01-01 2020-12-31 0001099800 ew:UnitedStatesSegmentMember 2020-12-31 0001099800 ew:EuropeSegmentMember 2020-12-31 0001099800 ew:RestOfWorldSegmentMember 2020-12-31 0001099800 us-gaap:PatentsMember 2020-01-01 2020-12-31 0001099800 us-gaap:PatentsMember 2020-12-31 0001099800 us-gaap:PatentsMember 2019-12-31 0001099800 us-gaap:DevelopedTechnologyRightsMember 2020-01-01 2020-12-31 0001099800 us-gaap:DevelopedTechnologyRightsMember 2020-12-31 0001099800 us-gaap:DevelopedTechnologyRightsMember 2019-12-31 0001099800 us-gaap:OtherIntangibleAssetsMember 2020-01-01 2020-12-31 0001099800 us-gaap:OtherIntangibleAssetsMember 2020-12-31 0001099800 us-gaap:OtherIntangibleAssetsMember 2019-12-31 0001099800 us-gaap:InProcessResearchAndDevelopmentMember 2020-12-31 0001099800 us-gaap:InProcessResearchAndDevelopmentMember 2019-12-31 0001099800 ew:FixedRate4.3002018NotesMember us-gaap:SeniorNotesMember 2018-06-30 0001099800 ew:SeniorNotesDue2018Member 2018-06-01 2018-06-30 0001099800 ew:FixedRate4.3002018NotesMember us-gaap:SeniorNotesMember 2020-12-31 0001099800 ew:FixedRate4.3002018NotesMember us-gaap:SeniorNotesMember 2019-12-31 0001099800 us-gaap:SeniorNotesMember 2020-12-31 0001099800 us-gaap:SeniorNotesMember 2019-12-31 0001099800 us-gaap:FairValueInputsLevel2Member ew:SeniorNotesDue2018Member 2020-12-31 0001099800 us-gaap:FairValueInputsLevel2Member ew:SeniorNotesDue2018Member 2019-12-31 0001099800 ew:CreditAgreementMaturityJuly2019Member us-gaap:LineOfCreditMember 2018-04-01 2018-04-30 0001099800 ew:CreditAgreementMaturityApril2023Member us-gaap:LineOfCreditMember 2018-04-30 0001099800 srt:MaximumMember ew:CreditAgreementMaturityApril2023Member us-gaap:LineOfCreditMember 2018-04-30 0001099800 srt:MinimumMember ew:CreditAgreementMaturityApril2023Member us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-04-01 2018-04-30 0001099800 srt:MaximumMember ew:CreditAgreementMaturityApril2023Member us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-04-01 2018-04-30 0001099800 srt:MinimumMember ew:CreditAgreementMaturityApril2023Member us-gaap:LineOfCreditMember 2018-04-01 2018-04-30 0001099800 srt:MaximumMember ew:CreditAgreementMaturityApril2023Member us-gaap:LineOfCreditMember 2018-04-01 2018-04-30 0001099800 ew:CreditAgreementMaturityApril2023Member us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2020-01-01 2020-12-31 0001099800 ew:CreditAgreementMaturityApril2023Member us-gaap:LineOfCreditMember 2020-01-01 2020-12-31 0001099800 ew:CreditAgreementMaturityApril2023Member us-gaap:LineOfCreditMember 2020-12-31 0001099800 ew:CreditAgreementMaturityApril2023Member us-gaap:LineOfCreditMember 2019-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:BankTimeDepositsMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:BankTimeDepositsMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:BankTimeDepositsMember 2020-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:BankTimeDepositsMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2020-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2020-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2020-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2020-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:BankTimeDepositsMember 2019-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:BankTimeDepositsMember 2019-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:BankTimeDepositsMember 2019-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:BankTimeDepositsMember 2019-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2019-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2019-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2019-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2019-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2019-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2019-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2019-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2019-12-31 0001099800 ew:TwoPreviousAcquisitionsMember 2020-01-01 2020-12-31 0001099800 ew:TwoPreviousAcquisitionsMember 2019-01-01 2019-12-31 0001099800 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:ObligationsMember us-gaap:MeasurementInputDiscountRateMember 2020-12-31 0001099800 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:ObligationsMember us-gaap:MeasurementInputDiscountRateMember 2020-12-31 0001099800 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:ObligationsMember us-gaap:MeasurementInputDiscountRateMember 2020-12-31 0001099800 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:ObligationsMember ew:MeasurementInputProbabilityOfMilestoneAchievementMember 2020-12-31 0001099800 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:ObligationsMember ew:MeasurementInputProbabilityOfMilestoneAchievementMember 2020-12-31 0001099800 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:ObligationsMember ew:MeasurementInputProbabilityOfMilestoneAchievementMember 2020-12-31 0001099800 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:ObligationsMember ew:MeasurementInputVolatilityOfFutureRevenueMember 2020-12-31 0001099800 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:ObligationsMember ew:MeasurementInputVolatilityOfFutureRevenueMember 2020-12-31 0001099800 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:ObligationsMember ew:MeasurementInputVolatilityOfFutureRevenueMember 2020-12-31 0001099800 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001099800 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001099800 us-gaap:CurrencySwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001099800 us-gaap:CurrencySwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001099800 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001099800 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001099800 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001099800 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001099800 us-gaap:OtherNoncurrentAssetsMember us-gaap:CurrencySwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001099800 us-gaap:OtherNoncurrentAssetsMember us-gaap:CurrencySwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001099800 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001099800 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001099800 us-gaap:ForeignExchangeContractMember 2020-12-31 0001099800 us-gaap:CurrencySwapMember 2020-12-31 0001099800 us-gaap:ForeignExchangeContractMember 2019-12-31 0001099800 us-gaap:CurrencySwapMember 2019-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2020-01-01 2020-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2019-01-01 2019-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-12-31 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-12-31 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-12-31 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2020-01-01 2020-12-31 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2019-01-01 2019-12-31 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2020-01-01 2020-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-01-01 2019-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2018-01-01 2018-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2020-01-01 2020-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-01-01 2019-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2018-01-01 2018-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2020-01-01 2020-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:OtherNonoperatingIncomeExpenseMember 2020-01-01 2020-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2020-01-01 2020-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2020-01-01 2020-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2019-01-01 2019-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-01-01 2019-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2019-01-01 2019-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-01-01 2019-12-31 0001099800 us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001099800 us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-12-31 0001099800 us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-12-31 0001099800 us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanDebtSecurityMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:OtherInvestmentsMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:USGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:USGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:USGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:USGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:MortgagesMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:MortgagesMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:MortgagesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:MortgagesMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001099800 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:USGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:USGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:USGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:USGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:MortgagesMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:MortgagesMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:MortgagesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:MortgagesMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-12-31 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-12-31 0001099800 country:US 2020-01-01 2020-12-31 0001099800 country:PR 2020-01-01 2020-12-31 0001099800 ew:NonqualifiedDeferredCompensationPlanSelectEmployeeGroupMember 2020-12-31 0001099800 ew:NonqualifiedDeferredCompensationPlanSelectEmployeeGroupMember 2019-12-31 0001099800 ew:May2019StockRepurchaseProgramMember 2019-05-31 0001099800 ew:April2018StockRepurchaseProgramMember 2018-04-30 0001099800 ew:April2018StockRepurchaseProgramMember 2018-04-01 2018-04-30 0001099800 ew:July2018StockRepurchaseProgramMember 2018-07-01 2018-07-31 0001099800 ew:AcceleratedShareRepurchaseAgreementsEnteredIntoOctober2018Member 2018-10-31 0001099800 ew:AcceleratedShareRepurchaseAgreementsEnteredIntoOctober2018Member 2018-10-01 2018-10-31 0001099800 ew:AcceleratedShareRepurchaseAgreementsEnteredIntoNovember2018Member 2018-11-01 2018-11-30 0001099800 ew:InitialDeliveryofSharesSettledMay2019Member 2019-05-31 0001099800 ew:InitialDeliveryofSharesSettledMay2019Member 2019-05-01 2019-05-31 0001099800 ew:May2019StockRepurchaseProgramSharesPurchasedAndSoldInMay2019Member 2019-05-01 2019-05-31 0001099800 ew:InitialDeliveryOfSharesSettledJune2019Member 2019-05-31 0001099800 ew:InitialDeliveryOfSharesSettledJune2019Member 2019-05-01 2019-05-31 0001099800 ew:May2019StockRepurchaseProgramSharesSoldInJune2019Member 2019-06-01 2019-06-30 0001099800 2020-05-29 2020-05-29 0001099800 srt:MinimumMember ew:EmployeeAndNonemployeeStockOptionsMember ew:LongTermStockIncentiveCompensationProgramMember 2020-01-01 2020-12-31 0001099800 srt:MaximumMember ew:EmployeeAndNonemployeeStockOptionsMember ew:LongTermStockIncentiveCompensationProgramMember 2020-01-01 2020-12-31 0001099800 ew:EmployeeAndNonemployeeStockOptionsMember ew:LongTermStockIncentiveCompensationProgramMember 2020-01-01 2020-12-31 0001099800 srt:MinimumMember us-gaap:RestrictedStockUnitsRSUMember ew:LongTermStockIncentiveCompensationProgramMember 2020-01-01 2020-12-31 0001099800 srt:MaximumMember us-gaap:RestrictedStockUnitsRSUMember ew:LongTermStockIncentiveCompensationProgramMember 2020-01-01 2020-12-31 0001099800 ew:MarketBasedRestrictedStockUnitsMember ew:LongTermStockIncentiveCompensationProgramMember 2020-01-01 2020-12-31 0001099800 ew:LongTermStockIncentiveCompensationProgramMember 2020-12-31 0001099800 srt:MaximumMember ew:RestrictedStockAndRestrictedStockUnitAwardsMember ew:LongTermStockIncentiveCompensationProgramMember 2020-12-31 0001099800 srt:MaximumMember ew:ShareBasedCompensationArrangementsAwardGrantedAnnuallyToNonemployeeDirectorMember ew:EmployeeAndNonemployeeStockOptionsMember ew:NonemployeeDirectorsStockIncentiveCompensationProgramMember 2020-12-31 0001099800 srt:MaximumMember ew:ShareBasedCompensationArrangementsAwardGrantedAnnuallyToNonemployeeDirectorMember us-gaap:RestrictedStockUnitsRSUMember ew:NonemployeeDirectorsStockIncentiveCompensationProgramMember 2020-12-31 0001099800 ew:ShareBasedCompensationArrangementsAwardGrantedAnnuallyToNonemployeeDirectorMember ew:NonemployeeDirectorsStockIncentiveCompensationProgramMember 2020-01-01 2020-12-31 0001099800 ew:ShareBasedCompensationArrangementsAwardsGranted2012AndAfterMember ew:EmployeeAndNonemployeeStockOptionsMember ew:NonemployeeDirectorsStockIncentiveCompensationProgramMember 2020-01-01 2020-12-31 0001099800 ew:NonemployeeDirectorsStockIncentiveCompensationProgramMember 2020-12-31 0001099800 us-gaap:EmployeeStockMember ew:EmployeeStockPurchasePlanMember 2020-01-01 2020-12-31 0001099800 us-gaap:EmployeeStockMember ew:EmployeeStockPurchasePlanMember 2020-12-31 0001099800 us-gaap:EmployeeStockMember ew:EmployeeStockPurchasePlanMember us-gaap:SubsequentEventMember 2021-01-01 0001099800 ew:EmployeeAndNonemployeeStockOptionsMember 2020-01-01 2020-12-31 0001099800 ew:EmployeeAndNonemployeeStockOptionsMember 2019-01-01 2019-12-31 0001099800 ew:EmployeeAndNonemployeeStockOptionsMember 2018-01-01 2018-12-31 0001099800 us-gaap:EmployeeStockMember 2020-01-01 2020-12-31 0001099800 us-gaap:EmployeeStockMember 2019-01-01 2019-12-31 0001099800 us-gaap:EmployeeStockMember 2018-01-01 2018-12-31 0001099800 ew:MarketBasedRestrictedStockUnitsMember 2020-01-01 2020-12-31 0001099800 ew:MarketBasedRestrictedStockUnitsMember 2019-01-01 2019-12-31 0001099800 ew:MarketBasedRestrictedStockUnitsMember 2018-01-01 2018-12-31 0001099800 ew:EmployeeAndNonemployeeStockOptionsMember 2019-12-31 0001099800 ew:EmployeeAndNonemployeeStockOptionsMember 2020-12-31 0001099800 us-gaap:RestrictedStockUnitsRSUMember 2019-12-31 0001099800 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2017-12-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2017-12-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-12-31 0001099800 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccumulatedTranslationAdjustmentMember 2017-12-31 0001099800 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2017-12-31 0001099800 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-12-31 0001099800 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-12-31 0001099800 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:AccumulatedTranslationAdjustmentMember 2017-12-31 0001099800 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2017-12-31 0001099800 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-12-31 0001099800 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-12-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2018-01-01 2018-12-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-01-01 2018-12-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-01-01 2018-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-01-01 2018-12-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-12-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-12-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-01-01 2019-12-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-12-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-12-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-12-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-01-01 2020-12-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-01-01 2020-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-12-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-12-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2020-01-01 2020-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2020-01-01 2020-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2019-01-01 2019-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2019-01-01 2019-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2018-01-01 2018-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2018-01-01 2018-12-31 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-12-31 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-12-31 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-01-01 2020-12-31 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-01-01 2019-12-31 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-01-01 2020-12-31 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-12-31 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-12-31 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-12-31 0001099800 country:US us-gaap:DomesticCountryMember ew:CarryforwardPeriodEnds20302037Member 2020-12-31 0001099800 country:US us-gaap:DomesticCountryMember ew:TaxCarryforwardsNoExpirationMember 2020-12-31 0001099800 country:US us-gaap:StateAndLocalJurisdictionMember ew:TaxCarryforwardsExpirationPeriodYears20262039Member 2020-12-31 0001099800 country:US us-gaap:StateAndLocalJurisdictionMember ew:TaxCarryforwardsNoExpirationMember 2020-12-31 0001099800 us-gaap:NonUsMember us-gaap:ForeignCountryMember ew:TaxCarryforwardsExpirationPeriodYears20202027Member 2020-12-31 0001099800 us-gaap:NonUsMember us-gaap:ForeignCountryMember ew:TaxCarryforwardsNoExpirationMember 2020-12-31 0001099800 country:US us-gaap:DomesticCountryMember ew:CapitalLossCarryforwardPeriodEnds2022Member 2020-12-31 0001099800 stpr:CA us-gaap:StateAndLocalJurisdictionMember us-gaap:ResearchMember ew:TaxCarryforwardsNoExpirationMember 2020-12-31 0001099800 country:US us-gaap:DomesticCountryMember us-gaap:ResearchMember ew:TaxCarryforwardsNoExpirationMember 2020-12-31 0001099800 country:PR us-gaap:ForeignCountryMember ew:PurchaseCreditMember ew:TaxCarryforwardsNoExpirationMember 2020-12-31 0001099800 country:PR us-gaap:ForeignCountryMember ew:PuertoRicoPurchasesCreditMember ew:TaxCarryforwardsNoExpirationMember 2020-12-31 0001099800 2017-01-01 2017-12-31 0001099800 us-gaap:ForeignCountryMember 2020-01-01 2020-12-31 0001099800 us-gaap:ForeignCountryMember 2019-01-01 2019-12-31 0001099800 us-gaap:ForeignCountryMember 2018-01-01 2018-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:UnitedStatesSegmentMember 2020-01-01 2020-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:UnitedStatesSegmentMember 2019-01-01 2019-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:UnitedStatesSegmentMember 2018-01-01 2018-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:EuropeSegmentMember 2020-01-01 2020-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:EuropeSegmentMember 2019-01-01 2019-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:EuropeSegmentMember 2018-01-01 2018-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:JapanSegmentMember 2020-01-01 2020-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:JapanSegmentMember 2019-01-01 2019-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:JapanSegmentMember 2018-01-01 2018-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:RestOfWorldSegmentMember 2020-01-01 2020-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:RestOfWorldSegmentMember 2019-01-01 2019-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:RestOfWorldSegmentMember 2018-01-01 2018-12-31 0001099800 us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0001099800 us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0001099800 us-gaap:OperatingSegmentsMember 2018-01-01 2018-12-31 0001099800 us-gaap:MaterialReconcilingItemsMember 2020-01-01 2020-12-31 0001099800 us-gaap:MaterialReconcilingItemsMember 2019-01-01 2019-12-31 0001099800 us-gaap:MaterialReconcilingItemsMember 2018-01-01 2018-12-31 0001099800 us-gaap:CorporateNonSegmentMember 2020-01-01 2020-12-31 0001099800 us-gaap:CorporateNonSegmentMember 2019-01-01 2019-12-31 0001099800 us-gaap:CorporateNonSegmentMember 2018-01-01 2018-12-31 0001099800 country:US 2020-01-01 2020-12-31 0001099800 country:US 2019-01-01 2019-12-31 0001099800 country:US 2018-01-01 2018-12-31 0001099800 srt:EuropeMember 2020-01-01 2020-12-31 0001099800 srt:EuropeMember 2019-01-01 2019-12-31 0001099800 srt:EuropeMember 2018-01-01 2018-12-31 0001099800 country:JP 2020-01-01 2020-12-31 0001099800 country:JP 2019-01-01 2019-12-31 0001099800 country:JP 2018-01-01 2018-12-31 0001099800 ew:RestOfWorldMember 2020-01-01 2020-12-31 0001099800 ew:RestOfWorldMember 2019-01-01 2019-12-31 0001099800 ew:RestOfWorldMember 2018-01-01 2018-12-31 0001099800 ew:TranscatheterAorticValveReplacementMember 2020-01-01 2020-12-31 0001099800 ew:TranscatheterAorticValveReplacementMember 2019-01-01 2019-12-31 0001099800 ew:TranscatheterAorticValveReplacementMember 2018-01-01 2018-12-31 0001099800 ew:TranscatheterMitralAndTricuspidTherapiesMember 2020-01-01 2020-12-31 0001099800 ew:TranscatheterMitralAndTricuspidTherapiesMember 2019-01-01 2019-12-31 0001099800 ew:TranscatheterMitralAndTricuspidTherapiesMember 2018-01-01 2018-12-31 0001099800 ew:SurgicalHeartValveTherapyMember 2020-01-01 2020-12-31 0001099800 ew:SurgicalHeartValveTherapyMember 2019-01-01 2019-12-31 0001099800 ew:SurgicalHeartValveTherapyMember 2018-01-01 2018-12-31 0001099800 ew:CriticalCareMember 2020-01-01 2020-12-31 0001099800 ew:CriticalCareMember 2019-01-01 2019-12-31 0001099800 ew:CriticalCareMember 2018-01-01 2018-12-31 0001099800 country:US 2020-12-31 0001099800 country:US 2019-12-31 0001099800 country:US 2018-12-31 0001099800 srt:EuropeMember 2020-12-31 0001099800 srt:EuropeMember 2019-12-31 0001099800 srt:EuropeMember 2018-12-31 0001099800 country:JP 2020-12-31 0001099800 country:JP 2019-12-31 0001099800 country:JP 2018-12-31 0001099800 ew:RestOfWorldMember 2020-12-31 0001099800 ew:RestOfWorldMember 2019-12-31 0001099800 ew:RestOfWorldMember 2018-12-31 0001099800 2020-01-01 2020-03-31 0001099800 2020-04-01 2020-06-30 0001099800 2020-07-01 2020-09-30 0001099800 2020-10-01 2020-12-31 0001099800 srt:MaximumMember 2020-01-01 2020-03-31 0001099800 srt:MaximumMember 2020-04-01 2020-06-30 0001099800 srt:MaximumMember 2020-07-01 2020-09-30 0001099800 srt:MaximumMember 2020-10-01 2020-12-31 0001099800 srt:MinimumMember 2020-01-01 2020-03-31 0001099800 srt:MinimumMember 2020-04-01 2020-06-30 0001099800 srt:MinimumMember 2020-07-01 2020-09-30 0001099800 srt:MinimumMember 2020-10-01 2020-12-31 0001099800 2019-01-01 2019-03-31 0001099800 2019-04-01 2019-06-30 0001099800 2019-07-01 2019-09-30 0001099800 2019-10-01 2019-12-31 0001099800 srt:MaximumMember 2019-01-01 2019-03-31 0001099800 srt:MaximumMember 2019-04-01 2019-06-30 0001099800 srt:MaximumMember 2019-07-01 2019-09-30 0001099800 srt:MaximumMember 2019-10-01 2019-12-31 0001099800 srt:MaximumMember 2019-01-01 2019-12-31 0001099800 srt:MinimumMember 2019-01-01 2019-03-31 0001099800 srt:MinimumMember 2019-04-01 2019-06-30 0001099800 srt:MinimumMember 2019-07-01 2019-09-30 0001099800 srt:MinimumMember 2019-10-01 2019-12-31 0001099800 srt:MinimumMember 2019-01-01 2019-12-31 0001099800 ew:ValtechCardioLtdMember us-gaap:DevelopedTechnologyRightsMember 2020-10-01 2020-12-31 0001099800 us-gaap:AllowanceForCreditLossMember 2019-12-31 0001099800 us-gaap:AllowanceForCreditLossMember 2020-01-01 2020-12-31 0001099800 us-gaap:AllowanceForCreditLossMember 2020-12-31 0001099800 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2019-12-31 0001099800 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2020-01-01 2020-12-31 0001099800 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2020-12-31 0001099800 us-gaap:AllowanceForCreditLossMember 2018-12-31 0001099800 us-gaap:AllowanceForCreditLossMember 2019-01-01 2019-12-31 0001099800 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2018-12-31 0001099800 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2019-01-01 2019-12-31 0001099800 us-gaap:AllowanceForCreditLossMember 2017-12-31 0001099800 us-gaap:AllowanceForCreditLossMember 2018-01-01 2018-12-31 0001099800 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2017-12-31 0001099800 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2018-01-01 2018-12-31 0001099800 ew:February2021StockRepurchaseProgramMember us-gaap:SubsequentEventMember 2021-02-12 0001099800 ew:February2021StockRepurchaseProgramMember us-gaap:SubsequentEventMember 2021-02-01 2021-02-12 iso4217:USD shares iso4217:USD shares utr:Rate pure ew:investment iso4217:EUR ew:lawsuit 0001099800 false 2020 FY P3Y P3Y 10-K true 2020-12-31 --12-31 false 1-15525 EDWARDS LIFESCIENCES CORPORATION DE 36-4316614 One Edwards Way Irvine CA 92614 949 250-2500 Common Stock, par value $1.00 per share EW NYSE Yes No Yes Yes Large Accelerated Filer false false true false 42640586293 624518873 Portions of the registrant's proxy statement for the 2021 Annual Meeting of Stockholders (to be filed within 120 days of December 31, 2020) are incorporated by reference into Part III, as indicated herein. 1183200000 1179100000 219400000 337800000 9600000 8700000 514600000 543600000 88200000 55500000 802300000 640900000 75100000 59100000 208200000 168000000.0 3091000000.0 2984000000.0 801600000 585500000 1395200000 1060300000 94200000 80100000 1173200000 1167700000 331400000 336500000 230900000 172200000 119600000 101800000 7237100000 6488100000 196500000 180400000 670200000 696500000 27200000 25500000 893900000 902400000 595000000.0 594400000 186100000 172500000 215300000 236600000 72700000 58900000 214400000 171700000 233000000.0 0 252400000 203300000 0.01 0.01 50000000.0 50000000.0 0 0 0 0 1.00 1.00 1050000000.0 1050000000.0 636400000 218100000 624300000 209100000 636400000 218100000 1438100000 1623300000 4565000000.0 3741600000 -161100000 -156000000.0 12100000 9000000.0 1904100000 1278700000 4574300000 4148300000 7237100000 6488100000 4386300000 4348000000.0 3722800000 1080600000 1114400000 939400000 3305700000 3233600000 2783400000 1228400000 1242200000 1088500000 760700000 752700000 622200000 405400000 33400000 214000000.0 13600000 -6100000 -5700000 0 64600000 116200000 897600000 1146800000 748200000 15800000 20700000 29900000 23400000 32200000 32000000.0 0 0 -7100000 11500000 8200000 4000000.0 916700000 1166500000 761400000 93300000 119600000 39200000 823400000 1046900000 722200000 1.32 1.68 1.15 1.30 1.64 1.13 622600000 624800000 627600000 631900000 636700000 640900000 823400000 1046900000 722200000 32400000 -11200000 -38600000 -40200000 -11100000 40400000 4200000 1900000 -600000 6600000 6300000 -3300000 -300000 -400000 -2900000 -5100000 -17500000 2000000.0 818300000 1029400000 724200000 823400000 1046900000 722200000 107200000 89300000 77400000 28200000 25300000 0 92600000 81300000 71000000.0 0 73100000 0 0 40600000 118800000 13600000 -6100000 -5700000 49400000 -12100000 27300000 0 24000000.0 0 3500000 2800000 -13000000.0 -41900000 88000000.0 28700000 120600000 105400000 65700000 28500000 6800000 -15600000 -84500000 116500000 12500000 270500000 -180000000.0 180000000.0 -52900000 43200000 -157800000 -16300000 -19700000 -1400000 1054300000 1182900000 926700000 407000000.0 254400000 238700000 162000000.0 130200000 210000000.0 212200000 50000000.0 578100000 689700000 437900000 249300000 564800000 359900000 223200000 0 100200000 0 10000000.0 35000000.0 0 27000000.0 12900000 600000 300000 24000000.0 3000000.0 12100000 11100000 23000000.0 -531100000 -595800000 76700000 16200000 18900000 688000000.0 17000000.0 28900000 1125300000 625400000 263300000 795500000 140500000 160500000 147000000.0 0 0 15100000 -1200000 -2800000 -300000 -486900000 -115600000 -1101200000 -20500000 -3000000.0 -6500000 15800000 468500000 -104300000 1184400000 715900000 820200000 1200200000 1184400000 715900000 212000000.0 212000000.0 2300000 -252100000 1166900000 1962100000 -132700000 2956200000 10400000 -7800000 2600000 212000000.0 212000000.0 2300000 -252100000 1166900000 1972500000 -140500000 2958800000 722200000 722200000 2000000.0 2000000.0 3200000 3200000 143800000 147000000.0 71000000.0 71000000.0 300000 32200000 2700000 34900000 5500000 795500000 795500000 215200000 215200000 7500000 -1015400000 1384400000 2694700000 -138500000 3140400000 1046900000 1046900000 -17500000 -17500000 2900000 2900000 157600000 160500000 81300000 81300000 1500000 263300000 263300000 218100000 218100000 9000000.0 -1278700000 1623300000 3741600000 -156000000.0 4148300000 823400000 823400000 -5100000 -5100000 4500000 4500000 136000000.0 140500000 92600000 92600000 3100000 625400000 625400000 413800000 -413800000 413800000 0 636400000 636400000 12100000 -1904100000 1438100000 4565000000.0 -161100000 4574300000 DESCRIPTION OF BUSINESSEdwards Lifesciences Corporation ("Edwards Lifesciences" or the "Company") conducts operations worldwide and is managed in the following geographical regions: United States, Europe, Japan, and Rest of World. Edwards Lifesciences is focused on technologies that treat structural heart disease and critically ill patients. The products and technologies provided by Edwards Lifesciences are categorized into the following main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements include the accounts of Edwards Lifesciences and its majority-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The Company reviews its investments in other entities to determine whether the Company is the primary beneficiary of a variable interest entity ("VIE"). The Company would be the primary beneficiary of the VIE, and would be required to consolidate the VIE, if it has the power to direct the significant activities of the entity and the obligation to absorb losses or receive benefits from the entity that may be significant to the VIE. Based on the Company's analysis, it determined it is not the primary beneficiary of any VIEs; however, future events may require VIEs to be consolidated if the Company becomes the primary beneficiary.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications of previously reported amounts have been made to conform to classifications used in the current year.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Split</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 7, 2020, the Company’s Board of Directors declared a three-for-one stock split of its outstanding shares of common stock effected in the form of a stock dividend, distributed on May 29, 2020 to stockholders of record on May 18, 2020. The Company distributed two newly issued shares of common stock to holders of record of each share of common stock to effect the stock split. All applicable share and per-share amounts in the consolidated financial statements and the notes to consolidated financial statements have been retroactively adjusted to reflect this stock split. The consolidated balance sheet as of December 31, 2019 and the consolidated statements of stockholders’ equity for the twelve months ended December 31, 2019 have not been retroactively adjusted to reflect the stock split.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements of Edwards Lifesciences have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") which have been applied consistently in all material respects. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. In particular, the novel Coronavirus ("COVID-19") pandemic has adversely impacted and is likely to further adversely impact nearly all aspects of our business and markets, including our workforce and the operations of our customers, suppliers, and business partners. The full extent to which the pandemic will directly or indirectly impact the Company's business, results of operations and financial condition, including sales, expenses, manufacturing, clinical trials, research and development costs, reserves and allowances, fair value measurements, asset impairment charges, contingent consideration obligations, and the effectiveness of the Company's hedging instruments, will depend on future developments that are highly uncertain and difficult to predict. These developments include, but are not limited to, the duration and spread of the outbreak (including new variants of COVID-19), its severity, the actions to contain the virus or address its impact, the timing, distribution, and efficacy of vaccines and other treatments, U.S. and foreign government actions to respond to the reduction in global economic activity, and how quickly and to what extent normal economic and operating conditions can resume.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the local currency of the Company's foreign entities is the functional currency, all assets and liabilities are translated into United States dollars at the rate of exchange in effect at the balance sheet date. Income and expense items are translated at the weighted-average exchange rate prevailing during the period. The effects of foreign currency translation adjustments for these entities are deferred and reported in stockholders' equity as a component of "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." The effects of foreign currency transactions denominated in a currency other than an entity's functional currency are included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, net.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those products or services.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates nearly all of its revenue from direct product sales and sales of products under consignment arrangements. Revenue from direct product sales is recognized at a point in time when the performance obligation is satisfied upon delivery of the product. Revenue from sales of consigned inventory is recognized at a point in time when the performance obligation is satisfied once the product has been implanted or used by the customer. The Company periodically reviews consignment inventories to confirm the accuracy of customer reporting. The Company also generates a small portion of its revenue from service contracts, and recognizes revenue from service contracts ratably over the term of the contracts. Sales taxes and other similar taxes that the Company collects concurrent with revenue-producing activities are excluded from revenue. The Company does not typically have any significant unusual payment terms beyond 90 days in its contracts with customers. In addition, the Company receives royalty payments for the licensing of certain intellectual property and recognizes the royalty when the subsequent sale of product using the intellectual property occurs.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of consideration the Company ultimately receives varies depending upon the return terms, sales rebates, discounts, and other incentives that the Company may offer, which are accounted for as variable consideration when estimating the amount of revenue to recognize. The Company includes estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely upon an assessment of historical payment experience, historical relationship to revenues, estimated customer inventory levels, and current contract sales terms with direct and indirect customers.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's sales adjustment related to distributor rebates given to the Company's United States distributors represents the difference between the Company's sales price to the distributor and the negotiated price to be paid by the end-customer. This distributor rebate is recorded as a reduction to sales and a reduction to the distributor's accounts receivable at the time of sale to a distributor. The Company periodically monitors current pricing trends and distributor inventory levels to ensure the credit for future distributor rebates is fairly stated.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers volume rebates to certain group purchasing organizations ("GPOs") and customers based upon targeted sales levels. Volume rebates offered to GPOs are recorded as a reduction to sales and an obligation to the GPOs, as the Company expects to pay in cash. Volume rebates offered to customers are recorded as a reduction to sales and either accounts receivable if the Company expects a net payment from the customer, or as an obligation to the customer if the Company expects to pay in cash. The provision for volume rebates is estimated based upon customers' contracted rebate programs, projected sales levels, and historical experience of rebates paid. The Company periodically monitors its customer rebate programs to ensure that the allowance and liability for accrued rebates is fairly stated.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product returns are typically not significant because returns are generally not allowed unless the product is damaged at time of receipt. In limited circumstances, the Company may allow customers to return previously purchased products, such as for next-generation product offerings. For these transactions, the Company defers recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells separately priced service contracts, which range from 12 to 36 months, to owners of its hemodynamic monitors. The Company invoices the customer the total amount of consideration at the inception of the contract and recognizes revenue ratably over the term of the contract. As of December 31, 2020 and December 31, 2019, $6.3 million and $8.4 million, respectively, of deferred revenue associated with outstanding service contracts was recorded in “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accrued and Other Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">” and "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Long-term Liabilities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" During 2020, the Company recognized as revenue $6.3 million that was included in the balance of deferred revenue as of December 31, 2019, and during 2019, the Company recognized as revenue $5.5 million that was included in the balance of deferred revenue as of December 31, 2018.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited number of the Company’s contracts with customers contain multiple performance obligations. For these contracts, the transaction price is allocated to each performance obligation based on its relative standalone selling price charged to other customers.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the optional exemption of not disclosing the amount of the transaction price allocated to unsatisfied performance obligations for contracts with an original expected duration of one year or less.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling Costs</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping costs, which are costs incurred to physically move product from the Company's premises or third party distribution centers, including storage, to the customer's premises, are included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General, and Administrative Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." Handling costs, which are costs incurred to store at the Company's premises, move, and prepare products for shipment, are included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Sales</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." For the years ended December 31, 2020, 2019, and 2018, shipping costs of $74.0 million, $71.5 million, and $70.6 million, respectively, were included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General, and Administrative Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">."</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Equivalents</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers highly liquid investments with original maturities of three months or less to be cash equivalents. These investments are valued at cost, which approximates fair value.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investments</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company invests its excess cash in debt securities, including time deposits, commercial paper, U.S. government and agency securities, asset-backed securities, corporate debt securities, and municipal debt securities. Investments with maturities of one year or less are classified as short-term, and investments with maturities greater than one year are classified as long-term. Investments that the Company has the ability and intent to hold until maturity are classified as held-to-maturity and carried at amortized cost. Investments in debt securities that are classified as available-for-sale are carried at fair value with unrealized gains and losses included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." The Company determines the appropriate classification of its investments in debt securities at the time of purchase and reevaluates such designation at each balance sheet date.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has long-term equity investments in companies that are in various stages of development. These investments are reported at fair value or under the equity method of accounting, as appropriate. Equity investments that do not have readily determinable fair values are recorded at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. The Company accounts for investments in limited partnerships and limited liability corporations, whereby the Company owns a minimum of 5% of the investee's outstanding voting stock, under the equity method of accounting. These investments are recorded at the amount of the Company's investment and adjusted each period for the Company's share of the investee's income or loss, and dividends paid. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized gains and losses on investments that are sold are determined using the specific identification method, or the first-in, first-out method, depending on the investment type, and recorded to "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." Income relating to investments in debt securities is recorded to "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Income.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Equity investments without readily determinable fair value are considered impaired when there is an indication that the fair value of the Company's interest is less than the carrying amount. Equity method investments are considered impaired when there is an indication of an other-than-temporary decline in value below the carrying amount. Impairments of equity investments are recorded in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other Income, net.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">" </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Debt securities in an unrealized loss position are written down to fair value through “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other Income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">” if the Company intends to sell the security or it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. For debt securities in an unrealized loss position that do not meet the aforementioned criteria, the Company assesses whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost, changes to the rating of the security by a rating agency, and any adverse conditions specifically related to the security, among other factors. When a credit loss exists, the Company compares the present value of cash flows expected to be collected from the debt security to the amortized cost basis of the security to determine the allowance amount that should be recorded, if any. For available-to-sale debt securities, any additional impairment not recorded through an allowance for credit losses is recognized in “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Accumulated Other Comprehensive Loss.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">”</span></div><div style="padding-left:36pt;text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The majority of the Company’s accounts receivable arise from direct product sales and sales of products under consignment arrangements, and have payment terms that generally require payment within 30 to 90 days. The Company does not adjust its receivables for the effects of a significant financing component at contract exception if collection of the receivable is expected within one year or less from the time of sale. In countries where the Company has experienced a pattern of payments extending beyond the stated terms and collection of the receivable is expected beyond one year from the time of sale, the Company assesses whether the customer has a significant financing component and discounts the receivable and reduces the related revenues over the period of time that the Company estimates those amounts will be paid using the country’s market-based borrowing rate for such period.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company provides reserves against accounts receivable for estimated losses that may result from a customer’s inability to pay based on customer-specific analysis and general matters such as current assessments of past due balances, economic conditions and forecasts, and historical credit loss activity. Amounts determined to be uncollectible are charged or written-off against the reserve.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value. Market value for raw materials is based on replacement costs, and for other inventory classifications is based on net realizable value.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A write-down for excess or slow moving inventory is recorded for inventory which is obsolete, damaged, nearing its expiration date (generally triggered at six months prior to expiration), or slow moving (generally defined as quantities in excess of a two-year supply). </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company allocates to inventory general and administrative costs that are related to the production process. These costs include insurance, manufacturing accounting personnel, human resources personnel, and information technology. During the years ended December 31, 2020, 2019, and 2018, the Company allocated $63.1 million, $56.6 million, and $45.0 million, respectively, of general and administrative costs to inventory. General and administrative costs included in inventory at December 31, 2020 and 2019 were $30.7 million and $22.8 million, respectively.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020 and 2019, $130.0 million and $117.8 million, respectively, of the Company's finished goods inventories were held on consignment.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant, and Equipment</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant, and equipment are recorded at cost. Depreciation is principally calculated for financial reporting purposes on the straight-line method over the estimated useful lives of the related assets, which range from 10 to 40 years for buildings and improvements, from 3 to 15 years for machinery and equipment, and from 3 to 5 years for software. Leasehold improvements are amortized over the life of the related facility leases or the asset, whichever is shorter. Straight-line and accelerated methods of depreciation are used for income tax purposes. Construction in progress is not depreciated until the asset is ready for its intended use.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense for property, plant, and equipment was $101.8 million, $84.7 million, and $74.9 million for the years ended December 31, 2020, 2019, and 2018, respectively. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On January 1, 2019, the Company adopted an amendment to the guidance on leases using a modified retrospective transition approach. The Company determines whether a contract is, or contains, a lease at inception. Right-of-use assets represent the Company’s right to use an underlying asset during the lease term, and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at lease commencement based upon the estimated present value of unpaid lease payments over the lease term. The Company uses its incremental borrowing rate based on the information available at lease commencement in determining the present value of unpaid lease payments. The Company's incremental borrowing rate is determined based on the estimated rate of interest for collateralized borrowing over a similar term as the associated lease. Right-of-use assets also include any lease payments made at or before lease commencement and any initial direct costs incurred, and exclude any lease incentives received.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the lease term as the noncancellable period of the lease, and may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Leases with a term of 12 months or less are not recognized on the balance sheet. Certain of the Company’s leases include variable lease payments that are based on costs incurred or actual usage, or adjusted periodically based on an index or a rate. The Company’s leases do not contain any residual value guarantees.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for the lease and non-lease components as a single lease component for all of its leases except vehicle leases, for which the lease and non-lease components are accounted for separately.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases are included in “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Lease Right-of-Use Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">” and “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Lease Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">” on the Company’s consolidated balance sheets. See Note 6 for further information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Goodwill and Long-lived Assets</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is reviewed for impairment annually in the fourth quarter of each fiscal year, or whenever an event occurs or circumstances change that would indicate that the carrying amount may be impaired. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the Company performs a quantitative impairment test. The Company determined, after performing a qualitative review of each reporting unit, that it is more likely than not that the fair value of each of its reporting units substantially exceeds the respective carrying amounts. Accordingly, in 2020, 2019, and 2018, the Company did not record any impairment loss.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets relate to in-process research and development acquired in business combinations. The estimated fair values of in-process research and development projects acquired in a business combination which have not reached technological feasibility are capitalized and accounted for as indefinite-lived intangible assets subject to impairment testing until completion or abandonment of the projects. Upon successful completion of the project, the capitalized amount is amortized over its estimated useful life. If the project is abandoned, all remaining capitalized amounts are written off immediately. Indefinite-lived intangible assets are reviewed for impairment annually in the fourth quarter of each fiscal year, or whenever an event occurs or circumstances change that would indicate the carrying amount may be impaired. An impairment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">loss is recognized when the asset's carrying value exceeds its fair value. In-process research and development projects acquired in an asset acquisition are expensed unless the project has an alternative future use. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management reviews the carrying amounts of other finite-lived intangible assets and long-lived tangible assets whenever events or circumstances indicate that the carrying amounts of an asset may not be recoverable. Impairment indicators include, among other conditions, cash flow deficits, historic or anticipated declines in revenue or operating profit, and adverse legal or regulatory developments. If it is determined that such indicators are present and the review indicates that the assets will not be fully recoverable, based on undiscounted estimated cash flows over the remaining amortization periods, their carrying values are reduced to estimated fair market value. Estimated fair market value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved. For the purposes of identifying and measuring impairment, long-lived assets are grouped with other assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In 2020, the Company did not record any impairment loss related to its in-process research and development assets. In 2019, the Company recorded a $40.6 million charge related to the impairment of certain in-process research and development assets. In 2018, the Company recorded a $116.2 million charge related to the impairment of certain developed technology and in-process research and development assets. See Note 4 for further information. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to income taxes in the United States and numerous foreign jurisdictions. Significant judgment is required in evaluating the Company's uncertain tax positions and determining its provision for income taxes. The Company recognizes the financial statement benefit of a tax position only after determining that a position would more likely than not be sustained based upon its technical merit if challenged by the relevant taxing authority and taken by management to the court of last resort. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon settlement with the relevant tax authority. The Company recognizes interest and penalties related to income tax matters in income tax expense. The Company has made an accounting policy election to recognize the U.S. tax effects of global intangible low-taxed income as a component of income tax expense in the period the tax arises. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities are recognized for the expected future tax consequences of events that have been recognized in the Company's financial statements or tax returns. The Company evaluates quarterly the realizability of its deferred tax assets by assessing its valuation allowance and adjusting the amount, if necessary. The factors used to assess the likelihood of realization are both historical experience and the Company's forecast of future taxable income and available tax planning strategies that could be implemented to realize the net deferred tax assets. Failure to achieve forecasted taxable income in the applicable taxing jurisdictions could affect the ultimate realization of deferred tax assets and could result in an increase in the Company's effective tax rate on future earnings.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Costs</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are charged to expense when incurred.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings per Share</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed by dividing net income by the weighted-average common shares outstanding during a period. Diluted earnings per share is computed based on the weighted-average common shares outstanding plus the effect of dilutive potential common shares outstanding during the period calculated using the treasury stock method. Dilutive potential common shares include employee equity share options, nonvested shares, and similar equity instruments granted by the Company. Potential common share equivalents have been excluded where their inclusion would be anti-dilutive.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622.6 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624.8 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627.6 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32 </span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.68 </span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.15 </span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622.6 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624.8 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627.6 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock plans</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.30 </span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.64 </span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.13 </span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options, restricted stock units, and market-based restricted stock units to purchase approximately 2.0 million, 1.5 million, and 3.2 million shares were outstanding for the years ended December 31, 2020, 2019, and 2018, respectively, but were not included in the computation of diluted earnings per share because the effect would have been anti-dilutive.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-based Compensation</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures and recognizes compensation expense for all stock-based awards based on estimated fair values. Stock-based awards consist of stock options, restricted stock units (service-based, market-based, and performance-based), and employee stock purchase subscriptions. Stock-based compensation expense is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period (vesting period) on a straight-line basis. For performance-based restricted stock units, the Company recognizes stock-based compensation expense if and when the Company concludes that it is probable that the performance condition will be achieved, net of estimated forfeitures. The Company reassesses the probability of vesting at each quarter end and adjusts the stock-based compensation expense based on its probability assessment. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Upon exercise of stock options or vesting of restricted stock units, the Company issues common stock.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense was as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.6 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.3 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.0 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense, net of tax</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.2 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.5 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.6 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon a participant's retirement, all unvested stock options and performance-based restricted stock units are immediately forfeited. In addition, upon retirement, a participant will immediately vest in 25% of service-based restricted stock units for each full year of employment with the Company measured from the grant date. All remaining unvested service-based restricted stock units are immediately forfeited. For market-based restricted stock units, upon retirement and in certain other specified cases, a participant will receive a pro-rated portion of the shares that would ultimately be issued based on attainment of the </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">performance goals as determined on the vesting date. The pro-rated portion is based on the participant's whole months of service with the Company during the performance period prior to the date of termination.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments to manage interest rate and foreign currency risks. It is the Company's policy not to enter into derivative financial instruments for speculative purposes. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative financial instruments involve credit risk in the event the counterparty should default. It is the Company's policy to execute such instruments with global financial institutions that the Company believes to be creditworthy. The Company diversifies its derivative financial instruments among counterparties to minimize exposure to any one of these entities. The Company also uses International Swap Dealers Association master-netting agreements. The master-netting agreements provide for the net settlement of all contracts through a single payment in a single currency in the event of default, as defined by the agreements.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses foreign currency forward exchange contracts, cross currency swap contracts, and foreign currency denominated debt to manage its exposure to changes in currency exchange rates from (1) future cash flows associated with intercompany transactions and certain local currency expenses expected to occur within the next 13 months (designated as cash flow hedges), (2) its net investment in certain foreign subsidiaries (designated as net investment hedges) and (3) foreign currency denominated assets or liabilities (designated as fair value hedges). The Company also uses foreign currency forward exchange contracts that are not designated as hedging instruments to offset the transaction gains and losses associated with certain assets and liabilities denominated in currencies other than their functional currencies resulting principally from intercompany and local currency transactions. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative financial instruments are recognized at fair value in the consolidated balance sheets. For each derivative instrument that is designated as a fair value hedge, the gain or loss on the derivative included in the assessment of hedge effectiveness is recognized immediately to earnings, and offsets the loss or gain on the underlying hedged item. The Company reports in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" the gain or loss on derivative financial instruments that are designated, and that qualify, as cash flow hedges. The Company reclassifies these gains and losses into earnings in the same line item and in the same period in which the underlying hedged transactions affect earnings. Changes in the fair value of net investment hedges are reported in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" as a part of the cumulative translation adjustment and would be reclassified into earnings if the underlying net investment is sold or substantially liquidated. The portion of the change in fair value related to components excluded from the hedge effectiveness assessment are amortized into earnings over the life of the derivative. The gains and losses on derivative financial instruments for which the Company does not elect hedge accounting treatment are recognized in the consolidated statements of operations in each period based upon the change in the fair value of the derivative financial instrument. Cash flows from net investment hedges are reported as investing activities in the consolidated statements of cash flows, and cash flows from all other derivative financial instruments are reported as operating activities.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on cloud computing service arrangements. The guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The guidance also requires an entity to expense the capitalized implementation costs of a hosting arrangement that is a service contract over the term of the hosting arrangement. The guidance was effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. The adoption of this guidance on January 1, 2020 did not have a material impact on the Company's consolidated financial statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued an amendment to the accounting guidance on fair value measurements. The guidance modifies the disclosure requirements on fair value measurements, including the removal of disclosures of the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation processes for Level 3 fair value measurements. The guidance also adds certain disclosure requirements related to Level 3 fair value measurements. The guidance was effective for fiscal years, and interim periods within those fiscal years, </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">beginning after December 15, 2019. The adoption of this guidance on January 1, 2020 did not have a material impact on the Company's consolidated financial statements.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued an amendment to the guidance on the measurement of credit losses on financial instruments. The amendment updates the guidance for measuring and recording credit losses on financial assets measured at amortized cost by replacing the “incurred loss” model with an “expected loss” model. Accordingly, these financial assets will be presented at the net amount expected to be collected. The amendment also requires that credit losses related to available-for-sale debt securities be recorded as an allowance through net income rather than reducing the carrying amount under the current, other-than-temporary-impairment model. The guidance was effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The adoption of this guidance on January 1, 2020 did not have a material impact on the Company's consolidated financial statements.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements include the accounts of Edwards Lifesciences and its majority-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The Company reviews its investments in other entities to determine whether the Company is the primary beneficiary of a variable interest entity ("VIE"). The Company would be the primary beneficiary of the VIE, and would be required to consolidate the VIE, if it has the power to direct the significant activities of the entity and the obligation to absorb losses or receive benefits from the entity that may be significant to the VIE. Based on the Company's analysis, it determined it is not the primary beneficiary of any VIEs; however, future events may require VIEs to be consolidated if the Company becomes the primary beneficiary.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications of previously reported amounts have been made to conform to classifications used in the current year.</span></div> 3 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements of Edwards Lifesciences have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") which have been applied consistently in all material respects. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. In particular, the novel Coronavirus ("COVID-19") pandemic has adversely impacted and is likely to further adversely impact nearly all aspects of our business and markets, including our workforce and the operations of our customers, suppliers, and business partners. The full extent to which the pandemic will directly or indirectly impact the Company's business, results of operations and financial condition, including sales, expenses, manufacturing, clinical trials, research and development costs, reserves and allowances, fair value measurements, asset impairment charges, contingent consideration obligations, and the effectiveness of the Company's hedging instruments, will depend on future developments that are highly uncertain and difficult to predict. These developments include, but are not limited to, the duration and spread of the outbreak (including new variants of COVID-19), its severity, the actions to contain the virus or address its impact, the timing, distribution, and efficacy of vaccines and other treatments, U.S. and foreign government actions to respond to the reduction in global economic activity, and how quickly and to what extent normal economic and operating conditions can resume.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the local currency of the Company's foreign entities is the functional currency, all assets and liabilities are translated into United States dollars at the rate of exchange in effect at the balance sheet date. Income and expense items are translated at the weighted-average exchange rate prevailing during the period. The effects of foreign currency translation adjustments for these entities are deferred and reported in stockholders' equity as a component of "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." The effects of foreign currency transactions denominated in a currency other than an entity's functional currency are included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, net.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those products or services.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates nearly all of its revenue from direct product sales and sales of products under consignment arrangements. Revenue from direct product sales is recognized at a point in time when the performance obligation is satisfied upon delivery of the product. Revenue from sales of consigned inventory is recognized at a point in time when the performance obligation is satisfied once the product has been implanted or used by the customer. The Company periodically reviews consignment inventories to confirm the accuracy of customer reporting. The Company also generates a small portion of its revenue from service contracts, and recognizes revenue from service contracts ratably over the term of the contracts. Sales taxes and other similar taxes that the Company collects concurrent with revenue-producing activities are excluded from revenue. The Company does not typically have any significant unusual payment terms beyond 90 days in its contracts with customers. In addition, the Company receives royalty payments for the licensing of certain intellectual property and recognizes the royalty when the subsequent sale of product using the intellectual property occurs.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of consideration the Company ultimately receives varies depending upon the return terms, sales rebates, discounts, and other incentives that the Company may offer, which are accounted for as variable consideration when estimating the amount of revenue to recognize. The Company includes estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely upon an assessment of historical payment experience, historical relationship to revenues, estimated customer inventory levels, and current contract sales terms with direct and indirect customers.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's sales adjustment related to distributor rebates given to the Company's United States distributors represents the difference between the Company's sales price to the distributor and the negotiated price to be paid by the end-customer. This distributor rebate is recorded as a reduction to sales and a reduction to the distributor's accounts receivable at the time of sale to a distributor. The Company periodically monitors current pricing trends and distributor inventory levels to ensure the credit for future distributor rebates is fairly stated.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers volume rebates to certain group purchasing organizations ("GPOs") and customers based upon targeted sales levels. Volume rebates offered to GPOs are recorded as a reduction to sales and an obligation to the GPOs, as the Company expects to pay in cash. Volume rebates offered to customers are recorded as a reduction to sales and either accounts receivable if the Company expects a net payment from the customer, or as an obligation to the customer if the Company expects to pay in cash. The provision for volume rebates is estimated based upon customers' contracted rebate programs, projected sales levels, and historical experience of rebates paid. The Company periodically monitors its customer rebate programs to ensure that the allowance and liability for accrued rebates is fairly stated.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product returns are typically not significant because returns are generally not allowed unless the product is damaged at time of receipt. In limited circumstances, the Company may allow customers to return previously purchased products, such as for next-generation product offerings. For these transactions, the Company defers recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells separately priced service contracts, which range from 12 to 36 months, to owners of its hemodynamic monitors. The Company invoices the customer the total amount of consideration at the inception of the contract and recognizes revenue ratably over the term of the contract. As of December 31, 2020 and December 31, 2019, $6.3 million and $8.4 million, respectively, of deferred revenue associated with outstanding service contracts was recorded in “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accrued and Other Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">” and "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Long-term Liabilities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" During 2020, the Company recognized as revenue $6.3 million that was included in the balance of deferred revenue as of December 31, 2019, and during 2019, the Company recognized as revenue $5.5 million that was included in the balance of deferred revenue as of December 31, 2018.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited number of the Company’s contracts with customers contain multiple performance obligations. For these contracts, the transaction price is allocated to each performance obligation based on its relative standalone selling price charged to other customers.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the optional exemption of not disclosing the amount of the transaction price allocated to unsatisfied performance obligations for contracts with an original expected duration of one year or less.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling Costs</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping costs, which are costs incurred to physically move product from the Company's premises or third party distribution centers, including storage, to the customer's premises, are included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General, and Administrative Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." Handling costs, which are costs incurred to store at the Company's premises, move, and prepare products for shipment, are included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Sales</span>." The Company sells separately priced service contracts, which range from 12 to 36 months, to owners of its hemodynamic monitors. 6300000 8400000 6300000 5500000 74000000.0 71500000 70600000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Equivalents</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers highly liquid investments with original maturities of three months or less to be cash equivalents. These investments are valued at cost, which approximates fair value.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investments</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company invests its excess cash in debt securities, including time deposits, commercial paper, U.S. government and agency securities, asset-backed securities, corporate debt securities, and municipal debt securities. Investments with maturities of one year or less are classified as short-term, and investments with maturities greater than one year are classified as long-term. Investments that the Company has the ability and intent to hold until maturity are classified as held-to-maturity and carried at amortized cost. Investments in debt securities that are classified as available-for-sale are carried at fair value with unrealized gains and losses included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." The Company determines the appropriate classification of its investments in debt securities at the time of purchase and reevaluates such designation at each balance sheet date.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has long-term equity investments in companies that are in various stages of development. These investments are reported at fair value or under the equity method of accounting, as appropriate. Equity investments that do not have readily determinable fair values are recorded at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. The Company accounts for investments in limited partnerships and limited liability corporations, whereby the Company owns a minimum of 5% of the investee's outstanding voting stock, under the equity method of accounting. These investments are recorded at the amount of the Company's investment and adjusted each period for the Company's share of the investee's income or loss, and dividends paid. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized gains and losses on investments that are sold are determined using the specific identification method, or the first-in, first-out method, depending on the investment type, and recorded to "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." Income relating to investments in debt securities is recorded to "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Income.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Equity investments without readily determinable fair value are considered impaired when there is an indication that the fair value of the Company's interest is less than the carrying amount. Equity method investments are considered impaired when there is an indication of an other-than-temporary decline in value below the carrying amount. Impairments of equity investments are recorded in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other Income, net.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">" </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Debt securities in an unrealized loss position are written down to fair value through “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other Income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">” if the Company intends to sell the security or it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. For debt securities in an unrealized loss position that do not meet the aforementioned criteria, the Company assesses whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost, changes to the rating of the security by a rating agency, and any adverse conditions specifically related to the security, among other factors. When a credit loss exists, the Company compares the present value of cash flows expected to be collected from the debt security to the amortized cost basis of the security to determine the allowance amount that should be recorded, if any. For available-to-sale debt securities, any additional impairment not recorded through an allowance for credit losses is recognized in “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Accumulated Other Comprehensive Loss.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">”</span></div> 0.05 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The majority of the Company’s accounts receivable arise from direct product sales and sales of products under consignment arrangements, and have payment terms that generally require payment within 30 to 90 days. The Company does not adjust its receivables for the effects of a significant financing component at contract exception if collection of the receivable is expected within one year or less from the time of sale. In countries where the Company has experienced a pattern of payments extending beyond the stated terms and collection of the receivable is expected beyond one year from the time of sale, the Company assesses whether the customer has a significant financing component and discounts the receivable and reduces the related revenues over the period of time that the Company estimates those amounts will be paid using the country’s market-based borrowing rate for such period.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company provides reserves against accounts receivable for estimated losses that may result from a customer’s inability to pay based on customer-specific analysis and general matters such as current assessments of past due balances, economic conditions and forecasts, and historical credit loss activity. Amounts determined to be uncollectible are charged or written-off against the reserve.</span></div> P30D P90D <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value. Market value for raw materials is based on replacement costs, and for other inventory classifications is based on net realizable value.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A write-down for excess or slow moving inventory is recorded for inventory which is obsolete, damaged, nearing its expiration date (generally triggered at six months prior to expiration), or slow moving (generally defined as quantities in excess of a two-year supply). </span></div>The Company allocates to inventory general and administrative costs that are related to the production process. These costs include insurance, manufacturing accounting personnel, human resources personnel, and information technology. P6M P2Y 63100000 56600000 45000000.0 30700000 22800000 130000000.0 117800000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant, and Equipment</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant, and equipment are recorded at cost. Depreciation is principally calculated for financial reporting purposes on the straight-line method over the estimated useful lives of the related assets, which range from 10 to 40 years for buildings and improvements, from 3 to 15 years for machinery and equipment, and from 3 to 5 years for software. Leasehold improvements are amortized over the life of the related facility leases or the asset, whichever is shorter. Straight-line and accelerated methods of depreciation are used for income tax purposes. Construction in progress is not depreciated until the asset is ready for its intended use.</span></div> P10Y P40Y P3Y P15Y P3Y P5Y 101800000 84700000 74900000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On January 1, 2019, the Company adopted an amendment to the guidance on leases using a modified retrospective transition approach. The Company determines whether a contract is, or contains, a lease at inception. Right-of-use assets represent the Company’s right to use an underlying asset during the lease term, and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at lease commencement based upon the estimated present value of unpaid lease payments over the lease term. The Company uses its incremental borrowing rate based on the information available at lease commencement in determining the present value of unpaid lease payments. The Company's incremental borrowing rate is determined based on the estimated rate of interest for collateralized borrowing over a similar term as the associated lease. Right-of-use assets also include any lease payments made at or before lease commencement and any initial direct costs incurred, and exclude any lease incentives received.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the lease term as the noncancellable period of the lease, and may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Leases with a term of 12 months or less are not recognized on the balance sheet. Certain of the Company’s leases include variable lease payments that are based on costs incurred or actual usage, or adjusted periodically based on an index or a rate. The Company’s leases do not contain any residual value guarantees.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for the lease and non-lease components as a single lease component for all of its leases except vehicle leases, for which the lease and non-lease components are accounted for separately.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases are included in “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Lease Right-of-Use Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">” and “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Lease Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">” on the Company’s consolidated balance sheets. See Note 6 for further information.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Goodwill and Long-lived Assets</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is reviewed for impairment annually in the fourth quarter of each fiscal year, or whenever an event occurs or circumstances change that would indicate that the carrying amount may be impaired. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the Company performs a quantitative impairment test. The Company determined, after performing a qualitative review of each reporting unit, that it is more likely than not that the fair value of each of its reporting units substantially exceeds the respective carrying amounts. Accordingly, in 2020, 2019, and 2018, the Company did not record any impairment loss.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets relate to in-process research and development acquired in business combinations. The estimated fair values of in-process research and development projects acquired in a business combination which have not reached technological feasibility are capitalized and accounted for as indefinite-lived intangible assets subject to impairment testing until completion or abandonment of the projects. Upon successful completion of the project, the capitalized amount is amortized over its estimated useful life. If the project is abandoned, all remaining capitalized amounts are written off immediately. Indefinite-lived intangible assets are reviewed for impairment annually in the fourth quarter of each fiscal year, or whenever an event occurs or circumstances change that would indicate the carrying amount may be impaired. An impairment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">loss is recognized when the asset's carrying value exceeds its fair value. In-process research and development projects acquired in an asset acquisition are expensed unless the project has an alternative future use. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management reviews the carrying amounts of other finite-lived intangible assets and long-lived tangible assets whenever events or circumstances indicate that the carrying amounts of an asset may not be recoverable. Impairment indicators include, among other conditions, cash flow deficits, historic or anticipated declines in revenue or operating profit, and adverse legal or regulatory developments. If it is determined that such indicators are present and the review indicates that the assets will not be fully recoverable, based on undiscounted estimated cash flows over the remaining amortization periods, their carrying values are reduced to estimated fair market value. Estimated fair market value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved. For the purposes of identifying and measuring impairment, long-lived assets are grouped with other assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. </span></div> In 2020, the Company did not record any impairment loss related to its in-process research and development assets. In 2019, the Company recorded a $40.6 million charge related to the impairment of certain in-process research and development assets. In 2018, the Company recorded a $116.2 million charge related to the impairment of certain developed technology and in-process research and development assets. See Note 4 for further information. 0 40600000 116200000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to income taxes in the United States and numerous foreign jurisdictions. Significant judgment is required in evaluating the Company's uncertain tax positions and determining its provision for income taxes. The Company recognizes the financial statement benefit of a tax position only after determining that a position would more likely than not be sustained based upon its technical merit if challenged by the relevant taxing authority and taken by management to the court of last resort. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon settlement with the relevant tax authority. The Company recognizes interest and penalties related to income tax matters in income tax expense. The Company has made an accounting policy election to recognize the U.S. tax effects of global intangible low-taxed income as a component of income tax expense in the period the tax arises. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities are recognized for the expected future tax consequences of events that have been recognized in the Company's financial statements or tax returns. The Company evaluates quarterly the realizability of its deferred tax assets by assessing its valuation allowance and adjusting the amount, if necessary. The factors used to assess the likelihood of realization are both historical experience and the Company's forecast of future taxable income and available tax planning strategies that could be implemented to realize the net deferred tax assets. Failure to achieve forecasted taxable income in the applicable taxing jurisdictions could affect the ultimate realization of deferred tax assets and could result in an increase in the Company's effective tax rate on future earnings.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Costs</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are charged to expense when incurred.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings per Share</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed by dividing net income by the weighted-average common shares outstanding during a period. Diluted earnings per share is computed based on the weighted-average common shares outstanding plus the effect of dilutive potential common shares outstanding during the period calculated using the treasury stock method. Dilutive potential common shares include employee equity share options, nonvested shares, and similar equity instruments granted by the Company. Potential common share equivalents have been excluded where their inclusion would be anti-dilutive.</span></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622.6 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624.8 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627.6 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32 </span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.68 </span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.15 </span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622.6 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624.8 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627.6 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock plans</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.30 </span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.64 </span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.13 </span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 823400000 1046900000 722200000 622600000 624800000 627600000 1.32 1.68 1.15 823400000 1046900000 722200000 622600000 624800000 627600000 9300000 11900000 13300000 631900000 636700000 640900000 1.30 1.64 1.13 2000000.0 1500000 3200000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-based Compensation</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures and recognizes compensation expense for all stock-based awards based on estimated fair values. Stock-based awards consist of stock options, restricted stock units (service-based, market-based, and performance-based), and employee stock purchase subscriptions. Stock-based compensation expense is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period (vesting period) on a straight-line basis. For performance-based restricted stock units, the Company recognizes stock-based compensation expense if and when the Company concludes that it is probable that the performance condition will be achieved, net of estimated forfeitures. The Company reassesses the probability of vesting at each quarter end and adjusts the stock-based compensation expense based on its probability assessment. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Upon exercise of stock options or vesting of restricted stock units, the Company issues common stock.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense was as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.6 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.3 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.0 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense, net of tax</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.2 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.5 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.6 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon a participant's retirement, all unvested stock options and performance-based restricted stock units are immediately forfeited. In addition, upon retirement, a participant will immediately vest in 25% of service-based restricted stock units for each full year of employment with the Company measured from the grant date. All remaining unvested service-based restricted stock units are immediately forfeited. For market-based restricted stock units, upon retirement and in certain other specified cases, a participant will receive a pro-rated portion of the shares that would ultimately be issued based on attainment of the </span></div>performance goals as determined on the vesting date. The pro-rated portion is based on the participant's whole months of service with the Company during the performance period prior to the date of termination. <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense was as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.6 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.3 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.0 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense, net of tax</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.2 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.5 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.6 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 17200000 14700000 11400000 56600000 51200000 46300000 18800000 15400000 13300000 92600000 81300000 71000000.0 15400000 14800000 13400000 77200000 66500000 57600000 0.25 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments to manage interest rate and foreign currency risks. It is the Company's policy not to enter into derivative financial instruments for speculative purposes. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative financial instruments involve credit risk in the event the counterparty should default. It is the Company's policy to execute such instruments with global financial institutions that the Company believes to be creditworthy. The Company diversifies its derivative financial instruments among counterparties to minimize exposure to any one of these entities. The Company also uses International Swap Dealers Association master-netting agreements. The master-netting agreements provide for the net settlement of all contracts through a single payment in a single currency in the event of default, as defined by the agreements.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses foreign currency forward exchange contracts, cross currency swap contracts, and foreign currency denominated debt to manage its exposure to changes in currency exchange rates from (1) future cash flows associated with intercompany transactions and certain local currency expenses expected to occur within the next 13 months (designated as cash flow hedges), (2) its net investment in certain foreign subsidiaries (designated as net investment hedges) and (3) foreign currency denominated assets or liabilities (designated as fair value hedges). The Company also uses foreign currency forward exchange contracts that are not designated as hedging instruments to offset the transaction gains and losses associated with certain assets and liabilities denominated in currencies other than their functional currencies resulting principally from intercompany and local currency transactions. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative financial instruments are recognized at fair value in the consolidated balance sheets. For each derivative instrument that is designated as a fair value hedge, the gain or loss on the derivative included in the assessment of hedge effectiveness is recognized immediately to earnings, and offsets the loss or gain on the underlying hedged item. The Company reports in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" the gain or loss on derivative financial instruments that are designated, and that qualify, as cash flow hedges. The Company reclassifies these gains and losses into earnings in the same line item and in the same period in which the underlying hedged transactions affect earnings. Changes in the fair value of net investment hedges are reported in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" as a part of the cumulative translation adjustment and would be reclassified into earnings if the underlying net investment is sold or substantially liquidated. The portion of the change in fair value related to components excluded from the hedge effectiveness assessment are amortized into earnings over the life of the derivative. The gains and losses on derivative financial instruments for which the Company does not elect hedge accounting treatment are recognized in the consolidated statements of operations in each period based upon the change in the fair value of the derivative financial instrument. Cash flows from net investment hedges are reported as investing activities in the consolidated statements of cash flows, and cash flows from all other derivative financial instruments are reported as operating activities.</span></div> P13M <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on cloud computing service arrangements. The guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The guidance also requires an entity to expense the capitalized implementation costs of a hosting arrangement that is a service contract over the term of the hosting arrangement. The guidance was effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. The adoption of this guidance on January 1, 2020 did not have a material impact on the Company's consolidated financial statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued an amendment to the accounting guidance on fair value measurements. The guidance modifies the disclosure requirements on fair value measurements, including the removal of disclosures of the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation processes for Level 3 fair value measurements. The guidance also adds certain disclosure requirements related to Level 3 fair value measurements. The guidance was effective for fiscal years, and interim periods within those fiscal years, </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">beginning after December 15, 2019. The adoption of this guidance on January 1, 2020 did not have a material impact on the Company's consolidated financial statements.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued an amendment to the guidance on the measurement of credit losses on financial instruments. The amendment updates the guidance for measuring and recording credit losses on financial assets measured at amortized cost by replacing the “incurred loss” model with an “expected loss” model. Accordingly, these financial assets will be presented at the net amount expected to be collected. The amendment also requires that credit losses related to available-for-sale debt securities be recorded as an allowance through net income rather than reducing the carrying amount under the current, other-than-temporary-impairment model. The guidance was effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The adoption of this guidance on January 1, 2020 did not have a material impact on the Company's consolidated financial statements.</span></div> INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred intellectual property litigation expenses, including settlements and external legal costs, of $405.4 million, $33.4 million and $214.0 million during 2020, 2019 and 2018, respectively. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 12, 2020, the Company reached an agreement with Abbott Laboratories and its direct and indirect subsidiaries ("Abbott") to, among other things, settle all outstanding patent disputes between the companies (the “Settlement Agreement”) in cases related to transcatheter mitral and tricuspid repair products. See Note 18 for additional information. The Settlement Agreement resulted in the Company recording an estimated $367.9 million pre-tax charge and related liability in June 2020 related to past damages. In addition, the Company will incur royalty expenses through May 2024 totaling an estimated $100 million. The Company made a one-time $100.0 million payment to Abbott in July 2020, and will make quarterly payments in future years. </span></div>In January 2019, the Company reached an agreement with Boston Scientific Corporation ("Boston Scientific") to settle all outstanding patent disputes for a one-time payment to Boston Scientific of $180.0 million, which was included as an expense in 2018. The settlement covered alleged past damages and no further royalties will be owed by either party. 405400000 33400000 214000000.0 367900000 100000000 100000000.0 -180000000.0 SPECIAL CHARGES (GAIN)<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Impairment of Long-lived Assets</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Company recorded a charge of $40.6 million related to the impairment of certain in-process research and development assets, and in December 2018, the Company recorded a charge of $116.2 million related to the impairment of certain developed technology and in-process research and development assets. These assets were acquired as part of the acquisition of Valtech Cardio Ltd. ("Valtech"). The Company measured the amount of the impairments by calculating the amount by which the carrying values exceeded the estimated fair values, which were based on projected discounted future net cash flows. Based on market and clinical trial developments at the time of the impairments, the Company re-evaluated the clinical development plans for the technologies acquired from Valtech, which resulted in a reduction to the projected near-term discounted future net cash flows related to the acquired mitral technology for the 2018 charge, and related to the acquired mitral and tricuspid technology for the 2019 charge. The impairments were recorded to the Company’s Rest of World segment.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Acquisition of Intellectual Property</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2019, the Company recorded a $24.0 million charge related to the acquisition of early-stage transcatheter intellectual property and associated clinical and regulatory experience.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Pension Gain</span></div>In March 2018, the Company recorded a $7.1 million gain related to the curtailment of its defined benefit plan in Switzerland resulting from the closure of its manufacturing plant. 40600000 116200000 24000000.0 7100000 OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Composition of Certain Financial Statement Captions</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of selected captions in the consolidated balance sheets are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment with customers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,993.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(598.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(512.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,395.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and withholdings</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, payroll, and other taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlement (Notes 3 and 18)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation and insurance reserves (Note 18)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued marketing expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued realignment reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued relocation related costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, the Company recorded a $73.1 million charge to "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Sales</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">," primarily comprised of the write off of inventory related to strategic decisions regarding its transcatheter aortic valve portfolio, including the decision to discontinue its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CENTERA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> program.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplemental Cash Flow Information</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.600%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.846%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the year for:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash investing and financing transactions:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of shares issued in payment for contingent consideration liabilities </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures accruals</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:5pt;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.600%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.846%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,183.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,179.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,184.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts included in restricted cash primarily represent funds placed in escrow related to litigation and real estate purchases, and funds restricted for construction.</span></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of selected captions in the consolidated balance sheets are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment with customers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,993.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(598.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(512.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,395.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and withholdings</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, payroll, and other taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlement (Notes 3 and 18)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation and insurance reserves (Note 18)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued marketing expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued realignment reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued relocation related costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 136700000 118000000.0 140000000.0 121700000 525600000 401200000 802300000 640900000 97600000 98000000.0 881500000 619800000 564900000 466300000 42200000 35600000 94200000 87900000 313300000 265000000.0 1993700000 1572600000 598500000 512300000 1395200000 1060300000 236700000 295800000 67200000 67100000 49700000 51400000 52300000 51400000 37500000 0 23300000 20000000.0 18600000 52900000 39300000 6400000 14300000 17500000 7600000 10100000 14500000 16700000 21000000.0 17400000 88200000 89800000 670200000 696500000 73100000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplemental Cash Flow Information</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.600%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.846%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the year for:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash investing and financing transactions:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of shares issued in payment for contingent consideration liabilities </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures accruals</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 19900000 19900000 30100000 197900000 61500000 223700000 29700000 28600000 0 0 0 34300000 39700000 49600000 0 80400000 50800000 18700000 <div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.600%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.846%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,183.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,179.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,184.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.600%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.846%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,183.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,179.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,184.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1183200000 1179100000 714100000 16600000 1600000 1500000 400000 3700000 300000 1200200000 1184400000 715900000 LEASES<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases certain office space, manufacturing facilities, land, apartments, warehouses, vehicles, and equipment with remaining lease terms ranging from less than 1 year to 20 years, some of which include options to extend or terminate the leases.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease costs for the years ended December 31, 2020, 2019, and 2018 were $30.5 million, $27.9 million, and $27.0 million, respectively. Short-term and variable lease costs were not material for the years ended December 31, 2020 and 2019.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to operating leases was as follows (in millions, except lease term and discount rate):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.753%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, current portion</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, long-term portion</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of operating lease liabilities at December 31, 2020 were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.181%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information on the lease terms and discount rates:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.753%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div>As of December 31, 2020, the Company had no additional operating lease commitments for office space that have not yet commenced. P1Y P20Y 30500000 27900000 27000000.0 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to operating leases was as follows (in millions, except lease term and discount rate):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.753%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, current portion</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, long-term portion</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 94200000 80100000 27200000 25500000 72700000 58900000 99900000 84400000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of operating lease liabilities at December 31, 2020 were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.181%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information on the lease terms and discount rates:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.753%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.183%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 30000000.0 20700000 14400000 8800000 6100000 28100000 108100000 8200000 99900000 P6Y7M6D P5Y3M18D 0.027 0.028 0 INVESTMENTS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Debt Securities</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in debt securities at the end of each period were as follows (in millions):</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.092%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Held-to-maturity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank time deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank time deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">935.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">790.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">793.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost and fair value of investments in debt securities, by contractual maturity, as of December 31, 2020 were as follows:</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-to-Maturity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in 1 year or less</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after 1 year through 5 years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments not due at a single maturity date</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">935.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual maturities may differ from the contractual maturities due to call or prepayment rights.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no investments that were in an unrealized loss position as of December 31, 2020. The following table presents gross unrealized losses and fair values for those investments that were in an unrealized loss position as of December 31, 2019, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.849%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:5pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.849%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Investments in Unconsolidated Affiliates</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a number of equity investments in privately and publicly held companies. Investments in these unconsolidated affiliates are recorded in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated balance sheets, and are as follows:</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of equity method investments</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of non-marketable equity securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total investments in unconsolidated affiliates</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-marketable equity securities consist of investments in privately held companies without readily determinable fair values, and are reported at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. The Company recorded an upward adjustment of $1.8 million based on observable price changes and a downward adjustment of $0.7 million due to an impairment during 2020, and an upward adjustment of $0.3 million based on observable price changes during 2019. As of December 31, 2020 and 2019, the Company had recorded accumulated upward adjustments of $3.8 million and $2.0 million, respectively, based on observable price changes, and accumulated downward adjustments of $2.6 million and $1.9 million, respectively, due to impairment and observable price changes.</span></div>During 2020, 2019, and 2018, the gross realized gains or losses from sales of available-for-sale investments were not material. <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in debt securities at the end of each period were as follows (in millions):</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.092%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Held-to-maturity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank time deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank time deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">935.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">790.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">793.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 50000000.0 0 0 50000000.0 100200000 0 0 100200000 24100000 0 0 24100000 13100000 0 0 13100000 0 0 0 0 34300000 0 0 34300000 147000000.0 2200000 0 149200000 113200000 600000 0 113800000 0 0 0 0 1700000 0 0 1700000 149600000 1900000 0 151500000 141200000 600000 100000 141700000 600800000 7500000 0 608300000 487000000.0 2300000 100000 489200000 2800000 0 0 2800000 0 0 0 0 924300000 11600000 0 935900000 790500000 3500000 200000 793800000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost and fair value of investments in debt securities, by contractual maturity, as of December 31, 2020 were as follows:</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-to-Maturity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in 1 year or less</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after 1 year through 5 years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments not due at a single maturity date</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">935.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 50000000.0 50000000.0 168400000 169400000 0 0 578200000 586500000 0 0 177700000 180000000.0 50000000.0 50000000.0 924300000 935900000 0 The following table presents gross unrealized losses and fair values for those investments that were in an unrealized loss position as of December 31, 2019, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.849%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 73400000 100000 0 0 73400000 100000 81400000 100000 0 0 81400000 100000 154800000 200000 0 0 154800000 200000 Investments in these unconsolidated affiliates are recorded in "<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated balance sheets, and are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of equity method investments</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of non-marketable equity securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total investments in unconsolidated affiliates</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 5700000 6200000 29400000 23100000 35100000 29300000 1800000 700000 300000 3800000 2000000.0 2600000 1900000 ACQUISITIONS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAS Medical Systems, Inc.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 11, 2019, the Company entered into an agreement and plan of merger to acquire all the outstanding shares of CAS Medical Systems, Inc. ("CASMED") for an aggregate cash purchase price of $2.45 per share of common stock, or an equity value of approximately $100 million. The transaction closed on April 18, 2019, and the cash purchase price was $100.8 million. Acquisition-related costs of $2.0 million were recorded in “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General, and Administrative Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">” during the year ended December 31, 2019.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CASMED is a medical technology company dedicated to noninvasive monitoring of tissue oxygenation in the brain. The Company integrated the acquired technology platform into its hemodynamic monitoring platform. The acquisition was accounted for as a business combination. Tangible and intangible assets acquired were recorded based on their estimated fair values at the acquisition date. The excess of the purchase price over the fair value of net assets acquired was recorded to goodwill. The following table summarizes the fair values of the assets acquired and liabilities assumed (in millions):</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.642%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.117%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: cash acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price, net of cash acquired</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill includes expected synergies and other benefits the Company believes will result from the acquisition. Goodwill was assigned to the Company’s United States segment and is not deductible for tax purposes. Developed technology assets are being amortized over a weighted-average useful life of 14 years. Customer relationships assets are being amortized over a weighted-average useful life of 10 years. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for CASMED have been included in the accompanying consolidated financial statements from the date of acquisition. Pro forma results have not been presented as the results of CASMED are not material in relation to the consolidated financial statements of Edwards Lifesciences.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Harpoon Medical, Inc.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 1, 2017, the Company acquired all the outstanding shares of Harpoon Medical, Inc. for an aggregate cash purchase price of $119.5 million, which includes $16.0 million paid previously for a cost method investment and an exclusive option to acquire Harpoon Medical, Inc., and is net of $8.0 million received from the sale of the Company's previous ownership interest. In addition, the Company agreed to pay up to an additional $150.0 million in pre-specified milestone-driven payments over the next 10 years. The Company recognized in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" a $59.7 million liability for the estimated fair value of the contingent milestone payments. The fair value of the contingent milestone payments are remeasured each quarter, with changes in the fair value recognized within operating expenses on the consolidated statements of operations. For further information on the fair value of the contingent milestone payments, see Note 11. </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In-process research and development assets acquired as part of this transaction were capitalized at fair value, which was determined using the income approach. This approach determines fair value based on cash flow projections which are discounted to present value using a risk-adjusted rate of return. Completion of successful design developments, bench testing, pre-clinical studies and human clinical studies are required prior to selling any product. The risks and uncertainties associated with completing development within a reasonable period of time include those related to the design, development, and manufacturability of the product, the success of pre-clinical and clinical studies, and the timing of regulatory approvals. The valuation assumed $41.4 million of additional research and development expenditures would be incurred prior to the date of product introduction. In the valuation, net cash inflows were modeled to commence in Europe in 2018, and in the United States and Japan in 2022. The Company does not currently anticipate significant changes to forecasted research and development expenditures, and net cash inflows commenced in Europe in 2020 and are now expected to commence in the United States and Japan in 2023. Upon completion of development, the underlying in-process research and development asset will be amortized over its estimated useful life. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Valtech Cardio Ltd.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 26, 2016, the Company entered into an agreement and plan of merger to acquire Valtech Cardio Ltd. ("Valtech") for approximately $340.0 million, subject to certain adjustments, with the potential for up to an additional $350.0 million in pre-specified milestone-driven payments over the next 10.0 years. The transaction closed on January 23, 2017, and the consideration paid included the issuance of approximately 2.8 million shares of the Company's common stock (fair value of $266.5 million) and cash of $86.2 million. The Company recognized in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" a $162.9 million liability for the estimated fair value of the contingent milestone payments. For further information on the fair value of the contingent milestone payments, see Note 11. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the close of the transaction, Valtech spun off its early-stage transseptal mitral valve replacement technology program. Concurrent with the closing, the Company entered into an agreement for an exclusive option to acquire that program and its associated intellectual property for approximately $200.0 million, subject to certain adjustments, plus an additional $50.0 million if a certain European regulatory approval is obtained within 10 years of the acquisition closing date. The option expired in January 2020. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In-process research and development assets acquired as part of this transaction were capitalized at fair value, which was determined using the income approach. This approach determines fair value based on cash flow projections which are discounted to present value using a risk-adjusted rate of return. The valuation assumed $87.3 million of additional research and development expenditures would be incurred prior to the date of product introduction and that net cash inflows would commence in 2019. In December 2018, the Company recorded a $116.2 million impairment charge related to Valtech's intangible assets, and in December 2019, the Company recorded a $40.6 million impairment charge to write off the remaining in-process research and development assets. For further information, see Note 4. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CardiAQ Valve Technologies, Inc.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 3, 2015, the Company entered into an agreement and plan of merger to acquire CardiAQ Valve Technologies, Inc. ("CardiAQ") for an aggregate cash purchase price of $350.0 million, subject to certain adjustments. The transaction closed on August 26, 2015, and the cash purchase price after the adjustments was $348.0 million. In addition, the Company agreed to pay an additional $50.0 million if a certain European regulatory approval is obtained within 48 months of the acquisition closing date. The Company recognized in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" a $30.3 million liability for the estimated fair value of this contingent milestone payment. The Company estimated this milestone would not be achieved and reversed the liability in 2018. For further information on the fair value of the contingent milestone payment, see Note 11.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In-process research and development assets acquired as part of this acquisition were capitalized at fair value, which was determined using the income approach. This approach determines fair value based on cash flow projections which are discounted to present value using a risk-adjusted rate of return. Completion of successful design developments, bench testing, pre-clinical studies and human clinical studies are required prior to selling any product. The risks and uncertainties associated with completing development within a reasonable period of time include those related to the design, development, and manufacturability of the product, the success of pre-clinical and clinical studies, and the timing of regulatory approvals. The valuation assumed $97.7 million of additional research and development expenditures would be incurred prior to the date of </span></div>product introduction and that net cash inflows would commence in late 2018. As a result of certain design enhancements to increase the product's commercial life and applicability to a broader group of patients, the Company has incurred incremental research and development expenditures; however, the Company expects an increase in the net cash inflows, commencing in 2023. Upon completion of development, the underlying research and development intangible asset will be amortized over its estimated useful life. 2.45 100000000 100800000 2000000.0 The following table summarizes the fair values of the assets acquired and liabilities assumed (in millions):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.642%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.117%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: cash acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price, net of cash acquired</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table> 6100000 1300000 64400000 35900000 8800000 2200000 17900000 100800000 600000 100200000 P14Y P10Y 119500000 16000000.0 8000000.0 150000000.0 P10Y 59700000 41400000 340000000.0 350000000.0 P10Y 2800000 266500000 86200000 162900000 200000000.0 50000000.0 P10Y 87300000 116200000 40600000 350000000.0 348000000.0 50000000.0 P48M 30300000 97700000 GOODWILL AND OTHER INTANGIBLE ASSETS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and in-process research and development assets resulting from purchase business combinations are not subject to amortization. Other acquired intangible assets with finite lives are amortized over their expected useful lives on a straight-line basis, or if reliably determinable, based on the pattern in which the economic benefit of the asset is expected to be used. The Company expenses costs incurred to renew or extend the term of acquired intangible assets.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2019, the Company acquired CASMED. This transaction resulted in an increase to goodwill of $64.4 million and developed technology of $35.9 million. For further information, see Note 8.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill, by segment, during the years ended December 31, 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2019 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:46.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.659%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United<br/>States</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at December 31, 2018</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,112.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,173.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets consist of the following (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.684%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.102%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Useful Life (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">572.0 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240.6)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.4 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569.6 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233.1)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336.5 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense related to other intangible assets for the years ended December 31, 2020, 2019, and 2018 was $5.4 million, $4.6 million, and $2.5 million, respectively. Estimated amortization expense for each of the years ending December 31 is as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 64400000 35900000 <div style="text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill, by segment, during the years ended December 31, 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2019 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:46.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.659%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United<br/>States</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at December 31, 2018</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,112.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,173.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 709300000 64200000 338700000 1112200000 64400000 0 0 64400000 0 -1400000 -7500000 -8900000 773700000 62800000 331200000 1167700000 0 5500000 0 5500000 773700000 68300000 331200000 1173200000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets consist of the following (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.684%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.102%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Useful Life (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">572.0 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240.6)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.4 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569.6 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233.1)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336.5 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets consist of the following (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.684%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.102%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Useful Life (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">572.0 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240.6)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.4 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569.6 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233.1)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336.5 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> P7Y4M24D 186100000 183600000 2500000 185700000 182100000 3600000 P13Y1M6D 155200000 51000000.0 104200000 153500000 46600000 106900000 P10Y 12600000 6000000.0 6600000 12300000 4400000 7900000 P12Y7M6D 353900000 240600000 113300000 351500000 233100000 118400000 218100000 218100000 218100000 218100000 572000000.0 240600000 331400000 569600000 233100000 336500000 5400000 4600000 2500000 Estimated amortization expense for each of the years ending December 31 is as follows (in millions):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 5200000 7600000 10100000 12200000 14800000 DEBT AND CREDIT FACILITIES<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2018, the Company issued $600.0 million of fixed-rate unsecured senior notes (the "Notes") due June 15, 2028. Interest is payable semi-annually in arrears, with payments due in June and December of each year. The Company may redeem the Notes, in whole or in part, at any time and from time to time at specified redemption prices. In addition, upon the occurrence of certain change of control triggering events, the Company may be required to repurchase all or a portion of the Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest. The Notes also include covenants that limit the Company's ability to incur secured indebtedness, enter into sale and leaseback transactions, and consolidate, merge, or transfer all or substantially all of its assets. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Notes as of December 31, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective<br/>Interest Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective<br/>Interest Rate</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed-rate 4.300% 2018 Notes</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.329 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.329 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total carrying amount</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020 and 2019, the fair value of the Notes was $711.2 million and $667.6 million, respectively, based on observable market prices in less active markets and categorized as Level 2 (Note 11). The debt issuance costs, as well as the discount, are being amortized to interest expense over the term of the notes. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a Five-Year Credit Agreement ("the Credit Agreement") which matures on April 28, 2023. The Credit Agreement provides up to an aggregate of $750.0 million in borrowings in multiple currencies. The Company may increase the amount available under the Credit Agreement, subject to agreement of the lenders, by up to an additional $250.0 million in the aggregate. Borrowings generally bear interest at the London interbank offered rate ("LIBOR"), or a comparable or successor rate, plus a spread ranging from 0.9% to 1.3%, depending on the leverage ratio, as defined in the Credit Agreement. The Company also pays a facility fee ranging from 0.1% to 0.2%, depending on the leverage ratio, on the entire credit commitment available, whether drawn or not. The facility fee is expensed as incurred. During 2020, the spread over LIBOR was 0.9% and the facility fee was 0.1%. Issuance costs of $2.4 million are being amortized to interest expense over the term of the Credit Agreement. As of December 31, 2020 and 2019, there were no borrowings outstanding under the Credit Agreement. Amounts outstanding under the Credit Agreement, if any from time to time, are classified as long-term obligations in accordance with the terms of the Credit Agreement. The Credit Agreement is unsecured and contains various financial and other covenants, including a maximum leverage ratio, as defined in the Credit Agreement. The Company was in compliance with all covenants at December 31, 2020.</span></div>The weighted-average interest rate under all debt obligations was 3.5% and 3.4% at December 31, 2020 and 2019, respectively. 600000000.0 1.01 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Notes as of December 31, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective<br/>Interest Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective<br/>Interest Rate</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed-rate 4.300% 2018 Notes</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.329 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.329 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total carrying amount</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr></table></div> 0.04300 600000000.0 0.04329 600000000.0 0.04329 1100000 1200000 3900000 4400000 595000000.0 594400000 711200000 667600000 P5Y 750000000.0 250000000.0 0.009 0.013 0.001 0.002 0.009 0.001 2400000 0 0 0.035 0.034 FAIR VALUE MEASUREMENTS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include financial instruments for which the fair market value of such instruments may differ from amounts reflected on a historical cost basis. Financial instruments of the Company consist of cash deposits, accounts and other receivables, investments, accounts payable, certain accrued liabilities, and borrowings under a revolving credit agreement. The carrying value of these financial instruments generally approximates fair value due to their short-term nature. Financial instruments also include notes payable. See Note 10 for further information on the fair value of the notes payable.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The Company prioritizes the inputs used to determine fair values in one of the following three categories:</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1—Quoted market prices in active markets for identical assets or liabilities.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2—Inputs, other than quoted prices in active markets, that are observable, either directly or indirectly.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3—Unobservable inputs that are not corroborated by market data.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis as of December 31, 2020 and 2019 (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held for deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">887.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign government bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held for deferred compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in fair value of the contingent consideration obligation for the years ended December 31, 2020 and 2019 (in millions):</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:77.962%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in 2020 in fair value of the contingent consideration obligation were primarily driven by the accretion of interest due to the passage of time and adjustments to discount rates, partially offset by a $12.7 million reduction to the liability due to changes in the projected probability and timing of milestone achievements, and the projected timing of cash inflows. During 2019, the contingent consideration liability was reduced by $24.1 million due to delays in product development, which reduced the probability of milestone achievement. This reduction was partially offset by changes in the fair value of the liabilities associated primarily with adjustments to discount rates and accretion of interest due to the passage of time.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Equivalents and Available-for-sale Investments</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the fair values of its money market funds based on quoted prices in active markets for identical assets. The Company estimates the fair values of its time deposits, commercial paper, U.S. and foreign government and agency securities, municipal securities, asset-backed securities, and corporate debt securities by taking into consideration valuations obtained from third-party pricing services. The pricing services use industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include reported trades and broker-dealer quotes on the same or similar securities, benchmark yields, credit spreads, prepayment and default projections based on historical data, and other observable inputs. The Company independently reviews and validates the pricing received from the third-party pricing service by comparing the prices to prices reported by a secondary pricing source. The Company’s validation procedures have not resulted in an adjustment to the pricing received from the pricing service.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Compensation Plans</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds investments in trading securities related to its deferred compensation plans. The investments are in a variety of stock, bond, and money market mutual funds. The fair values of these investments and the corresponding liabilities are based on quoted market prices.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments in the form of foreign currency forward exchange contracts and cross currency swap contracts to manage foreign currency exposures. All derivatives contracts are recognized on the balance sheet at their fair value. The fair value of foreign currency derivative financial instruments and the cross currency swap contracts was estimated based on quoted market foreign exchange rates, cross currency swap basis rates, and market discount rates. Judgment was employed in interpreting market data to develop estimates of fair value; accordingly, the estimates presented herein are not necessarily indicative of the amounts that the Company could realize in a current market exchange. The use of different market assumptions or valuation methodologies could have a material effect on the estimated fair value amounts.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration Liabilities</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company's acquisitions involve contingent consideration arrangements. Payment of additional consideration is contingent upon the acquired company reaching certain performance milestones, such as attaining specified revenue levels or obtaining regulatory approvals. These contingent consideration liabilities are measured at estimated fair value using either a probability weighted discounted cash flow analysis or a Monte Carlo simulation model, both of which consider significant unobservable inputs. These inputs include (1) the discount rate used to present value the projected cash flows </span></div>(ranging from 0.08% to 8.53%; weighted average of 3.1%), (2) the probability of milestone achievement (ranging from 0.4% to 99.7%; weighted average of 70.7%), (3) the projected payment dates (ranging from 2023 to 2027; weighted average of 2026), and (4) the volatility of future revenue (ranging from 37.0% to 40.0%; weighted average of 38.8%). The weighted average of each of the above inputs was determined based on the relative fair value of each obligation. The use of different assumptions could have a material effect on the estimated fair value amounts. <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis as of December 31, 2020 and 2019 (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held for deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">887.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign government bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held for deferred compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 16200000 0 0 16200000 0 24100000 0 24100000 0 608300000 0 608300000 0 151500000 0 151500000 56900000 92200000 0 149100000 0 2800000 0 2800000 111200000 0 0 111200000 0 8100000 0 8100000 184300000 887000000.0 0 1071300000 0 39300000 0 39300000 111600000 0 0 111600000 0 0 186100000 186100000 111600000 39300000 186100000 337000000.0 700000 31700000 0 32400000 0 13100000 0 13100000 0 489200000 0 489200000 0 141700000 0 141700000 76100000 37700000 0 113800000 0 1700000 0 1700000 0 34300000 0 34300000 88900000 0 0 88900000 0 30700000 0 30700000 165700000 780100000 0 945800000 0 6400000 0 6400000 88700000 0 0 88700000 0 0 172500000 172500000 88700000 6400000 172500000 267600000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in fair value of the contingent consideration obligation for the years ended December 31, 2020 and 2019 (in millions):</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:77.962%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 172500000 178600000 -13600000 6100000 186100000 172500000 -12700000 -24100000 0.0008 0.0853 0.031 0.004 0.997 0.707 0.370 0.400 0.388 DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,525.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,336.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the location and fair value amounts of derivative instruments reported in the consolidated balance sheets (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.139%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of master-netting agreements and rights of offset on the consolidated balance sheets (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:26.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.298%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts Not Offset in the Consolidated Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts<br/>Offset in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts<br/>Presented in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Amounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash<br/>Collateral<br/>Received</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated statements of operations and consolidated statements of comprehensive income:</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:28.812%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.697%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.697%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.838%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.847%"/><td style="width:0.1%"/></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss) Reclassified from Accumulated OCI into Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:28.812%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.697%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.697%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.838%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:45pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in OCI<br/>on Derivative<br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss) Reclassified from Accumulated OCI into Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on Derivative (Amount Excluded from<br/> Effectiveness Testing)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cross currency swaps have an expiration date of June 15, 2028. At maturity of the cross currency swap contracts, the Company will deliver the notional amount of €257.2 million and will receive $300.0 million from the counterparties. The Company will receive semi-annual interest payments from the counterparties based on a fixed interest rate until maturity of the agreements.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:36.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.936%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or<br/>(Loss) Recognized in<br/>Income on Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or<br/>(Loss) Recognized in<br/>Income on Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:36.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.936%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or<br/>(Loss) Recognized in<br/>Income on Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or<br/>(Loss) Recognized in<br/>Income on Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of fair value and cash flow hedge accounting on the consolidated statements of operations:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.090%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Income, net</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts of income and expense line items shown in the consolidated statements of operations in which the effects of fair value or cash flow hedges are recorded</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,080.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,228.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The effects of fair value and cash flow hedging:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on fair value hedging relationships:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized in earnings based on an amortization approach</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) reclassified from accumulated OCI into income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.090%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2019</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Income, net</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts of income and expense line items shown in the consolidated statements of operations in which the effects of fair value or cash flow hedges are recorded</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,114.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,242.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The effects of fair value and cash flow hedging:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on fair value hedging relationships:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized in earnings based on an amortization approach</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) reclassified from accumulated OCI into income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects that during 2021 it will reclassify to earnings a $7.0 million loss currently recorded in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." For the years ended December 31, 2020, 2019, and 2018, the Company did not record any gains or losses due to hedge ineffectiveness.</span></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,525.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,336.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 1525500000 1336500000 300000000.0 300000000.0 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the location and fair value amounts of derivative instruments reported in the consolidated balance sheets (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.139%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 7300000 14200000 0 3200000 800000 13300000 39300000 6400000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of master-netting agreements and rights of offset on the consolidated balance sheets (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:26.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.298%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts Not Offset in the Consolidated Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts<br/>Offset in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts<br/>Presented in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Amounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash<br/>Collateral<br/>Received</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of master-netting agreements and rights of offset on the consolidated balance sheets (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:26.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.298%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts Not Offset in the Consolidated Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts<br/>Offset in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts<br/>Presented in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Amounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash<br/>Collateral<br/>Received</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 7300000 0 7300000 6100000 0 1200000 800000 0 800000 0 0 800000 39300000 0 39300000 6100000 0 33200000 17400000 0 17400000 5700000 0 11700000 13300000 0 13300000 0 0 13300000 6400000 0 6400000 5700000 0 700000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated statements of operations and consolidated statements of comprehensive income:</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:28.812%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.697%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.697%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.838%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.847%"/><td style="width:0.1%"/></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss) Reclassified from Accumulated OCI into Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:28.812%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.697%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.697%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.838%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:45pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in OCI<br/>on Derivative<br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss) Reclassified from Accumulated OCI into Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on Derivative (Amount Excluded from<br/> Effectiveness Testing)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cross currency swaps have an expiration date of June 15, 2028. At maturity of the cross currency swap contracts, the Company will deliver the notional amount of €257.2 million and will receive $300.0 million from the counterparties. The Company will receive semi-annual interest payments from the counterparties based on a fixed interest rate until maturity of the agreements.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:36.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.936%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or<br/>(Loss) Recognized in<br/>Income on Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or<br/>(Loss) Recognized in<br/>Income on Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:36.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.936%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or<br/>(Loss) Recognized in<br/>Income on Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or<br/>(Loss) Recognized in<br/>Income on Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> -33700000 23500000 18400000 40900000 2200000 1900000 -12600000 12500000 6400000 6600000 257200000 300000000.0 -1400000 1400000 500000 -15100000 300000 9700000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of fair value and cash flow hedge accounting on the consolidated statements of operations:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.090%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Income, net</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts of income and expense line items shown in the consolidated statements of operations in which the effects of fair value or cash flow hedges are recorded</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,080.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,228.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The effects of fair value and cash flow hedging:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on fair value hedging relationships:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized in earnings based on an amortization approach</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) reclassified from accumulated OCI into income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.090%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2019</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Income, net</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts of income and expense line items shown in the consolidated statements of operations in which the effects of fair value or cash flow hedges are recorded</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,114.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,242.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The effects of fair value and cash flow hedging:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on fair value hedging relationships:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized in earnings based on an amortization approach</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) reclassified from accumulated OCI into income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 1080600000 1228400000 11500000 0 0 4800000 0 0 -4800000 0 0 3400000 18400000 2200000 0 1114400000 1242200000 8200000 0 0 2900000 0 0 -2900000 0 0 4300000 40900000 1900000 0 -7000000.0 EMPLOYEE BENEFIT PLANS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Defined Benefit Plans</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Edwards Lifesciences maintains defined benefit pension plans in Japan and certain European countries. In 2018, the Company curtailed its defined benefit plan in Horw, Switzerland (see Note 4). </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in projected benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participant contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan amendment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate changes and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in fair value of plan assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participant contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate changes and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded Status</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan assets at fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Underfunded status</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net amounts recognized on the consolidated balance sheet:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss, net of tax:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net prior service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accumulated benefit obligation ("ABO") for all defined benefit pension plans was $120.9 million and $101.1 million as of December 31, 2020 and 2019, respectively. The projected benefit obligation and ABO were in excess of plan assets for all pension plans as of December 31, 2020 and 2019. </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net periodic pension benefit cost (credit) are as follows (in millions):</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements and curtailment gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension benefit cost (credit)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected long-term returns for each of the plans' strategic asset classes were developed through consultation with investment advisors. Several factors were considered, including a survey of investment managers' expectations, current market data, minimum guaranteed returns in certain insurance contracts, and historical market returns over long periods. Using policy target allocation percentages and the asset class expected returns, a weighted-average expected return was calculated.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To select the discount rates for the defined benefit pension plans, the Company uses a modeling process that involves matching the expected duration of its benefit plans to a yield curve constructed from a portfolio of AA-rated fixed-income debt instruments, or their equivalent. For each country, the Company uses the implied yield of this hypothetical portfolio at the appropriate duration as a discount rate benchmark.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used to determine the benefit obligations are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash balance interest crediting rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Social securities increase</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used to determine the net periodic pension benefit cost are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash balance interest crediting rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Social securities increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension increase</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan Assets</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's investment strategy for plan assets is to seek a competitive rate of return relative to an appropriate level of risk and to earn performance rates of return in accordance with the benchmarks adopted for each asset class. Risk management practices include diversification across asset classes and investment styles, and periodic rebalancing toward asset allocation targets.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Administrative and Investment Committee decides on the defined benefit plan provider in each location and that provider decides the target allocation for the Company's defined benefit plan at that location. The target asset allocation selected reflects a risk/return profile the Company feels is appropriate relative to the plans' liability structure and return goals. In certain plans, asset allocations may be governed by local requirements. Target weighted-average asset allocations at December 31, 2020, by asset category, are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company's defined benefit plan assets at December 31, 2020 and 2019, by asset category, are as follows (in millions): </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States equities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International equities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International government bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgages</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets measured at fair value</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alternative investments measured at net asset value (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States equities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International equities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International government bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgages</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.5 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.1 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alternative investments measured at net asset value (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.2 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)     Certain investments that were measured at net asset value per share have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the total plan assets.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in fair value of the Company's defined benefit plan assets that have been classified as Level 3 for the years ended December 31, 2020 and 2019 (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.281%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance<br/>Contracts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales and settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity and debt securities are valued at fair value based on quoted market prices reported on the active markets on which the individual securities are traded. Real estate investments are valued by discounting to present value the cash flows expected to be generated by the specific properties. Investments in mortgages are valued at cost, which is deemed to approximate its fair value. The insurance contracts are valued at the cash surrender value of the contracts, which is deemed to approximate its fair value. Alternative investments include hedge funds, private equity funds and other miscellaneous investments, and are valued using the net asset value provided by the fund administrator as a practical expedient. The net asset value is based on the fair value of the underlying assets owned by the fund divided by the number of shares outstanding.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following benefit payments, which reflect expected future service, as appropriate, at December 31, 2020, are expected to be paid (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024-2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, expected employer contributions for 2021 are $2.5 million.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Defined Contribution Plans </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's employees in the United States and Puerto Rico are eligible to participate in a qualified defined contribution plan. In the United States, participants may contribute up to 25% of their eligible compensation (subject to tax code limitation) to the plan. Edwards Lifesciences matches the first 4% of the participant's annual eligible compensation contributed to the plan on a dollar-for-dollar basis. Edwards Lifesciences matches the next 2% of the participant's annual eligible compensation to the plan on a 50% basis. In Puerto Rico, participants may contribute up to 25% of their annual compensation (subject to tax code limitation) to the plan. Edwards Lifesciences matches the first 4% of participant's annual eligible compensation contributed to the plan on a 50% basis. The Company also provides a 2% profit sharing contribution calculated on eligible earnings for each employee. Matching contributions relating to Edwards Lifesciences employees were $36.6 million, $31.4 million, and $26.6 million in 2020, 2019, and 2018, respectively.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has nonqualified deferred compensation plans for a select group of employees. The plans provide eligible participants the opportunity to defer eligible compensation to future dates specified by the participant with a return based on investment alternatives selected by the participant. The amount accrued under these nonqualified plans was $111.6 million and $88.7 million at December 31, 2020 and 2019, respectively.</span></div> <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in projected benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participant contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan amendment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate changes and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in fair value of plan assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participant contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate changes and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded Status</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan assets at fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Underfunded status</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net amounts recognized on the consolidated balance sheet:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss, net of tax:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net prior service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 105200000 97400000 6300000 5200000 500000 900000 1500000 1300000 -2900000 -8200000 600000 4200000 0 4600000 -10400000 -1000000.0 126200000 105200000 63200000 60400000 400000 2000000.0 2800000 2600000 1500000 1300000 600000 4200000 6000000.0 1100000 73300000 63200000 126200000 105200000 73300000 63200000 -52900000 -42000000.0 52900000 42000000.0 -30800000 -26300000 -6600000 -6700000 -4600000 -4200000 19600000 15400000 120900000 101100000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net periodic pension benefit cost (credit) are as follows (in millions):</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements and curtailment gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension benefit cost (credit)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 6300000 5200000 6000000.0 500000 900000 800000 1000000.0 1400000 1300000 0 0 7400000 -1600000 -900000 -800000 -700000 -200000 -100000 6700000 5400000 -1200000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used to determine the benefit obligations are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash balance interest crediting rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Social securities increase</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used to determine the net periodic pension benefit cost are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash balance interest crediting rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Social securities increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension increase</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 0.003 0.005 0.026 0.027 0.025 0.026 0.016 0.016 0.018 0.018 0.005 0.009 0.009 0.015 0.023 0.023 0.027 0.028 0.026 0.015 0.015 0.015 0.016 0.018 0.015 0.018 0.018 0.018 Target weighted-average asset allocations at December 31, 2020, by asset category, are as follows:<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company's defined benefit plan assets at December 31, 2020 and 2019, by asset category, are as follows (in millions): </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States equities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International equities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International government bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgages</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets measured at fair value</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alternative investments measured at net asset value (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States equities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International equities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International government bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgages</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.5 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.1 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alternative investments measured at net asset value (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.2 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)     Certain investments that were measured at net asset value per share have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the total plan assets.</span></div> 0.253 0.475 0.077 0.195 1.000 3000000.0 0 0 3000000.0 3300000 0 0 3300000 16100000 0 0 16100000 7400000 0 0 7400000 26000000.0 0 0 26000000.0 0 5600000 0 5600000 0 3100000 0 3100000 0 0 1000000.0 1000000.0 55800000 8700000 1000000.0 65500000 7800000 73300000 3800000 0 0 3800000 3000000.0 0 0 3000000.0 11200000 0 0 11200000 8200000 0 0 8200000 22300000 0 0 22300000 0 4400000 0 4400000 0 2300000 0 2300000 0 0 900000 900000 48500000 6700000 900000 56100000 7100000 63200000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in fair value of the Company's defined benefit plan assets that have been classified as Level 3 for the years ended December 31, 2020 and 2019 (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.281%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance<br/>Contracts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales and settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1000000.0 -100000 900000 100000 1000000.0 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following benefit payments, which reflect expected future service, as appropriate, at December 31, 2020, are expected to be paid (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024-2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 4600000 4900000 6700000 5600000 5300000 36700000 2500000 0.25 0.04 0.02 0.50 0.25 0.04 0.50 0.02 36600000 31400000 26600000 111600000 88700000 COMMON STOCK<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Treasury Stock</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2019, the Board of Directors approved a stock repurchase program authorizing the Company to purchase up to $1.0 billion of the Company's common stock. The repurchase program does not have an expiration date. Stock repurchased under the program may be used to offset obligations under the Company's employee stock-based benefit programs and stock-based business acquisitions, and will reduce the total shares outstanding.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, 2019, and 2018, the Company repurchased 3.1 million, 1.5 million, and 5.5 million shares, respectively, at an aggregate cost of $625.4 million, $263.3 million, and $795.5 million, respectively, including shares purchased under the accelerated share repurchase ("ASR") agreements described below and shares acquired to satisfy tax withholding obligations in connection with the vesting of restricted stock units issued to employees. The timing and size of any future stock repurchases are subject to a variety of factors, including expected dilution from stock plans, cash capacity, and the market price of the Company's common stock.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accelerated Share Repurchase</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2019 and 2018, the Company entered into ASR agreements providing for the repurchase of the Company's common stock based on the volume-weighted average price ("VWAP") of the Company's common stock during the term of the agreements, less a discount. The following table summarizes the terms of the ASR agreements (dollars and shares in millions, except per share data):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:20.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.535%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.458%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.478%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Initial Delivery</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Settlement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agreement Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount<br/>Paid</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Received</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Price per<br/>Share (a)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value of<br/>Shares as %<br/>of Contract<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlement<br/>Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Shares<br/>Received</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price<br/>per Share (a)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.36 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.37 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.22 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.54 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.66 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.42 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.02 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.46 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________________________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)    The three-for-one stock split distributed on May 29, 2020 excluded treasury shares. The shares and per share prices in the table are reflected at the pre-split amounts and prices at the time of the transaction.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ASR agreements were accounted for as two separate transactions: (1) the value of the initial delivery of shares was recorded as shares of common stock acquired in a treasury stock transaction on the acquisition date and (2) the remaining amount of the purchase price paid was recorded as a forward contract indexed to the Company's own common stock and was recorded in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Additional Paid-in Capital</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated balance sheets. The initial delivery of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted-average common shares outstanding for basic and diluted earnings per share. The Company determined that the forward contract indexed to the Company's common stock met all the applicable criteria for equity classification and, therefore, was not accounted for as a derivative instrument.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee and Director Stock Plans</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Edwards Lifesciences Corporation Long-term Stock Incentive Compensation Program (the "Program") provides for the grant of incentive and non-qualified stock options, restricted stock, and restricted stock units for eligible employees of the Company. Under the Program, these grants are awarded at a price equal to the fair market value at the date of grant based upon the closing price on that date. Options to purchase shares of the Company's common stock granted under the Program generally vest over predetermined periods of between <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxMjcyNWU4MjBiNjQwZDNiZTQ3OGU5MjQ5NjQxMDc4L3NlYzpmMTI3MjVlODIwYjY0MGQzYmU0NzhlOTI0OTY0MTA3OF8xMzYvZnJhZzoyMTZkMzg4N2U1YTA0ZTU3YTA5ODdiNWM1NDU4NjQ4NS90ZXh0cmVnaW9uOjIxNmQzODg3ZTVhMDRlNTdhMDk4N2I1YzU0NTg2NDg1XzMwNjI_9c2d4b4c-88e4-4b5b-982c-5c4892ed023f">three</span> to four years and expire seven years after the date of grant. Service-based restricted stock units of the Company's common stock granted under the Program generally vest over predetermined periods ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYxMjcyNWU4MjBiNjQwZDNiZTQ3OGU5MjQ5NjQxMDc4L3NlYzpmMTI3MjVlODIwYjY0MGQzYmU0NzhlOTI0OTY0MTA3OF8xMzYvZnJhZzoyMTZkMzg4N2U1YTA0ZTU3YTA5ODdiNWM1NDU4NjQ4NS90ZXh0cmVnaW9uOjIxNmQzODg3ZTVhMDRlNTdhMDk4N2I1YzU0NTg2NDg1XzMyNTg_1d5bcae3-e88d-41db-ac6c-31adc9a0e7d8">three</span> to four years after the date of grant. Market-based restricted stock units of the Company's common stock granted under the Program vest over three years based on a combination of certain service and market conditions. The actual number of shares issued will be determined based on the Company's total stockholder return relative to a selected industry peer group. Performance-based restricted stock units vest based on a combination of certain service conditions and upon achievement of specified milestones. Under the Program, the number of shares of common stock available for issuance under the Program was 327.6 million shares. No more than 33.6 million shares reserved for issuance may be granted in the form of restricted stock or restricted stock units.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains the Nonemployee Directors Stock Incentive Compensation Program (the "Nonemployee Directors Program"). Under the Nonemployee Directors Program, annually each nonemployee director may receive up to 120,000 stock options or 48,000 restricted stock units of the Company's common stock, or a combination thereof, provided that in no event may the total value of the combined annual award exceed $0.2 million. These grants generally vest over one year from the date of grant. Under the Nonemployee Directors Program, an aggregate of 8.4 million shares of the Company's common stock has been authorized for issuance.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an employee stock purchase plan for United States employees and a plan for international employees (collectively "ESPP"). Under the ESPP, eligible employees may purchase shares of the Company's common stock at 85% of the lower of the fair market value of Edwards Lifesciences common stock on the effective date of subscription or the date of </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">purchase. Under the ESPP, employees can authorize the Company to withhold up to 12% (15% effective January 1, 2021) of their compensation for common stock purchases, subject to certain limitations. The ESPP is available to all active employees of the Company paid from the United States payroll and to eligible employees of the Company outside the United States, to the extent permitted by local law. The ESPP for United States employees is qualified under Section 423 of the Internal Revenue Code. The number of shares of common stock authorized for issuance under the ESPP was 45.9 million shares.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each option award and employee stock purchase subscription is estimated on the date of grant using the Black-Scholes option valuation model that uses the assumptions noted in the following tables. The risk-free interest rate is estimated using the U.S. Treasury yield curve and is based on the expected term of the award. Expected volatility is estimated based on a blend of the weighted-average of the historical volatility of Edwards Lifesciences' stock and the implied volatility from traded options on Edwards Lifesciences' stock. The expected term of awards granted is estimated from the vesting period of the award, as well as historical exercise behavior, and represents the period of time that awards granted are expected to be outstanding. The Company uses historical data to estimate forfeitures and has estimated an annual forfeiture rate of 6.4%.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option pricing model was used with the following weighted-average assumptions for options granted during the following periods:</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Option Awards</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.70 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option pricing model was used with the following weighted-average assumptions for ESPP subscriptions granted during the following periods:</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ESPP</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.61 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of market-based restricted stock units was determined using a Monte Carlo simulation model, which uses multiple input variables to determine the probability of satisfying the market condition requirements. The weighted-average assumptions used to determine the fair value of the market-based restricted stock units during the years ended December 31, 2020, 2019, and 2018 included a risk-free interest rate of 0.2%, 2.2%, and 2.7%, respectively, and an expected volatility rate of 32.7%, 29.4%, and 29.7%, respectively.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity during the year ended December 31, 2020 under the Program and the Nonemployee Directors Program was as follows (in millions, except years and per-share amounts):</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.19 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.02 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.74 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2020</span></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5 </span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.32 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vested and expected to vest as of December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes nonvested restricted stock unit activity during the year ended December 31, 2020 under the Program and the Nonemployee Directors Program (in millions, except per-share amounts):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant-Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested as of December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.89 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted (a)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.31 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.03 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.90 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested as of December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.59 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________________________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)    The shares granted includes 0.1 million shares of market-based restricted stock units granted during 2020, which represents the target number of shares to be issued, and 0.1 million shares related to a previous year's grant of market-based restricted stock units since the payout percentage achieved at the end of the performance period was in excess of target. As described above, the actual number of shares ultimately issued is determined based on the Company's total stockholder return relative to a selected industry peer group. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intrinsic value of stock options exercised and restricted stock units vested during the years ended December 31, 2020, 2019, and 2018 were $323.5 million, $382.1 million, and $281.1 million, respectively. The intrinsic value of stock options is calculated as the amount by which the market price of the Company's common stock exceeds the exercise price of the option. During the years ended December 31, 2020, 2019, and 2018, the Company received cash from exercises of stock options of $79.2 million, $110.4 million, and $103.7 million, respectively, and tax benefits from exercises of stock options and vesting of restricted stock units of $72.1 million, $85.1 million, and $62.5 million, respectively. The total grant-date fair value of stock options vested during the years ended December 31, 2020, 2019, and 2018 were $34.0 million, $31.2 million, and $29.0 million, respectively.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, the total remaining unrecognized compensation expense related to nonvested stock options, restricted stock units, and employee stock purchase subscriptions amounted to $140.9 million, which will be amortized over the weighted-average remaining requisite service period of 30 months.</span></div> 1000000000.0 3100000 1500000 5500000 625400000 263300000 795500000 The following table summarizes the terms of the ASR agreements (dollars and shares in millions, except per share data):<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:20.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.535%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.458%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.478%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Initial Delivery</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Settlement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agreement Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount<br/>Paid</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Received</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Price per<br/>Share (a)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value of<br/>Shares as %<br/>of Contract<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlement<br/>Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Shares<br/>Received</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price<br/>per Share (a)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.36 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.37 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.22 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.54 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.66 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.42 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.02 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.46 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________________________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)    The three-for-one stock split distributed on May 29, 2020 excluded treasury shares. The shares and per share prices in the table are reflected at the pre-split amounts and prices at the time of the transaction.</span></div> 400000000.0 2500000 127.36 0.80 2800000 142.37 250000000.0 1400000 139.22 0.80 1700000 150.54 150000000.0 700000 178.66 0.80 800000 178.42 100000000.0 500000 170.02 0.80 600000 178.46 3 P4Y P7Y P4Y P3Y 327600000 33600000 120000 48000 200000 P1Y 8400000 0.85 0.12 0.15 45900000 0.064 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option pricing model was used with the following weighted-average assumptions for options granted during the following periods:</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Option Awards</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.70 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0.003 0.023 0.029 0 0 0 0.33 0.30 0.29 P5Y P5Y1M6D P5Y 21.70 18.17 14.17 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option pricing model was used with the following weighted-average assumptions for ESPP subscriptions granted during the following periods:</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ESPP</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.61 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0.013 0.024 0.017 0 0 0 0.33 0.27 0.31 P0Y7M6D P0Y7M6D P0Y7M6D 16.61 16.43 12.18 0.002 0.022 0.027 0.327 0.294 0.297 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity during the year ended December 31, 2020 under the Program and the Nonemployee Directors Program was as follows (in millions, except years and per-share amounts):</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.19 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.02 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.74 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2020</span></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5 </span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.32 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vested and expected to vest as of December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 17100000 32.19 1800000 73.02 4300000 18.16 300000 49.74 14300000 41.27 P3Y4M24D 712500000 9500000 32.32 P2Y6M 558100000 13600000 40.37 P3Y3M18D 690400000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes nonvested restricted stock unit activity during the year ended December 31, 2020 under the Program and the Nonemployee Directors Program (in millions, except per-share amounts):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant-Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested as of December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.89 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted (a)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.31 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.03 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.90 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested as of December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.59 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________________________________________________________</span></div>(a)    The shares granted includes 0.1 million shares of market-based restricted stock units granted during 2020, which represents the target number of shares to be issued, and 0.1 million shares related to a previous year's grant of market-based restricted stock units since the payout percentage achieved at the end of the performance period was in excess of target. As described above, the actual number of shares ultimately issued is determined based on the Company's total stockholder return relative to a selected industry peer group. 2700000 46.89 900000 71.31 900000 40.03 100000 49.90 2600000 57.59 100000 100000 323500000 382100000 281100000 79200000 110400000 103700000 72100000 85100000 62500000 34000000.0 31200000 29000000.0 140900000 P30M ACCUMULATED OTHER COMPREHENSIVE LOSS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Presented below is a summary of activity for each component of "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" for the years ended December 31, 2020, 2019, and 2018. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized (Loss) Gain on Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized (Loss) Gain on<br/>Available-for-sale<br/>Investments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Pension<br/>Costs (a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2017</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact from adoption of ASU 2016-16 and ASU 2018-02</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications          </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications          </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (expense) benefit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(156.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications          </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit (expense)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________________________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">For the years ended December 31, 2020, 2019, and 2018, the change in unrealized pension costs consisted of the following (in millions):</span></div><div style="margin-top:5pt;padding-left:18pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-Tax<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax (Expense) Benefit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net of Tax<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit arising during period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net prior service cost arising during period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss arising during period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized pension costs, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit arising during period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net prior service credit arising during period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss arising during period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized pension costs, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">2018</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit arising during period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net prior service credit arising during period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss arising during period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized pension credits, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about amounts reclassified from "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.769%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Details about Accumulated Other Comprehensive Loss<br/>Components</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affected Line on Consolidated<br/>Statements of Operations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) gain on hedges</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.9 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expenses</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) gain on available-for-sale investments</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of pension adjustments</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr></table></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Presented below is a summary of activity for each component of "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" for the years ended December 31, 2020, 2019, and 2018. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized (Loss) Gain on Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized (Loss) Gain on<br/>Available-for-sale<br/>Investments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Pension<br/>Costs (a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2017</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact from adoption of ASU 2016-16 and ASU 2018-02</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications          </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications          </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (expense) benefit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(156.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications          </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit (expense)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________________________________________________________</span></div> -100100000 -13900000 -4600000 -14100000 -132700000 -4900000 -2900000 0 0 -7800000 -105000000.0 -16800000 -4600000 -14100000 -140500000 -36700000 35100000 -3100000 7600000 2900000 0 -19100000 -2900000 6700000 -15300000 1900000 13800000 200000 300000 16200000 -143600000 23600000 -5000000.0 -13500000 -138500000 -1500000 27900000 7900000 -3200000 31100000 6600000 44200000 -400000 -700000 49700000 3100000 -5200000 1600000 -600000 -1100000 -154800000 12500000 1700000 -15400000 -156000000.0 35700000 -34800000 8000000.0 -5500000 3400000 6400000 19200000 -300000 -900000 24400000 -3100000 -13800000 1400000 -400000 -15900000 -122400000 -27700000 8600000 -19600000 -161100000 For the years ended December 31, 2020, 2019, and 2018, the change in unrealized pension costs consisted of the following (in millions):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-Tax<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax (Expense) Benefit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net of Tax<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit arising during period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net prior service cost arising during period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss arising during period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized pension costs, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit arising during period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net prior service credit arising during period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss arising during period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized pension costs, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">2018</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit arising during period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net prior service credit arising during period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss arising during period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized pension credits, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 600000 200000 400000 700000 100000 600000 -100000 100000 -200000 -4500000 -500000 -4000000.0 -4600000 -400000 -4200000 4600000 600000 4000000.0 200000 100000 100000 4400000 500000 3900000 -6900000 -1100000 -5800000 -2500000 -600000 -1900000 3300000 900000 2400000 100000 0 100000 3200000 900000 2300000 -2300000 -600000 -1700000 900000 300000 600000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about amounts reclassified from "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.769%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Details about Accumulated Other Comprehensive Loss<br/>Components</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affected Line on Consolidated<br/>Statements of Operations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) gain on hedges</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.9 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expenses</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) gain on available-for-sale investments</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of pension adjustments</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr></table></div> 6400000 6600000 1600000 1600000 4800000 5000000.0 -18400000 -40900000 -2200000 -1900000 1400000 -1400000 19200000 44200000 5000000.0 11000000.0 14200000 33200000 -300000 -400000 600000 300000 -900000 -700000 -900000 -700000 -200000 -100000 -700000 -600000 OTHER INCOME, NET<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.454%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gains, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-service cost components of net periodic pension benefit cost (credit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.454%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gains, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-service cost components of net periodic pension benefit cost (credit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 12300000 5900000 6700000 600000 500000 -1700000 400000 200000 -100000 -1000000.0 2000000.0 -1100000 11500000 8200000 4000000.0 INCOME TAXES<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's income before provision for income taxes was generated from United States and international operations as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International, including Puerto Rico</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">765.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">783.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">916.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,166.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes consists of the following (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International, including Puerto Rico</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current income tax expense</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.5 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.1 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.4 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International, including Puerto Rico</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (benefit) expense</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.2)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.2)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total income tax provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of deferred tax assets and liabilities are as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits from uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net tax credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow and net investment hedges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow and net investment hedges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax on foreign earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, net deferred tax assets increased $67.4 million, including items that were recorded to stockholders' equity and which did not impact the Company's income tax provision.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation allowance of $71.6 million as of December 31, 2020 reduces certain deferred tax assets to amounts that are more likely than not to be realized. This allowance primarily relates to the net operating loss carryforwards of certain non-United States subsidiaries and certain non-United States credit carryforwards.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net operating loss and capital loss carryforwards and the related carryforward periods at December 31, 2020 are summarized as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:34.039%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carryforward<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax Benefit<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation<br/>Allowance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Tax<br/>Benefit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carryforward<br/>Period Ends</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States federal net operating losses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030-2037</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States federal net operating losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States state net operating losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026-2039</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States state net operating losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-United States net operating losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020-2027</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-United States net operating losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States capital losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain tax attributes are subject to an annual limitation as a result of the acquisitions of Harpoon Medical, Inc. and CASMED (see Note 8), which constitute a change of ownership as defined under Internal Revenue Code Section 382.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross tax credit carryforwards and the related carryforward periods at December 31, 2020 are summarized as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carryforward<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation<br/>Allowance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Tax<br/>Benefit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carryforward<br/>Period Ends</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California research expenditure tax credits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal research expenditure tax credits</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026-2039</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Puerto Rico purchases credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.0 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.4)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146.6 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has $145.1 million of California research expenditure tax credits it expects to use in future periods. The credits may be carried forward indefinitely. Based upon anticipated future taxable income, the Company expects that it is more likely than not that all California research expenditure tax credits will be utilized, although the utilization of the full benefit is expected to occur over a number of years and into the distant future. Accordingly, no valuation allowance has been provided. The Company has $23.4 million of Puerto Rico purchases credit. Throughout its history and into the future, the Puerto Rico operations generate, or are expected to generate, credits each year in excess of its ability to utilize credits in those years. As a result, even though the credits have an indefinite life, the Company continues to record a valuation allowance on the credit carryforwards.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 22, 2017, Public Law 115-97, commonly referred to as the Tax Cuts and Jobs Act (the "2017 Act"), was signed into law. The 2017 Act a) reduced the U.S. federal corporate tax rate from 35 percent to 21 percent for tax years beginning after December 31, 2017, b) required companies to pay a one-time mandatory deemed repatriation tax on the cumulative earnings of certain foreign subsidiaries that were previously tax deferred, and c) created new taxes on certain foreign earnings in future years.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 22, 2017, Staff Accounting Bulletin No. 118 ("SAB 118") was issued to address the application of generally accepted accounting principles in the United States of America in situations when a registrant does not have the necessary information available, prepared, or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of the 2017 Act. In accordance with SAB 118, as of December 31, 2017, the Company had estimated provisional amounts for a) $3.3 million of tax benefits in connection with the remeasurement of certain tax assets and liabilities, b) $297.4 million of net tax expense in connection with the one-time mandatory deemed repatriation tax on cumulative earnings of certain foreign subsidiaries, and c) $32.3 million of tax benefits associated with a tax reform related restructuring. In accordance with SAB 118, during 2018 the Company adjusted the provisional amounts as described below. </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of Internal Revenue Service ("IRS") guidance issued subsequent to the 2017 Act, the $32.3 million of tax benefits associated with the tax reform related restructuring mentioned above were reversed in 2018. In addition, during 2018, the Company recorded a $12.8 million reduction in the repatriation tax and an additional benefit of $3.7 million in connection with the remeasurement of deferred tax assets. In accordance with SAB 118, the Company completed its accounting for the 2017 Act during the fourth quarter of 2018. In addition, the Company elected to pay the repatriation tax in installments over eight years.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company asserts that $1.1 billion of its foreign earnings continue to be indefinitely reinvested and it intends to repatriate $599.8 million of its foreign earnings as of December 31, 2020. The estimated net tax liability on the indefinitely reinvested earnings if repatriated is $21.1 million. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has received tax incentives in certain non-U.S. tax jurisdictions, the primary benefit for which will expire in 2029. The tax reductions as compared to the local statutory rates were $189.2 million ($0.30 per diluted share), $157.6 million ($0.25 per diluted share), and $144.9 million ($0.23 per diluted share) for the years ended December 31, 2020, 2019, and 2018, respectively. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the United States federal statutory income tax rate to the Company's effective income tax rate is as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense at U.S. federal statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign income taxed at different rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits, federal and state</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Build (release) of reserve for prior years' uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. tax on foreign earnings, net of credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on global intangible low-taxed income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign-derived intangible income deduction</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal deductible employee share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nondeductible employee share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact related to 2017 U.S. Tax Reform</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's effective tax rate for 2020 decreased slightly in comparison to 2019 primarily due to the tax benefit from the Settlement Agreement with Abbott (see Notes 3 and 18), partially offset by the increase in the U.S. tax on global intangible low-taxed income and the decrease in the tax benefit from employee share-based compensation. The Company's effective tax rate for 2019 increased in comparison to 2018 primarily because of the increase in the U.S. tax on global intangible low-taxed income and the tax benefit in 2018 from audit settlements. </span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Uncertain Tax Positions</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020 and 2019, the gross uncertain tax positions were $281.8 million and $203.1 million, respectively. The Company estimates that these liabilities would be reduced by $95.1 million and $50.1 million, respectively, from offsetting tax benefits associated with the correlative effects of potential transfer pricing adjustments, state income taxes, and timing adjustments. The net amounts of $186.7 million and $153.0 million, respectively, if not required, would favorably affect the Company's effective tax rate.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of uncertain tax positions, excluding interest, penalties, and foreign exchange, is as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain gross tax positions, January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year tax positions</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in prior year tax positions</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in prior year tax positions</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lapse of statutes of limitations</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain gross tax positions, December 31</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table above summarizes the gross amounts of uncertain tax positions without regard to reduction in tax liabilities or additions to deferred tax assets and liabilities if such uncertain tax positions were settled. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes interest and penalties, if any, related to uncertain tax positions in the provision for income taxes. As of December 31, 2020, the Company had accrued $14.3 million (net of $5.1 million tax benefit) of interest related to uncertain tax positions, and as of December 31, 2019, the Company had accrued $9.3 million (net of $3.5 million tax benefit) of interest related to uncertain tax positions. During 2020, 2019, and 2018, the Company recognized interest expense (benefit), net of tax benefit, of $5.0 million, $4.7 million, and $(2.8) million, respectively, in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Provision for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated statements of operations.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company strives to resolve open matters with each tax authority at the examination level and could reach agreement with a tax authority at any time. While the Company has accrued for matters it believes are more likely than not to require settlement, the final outcome with a tax authority may result in a tax liability that is more or less than that reflected in the consolidated financial statements. Furthermore, the Company may later decide to challenge any assessments, if made, and may exercise its right to appeal. The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new legislation, regulations, or case law. Management believes that adequate amounts of tax and related penalty and interest have been provided in income tax expense for any adjustments that may result from these uncertain tax positions.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">At December 31, 2020, all material state, local, and foreign income tax matters have been concluded for years through 2015. While not material, the Company continues to address matters in Wisconsin and India for years from 2010.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">During 2018, the Company executed an Advance Pricing Agreement (“APA”) between the United States and Switzerland governments for tax years 2009 through 2020 covering various, but not all, transfer pricing matters.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The unagreed transfer pricing matters, namely Surgical Structural Heart and Transcatheter Aortic Valve Replacement intercompany royalty transactions, then reverted to IRS Examination for further consideration as part of the respective years' regular tax audit.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In addition, the Company signed agreements during 2018 with the IRS to settle open tax years 2009 through 2014, including all transfer pricing matters for those years and the tax treatment of a portion of a litigation settlement payment received in 2014.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%"> </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The IRS began its examination of the 2015 and 2016 tax years during the fourth quarter of 2018 and later added the 2017 tax year to this audit cycle during the first quarter of 2019. The IRS audit field work for the 2015-2017 tax years was substantially completed during the fourth quarter of 2020, except for transfer pricing matters.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%"> </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">As a result, certain intercompany transactions covering tax years 2015 through 2020 that were not resolved under the APA program remain subject to IRS examination, and those transactions and related tax positions remain uncertain as of December 31, 2020.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The IRS has signaled that it may be preparing proposed audit adjustments related to these intercompany transactions for the 2015-2017 tax years which, if issued, could be provided to the Company during 2021. The Company has considered this information in its evaluation of its uncertain tax positions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%"> </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">These unresolved transfer pricing matters, net of any correlative repatriation tax adjustment, may be significant to the Company’s consolidated financial statements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Based on the information currently available and numerous possible outcomes, the Company cannot reasonably estimate what, if any, changes to its existing uncertain tax positions may occur in the next 12 months and, therefore, has continued to record the gross uncertain tax positions as a long-term liability.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company intends to file to renew the APA between the United States and Switzerland for the years 2021 and forward. In addition, the Company executed other APAs as follows: during 2017, an APA between the United States and Japan covering tax years 2015 through 2019; and during 2018, APAs between Japan and Singapore and between Switzerland and Japan covering tax years 2015 through 2019. The Company has filed to renew these APAs related to Japan for the years 2020 and forward. The execution of some or all of these APAs depends on a number of variables outside of the Company's control.</span></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's income before provision for income taxes was generated from United States and international operations as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International, including Puerto Rico</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">765.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">783.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">916.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,166.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 151300000 383400000 266100000 765400000 783100000 495300000 916700000 1166500000 761400000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes consists of the following (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International, including Puerto Rico</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current income tax expense</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.5 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.1 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.4 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International, including Puerto Rico</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (benefit) expense</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.2)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.2)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total income tax provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 23400000 31300000 10900000 48200000 48700000 13600000 73900000 29100000 35900000 145500000 109100000 60400000 11000000.0 28300000 -16100000 -32900000 -18300000 -22400000 -30300000 500000 17300000 -52200000 10500000 -21200000 93300000 119600000 39200000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of deferred tax assets and liabilities are as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits from uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net tax credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow and net investment hedges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow and net investment hedges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax on foreign earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 88600000 90100000 27000000.0 22500000 125500000 108400000 64100000 57600000 105000000.0 41300000 16300000 12900000 3300000 0 500000 500000 1800000 1500000 7700000 18400000 3600000 3400000 443400000 356600000 53400000 22600000 0 6800000 29200000 35300000 7000000.0 17500000 76300000 71000000.0 3100000 2200000 169000000.0 155400000 71600000 65800000 202800000 135400000 67400000 71600000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net operating loss and capital loss carryforwards and the related carryforward periods at December 31, 2020 are summarized as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:34.039%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carryforward<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax Benefit<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation<br/>Allowance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Tax<br/>Benefit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carryforward<br/>Period Ends</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States federal net operating losses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030-2037</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States federal net operating losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States state net operating losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026-2039</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States state net operating losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-United States net operating losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020-2027</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-United States net operating losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States capital losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr></table></div> 26600000 5600000 0 5600000 11300000 2400000 0 2400000 33500000 2100000 2100000 0 1000000.0 100000 100000 0 18200000 4700000 3600000 1100000 295100000 49200000 39900000 9300000 34100000 200000 200000 0 419800000 64300000 45900000 18400000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross tax credit carryforwards and the related carryforward periods at December 31, 2020 are summarized as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carryforward<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation<br/>Allowance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Tax<br/>Benefit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carryforward<br/>Period Ends</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California research expenditure tax credits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal research expenditure tax credits</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026-2039</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Puerto Rico purchases credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.0 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.4)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146.6 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr></table></div> 145100000 0 145100000 1500000 0 1500000 23400000 23400000 0 170000000.0 23400000 146600000 145100000 23400000 -3300000 297400000 -32300000 -32300000 -12800000 3700000 1100000000 599800000 21100000 189200000 0.30 157600000 0.25 144900000 0.23 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the United States federal statutory income tax rate to the Company's effective income tax rate is as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense at U.S. federal statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign income taxed at different rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits, federal and state</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Build (release) of reserve for prior years' uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. tax on foreign earnings, net of credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on global intangible low-taxed income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign-derived intangible income deduction</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal deductible employee share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nondeductible employee share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact related to 2017 U.S. Tax Reform</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 192500000 245000000.0 159900000 -80500000 -75000000.0 -16200000 5000000.0 11900000 6800000 43100000 42900000 36700000 4200000 5000000.0 -35500000 1500000 -2900000 -12200000 49200000 32000000.0 0 2600000 7200000 6600000 48300000 57600000 41800000 4200000 3200000 2800000 0 2800000 15800000 11200000 5300000 2900000 93300000 119600000 39200000 281800000 203100000 95100000 50100000 186700000 153000000.0 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of uncertain tax positions, excluding interest, penalties, and foreign exchange, is as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain gross tax positions, January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year tax positions</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in prior year tax positions</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in prior year tax positions</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lapse of statutes of limitations</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain gross tax positions, December 31</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 203100000 150700000 225600000 86400000 55400000 37800000 6000000.0 800000 13900000 10000000.0 3800000 78800000 3700000 0 46500000 0 0 1300000 281800000 203100000 150700000 14300000 5100000 9300000 3500000 5000000.0 4700000 -2800000 LEGAL PROCEEDINGS <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2019, Abbott filed lawsuits against Edwards Lifesciences and its direct and indirect subsidiaries (“Edwards”) in the Federal District Court in the District of Delaware, in the United Kingdom, Germany, Switzerland and Italy, and, in February 2020, in Ireland, alleging patent infringement involving Edwards’ </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PASCAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> heart valve repair system (collectively, the “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PASCAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> litigation”). In February 2019, Edwards filed a lawsuit against Abbott in the Federal District Court in the Central District of California alleging patent infringement involving Abbott's MITRACLIP device (with the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PASCAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> litigation, the “Abbott Matters”). On July 12, 2020, Edwards entered into the Settlement Agreement with Abbott to, among other things, settle all patent litigation between the parties related to alleged patent infringement involving Edwards’ </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PASCAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> heart valve repair system and Abbott’s MITRACLIP device. Pursuant to the Settlement Agreement, all of the Abbott Matters and related appeals in courts worldwide were dismissed. The Settlement Agreement resulted in the Company recording an estimated $367.9 million pre-tax net charge in June 2020 related to past damages. See Note 3 for additional information.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company is or may be a party to, or may otherwise be responsible for, pending or threatened lawsuits including those related to products and services currently or formerly manufactured or performed, as applicable, by the Company, workplace and employment matters, matters involving real estate, Company operations or health care regulations, or governmental investigations (the "Other Lawsuits"). The Other Lawsuits raise difficult and complex factual and legal issues and are subject to many uncertainties, including, but not limited to, the facts and circumstances of each particular case or claim, the jurisdiction in which each suit is brought, and differences in applicable law. Management does not believe that any loss relating to the Other Lawsuits would have a material adverse effect on the Company's overall financial condition, results of operations or cash flows. However, the resolution of one or more of the Other Lawsuits in any reporting period, could have a material adverse impact on the Company's financial results for that period. The Company is not able to estimate the amount or range of any loss for legal contingencies related to the Other Lawsuits for which there is no reserve or additional loss for matters already reserved.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company is subject to various environmental laws and regulations both within and outside of the United States. The Company's operations, like those of other medical device companies, involve the use of substances regulated under environmental laws, primarily in manufacturing and sterilization processes. While it is difficult to quantify the potential impact of continuing compliance with environmental protection laws, management believes that such compliance will not have a material impact on the Company's financial results. The Company's threshold of disclosing material environmental legal proceedings involving a governmental authority where potential monetary exposure is involved is $1 million.</span></div> 367900000 1 1000000 SEGMENT INFORMATION<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts operations worldwide and is managed in the following geographical regions: United States, Europe, Japan, and Rest of World. All regions sell products that are used to treat advanced cardiovascular disease.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's geographic segments are reported based on the financial information provided to the Chief Operating Decision Maker (the Chief Executive Officer). The Company evaluates the performance of its geographic segments based on net sales and operating income. The accounting policies of the segments are substantially the same as those described in Note 2. Segment net sales and segment operating income are based on internally derived standard foreign exchange rates, which may differ from year to year, and do not include inter-segment profits. Because of the interdependence of the reportable segments, </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the operating profit as presented may not be representative of the geographical distribution that would occur if the segments were not interdependent. Net sales by geographic area are based on the location of the customer.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain items are maintained at the corporate level and are not allocated to the segments. The non-allocated items include net interest expense, global marketing expenses, corporate research and development expenses, manufacturing variances, corporate headquarters costs, special gains and charges, stock-based compensation, foreign currency hedging activities, certain litigation costs, changes in the fair value of contingent consideration liabilities, and most of the Company's amortization expense. Although most of the Company's depreciation expense is included in segment operating income, due to the Company's methodology for cost build-up, it is impractical to determine the amount of depreciation expense included in each segment, and, therefore, a portion is maintained at the corporate level. The Company neither discretely allocates assets to its operating segments, nor evaluates the operating segments using discrete asset information.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents information about Edwards Lifesciences' reportable segments (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,516.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,532.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,055.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">448.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment net sales</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,362.1 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,333.5 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,676.0 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Operating Income</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,727.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,742.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,368.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,643.1 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,614.5 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,115.5 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated income before provision for income taxes ("pre-tax income") (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales Reconciliation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,362.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,333.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,676.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,386.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,348.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,722.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pre-tax Income Reconciliation</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,643.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,614.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,115.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,358.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,439.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,058.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Special charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intellectual property litigation expenses, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(405.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">897.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,146.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated pre-tax income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">916.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,166.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Enterprise-Wide Information</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated financial statements.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of or for the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Geographic Area</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,516.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,532.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,055.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">941.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">885.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,386.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,348.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,722.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Major Product Area</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Aortic Valve Replacement</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,857.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,737.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,283.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Mitral and Tricuspid Therapies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Structural Heart</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Critical Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">725.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,386.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,348.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,722.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-lived Tangible Assets by Geographic Area</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,084.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,608.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,241.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents information about Edwards Lifesciences' reportable segments (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,516.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,532.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,055.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">448.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment net sales</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,362.1 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,333.5 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,676.0 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Operating Income</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,727.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,742.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,368.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,643.1 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,614.5 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,115.5 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated income before provision for income taxes ("pre-tax income") (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales Reconciliation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,362.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,333.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,676.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,386.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,348.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,722.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pre-tax Income Reconciliation</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,643.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,614.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,115.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,358.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,439.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,058.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Special charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intellectual property litigation expenses, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(405.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">897.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,146.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated pre-tax income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">916.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,166.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2516800000 2532700000 2055200000 945200000 926100000 826400000 448600000 441400000 398400000 451500000 433300000 396000000.0 4362100000 4333500000 3676000000.0 1727300000 1742300000 1368100000 479300000 472000000.0 394800000 286400000 272300000 237000000.0 150100000 127900000 115600000 2643100000 2614500000 2115500000 4362100000 4333500000 3676000000.0 24200000 14500000 46800000 4386300000 4348000000.0 3722800000 2643100000 2614500000 2115500000 1358000000.0 1439700000 1058100000 0 64600000 116200000 405400000 33400000 214000000.0 13600000 -6100000 -5700000 31500000 63900000 15300000 897600000 1146800000 748200000 19100000 19700000 13200000 916700000 1166500000 761400000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated financial statements.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of or for the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Geographic Area</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,516.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,532.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,055.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">941.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">885.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,386.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,348.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,722.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Major Product Area</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Aortic Valve Replacement</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,857.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,737.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,283.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Mitral and Tricuspid Therapies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Structural Heart</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Critical Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">725.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,386.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,348.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,722.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-lived Tangible Assets by Geographic Area</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,084.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,608.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,241.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2516800000 2532700000 2055300000 973600000 941200000 885100000 460100000 444700000 396800000 435800000 429400000 385600000 4386300000 4348000000.0 3722800000 2857300000 2737900000 2283800000 41800000 28200000 2900000 761800000 841700000 761600000 725400000 740200000 674500000 4386300000 4348000000.0 3722800000 1084300000 849100000 642100000 192700000 101500000 36600000 20400000 21700000 6700000 311000000.0 269400000 214400000 1608400000 1241700000 899800000 QUARTERLY FINANCIAL RESULTS AND MARKET FOR THE COMPANY'S STOCK (UNAUDITED)<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First<br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Second<br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Third<br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fourth<br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Year</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,128.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,140.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,191.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,386.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">859.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,305.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) (a)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share (a):</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.20)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.52 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.49 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.52 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.49 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market price:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.90 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.79 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.08 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.08 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Low</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.51 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.44 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.87 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.92 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.51 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,086.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,094.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,174.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,348.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">782.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">887.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,233.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (b)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share (b):</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.39 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.44 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.45 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.68 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.39 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.38 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.64 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market price:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.95 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.00 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.06 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.55 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.55 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Low</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.95 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.23 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.00 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.08 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.95 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________________________________________________________</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)    The second quarter of 2020 includes a $367.9 million charge related to a litigation settlement. <br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) The first quarter of 2019 includes a $24.0 million charge related to the acquisition of early-stage transcatheter intellectual property and associated clinical and regulatory experience. The second and third quarters of 2019 include a $46.2 million and $26.9 million charge, respectively, related to the write off of inventory. The fourth quarter of 2019 includes a $40.6 million charge related to the impairment of certain in-process research and development assets.</span></div> <div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First<br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Second<br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Third<br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fourth<br/>Quarter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Year</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,128.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,140.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,191.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,386.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">859.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,305.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) (a)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share (a):</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.20)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.52 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.49 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.52 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.49 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market price:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.90 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.79 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.08 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.08 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Low</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.51 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.44 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.87 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.92 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.51 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,086.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,094.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,174.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,348.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">782.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">887.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,233.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (b)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share (b):</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.39 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.44 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.45 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.68 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.39 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.38 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.64 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market price:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.95 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.00 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.06 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.55 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.55 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Low</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.95 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.23 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.00 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.08 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.95 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________________________________________________________</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)    The second quarter of 2020 includes a $367.9 million charge related to a litigation settlement. <br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) The first quarter of 2019 includes a $24.0 million charge related to the acquisition of early-stage transcatheter intellectual property and associated clinical and regulatory experience. The second and third quarters of 2019 include a $46.2 million and $26.9 million charge, respectively, related to the write off of inventory. The fourth quarter of 2019 includes a $40.6 million charge related to the impairment of certain in-process research and development assets.</span></div> 1128700000 925000000.0 1140900000 1191700000 4386300000 863600000 686800000 859900000 895400000 3305700000 310600000 -121900000 325200000 309500000 823400000 0.50 -0.20 0.52 0.50 1.32 0.49 -0.20 0.52 0.49 1.30 81.90 78.43 87.79 92.08 92.08 51.51 56.44 66.87 70.92 51.51 993000000.0 1086900000 1094000000.0 1174100000 4348000000.0 761200000 782900000 801600000 887900000 3233600000 249700000 242300000 274700000 280200000 1046900000 0.40 0.39 0.44 0.45 1.68 0.39 0.38 0.43 0.44 1.64 65.95 65.00 76.06 82.55 82.55 46.95 55.23 61.00 71.08 46.95 367900000 24000000.0 46200000 26900000 40600000 VALUATION AND QUALIFYING ACCOUNTS<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.642%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at<br/>Beginning<br/>of Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged to<br/>Costs and<br/>Expenses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged to<br/>Other<br/>Accounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at<br/>End of<br/>Period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts (a)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax valuation allowance (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts (a)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax valuation allowance (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts (a)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax valuation allowance (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________________________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)    The deductions related to allowances for doubtful accounts represent accounts receivable which are written off.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)     The tax valuation allowances are provided for other-than-temporary impairments and unrealized losses related to certain investments that may not be recognized due to the uncertainty of the ready marketability of certain impaired investments, and net operating loss and credit carryforwards that may not be recognized due to insufficient taxable income.</span></div> 14700000 3100000 0 1400000 16400000 64000000.0 6300000 600000 1100000 69800000 13600000 4700000 200000 3800000 14700000 44900000 18900000 200000 0 64000000.0 13700000 2200000 1000000.0 3300000 13600000 41600000 7100000 -1800000 2000000.0 44900000 SUBSEQUENT EVENTIn February 2021, Edwards entered into an ASR agreement to repurchase $250.0 million of the Company's common stock based on the volume-weighted average price ("VWAP") of the Company's common stock during the term of the agreements, less a discount. Upon entering into the agreement, Edwards received an initial delivery of 2.4 million shares, representing approximately 80% of the shares to be repurchased. At the termination of the ASR, Edwards may receive additional shares or may be required to pay additional cash or shares (at the Company's election). The final settlement is based on the VWAP over the term of the agreement, less a discount. The ASR agreement has a scheduled termination date of March 18, 2021. 250000000.0 2400000 0.80 XML 31 R1.htm IDEA: XBRL DOCUMENT v3.20.4
Cover - USD ($)
 12 Months Ended
Dec. 31, 2020
Jan. 31, 2021
Jun. 30, 2020
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2020    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 1-15525    
Entity Registrant Name EDWARDS LIFESCIENCES CORPORATION    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 36-4316614    
Entity Address, Address Line One One Edwards Way    
Entity Address, City or Town Irvine    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 92614    
City Area Code 949    
Local Phone Number 250-2500    
Title of 12(b) Security Common Stock, par value $1.00 per share    
Trading Symbol EW    
Security Exchange Name NYSE    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Entity Shell Company false    
Entity Public Float     $ 42,640,586,293
Entity Common Stock, Shares Outstanding   624,518,873  
Documents Incorporated by Reference Portions of the registrant's proxy statement for the 2021 Annual Meeting of Stockholders (to be filed within 120 days of December 31, 2020) are incorporated by reference into Part III, as indicated herein.    
Entity Central Index Key 0001099800    
Amendment Flag false    
Document Fiscal Year Focus 2020    
Document Fiscal Period Focus FY    
XML 32 R2.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Current assets    
Cash and cash equivalents $ 1,183.2 $ 1,179.1
Short-term investments (Note 7) 219.4 337.8
Accounts receivable, net of allowances of $9.6 and $8.7, respectively 514.6 543.6
Other receivables 88.2 55.5
Inventories (Note 5) 802.3 640.9
Prepaid expenses 75.1 59.1
Other current assets 208.2 168.0
Total current assets 3,091.0 2,984.0
Long-term investments (Note 7) 801.6 585.5
Property, plant, and equipment, net (Note 5) 1,395.2 1,060.3
Operating lease right-of-use assets (Note 6) 94.2 80.1
Goodwill (Note 9) 1,173.2 1,167.7
Other intangible assets, net (Note 9) 331.4 336.5
Deferred income taxes 230.9 172.2
Other assets 119.6 101.8
Total assets 7,237.1 6,488.1
Current liabilities    
Accounts payable 196.5 180.4
Accrued and other liabilities (Note 5) 670.2 696.5
Operating lease liabilities (Note 6) 27.2 25.5
Total current liabilities 893.9 902.4
Long-term debt (Note 10) 595.0 594.4
Contingent consideration liabilities (Notes 8 and 11) 186.1 172.5
Taxes payable (Note 17) 215.3 236.6
Operating lease liabilities (Note 6) 72.7 58.9
Uncertain tax positions (Note 17) 214.4 171.7
Litigation settlement (Notes 3 and 18) 233.0 0.0
Other long-term liabilities 252.4 203.3
Commitments and contingencies (Notes 6, 10 and 18)
Stockholders' equity (Note 14)    
Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding 0.0 0.0
Common stock, $1.00 par value, 1,050.0 shares authorized, 636.4 and 218.1 shares issued, and 624.3 and 209.1 shares outstanding, respectively 636.4 218.1
Additional paid-in capital 1,438.1 1,623.3
Retained earnings 4,565.0 3,741.6
Accumulated other comprehensive loss (161.1) (156.0)
Treasury stock, at cost, 12.1 and 9.0 shares, respectively (1,904.1) (1,278.7)
Total stockholders' equity 4,574.3 4,148.3
Total liabilities and stockholders' equity $ 7,237.1 $ 6,488.1
Preferred stock, shares outstanding (in shares) 0 0
XML 33 R3.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Statement of Financial Position [Abstract]    
Allowance for doubtful accounts $ 9.6 $ 8.7
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, authorized shares (in shares) 50,000,000.0 50,000,000.0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 1.00 $ 1.00
Common stock, shares authorized (in shares) 1,050,000,000.0 1,050,000,000.0
Common stock, shares issued (in shares) 636,400,000 218,100,000
Common stock, shares outstanding (in shares) 624,300,000 209,100,000
Treasury stock, shares (in shares) 12,100,000 9,000,000.0
XML 34 R4.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Income Statement [Abstract]      
Net sales $ 4,386.3 $ 4,348.0 $ 3,722.8
Cost of sales 1,080.6 1,114.4 939.4
Gross profit 3,305.7 3,233.6 2,783.4
Selling, general, and administrative expenses 1,228.4 1,242.2 1,088.5
Research and development expenses 760.7 752.7 622.2
Intellectual property litigation expenses, net (Note 3) 405.4 33.4 214.0
Change in fair value of contingent consideration liabilities 13.6 (6.1) (5.7)
Special charges (Note 4) 0.0 64.6 116.2
Operating income 897.6 1,146.8 748.2
Interest expense 15.8 20.7 29.9
Interest income (23.4) (32.2) (32.0)
Special gain (Note 4) 0.0 0.0 (7.1)
Other income, net (Note 16) (11.5) (8.2) (4.0)
Income before provision for income taxes 916.7 1,166.5 761.4
Provision for income taxes (Note 17) 93.3 119.6 39.2
Net income $ 823.4 $ 1,046.9 $ 722.2
Earnings per share:      
Basic (in dollars per share) $ 1.32 $ 1.68 $ 1.15
Diluted (in dollars per share) $ 1.30 $ 1.64 $ 1.13
Weighted-average number of common shares outstanding:      
Basic (in shares) 622.6 624.8 627.6
Diluted (in shares) 631.9 636.7 640.9
XML 35 R5.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Statement of Comprehensive Income [Abstract]      
Net income $ 823.4 $ 1,046.9 $ 722.2
Other comprehensive (loss) income, net of tax (Note 15):      
Foreign currency translation adjustments 32.4 (11.2) (38.6)
Unrealized (loss) gain on hedges (40.2) (11.1) 40.4
Unrealized pension costs (4.2) (1.9) 0.6
Unrealized gain (loss) on available-for-sale investments 6.6 6.3 (3.3)
Reclassification of net realized investment loss to earnings 0.3 0.4 2.9
Other comprehensive (loss) income, net of tax (5.1) (17.5) 2.0
Comprehensive income $ 818.3 $ 1,029.4 $ 724.2
XML 36 R6.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities      
Net income $ 823.4 $ 1,046.9 $ 722.2
Adjustments to reconcile net income to cash provided by operating activities:      
Depreciation and amortization 107.2 89.3 77.4
Non-cash operating lease cost 28.2 25.3 0.0
Stock-based compensation (Notes 2 and 14) 92.6 81.3 71.0
Inventory write off 0.0 73.1 0.0
Impairment charges (Note 4) 0.0 40.6 118.8
Change in fair value of contingent consideration liabilities, net (Note 11) 13.6 (6.1) (5.7)
Deferred income taxes (49.4) 12.1 (27.3)
Purchased in-process research and development 0.0 24.0 0.0
Other (3.5) (2.8) 13.0
Changes in operating assets and liabilities:      
Accounts and other receivables, net 41.9 (88.0) (28.7)
Inventories (120.6) (105.4) (65.7)
Prepaid expenses and other current assets (28.5) (6.8) 15.6
Accounts payable and accrued liabilities (84.5) 116.5 12.5
Litigation settlement accrual 270.5 (180.0) 180.0
Income taxes (52.9) 43.2 (157.8)
Other 16.3 19.7 1.4
Net cash provided by operating activities 1,054.3 1,182.9 926.7
Cash flows from investing activities      
Capital expenditures (407.0) (254.4) (238.7)
Purchases of held-to-maturity investments (Note 7) (162.0) (130.2) (210.0)
Proceeds from sales and maturities of held-to-maturity investments (Note 7) 212.2 50.0 578.1
Purchases of available-for-sale investments (Note 7) (689.7) (437.9) (249.3)
Proceeds from sales and maturities of available-for-sale investments (Note 7) 564.8 359.9 223.2
Acquisition (Notes 8 and 9) 0.0 (100.2) 0.0
Payment for acquisition option (10.0) (35.0) 0.0
Issuances of notes receivable (27.0) (12.9) (0.6)
Investments in intangible assets and in-process research and development (0.3) (24.0) (3.0)
Other (12.1) (11.1) (23.0)
Net cash (used in) provided by investing activities (531.1) (595.8) 76.7
Cash flows from financing activities      
Proceeds from issuance of debt 16.2 18.9 688.0
Payments on debt and finance lease obligations (17.0) (28.9) (1,125.3)
Purchases of treasury stock (625.4) (263.3) (795.5)
Proceeds from stock plans 140.5 160.5 147.0
Payment of contingent consideration 0.0 0.0 (15.1)
Other (1.2) (2.8) (0.3)
Net cash used in financing activities (486.9) (115.6) (1,101.2)
Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash (20.5) (3.0) (6.5)
Net increase (decrease) in cash, cash equivalents, and restricted cash 15.8 468.5 (104.3)
Cash, cash equivalents, and restricted cash at beginning of year 1,184.4 715.9 820.2
Cash, cash equivalents, and restricted cash at end of year $ 1,200.2 $ 1,184.4 $ 715.9
XML 37 R7.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Treasury Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Impact to retained earnings from adoption of ASU 2016-16 and ASU 2018-02
Impact to retained earnings from adoption of ASU 2016-16 and ASU 2018-02
Retained Earnings
Impact to retained earnings from adoption of ASU 2016-16 and ASU 2018-02
Accumulated Other Comprehensive Loss
Cumulative Effect, Period of Adoption, Adjusted Balance
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Treasury Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained Earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2017   212.0 2.3               212.0 2.3      
Beginning balance at Dec. 31, 2017 $ 2,956.2 $ 212.0 $ (252.1) $ 1,166.9 $ 1,962.1 $ (132.7) $ 2.6 $ 10.4 $ (7.8) $ 2,958.8 $ 212.0 $ (252.1) $ 1,166.9 $ 1,972.5 $ (140.5)
Increase (Decrease) in Stockholders' Equity                              
Net income 722.2       722.2                    
Other comprehensive income (loss), net of tax 2.0         2.0                  
Common stock issued under equity plans, including tax benefits (in shares)   3.2                          
Common stock issued under equity plans 147.0 $ 3.2   143.8                      
Stock-based compensation expense 71.0     71.0                      
Stock issued in payment for contingent consideration liabilities (in shares)     (0.3)                        
Shares issued in payment for contingent consideration liabilities 34.9   $ 32.2 2.7                      
Purchases of treasury stock (in shares)     5.5                        
Purchases of treasury stock (795.5)   $ (795.5)                        
Ending balance (in shares) at Dec. 31, 2018   215.2 7.5                        
Ending balance at Dec. 31, 2018 3,140.4 $ 215.2 $ (1,015.4) 1,384.4 2,694.7 (138.5)                  
Increase (Decrease) in Stockholders' Equity                              
Net income 1,046.9       1,046.9                    
Other comprehensive income (loss), net of tax (17.5)         (17.5)                  
Common stock issued under equity plans, including tax benefits (in shares)   2.9                          
Common stock issued under equity plans 160.5 $ 2.9   157.6                      
Stock-based compensation expense 81.3     81.3                      
Purchases of treasury stock (in shares)     1.5                        
Purchases of treasury stock (263.3)   $ (263.3)                        
Ending balance (in shares) at Dec. 31, 2019   218.1 9.0                        
Ending balance at Dec. 31, 2019 4,148.3 $ 218.1 $ (1,278.7) 1,623.3 3,741.6 (156.0)                  
Increase (Decrease) in Stockholders' Equity                              
Net income 823.4       823.4                    
Other comprehensive income (loss), net of tax (5.1)         (5.1)                  
Common stock issued under equity plans, including tax benefits (in shares)   4.5                          
Common stock issued under equity plans 140.5 $ 4.5   136.0                      
Stock-based compensation expense 92.6     92.6                      
Purchases of treasury stock (in shares)     3.1                        
Purchases of treasury stock (625.4)   $ (625.4)                        
Stock issued to effect stock split (in shares)   413.8                          
Stock issued to effect stock split 0.0 $ 413.8   (413.8)                      
Ending balance (in shares) at Dec. 31, 2020   636.4 12.1                        
Ending balance at Dec. 31, 2020 $ 4,574.3 $ 636.4 $ (1,904.1) $ 1,438.1 $ 4,565.0 $ (161.1)                  
XML 38 R8.htm IDEA: XBRL DOCUMENT v3.20.4
DESCRIPTION OF BUSINESS
 12 Months Ended
Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
DESCRIPTION OF BUSINESS DESCRIPTION OF BUSINESSEdwards Lifesciences Corporation ("Edwards Lifesciences" or the "Company") conducts operations worldwide and is managed in the following geographical regions: United States, Europe, Japan, and Rest of World. Edwards Lifesciences is focused on technologies that treat structural heart disease and critically ill patients. The products and technologies provided by Edwards Lifesciences are categorized into the following main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care.
XML 39 R9.htm IDEA: XBRL DOCUMENT v3.20.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 12 Months Ended
Dec. 31, 2020
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Principles of Consolidation

The accompanying consolidated financial statements include the accounts of Edwards Lifesciences and its majority-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The Company reviews its investments in other entities to determine whether the Company is the primary beneficiary of a variable interest entity ("VIE"). The Company would be the primary beneficiary of the VIE, and would be required to consolidate the VIE, if it has the power to direct the significant activities of the entity and the obligation to absorb losses or receive benefits from the entity that may be significant to the VIE. Based on the Company's analysis, it determined it is not the primary beneficiary of any VIEs; however, future events may require VIEs to be consolidated if the Company becomes the primary beneficiary.

Certain reclassifications of previously reported amounts have been made to conform to classifications used in the current year.

Stock Split

On May 7, 2020, the Company’s Board of Directors declared a three-for-one stock split of its outstanding shares of common stock effected in the form of a stock dividend, distributed on May 29, 2020 to stockholders of record on May 18, 2020. The Company distributed two newly issued shares of common stock to holders of record of each share of common stock to effect the stock split. All applicable share and per-share amounts in the consolidated financial statements and the notes to consolidated financial statements have been retroactively adjusted to reflect this stock split. The consolidated balance sheet as of December 31, 2019 and the consolidated statements of stockholders’ equity for the twelve months ended December 31, 2019 have not been retroactively adjusted to reflect the stock split.

Use of Estimates

The consolidated financial statements of Edwards Lifesciences have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") which have been applied consistently in all material respects. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. In particular, the novel Coronavirus ("COVID-19") pandemic has adversely impacted and is likely to further adversely impact nearly all aspects of our business and markets, including our workforce and the operations of our customers, suppliers, and business partners. The full extent to which the pandemic will directly or indirectly impact the Company's business, results of operations and financial condition, including sales, expenses, manufacturing, clinical trials, research and development costs, reserves and allowances, fair value measurements, asset impairment charges, contingent consideration obligations, and the effectiveness of the Company's hedging instruments, will depend on future developments that are highly uncertain and difficult to predict. These developments include, but are not limited to, the duration and spread of the outbreak (including new variants of COVID-19), its severity, the actions to contain the virus or address its impact, the timing, distribution, and efficacy of vaccines and other treatments, U.S. and foreign government actions to respond to the reduction in global economic activity, and how quickly and to what extent normal economic and operating conditions can resume.
Foreign Currency Translation

When the local currency of the Company's foreign entities is the functional currency, all assets and liabilities are translated into United States dollars at the rate of exchange in effect at the balance sheet date. Income and expense items are translated at the weighted-average exchange rate prevailing during the period. The effects of foreign currency translation adjustments for these entities are deferred and reported in stockholders' equity as a component of "Accumulated Other Comprehensive Loss." The effects of foreign currency transactions denominated in a currency other than an entity's functional currency are included in "Other Income, net."

Revenue Recognition

Revenue is recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those products or services.

The Company generates nearly all of its revenue from direct product sales and sales of products under consignment arrangements. Revenue from direct product sales is recognized at a point in time when the performance obligation is satisfied upon delivery of the product. Revenue from sales of consigned inventory is recognized at a point in time when the performance obligation is satisfied once the product has been implanted or used by the customer. The Company periodically reviews consignment inventories to confirm the accuracy of customer reporting. The Company also generates a small portion of its revenue from service contracts, and recognizes revenue from service contracts ratably over the term of the contracts. Sales taxes and other similar taxes that the Company collects concurrent with revenue-producing activities are excluded from revenue. The Company does not typically have any significant unusual payment terms beyond 90 days in its contracts with customers. In addition, the Company receives royalty payments for the licensing of certain intellectual property and recognizes the royalty when the subsequent sale of product using the intellectual property occurs.

The amount of consideration the Company ultimately receives varies depending upon the return terms, sales rebates, discounts, and other incentives that the Company may offer, which are accounted for as variable consideration when estimating the amount of revenue to recognize. The Company includes estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely upon an assessment of historical payment experience, historical relationship to revenues, estimated customer inventory levels, and current contract sales terms with direct and indirect customers.

The Company's sales adjustment related to distributor rebates given to the Company's United States distributors represents the difference between the Company's sales price to the distributor and the negotiated price to be paid by the end-customer. This distributor rebate is recorded as a reduction to sales and a reduction to the distributor's accounts receivable at the time of sale to a distributor. The Company periodically monitors current pricing trends and distributor inventory levels to ensure the credit for future distributor rebates is fairly stated.

The Company offers volume rebates to certain group purchasing organizations ("GPOs") and customers based upon targeted sales levels. Volume rebates offered to GPOs are recorded as a reduction to sales and an obligation to the GPOs, as the Company expects to pay in cash. Volume rebates offered to customers are recorded as a reduction to sales and either accounts receivable if the Company expects a net payment from the customer, or as an obligation to the customer if the Company expects to pay in cash. The provision for volume rebates is estimated based upon customers' contracted rebate programs, projected sales levels, and historical experience of rebates paid. The Company periodically monitors its customer rebate programs to ensure that the allowance and liability for accrued rebates is fairly stated.

Product returns are typically not significant because returns are generally not allowed unless the product is damaged at time of receipt. In limited circumstances, the Company may allow customers to return previously purchased products, such as for next-generation product offerings. For these transactions, the Company defers recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer.
The Company sells separately priced service contracts, which range from 12 to 36 months, to owners of its hemodynamic monitors. The Company invoices the customer the total amount of consideration at the inception of the contract and recognizes revenue ratably over the term of the contract. As of December 31, 2020 and December 31, 2019, $6.3 million and $8.4 million, respectively, of deferred revenue associated with outstanding service contracts was recorded in “Accrued and Other Liabilities” and "Other Long-term Liabilities." During 2020, the Company recognized as revenue $6.3 million that was included in the balance of deferred revenue as of December 31, 2019, and during 2019, the Company recognized as revenue $5.5 million that was included in the balance of deferred revenue as of December 31, 2018.

A limited number of the Company’s contracts with customers contain multiple performance obligations. For these contracts, the transaction price is allocated to each performance obligation based on its relative standalone selling price charged to other customers.

The Company applies the optional exemption of not disclosing the amount of the transaction price allocated to unsatisfied performance obligations for contracts with an original expected duration of one year or less.

Shipping and Handling Costs

Shipping costs, which are costs incurred to physically move product from the Company's premises or third party distribution centers, including storage, to the customer's premises, are included in "Selling, General, and Administrative Expenses." Handling costs, which are costs incurred to store at the Company's premises, move, and prepare products for shipment, are included in "Cost of Sales." For the years ended December 31, 2020, 2019, and 2018, shipping costs of $74.0 million, $71.5 million, and $70.6 million, respectively, were included in "Selling, General, and Administrative Expenses."

Cash Equivalents

The Company considers highly liquid investments with original maturities of three months or less to be cash equivalents. These investments are valued at cost, which approximates fair value.

Investments

The Company invests its excess cash in debt securities, including time deposits, commercial paper, U.S. government and agency securities, asset-backed securities, corporate debt securities, and municipal debt securities. Investments with maturities of one year or less are classified as short-term, and investments with maturities greater than one year are classified as long-term. Investments that the Company has the ability and intent to hold until maturity are classified as held-to-maturity and carried at amortized cost. Investments in debt securities that are classified as available-for-sale are carried at fair value with unrealized gains and losses included in "Accumulated Other Comprehensive Loss." The Company determines the appropriate classification of its investments in debt securities at the time of purchase and reevaluates such designation at each balance sheet date.

The Company also has long-term equity investments in companies that are in various stages of development. These investments are reported at fair value or under the equity method of accounting, as appropriate. Equity investments that do not have readily determinable fair values are recorded at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. The Company accounts for investments in limited partnerships and limited liability corporations, whereby the Company owns a minimum of 5% of the investee's outstanding voting stock, under the equity method of accounting. These investments are recorded at the amount of the Company's investment and adjusted each period for the Company's share of the investee's income or loss, and dividends paid.

Realized gains and losses on investments that are sold are determined using the specific identification method, or the first-in, first-out method, depending on the investment type, and recorded to "Other Income, net." Income relating to investments in debt securities is recorded to "Interest Income."
Equity investments without readily determinable fair value are considered impaired when there is an indication that the fair value of the Company's interest is less than the carrying amount. Equity method investments are considered impaired when there is an indication of an other-than-temporary decline in value below the carrying amount. Impairments of equity investments are recorded in "Other Income, net."

Debt securities in an unrealized loss position are written down to fair value through “Other Income, net” if the Company intends to sell the security or it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. For debt securities in an unrealized loss position that do not meet the aforementioned criteria, the Company assesses whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost, changes to the rating of the security by a rating agency, and any adverse conditions specifically related to the security, among other factors. When a credit loss exists, the Company compares the present value of cash flows expected to be collected from the debt security to the amortized cost basis of the security to determine the allowance amount that should be recorded, if any. For available-to-sale debt securities, any additional impairment not recorded through an allowance for credit losses is recognized in “Accumulated Other Comprehensive Loss.”

Accounts Receivable

The majority of the Company’s accounts receivable arise from direct product sales and sales of products under consignment arrangements, and have payment terms that generally require payment within 30 to 90 days. The Company does not adjust its receivables for the effects of a significant financing component at contract exception if collection of the receivable is expected within one year or less from the time of sale. In countries where the Company has experienced a pattern of payments extending beyond the stated terms and collection of the receivable is expected beyond one year from the time of sale, the Company assesses whether the customer has a significant financing component and discounts the receivable and reduces the related revenues over the period of time that the Company estimates those amounts will be paid using the country’s market-based borrowing rate for such period.

The Company provides reserves against accounts receivable for estimated losses that may result from a customer’s inability to pay based on customer-specific analysis and general matters such as current assessments of past due balances, economic conditions and forecasts, and historical credit loss activity. Amounts determined to be uncollectible are charged or written-off against the reserve.

Inventories

Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value. Market value for raw materials is based on replacement costs, and for other inventory classifications is based on net realizable value.

A write-down for excess or slow moving inventory is recorded for inventory which is obsolete, damaged, nearing its expiration date (generally triggered at six months prior to expiration), or slow moving (generally defined as quantities in excess of a two-year supply).

The Company allocates to inventory general and administrative costs that are related to the production process. These costs include insurance, manufacturing accounting personnel, human resources personnel, and information technology. During the years ended December 31, 2020, 2019, and 2018, the Company allocated $63.1 million, $56.6 million, and $45.0 million, respectively, of general and administrative costs to inventory. General and administrative costs included in inventory at December 31, 2020 and 2019 were $30.7 million and $22.8 million, respectively.

At December 31, 2020 and 2019, $130.0 million and $117.8 million, respectively, of the Company's finished goods inventories were held on consignment.
Property, Plant, and Equipment

Property, plant, and equipment are recorded at cost. Depreciation is principally calculated for financial reporting purposes on the straight-line method over the estimated useful lives of the related assets, which range from 10 to 40 years for buildings and improvements, from 3 to 15 years for machinery and equipment, and from 3 to 5 years for software. Leasehold improvements are amortized over the life of the related facility leases or the asset, whichever is shorter. Straight-line and accelerated methods of depreciation are used for income tax purposes. Construction in progress is not depreciated until the asset is ready for its intended use.

Depreciation expense for property, plant, and equipment was $101.8 million, $84.7 million, and $74.9 million for the years ended December 31, 2020, 2019, and 2018, respectively.

Leases

On January 1, 2019, the Company adopted an amendment to the guidance on leases using a modified retrospective transition approach. The Company determines whether a contract is, or contains, a lease at inception. Right-of-use assets represent the Company’s right to use an underlying asset during the lease term, and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at lease commencement based upon the estimated present value of unpaid lease payments over the lease term. The Company uses its incremental borrowing rate based on the information available at lease commencement in determining the present value of unpaid lease payments. The Company's incremental borrowing rate is determined based on the estimated rate of interest for collateralized borrowing over a similar term as the associated lease. Right-of-use assets also include any lease payments made at or before lease commencement and any initial direct costs incurred, and exclude any lease incentives received.

The Company determines the lease term as the noncancellable period of the lease, and may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Leases with a term of 12 months or less are not recognized on the balance sheet. Certain of the Company’s leases include variable lease payments that are based on costs incurred or actual usage, or adjusted periodically based on an index or a rate. The Company’s leases do not contain any residual value guarantees.

The Company accounts for the lease and non-lease components as a single lease component for all of its leases except vehicle leases, for which the lease and non-lease components are accounted for separately.

Operating leases are included in “Operating Lease Right-of-Use Assets” and “Operating Lease Liabilities” on the Company’s consolidated balance sheets. See Note 6 for further information.

Impairment of Goodwill and Long-lived Assets

Goodwill is reviewed for impairment annually in the fourth quarter of each fiscal year, or whenever an event occurs or circumstances change that would indicate that the carrying amount may be impaired. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the Company performs a quantitative impairment test. The Company determined, after performing a qualitative review of each reporting unit, that it is more likely than not that the fair value of each of its reporting units substantially exceeds the respective carrying amounts. Accordingly, in 2020, 2019, and 2018, the Company did not record any impairment loss.

Indefinite-lived intangible assets relate to in-process research and development acquired in business combinations. The estimated fair values of in-process research and development projects acquired in a business combination which have not reached technological feasibility are capitalized and accounted for as indefinite-lived intangible assets subject to impairment testing until completion or abandonment of the projects. Upon successful completion of the project, the capitalized amount is amortized over its estimated useful life. If the project is abandoned, all remaining capitalized amounts are written off immediately. Indefinite-lived intangible assets are reviewed for impairment annually in the fourth quarter of each fiscal year, or whenever an event occurs or circumstances change that would indicate the carrying amount may be impaired. An impairment
loss is recognized when the asset's carrying value exceeds its fair value. In-process research and development projects acquired in an asset acquisition are expensed unless the project has an alternative future use.

Management reviews the carrying amounts of other finite-lived intangible assets and long-lived tangible assets whenever events or circumstances indicate that the carrying amounts of an asset may not be recoverable. Impairment indicators include, among other conditions, cash flow deficits, historic or anticipated declines in revenue or operating profit, and adverse legal or regulatory developments. If it is determined that such indicators are present and the review indicates that the assets will not be fully recoverable, based on undiscounted estimated cash flows over the remaining amortization periods, their carrying values are reduced to estimated fair market value. Estimated fair market value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved. For the purposes of identifying and measuring impairment, long-lived assets are grouped with other assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities.

In 2020, the Company did not record any impairment loss related to its in-process research and development assets. In 2019, the Company recorded a $40.6 million charge related to the impairment of certain in-process research and development assets. In 2018, the Company recorded a $116.2 million charge related to the impairment of certain developed technology and in-process research and development assets. See Note 4 for further information.

Income Taxes

The Company is subject to income taxes in the United States and numerous foreign jurisdictions. Significant judgment is required in evaluating the Company's uncertain tax positions and determining its provision for income taxes. The Company recognizes the financial statement benefit of a tax position only after determining that a position would more likely than not be sustained based upon its technical merit if challenged by the relevant taxing authority and taken by management to the court of last resort. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon settlement with the relevant tax authority. The Company recognizes interest and penalties related to income tax matters in income tax expense. The Company has made an accounting policy election to recognize the U.S. tax effects of global intangible low-taxed income as a component of income tax expense in the period the tax arises.

Deferred tax assets and liabilities are recognized for the expected future tax consequences of events that have been recognized in the Company's financial statements or tax returns. The Company evaluates quarterly the realizability of its deferred tax assets by assessing its valuation allowance and adjusting the amount, if necessary. The factors used to assess the likelihood of realization are both historical experience and the Company's forecast of future taxable income and available tax planning strategies that could be implemented to realize the net deferred tax assets. Failure to achieve forecasted taxable income in the applicable taxing jurisdictions could affect the ultimate realization of deferred tax assets and could result in an increase in the Company's effective tax rate on future earnings.

Research and Development Costs

Research and development costs are charged to expense when incurred.

Earnings per Share

Basic earnings per share is computed by dividing net income by the weighted-average common shares outstanding during a period. Diluted earnings per share is computed based on the weighted-average common shares outstanding plus the effect of dilutive potential common shares outstanding during the period calculated using the treasury stock method. Dilutive potential common shares include employee equity share options, nonvested shares, and similar equity instruments granted by the Company. Potential common share equivalents have been excluded where their inclusion would be anti-dilutive.
The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):
 Years Ended December 31,
 202020192018
Basic:   
Net income$823.4 $1,046.9 $722.2 
Weighted-average shares outstanding622.6 624.8 627.6 
Basic earnings per share$1.32 $1.68 $1.15 
Diluted:   
Net income$823.4 $1,046.9 $722.2 
Weighted-average shares outstanding622.6 624.8 627.6 
Dilutive effect of stock plans9.3 11.9 13.3 
Dilutive weighted-average shares outstanding631.9 636.7 640.9 
Diluted earnings per share$1.30 $1.64 $1.13 

Stock options, restricted stock units, and market-based restricted stock units to purchase approximately 2.0 million, 1.5 million, and 3.2 million shares were outstanding for the years ended December 31, 2020, 2019, and 2018, respectively, but were not included in the computation of diluted earnings per share because the effect would have been anti-dilutive.

Stock-based Compensation

The Company measures and recognizes compensation expense for all stock-based awards based on estimated fair values. Stock-based awards consist of stock options, restricted stock units (service-based, market-based, and performance-based), and employee stock purchase subscriptions. Stock-based compensation expense is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period (vesting period) on a straight-line basis. For performance-based restricted stock units, the Company recognizes stock-based compensation expense if and when the Company concludes that it is probable that the performance condition will be achieved, net of estimated forfeitures. The Company reassesses the probability of vesting at each quarter end and adjusts the stock-based compensation expense based on its probability assessment. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Upon exercise of stock options or vesting of restricted stock units, the Company issues common stock.

Total stock-based compensation expense was as follows (in millions):
 Years Ended December 31,
 202020192018
Cost of sales$17.2 $14.7 $11.4 
Selling, general, and administrative expenses56.6 51.2 46.3 
Research and development expenses18.8 15.4 13.3 
Total stock-based compensation expense92.6 81.3 71.0 
Income tax benefit(15.4)(14.8)(13.4)
Total stock-based compensation expense, net of tax$77.2 $66.5 $57.6 

Upon a participant's retirement, all unvested stock options and performance-based restricted stock units are immediately forfeited. In addition, upon retirement, a participant will immediately vest in 25% of service-based restricted stock units for each full year of employment with the Company measured from the grant date. All remaining unvested service-based restricted stock units are immediately forfeited. For market-based restricted stock units, upon retirement and in certain other specified cases, a participant will receive a pro-rated portion of the shares that would ultimately be issued based on attainment of the
performance goals as determined on the vesting date. The pro-rated portion is based on the participant's whole months of service with the Company during the performance period prior to the date of termination.

Derivatives

The Company uses derivative financial instruments to manage interest rate and foreign currency risks. It is the Company's policy not to enter into derivative financial instruments for speculative purposes.

Derivative financial instruments involve credit risk in the event the counterparty should default. It is the Company's policy to execute such instruments with global financial institutions that the Company believes to be creditworthy. The Company diversifies its derivative financial instruments among counterparties to minimize exposure to any one of these entities. The Company also uses International Swap Dealers Association master-netting agreements. The master-netting agreements provide for the net settlement of all contracts through a single payment in a single currency in the event of default, as defined by the agreements.

The Company uses foreign currency forward exchange contracts, cross currency swap contracts, and foreign currency denominated debt to manage its exposure to changes in currency exchange rates from (1) future cash flows associated with intercompany transactions and certain local currency expenses expected to occur within the next 13 months (designated as cash flow hedges), (2) its net investment in certain foreign subsidiaries (designated as net investment hedges) and (3) foreign currency denominated assets or liabilities (designated as fair value hedges). The Company also uses foreign currency forward exchange contracts that are not designated as hedging instruments to offset the transaction gains and losses associated with certain assets and liabilities denominated in currencies other than their functional currencies resulting principally from intercompany and local currency transactions.

All derivative financial instruments are recognized at fair value in the consolidated balance sheets. For each derivative instrument that is designated as a fair value hedge, the gain or loss on the derivative included in the assessment of hedge effectiveness is recognized immediately to earnings, and offsets the loss or gain on the underlying hedged item. The Company reports in "Accumulated Other Comprehensive Loss" the gain or loss on derivative financial instruments that are designated, and that qualify, as cash flow hedges. The Company reclassifies these gains and losses into earnings in the same line item and in the same period in which the underlying hedged transactions affect earnings. Changes in the fair value of net investment hedges are reported in "Accumulated Other Comprehensive Loss" as a part of the cumulative translation adjustment and would be reclassified into earnings if the underlying net investment is sold or substantially liquidated. The portion of the change in fair value related to components excluded from the hedge effectiveness assessment are amortized into earnings over the life of the derivative. The gains and losses on derivative financial instruments for which the Company does not elect hedge accounting treatment are recognized in the consolidated statements of operations in each period based upon the change in the fair value of the derivative financial instrument. Cash flows from net investment hedges are reported as investing activities in the consolidated statements of cash flows, and cash flows from all other derivative financial instruments are reported as operating activities.

Recently Adopted Accounting Standards

In August 2018, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on cloud computing service arrangements. The guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The guidance also requires an entity to expense the capitalized implementation costs of a hosting arrangement that is a service contract over the term of the hosting arrangement. The guidance was effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. The adoption of this guidance on January 1, 2020 did not have a material impact on the Company's consolidated financial statements.

In August 2018, the FASB issued an amendment to the accounting guidance on fair value measurements. The guidance modifies the disclosure requirements on fair value measurements, including the removal of disclosures of the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation processes for Level 3 fair value measurements. The guidance also adds certain disclosure requirements related to Level 3 fair value measurements. The guidance was effective for fiscal years, and interim periods within those fiscal years,
beginning after December 15, 2019. The adoption of this guidance on January 1, 2020 did not have a material impact on the Company's consolidated financial statements.

In June 2016, the FASB issued an amendment to the guidance on the measurement of credit losses on financial instruments. The amendment updates the guidance for measuring and recording credit losses on financial assets measured at amortized cost by replacing the “incurred loss” model with an “expected loss” model. Accordingly, these financial assets will be presented at the net amount expected to be collected. The amendment also requires that credit losses related to available-for-sale debt securities be recorded as an allowance through net income rather than reducing the carrying amount under the current, other-than-temporary-impairment model. The guidance was effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The adoption of this guidance on January 1, 2020 did not have a material impact on the Company's consolidated financial statements.
XML 40 R10.htm IDEA: XBRL DOCUMENT v3.20.4
INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET
 12 Months Ended
Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]  
INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET
The Company incurred intellectual property litigation expenses, including settlements and external legal costs, of $405.4 million, $33.4 million and $214.0 million during 2020, 2019 and 2018, respectively.

On July 12, 2020, the Company reached an agreement with Abbott Laboratories and its direct and indirect subsidiaries ("Abbott") to, among other things, settle all outstanding patent disputes between the companies (the “Settlement Agreement”) in cases related to transcatheter mitral and tricuspid repair products. See Note 18 for additional information. The Settlement Agreement resulted in the Company recording an estimated $367.9 million pre-tax charge and related liability in June 2020 related to past damages. In addition, the Company will incur royalty expenses through May 2024 totaling an estimated $100 million. The Company made a one-time $100.0 million payment to Abbott in July 2020, and will make quarterly payments in future years.
In January 2019, the Company reached an agreement with Boston Scientific Corporation ("Boston Scientific") to settle all outstanding patent disputes for a one-time payment to Boston Scientific of $180.0 million, which was included as an expense in 2018. The settlement covered alleged past damages and no further royalties will be owed by either party.
XML 41 R11.htm IDEA: XBRL DOCUMENT v3.20.4
SPECIAL CHARGES (GAIN)
 12 Months Ended
Dec. 31, 2020
Other Income and Expenses [Abstract]  
SPECIAL CHARGES (GAIN) SPECIAL CHARGES (GAIN)
Impairment of Long-lived Assets

In December 2019, the Company recorded a charge of $40.6 million related to the impairment of certain in-process research and development assets, and in December 2018, the Company recorded a charge of $116.2 million related to the impairment of certain developed technology and in-process research and development assets. These assets were acquired as part of the acquisition of Valtech Cardio Ltd. ("Valtech"). The Company measured the amount of the impairments by calculating the amount by which the carrying values exceeded the estimated fair values, which were based on projected discounted future net cash flows. Based on market and clinical trial developments at the time of the impairments, the Company re-evaluated the clinical development plans for the technologies acquired from Valtech, which resulted in a reduction to the projected near-term discounted future net cash flows related to the acquired mitral technology for the 2018 charge, and related to the acquired mitral and tricuspid technology for the 2019 charge. The impairments were recorded to the Company’s Rest of World segment.

Acquisition of Intellectual Property

In March 2019, the Company recorded a $24.0 million charge related to the acquisition of early-stage transcatheter intellectual property and associated clinical and regulatory experience.

Pension Gain
In March 2018, the Company recorded a $7.1 million gain related to the curtailment of its defined benefit plan in Switzerland resulting from the closure of its manufacturing plant.
XML 42 R12.htm IDEA: XBRL DOCUMENT v3.20.4
OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS
 12 Months Ended
Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS
Composition of Certain Financial Statement Captions

Components of selected captions in the consolidated balance sheets are as follows:
 As of December 31,
 20202019
 (in millions)
Inventories  
Raw materials$136.7 $118.0 
Work in process140.0 121.7 
Finished products525.6 401.2 
$802.3 $640.9 
Property, plant, and equipment, net  
Land$97.6 $98.0 
Buildings and leasehold improvements881.5 619.8 
Machinery and equipment564.9 466.3 
Equipment with customers42.2 35.6 
Software94.2 87.9 
Construction in progress313.3 265.0 
1,993.7 1,572.6 
Accumulated depreciation(598.5)(512.3)
$1,395.2 $1,060.3 
Accrued and other liabilities  
Employee compensation and withholdings$236.7 $295.8 
Accrued rebates67.2 67.1 
Property, payroll, and other taxes49.7 51.4 
Research and development accruals52.3 51.4 
Litigation settlement (Notes 3 and 18)37.5 — 
Litigation and insurance reserves (Note 18)23.3 20.0 
Taxes payable18.6 52.9 
Fair value of derivatives39.3 6.4 
Accrued marketing expenses14.3 17.5 
Accrued professional services7.6 10.1 
Accrued realignment reserves14.5 16.7 
Accrued relocation related costs21.0 17.4 
Other accrued liabilities88.2 89.8 
$670.2 $696.5 

In 2019, the Company recorded a $73.1 million charge to "Cost of Sales," primarily comprised of the write off of inventory related to strategic decisions regarding its transcatheter aortic valve portfolio, including the decision to discontinue its CENTERA program.
Supplemental Cash Flow Information
(in millions)
Years Ended December 31,
202020192018
Cash paid during the year for:   
Interest$19.9 $19.9 $30.1 
Income taxes$197.9 $61.5 $223.7 
Amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases
$29.7 $28.6 $— 
Non-cash investing and financing transactions:   
Fair value of shares issued in payment for contingent consideration liabilities $— $— $34.3 
Right-of-use assets obtained in exchange for new lease liabilities$39.7 $49.6 $— 
Capital expenditures accruals$80.4 $50.8 $18.7 

Cash, Cash Equivalents, and Restricted Cash
(in millions)
Years Ended December 31,
202020192018
Cash and cash equivalents$1,183.2 $1,179.1 $714.1 
Restricted cash included in other current assets16.6 1.6 1.5 
Restricted cash included in other assets0.4 3.7 0.3 
Total cash, cash equivalents, and restricted cash$1,200.2 $1,184.4 $715.9 

Amounts included in restricted cash primarily represent funds placed in escrow related to litigation and real estate purchases, and funds restricted for construction.
XML 43 R13.htm IDEA: XBRL DOCUMENT v3.20.4
LEASES
 12 Months Ended
Dec. 31, 2020
Leases [Abstract]  
LEASES LEASES
The Company leases certain office space, manufacturing facilities, land, apartments, warehouses, vehicles, and equipment with remaining lease terms ranging from less than 1 year to 20 years, some of which include options to extend or terminate the leases.

Operating lease costs for the years ended December 31, 2020, 2019, and 2018 were $30.5 million, $27.9 million, and $27.0 million, respectively. Short-term and variable lease costs were not material for the years ended December 31, 2020 and 2019.

Supplemental balance sheet information related to operating leases was as follows (in millions, except lease term and discount rate):
As of December 31,
20202019
Operating lease right-of-use assets$94.2 $80.1 
Operating lease liabilities, current portion$27.2 $25.5 
Operating lease liabilities, long-term portion72.7 58.9 
Total operating lease liabilities
$99.9 $84.4 
Maturities of operating lease liabilities at December 31, 2020 were as follows (in millions):
2021$30.0 
202220.7 
202314.4 
20248.8 
20256.1 
Thereafter28.1 
Total lease payments
108.1 
Less: imputed interest
(8.2)
Total lease liabilities
$99.9 

The following table provides information on the lease terms and discount rates:
Years Ended December 31,
20202019
Weighted-average remaining lease term (in years)6.65.3
Weighted-average discount rate2.7 %2.8 %
As of December 31, 2020, the Company had no additional operating lease commitments for office space that have not yet commenced.
XML 44 R14.htm IDEA: XBRL DOCUMENT v3.20.4
INVESTMENTS
 12 Months Ended
Dec. 31, 2020
Investments, Debt and Equity Securities [Abstract]  
INVESTMENTS INVESTMENTS
Debt Securities

Investments in debt securities at the end of each period were as follows (in millions):

 December 31, 2020December 31, 2019
Held-to-maturityAmortized CostGross Unrealized GainsGross Unrealized LossesFair ValueAmortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Bank time deposits$50.0 $— $— $50.0 $100.2 $— $— $100.2 
Available-for-sale
Bank time deposits$24.1 $— $— $24.1 $13.1 $— $— $13.1 
Commercial paper— — — — 34.3 — — 34.3 
U.S. government and agency securities
147.0 2.2 — 149.2 113.2 0.6 — 113.8 
Foreign government bonds— — — — 1.7 — — 1.7 
Asset-backed securities149.6 1.9 — 151.5 141.2 0.6 (0.1)141.7 
Corporate debt securities600.8 7.5 — 608.3 487.0 2.3 (0.1)489.2 
Municipal securities2.8 — — 2.8 — — — — 
$924.3 $11.6 $— $935.9 $790.5 $3.5 $(0.2)$793.8 
The cost and fair value of investments in debt securities, by contractual maturity, as of December 31, 2020 were as follows:

 Held-to-MaturityAvailable-for-Sale
 Amortized CostFair ValueAmortized CostFair Value
 (in millions)
Due in 1 year or less$50.0 $50.0 $168.4 $169.4 
Due after 1 year through 5 years— — 578.2 586.5 
Instruments not due at a single maturity date— — 177.7 180.0 
$50.0 $50.0 $924.3 $935.9 

Actual maturities may differ from the contractual maturities due to call or prepayment rights.

There were no investments that were in an unrealized loss position as of December 31, 2020. The following table presents gross unrealized losses and fair values for those investments that were in an unrealized loss position as of December 31, 2019, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):
December 31, 2019
Less than 12 Months12 Months or GreaterTotal
Fair ValueGross Unrealized LossesFair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
Asset-backed securities$73.4 $(0.1)$— $— $73.4 $(0.1)
Corporate debt securities81.4 (0.1)— — 81.4 (0.1)
$154.8 $(0.2)$— $— $154.8 $(0.2)

Investments in Unconsolidated Affiliates

The Company has a number of equity investments in privately and publicly held companies. Investments in these unconsolidated affiliates are recorded in "Long-term Investments" on the consolidated balance sheets, and are as follows:

 December 31,
 20202019
 (in millions)
Equity method investments  
Carrying value of equity method investments$5.7 $6.2 
Equity securities  
Carrying value of non-marketable equity securities29.4 23.1 
Total investments in unconsolidated affiliates$35.1 $29.3 

Non-marketable equity securities consist of investments in privately held companies without readily determinable fair values, and are reported at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. The Company recorded an upward adjustment of $1.8 million based on observable price changes and a downward adjustment of $0.7 million due to an impairment during 2020, and an upward adjustment of $0.3 million based on observable price changes during 2019. As of December 31, 2020 and 2019, the Company had recorded accumulated upward adjustments of $3.8 million and $2.0 million, respectively, based on observable price changes, and accumulated downward adjustments of $2.6 million and $1.9 million, respectively, due to impairment and observable price changes.
During 2020, 2019, and 2018, the gross realized gains or losses from sales of available-for-sale investments were not material.
XML 45 R15.htm IDEA: XBRL DOCUMENT v3.20.4
ACQUISITIONS
 12 Months Ended
Dec. 31, 2020
Business Combinations [Abstract]  
ACQUISITIONS ACQUISITIONS
CAS Medical Systems, Inc.

On February 11, 2019, the Company entered into an agreement and plan of merger to acquire all the outstanding shares of CAS Medical Systems, Inc. ("CASMED") for an aggregate cash purchase price of $2.45 per share of common stock, or an equity value of approximately $100 million. The transaction closed on April 18, 2019, and the cash purchase price was $100.8 million. Acquisition-related costs of $2.0 million were recorded in “Selling, General, and Administrative Expenses” during the year ended December 31, 2019.

CASMED is a medical technology company dedicated to noninvasive monitoring of tissue oxygenation in the brain. The Company integrated the acquired technology platform into its hemodynamic monitoring platform. The acquisition was accounted for as a business combination. Tangible and intangible assets acquired were recorded based on their estimated fair values at the acquisition date. The excess of the purchase price over the fair value of net assets acquired was recorded to goodwill. The following table summarizes the fair values of the assets acquired and liabilities assumed (in millions):

Current assets$6.1 
Property and equipment, net1.3 
Goodwill64.4 
Developed technology35.9 
Customer relationships8.8 
Deferred tax assets2.2 
Liabilities assumed(17.9)
Total purchase price
100.8 
Less: cash acquired(0.6)
Total purchase price, net of cash acquired
$100.2 

Goodwill includes expected synergies and other benefits the Company believes will result from the acquisition. Goodwill was assigned to the Company’s United States segment and is not deductible for tax purposes. Developed technology assets are being amortized over a weighted-average useful life of 14 years. Customer relationships assets are being amortized over a weighted-average useful life of 10 years.

The results of operations for CASMED have been included in the accompanying consolidated financial statements from the date of acquisition. Pro forma results have not been presented as the results of CASMED are not material in relation to the consolidated financial statements of Edwards Lifesciences.

Harpoon Medical, Inc.

On December 1, 2017, the Company acquired all the outstanding shares of Harpoon Medical, Inc. for an aggregate cash purchase price of $119.5 million, which includes $16.0 million paid previously for a cost method investment and an exclusive option to acquire Harpoon Medical, Inc., and is net of $8.0 million received from the sale of the Company's previous ownership interest. In addition, the Company agreed to pay up to an additional $150.0 million in pre-specified milestone-driven payments over the next 10 years. The Company recognized in "Contingent Consideration Liabilities" a $59.7 million liability for the estimated fair value of the contingent milestone payments. The fair value of the contingent milestone payments are remeasured each quarter, with changes in the fair value recognized within operating expenses on the consolidated statements of operations. For further information on the fair value of the contingent milestone payments, see Note 11.
In-process research and development assets acquired as part of this transaction were capitalized at fair value, which was determined using the income approach. This approach determines fair value based on cash flow projections which are discounted to present value using a risk-adjusted rate of return. Completion of successful design developments, bench testing, pre-clinical studies and human clinical studies are required prior to selling any product. The risks and uncertainties associated with completing development within a reasonable period of time include those related to the design, development, and manufacturability of the product, the success of pre-clinical and clinical studies, and the timing of regulatory approvals. The valuation assumed $41.4 million of additional research and development expenditures would be incurred prior to the date of product introduction. In the valuation, net cash inflows were modeled to commence in Europe in 2018, and in the United States and Japan in 2022. The Company does not currently anticipate significant changes to forecasted research and development expenditures, and net cash inflows commenced in Europe in 2020 and are now expected to commence in the United States and Japan in 2023. Upon completion of development, the underlying in-process research and development asset will be amortized over its estimated useful life.

Valtech Cardio Ltd.

On November 26, 2016, the Company entered into an agreement and plan of merger to acquire Valtech Cardio Ltd. ("Valtech") for approximately $340.0 million, subject to certain adjustments, with the potential for up to an additional $350.0 million in pre-specified milestone-driven payments over the next 10.0 years. The transaction closed on January 23, 2017, and the consideration paid included the issuance of approximately 2.8 million shares of the Company's common stock (fair value of $266.5 million) and cash of $86.2 million. The Company recognized in "Contingent Consideration Liabilities" a $162.9 million liability for the estimated fair value of the contingent milestone payments. For further information on the fair value of the contingent milestone payments, see Note 11.

Prior to the close of the transaction, Valtech spun off its early-stage transseptal mitral valve replacement technology program. Concurrent with the closing, the Company entered into an agreement for an exclusive option to acquire that program and its associated intellectual property for approximately $200.0 million, subject to certain adjustments, plus an additional $50.0 million if a certain European regulatory approval is obtained within 10 years of the acquisition closing date. The option expired in January 2020.

In-process research and development assets acquired as part of this transaction were capitalized at fair value, which was determined using the income approach. This approach determines fair value based on cash flow projections which are discounted to present value using a risk-adjusted rate of return. The valuation assumed $87.3 million of additional research and development expenditures would be incurred prior to the date of product introduction and that net cash inflows would commence in 2019. In December 2018, the Company recorded a $116.2 million impairment charge related to Valtech's intangible assets, and in December 2019, the Company recorded a $40.6 million impairment charge to write off the remaining in-process research and development assets. For further information, see Note 4.

CardiAQ Valve Technologies, Inc.

On July 3, 2015, the Company entered into an agreement and plan of merger to acquire CardiAQ Valve Technologies, Inc. ("CardiAQ") for an aggregate cash purchase price of $350.0 million, subject to certain adjustments. The transaction closed on August 26, 2015, and the cash purchase price after the adjustments was $348.0 million. In addition, the Company agreed to pay an additional $50.0 million if a certain European regulatory approval is obtained within 48 months of the acquisition closing date. The Company recognized in "Contingent Consideration Liabilities" a $30.3 million liability for the estimated fair value of this contingent milestone payment. The Company estimated this milestone would not be achieved and reversed the liability in 2018. For further information on the fair value of the contingent milestone payment, see Note 11.

In-process research and development assets acquired as part of this acquisition were capitalized at fair value, which was determined using the income approach. This approach determines fair value based on cash flow projections which are discounted to present value using a risk-adjusted rate of return. Completion of successful design developments, bench testing, pre-clinical studies and human clinical studies are required prior to selling any product. The risks and uncertainties associated with completing development within a reasonable period of time include those related to the design, development, and manufacturability of the product, the success of pre-clinical and clinical studies, and the timing of regulatory approvals. The valuation assumed $97.7 million of additional research and development expenditures would be incurred prior to the date of
product introduction and that net cash inflows would commence in late 2018. As a result of certain design enhancements to increase the product's commercial life and applicability to a broader group of patients, the Company has incurred incremental research and development expenditures; however, the Company expects an increase in the net cash inflows, commencing in 2023. Upon completion of development, the underlying research and development intangible asset will be amortized over its estimated useful life.
XML 46 R16.htm IDEA: XBRL DOCUMENT v3.20.4
GOODWILL AND OTHER INTANGIBLE ASSETS
 12 Months Ended
Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL AND OTHER INTANGIBLE ASSETS
Goodwill and in-process research and development assets resulting from purchase business combinations are not subject to amortization. Other acquired intangible assets with finite lives are amortized over their expected useful lives on a straight-line basis, or if reliably determinable, based on the pattern in which the economic benefit of the asset is expected to be used. The Company expenses costs incurred to renew or extend the term of acquired intangible assets.

In April 2019, the Company acquired CASMED. This transaction resulted in an increase to goodwill of $64.4 million and developed technology of $35.9 million. For further information, see Note 8.

The changes in the carrying amount of goodwill, by segment, during the years ended December 31, 2020 and 2019 were as follows:
 United
States		EuropeRest of WorldTotal
 (in millions)
Goodwill at December 31, 2018$709.3 $64.2 $338.7 $1,112.2 
Goodwill acquired during the year64.4 — — 64.4 
Currency translation adjustment— (1.4)(7.5)(8.9)
Goodwill at December 31, 2019773.7 62.8 331.2 1,167.7 
Currency translation adjustment— 5.5 — 5.5 
Goodwill at December 31, 2020$773.7 $68.3 $331.2 $1,173.2 

Other intangible assets consist of the following (in millions):

 December 31,
 Weighted-Average Useful Life (in years)20202019
 CostAccumulated
Amortization		Net
Carrying
Value		CostAccumulated
Amortization		Net
Carrying
Value
Finite-lived intangible assets      
Patents7.4$186.1 $(183.6)$2.5 $185.7 $(182.1)$3.6 
Developed technology13.1155.2 (51.0)104.2 153.5 (46.6)106.9 
Other10.012.6 (6.0)6.6 12.3 (4.4)7.9 
12.6353.9 (240.6)113.3 351.5 (233.1)118.4 
Indefinite-lived intangible assets      
In-process research and development218.1 — 218.1 218.1 — 218.1 
$572.0 $(240.6)$331.4 $569.6 $(233.1)$336.5 
Amortization expense related to other intangible assets for the years ended December 31, 2020, 2019, and 2018 was $5.4 million, $4.6 million, and $2.5 million, respectively. Estimated amortization expense for each of the years ending December 31 is as follows (in millions):
2021$5.2 
20227.6 
202310.1 
202412.2 
202514.8 
XML 47 R17.htm IDEA: XBRL DOCUMENT v3.20.4
DEBT AND CREDIT FACILITIES
 12 Months Ended
Dec. 31, 2020
Debt Disclosure [Abstract]  
DEBT AND CREDIT FACILITIES DEBT AND CREDIT FACILITIES
In June 2018, the Company issued $600.0 million of fixed-rate unsecured senior notes (the "Notes") due June 15, 2028. Interest is payable semi-annually in arrears, with payments due in June and December of each year. The Company may redeem the Notes, in whole or in part, at any time and from time to time at specified redemption prices. In addition, upon the occurrence of certain change of control triggering events, the Company may be required to repurchase all or a portion of the Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest. The Notes also include covenants that limit the Company's ability to incur secured indebtedness, enter into sale and leaseback transactions, and consolidate, merge, or transfer all or substantially all of its assets.

The following is a summary of the Notes as of December 31, 2020 and 2019:
 December 31,
 2020 2019
 AmountEffective
Interest Rate		 AmountEffective
Interest Rate
(in millions)(in millions)
Fixed-rate 4.300% 2018 Notes
$600.0 4.329 %$600.0 4.329 %
Unamortized discount(1.1)  (1.2) 
Unamortized debt issuance costs(3.9)(4.4)
Total carrying amount$595.0   $594.4  

As of December 31, 2020 and 2019, the fair value of the Notes was $711.2 million and $667.6 million, respectively, based on observable market prices in less active markets and categorized as Level 2 (Note 11). The debt issuance costs, as well as the discount, are being amortized to interest expense over the term of the notes.

The Company has a Five-Year Credit Agreement ("the Credit Agreement") which matures on April 28, 2023. The Credit Agreement provides up to an aggregate of $750.0 million in borrowings in multiple currencies. The Company may increase the amount available under the Credit Agreement, subject to agreement of the lenders, by up to an additional $250.0 million in the aggregate. Borrowings generally bear interest at the London interbank offered rate ("LIBOR"), or a comparable or successor rate, plus a spread ranging from 0.9% to 1.3%, depending on the leverage ratio, as defined in the Credit Agreement. The Company also pays a facility fee ranging from 0.1% to 0.2%, depending on the leverage ratio, on the entire credit commitment available, whether drawn or not. The facility fee is expensed as incurred. During 2020, the spread over LIBOR was 0.9% and the facility fee was 0.1%. Issuance costs of $2.4 million are being amortized to interest expense over the term of the Credit Agreement. As of December 31, 2020 and 2019, there were no borrowings outstanding under the Credit Agreement. Amounts outstanding under the Credit Agreement, if any from time to time, are classified as long-term obligations in accordance with the terms of the Credit Agreement. The Credit Agreement is unsecured and contains various financial and other covenants, including a maximum leverage ratio, as defined in the Credit Agreement. The Company was in compliance with all covenants at December 31, 2020.
The weighted-average interest rate under all debt obligations was 3.5% and 3.4% at December 31, 2020 and 2019, respectively.
XML 48 R18.htm IDEA: XBRL DOCUMENT v3.20.4
FAIR VALUE MEASUREMENTS
 12 Months Ended
Dec. 31, 2020
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS FAIR VALUE MEASUREMENTS
The consolidated financial statements include financial instruments for which the fair market value of such instruments may differ from amounts reflected on a historical cost basis. Financial instruments of the Company consist of cash deposits, accounts and other receivables, investments, accounts payable, certain accrued liabilities, and borrowings under a revolving credit agreement. The carrying value of these financial instruments generally approximates fair value due to their short-term nature. Financial instruments also include notes payable. See Note 10 for further information on the fair value of the notes payable.

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The Company prioritizes the inputs used to determine fair values in one of the following three categories:

Level 1—Quoted market prices in active markets for identical assets or liabilities.

Level 2—Inputs, other than quoted prices in active markets, that are observable, either directly or indirectly.

Level 3—Unobservable inputs that are not corroborated by market data.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety.
Assets and Liabilities Measured at Fair Value on a Recurring Basis

The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis as of December 31, 2020 and 2019 (in millions):

December 31, 2020Level 1Level 2Level 3Total
Assets    
Cash equivalents$16.2 $— $— $16.2 
Available-for-sale investments: 
Bank time deposits— 24.1 — 24.1 
Corporate debt securities— 608.3 — 608.3 
Asset-backed securities— 151.5 — 151.5 
U.S. government and agency securities56.9 92.2 — 149.1 
Municipal securities— 2.8 — 2.8 
Investments held for deferred compensation plans111.2 — — 111.2 
Derivatives— 8.1 — 8.1 
$184.3 $887.0 $— $1,071.3 
Liabilities    
Derivatives$— $39.3 $— $39.3 
Deferred compensation plans111.6 — — 111.6 
Contingent consideration liabilities— — 186.1 186.1 
$111.6 $39.3 $186.1 $337.0 
December 31, 2019
Assets
Cash equivalents$0.7 $31.7 $— $32.4 
Available-for-sale investments: 
Bank time deposits— 13.1 — 13.1 
Corporate debt securities— 489.2 — 489.2 
Asset-backed securities— 141.7 — 141.7 
U.S. government and agency securities76.1 37.7 — 113.8 
Foreign government bonds— 1.7 — 1.7 
Commercial paper— 34.3 — 34.3 
Investments held for deferred compensation plans88.9 — — 88.9 
Derivatives— 30.7 — 30.7 
$165.7 $780.1 $— $945.8 
Liabilities    
Derivatives$— $6.4 $— $6.4 
Deferred compensation plans88.7 — — 88.7 
Contingent consideration liabilities— — 172.5 172.5 
$88.7 $6.4 $172.5 $267.6 
The following table summarizes the changes in fair value of the contingent consideration obligation for the years ended December 31, 2020 and 2019 (in millions):

December 31,
20202019
Fair value, beginning of year$172.5 $178.6 
Changes in fair value13.6 (6.1)
Fair value, end of year$186.1 $172.5 

The changes in 2020 in fair value of the contingent consideration obligation were primarily driven by the accretion of interest due to the passage of time and adjustments to discount rates, partially offset by a $12.7 million reduction to the liability due to changes in the projected probability and timing of milestone achievements, and the projected timing of cash inflows. During 2019, the contingent consideration liability was reduced by $24.1 million due to delays in product development, which reduced the probability of milestone achievement. This reduction was partially offset by changes in the fair value of the liabilities associated primarily with adjustments to discount rates and accretion of interest due to the passage of time.

Cash Equivalents and Available-for-sale Investments

The Company estimates the fair values of its money market funds based on quoted prices in active markets for identical assets. The Company estimates the fair values of its time deposits, commercial paper, U.S. and foreign government and agency securities, municipal securities, asset-backed securities, and corporate debt securities by taking into consideration valuations obtained from third-party pricing services. The pricing services use industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include reported trades and broker-dealer quotes on the same or similar securities, benchmark yields, credit spreads, prepayment and default projections based on historical data, and other observable inputs. The Company independently reviews and validates the pricing received from the third-party pricing service by comparing the prices to prices reported by a secondary pricing source. The Company’s validation procedures have not resulted in an adjustment to the pricing received from the pricing service.

Deferred Compensation Plans

The Company holds investments in trading securities related to its deferred compensation plans. The investments are in a variety of stock, bond, and money market mutual funds. The fair values of these investments and the corresponding liabilities are based on quoted market prices.

Derivative Instruments

The Company uses derivative financial instruments in the form of foreign currency forward exchange contracts and cross currency swap contracts to manage foreign currency exposures. All derivatives contracts are recognized on the balance sheet at their fair value. The fair value of foreign currency derivative financial instruments and the cross currency swap contracts was estimated based on quoted market foreign exchange rates, cross currency swap basis rates, and market discount rates. Judgment was employed in interpreting market data to develop estimates of fair value; accordingly, the estimates presented herein are not necessarily indicative of the amounts that the Company could realize in a current market exchange. The use of different market assumptions or valuation methodologies could have a material effect on the estimated fair value amounts.

Contingent Consideration Liabilities

Certain of the Company's acquisitions involve contingent consideration arrangements. Payment of additional consideration is contingent upon the acquired company reaching certain performance milestones, such as attaining specified revenue levels or obtaining regulatory approvals. These contingent consideration liabilities are measured at estimated fair value using either a probability weighted discounted cash flow analysis or a Monte Carlo simulation model, both of which consider significant unobservable inputs. These inputs include (1) the discount rate used to present value the projected cash flows
(ranging from 0.08% to 8.53%; weighted average of 3.1%), (2) the probability of milestone achievement (ranging from 0.4% to 99.7%; weighted average of 70.7%), (3) the projected payment dates (ranging from 2023 to 2027; weighted average of 2026), and (4) the volatility of future revenue (ranging from 37.0% to 40.0%; weighted average of 38.8%). The weighted average of each of the above inputs was determined based on the relative fair value of each obligation. The use of different assumptions could have a material effect on the estimated fair value amounts.
XML 49 R19.htm IDEA: XBRL DOCUMENT v3.20.4
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
 12 Months Ended
Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.
 Notional Amount
 December 31, 2020December 31, 2019
 (in millions)
Foreign currency forward exchange contracts$1,525.5 $1,336.5 
Cross currency swap contracts300.0 300.0 

The following table presents the location and fair value amounts of derivative instruments reported in the consolidated balance sheets (in millions):

  Fair Value
 Balance Sheet LocationDecember 31, 2020December 31, 2019
Derivatives designated as hedging instruments   
Assets   
Foreign currency contractsOther current assets$7.3 $14.2 
Foreign currency contractsOther assets$— $3.2 
Cross currency swap contractsOther assets$0.8 $13.3 
Liabilities   
Foreign currency contractsAccrued and other liabilities$39.3 $6.4 
The following table presents the effect of master-netting agreements and rights of offset on the consolidated balance sheets (in millions):

    Gross Amounts Not Offset in the Consolidated Balance Sheet 
  Gross Amounts
Offset in the
Consolidated
Balance Sheet		Net Amounts
Presented in the
Consolidated
Balance Sheet
December 31, 2020Gross
Amounts		Financial
Instruments		Cash
Collateral
Received		Net
Amount
Derivative Assets      
Foreign currency contracts$7.3 $— $7.3 $(6.1)$— $1.2 
Cross currency swap contracts$0.8 $— $0.8 $— $— $0.8 
Derivative Liabilities      
Foreign currency contracts$39.3 $— $39.3 $(6.1)$— $33.2 
December 31, 2019      
Derivative Assets      
Foreign currency contracts$17.4 $— $17.4 $(5.7)$— $11.7 
Cross currency swap contracts$13.3 $— $13.3 $— $— $13.3 
Derivative Liabilities      
Foreign currency contracts$6.4 $— $6.4 $(5.7)$— $0.7 
 
The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated statements of operations and consolidated statements of comprehensive income:

 Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)Location of Gain or (Loss) Reclassified from Accumulated OCI into IncomeAmount of Gain or (Loss) Reclassified from Accumulated OCI into Income
 
 2020201920202019
(in millions)(in millions)
Cash flow hedges
Foreign currency contracts$(33.7)$23.5 Cost of sales$18.4 $40.9 
Selling, general, and administrative expenses$2.2 $1.9 
 Amount of Gain or (Loss)
Recognized in OCI
on Derivative
(Effective Portion)		Location of Gain or (Loss) Reclassified from Accumulated OCI into IncomeAmount of Gain or (Loss)
Recognized in Income on Derivative (Amount Excluded from
Effectiveness Testing)
2020201920202019
(in millions) (in millions)
Net investment hedges
Cross currency swap contracts$(12.6)$12.5 Interest expense$6.4 $6.6 

The cross currency swaps have an expiration date of June 15, 2028. At maturity of the cross currency swap contracts, the Company will deliver the notional amount of €257.2 million and will receive $300.0 million from the counterparties. The Company will receive semi-annual interest payments from the counterparties based on a fixed interest rate until maturity of the agreements.
  Amount of Gain or
(Loss) Recognized in
Income on Derivative
 Location of Gain or
(Loss) Recognized in
Income on Derivative
 202020192018
 (in millions)
Fair value hedges
Foreign currency contractsOther income, net$(1.4)$1.4 $0.5 

  Amount of Gain or
(Loss) Recognized in
Income on Derivative
 Location of Gain or
(Loss) Recognized in
Income on Derivative
 202020192018
 (in millions)
Derivatives not designated as hedging instruments
Foreign currency contractsOther income, net$(15.1)$0.3 $9.7 

The following table presents the effect of fair value and cash flow hedge accounting on the consolidated statements of operations:

Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships
 Twelve Months Ended December 31, 2020
 Cost of salesSelling, general, and administrative expensesOther Income, net
Total amounts of income and expense line items shown in the consolidated statements of operations in which the effects of fair value or cash flow hedges are recorded$(1,080.6)$(1,228.4)$11.5 
The effects of fair value and cash flow hedging:
Gain (loss) on fair value hedging relationships:
Foreign currency contracts:
Hedged items
— — 4.8 
Derivatives designated as hedging instruments
— — (4.8)
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach
— — 3.4 
Gain (loss) on cash flow hedging relationships:
Foreign currency contracts:
Amount of gain (loss) reclassified from accumulated OCI into income
18.4 2.2 — 
Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships
 Twelve Months Ended December 31, 2019
 Cost of salesSelling, general, and administrative expensesOther Income, net
Total amounts of income and expense line items shown in the consolidated statements of operations in which the effects of fair value or cash flow hedges are recorded$(1,114.4)$(1,242.2)$8.2 
The effects of fair value and cash flow hedging:
Gain (loss) on fair value hedging relationships:
Foreign currency contracts:
Hedged items
— — 2.9 
Derivatives designated as hedging instruments
— — (2.9)
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach
— — 4.3 
Gain (loss) on cash flow hedging relationships:
Foreign currency contracts:
Amount of gain (loss) reclassified from accumulated OCI into income
40.9 1.9 — 
The Company expects that during 2021 it will reclassify to earnings a $7.0 million loss currently recorded in "Accumulated Other Comprehensive Loss." For the years ended December 31, 2020, 2019, and 2018, the Company did not record any gains or losses due to hedge ineffectiveness.
XML 50 R20.htm IDEA: XBRL DOCUMENT v3.20.4
EMPLOYEE BENEFIT PLANS
 12 Months Ended
Dec. 31, 2020
Retirement Benefits [Abstract]  
EMPLOYEE BENEFIT PLANS EMPLOYEE BENEFIT PLANS
Defined Benefit Plans

Edwards Lifesciences maintains defined benefit pension plans in Japan and certain European countries. In 2018, the Company curtailed its defined benefit plan in Horw, Switzerland (see Note 4).
 Years Ended December 31,
 20202019
(in millions)
Change in projected benefit obligation:  
Beginning of year$105.2 $97.4 
Service cost6.3 5.2 
Interest cost0.5 0.9 
Participant contributions1.5 1.3 
Actuarial loss2.9 8.2 
Benefits paid(0.6)(4.2)
Plan amendment— (4.6)
Currency exchange rate changes and other10.4 1.0 
End of year$126.2 $105.2 
Change in fair value of plan assets:  
Beginning of year$63.2 $60.4 
Actual return on plan assets0.4 2.0 
Employer contributions2.8 2.6 
Participant contributions1.5 1.3 
Benefits paid(0.6)(4.2)
Currency exchange rate changes and other6.0 1.1 
End of year$73.3 $63.2 
Funded Status  
Projected benefit obligation$(126.2)$(105.2)
Plan assets at fair value73.3 63.2 
Underfunded status$(52.9)$(42.0)
Net amounts recognized on the consolidated balance sheet:  
Other long-term liabilities$52.9 $42.0 
Accumulated other comprehensive loss, net of tax:  
Net actuarial loss$(30.8)$(26.3)
Net prior service cost6.6 6.7 
Deferred income tax benefit4.6 4.2 
Total$(19.6)$(15.4)

The accumulated benefit obligation ("ABO") for all defined benefit pension plans was $120.9 million and $101.1 million as of December 31, 2020 and 2019, respectively. The projected benefit obligation and ABO were in excess of plan assets for all pension plans as of December 31, 2020 and 2019.
The components of net periodic pension benefit cost (credit) are as follows (in millions):

 Years Ended December 31,
 202020192018
Service cost, net$6.3 $5.2 $6.0 
Interest cost0.5 0.9 0.8 
Expected return on plan assets(1.0)(1.4)(1.3)
Settlements and curtailment gain— — (7.4)
Amortization of actuarial loss1.6 0.9 0.8 
Amortization of prior service credit (0.7)(0.2)(0.1)
Net periodic pension benefit cost (credit)$6.7 $5.4 $(1.2)

Expected long-term returns for each of the plans' strategic asset classes were developed through consultation with investment advisors. Several factors were considered, including a survey of investment managers' expectations, current market data, minimum guaranteed returns in certain insurance contracts, and historical market returns over long periods. Using policy target allocation percentages and the asset class expected returns, a weighted-average expected return was calculated.

To select the discount rates for the defined benefit pension plans, the Company uses a modeling process that involves matching the expected duration of its benefit plans to a yield curve constructed from a portfolio of AA-rated fixed-income debt instruments, or their equivalent. For each country, the Company uses the implied yield of this hypothetical portfolio at the appropriate duration as a discount rate benchmark.

The weighted-average assumptions used to determine the benefit obligations are as follows:
 December 31,
 20202019
Discount rate0.3 %0.5 %
Rate of compensation increase2.6 %2.7 %
Cash balance interest crediting rate2.5 %2.6 %
Social securities increase1.6 %1.6 %
Pension increase1.8 %1.8 %

The weighted-average assumptions used to determine the net periodic pension benefit cost are as follows:
 Years ended December 31,
 202020192018
Discount rate0.5 %0.9 %0.9 %
Expected return on plan assets1.5 %2.3 %2.3 %
Rate of compensation increase2.7 %2.8 %2.6 %
Cash balance interest crediting rate1.5 %1.5 %1.5 %
Social securities increase1.6 %1.8 %1.5 %
Pension increase1.8 %1.8 %1.8 %
Plan Assets

The Company's investment strategy for plan assets is to seek a competitive rate of return relative to an appropriate level of risk and to earn performance rates of return in accordance with the benchmarks adopted for each asset class. Risk management practices include diversification across asset classes and investment styles, and periodic rebalancing toward asset allocation targets.

The Administrative and Investment Committee decides on the defined benefit plan provider in each location and that provider decides the target allocation for the Company's defined benefit plan at that location. The target asset allocation selected reflects a risk/return profile the Company feels is appropriate relative to the plans' liability structure and return goals. In certain plans, asset allocations may be governed by local requirements. Target weighted-average asset allocations at December 31, 2020, by asset category, are as follows:
Equity securities25.3 %
Debt securities47.5 %
Real estate7.7 %
Other19.5 %
Total100.0 %

The fair values of the Company's defined benefit plan assets at December 31, 2020 and 2019, by asset category, are as follows (in millions):
December 31, 2020Level 1Level 2Level 3Total
Asset Category    
Cash$3.0 $— $— $3.0 
Equity securities:    
United States equities3.3 — — 3.3 
International equities16.1 — — 16.1 
Debt securities:    
United States government bonds7.4 — — 7.4 
International government bonds26.0 — — 26.0 
Real estate— 5.6 — 5.6 
Mortgages— 3.1 — 3.1 
Insurance contracts— — 1.0 1.0 
Total plan assets measured at fair value
$55.8 $8.7 $1.0 $65.5 
Alternative investments measured at net asset value (a)7.8 
Total plan assets
$73.3 
 
December 31, 2019Level 1Level 2Level 3Total
Asset Category
Cash$3.8 $— $— $3.8 
Equity securities:
United States equities3.0 — — 3.0 
International equities11.2 — — 11.2 
Debt securities:
United States government bonds8.2 — — 8.2 
International government bonds22.3 — — 22.3 
Real estate— 4.4 — 4.4 
Mortgages— 2.3 — 2.3 
Insurance contracts— — 0.9 0.9 
Total plan assets $48.5 $6.7 $0.9 $56.1 
Alternative investments measured at net asset value (a)7.1 
Total plan assets $63.2 
_______________________________________
(a)     Certain investments that were measured at net asset value per share have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the total plan assets.

The following table summarizes the changes in fair value of the Company's defined benefit plan assets that have been classified as Level 3 for the years ended December 31, 2020 and 2019 (in millions):

 Insurance
Contracts
Balance at December 31, 2018$1.0 
Purchases, sales and settlements(0.1)
Balance at December 31, 20190.9 
Currency exchange rate impact0.1 
Balance at December 31, 2020$1.0 

Equity and debt securities are valued at fair value based on quoted market prices reported on the active markets on which the individual securities are traded. Real estate investments are valued by discounting to present value the cash flows expected to be generated by the specific properties. Investments in mortgages are valued at cost, which is deemed to approximate its fair value. The insurance contracts are valued at the cash surrender value of the contracts, which is deemed to approximate its fair value. Alternative investments include hedge funds, private equity funds and other miscellaneous investments, and are valued using the net asset value provided by the fund administrator as a practical expedient. The net asset value is based on the fair value of the underlying assets owned by the fund divided by the number of shares outstanding.
The following benefit payments, which reflect expected future service, as appropriate, at December 31, 2020, are expected to be paid (in millions):

2021$4.6 
20224.9 
20236.7 
20245.6 
20255.3 
2024-202636.7 

As of December 31, 2020, expected employer contributions for 2021 are $2.5 million.

Defined Contribution Plans

The Company's employees in the United States and Puerto Rico are eligible to participate in a qualified defined contribution plan. In the United States, participants may contribute up to 25% of their eligible compensation (subject to tax code limitation) to the plan. Edwards Lifesciences matches the first 4% of the participant's annual eligible compensation contributed to the plan on a dollar-for-dollar basis. Edwards Lifesciences matches the next 2% of the participant's annual eligible compensation to the plan on a 50% basis. In Puerto Rico, participants may contribute up to 25% of their annual compensation (subject to tax code limitation) to the plan. Edwards Lifesciences matches the first 4% of participant's annual eligible compensation contributed to the plan on a 50% basis. The Company also provides a 2% profit sharing contribution calculated on eligible earnings for each employee. Matching contributions relating to Edwards Lifesciences employees were $36.6 million, $31.4 million, and $26.6 million in 2020, 2019, and 2018, respectively.

The Company also has nonqualified deferred compensation plans for a select group of employees. The plans provide eligible participants the opportunity to defer eligible compensation to future dates specified by the participant with a return based on investment alternatives selected by the participant. The amount accrued under these nonqualified plans was $111.6 million and $88.7 million at December 31, 2020 and 2019, respectively.
XML 51 R21.htm IDEA: XBRL DOCUMENT v3.20.4
COMMON STOCK
 12 Months Ended
Dec. 31, 2020
Equity [Abstract]  
COMMON STOCK COMMON STOCK
Treasury Stock

In May 2019, the Board of Directors approved a stock repurchase program authorizing the Company to purchase up to $1.0 billion of the Company's common stock. The repurchase program does not have an expiration date. Stock repurchased under the program may be used to offset obligations under the Company's employee stock-based benefit programs and stock-based business acquisitions, and will reduce the total shares outstanding.

During 2020, 2019, and 2018, the Company repurchased 3.1 million, 1.5 million, and 5.5 million shares, respectively, at an aggregate cost of $625.4 million, $263.3 million, and $795.5 million, respectively, including shares purchased under the accelerated share repurchase ("ASR") agreements described below and shares acquired to satisfy tax withholding obligations in connection with the vesting of restricted stock units issued to employees. The timing and size of any future stock repurchases are subject to a variety of factors, including expected dilution from stock plans, cash capacity, and the market price of the Company's common stock.
Accelerated Share Repurchase

During 2019 and 2018, the Company entered into ASR agreements providing for the repurchase of the Company's common stock based on the volume-weighted average price ("VWAP") of the Company's common stock during the term of the agreements, less a discount. The following table summarizes the terms of the ASR agreements (dollars and shares in millions, except per share data):
  Initial DeliveryFinal Settlement
Agreement DateAmount
Paid		Shares
Received		Price per
Share (a)		Value of
Shares as %
of Contract
Value		Settlement
Date		Total Shares
Received		Average Price
per Share (a)
April 2018$400.0 2.5 $127.36 80 %July 20182.8 $142.37 
October 2018$250.0 1.4 $139.22 80 %November 20181.7 $150.54 
May 2019$150.0 0.7 $178.66 80 %May 20190.8 $178.42 
May 2019$100.0 0.5 $170.02 80 %June 20190.6 $178.46 
_______________________________________________________________________________
(a)    The three-for-one stock split distributed on May 29, 2020 excluded treasury shares. The shares and per share prices in the table are reflected at the pre-split amounts and prices at the time of the transaction.

The ASR agreements were accounted for as two separate transactions: (1) the value of the initial delivery of shares was recorded as shares of common stock acquired in a treasury stock transaction on the acquisition date and (2) the remaining amount of the purchase price paid was recorded as a forward contract indexed to the Company's own common stock and was recorded in "Additional Paid-in Capital" on the consolidated balance sheets. The initial delivery of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted-average common shares outstanding for basic and diluted earnings per share. The Company determined that the forward contract indexed to the Company's common stock met all the applicable criteria for equity classification and, therefore, was not accounted for as a derivative instrument.

Employee and Director Stock Plans

The Edwards Lifesciences Corporation Long-term Stock Incentive Compensation Program (the "Program") provides for the grant of incentive and non-qualified stock options, restricted stock, and restricted stock units for eligible employees of the Company. Under the Program, these grants are awarded at a price equal to the fair market value at the date of grant based upon the closing price on that date. Options to purchase shares of the Company's common stock granted under the Program generally vest over predetermined periods of between three to four years and expire seven years after the date of grant. Service-based restricted stock units of the Company's common stock granted under the Program generally vest over predetermined periods ranging from three to four years after the date of grant. Market-based restricted stock units of the Company's common stock granted under the Program vest over three years based on a combination of certain service and market conditions. The actual number of shares issued will be determined based on the Company's total stockholder return relative to a selected industry peer group. Performance-based restricted stock units vest based on a combination of certain service conditions and upon achievement of specified milestones. Under the Program, the number of shares of common stock available for issuance under the Program was 327.6 million shares. No more than 33.6 million shares reserved for issuance may be granted in the form of restricted stock or restricted stock units.

The Company also maintains the Nonemployee Directors Stock Incentive Compensation Program (the "Nonemployee Directors Program"). Under the Nonemployee Directors Program, annually each nonemployee director may receive up to 120,000 stock options or 48,000 restricted stock units of the Company's common stock, or a combination thereof, provided that in no event may the total value of the combined annual award exceed $0.2 million. These grants generally vest over one year from the date of grant. Under the Nonemployee Directors Program, an aggregate of 8.4 million shares of the Company's common stock has been authorized for issuance.

The Company has an employee stock purchase plan for United States employees and a plan for international employees (collectively "ESPP"). Under the ESPP, eligible employees may purchase shares of the Company's common stock at 85% of the lower of the fair market value of Edwards Lifesciences common stock on the effective date of subscription or the date of
purchase. Under the ESPP, employees can authorize the Company to withhold up to 12% (15% effective January 1, 2021) of their compensation for common stock purchases, subject to certain limitations. The ESPP is available to all active employees of the Company paid from the United States payroll and to eligible employees of the Company outside the United States, to the extent permitted by local law. The ESPP for United States employees is qualified under Section 423 of the Internal Revenue Code. The number of shares of common stock authorized for issuance under the ESPP was 45.9 million shares.

The fair value of each option award and employee stock purchase subscription is estimated on the date of grant using the Black-Scholes option valuation model that uses the assumptions noted in the following tables. The risk-free interest rate is estimated using the U.S. Treasury yield curve and is based on the expected term of the award. Expected volatility is estimated based on a blend of the weighted-average of the historical volatility of Edwards Lifesciences' stock and the implied volatility from traded options on Edwards Lifesciences' stock. The expected term of awards granted is estimated from the vesting period of the award, as well as historical exercise behavior, and represents the period of time that awards granted are expected to be outstanding. The Company uses historical data to estimate forfeitures and has estimated an annual forfeiture rate of 6.4%.

The Black-Scholes option pricing model was used with the following weighted-average assumptions for options granted during the following periods:

Option Awards
202020192018
Average risk-free interest rate0.3 %2.3 %2.9 %
Expected dividend yieldNoneNoneNone
Expected volatility33 %30 %29 %
Expected life (years)5.05.15.0
Fair value, per share$21.70 $18.17 $14.17 

The Black-Scholes option pricing model was used with the following weighted-average assumptions for ESPP subscriptions granted during the following periods:

ESPP
202020192018
Average risk-free interest rate1.3 %2.4 %1.7 %
Expected dividend yieldNoneNoneNone
Expected volatility33 %27 %31 %
Expected life (years)0.60.60.6
Fair value, per share$16.61 $16.43 $12.18 

The fair value of market-based restricted stock units was determined using a Monte Carlo simulation model, which uses multiple input variables to determine the probability of satisfying the market condition requirements. The weighted-average assumptions used to determine the fair value of the market-based restricted stock units during the years ended December 31, 2020, 2019, and 2018 included a risk-free interest rate of 0.2%, 2.2%, and 2.7%, respectively, and an expected volatility rate of 32.7%, 29.4%, and 29.7%, respectively.
Stock option activity during the year ended December 31, 2020 under the Program and the Nonemployee Directors Program was as follows (in millions, except years and per-share amounts):

 SharesWeighted-
Average
Exercise
Price		Weighted-
Average
Remaining
Contractual
Term		Aggregate
Intrinsic Value
Outstanding as of December 31, 201917.1 $32.19   
Options granted1.8 73.02   
Options exercised(4.3)18.16   
Options forfeited(0.3)49.74   
Outstanding as of December 31, 202014.3 41.27 3.4 years$712.5 
Exercisable as of December 31, 20209.5 32.32 2.5 years558.1 
Vested and expected to vest as of December 31, 202013.6 40.37 3.3 years690.4 

The following table summarizes nonvested restricted stock unit activity during the year ended December 31, 2020 under the Program and the Nonemployee Directors Program (in millions, except per-share amounts):

 SharesWeighted-
Average
Grant-Date
Fair Value
Nonvested as of December 31, 20192.7 $46.89 
Granted (a)0.9 71.31 
Vested(0.9)40.03 
Forfeited(0.1)49.90 
Nonvested as of December 31, 20202.6 57.59 
_______________________________________________________________________________
(a)    The shares granted includes 0.1 million shares of market-based restricted stock units granted during 2020, which represents the target number of shares to be issued, and 0.1 million shares related to a previous year's grant of market-based restricted stock units since the payout percentage achieved at the end of the performance period was in excess of target. As described above, the actual number of shares ultimately issued is determined based on the Company's total stockholder return relative to a selected industry peer group.

The intrinsic value of stock options exercised and restricted stock units vested during the years ended December 31, 2020, 2019, and 2018 were $323.5 million, $382.1 million, and $281.1 million, respectively. The intrinsic value of stock options is calculated as the amount by which the market price of the Company's common stock exceeds the exercise price of the option. During the years ended December 31, 2020, 2019, and 2018, the Company received cash from exercises of stock options of $79.2 million, $110.4 million, and $103.7 million, respectively, and tax benefits from exercises of stock options and vesting of restricted stock units of $72.1 million, $85.1 million, and $62.5 million, respectively. The total grant-date fair value of stock options vested during the years ended December 31, 2020, 2019, and 2018 were $34.0 million, $31.2 million, and $29.0 million, respectively.

As of December 31, 2020, the total remaining unrecognized compensation expense related to nonvested stock options, restricted stock units, and employee stock purchase subscriptions amounted to $140.9 million, which will be amortized over the weighted-average remaining requisite service period of 30 months.
XML 52 R22.htm IDEA: XBRL DOCUMENT v3.20.4
ACCUMULATED OTHER COMPREHENSIVE LOSS
 12 Months Ended
Dec. 31, 2020
Equity [Abstract]  
ACCUMULATED OTHER COMPREHENSIVE LOSS ACCUMULATED OTHER COMPREHENSIVE LOSS
Presented below is a summary of activity for each component of "Accumulated Other Comprehensive Loss" for the years ended December 31, 2020, 2019, and 2018.

 Foreign
Currency
Translation
Adjustments		Unrealized (Loss) Gain on HedgesUnrealized (Loss) Gain on
Available-for-sale
Investments		Unrealized
Pension
Costs (a)		Total
Accumulated
Other
Comprehensive
Loss
 (in millions)
December 31, 2017$(100.1)$(13.9)$(4.6)$(14.1)$(132.7)
Impact from adoption of ASU 2016-16 and ASU 2018-02(4.9)(2.9)— — (7.8)
January 1, 2018(105.0)(16.8)(4.6)(14.1)(140.5)
Other comprehensive (loss) income before reclassifications          (36.7)35.1 (3.1)7.6 2.9 
Amounts reclassified from accumulated other comprehensive loss— 19.1 2.9 (6.7)15.3 
Deferred income tax expense(1.9)(13.8)(0.2)(0.3)(16.2)
December 31, 2018(143.6)23.6 (5.0)(13.5)(138.5)
Other comprehensive (loss) income before reclassifications          (1.5)27.9 7.9 (3.2)31.1 
Amounts reclassified from accumulated other comprehensive loss(6.6)(44.2)0.4 0.7 (49.7)
Deferred income tax (expense) benefit(3.1)5.2 (1.6)0.6 1.1 
December 31, 2019(154.8)12.5 1.7 (15.4)(156.0)
Other comprehensive income (loss) before reclassifications          35.7 (34.8)8.0 (5.5)3.4 
Amounts reclassified from accumulated other comprehensive loss(6.4)(19.2)0.3 0.9 (24.4)
Deferred income tax benefit (expense)3.1 13.8 (1.4)0.4 15.9 
December 31, 2020$(122.4)$(27.7)$8.6 $(19.6)$(161.1)
_______________________________________________________________________________
(a)For the years ended December 31, 2020, 2019, and 2018, the change in unrealized pension costs consisted of the following (in millions):
 Pre-Tax
Amount		Tax (Expense) BenefitNet of Tax
Amount
2020   
Prior service credit arising during period$0.6 $(0.2)$0.4 
Amortization of prior service credit(0.7)0.1 (0.6)
Net prior service cost arising during period(0.1)(0.1)(0.2)
Net actuarial loss arising during period(4.5)0.5 (4.0)
Unrealized pension costs, net$(4.6)$0.4 $(4.2)
2019   
Prior service credit arising during period$4.6 $(0.6)$4.0 
Amortization of prior service credit(0.2)0.1 (0.1)
Net prior service credit arising during period4.4 (0.5)3.9 
Net actuarial loss arising during period(6.9)1.1 (5.8)
Unrealized pension costs, net$(2.5)$0.6 $(1.9)
2018   
Prior service credit arising during period$3.3 $(0.9)$2.4 
Amortization of prior service credit(0.1)— (0.1)
Net prior service credit arising during period3.2 (0.9)2.3 
Net actuarial loss arising during period(2.3)0.6 (1.7)
Unrealized pension credits, net$0.9 $(0.3)$0.6 

The following table provides information about amounts reclassified from "Accumulated Other Comprehensive Loss" (in millions):
 Years Ended December 31, 
Details about Accumulated Other Comprehensive Loss
Components		20202019Affected Line on Consolidated
Statements of Operations
Foreign currency translation adjustments$6.4 $6.6 Other income, net
(1.6)(1.6)Provision for income taxes
$4.8 $5.0 Net of tax
(Loss) gain on hedges$18.4 $40.9 Cost of sales
2.2 1.9 Selling, general, and administrative expenses
(1.4)1.4 Other income, net
19.2 44.2 Total before tax
(5.0)(11.0)Provision for income taxes
$14.2 $33.2 Net of tax
(Loss) gain on available-for-sale investments$(0.3)$(0.4)Other income, net
(0.6)(0.3)Provision for income taxes
$(0.9)$(0.7)Net of tax
Amortization of pension adjustments$(0.9)$(0.7)Other income, net
0.2 0.1 Provision for income taxes
$(0.7)$(0.6)Net of tax
XML 53 R23.htm IDEA: XBRL DOCUMENT v3.20.4
OTHER INCOME, NET
 12 Months Ended
Dec. 31, 2020
Other Income and Expenses [Abstract]  
OTHER INCOME, NET OTHER INCOME, NET
 Years Ended December 31,
 202020192018
(in millions)
Foreign exchange gains, net$(12.3)$(5.9)$(6.7)
Gain on investments(0.6)(0.5)1.7 
Non-service cost components of net periodic pension benefit cost (credit)0.4 0.2 (0.1)
Other1.0 (2.0)1.1 
Total other income, net$(11.5)$(8.2)$(4.0)
XML 54 R24.htm IDEA: XBRL DOCUMENT v3.20.4
INCOME TAXES
 12 Months Ended
Dec. 31, 2020
Income Tax Disclosure [Abstract]  
INCOME TAXES INCOME TAXES
The Company's income before provision for income taxes was generated from United States and international operations as follows (in millions):
 Years Ended December 31,
 202020192018
United States$151.3 $383.4 $266.1 
International, including Puerto Rico765.4 783.1 495.3 
$916.7 $1,166.5 $761.4 

The provision for income taxes consists of the following (in millions):
 Years Ended December 31,
 202020192018
Current   
United States:   
Federal$23.4 $31.3 $10.9 
State and local48.2 48.7 13.6 
International, including Puerto Rico73.9 29.1 35.9 
Current income tax expense$145.5 $109.1 $60.4 
Deferred   
United States:   
Federal$11.0 $28.3 $(16.1)
State and local(32.9)(18.3)(22.4)
International, including Puerto Rico(30.3)0.5 17.3 
Deferred income tax (benefit) expense(52.2)10.5 (21.2)
Total income tax provision$93.3 $119.6 $39.2 
The components of deferred tax assets and liabilities are as follows (in millions):
 December 31,
 20202019
Deferred tax assets  
Compensation and benefits$88.6 $90.1 
Benefits from uncertain tax positions27.0 22.5 
Net tax credit carryforwards125.5 108.4 
Net operating loss carryforwards64.1 57.6 
Accrued liabilities105.0 41.3 
Inventories16.3 12.9 
Cash flow and net investment hedges3.3 — 
State income taxes0.5 0.5 
Investments1.8 1.5 
Lease liability obligations7.7 18.4 
Other3.6 3.4 
Total deferred tax assets443.4 356.6 
Deferred tax liabilities  
Property, plant, and equipment(53.4)(22.6)
Cash flow and net investment hedges— (6.8)
Deferred tax on foreign earnings(29.2)(35.3)
Right-of-use assets (7.0)(17.5)
Other intangible assets(76.3)(71.0)
Other(3.1)(2.2)
Total deferred tax liabilities(169.0)(155.4)
Valuation allowance(71.6)(65.8)
Net deferred tax assets$202.8 $135.4 

During 2020, net deferred tax assets increased $67.4 million, including items that were recorded to stockholders' equity and which did not impact the Company's income tax provision.

The valuation allowance of $71.6 million as of December 31, 2020 reduces certain deferred tax assets to amounts that are more likely than not to be realized. This allowance primarily relates to the net operating loss carryforwards of certain non-United States subsidiaries and certain non-United States credit carryforwards.
Net operating loss and capital loss carryforwards and the related carryforward periods at December 31, 2020 are summarized as follows (in millions):
 Carryforward
Amount		Tax Benefit
Amount		Valuation
Allowance		Net Tax
Benefit		Carryforward
Period Ends
United States federal net operating losses$26.6 $5.6 $— $5.6 2030-2037
United States federal net operating losses11.3 2.4 — 2.4 Indefinite
United States state net operating losses33.5 2.1 (2.1)— 2026-2039
United States state net operating losses1.0 0.1 (0.1)— Indefinite
Non-United States net operating losses18.2 4.7 (3.6)1.1 2020-2027
Non-United States net operating losses295.1 49.2 (39.9)9.3 Indefinite
United States capital losses34.1 0.2 (0.2)— 2024
Total$419.8 $64.3 $(45.9)$18.4  

Certain tax attributes are subject to an annual limitation as a result of the acquisitions of Harpoon Medical, Inc. and CASMED (see Note 8), which constitute a change of ownership as defined under Internal Revenue Code Section 382.

The gross tax credit carryforwards and the related carryforward periods at December 31, 2020 are summarized as follows (in millions):
 Carryforward
Amount		Valuation
Allowance		Net Tax
Benefit		Carryforward
Period Ends
California research expenditure tax credits$145.1 $— $145.1 Indefinite
Federal research expenditure tax credits1.5 — 1.5 2026-2039
Puerto Rico purchases credit23.4 (23.4)— Indefinite
Total$170.0 $(23.4)$146.6  

The Company has $145.1 million of California research expenditure tax credits it expects to use in future periods. The credits may be carried forward indefinitely. Based upon anticipated future taxable income, the Company expects that it is more likely than not that all California research expenditure tax credits will be utilized, although the utilization of the full benefit is expected to occur over a number of years and into the distant future. Accordingly, no valuation allowance has been provided. The Company has $23.4 million of Puerto Rico purchases credit. Throughout its history and into the future, the Puerto Rico operations generate, or are expected to generate, credits each year in excess of its ability to utilize credits in those years. As a result, even though the credits have an indefinite life, the Company continues to record a valuation allowance on the credit carryforwards.

On December 22, 2017, Public Law 115-97, commonly referred to as the Tax Cuts and Jobs Act (the "2017 Act"), was signed into law. The 2017 Act a) reduced the U.S. federal corporate tax rate from 35 percent to 21 percent for tax years beginning after December 31, 2017, b) required companies to pay a one-time mandatory deemed repatriation tax on the cumulative earnings of certain foreign subsidiaries that were previously tax deferred, and c) created new taxes on certain foreign earnings in future years.

On December 22, 2017, Staff Accounting Bulletin No. 118 ("SAB 118") was issued to address the application of generally accepted accounting principles in the United States of America in situations when a registrant does not have the necessary information available, prepared, or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of the 2017 Act. In accordance with SAB 118, as of December 31, 2017, the Company had estimated provisional amounts for a) $3.3 million of tax benefits in connection with the remeasurement of certain tax assets and liabilities, b) $297.4 million of net tax expense in connection with the one-time mandatory deemed repatriation tax on cumulative earnings of certain foreign subsidiaries, and c) $32.3 million of tax benefits associated with a tax reform related restructuring. In accordance with SAB 118, during 2018 the Company adjusted the provisional amounts as described below.
As a result of Internal Revenue Service ("IRS") guidance issued subsequent to the 2017 Act, the $32.3 million of tax benefits associated with the tax reform related restructuring mentioned above were reversed in 2018. In addition, during 2018, the Company recorded a $12.8 million reduction in the repatriation tax and an additional benefit of $3.7 million in connection with the remeasurement of deferred tax assets. In accordance with SAB 118, the Company completed its accounting for the 2017 Act during the fourth quarter of 2018. In addition, the Company elected to pay the repatriation tax in installments over eight years.

The Company asserts that $1.1 billion of its foreign earnings continue to be indefinitely reinvested and it intends to repatriate $599.8 million of its foreign earnings as of December 31, 2020. The estimated net tax liability on the indefinitely reinvested earnings if repatriated is $21.1 million.

The Company has received tax incentives in certain non-U.S. tax jurisdictions, the primary benefit for which will expire in 2029. The tax reductions as compared to the local statutory rates were $189.2 million ($0.30 per diluted share), $157.6 million ($0.25 per diluted share), and $144.9 million ($0.23 per diluted share) for the years ended December 31, 2020, 2019, and 2018, respectively.

A reconciliation of the United States federal statutory income tax rate to the Company's effective income tax rate is as follows (in millions):
 Years Ended December 31,
 202020192018
Income tax expense at U.S. federal statutory rate$192.5 $245.0 $159.9 
Foreign income taxed at different rates(80.5)(75.0)(16.2)
State and local taxes, net of federal tax benefit5.0 11.9 6.8 
Tax credits, federal and state(43.1)(42.9)(36.7)
Build (release) of reserve for prior years' uncertain tax positions4.2 5.0 (35.5)
U.S. tax on foreign earnings, net of credits1.5 (2.9)(12.2)
Tax on global intangible low-taxed income49.2 32.0 — 
Foreign-derived intangible income deduction(2.6)(7.2)(6.6)
U.S. federal deductible employee share-based compensation(48.3)(57.6)(41.8)
Nondeductible employee share-based compensation4.2 3.2 2.8 
Impact related to 2017 U.S. Tax Reform— 2.8 15.8 
Other11.2 5.3 2.9 
Income tax provision$93.3 $119.6 $39.2 

The Company's effective tax rate for 2020 decreased slightly in comparison to 2019 primarily due to the tax benefit from the Settlement Agreement with Abbott (see Notes 3 and 18), partially offset by the increase in the U.S. tax on global intangible low-taxed income and the decrease in the tax benefit from employee share-based compensation. The Company's effective tax rate for 2019 increased in comparison to 2018 primarily because of the increase in the U.S. tax on global intangible low-taxed income and the tax benefit in 2018 from audit settlements.
Uncertain Tax Positions

As of December 31, 2020 and 2019, the gross uncertain tax positions were $281.8 million and $203.1 million, respectively. The Company estimates that these liabilities would be reduced by $95.1 million and $50.1 million, respectively, from offsetting tax benefits associated with the correlative effects of potential transfer pricing adjustments, state income taxes, and timing adjustments. The net amounts of $186.7 million and $153.0 million, respectively, if not required, would favorably affect the Company's effective tax rate.
A reconciliation of the beginning and ending amount of uncertain tax positions, excluding interest, penalties, and foreign exchange, is as follows (in millions):
 December 31,
 202020192018
Uncertain gross tax positions, January 1$203.1 $150.7 $225.6 
Current year tax positions
86.4 55.4 37.8 
Increase in prior year tax positions
6.0 0.8 13.9 
Decrease in prior year tax positions
(10.0)(3.8)(78.8)
Settlements
(3.7)— (46.5)
Lapse of statutes of limitations
— — (1.3)
Uncertain gross tax positions, December 31$281.8 $203.1 $150.7 

The table above summarizes the gross amounts of uncertain tax positions without regard to reduction in tax liabilities or additions to deferred tax assets and liabilities if such uncertain tax positions were settled.

The Company recognizes interest and penalties, if any, related to uncertain tax positions in the provision for income taxes. As of December 31, 2020, the Company had accrued $14.3 million (net of $5.1 million tax benefit) of interest related to uncertain tax positions, and as of December 31, 2019, the Company had accrued $9.3 million (net of $3.5 million tax benefit) of interest related to uncertain tax positions. During 2020, 2019, and 2018, the Company recognized interest expense (benefit), net of tax benefit, of $5.0 million, $4.7 million, and $(2.8) million, respectively, in "Provision for Income Taxes" on the consolidated statements of operations.

The Company strives to resolve open matters with each tax authority at the examination level and could reach agreement with a tax authority at any time. While the Company has accrued for matters it believes are more likely than not to require settlement, the final outcome with a tax authority may result in a tax liability that is more or less than that reflected in the consolidated financial statements. Furthermore, the Company may later decide to challenge any assessments, if made, and may exercise its right to appeal. The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new legislation, regulations, or case law. Management believes that adequate amounts of tax and related penalty and interest have been provided in income tax expense for any adjustments that may result from these uncertain tax positions.

At December 31, 2020, all material state, local, and foreign income tax matters have been concluded for years through 2015. While not material, the Company continues to address matters in Wisconsin and India for years from 2010.

During 2018, the Company executed an Advance Pricing Agreement (“APA”) between the United States and Switzerland governments for tax years 2009 through 2020 covering various, but not all, transfer pricing matters. The unagreed transfer pricing matters, namely Surgical Structural Heart and Transcatheter Aortic Valve Replacement intercompany royalty transactions, then reverted to IRS Examination for further consideration as part of the respective years' regular tax audit. In addition, the Company signed agreements during 2018 with the IRS to settle open tax years 2009 through 2014, including all transfer pricing matters for those years and the tax treatment of a portion of a litigation settlement payment received in 2014.

The IRS began its examination of the 2015 and 2016 tax years during the fourth quarter of 2018 and later added the 2017 tax year to this audit cycle during the first quarter of 2019. The IRS audit field work for the 2015-2017 tax years was substantially completed during the fourth quarter of 2020, except for transfer pricing matters.

As a result, certain intercompany transactions covering tax years 2015 through 2020 that were not resolved under the APA program remain subject to IRS examination, and those transactions and related tax positions remain uncertain as of December 31, 2020. The IRS has signaled that it may be preparing proposed audit adjustments related to these intercompany transactions for the 2015-2017 tax years which, if issued, could be provided to the Company during 2021. The Company has considered this information in its evaluation of its uncertain tax positions.
These unresolved transfer pricing matters, net of any correlative repatriation tax adjustment, may be significant to the Company’s consolidated financial statements. Based on the information currently available and numerous possible outcomes, the Company cannot reasonably estimate what, if any, changes to its existing uncertain tax positions may occur in the next 12 months and, therefore, has continued to record the gross uncertain tax positions as a long-term liability.

The Company intends to file to renew the APA between the United States and Switzerland for the years 2021 and forward. In addition, the Company executed other APAs as follows: during 2017, an APA between the United States and Japan covering tax years 2015 through 2019; and during 2018, APAs between Japan and Singapore and between Switzerland and Japan covering tax years 2015 through 2019. The Company has filed to renew these APAs related to Japan for the years 2020 and forward. The execution of some or all of these APAs depends on a number of variables outside of the Company's control.
XML 55 R25.htm IDEA: XBRL DOCUMENT v3.20.4
LEGAL PROCEEDINGS
 12 Months Ended
Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]  
LEGAL PROCEEDINGS LEGAL PROCEEDINGS
In January 2019, Abbott filed lawsuits against Edwards Lifesciences and its direct and indirect subsidiaries (“Edwards”) in the Federal District Court in the District of Delaware, in the United Kingdom, Germany, Switzerland and Italy, and, in February 2020, in Ireland, alleging patent infringement involving Edwards’ PASCAL heart valve repair system (collectively, the “PASCAL litigation”). In February 2019, Edwards filed a lawsuit against Abbott in the Federal District Court in the Central District of California alleging patent infringement involving Abbott's MITRACLIP device (with the PASCAL litigation, the “Abbott Matters”). On July 12, 2020, Edwards entered into the Settlement Agreement with Abbott to, among other things, settle all patent litigation between the parties related to alleged patent infringement involving Edwards’ PASCAL heart valve repair system and Abbott’s MITRACLIP device. Pursuant to the Settlement Agreement, all of the Abbott Matters and related appeals in courts worldwide were dismissed. The Settlement Agreement resulted in the Company recording an estimated $367.9 million pre-tax net charge in June 2020 related to past damages. See Note 3 for additional information.

In addition, the Company is or may be a party to, or may otherwise be responsible for, pending or threatened lawsuits including those related to products and services currently or formerly manufactured or performed, as applicable, by the Company, workplace and employment matters, matters involving real estate, Company operations or health care regulations, or governmental investigations (the "Other Lawsuits"). The Other Lawsuits raise difficult and complex factual and legal issues and are subject to many uncertainties, including, but not limited to, the facts and circumstances of each particular case or claim, the jurisdiction in which each suit is brought, and differences in applicable law. Management does not believe that any loss relating to the Other Lawsuits would have a material adverse effect on the Company's overall financial condition, results of operations or cash flows. However, the resolution of one or more of the Other Lawsuits in any reporting period, could have a material adverse impact on the Company's financial results for that period. The Company is not able to estimate the amount or range of any loss for legal contingencies related to the Other Lawsuits for which there is no reserve or additional loss for matters already reserved.

The Company is subject to various environmental laws and regulations both within and outside of the United States. The Company's operations, like those of other medical device companies, involve the use of substances regulated under environmental laws, primarily in manufacturing and sterilization processes. While it is difficult to quantify the potential impact of continuing compliance with environmental protection laws, management believes that such compliance will not have a material impact on the Company's financial results. The Company's threshold of disclosing material environmental legal proceedings involving a governmental authority where potential monetary exposure is involved is $1 million.
XML 56 R26.htm IDEA: XBRL DOCUMENT v3.20.4
SEGMENT INFORMATION
 12 Months Ended
Dec. 31, 2020
Segment Reporting [Abstract]  
SEGMENT INFORMATION SEGMENT INFORMATION
The Company conducts operations worldwide and is managed in the following geographical regions: United States, Europe, Japan, and Rest of World. All regions sell products that are used to treat advanced cardiovascular disease.

The Company's geographic segments are reported based on the financial information provided to the Chief Operating Decision Maker (the Chief Executive Officer). The Company evaluates the performance of its geographic segments based on net sales and operating income. The accounting policies of the segments are substantially the same as those described in Note 2. Segment net sales and segment operating income are based on internally derived standard foreign exchange rates, which may differ from year to year, and do not include inter-segment profits. Because of the interdependence of the reportable segments,
the operating profit as presented may not be representative of the geographical distribution that would occur if the segments were not interdependent. Net sales by geographic area are based on the location of the customer.

Certain items are maintained at the corporate level and are not allocated to the segments. The non-allocated items include net interest expense, global marketing expenses, corporate research and development expenses, manufacturing variances, corporate headquarters costs, special gains and charges, stock-based compensation, foreign currency hedging activities, certain litigation costs, changes in the fair value of contingent consideration liabilities, and most of the Company's amortization expense. Although most of the Company's depreciation expense is included in segment operating income, due to the Company's methodology for cost build-up, it is impractical to determine the amount of depreciation expense included in each segment, and, therefore, a portion is maintained at the corporate level. The Company neither discretely allocates assets to its operating segments, nor evaluates the operating segments using discrete asset information.

The table below presents information about Edwards Lifesciences' reportable segments (in millions):
 Years Ended December 31,
 202020192018
Segment Net Sales   
United States$2,516.8 $2,532.7 $2,055.2 
Europe945.2 926.1 826.4 
Japan448.6 441.4 398.4 
Rest of World451.5 433.3 396.0 
Total segment net sales$4,362.1 $4,333.5 $3,676.0 
Segment Operating Income  
United States$1,727.3 $1,742.3 $1,368.1 
Europe479.3 472.0 394.8 
Japan286.4 272.3 237.0 
Rest of World150.1 127.9 115.6 
Total segment operating income$2,643.1 $2,614.5 $2,115.5 
The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated income before provision for income taxes ("pre-tax income") (in millions):
 Years Ended December 31,
 202020192018
Net Sales Reconciliation   
Segment net sales$4,362.1 $4,333.5 $3,676.0 
Foreign currency24.2 14.5 46.8 
Consolidated net sales$4,386.3 $4,348.0 $3,722.8 
Pre-tax Income Reconciliation  
Segment operating income$2,643.1 $2,614.5 $2,115.5 
Unallocated amounts:
Corporate items(1,358.0)(1,439.7)(1,058.1)
Special charges— (64.6)(116.2)
Intellectual property litigation expenses, net(405.4)(33.4)(214.0)
Change in fair value of contingent consideration liabilities, net(13.6)6.1 5.7 
Foreign currency31.5 63.9 15.3 
Consolidated operating income897.6 1,146.8 748.2 
Non-operating income19.1 19.7 13.2 
Consolidated pre-tax income$916.7 $1,166.5 $761.4 
Enterprise-Wide Information

Enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated financial statements.

 As of or for the Years Ended December 31,
 202020192018
(in millions)
Net Sales by Geographic Area   
United States$2,516.8 $2,532.7 $2,055.3 
Europe973.6 941.2 885.1 
Japan460.1 444.7 396.8 
Rest of World435.8 429.4 385.6 
$4,386.3 $4,348.0 $3,722.8 
Net Sales by Major Product Area  
Transcatheter Aortic Valve Replacement$2,857.3 $2,737.9 $2,283.8 
Transcatheter Mitral and Tricuspid Therapies41.8 28.2 2.9 
Surgical Structural Heart761.8 841.7 761.6 
Critical Care725.4 740.2 674.5 
$4,386.3 $4,348.0 $3,722.8 
Long-lived Tangible Assets by Geographic Area   
United States$1,084.3 $849.1 $642.1 
Europe192.7 101.5 36.6 
Japan20.4 21.7 6.7 
Rest of World311.0 269.4 214.4 
$1,608.4 $1,241.7 $899.8 
XML 57 R27.htm IDEA: XBRL DOCUMENT v3.20.4
QUARTERLY FINANCIAL RESULTS AND MARKET FOR THE COMPANY'S STOCK (UNAUDITED)
 12 Months Ended
Dec. 31, 2020
Quarterly Financial Information Disclosure [Abstract]  
QUARTERLY FINANCIAL RESULTS AND MARKET FOR THE COMPANY'S STOCK (UNAUDITED) QUARTERLY FINANCIAL RESULTS AND MARKET FOR THE COMPANY'S STOCK (UNAUDITED)
Years Ended December 31,First
Quarter		Second
Quarter		Third
Quarter		Fourth
Quarter		Total
Year
 (in millions, except per share data)
2020     
Net sales$1,128.7 $925.0 $1,140.9 $1,191.7 $4,386.3 
Gross profit863.6 686.8 859.9 895.4 3,305.7 
Net income (loss) (a)310.6 (121.9)325.2 309.5 823.4 
Earnings (loss) per common share (a):     
Basic0.50 (0.20)0.52 0.50 1.32 
Diluted0.49 (0.20)0.52 0.49 1.30 
Market price:     
High$81.90 $78.43 $87.79 $92.08 $92.08 
Low51.51 56.44 66.87 70.92 51.51 
2019     
Net sales$993.0 $1,086.9 $1,094.0 $1,174.1 $4,348.0 
Gross profit761.2 782.9 801.6 887.9 3,233.6 
Net income (b)249.7 242.3 274.7 280.2 1,046.9 
Earnings per common share (b):     
Basic0.40 0.39 0.44 0.45 1.68 
Diluted0.39 0.38 0.43 0.44 1.64 
Market price:     
High$65.95 $65.00 $76.06 $82.55 $82.55 
Low46.95 55.23 61.00 71.08 46.95 
_______________________________________________________________________________
(a)    The second quarter of 2020 includes a $367.9 million charge related to a litigation settlement.
(b) The first quarter of 2019 includes a $24.0 million charge related to the acquisition of early-stage transcatheter intellectual property and associated clinical and regulatory experience. The second and third quarters of 2019 include a $46.2 million and $26.9 million charge, respectively, related to the write off of inventory. The fourth quarter of 2019 includes a $40.6 million charge related to the impairment of certain in-process research and development assets.
XML 58 R28.htm IDEA: XBRL DOCUMENT v3.20.4
VALUATION AND QUALIFYING ACCOUNTS
 12 Months Ended
Dec. 31, 2020
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
VALUATION AND QUALIFYING ACCOUNTS VALUATION AND QUALIFYING ACCOUNTS
  Additions  
 Balance at
Beginning
of Period		Charged to
Costs and
Expenses		Charged to
Other
Accounts		DeductionsBalance at
End of
Period
 (in millions)
Year ended December 31, 2020     
Allowance for doubtful accounts (a)$14.7 $3.1 $— $(1.4)$16.4 
Tax valuation allowance (b)64.0 6.3 0.6 (1.1)69.8 
Year ended December 31, 2019     
Allowance for doubtful accounts (a)$13.6 $4.7 $0.2 $(3.8)$14.7 
Tax valuation allowance (b)44.9 18.9 0.2 — 64.0 
Year ended December 31, 2018     
Allowance for doubtful accounts (a)$13.7 $2.2 $1.0 $(3.3)$13.6 
Tax valuation allowance (b)41.6 7.1 (1.8)(2.0)44.9 
_______________________________________________________________________________
(a)    The deductions related to allowances for doubtful accounts represent accounts receivable which are written off.

(b)     The tax valuation allowances are provided for other-than-temporary impairments and unrealized losses related to certain investments that may not be recognized due to the uncertainty of the ready marketability of certain impaired investments, and net operating loss and credit carryforwards that may not be recognized due to insufficient taxable income.
XML 59 R29.htm IDEA: XBRL DOCUMENT v3.20.4
SUBSEQUENT EVENT
 12 Months Ended
Dec. 31, 2020
Subsequent Events [Abstract]  
SUBSEQUENT EVENT SUBSEQUENT EVENTIn February 2021, Edwards entered into an ASR agreement to repurchase $250.0 million of the Company's common stock based on the volume-weighted average price ("VWAP") of the Company's common stock during the term of the agreements, less a discount. Upon entering into the agreement, Edwards received an initial delivery of 2.4 million shares, representing approximately 80% of the shares to be repurchased. At the termination of the ASR, Edwards may receive additional shares or may be required to pay additional cash or shares (at the Company's election). The final settlement is based on the VWAP over the term of the agreement, less a discount. The ASR agreement has a scheduled termination date of March 18, 2021.
XML 60 R30.htm IDEA: XBRL DOCUMENT v3.20.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 12 Months Ended
Dec. 31, 2020
Accounting Policies [Abstract]  
Principles of Consolidation
Principles of Consolidation

The accompanying consolidated financial statements include the accounts of Edwards Lifesciences and its majority-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The Company reviews its investments in other entities to determine whether the Company is the primary beneficiary of a variable interest entity ("VIE"). The Company would be the primary beneficiary of the VIE, and would be required to consolidate the VIE, if it has the power to direct the significant activities of the entity and the obligation to absorb losses or receive benefits from the entity that may be significant to the VIE. Based on the Company's analysis, it determined it is not the primary beneficiary of any VIEs; however, future events may require VIEs to be consolidated if the Company becomes the primary beneficiary.

Certain reclassifications of previously reported amounts have been made to conform to classifications used in the current year.
Use of Estimates
Use of Estimates

The consolidated financial statements of Edwards Lifesciences have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") which have been applied consistently in all material respects. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. In particular, the novel Coronavirus ("COVID-19") pandemic has adversely impacted and is likely to further adversely impact nearly all aspects of our business and markets, including our workforce and the operations of our customers, suppliers, and business partners. The full extent to which the pandemic will directly or indirectly impact the Company's business, results of operations and financial condition, including sales, expenses, manufacturing, clinical trials, research and development costs, reserves and allowances, fair value measurements, asset impairment charges, contingent consideration obligations, and the effectiveness of the Company's hedging instruments, will depend on future developments that are highly uncertain and difficult to predict. These developments include, but are not limited to, the duration and spread of the outbreak (including new variants of COVID-19), its severity, the actions to contain the virus or address its impact, the timing, distribution, and efficacy of vaccines and other treatments, U.S. and foreign government actions to respond to the reduction in global economic activity, and how quickly and to what extent normal economic and operating conditions can resume.
Foreign Currency Translation
Foreign Currency Translation

When the local currency of the Company's foreign entities is the functional currency, all assets and liabilities are translated into United States dollars at the rate of exchange in effect at the balance sheet date. Income and expense items are translated at the weighted-average exchange rate prevailing during the period. The effects of foreign currency translation adjustments for these entities are deferred and reported in stockholders' equity as a component of "Accumulated Other Comprehensive Loss." The effects of foreign currency transactions denominated in a currency other than an entity's functional currency are included in "Other Income, net."
Revenue Recognition
Revenue Recognition

Revenue is recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those products or services.

The Company generates nearly all of its revenue from direct product sales and sales of products under consignment arrangements. Revenue from direct product sales is recognized at a point in time when the performance obligation is satisfied upon delivery of the product. Revenue from sales of consigned inventory is recognized at a point in time when the performance obligation is satisfied once the product has been implanted or used by the customer. The Company periodically reviews consignment inventories to confirm the accuracy of customer reporting. The Company also generates a small portion of its revenue from service contracts, and recognizes revenue from service contracts ratably over the term of the contracts. Sales taxes and other similar taxes that the Company collects concurrent with revenue-producing activities are excluded from revenue. The Company does not typically have any significant unusual payment terms beyond 90 days in its contracts with customers. In addition, the Company receives royalty payments for the licensing of certain intellectual property and recognizes the royalty when the subsequent sale of product using the intellectual property occurs.

The amount of consideration the Company ultimately receives varies depending upon the return terms, sales rebates, discounts, and other incentives that the Company may offer, which are accounted for as variable consideration when estimating the amount of revenue to recognize. The Company includes estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely upon an assessment of historical payment experience, historical relationship to revenues, estimated customer inventory levels, and current contract sales terms with direct and indirect customers.

The Company's sales adjustment related to distributor rebates given to the Company's United States distributors represents the difference between the Company's sales price to the distributor and the negotiated price to be paid by the end-customer. This distributor rebate is recorded as a reduction to sales and a reduction to the distributor's accounts receivable at the time of sale to a distributor. The Company periodically monitors current pricing trends and distributor inventory levels to ensure the credit for future distributor rebates is fairly stated.

The Company offers volume rebates to certain group purchasing organizations ("GPOs") and customers based upon targeted sales levels. Volume rebates offered to GPOs are recorded as a reduction to sales and an obligation to the GPOs, as the Company expects to pay in cash. Volume rebates offered to customers are recorded as a reduction to sales and either accounts receivable if the Company expects a net payment from the customer, or as an obligation to the customer if the Company expects to pay in cash. The provision for volume rebates is estimated based upon customers' contracted rebate programs, projected sales levels, and historical experience of rebates paid. The Company periodically monitors its customer rebate programs to ensure that the allowance and liability for accrued rebates is fairly stated.

Product returns are typically not significant because returns are generally not allowed unless the product is damaged at time of receipt. In limited circumstances, the Company may allow customers to return previously purchased products, such as for next-generation product offerings. For these transactions, the Company defers recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer.
The Company sells separately priced service contracts, which range from 12 to 36 months, to owners of its hemodynamic monitors. The Company invoices the customer the total amount of consideration at the inception of the contract and recognizes revenue ratably over the term of the contract. As of December 31, 2020 and December 31, 2019, $6.3 million and $8.4 million, respectively, of deferred revenue associated with outstanding service contracts was recorded in “Accrued and Other Liabilities” and "Other Long-term Liabilities." During 2020, the Company recognized as revenue $6.3 million that was included in the balance of deferred revenue as of December 31, 2019, and during 2019, the Company recognized as revenue $5.5 million that was included in the balance of deferred revenue as of December 31, 2018.

A limited number of the Company’s contracts with customers contain multiple performance obligations. For these contracts, the transaction price is allocated to each performance obligation based on its relative standalone selling price charged to other customers.

The Company applies the optional exemption of not disclosing the amount of the transaction price allocated to unsatisfied performance obligations for contracts with an original expected duration of one year or less.

Shipping and Handling Costs
Shipping costs, which are costs incurred to physically move product from the Company's premises or third party distribution centers, including storage, to the customer's premises, are included in "Selling, General, and Administrative Expenses." Handling costs, which are costs incurred to store at the Company's premises, move, and prepare products for shipment, are included in "Cost of Sales."
Cash Equivalents
Cash Equivalents

The Company considers highly liquid investments with original maturities of three months or less to be cash equivalents. These investments are valued at cost, which approximates fair value.
Investments
Investments

The Company invests its excess cash in debt securities, including time deposits, commercial paper, U.S. government and agency securities, asset-backed securities, corporate debt securities, and municipal debt securities. Investments with maturities of one year or less are classified as short-term, and investments with maturities greater than one year are classified as long-term. Investments that the Company has the ability and intent to hold until maturity are classified as held-to-maturity and carried at amortized cost. Investments in debt securities that are classified as available-for-sale are carried at fair value with unrealized gains and losses included in "Accumulated Other Comprehensive Loss." The Company determines the appropriate classification of its investments in debt securities at the time of purchase and reevaluates such designation at each balance sheet date.

The Company also has long-term equity investments in companies that are in various stages of development. These investments are reported at fair value or under the equity method of accounting, as appropriate. Equity investments that do not have readily determinable fair values are recorded at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. The Company accounts for investments in limited partnerships and limited liability corporations, whereby the Company owns a minimum of 5% of the investee's outstanding voting stock, under the equity method of accounting. These investments are recorded at the amount of the Company's investment and adjusted each period for the Company's share of the investee's income or loss, and dividends paid.

Realized gains and losses on investments that are sold are determined using the specific identification method, or the first-in, first-out method, depending on the investment type, and recorded to "Other Income, net." Income relating to investments in debt securities is recorded to "Interest Income."
Equity investments without readily determinable fair value are considered impaired when there is an indication that the fair value of the Company's interest is less than the carrying amount. Equity method investments are considered impaired when there is an indication of an other-than-temporary decline in value below the carrying amount. Impairments of equity investments are recorded in "Other Income, net."

Debt securities in an unrealized loss position are written down to fair value through “Other Income, net” if the Company intends to sell the security or it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. For debt securities in an unrealized loss position that do not meet the aforementioned criteria, the Company assesses whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost, changes to the rating of the security by a rating agency, and any adverse conditions specifically related to the security, among other factors. When a credit loss exists, the Company compares the present value of cash flows expected to be collected from the debt security to the amortized cost basis of the security to determine the allowance amount that should be recorded, if any. For available-to-sale debt securities, any additional impairment not recorded through an allowance for credit losses is recognized in “Accumulated Other Comprehensive Loss.”
Accounts Receivable
Accounts Receivable

The majority of the Company’s accounts receivable arise from direct product sales and sales of products under consignment arrangements, and have payment terms that generally require payment within 30 to 90 days. The Company does not adjust its receivables for the effects of a significant financing component at contract exception if collection of the receivable is expected within one year or less from the time of sale. In countries where the Company has experienced a pattern of payments extending beyond the stated terms and collection of the receivable is expected beyond one year from the time of sale, the Company assesses whether the customer has a significant financing component and discounts the receivable and reduces the related revenues over the period of time that the Company estimates those amounts will be paid using the country’s market-based borrowing rate for such period.

The Company provides reserves against accounts receivable for estimated losses that may result from a customer’s inability to pay based on customer-specific analysis and general matters such as current assessments of past due balances, economic conditions and forecasts, and historical credit loss activity. Amounts determined to be uncollectible are charged or written-off against the reserve.
Inventories
Inventories

Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value. Market value for raw materials is based on replacement costs, and for other inventory classifications is based on net realizable value.

A write-down for excess or slow moving inventory is recorded for inventory which is obsolete, damaged, nearing its expiration date (generally triggered at six months prior to expiration), or slow moving (generally defined as quantities in excess of a two-year supply).
The Company allocates to inventory general and administrative costs that are related to the production process. These costs include insurance, manufacturing accounting personnel, human resources personnel, and information technology.
Property, Plant and Equipment
Property, Plant, and Equipment

Property, plant, and equipment are recorded at cost. Depreciation is principally calculated for financial reporting purposes on the straight-line method over the estimated useful lives of the related assets, which range from 10 to 40 years for buildings and improvements, from 3 to 15 years for machinery and equipment, and from 3 to 5 years for software. Leasehold improvements are amortized over the life of the related facility leases or the asset, whichever is shorter. Straight-line and accelerated methods of depreciation are used for income tax purposes. Construction in progress is not depreciated until the asset is ready for its intended use.
Leases
Leases

On January 1, 2019, the Company adopted an amendment to the guidance on leases using a modified retrospective transition approach. The Company determines whether a contract is, or contains, a lease at inception. Right-of-use assets represent the Company’s right to use an underlying asset during the lease term, and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at lease commencement based upon the estimated present value of unpaid lease payments over the lease term. The Company uses its incremental borrowing rate based on the information available at lease commencement in determining the present value of unpaid lease payments. The Company's incremental borrowing rate is determined based on the estimated rate of interest for collateralized borrowing over a similar term as the associated lease. Right-of-use assets also include any lease payments made at or before lease commencement and any initial direct costs incurred, and exclude any lease incentives received.

The Company determines the lease term as the noncancellable period of the lease, and may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Leases with a term of 12 months or less are not recognized on the balance sheet. Certain of the Company’s leases include variable lease payments that are based on costs incurred or actual usage, or adjusted periodically based on an index or a rate. The Company’s leases do not contain any residual value guarantees.

The Company accounts for the lease and non-lease components as a single lease component for all of its leases except vehicle leases, for which the lease and non-lease components are accounted for separately.

Operating leases are included in “Operating Lease Right-of-Use Assets” and “Operating Lease Liabilities” on the Company’s consolidated balance sheets. See Note 6 for further information.
Impairment of Goodwill and Long-lived Assets
Impairment of Goodwill and Long-lived Assets

Goodwill is reviewed for impairment annually in the fourth quarter of each fiscal year, or whenever an event occurs or circumstances change that would indicate that the carrying amount may be impaired. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the Company performs a quantitative impairment test. The Company determined, after performing a qualitative review of each reporting unit, that it is more likely than not that the fair value of each of its reporting units substantially exceeds the respective carrying amounts. Accordingly, in 2020, 2019, and 2018, the Company did not record any impairment loss.

Indefinite-lived intangible assets relate to in-process research and development acquired in business combinations. The estimated fair values of in-process research and development projects acquired in a business combination which have not reached technological feasibility are capitalized and accounted for as indefinite-lived intangible assets subject to impairment testing until completion or abandonment of the projects. Upon successful completion of the project, the capitalized amount is amortized over its estimated useful life. If the project is abandoned, all remaining capitalized amounts are written off immediately. Indefinite-lived intangible assets are reviewed for impairment annually in the fourth quarter of each fiscal year, or whenever an event occurs or circumstances change that would indicate the carrying amount may be impaired. An impairment
loss is recognized when the asset's carrying value exceeds its fair value. In-process research and development projects acquired in an asset acquisition are expensed unless the project has an alternative future use.

Management reviews the carrying amounts of other finite-lived intangible assets and long-lived tangible assets whenever events or circumstances indicate that the carrying amounts of an asset may not be recoverable. Impairment indicators include, among other conditions, cash flow deficits, historic or anticipated declines in revenue or operating profit, and adverse legal or regulatory developments. If it is determined that such indicators are present and the review indicates that the assets will not be fully recoverable, based on undiscounted estimated cash flows over the remaining amortization periods, their carrying values are reduced to estimated fair market value. Estimated fair market value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved. For the purposes of identifying and measuring impairment, long-lived assets are grouped with other assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities.
In 2020, the Company did not record any impairment loss related to its in-process research and development assets. In 2019, the Company recorded a $40.6 million charge related to the impairment of certain in-process research and development assets. In 2018, the Company recorded a $116.2 million charge related to the impairment of certain developed technology and in-process research and development assets. See Note 4 for further information.
Income Taxes
Income Taxes

The Company is subject to income taxes in the United States and numerous foreign jurisdictions. Significant judgment is required in evaluating the Company's uncertain tax positions and determining its provision for income taxes. The Company recognizes the financial statement benefit of a tax position only after determining that a position would more likely than not be sustained based upon its technical merit if challenged by the relevant taxing authority and taken by management to the court of last resort. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon settlement with the relevant tax authority. The Company recognizes interest and penalties related to income tax matters in income tax expense. The Company has made an accounting policy election to recognize the U.S. tax effects of global intangible low-taxed income as a component of income tax expense in the period the tax arises.

Deferred tax assets and liabilities are recognized for the expected future tax consequences of events that have been recognized in the Company's financial statements or tax returns. The Company evaluates quarterly the realizability of its deferred tax assets by assessing its valuation allowance and adjusting the amount, if necessary. The factors used to assess the likelihood of realization are both historical experience and the Company's forecast of future taxable income and available tax planning strategies that could be implemented to realize the net deferred tax assets. Failure to achieve forecasted taxable income in the applicable taxing jurisdictions could affect the ultimate realization of deferred tax assets and could result in an increase in the Company's effective tax rate on future earnings.
Research and Development Costs
Research and Development Costs

Research and development costs are charged to expense when incurred.
Earnings per Share
Earnings per Share

Basic earnings per share is computed by dividing net income by the weighted-average common shares outstanding during a period. Diluted earnings per share is computed based on the weighted-average common shares outstanding plus the effect of dilutive potential common shares outstanding during the period calculated using the treasury stock method. Dilutive potential common shares include employee equity share options, nonvested shares, and similar equity instruments granted by the Company. Potential common share equivalents have been excluded where their inclusion would be anti-dilutive.
Stock-based Compensation
Stock-based Compensation

The Company measures and recognizes compensation expense for all stock-based awards based on estimated fair values. Stock-based awards consist of stock options, restricted stock units (service-based, market-based, and performance-based), and employee stock purchase subscriptions. Stock-based compensation expense is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period (vesting period) on a straight-line basis. For performance-based restricted stock units, the Company recognizes stock-based compensation expense if and when the Company concludes that it is probable that the performance condition will be achieved, net of estimated forfeitures. The Company reassesses the probability of vesting at each quarter end and adjusts the stock-based compensation expense based on its probability assessment. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Upon exercise of stock options or vesting of restricted stock units, the Company issues common stock.

Total stock-based compensation expense was as follows (in millions):
 Years Ended December 31,
 202020192018
Cost of sales$17.2 $14.7 $11.4 
Selling, general, and administrative expenses56.6 51.2 46.3 
Research and development expenses18.8 15.4 13.3 
Total stock-based compensation expense92.6 81.3 71.0 
Income tax benefit(15.4)(14.8)(13.4)
Total stock-based compensation expense, net of tax$77.2 $66.5 $57.6 

Upon a participant's retirement, all unvested stock options and performance-based restricted stock units are immediately forfeited. In addition, upon retirement, a participant will immediately vest in 25% of service-based restricted stock units for each full year of employment with the Company measured from the grant date. All remaining unvested service-based restricted stock units are immediately forfeited. For market-based restricted stock units, upon retirement and in certain other specified cases, a participant will receive a pro-rated portion of the shares that would ultimately be issued based on attainment of the
performance goals as determined on the vesting date. The pro-rated portion is based on the participant's whole months of service with the Company during the performance period prior to the date of termination.
Derivatives
Derivatives

The Company uses derivative financial instruments to manage interest rate and foreign currency risks. It is the Company's policy not to enter into derivative financial instruments for speculative purposes.

Derivative financial instruments involve credit risk in the event the counterparty should default. It is the Company's policy to execute such instruments with global financial institutions that the Company believes to be creditworthy. The Company diversifies its derivative financial instruments among counterparties to minimize exposure to any one of these entities. The Company also uses International Swap Dealers Association master-netting agreements. The master-netting agreements provide for the net settlement of all contracts through a single payment in a single currency in the event of default, as defined by the agreements.

The Company uses foreign currency forward exchange contracts, cross currency swap contracts, and foreign currency denominated debt to manage its exposure to changes in currency exchange rates from (1) future cash flows associated with intercompany transactions and certain local currency expenses expected to occur within the next 13 months (designated as cash flow hedges), (2) its net investment in certain foreign subsidiaries (designated as net investment hedges) and (3) foreign currency denominated assets or liabilities (designated as fair value hedges). The Company also uses foreign currency forward exchange contracts that are not designated as hedging instruments to offset the transaction gains and losses associated with certain assets and liabilities denominated in currencies other than their functional currencies resulting principally from intercompany and local currency transactions.

All derivative financial instruments are recognized at fair value in the consolidated balance sheets. For each derivative instrument that is designated as a fair value hedge, the gain or loss on the derivative included in the assessment of hedge effectiveness is recognized immediately to earnings, and offsets the loss or gain on the underlying hedged item. The Company reports in "Accumulated Other Comprehensive Loss" the gain or loss on derivative financial instruments that are designated, and that qualify, as cash flow hedges. The Company reclassifies these gains and losses into earnings in the same line item and in the same period in which the underlying hedged transactions affect earnings. Changes in the fair value of net investment hedges are reported in "Accumulated Other Comprehensive Loss" as a part of the cumulative translation adjustment and would be reclassified into earnings if the underlying net investment is sold or substantially liquidated. The portion of the change in fair value related to components excluded from the hedge effectiveness assessment are amortized into earnings over the life of the derivative. The gains and losses on derivative financial instruments for which the Company does not elect hedge accounting treatment are recognized in the consolidated statements of operations in each period based upon the change in the fair value of the derivative financial instrument. Cash flows from net investment hedges are reported as investing activities in the consolidated statements of cash flows, and cash flows from all other derivative financial instruments are reported as operating activities.
Recently Adopted Accounting Standards
Recently Adopted Accounting Standards

In August 2018, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on cloud computing service arrangements. The guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The guidance also requires an entity to expense the capitalized implementation costs of a hosting arrangement that is a service contract over the term of the hosting arrangement. The guidance was effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. The adoption of this guidance on January 1, 2020 did not have a material impact on the Company's consolidated financial statements.

In August 2018, the FASB issued an amendment to the accounting guidance on fair value measurements. The guidance modifies the disclosure requirements on fair value measurements, including the removal of disclosures of the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation processes for Level 3 fair value measurements. The guidance also adds certain disclosure requirements related to Level 3 fair value measurements. The guidance was effective for fiscal years, and interim periods within those fiscal years,
beginning after December 15, 2019. The adoption of this guidance on January 1, 2020 did not have a material impact on the Company's consolidated financial statements.

In June 2016, the FASB issued an amendment to the guidance on the measurement of credit losses on financial instruments. The amendment updates the guidance for measuring and recording credit losses on financial assets measured at amortized cost by replacing the “incurred loss” model with an “expected loss” model. Accordingly, these financial assets will be presented at the net amount expected to be collected. The amendment also requires that credit losses related to available-for-sale debt securities be recorded as an allowance through net income rather than reducing the carrying amount under the current, other-than-temporary-impairment model. The guidance was effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The adoption of this guidance on January 1, 2020 did not have a material impact on the Company's consolidated financial statements.
XML 61 R31.htm IDEA: XBRL DOCUMENT v3.20.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 12 Months Ended
Dec. 31, 2020
Accounting Policies [Abstract]  
Schedule of Computation of Basic and Diluted Earnings Per Share
The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):
 Years Ended December 31,
 202020192018
Basic:   
Net income$823.4 $1,046.9 $722.2 
Weighted-average shares outstanding622.6 624.8 627.6 
Basic earnings per share$1.32 $1.68 $1.15 
Diluted:   
Net income$823.4 $1,046.9 $722.2 
Weighted-average shares outstanding622.6 624.8 627.6 
Dilutive effect of stock plans9.3 11.9 13.3 
Dilutive weighted-average shares outstanding631.9 636.7 640.9 
Diluted earnings per share$1.30 $1.64 $1.13 
Schedule of Stock-Based Compensation Expense
Total stock-based compensation expense was as follows (in millions):
 Years Ended December 31,
 202020192018
Cost of sales$17.2 $14.7 $11.4 
Selling, general, and administrative expenses56.6 51.2 46.3 
Research and development expenses18.8 15.4 13.3 
Total stock-based compensation expense92.6 81.3 71.0 
Income tax benefit(15.4)(14.8)(13.4)
Total stock-based compensation expense, net of tax$77.2 $66.5 $57.6 
XML 62 R32.htm IDEA: XBRL DOCUMENT v3.20.4
OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables)
 12 Months Ended
Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Components of Selected Captions in the Consolidated Balance Sheets
Components of selected captions in the consolidated balance sheets are as follows:
 As of December 31,
 20202019
 (in millions)
Inventories  
Raw materials$136.7 $118.0 
Work in process140.0 121.7 
Finished products525.6 401.2 
$802.3 $640.9 
Property, plant, and equipment, net  
Land$97.6 $98.0 
Buildings and leasehold improvements881.5 619.8 
Machinery and equipment564.9 466.3 
Equipment with customers42.2 35.6 
Software94.2 87.9 
Construction in progress313.3 265.0 
1,993.7 1,572.6 
Accumulated depreciation(598.5)(512.3)
$1,395.2 $1,060.3 
Accrued and other liabilities  
Employee compensation and withholdings$236.7 $295.8 
Accrued rebates67.2 67.1 
Property, payroll, and other taxes49.7 51.4 
Research and development accruals52.3 51.4 
Litigation settlement (Notes 3 and 18)37.5 — 
Litigation and insurance reserves (Note 18)23.3 20.0 
Taxes payable18.6 52.9 
Fair value of derivatives39.3 6.4 
Accrued marketing expenses14.3 17.5 
Accrued professional services7.6 10.1 
Accrued realignment reserves14.5 16.7 
Accrued relocation related costs21.0 17.4 
Other accrued liabilities88.2 89.8 
$670.2 $696.5 
Supplemental Cash Flow Information
Supplemental Cash Flow Information
(in millions)
Years Ended December 31,
202020192018
Cash paid during the year for:   
Interest$19.9 $19.9 $30.1 
Income taxes$197.9 $61.5 $223.7 
Amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases
$29.7 $28.6 $— 
Non-cash investing and financing transactions:   
Fair value of shares issued in payment for contingent consideration liabilities $— $— $34.3 
Right-of-use assets obtained in exchange for new lease liabilities$39.7 $49.6 $— 
Capital expenditures accruals$80.4 $50.8 $18.7 
Schedule of Cash and Cash Equivalents
Cash, Cash Equivalents, and Restricted Cash
(in millions)
Years Ended December 31,
202020192018
Cash and cash equivalents$1,183.2 $1,179.1 $714.1 
Restricted cash included in other current assets16.6 1.6 1.5 
Restricted cash included in other assets0.4 3.7 0.3 
Total cash, cash equivalents, and restricted cash$1,200.2 $1,184.4 $715.9 
Schedule of Restricted Cash
Cash, Cash Equivalents, and Restricted Cash
(in millions)
Years Ended December 31,
202020192018
Cash and cash equivalents$1,183.2 $1,179.1 $714.1 
Restricted cash included in other current assets16.6 1.6 1.5 
Restricted cash included in other assets0.4 3.7 0.3 
Total cash, cash equivalents, and restricted cash$1,200.2 $1,184.4 $715.9 
XML 63 R33.htm IDEA: XBRL DOCUMENT v3.20.4
LEASES (Tables)
 12 Months Ended
Dec. 31, 2020
Leases [Abstract]  
Assets And Liabilities Of Lessee
Supplemental balance sheet information related to operating leases was as follows (in millions, except lease term and discount rate):
As of December 31,
20202019
Operating lease right-of-use assets$94.2 $80.1 
Operating lease liabilities, current portion$27.2 $25.5 
Operating lease liabilities, long-term portion72.7 58.9 
Total operating lease liabilities
$99.9 $84.4 
Lessee, Operating Lease, Liability, Maturity
Maturities of operating lease liabilities at December 31, 2020 were as follows (in millions):
2021$30.0 
202220.7 
202314.4 
20248.8 
20256.1 
Thereafter28.1 
Total lease payments
108.1 
Less: imputed interest
(8.2)
Total lease liabilities
$99.9 

The following table provides information on the lease terms and discount rates:
Years Ended December 31,
20202019
Weighted-average remaining lease term (in years)6.65.3
Weighted-average discount rate2.7 %2.8 %
XML 64 R34.htm IDEA: XBRL DOCUMENT v3.20.4
INVESTMENTS (Tables)
 12 Months Ended
Dec. 31, 2020
Investments, Debt and Equity Securities [Abstract]  
Schedule of Investments in Debt Securities
Investments in debt securities at the end of each period were as follows (in millions):

 December 31, 2020December 31, 2019
Held-to-maturityAmortized CostGross Unrealized GainsGross Unrealized LossesFair ValueAmortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Bank time deposits$50.0 $— $— $50.0 $100.2 $— $— $100.2 
Available-for-sale
Bank time deposits$24.1 $— $— $24.1 $13.1 $— $— $13.1 
Commercial paper— — — — 34.3 — — 34.3 
U.S. government and agency securities
147.0 2.2 — 149.2 113.2 0.6 — 113.8 
Foreign government bonds— — — — 1.7 — — 1.7 
Asset-backed securities149.6 1.9 — 151.5 141.2 0.6 (0.1)141.7 
Corporate debt securities600.8 7.5 — 608.3 487.0 2.3 (0.1)489.2 
Municipal securities2.8 — — 2.8 — — — — 
$924.3 $11.6 $— $935.9 $790.5 $3.5 $(0.2)$793.8 
Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity
The cost and fair value of investments in debt securities, by contractual maturity, as of December 31, 2020 were as follows:

 Held-to-MaturityAvailable-for-Sale
 Amortized CostFair ValueAmortized CostFair Value
 (in millions)
Due in 1 year or less$50.0 $50.0 $168.4 $169.4 
Due after 1 year through 5 years— — 578.2 586.5 
Instruments not due at a single maturity date— — 177.7 180.0 
$50.0 $50.0 $924.3 $935.9 
Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position The following table presents gross unrealized losses and fair values for those investments that were in an unrealized loss position as of December 31, 2019, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):
December 31, 2019
Less than 12 Months12 Months or GreaterTotal
Fair ValueGross Unrealized LossesFair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
Asset-backed securities$73.4 $(0.1)$— $— $73.4 $(0.1)
Corporate debt securities81.4 (0.1)— — 81.4 (0.1)
$154.8 $(0.2)$— $— $154.8 $(0.2)
Schedule of Investments in Unconsolidated Affiliates Investments in these unconsolidated affiliates are recorded in "Long-term Investments" on the consolidated balance sheets, and are as follows:
 December 31,
 20202019
 (in millions)
Equity method investments  
Carrying value of equity method investments$5.7 $6.2 
Equity securities  
Carrying value of non-marketable equity securities29.4 23.1 
Total investments in unconsolidated affiliates$35.1 $29.3 
XML 65 R35.htm IDEA: XBRL DOCUMENT v3.20.4
ACQUISITIONS (Tables)
 12 Months Ended
Dec. 31, 2020
Business Combinations [Abstract]  
Summary of Fair Values of Assets Acquired and Liabilities Assumed The following table summarizes the fair values of the assets acquired and liabilities assumed (in millions):
Current assets$6.1 
Property and equipment, net1.3 
Goodwill64.4 
Developed technology35.9 
Customer relationships8.8 
Deferred tax assets2.2 
Liabilities assumed(17.9)
Total purchase price
100.8 
Less: cash acquired(0.6)
Total purchase price, net of cash acquired
$100.2 
XML 66 R36.htm IDEA: XBRL DOCUMENT v3.20.4
GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)
 12 Months Ended
Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Changes in the Carrying Amount of Goodwill, by Segment
The changes in the carrying amount of goodwill, by segment, during the years ended December 31, 2020 and 2019 were as follows:
 United
States		EuropeRest of WorldTotal
 (in millions)
Goodwill at December 31, 2018$709.3 $64.2 $338.7 $1,112.2 
Goodwill acquired during the year64.4 — — 64.4 
Currency translation adjustment— (1.4)(7.5)(8.9)
Goodwill at December 31, 2019773.7 62.8 331.2 1,167.7 
Currency translation adjustment— 5.5 — 5.5 
Goodwill at December 31, 2020$773.7 $68.3 $331.2 $1,173.2 
Schedule of Finite-Lived Other Intangible Assets
Other intangible assets consist of the following (in millions):

 December 31,
 Weighted-Average Useful Life (in years)20202019
 CostAccumulated
Amortization		Net
Carrying
Value		CostAccumulated
Amortization		Net
Carrying
Value
Finite-lived intangible assets      
Patents7.4$186.1 $(183.6)$2.5 $185.7 $(182.1)$3.6 
Developed technology13.1155.2 (51.0)104.2 153.5 (46.6)106.9 
Other10.012.6 (6.0)6.6 12.3 (4.4)7.9 
12.6353.9 (240.6)113.3 351.5 (233.1)118.4 
Indefinite-lived intangible assets      
In-process research and development218.1 — 218.1 218.1 — 218.1 
$572.0 $(240.6)$331.4 $569.6 $(233.1)$336.5 
Schedule of Indefinite-Lived Other Intangible Assets
Other intangible assets consist of the following (in millions):

 December 31,
 Weighted-Average Useful Life (in years)20202019
 CostAccumulated
Amortization		Net
Carrying
Value		CostAccumulated
Amortization		Net
Carrying
Value
Finite-lived intangible assets      
Patents7.4$186.1 $(183.6)$2.5 $185.7 $(182.1)$3.6 
Developed technology13.1155.2 (51.0)104.2 153.5 (46.6)106.9 
Other10.012.6 (6.0)6.6 12.3 (4.4)7.9 
12.6353.9 (240.6)113.3 351.5 (233.1)118.4 
Indefinite-lived intangible assets      
In-process research and development218.1 — 218.1 218.1 — 218.1 
$572.0 $(240.6)$331.4 $569.6 $(233.1)$336.5 
Schedule of Estimated Amortization Expense Estimated amortization expense for each of the years ending December 31 is as follows (in millions):
2021$5.2 
20227.6 
202310.1 
202412.2 
202514.8 
XML 67 R37.htm IDEA: XBRL DOCUMENT v3.20.4
DEBT AND CREDIT FACILITIES (Tables)
 12 Months Ended
Dec. 31, 2020
Debt Disclosure [Abstract]  
Summary of the Notes
The following is a summary of the Notes as of December 31, 2020 and 2019:
 December 31,
 2020 2019
 AmountEffective
Interest Rate		 AmountEffective
Interest Rate
(in millions)(in millions)
Fixed-rate 4.300% 2018 Notes
$600.0 4.329 %$600.0 4.329 %
Unamortized discount(1.1)  (1.2) 
Unamortized debt issuance costs(3.9)(4.4)
Total carrying amount$595.0   $594.4  
XML 68 R38.htm IDEA: XBRL DOCUMENT v3.20.4
FAIR VALUE MEASUREMENTS (Tables)
 12 Months Ended
Dec. 31, 2020
Fair Value Disclosures [Abstract]  
Summary of Financial Instruments Measured at Fair Value on a Recurring Basis
The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis as of December 31, 2020 and 2019 (in millions):

December 31, 2020Level 1Level 2Level 3Total
Assets    
Cash equivalents$16.2 $— $— $16.2 
Available-for-sale investments: 
Bank time deposits— 24.1 — 24.1 
Corporate debt securities— 608.3 — 608.3 
Asset-backed securities— 151.5 — 151.5 
U.S. government and agency securities56.9 92.2 — 149.1 
Municipal securities— 2.8 — 2.8 
Investments held for deferred compensation plans111.2 — — 111.2 
Derivatives— 8.1 — 8.1 
$184.3 $887.0 $— $1,071.3 
Liabilities    
Derivatives$— $39.3 $— $39.3 
Deferred compensation plans111.6 — — 111.6 
Contingent consideration liabilities— — 186.1 186.1 
$111.6 $39.3 $186.1 $337.0 
December 31, 2019
Assets
Cash equivalents$0.7 $31.7 $— $32.4 
Available-for-sale investments: 
Bank time deposits— 13.1 — 13.1 
Corporate debt securities— 489.2 — 489.2 
Asset-backed securities— 141.7 — 141.7 
U.S. government and agency securities76.1 37.7 — 113.8 
Foreign government bonds— 1.7 — 1.7 
Commercial paper— 34.3 — 34.3 
Investments held for deferred compensation plans88.9 — — 88.9 
Derivatives— 30.7 — 30.7 
$165.7 $780.1 $— $945.8 
Liabilities    
Derivatives$— $6.4 $— $6.4 
Deferred compensation plans88.7 — — 88.7 
Contingent consideration liabilities— — 172.5 172.5 
$88.7 $6.4 $172.5 $267.6 
Summary of Changes in Fair Value of Contingent Consideration Obligation
The following table summarizes the changes in fair value of the contingent consideration obligation for the years ended December 31, 2020 and 2019 (in millions):

December 31,
20202019
Fair value, beginning of year$172.5 $178.6 
Changes in fair value13.6 (6.1)
Fair value, end of year$186.1 $172.5 
XML 69 R39.htm IDEA: XBRL DOCUMENT v3.20.4
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)
 12 Months Ended
Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Summary of Derivative Financial Instruments Used to Manage Currency Exchange and Interest Rate Risk
The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.
 Notional Amount
 December 31, 2020December 31, 2019
 (in millions)
Foreign currency forward exchange contracts$1,525.5 $1,336.5 
Cross currency swap contracts300.0 300.0 
Schedule of Location and Fair Value Amounts of Derivative Instruments
The following table presents the location and fair value amounts of derivative instruments reported in the consolidated balance sheets (in millions):

  Fair Value
 Balance Sheet LocationDecember 31, 2020December 31, 2019
Derivatives designated as hedging instruments   
Assets   
Foreign currency contractsOther current assets$7.3 $14.2 
Foreign currency contractsOther assets$— $3.2 
Cross currency swap contractsOther assets$0.8 $13.3 
Liabilities   
Foreign currency contractsAccrued and other liabilities$39.3 $6.4 
Schedule of Effect of Master-Netting Agreements and Rights of Offset, Assets
The following table presents the effect of master-netting agreements and rights of offset on the consolidated balance sheets (in millions):

    Gross Amounts Not Offset in the Consolidated Balance Sheet 
  Gross Amounts
Offset in the
Consolidated
Balance Sheet		Net Amounts
Presented in the
Consolidated
Balance Sheet
December 31, 2020Gross
Amounts		Financial
Instruments		Cash
Collateral
Received		Net
Amount
Derivative Assets      
Foreign currency contracts$7.3 $— $7.3 $(6.1)$— $1.2 
Cross currency swap contracts$0.8 $— $0.8 $— $— $0.8 
Derivative Liabilities      
Foreign currency contracts$39.3 $— $39.3 $(6.1)$— $33.2 
December 31, 2019      
Derivative Assets      
Foreign currency contracts$17.4 $— $17.4 $(5.7)$— $11.7 
Cross currency swap contracts$13.3 $— $13.3 $— $— $13.3 
Derivative Liabilities      
Foreign currency contracts$6.4 $— $6.4 $(5.7)$— $0.7 
Schedule of Effect of Master-Netting Agreements and Rights of Offset, Liabilities
The following table presents the effect of master-netting agreements and rights of offset on the consolidated balance sheets (in millions):

    Gross Amounts Not Offset in the Consolidated Balance Sheet 
  Gross Amounts
Offset in the
Consolidated
Balance Sheet		Net Amounts
Presented in the
Consolidated
Balance Sheet
December 31, 2020Gross
Amounts		Financial
Instruments		Cash
Collateral
Received		Net
Amount
Derivative Assets      
Foreign currency contracts$7.3 $— $7.3 $(6.1)$— $1.2 
Cross currency swap contracts$0.8 $— $0.8 $— $— $0.8 
Derivative Liabilities      
Foreign currency contracts$39.3 $— $39.3 $(6.1)$— $33.2 
December 31, 2019      
Derivative Assets      
Foreign currency contracts$17.4 $— $17.4 $(5.7)$— $11.7 
Cross currency swap contracts$13.3 $— $13.3 $— $— $13.3 
Derivative Liabilities      
Foreign currency contracts$6.4 $— $6.4 $(5.7)$— $0.7 
Schedule of Effect of Derivative Instruments
The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated statements of operations and consolidated statements of comprehensive income:

 Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)Location of Gain or (Loss) Reclassified from Accumulated OCI into IncomeAmount of Gain or (Loss) Reclassified from Accumulated OCI into Income
 
 2020201920202019
(in millions)(in millions)
Cash flow hedges
Foreign currency contracts$(33.7)$23.5 Cost of sales$18.4 $40.9 
Selling, general, and administrative expenses$2.2 $1.9 
 Amount of Gain or (Loss)
Recognized in OCI
on Derivative
(Effective Portion)		Location of Gain or (Loss) Reclassified from Accumulated OCI into IncomeAmount of Gain or (Loss)
Recognized in Income on Derivative (Amount Excluded from
Effectiveness Testing)
2020201920202019
(in millions) (in millions)
Net investment hedges
Cross currency swap contracts$(12.6)$12.5 Interest expense$6.4 $6.6 

The cross currency swaps have an expiration date of June 15, 2028. At maturity of the cross currency swap contracts, the Company will deliver the notional amount of €257.2 million and will receive $300.0 million from the counterparties. The Company will receive semi-annual interest payments from the counterparties based on a fixed interest rate until maturity of the agreements.
  Amount of Gain or
(Loss) Recognized in
Income on Derivative
 Location of Gain or
(Loss) Recognized in
Income on Derivative
 202020192018
 (in millions)
Fair value hedges
Foreign currency contractsOther income, net$(1.4)$1.4 $0.5 

  Amount of Gain or
(Loss) Recognized in
Income on Derivative
 Location of Gain or
(Loss) Recognized in
Income on Derivative
 202020192018
 (in millions)
Derivatives not designated as hedging instruments
Foreign currency contractsOther income, net$(15.1)$0.3 $9.7 
Schedule of the Effect of Fair Value and Cash Flow Hedge
The following table presents the effect of fair value and cash flow hedge accounting on the consolidated statements of operations:

Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships
 Twelve Months Ended December 31, 2020
 Cost of salesSelling, general, and administrative expensesOther Income, net
Total amounts of income and expense line items shown in the consolidated statements of operations in which the effects of fair value or cash flow hedges are recorded$(1,080.6)$(1,228.4)$11.5 
The effects of fair value and cash flow hedging:
Gain (loss) on fair value hedging relationships:
Foreign currency contracts:
Hedged items
— — 4.8 
Derivatives designated as hedging instruments
— — (4.8)
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach
— — 3.4 
Gain (loss) on cash flow hedging relationships:
Foreign currency contracts:
Amount of gain (loss) reclassified from accumulated OCI into income
18.4 2.2 — 
Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships
 Twelve Months Ended December 31, 2019
 Cost of salesSelling, general, and administrative expensesOther Income, net
Total amounts of income and expense line items shown in the consolidated statements of operations in which the effects of fair value or cash flow hedges are recorded$(1,114.4)$(1,242.2)$8.2 
The effects of fair value and cash flow hedging:
Gain (loss) on fair value hedging relationships:
Foreign currency contracts:
Hedged items
— — 2.9 
Derivatives designated as hedging instruments
— — (2.9)
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach
— — 4.3 
Gain (loss) on cash flow hedging relationships:
Foreign currency contracts:
Amount of gain (loss) reclassified from accumulated OCI into income
40.9 1.9 — 
XML 70 R40.htm IDEA: XBRL DOCUMENT v3.20.4
EMPLOYEE BENEFIT PLANS (Tables)
 12 Months Ended
Dec. 31, 2020
Retirement Benefits [Abstract]  
Schedule of Information Regarding Defined Benefit Pension Plans
 Years Ended December 31,
 20202019
(in millions)
Change in projected benefit obligation:  
Beginning of year$105.2 $97.4 
Service cost6.3 5.2 
Interest cost0.5 0.9 
Participant contributions1.5 1.3 
Actuarial loss2.9 8.2 
Benefits paid(0.6)(4.2)
Plan amendment— (4.6)
Currency exchange rate changes and other10.4 1.0 
End of year$126.2 $105.2 
Change in fair value of plan assets:  
Beginning of year$63.2 $60.4 
Actual return on plan assets0.4 2.0 
Employer contributions2.8 2.6 
Participant contributions1.5 1.3 
Benefits paid(0.6)(4.2)
Currency exchange rate changes and other6.0 1.1 
End of year$73.3 $63.2 
Funded Status  
Projected benefit obligation$(126.2)$(105.2)
Plan assets at fair value73.3 63.2 
Underfunded status$(52.9)$(42.0)
Net amounts recognized on the consolidated balance sheet:  
Other long-term liabilities$52.9 $42.0 
Accumulated other comprehensive loss, net of tax:  
Net actuarial loss$(30.8)$(26.3)
Net prior service cost6.6 6.7 
Deferred income tax benefit4.6 4.2 
Total$(19.6)$(15.4)
Components of Net Periodic Benefit Cost
The components of net periodic pension benefit cost (credit) are as follows (in millions):

 Years Ended December 31,
 202020192018
Service cost, net$6.3 $5.2 $6.0 
Interest cost0.5 0.9 0.8 
Expected return on plan assets(1.0)(1.4)(1.3)
Settlements and curtailment gain— — (7.4)
Amortization of actuarial loss1.6 0.9 0.8 
Amortization of prior service credit (0.7)(0.2)(0.1)
Net periodic pension benefit cost (credit)$6.7 $5.4 $(1.2)
Schedule of Weighted-Average Assumptions Used to Determine Benefit Obligations
The weighted-average assumptions used to determine the benefit obligations are as follows:
 December 31,
 20202019
Discount rate0.3 %0.5 %
Rate of compensation increase2.6 %2.7 %
Cash balance interest crediting rate2.5 %2.6 %
Social securities increase1.6 %1.6 %
Pension increase1.8 %1.8 %

The weighted-average assumptions used to determine the net periodic pension benefit cost are as follows:
 Years ended December 31,
 202020192018
Discount rate0.5 %0.9 %0.9 %
Expected return on plan assets1.5 %2.3 %2.3 %
Rate of compensation increase2.7 %2.8 %2.6 %
Cash balance interest crediting rate1.5 %1.5 %1.5 %
Social securities increase1.6 %1.8 %1.5 %
Pension increase1.8 %1.8 %1.8 %
Schedule of Target Weighted-Average Asset Allocations and Fair Value Target weighted-average asset allocations at December 31, 2020, by asset category, are as follows:
Equity securities25.3 %
Debt securities47.5 %
Real estate7.7 %
Other19.5 %
Total100.0 %

The fair values of the Company's defined benefit plan assets at December 31, 2020 and 2019, by asset category, are as follows (in millions):
December 31, 2020Level 1Level 2Level 3Total
Asset Category    
Cash$3.0 $— $— $3.0 
Equity securities:    
United States equities3.3 — — 3.3 
International equities16.1 — — 16.1 
Debt securities:    
United States government bonds7.4 — — 7.4 
International government bonds26.0 — — 26.0 
Real estate— 5.6 — 5.6 
Mortgages— 3.1 — 3.1 
Insurance contracts— — 1.0 1.0 
Total plan assets measured at fair value
$55.8 $8.7 $1.0 $65.5 
Alternative investments measured at net asset value (a)7.8 
Total plan assets
$73.3 
 
December 31, 2019Level 1Level 2Level 3Total
Asset Category
Cash$3.8 $— $— $3.8 
Equity securities:
United States equities3.0 — — 3.0 
International equities11.2 — — 11.2 
Debt securities:
United States government bonds8.2 — — 8.2 
International government bonds22.3 — — 22.3 
Real estate— 4.4 — 4.4 
Mortgages— 2.3 — 2.3 
Insurance contracts— — 0.9 0.9 
Total plan assets $48.5 $6.7 $0.9 $56.1 
Alternative investments measured at net asset value (a)7.1 
Total plan assets $63.2 
_______________________________________
(a)     Certain investments that were measured at net asset value per share have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the total plan assets.
Summary of Changes in Fair Value of Defined Benefit Plan Assets Classified as Level 3
The following table summarizes the changes in fair value of the Company's defined benefit plan assets that have been classified as Level 3 for the years ended December 31, 2020 and 2019 (in millions):

 Insurance
Contracts
Balance at December 31, 2018$1.0 
Purchases, sales and settlements(0.1)
Balance at December 31, 20190.9 
Currency exchange rate impact0.1 
Balance at December 31, 2020$1.0 
Schedule of Benefit Payments Which Reflect Expected Future Service
The following benefit payments, which reflect expected future service, as appropriate, at December 31, 2020, are expected to be paid (in millions):

2021$4.6 
20224.9 
20236.7 
20245.6 
20255.3 
2024-202636.7 
XML 71 R41.htm IDEA: XBRL DOCUMENT v3.20.4
COMMON STOCK (Tables)
 12 Months Ended
Dec. 31, 2020
Equity [Abstract]  
Accelerated Share Repurchases The following table summarizes the terms of the ASR agreements (dollars and shares in millions, except per share data):
  Initial DeliveryFinal Settlement
Agreement DateAmount
Paid		Shares
Received		Price per
Share (a)		Value of
Shares as %
of Contract
Value		Settlement
Date		Total Shares
Received		Average Price
per Share (a)
April 2018$400.0 2.5 $127.36 80 %July 20182.8 $142.37 
October 2018$250.0 1.4 $139.22 80 %November 20181.7 $150.54 
May 2019$150.0 0.7 $178.66 80 %May 20190.8 $178.42 
May 2019$100.0 0.5 $170.02 80 %June 20190.6 $178.46 
_______________________________________________________________________________
(a)    The three-for-one stock split distributed on May 29, 2020 excluded treasury shares. The shares and per share prices in the table are reflected at the pre-split amounts and prices at the time of the transaction.
Schedule of Weighted-Average Assumptions for Options Granted
The Black-Scholes option pricing model was used with the following weighted-average assumptions for options granted during the following periods:

Option Awards
202020192018
Average risk-free interest rate0.3 %2.3 %2.9 %
Expected dividend yieldNoneNoneNone
Expected volatility33 %30 %29 %
Expected life (years)5.05.15.0
Fair value, per share$21.70 $18.17 $14.17 
Schedule of Weighted-Average Assumptions for ESPP Subscriptions
The Black-Scholes option pricing model was used with the following weighted-average assumptions for ESPP subscriptions granted during the following periods:

ESPP
202020192018
Average risk-free interest rate1.3 %2.4 %1.7 %
Expected dividend yieldNoneNoneNone
Expected volatility33 %27 %31 %
Expected life (years)0.60.60.6
Fair value, per share$16.61 $16.43 $12.18 
Schedule of Stock Option Activity
Stock option activity during the year ended December 31, 2020 under the Program and the Nonemployee Directors Program was as follows (in millions, except years and per-share amounts):

 SharesWeighted-
Average
Exercise
Price		Weighted-
Average
Remaining
Contractual
Term		Aggregate
Intrinsic Value
Outstanding as of December 31, 201917.1 $32.19   
Options granted1.8 73.02   
Options exercised(4.3)18.16   
Options forfeited(0.3)49.74   
Outstanding as of December 31, 202014.3 41.27 3.4 years$712.5 
Exercisable as of December 31, 20209.5 32.32 2.5 years558.1 
Vested and expected to vest as of December 31, 202013.6 40.37 3.3 years690.4 
Schedule of Restricted Stock Unit Activity
The following table summarizes nonvested restricted stock unit activity during the year ended December 31, 2020 under the Program and the Nonemployee Directors Program (in millions, except per-share amounts):

 SharesWeighted-
Average
Grant-Date
Fair Value
Nonvested as of December 31, 20192.7 $46.89 
Granted (a)0.9 71.31 
Vested(0.9)40.03 
Forfeited(0.1)49.90 
Nonvested as of December 31, 20202.6 57.59 
_______________________________________________________________________________
(a)    The shares granted includes 0.1 million shares of market-based restricted stock units granted during 2020, which represents the target number of shares to be issued, and 0.1 million shares related to a previous year's grant of market-based restricted stock units since the payout percentage achieved at the end of the performance period was in excess of target. As described above, the actual number of shares ultimately issued is determined based on the Company's total stockholder return relative to a selected industry peer group.
XML 72 R42.htm IDEA: XBRL DOCUMENT v3.20.4
ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)
 12 Months Ended
Dec. 31, 2020
Equity [Abstract]  
Summary of Activity for Each Component of Accumulated Other Comprehensive Loss
Presented below is a summary of activity for each component of "Accumulated Other Comprehensive Loss" for the years ended December 31, 2020, 2019, and 2018.

 Foreign
Currency
Translation
Adjustments		Unrealized (Loss) Gain on HedgesUnrealized (Loss) Gain on
Available-for-sale
Investments		Unrealized
Pension
Costs (a)		Total
Accumulated
Other
Comprehensive
Loss
 (in millions)
December 31, 2017$(100.1)$(13.9)$(4.6)$(14.1)$(132.7)
Impact from adoption of ASU 2016-16 and ASU 2018-02(4.9)(2.9)— — (7.8)
January 1, 2018(105.0)(16.8)(4.6)(14.1)(140.5)
Other comprehensive (loss) income before reclassifications          (36.7)35.1 (3.1)7.6 2.9 
Amounts reclassified from accumulated other comprehensive loss— 19.1 2.9 (6.7)15.3 
Deferred income tax expense(1.9)(13.8)(0.2)(0.3)(16.2)
December 31, 2018(143.6)23.6 (5.0)(13.5)(138.5)
Other comprehensive (loss) income before reclassifications          (1.5)27.9 7.9 (3.2)31.1 
Amounts reclassified from accumulated other comprehensive loss(6.6)(44.2)0.4 0.7 (49.7)
Deferred income tax (expense) benefit(3.1)5.2 (1.6)0.6 1.1 
December 31, 2019(154.8)12.5 1.7 (15.4)(156.0)
Other comprehensive income (loss) before reclassifications          35.7 (34.8)8.0 (5.5)3.4 
Amounts reclassified from accumulated other comprehensive loss(6.4)(19.2)0.3 0.9 (24.4)
Deferred income tax benefit (expense)3.1 13.8 (1.4)0.4 15.9 
December 31, 2020$(122.4)$(27.7)$8.6 $(19.6)$(161.1)
_______________________________________________________________________________
Change in Unrealized Pension Costs For the years ended December 31, 2020, 2019, and 2018, the change in unrealized pension costs consisted of the following (in millions):
 Pre-Tax
Amount		Tax (Expense) BenefitNet of Tax
Amount
2020   
Prior service credit arising during period$0.6 $(0.2)$0.4 
Amortization of prior service credit(0.7)0.1 (0.6)
Net prior service cost arising during period(0.1)(0.1)(0.2)
Net actuarial loss arising during period(4.5)0.5 (4.0)
Unrealized pension costs, net$(4.6)$0.4 $(4.2)
2019   
Prior service credit arising during period$4.6 $(0.6)$4.0 
Amortization of prior service credit(0.2)0.1 (0.1)
Net prior service credit arising during period4.4 (0.5)3.9 
Net actuarial loss arising during period(6.9)1.1 (5.8)
Unrealized pension costs, net$(2.5)$0.6 $(1.9)
2018   
Prior service credit arising during period$3.3 $(0.9)$2.4 
Amortization of prior service credit(0.1)— (0.1)
Net prior service credit arising during period3.2 (0.9)2.3 
Net actuarial loss arising during period(2.3)0.6 (1.7)
Unrealized pension credits, net$0.9 $(0.3)$0.6 
Schedule of Information About Amounts Reclassified from Accumulated Other Comprehensive Loss
The following table provides information about amounts reclassified from "Accumulated Other Comprehensive Loss" (in millions):
 Years Ended December 31, 
Details about Accumulated Other Comprehensive Loss
Components		20202019Affected Line on Consolidated
Statements of Operations
Foreign currency translation adjustments$6.4 $6.6 Other income, net
(1.6)(1.6)Provision for income taxes
$4.8 $5.0 Net of tax
(Loss) gain on hedges$18.4 $40.9 Cost of sales
2.2 1.9 Selling, general, and administrative expenses
(1.4)1.4 Other income, net
19.2 44.2 Total before tax
(5.0)(11.0)Provision for income taxes
$14.2 $33.2 Net of tax
(Loss) gain on available-for-sale investments$(0.3)$(0.4)Other income, net
(0.6)(0.3)Provision for income taxes
$(0.9)$(0.7)Net of tax
Amortization of pension adjustments$(0.9)$(0.7)Other income, net
0.2 0.1 Provision for income taxes
$(0.7)$(0.6)Net of tax
XML 73 R43.htm IDEA: XBRL DOCUMENT v3.20.4
OTHER INCOME, NET (Tables)
 12 Months Ended
Dec. 31, 2020
Other Income and Expenses [Abstract]  
Schedule of Other Expense, Net
 Years Ended December 31,
 202020192018
(in millions)
Foreign exchange gains, net$(12.3)$(5.9)$(6.7)
Gain on investments(0.6)(0.5)1.7 
Non-service cost components of net periodic pension benefit cost (credit)0.4 0.2 (0.1)
Other1.0 (2.0)1.1 
Total other income, net$(11.5)$(8.2)$(4.0)
XML 74 R44.htm IDEA: XBRL DOCUMENT v3.20.4
INCOME TAXES (Tables)
 12 Months Ended
Dec. 31, 2020
Income Tax Disclosure [Abstract]  
Schedule of Income Before Provisions for Income Taxes
The Company's income before provision for income taxes was generated from United States and international operations as follows (in millions):
 Years Ended December 31,
 202020192018
United States$151.3 $383.4 $266.1 
International, including Puerto Rico765.4 783.1 495.3 
$916.7 $1,166.5 $761.4 
Schedule of Provision for Income Taxes
The provision for income taxes consists of the following (in millions):
 Years Ended December 31,
 202020192018
Current   
United States:   
Federal$23.4 $31.3 $10.9 
State and local48.2 48.7 13.6 
International, including Puerto Rico73.9 29.1 35.9 
Current income tax expense$145.5 $109.1 $60.4 
Deferred   
United States:   
Federal$11.0 $28.3 $(16.1)
State and local(32.9)(18.3)(22.4)
International, including Puerto Rico(30.3)0.5 17.3 
Deferred income tax (benefit) expense(52.2)10.5 (21.2)
Total income tax provision$93.3 $119.6 $39.2 
Components of Deferred Tax Assets and Liabilities
The components of deferred tax assets and liabilities are as follows (in millions):
 December 31,
 20202019
Deferred tax assets  
Compensation and benefits$88.6 $90.1 
Benefits from uncertain tax positions27.0 22.5 
Net tax credit carryforwards125.5 108.4 
Net operating loss carryforwards64.1 57.6 
Accrued liabilities105.0 41.3 
Inventories16.3 12.9 
Cash flow and net investment hedges3.3 — 
State income taxes0.5 0.5 
Investments1.8 1.5 
Lease liability obligations7.7 18.4 
Other3.6 3.4 
Total deferred tax assets443.4 356.6 
Deferred tax liabilities  
Property, plant, and equipment(53.4)(22.6)
Cash flow and net investment hedges— (6.8)
Deferred tax on foreign earnings(29.2)(35.3)
Right-of-use assets (7.0)(17.5)
Other intangible assets(76.3)(71.0)
Other(3.1)(2.2)
Total deferred tax liabilities(169.0)(155.4)
Valuation allowance(71.6)(65.8)
Net deferred tax assets$202.8 $135.4 
Summary of Net Operating Loss Carryforwards
Net operating loss and capital loss carryforwards and the related carryforward periods at December 31, 2020 are summarized as follows (in millions):
 Carryforward
Amount		Tax Benefit
Amount		Valuation
Allowance		Net Tax
Benefit		Carryforward
Period Ends
United States federal net operating losses$26.6 $5.6 $— $5.6 2030-2037
United States federal net operating losses11.3 2.4 — 2.4 Indefinite
United States state net operating losses33.5 2.1 (2.1)— 2026-2039
United States state net operating losses1.0 0.1 (0.1)— Indefinite
Non-United States net operating losses18.2 4.7 (3.6)1.1 2020-2027
Non-United States net operating losses295.1 49.2 (39.9)9.3 Indefinite
United States capital losses34.1 0.2 (0.2)— 2024
Total$419.8 $64.3 $(45.9)$18.4  
Summary of Tax Credit Carryforwards
The gross tax credit carryforwards and the related carryforward periods at December 31, 2020 are summarized as follows (in millions):
 Carryforward
Amount		Valuation
Allowance		Net Tax
Benefit		Carryforward
Period Ends
California research expenditure tax credits$145.1 $— $145.1 Indefinite
Federal research expenditure tax credits1.5 — 1.5 2026-2039
Puerto Rico purchases credit23.4 (23.4)— Indefinite
Total$170.0 $(23.4)$146.6  
Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate
A reconciliation of the United States federal statutory income tax rate to the Company's effective income tax rate is as follows (in millions):
 Years Ended December 31,
 202020192018
Income tax expense at U.S. federal statutory rate$192.5 $245.0 $159.9 
Foreign income taxed at different rates(80.5)(75.0)(16.2)
State and local taxes, net of federal tax benefit5.0 11.9 6.8 
Tax credits, federal and state(43.1)(42.9)(36.7)
Build (release) of reserve for prior years' uncertain tax positions4.2 5.0 (35.5)
U.S. tax on foreign earnings, net of credits1.5 (2.9)(12.2)
Tax on global intangible low-taxed income49.2 32.0 — 
Foreign-derived intangible income deduction(2.6)(7.2)(6.6)
U.S. federal deductible employee share-based compensation(48.3)(57.6)(41.8)
Nondeductible employee share-based compensation4.2 3.2 2.8 
Impact related to 2017 U.S. Tax Reform— 2.8 15.8 
Other11.2 5.3 2.9 
Income tax provision$93.3 $119.6 $39.2 
Reconciliation of Beginning and Ending Amount of Uncertain Tax Positions
A reconciliation of the beginning and ending amount of uncertain tax positions, excluding interest, penalties, and foreign exchange, is as follows (in millions):
 December 31,
 202020192018
Uncertain gross tax positions, January 1$203.1 $150.7 $225.6 
Current year tax positions
86.4 55.4 37.8 
Increase in prior year tax positions
6.0 0.8 13.9 
Decrease in prior year tax positions
(10.0)(3.8)(78.8)
Settlements
(3.7)— (46.5)
Lapse of statutes of limitations
— — (1.3)
Uncertain gross tax positions, December 31$281.8 $203.1 $150.7 
XML 75 R45.htm IDEA: XBRL DOCUMENT v3.20.4
SEGMENT INFORMATION (Tables)
 12 Months Ended
Dec. 31, 2020
Segment Reporting [Abstract]  
Schedule of Information About Reportable Segments and Reconciliation of Segment Net Sales and Pre-Tax Income
The table below presents information about Edwards Lifesciences' reportable segments (in millions):
 Years Ended December 31,
 202020192018
Segment Net Sales   
United States$2,516.8 $2,532.7 $2,055.2 
Europe945.2 926.1 826.4 
Japan448.6 441.4 398.4 
Rest of World451.5 433.3 396.0 
Total segment net sales$4,362.1 $4,333.5 $3,676.0 
Segment Operating Income  
United States$1,727.3 $1,742.3 $1,368.1 
Europe479.3 472.0 394.8 
Japan286.4 272.3 237.0 
Rest of World150.1 127.9 115.6 
Total segment operating income$2,643.1 $2,614.5 $2,115.5 
The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated income before provision for income taxes ("pre-tax income") (in millions):
 Years Ended December 31,
 202020192018
Net Sales Reconciliation   
Segment net sales$4,362.1 $4,333.5 $3,676.0 
Foreign currency24.2 14.5 46.8 
Consolidated net sales$4,386.3 $4,348.0 $3,722.8 
Pre-tax Income Reconciliation  
Segment operating income$2,643.1 $2,614.5 $2,115.5 
Unallocated amounts:
Corporate items(1,358.0)(1,439.7)(1,058.1)
Special charges— (64.6)(116.2)
Intellectual property litigation expenses, net(405.4)(33.4)(214.0)
Change in fair value of contingent consideration liabilities, net(13.6)6.1 5.7 
Foreign currency31.5 63.9 15.3 
Consolidated operating income897.6 1,146.8 748.2 
Non-operating income19.1 19.7 13.2 
Consolidated pre-tax income$916.7 $1,166.5 $761.4 
Schedule of Enterprise-Wide Information
Enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated financial statements.

 As of or for the Years Ended December 31,
 202020192018
(in millions)
Net Sales by Geographic Area   
United States$2,516.8 $2,532.7 $2,055.3 
Europe973.6 941.2 885.1 
Japan460.1 444.7 396.8 
Rest of World435.8 429.4 385.6 
$4,386.3 $4,348.0 $3,722.8 
Net Sales by Major Product Area  
Transcatheter Aortic Valve Replacement$2,857.3 $2,737.9 $2,283.8 
Transcatheter Mitral and Tricuspid Therapies41.8 28.2 2.9 
Surgical Structural Heart761.8 841.7 761.6 
Critical Care725.4 740.2 674.5 
$4,386.3 $4,348.0 $3,722.8 
Long-lived Tangible Assets by Geographic Area   
United States$1,084.3 $849.1 $642.1 
Europe192.7 101.5 36.6 
Japan20.4 21.7 6.7 
Rest of World311.0 269.4 214.4 
$1,608.4 $1,241.7 $899.8 
XML 76 R46.htm IDEA: XBRL DOCUMENT v3.20.4
QUARTERLY FINANCIAL RESULTS AND MARKET FOR THE COMPANY'S STOCK (UNAUDITED) (Tables)
 12 Months Ended
Dec. 31, 2020
Quarterly Financial Information Disclosure [Abstract]  
Schedule of Quarterly Financial Results and Market for the Company's Stock
Years Ended December 31,First
Quarter		Second
Quarter		Third
Quarter		Fourth
Quarter		Total
Year
 (in millions, except per share data)
2020     
Net sales$1,128.7 $925.0 $1,140.9 $1,191.7 $4,386.3 
Gross profit863.6 686.8 859.9 895.4 3,305.7 
Net income (loss) (a)310.6 (121.9)325.2 309.5 823.4 
Earnings (loss) per common share (a):     
Basic0.50 (0.20)0.52 0.50 1.32 
Diluted0.49 (0.20)0.52 0.49 1.30 
Market price:     
High$81.90 $78.43 $87.79 $92.08 $92.08 
Low51.51 56.44 66.87 70.92 51.51 
2019     
Net sales$993.0 $1,086.9 $1,094.0 $1,174.1 $4,348.0 
Gross profit761.2 782.9 801.6 887.9 3,233.6 
Net income (b)249.7 242.3 274.7 280.2 1,046.9 
Earnings per common share (b):     
Basic0.40 0.39 0.44 0.45 1.68 
Diluted0.39 0.38 0.43 0.44 1.64 
Market price:     
High$65.95 $65.00 $76.06 $82.55 $82.55 
Low46.95 55.23 61.00 71.08 46.95 
_______________________________________________________________________________
(a)    The second quarter of 2020 includes a $367.9 million charge related to a litigation settlement.
(b) The first quarter of 2019 includes a $24.0 million charge related to the acquisition of early-stage transcatheter intellectual property and associated clinical and regulatory experience. The second and third quarters of 2019 include a $46.2 million and $26.9 million charge, respectively, related to the write off of inventory. The fourth quarter of 2019 includes a $40.6 million charge related to the impairment of certain in-process research and development assets.
XML 77 R47.htm IDEA: XBRL DOCUMENT v3.20.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue (Narrative) (Details) - USD ($)
$ in Millions
 12 Months Ended
May 29, 2020
May 07, 2020
Dec. 31, 2020
Dec. 31, 2019
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]        
Stock split, conversion ratio 300.00% 300.00%    
Deferred revenue     $ 6.3 $ 8.4
Revenue recognized that was previously deferred     $ 6.3 $ 5.5
Hemodynamic Monitors        
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]        
Contract length     The Company sells separately priced service contracts, which range from 12 to 36 months, to owners of its hemodynamic monitors.  
XML 78 R48.htm IDEA: XBRL DOCUMENT v3.20.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Shipping and Handling Costs (Narrative) (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Product Information [Line Items]      
Cost of sales $ 1,080.6 $ 1,114.4 $ 939.4
Shipping and Handling      
Product Information [Line Items]      
Cost of sales $ 74.0 $ 71.5 $ 70.6
XML 79 R49.htm IDEA: XBRL DOCUMENT v3.20.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investments (Narrative) (Details)
Dec. 31, 2020
Minimum  
Schedule of Equity Method Investments [Line Items]  
Equity method investment, ownership percentage 5.00%
XML 80 R50.htm IDEA: XBRL DOCUMENT v3.20.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounts Receivable (Details)
 12 Months Ended
Dec. 31, 2020
Minimum  
Accounts, Notes, Loans and Financing Receivable [Line Items]  
Accounts receivable, required payment terms 30 days
Maximum  
Accounts, Notes, Loans and Financing Receivable [Line Items]  
Accounts receivable, required payment terms 90 days
XML 81 R51.htm IDEA: XBRL DOCUMENT v3.20.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Inventories (Narrative) (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Accounting Policies [Abstract]      
Period prior to expiration date which triggers write-down of inventory 6 months    
Period used to evaluate slow-moving inventory levels 2 years    
General and administrative costs allocated to inventory $ 63.1 $ 56.6 $ 45.0
General and administrative costs included in inventory 30.7 22.8  
Finished goods inventories held on consignment $ 130.0 $ 117.8  
XML 82 R52.htm IDEA: XBRL DOCUMENT v3.20.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property, Plant, and Equipment (Narrative) (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Property, Plant and Equipment [Line Items]      
Depreciation expense for property, plant and equipment $ 101.8 $ 84.7 $ 74.9
Buildings and improvements | Minimum      
Property, Plant and Equipment [Line Items]      
Estimated useful life 10 years    
Buildings and improvements | Maximum      
Property, Plant and Equipment [Line Items]      
Estimated useful life 40 years    
Machinery and equipment | Minimum      
Property, Plant and Equipment [Line Items]      
Estimated useful life 3 years    
Machinery and equipment | Maximum      
Property, Plant and Equipment [Line Items]      
Estimated useful life 15 years    
Software | Minimum      
Property, Plant and Equipment [Line Items]      
Estimated useful life 3 years    
Software | Maximum      
Property, Plant and Equipment [Line Items]      
Estimated useful life 5 years    
XML 83 R53.htm IDEA: XBRL DOCUMENT v3.20.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Goodwill and Intangible Assets (Narrative) (Details) - USD ($)
$ in Millions
 1 Months Ended 12 Months Ended
Dec. 31, 2018
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
In-process research and development        
Indefinite-lived Intangible Assets [Line Items]        
Impairment of intangible assets   $ 0.0 $ 40.6  
Developed Technology and In-process Research and Development | Valtech        
Indefinite-lived Intangible Assets [Line Items]        
Impairment of intangible assets $ 116.2     $ 116.2
XML 84 R54.htm IDEA: XBRL DOCUMENT v3.20.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Basic:                      
Net income $ 309.5 $ 325.2 $ (121.9) $ 310.6 $ 280.2 $ 274.7 $ 242.3 $ 249.7 $ 823.4 $ 1,046.9 $ 722.2
Weighted-average shares outstanding (in shares)                 622.6 624.8 627.6
Basic earnings per share (in dollars per share) $ 0.50 $ 0.52 $ (0.20) $ 0.50 $ 0.45 $ 0.44 $ 0.39 $ 0.40 $ 1.32 $ 1.68 $ 1.15
Diluted:                      
Net income $ 309.5 $ 325.2 $ (121.9) $ 310.6 $ 280.2 $ 274.7 $ 242.3 $ 249.7 $ 823.4 $ 1,046.9 $ 722.2
Weighted-average shares outstanding (in shares)                 622.6 624.8 627.6
Dilutive effect of stock plans (in shares)                 9.3 11.9 13.3
Dilutive weighted-average shares outstanding (in shares)                 631.9 636.7 640.9
Diluted earnings per share (in dollars per share) $ 0.49 $ 0.52 $ (0.20) $ 0.49 $ 0.44 $ 0.43 $ 0.38 $ 0.39 $ 1.30 $ 1.64 $ 1.13
XML 85 R55.htm IDEA: XBRL DOCUMENT v3.20.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per Share (Narrative) (Details) - shares
shares in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Stock compensation plan      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Anti-dilutive securities excluded from the computation of earnings per share (in shares) 2.0 1.5 3.2
XML 86 R56.htm IDEA: XBRL DOCUMENT v3.20.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Stock-Based Compensation Expense (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Allocation of stock-based compensation expense      
Total stock-based compensation expense $ 92.6 $ 81.3 $ 71.0
Income tax benefit (15.4) (14.8) (13.4)
Total stock-based compensation expense, net of tax 77.2 66.5 57.6
Cost of sales      
Allocation of stock-based compensation expense      
Total stock-based compensation expense 17.2 14.7 11.4
Selling, general, and administrative expenses      
Allocation of stock-based compensation expense      
Total stock-based compensation expense 56.6 51.2 46.3
Research and development expenses      
Allocation of stock-based compensation expense      
Total stock-based compensation expense $ 18.8 $ 15.4 $ 13.3
XML 87 R57.htm IDEA: XBRL DOCUMENT v3.20.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Stock-based Compensation (Narrative) (Details)
 12 Months Ended
Dec. 31, 2020
Restricted stock units  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Percentage vesting upon retirement for each full year of employment subsequent to the grant date 25.00%
XML 88 R58.htm IDEA: XBRL DOCUMENT v3.20.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Derivatives (Narrative) (Details)
 12 Months Ended
Dec. 31, 2020
Accounting Policies [Abstract]  
Period when cash flows associated with future transactions and certain local currency expenses are expected to occur 13 months
XML 89 R59.htm IDEA: XBRL DOCUMENT v3.20.4
INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET (Details) - USD ($)
$ in Millions
 1 Months Ended 3 Months Ended 12 Months Ended 41 Months Ended
Jul. 31, 2020
Jun. 30, 2020
Jun. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
May 31, 2024
Loss Contingencies [Line Items]              
Intellectual property litigation expenses       $ 405.4 $ 33.4 $ 214.0  
Gain (loss) on litigation settlement     $ 367.9        
Abbott Laboratories              
Loss Contingencies [Line Items]              
Intellectual property litigation expenses   $ 367.9          
Payments for Legal Settlements $ 100.0            
Abbott Laboratories | Forecast | Subsequent Event              
Loss Contingencies [Line Items]              
Royalty Expense             $ 100.0
Transcatheter Mitral Valve Replacement              
Loss Contingencies [Line Items]              
Gain (loss) on litigation settlement           $ (180.0)  
XML 90 R60.htm IDEA: XBRL DOCUMENT v3.20.4
SPECIAL CHARGES (GAIN) - Impairment of Long-lived Assets (Details) - Valtech - USD ($)
$ in Millions
 1 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2020
Dec. 31, 2018
Developed technology        
Indefinite-lived Intangible Assets [Line Items]        
Impairment of intangible assets     $ 40.6  
Developed Technology and In-process Research and Development        
Indefinite-lived Intangible Assets [Line Items]        
Impairment of intangible assets   $ 116.2   $ 116.2
Rest of World | Developed technology        
Indefinite-lived Intangible Assets [Line Items]        
Impairment of intangible assets $ 40.6      
Rest of World | Developed Technology and In-process Research and Development        
Indefinite-lived Intangible Assets [Line Items]        
Impairment of intangible assets   $ 116.2    
XML 91 R61.htm IDEA: XBRL DOCUMENT v3.20.4
SPECIAL CHARGES (GAIN) - Acquisition of Intellectual Property (Details)
$ in Millions
Mar. 31, 2019
USD ($)
Early-stage Transcatheter Intellectual Property  
Business Acquisition [Line Items]  
Acquisition transaction costs $ 24.0
XML 92 R62.htm IDEA: XBRL DOCUMENT v3.20.4
SPECIAL CHARGES (GAIN) - Realignment Expenses (Details)
$ in Millions
 1 Months Ended
Mar. 31, 2018
USD ($)
Defined benefit pension plans  
Restructuring Cost and Reserve [Line Items]  
Gain due to curtailment $ 7.1
XML 93 R63.htm IDEA: XBRL DOCUMENT v3.20.4
OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Components of Selected Captions (Details) - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Inventories    
Raw materials $ 136.7 $ 118.0
Work in process 140.0 121.7
Finished products 525.6 401.2
Total inventories 802.3 640.9
Property, plant, and equipment, net    
Land 97.6 98.0
Buildings and leasehold improvements 881.5 619.8
Machinery and equipment 564.9 466.3
Equipment with customers 42.2 35.6
Software 94.2 87.9
Construction in progress 313.3 265.0
Total property, plant and equipment, gross 1,993.7 1,572.6
Accumulated depreciation (598.5) (512.3)
Total property, plant and equipment, net 1,395.2 1,060.3
Accrued and other liabilities    
Employee compensation and withholdings 236.7 295.8
Accrued rebates 67.2 67.1
Property, payroll, and other taxes 49.7 51.4
Research and development accruals 52.3 51.4
Litigation settlement (Notes 3 and 18) 37.5 0.0
Litigation and insurance reserves (Note 18) 23.3 20.0
Taxes payable 18.6 52.9
Fair value of derivatives 39.3 6.4
Accrued marketing expenses 14.3 17.5
Accrued professional services 7.6 10.1
Accrued realignment reserves 14.5 16.7
Accrued relocation related costs 21.0 17.4
Other accrued liabilities 88.2 89.8
Total accrued and other liabilities $ 670.2 $ 696.5
XML 94 R64.htm IDEA: XBRL DOCUMENT v3.20.4
OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Sep. 30, 2019
Jun. 30, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Statement of Financial Position [Abstract]          
Inventory write off $ 26.9 $ 46.2 $ 0.0 $ 73.1 $ 0.0
XML 95 R65.htm IDEA: XBRL DOCUMENT v3.20.4
OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Supplemental Cash Flow Information (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Cash paid during the year for:      
Interest $ 19.9 $ 19.9 $ 30.1
Income taxes 197.9 61.5 223.7
Amounts included in the measurement of lease liabilities:      
Operating cash flows from operating leases 29.7 28.6 0.0
Non-cash investing and financing transactions:      
Fair value of shares issued in payment for contingent consideration liabilities 0.0 0.0 34.3
Right-of-use assets obtained in exchange for new lease liabilities 39.7 49.6 0.0
Capital expenditures accruals $ 80.4 $ 50.8 $ 18.7
XML 96 R66.htm IDEA: XBRL DOCUMENT v3.20.4
OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Cash, Cash Equivalents, and Restricted Cash (Details) - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Inventory Disclosure [Abstract]        
Cash and cash equivalents $ 1,183.2 $ 1,179.1 $ 714.1  
Restricted cash included in other current assets 16.6 1.6 1.5  
Restricted cash included in other assets 0.4 3.7 0.3  
Total cash, cash equivalents, and restricted cash $ 1,200.2 $ 1,184.4 $ 715.9 $ 820.2
XML 97 R67.htm IDEA: XBRL DOCUMENT v3.20.4
LEASES - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Lessee, Lease, Description [Line Items]      
Operating lease cost $ 30.5 $ 27.9 $ 27.0
Lease commitments for leases not yet commenced $ 0.0    
Minimum      
Lessee, Lease, Description [Line Items]      
Lease term 1 year    
Maximum      
Lessee, Lease, Description [Line Items]      
Lease term 20 years    
XML 98 R68.htm IDEA: XBRL DOCUMENT v3.20.4
LEASES - Assets and Liabilities of Operating Leases (Details) - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Leases [Abstract]    
Operating lease right-of-use assets $ 94.2 $ 80.1
Operating lease liabilities, current portion 27.2 25.5
Operating lease liabilities, long-term portion 72.7 58.9
Total operating lease liabilities $ 99.9 $ 84.4
XML 99 R69.htm IDEA: XBRL DOCUMENT v3.20.4
LEASES - Maturities Of Operating Lease Liabilities (Details) - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Leases [Abstract]    
2021 $ 30.0  
2022 20.7  
2023 14.4  
2024 8.8  
2025 6.1  
Thereafter 28.1  
Total lease payments 108.1  
Less: imputed interest (8.2)  
Total lease liabilities $ 99.9 $ 84.4
Weighted-average remaining lease term (in years) 6 years 7 months 6 days 5 years 3 months 18 days
Weighted-average discount rate 2.70% 2.80%
XML 100 R70.htm IDEA: XBRL DOCUMENT v3.20.4
INVESTMENTS - Schedule of Investments in Debt Securities (Details) - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Available-for-sale    
Amortized Cost $ 924.3 $ 790.5
Gross Unrealized Gains 11.6 3.5
Gross Unrealized Losses 0.0 (0.2)
Fair Value 935.9 793.8
Held-to-maturity    
Amortized Cost 50.0  
Fair Value 50.0  
Bank time deposits    
Available-for-sale    
Amortized Cost 24.1 13.1
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses 0.0 0.0
Fair Value 24.1 13.1
Held-to-maturity    
Amortized Cost 50.0 100.2
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses 0.0 0.0
Fair Value 50.0 100.2
Commercial paper    
Available-for-sale    
Amortized Cost 0.0 34.3
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses 0.0 0.0
Fair Value 0.0 34.3
U.S. government and agency securities    
Available-for-sale    
Amortized Cost 147.0 113.2
Gross Unrealized Gains 2.2 0.6
Gross Unrealized Losses 0.0 0.0
Fair Value 149.2 113.8
Foreign government bonds    
Available-for-sale    
Amortized Cost 0.0 1.7
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses 0.0 0.0
Fair Value 0.0 1.7
Asset-backed securities    
Available-for-sale    
Amortized Cost 149.6 141.2
Gross Unrealized Gains 1.9 0.6
Gross Unrealized Losses 0.0 (0.1)
Fair Value 151.5 141.7
Corporate debt securities    
Available-for-sale    
Amortized Cost 600.8 487.0
Gross Unrealized Gains 7.5 2.3
Gross Unrealized Losses 0.0 (0.1)
Fair Value 608.3 489.2
Municipal securities    
Available-for-sale    
Amortized Cost 2.8 0.0
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses 0.0 0.0
Fair Value $ 2.8 $ 0.0
XML 101 R71.htm IDEA: XBRL DOCUMENT v3.20.4
INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details) - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Amortized Cost    
Due in 1 year or less $ 50.0  
Due after 1 year through 5 years 0.0  
Instruments not due at a single maturity date 0.0  
Amortized Cost 50.0  
Fair Value    
Due in 1 year or less 50.0  
Due after 1 year through 5 years 0.0  
Instruments not due at a single maturity date 0.0  
Total 50.0  
Amortized Cost    
Due in 1 year or less 168.4  
Due after 1 year through 5 years 578.2  
Instruments not due at a single maturity date 177.7  
Amortized Cost 924.3 $ 790.5
Fair Value    
Due in 1 year or less 169.4  
Due after 1 year through 5 years 586.5  
Instruments not due at a single maturity date 180.0  
Total $ 935.9 $ 793.8
XML 102 R72.htm IDEA: XBRL DOCUMENT v3.20.4
INVESTMENTS - Narrative (Details)
$ in Millions
 12 Months Ended
Dec. 31, 2020
USD ($)
investment
Dec. 31, 2019
USD ($)
Debt and Equity Securities, FV-NI [Line Items]    
Number of Investments | investment 0  
Upward price adjustments $ 1.8 $ 0.3
Impairment of equity securities 0.7  
Other income, net    
Debt and Equity Securities, FV-NI [Line Items]    
Increase in non-marketable equity securities due to observable price changes 3.8 2.0
Decrease in non-marketable equity securities due to observable price changes $ 2.6 $ 1.9
XML 103 R73.htm IDEA: XBRL DOCUMENT v3.20.4
INVESTMENTS - Schedule of Unrealized Losses on Debt Securities (Details)
$ in Millions
Dec. 31, 2019
USD ($)
Debt Securities, Available-for-sale [Line Items]  
Fair value, less than 12 months $ 154.8
Gross unrealized losses, less than 12 months (0.2)
Fair value, 12 months or greater 0.0
Gross unrealized losses, 12 months or greater 0.0
Total fair value 154.8
Total gross unrealized losses (0.2)
Asset-backed securities  
Debt Securities, Available-for-sale [Line Items]  
Fair value, less than 12 months 73.4
Gross unrealized losses, less than 12 months (0.1)
Fair value, 12 months or greater 0.0
Gross unrealized losses, 12 months or greater 0.0
Total fair value 73.4
Total gross unrealized losses (0.1)
Corporate debt securities  
Debt Securities, Available-for-sale [Line Items]  
Fair value, less than 12 months 81.4
Gross unrealized losses, less than 12 months (0.1)
Fair value, 12 months or greater 0.0
Gross unrealized losses, 12 months or greater 0.0
Total fair value 81.4
Total gross unrealized losses $ (0.1)
XML 104 R74.htm IDEA: XBRL DOCUMENT v3.20.4
INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details) - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Equity method investments    
Carrying value of equity method investments $ 5.7 $ 6.2
Equity securities    
Carrying value of non-marketable equity securities 29.4 23.1
Total investments in unconsolidated affiliates $ 35.1 $ 29.3
XML 105 R75.htm IDEA: XBRL DOCUMENT v3.20.4
ACQUISITIONS - CAS Medical Systems, Inc. (Narrative) (Details) - CAS Medical Systems, Inc. - USD ($)
$ / shares in Units, $ in Millions
 12 Months Ended
Apr. 18, 2019
Feb. 11, 2019
Dec. 31, 2019
Business Acquisition [Line Items]      
Consideration per share to be transferred (in dollars per share)   $ 2.45  
Acquisition price, subject uncertain adjustments   $ 100.0  
Cash purchase price $ 100.8    
Acquisition-related costs     $ 2.0
Developed technology      
Business Acquisition [Line Items]      
Weighted average useful life 14 years    
Customer Relationships      
Business Acquisition [Line Items]      
Weighted average useful life 10 years    
XML 106 R76.htm IDEA: XBRL DOCUMENT v3.20.4
ACQUISITIONS - Summary of Fair Values of Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Millions
Apr. 18, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Business Acquisition [Line Items]        
Goodwill   $ 1,173.2 $ 1,167.7 $ 1,112.2
CAS Medical Systems, Inc.        
Business Acquisition [Line Items]        
Current assets $ 6.1      
Property and equipment, net 1.3      
Goodwill 64.4      
Deferred tax assets 2.2      
Liabilities assumed (17.9)      
Total purchase price 100.8      
Less: cash acquired (0.6)      
Total purchase price, net of cash acquired 100.2      
Developed technology | CAS Medical Systems, Inc.        
Business Acquisition [Line Items]        
Finite lived intangible assets 35.9      
Customer Relationships | CAS Medical Systems, Inc.        
Business Acquisition [Line Items]        
Finite lived intangible assets $ 8.8      
XML 107 R77.htm IDEA: XBRL DOCUMENT v3.20.4
ACQUISITIONS - Harpoon Medical, Inc. (Narrative) (Details) - Harpoon Medical - USD ($)
$ in Millions
 24 Months Ended
Dec. 01, 2017
Nov. 30, 2017
Business Acquisition [Line Items]    
Purchase price subject to certain adjustments $ 119.5  
Cash previously paid for cost method investment   $ 16.0
Net proceeds from sale of previous ownership   $ 8.0
Potential milestone-driven payments $ 150.0  
Period to make additional pre-specified milestone-driven payments 10 years  
Liability for estimated fair value of contingent milestone payment $ 59.7  
Additional research and development expenditures to be incurred prior to product introduction $ 41.4  
XML 108 R78.htm IDEA: XBRL DOCUMENT v3.20.4
ACQUISITIONS - Valtech Cardio, Ltd. (Narrative) (Details) - USD ($)
shares in Millions, $ in Millions
 1 Months Ended 3 Months Ended 12 Months Ended
Jan. 23, 2017
Nov. 26, 2016
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2020
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Business Acquisition [Line Items]                
Cash paid to acquire business           $ 0.0 $ 100.2 $ 0.0
Valtech                
Business Acquisition [Line Items]                
Purchase price subject to certain adjustments   $ 340.0            
Potential milestone-driven payments   $ 350.0            
Period to make additional pre-specified milestone-driven payments   10 years            
Issuance of shares of common stock (in shares) 2.8              
Fair value of shares issued in connection with business combinations (Note 8) $ 266.5              
Cash paid to acquire business 86.2              
Liability for estimated fair value of contingent milestone payment 162.9              
Additional research and development expenditures to be incurred prior to product introduction 87.3              
Valtech spin off                
Business Acquisition [Line Items]                
Future option to acquire business, amount 200.0              
Future option to acquire business, additional amount subject to regulatory approval $ 50.0              
Future option to acquire business, period to obtain regulatory approval 10 years              
Developed Technology and In-process Research and Development | Valtech                
Business Acquisition [Line Items]                
Impairment of intangible assets       $ 116.2       $ 116.2
Developed technology | Valtech                
Business Acquisition [Line Items]                
Impairment of intangible assets         $ 40.6      
Rest of World | Developed Technology and In-process Research and Development | Valtech                
Business Acquisition [Line Items]                
Impairment of intangible assets       $ 116.2        
Rest of World | Developed technology | Valtech                
Business Acquisition [Line Items]                
Impairment of intangible assets     $ 40.6          
XML 109 R79.htm IDEA: XBRL DOCUMENT v3.20.4
ACQUISITIONS - CardiAQ Valve Technologies, Inc. (Narrative) (Details) - USD ($)
$ in Millions
 12 Months Ended
Aug. 26, 2015
Jul. 03, 2015
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Business Acquisition [Line Items]          
Cash purchase price subject to certain adjustments     $ 0.0 $ 100.2 $ 0.0
CardiAQ          
Business Acquisition [Line Items]          
Cash purchase price subject to certain adjustments   $ 350.0      
Purchase price subject to certain adjustments $ 348.0        
Additional payments if certain European regulatory approval is obtained $ 50.0        
Period to obtain certain European regulatory approval 48 months        
Liability for estimated fair value of contingent milestone payment $ 30.3        
Additional research and development expenditures to be incurred prior to product introduction $ 97.7        
XML 110 R80.htm IDEA: XBRL DOCUMENT v3.20.4
GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details) - USD ($)
$ in Millions
 1 Months Ended 12 Months Ended
Apr. 30, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Finite-Lived Intangible Assets [Line Items]        
Increase to goodwill     $ 64.4  
Amortization expense related to other intangible assets   $ 5.4 $ 4.6 $ 2.5
Casmed        
Finite-Lived Intangible Assets [Line Items]        
Increase to goodwill $ 64.4      
Increase to intangible assets $ 35.9      
XML 111 R81.htm IDEA: XBRL DOCUMENT v3.20.4
GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in the Carrying Amount of Goodwill, by Segment (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Goodwill    
Beginning balance $ 1,167.7 $ 1,112.2
Goodwill acquired during the year   64.4
Currency translation adjustment 5.5 (8.9)
Ending balance 1,173.2 1,167.7
United States    
Goodwill    
Beginning balance 773.7 709.3
Goodwill acquired during the year   64.4
Currency translation adjustment 0.0 0.0
Ending balance 773.7 773.7
Europe    
Goodwill    
Beginning balance 62.8 64.2
Goodwill acquired during the year   0.0
Currency translation adjustment 5.5 (1.4)
Ending balance 68.3 62.8
Rest of World    
Goodwill    
Beginning balance 331.2 338.7
Goodwill acquired during the year   0.0
Currency translation adjustment 0.0 (7.5)
Ending balance $ 331.2 $ 331.2
XML 112 R82.htm IDEA: XBRL DOCUMENT v3.20.4
GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Finite-lived intangible assets    
Weighted-Average Useful Life (in years) 12 years 7 months 6 days  
Cost $ 353.9 $ 351.5
Accumulated Amortization (240.6) (233.1)
Net Carrying Value 113.3 118.4
Indefinite-lived intangible assets    
Cost 572.0 569.6
Net Carrying Value 331.4 336.5
In-process research and development    
Indefinite-lived intangible assets    
In-process research and development $ 218.1 218.1
Patents    
Finite-lived intangible assets    
Weighted-Average Useful Life (in years) 7 years 4 months 24 days  
Cost $ 186.1 185.7
Accumulated Amortization (183.6) (182.1)
Net Carrying Value $ 2.5 3.6
Developed technology    
Finite-lived intangible assets    
Weighted-Average Useful Life (in years) 13 years 1 month 6 days  
Cost $ 155.2 153.5
Accumulated Amortization (51.0) (46.6)
Net Carrying Value $ 104.2 106.9
Other    
Finite-lived intangible assets    
Weighted-Average Useful Life (in years) 10 years  
Cost $ 12.6 12.3
Accumulated Amortization (6.0) (4.4)
Net Carrying Value $ 6.6 $ 7.9
XML 113 R83.htm IDEA: XBRL DOCUMENT v3.20.4
GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Estimated Amortization Expense (Details)
$ in Millions
Dec. 31, 2020
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
2021 $ 5.2
2022 7.6
2023 10.1
2024 12.2
2025 $ 14.8
XML 114 R84.htm IDEA: XBRL DOCUMENT v3.20.4
DEBT AND CREDIT FACILITIES - Narrative (Details) - USD ($)
 1 Months Ended 12 Months Ended
Jun. 30, 2018
Apr. 30, 2018
Dec. 31, 2020
Dec. 31, 2019
Debt Instrument [Line Items]        
Weighted-average interest rate under all debt obligations (as a percent)     3.50% 3.40%
Senior Notes | Fixed-rate 4.300% 2018 Notes        
Debt Instrument [Line Items]        
Fixed-rate unsecured senior notes $ 600,000,000.0      
2013 Notes        
Debt Instrument [Line Items]        
Price equal to principal amount, plus accrued and unpaid interest (as a percent) 101.00%      
2013 Notes | Level 2        
Debt Instrument [Line Items]        
Fair value of the notes, based on Level 2 inputs     $ 711,200,000 $ 667,600,000
Credit agreement, maturity July 2019 | Credit Facility        
Debt Instrument [Line Items]        
Term of the credit agreement   5 years    
Credit Agreement Maturity April 2023 | Credit Facility        
Debt Instrument [Line Items]        
Aggregate borrowings in multiple currencies   $ 750,000,000.0    
Facility fee (as a percent)     0.10%  
Issuance costs     $ 2,400,000  
Borrowings outstanding     $ 0 $ 0
Credit Agreement Maturity April 2023 | Credit Facility | LIBOR        
Debt Instrument [Line Items]        
Basis spread on variable rate (as a percent)     0.90%  
Credit Agreement Maturity April 2023 | Credit Facility | Low        
Debt Instrument [Line Items]        
Facility fee (as a percent)   0.10%    
Credit Agreement Maturity April 2023 | Credit Facility | Low | LIBOR        
Debt Instrument [Line Items]        
Basis spread on variable rate (as a percent)   0.90%    
Credit Agreement Maturity April 2023 | Credit Facility | High        
Debt Instrument [Line Items]        
Additional amount available, subject to lender approval   $ 250,000,000.0    
Facility fee (as a percent)   0.20%    
Credit Agreement Maturity April 2023 | Credit Facility | High | LIBOR        
Debt Instrument [Line Items]        
Basis spread on variable rate (as a percent)   1.30%    
XML 115 R85.htm IDEA: XBRL DOCUMENT v3.20.4
DEBT AND CREDIT FACILITIES - Summary of the Notes (Details) - Senior Notes - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Debt Instrument [Line Items]    
Unamortized discount $ (1.1) $ (1.2)
Unamortized debt issuance costs (3.9) (4.4)
Total carrying amount $ 595.0 594.4
Fixed-rate 4.300% 2018 Notes    
Debt Instrument [Line Items]    
Fixed interest rate 4.30%  
Amount $ 600.0 $ 600.0
Effective Interest Rate 4.329% 4.329%
XML 116 R86.htm IDEA: XBRL DOCUMENT v3.20.4
FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Assets    
Available-for-sale investments $ 935.9 $ 793.8
Fair Value on a Recurring Basis | Estimate of Fair Value Measurement    
Assets    
Cash equivalents 16.2 32.4
Investments held for deferred compensation plans 111.2 88.9
Derivatives 8.1 30.7
Total assets 1,071.3 945.8
Liabilities    
Derivatives 39.3 6.4
Deferred compensation plans 111.6 88.7
Contingent consideration liabilities 186.1 172.5
Total liabilities 337.0 267.6
Fair Value on a Recurring Basis | Level 1 | Estimate of Fair Value Measurement    
Assets    
Cash equivalents 16.2 0.7
Investments held for deferred compensation plans 111.2 88.9
Derivatives 0.0 0.0
Total assets 184.3 165.7
Liabilities    
Derivatives 0.0 0.0
Deferred compensation plans 111.6 88.7
Contingent consideration liabilities 0.0 0.0
Total liabilities 111.6 88.7
Fair Value on a Recurring Basis | Level 2 | Estimate of Fair Value Measurement    
Assets    
Cash equivalents 0.0 31.7
Investments held for deferred compensation plans 0.0 0.0
Derivatives 8.1 30.7
Total assets 887.0 780.1
Liabilities    
Derivatives 39.3 6.4
Deferred compensation plans 0.0 0.0
Contingent consideration liabilities 0.0 0.0
Total liabilities 39.3 6.4
Fair Value on a Recurring Basis | Level 3 | Estimate of Fair Value Measurement    
Assets    
Cash equivalents 0.0 0.0
Investments held for deferred compensation plans 0.0 0.0
Derivatives 0.0 0.0
Total assets 0.0 0.0
Liabilities    
Derivatives 0.0 0.0
Deferred compensation plans 0.0 0.0
Contingent consideration liabilities 186.1 172.5
Total liabilities 186.1 172.5
Bank time deposits    
Assets    
Available-for-sale investments 24.1 13.1
Bank time deposits | Fair Value on a Recurring Basis | Estimate of Fair Value Measurement    
Assets    
Available-for-sale investments 24.1 13.1
Bank time deposits | Fair Value on a Recurring Basis | Level 1 | Estimate of Fair Value Measurement    
Assets    
Available-for-sale investments 0.0 0.0
Bank time deposits | Fair Value on a Recurring Basis | Level 2 | Estimate of Fair Value Measurement    
Assets    
Available-for-sale investments 24.1 13.1
Bank time deposits | Fair Value on a Recurring Basis | Level 3 | Estimate of Fair Value Measurement    
Assets    
Available-for-sale investments 0.0 0.0
Corporate debt securities    
Assets    
Available-for-sale investments 608.3 489.2
Corporate debt securities | Fair Value on a Recurring Basis | Estimate of Fair Value Measurement    
Assets    
Available-for-sale investments 608.3 489.2
Corporate debt securities | Fair Value on a Recurring Basis | Level 1 | Estimate of Fair Value Measurement    
Assets    
Available-for-sale investments 0.0 0.0
Corporate debt securities | Fair Value on a Recurring Basis | Level 2 | Estimate of Fair Value Measurement    
Assets    
Available-for-sale investments 608.3 489.2
Corporate debt securities | Fair Value on a Recurring Basis | Level 3 | Estimate of Fair Value Measurement    
Assets    
Available-for-sale investments 0.0 0.0
Asset-backed securities    
Assets    
Available-for-sale investments 151.5 141.7
Asset-backed securities | Fair Value on a Recurring Basis | Estimate of Fair Value Measurement    
Assets    
Available-for-sale investments 151.5 141.7
Asset-backed securities | Fair Value on a Recurring Basis | Level 1 | Estimate of Fair Value Measurement    
Assets    
Available-for-sale investments 0.0 0.0
Asset-backed securities | Fair Value on a Recurring Basis | Level 2 | Estimate of Fair Value Measurement    
Assets    
Available-for-sale investments 151.5 141.7
Asset-backed securities | Fair Value on a Recurring Basis | Level 3 | Estimate of Fair Value Measurement    
Assets    
Available-for-sale investments 0.0 0.0
U.S. government and agency securities    
Assets    
Available-for-sale investments 149.2 113.8
U.S. government and agency securities | Fair Value on a Recurring Basis | Estimate of Fair Value Measurement    
Assets    
Available-for-sale investments 149.1 113.8
U.S. government and agency securities | Fair Value on a Recurring Basis | Level 1 | Estimate of Fair Value Measurement    
Assets    
Available-for-sale investments 56.9 76.1
U.S. government and agency securities | Fair Value on a Recurring Basis | Level 2 | Estimate of Fair Value Measurement    
Assets    
Available-for-sale investments 92.2 37.7
U.S. government and agency securities | Fair Value on a Recurring Basis | Level 3 | Estimate of Fair Value Measurement    
Assets    
Available-for-sale investments 0.0 0.0
Municipal securities    
Assets    
Available-for-sale investments 2.8 0.0
Municipal securities | Fair Value on a Recurring Basis | Estimate of Fair Value Measurement    
Assets    
Available-for-sale investments 2.8  
Municipal securities | Fair Value on a Recurring Basis | Level 1 | Estimate of Fair Value Measurement    
Assets    
Available-for-sale investments 0.0  
Municipal securities | Fair Value on a Recurring Basis | Level 2 | Estimate of Fair Value Measurement    
Assets    
Available-for-sale investments 2.8  
Municipal securities | Fair Value on a Recurring Basis | Level 3 | Estimate of Fair Value Measurement    
Assets    
Available-for-sale investments 0.0  
Foreign government bonds    
Assets    
Available-for-sale investments 0.0 1.7
Foreign government bonds | Fair Value on a Recurring Basis | Estimate of Fair Value Measurement    
Assets    
Available-for-sale investments   1.7
Foreign government bonds | Fair Value on a Recurring Basis | Level 1 | Estimate of Fair Value Measurement    
Assets    
Available-for-sale investments   0.0
Foreign government bonds | Fair Value on a Recurring Basis | Level 2 | Estimate of Fair Value Measurement    
Assets    
Available-for-sale investments   1.7
Foreign government bonds | Fair Value on a Recurring Basis | Level 3 | Estimate of Fair Value Measurement    
Assets    
Available-for-sale investments   0.0
Commercial paper    
Assets    
Available-for-sale investments $ 0.0 34.3
Commercial paper | Fair Value on a Recurring Basis | Estimate of Fair Value Measurement    
Assets    
Available-for-sale investments   34.3
Commercial paper | Fair Value on a Recurring Basis | Level 1 | Estimate of Fair Value Measurement    
Assets    
Available-for-sale investments   0.0
Commercial paper | Fair Value on a Recurring Basis | Level 2 | Estimate of Fair Value Measurement    
Assets    
Available-for-sale investments   34.3
Commercial paper | Fair Value on a Recurring Basis | Level 3 | Estimate of Fair Value Measurement    
Assets    
Available-for-sale investments   $ 0.0
XML 117 R87.htm IDEA: XBRL DOCUMENT v3.20.4
FAIR VALUE MEASUREMENTS - Summary of Changes in Fair Value of Contingent Consideration Obligation (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation    
Fair value, beginning of year $ 172.5 $ 178.6
Changes in fair value 13.6 (6.1)
Fair value, end of year $ 186.1 $ 172.5
XML 118 R88.htm IDEA: XBRL DOCUMENT v3.20.4
FAIR VALUE MEASUREMENTS - Narrative (Details)
$ in Millions
 12 Months Ended
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Change in fair value of contingent consideration liabilities, net $ (13.6) $ 6.1 $ 5.7
Measurement Input, Discount Rate | Minimum | Level 3 | Obligations      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Contingent consideration liability measurement input 0.0008    
Measurement Input, Discount Rate | Maximum | Level 3 | Obligations      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Contingent consideration liability measurement input 0.0853    
Measurement Input, Discount Rate | Weighted Average | Level 3 | Obligations      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Contingent consideration liability measurement input 0.031    
Measurement Input, Probability of Milestone Achievement | Minimum | Level 3 | Obligations      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Contingent consideration liability measurement input 0.004    
Measurement Input, Probability of Milestone Achievement | Maximum | Level 3 | Obligations      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Contingent consideration liability measurement input 0.997    
Measurement Input, Probability of Milestone Achievement | Weighted Average | Level 3 | Obligations      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Contingent consideration liability measurement input 0.707    
Measurement Input, Volatility of Future Revenue | Minimum | Level 3 | Obligations      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Contingent consideration liability measurement input 0.370    
Measurement Input, Volatility of Future Revenue | Maximum | Level 3 | Obligations      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Contingent consideration liability measurement input 0.400    
Measurement Input, Volatility of Future Revenue | Weighted Average | Level 3 | Obligations      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Contingent consideration liability measurement input 0.388    
Two Previous Acquisitions      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Change in fair value of contingent consideration liabilities, net $ 12.7 $ 24.1  
XML 119 R89.htm IDEA: XBRL DOCUMENT v3.20.4
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Summary of Derivative Financial Instruments Used to Manage Currency Exchange and Interest Rate Risk (Details) - Derivatives designated as hedging instruments - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Foreign currency forward exchange contracts    
Derivative [Line Items]    
Notional Amount $ 1,525.5 $ 1,336.5
Cross currency swap contracts    
Derivative [Line Items]    
Notional Amount $ 300.0 $ 300.0
XML 120 R90.htm IDEA: XBRL DOCUMENT v3.20.4
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments (Details) - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Foreign currency contracts    
Assets    
Fair Value $ 7.3 $ 17.4
Liabilities    
Fair Value 39.3 6.4
Cross currency swap contracts    
Assets    
Fair Value 0.8 13.3
Derivatives designated as hedging instruments | Foreign currency contracts | Other current assets    
Assets    
Fair Value 7.3 14.2
Derivatives designated as hedging instruments | Foreign currency contracts | Other assets    
Assets    
Fair Value 0.0 3.2
Derivatives designated as hedging instruments | Foreign currency contracts | Accrued and other liabilities    
Liabilities    
Fair Value 39.3 6.4
Derivatives designated as hedging instruments | Cross currency swap contracts | Other assets    
Assets    
Fair Value $ 0.8 $ 13.3
XML 121 R91.htm IDEA: XBRL DOCUMENT v3.20.4
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset (Details) - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Foreign currency contracts    
Derivative Assets    
Gross Amounts $ 7.3 $ 17.4
Gross Amounts Offset in the Consolidated Balance Sheet 0.0 0.0
Net Amounts Presented in the Consolidated Balance Sheet 7.3 17.4
Gross Amounts Not Offset in the Consolidated Balance Sheet    
Financial Instruments (6.1) (5.7)
Cash Collateral Received 0.0 0.0
Net Amount 1.2 11.7
Derivative Liabilities    
Gross Amounts 39.3 6.4
Gross Amounts Offset in the Consolidated Balance Sheet 0.0 0.0
Net Amounts Presented in the Consolidated Balance Sheet 39.3 6.4
Gross Amounts Not Offset in the Consolidated Balance Sheet    
Financial Instruments (6.1) (5.7)
Cash Collateral Received 0.0 0.0
Net Amount 33.2 0.7
Cross currency swap contracts    
Derivative Assets    
Gross Amounts 0.8 13.3
Gross Amounts Offset in the Consolidated Balance Sheet 0.0 0.0
Net Amounts Presented in the Consolidated Balance Sheet 0.8 13.3
Gross Amounts Not Offset in the Consolidated Balance Sheet    
Financial Instruments 0.0 0.0
Cash Collateral Received 0.0 0.0
Net Amount $ 0.8 $ 13.3
XML 122 R92.htm IDEA: XBRL DOCUMENT v3.20.4
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Foreign currency contracts | Other income, net | Derivatives not designated as hedging instruments      
Derivative Instruments, Gain (Loss)      
Amount of Gain or (Loss) Recognized in Income on Derivative $ (15.1) $ 0.3 $ 9.7
Cash flow hedges | Foreign currency contracts | Derivatives designated as hedging instruments      
Derivative Instruments, Gain (Loss)      
Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion) (33.7) 23.5  
Cash flow hedges | Foreign currency contracts | Cost of sales | Derivatives designated as hedging instruments      
Derivative Instruments, Gain (Loss)      
Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income 18.4 40.9  
Cash flow hedges | Foreign currency contracts | Selling, general, and administrative expenses | Derivatives designated as hedging instruments      
Derivative Instruments, Gain (Loss)      
Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income 2.2 1.9  
Net investment hedges | Cross currency swap contracts | Derivatives designated as hedging instruments      
Derivative Instruments, Gain (Loss)      
Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion) (12.6) 12.5  
Net investment hedges | Cross currency swap contracts | Interest expense | Derivatives designated as hedging instruments      
Derivative Instruments, Gain (Loss)      
Amount of Gain or (Loss) Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing) 6.4 6.6  
Fair value hedges | Foreign currency contracts | Other income, net | Derivatives designated as hedging instruments      
Derivative Instruments, Gain (Loss)      
Amount of Gain or (Loss) Recognized in Income on Derivative $ (1.4) $ 1.4 $ 0.5
XML 123 R93.htm IDEA: XBRL DOCUMENT v3.20.4
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location of Gain or Loss on Derivative Instruments (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Derivative Instruments, Gain (Loss)      
Cost of sales $ (1,080.6) $ (1,114.4) $ (939.4)
Selling, general, and administrative expenses (1,228.4) (1,242.2) (1,088.5)
Other income, net 11.5 8.2 $ 4.0
Foreign currency contracts | Cost of sales      
Gain (loss) on fair value hedging relationships:      
Hedged items 0.0 0.0  
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach 0.0 0.0  
Gain (loss) on cash flow hedging relationships:      
Amount of gain (loss) reclassified from accumulated OCI into income 18.4 40.9  
Foreign currency contracts | Cost of sales | Derivatives designated as hedging instruments      
Gain (loss) on fair value hedging relationships:      
Derivatives designated as hedging instruments 0.0 0.0  
Foreign currency contracts | Selling, general, and administrative expenses      
Gain (loss) on fair value hedging relationships:      
Hedged items 0.0 0.0  
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach 0.0 0.0  
Gain (loss) on cash flow hedging relationships:      
Amount of gain (loss) reclassified from accumulated OCI into income 2.2 1.9  
Foreign currency contracts | Selling, general, and administrative expenses | Derivatives designated as hedging instruments      
Gain (loss) on fair value hedging relationships:      
Derivatives designated as hedging instruments 0.0 0.0  
Foreign currency contracts | Other income, net      
Gain (loss) on fair value hedging relationships:      
Hedged items 4.8 2.9  
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach 3.4 4.3  
Gain (loss) on cash flow hedging relationships:      
Amount of gain (loss) reclassified from accumulated OCI into income 0.0 0.0  
Foreign currency contracts | Other income, net | Derivatives designated as hedging instruments      
Gain (loss) on fair value hedging relationships:      
Derivatives designated as hedging instruments $ (4.8) $ (2.9)  
XML 124 R94.htm IDEA: XBRL DOCUMENT v3.20.4
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details)
€ in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2020
USD ($)
Dec. 31, 2020
EUR (€)
Dec. 31, 2019
USD ($)
Derivative Instruments, Gain (Loss)      
Cash flow hedge loss to be reclassified $ 7.0    
Cross currency swap contracts | Derivatives designated as hedging instruments      
Derivative Instruments, Gain (Loss)      
Notional Amount 300.0   $ 300.0
Cross currency swap contracts | Net investment hedges | Derivatives designated as hedging instruments      
Derivative Instruments, Gain (Loss)      
Notional Amount $ 300.0 € 257.2  
XML 125 R95.htm IDEA: XBRL DOCUMENT v3.20.4
EMPLOYEE BENEFIT PLANS - Schedule of Information Regarding Defined Benefit Pension Plans (Details) - Defined benefit pension plans - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2020
Dec. 31, 2019
Change in projected benefit obligation:          
Beginning of year $ 105.2 $ 97.4      
Service cost 6.3 5.2 $ 6.0    
Interest cost 0.5 0.9 0.8    
Participant contributions 1.5 1.3      
Actuarial loss 2.9 8.2      
Benefits paid (0.6) (4.2)      
Plan amendment 0.0 (4.6)      
Currency exchange rate changes and other 10.4 1.0      
End of year 126.2 105.2 97.4    
Change in fair value of plan assets:          
Beginning of year 63.2 60.4      
Actual return on plan assets 0.4 2.0      
Employer contributions 2.8 2.6      
Participant contributions 1.5 1.3      
Benefits paid (0.6) (4.2)      
Currency exchange rate changes and other 6.0 1.1      
End of year 73.3 63.2 60.4    
Funded Status          
Projected benefit obligation (126.2) (97.4) (97.4) $ (126.2) $ (105.2)
Plan assets at fair value $ 73.3 $ 60.4 $ 60.4 73.3 63.2
Underfunded status       (52.9) (42.0)
Accumulated other comprehensive loss, net of tax:          
Net actuarial loss       (30.8) (26.3)
Net prior service cost       6.6 6.7
Deferred income tax benefit       4.6 4.2
Total       (19.6) (15.4)
Other long-term liabilities          
Net amounts recognized on the consolidated balance sheet:          
Other long-term liabilities       $ 52.9 $ 42.0
XML 126 R96.htm IDEA: XBRL DOCUMENT v3.20.4
EMPLOYEE BENEFIT PLANS - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Defined Contribution Plans      
Expected employer contributions $ 2.5    
Matching contributions relating to entity's employees 36.6 $ 31.4 $ 26.6
Defined benefit pension plans      
Defined Contribution Plans      
Accumulated benefit obligation 120.9 101.1  
Nonqualified deferred compensation plans      
Defined Contribution Plans      
Amount accrued under nonqualified plans $ 111.6 $ 88.7  
United States      
Defined Contribution Plans      
Maximum contributions of a participant's eligible compensation (as a percent) 25.00%    
Dollar-for-dollar match of employee's annual eligible compensation (as a percent) 4.00%    
Company match of eligible compensation after dollar-for-dollar basis (as a percent) 2.00%    
Company match, second level (as a percent) 50.00%    
Puerto Rico      
Defined Contribution Plans      
Maximum contributions of a participant's eligible compensation (as a percent) 25.00%    
Dollar-for-dollar match of employee's annual eligible compensation (as a percent) 4.00%    
Company match, first level (as a percent) 50.00%    
Profit sharing contribution calculated on eligible earnings (as a percent) 2.00%    
XML 127 R97.htm IDEA: XBRL DOCUMENT v3.20.4
EMPLOYEE BENEFIT PLANS - Components of Net Periodic Benefit Cost (Details) - Defined benefit pension plans - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Defined Benefit Plan Disclosure [Line Items]      
Service cost, net $ 6.3 $ 5.2 $ 6.0
Interest cost 0.5 0.9 0.8
Expected return on plan assets (1.0) (1.4) (1.3)
Settlements and curtailment gain 0.0 0.0 (7.4)
Amortization of actuarial loss 1.6 0.9 0.8
Amortization of prior service credit (0.7) (0.2) (0.1)
Net periodic pension benefit cost (credit) $ 6.7 $ 5.4 $ (1.2)
XML 128 R98.htm IDEA: XBRL DOCUMENT v3.20.4
EMPLOYEE BENEFIT PLANS - Schedule of Weighted-Average Assumptions Used to Determine Benefit Obligations (Details) - Defined benefit pension plans
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Weighted-average assumptions used to determine the benefit obligations      
Discount rate 0.30% 0.50%  
Rate of compensation increase 2.60% 2.70%  
Cash balance interest crediting rate 2.50% 2.60%  
Social securities increase 1.60% 1.60%  
Pension increase 1.80% 1.80%  
Weighted-average assumptions used to determine the net periodic benefit cost      
Discount rate 0.50% 0.90% 0.90%
Expected return on plan assets 1.50% 2.30% 2.30%
Rate of compensation increase 2.70% 2.80% 2.60%
Cash balance interest crediting rate 1.50% 1.50% 1.50%
Social securities increase 1.60% 1.80% 1.50%
Pension increase 1.80% 1.80% 1.80%
XML 129 R99.htm IDEA: XBRL DOCUMENT v3.20.4
EMPLOYEE BENEFIT PLANS - Schedule of Target Weighted-Average Asset Allocations and Fair Value (Details) - Defined benefit pension plans - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Defined Benefit Plan Disclosure [Line Items]      
Target asset allocations (as a percent) 100.00%    
Plan assets at fair value $ 73.3 $ 63.2 $ 60.4
Total plan assets measured at fair value      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 65.5 56.1  
Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 55.8 48.5  
Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 8.7 6.7  
Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 1.0 0.9  
Alternative investments measured at net asset value      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 7.8 7.1  
Cash | Total plan assets measured at fair value      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 3.0 3.8  
Cash | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 3.0 3.8  
Cash | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
Cash | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value $ 0.0 0.0  
Equity securities      
Defined Benefit Plan Disclosure [Line Items]      
Target asset allocations (as a percent) 25.30%    
United States equities | Total plan assets measured at fair value      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value $ 3.3 3.0  
United States equities | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 3.3 3.0  
United States equities | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
United States equities | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
International equities | Total plan assets measured at fair value      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 16.1 11.2  
International equities | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 16.1 11.2  
International equities | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
International equities | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value $ 0.0 0.0  
Debt securities      
Defined Benefit Plan Disclosure [Line Items]      
Target asset allocations (as a percent) 47.50%    
United States government bonds | Total plan assets measured at fair value      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value $ 7.4 8.2  
United States government bonds | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 7.4 8.2  
United States government bonds | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
United States government bonds | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
Foreign government bonds | Total plan assets measured at fair value      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 26.0 22.3  
Foreign government bonds | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 26.0 22.3  
Foreign government bonds | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
Foreign government bonds | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value $ 0.0 0.0  
Real estate      
Defined Benefit Plan Disclosure [Line Items]      
Target asset allocations (as a percent) 7.70%    
Real estate | Total plan assets measured at fair value      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value $ 5.6 4.4  
Real estate | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
Real estate | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 5.6 4.4  
Real estate | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
Mortgages | Total plan assets measured at fair value      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 3.1 2.3  
Mortgages | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
Mortgages | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 3.1 2.3  
Mortgages | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
Insurance contracts | Total plan assets measured at fair value      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 1.0 0.9  
Insurance contracts | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
Insurance contracts | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
Insurance contracts | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value $ 1.0 $ 0.9 $ 1.0
Other      
Defined Benefit Plan Disclosure [Line Items]      
Target asset allocations (as a percent) 19.50%    
XML 130 R100.htm IDEA: XBRL DOCUMENT v3.20.4
EMPLOYEE BENEFIT PLANS - Summary of Changes in Fair Value of Defined Benefit Plan Assets Classified as Level 3 (Details) - Defined benefit pension plans - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Defined Benefit Plan Disclosure [Line Items]    
Beginning of year $ 63.2 $ 60.4
Currency exchange rate impact 6.0 1.1
End of year 73.3 63.2
Level 3    
Defined Benefit Plan Disclosure [Line Items]    
Beginning of year 0.9  
End of year 1.0 0.9
Level 3 | Insurance Contracts    
Defined Benefit Plan Disclosure [Line Items]    
Beginning of year 0.9 1.0
Purchases, sales and settlements   (0.1)
Currency exchange rate impact 0.1  
End of year $ 1.0 $ 0.9
XML 131 R101.htm IDEA: XBRL DOCUMENT v3.20.4
EMPLOYEE BENEFIT PLANS - Schedule of Benefit Payments Which Reflect Expected Future Service (Details)
$ in Millions
Dec. 31, 2020
USD ($)
Retirement Benefits [Abstract]  
2021 $ 4.6
2022 4.9
2023 6.7
2024 5.6
2025 5.3
2024-2026 $ 36.7
XML 132 R102.htm IDEA: XBRL DOCUMENT v3.20.4
COMMON STOCK - Treasury Stock (Narrative) (Details) - USD ($)
shares in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
May 31, 2019
Treasury Stock        
Aggregate cost of stock repurchases $ 625,400,000 $ 263,300,000 $ 795,500,000  
Treasury Stock        
Treasury Stock        
Shares repurchased (in shares) 3.1 1.5 5.5  
Aggregate cost of stock repurchases $ 625,400,000 $ 263,300,000 $ 795,500,000  
May 2019        
Treasury Stock        
Authorized amount for share repurchase       $ 1,000,000,000.0
XML 133 R103.htm IDEA: XBRL DOCUMENT v3.20.4
COMMON STOCK - Accelerated Share Repurchases (Details) - USD ($)
$ / shares in Units, shares in Millions
 1 Months Ended
May 29, 2020
May 07, 2020
Jun. 30, 2019
May 31, 2019
Nov. 30, 2018
Oct. 31, 2018
Jul. 31, 2018
Apr. 30, 2018
Accelerated Share Repurchase                
Stock split, conversion ratio 300.00% 300.00%            
April 2018                
Accelerated Share Repurchase                
Amount Paid               $ 400,000,000.0
Shares repurchased (in shares)               2.5
Initial delivery, price per share (in dollars per share)               $ 127.36
Value of Shares as % of Contract Value               80.00%
July 2018                
Accelerated Share Repurchase                
Shares repurchased (in shares)             2.8  
Final settlement per share price (in dollars per share)             $ 142.37  
October 2018                
Accelerated Share Repurchase                
Amount Paid           $ 250,000,000.0    
Shares repurchased (in shares)           1.4    
Initial delivery, price per share (in dollars per share)           $ 139.22    
Value of Shares as % of Contract Value           80.00%    
November 2018                
Accelerated Share Repurchase                
Shares repurchased (in shares)         1.7      
Final settlement per share price (in dollars per share)         $ 150.54      
Initial Delivery of Shares Settled May 2019                
Accelerated Share Repurchase                
Amount Paid       $ 150,000,000.0        
Shares repurchased (in shares)       0.7        
Initial delivery, price per share (in dollars per share)       $ 178.66        
Value of Shares as % of Contract Value       80.00%        
Purchased and sold in May 2019                
Accelerated Share Repurchase                
Shares repurchased (in shares)       0.8        
Final settlement per share price (in dollars per share)       $ 178.42        
Initial Delivery of Shares Settled June 2019                
Accelerated Share Repurchase                
Amount Paid       $ 100,000,000.0        
Shares repurchased (in shares)       0.5        
Initial delivery, price per share (in dollars per share)       $ 170.02        
Value of Shares as % of Contract Value       80.00%        
Purchased in May 2019 and sold in June 2019                
Accelerated Share Repurchase                
Shares repurchased (in shares)     0.6          
Final settlement per share price (in dollars per share)     $ 178.46          
XML 134 R104.htm IDEA: XBRL DOCUMENT v3.20.4
COMMON STOCK - Employee and Director Stock Plans (Narrative) (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Jan. 01, 2021
Option Awards        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Estimated annual forfeiture rate 6.40%      
Average risk-free interest rate 0.30% 2.30% 2.90%  
Expected volatility 33.00% 30.00% 29.00%  
MRSUs        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Average risk-free interest rate 0.20% 2.20% 2.70%  
Expected volatility 32.70% 29.40% 29.70%  
ESPP        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Average risk-free interest rate 1.30% 2.40% 1.70%  
Expected volatility 33.00% 27.00% 31.00%  
The Program        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Common stock available for issuance (in shares) 327,600,000      
The Program | Option Awards        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Expiration date 7 years      
The Program | Option Awards | Low        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Vesting period 3 years      
The Program | Option Awards | High        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Vesting period 4 years      
The Program | Restricted stock units | Low        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Vesting period 3 years      
The Program | Restricted stock units | High        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Vesting period 4 years      
The Program | MRSUs        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Vesting period 3 years      
The Program | Restricted stock or restricted stock units | High        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Common stock available for issuance (in shares) 33,600,000      
Nonemployee Directors Program        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Common stock available for issuance (in shares) 8,400,000      
Nonemployee Directors Program | Annual award to nonemployee director        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Limit on total value of the award $ 0.2      
Nonemployee Directors Program | Option Awards | Awards granted in 2012 and later        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Vesting period 1 year      
Nonemployee Directors Program | Option Awards | High | Annual award to nonemployee director        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Common stock available for issuance (in shares) 120,000      
Nonemployee Directors Program | Restricted stock units | High | Annual award to nonemployee director        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Common stock available for issuance (in shares) 48,000      
ESPP | ESPP        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Common stock available for issuance (in shares) 45,900,000      
Percentage of lower of fair market value of common stock on effective date of subscription or date of purchase 85.00%      
Maximum percentage of compensation employees can authorize to be withheld for common stock purchases 12.00%      
ESPP | ESPP | Subsequent Event        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Maximum percentage of compensation employees can authorize to be withheld for common stock purchases       15.00%
XML 135 R105.htm IDEA: XBRL DOCUMENT v3.20.4
COMMON STOCK - Schedule of Weighted-Average Assumptions (Details) - $ / shares
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Option Awards      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Average risk-free interest rate 0.30% 2.30% 2.90%
Expected dividend yield 0.00% 0.00% 0.00%
Expected volatility 33.00% 30.00% 29.00%
Expected life (years) 5 years 5 years 1 month 6 days 5 years
Fair value, per share (in dollars per share) $ 21.70 $ 18.17 $ 14.17
ESPP      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Average risk-free interest rate 1.30% 2.40% 1.70%
Expected dividend yield 0.00% 0.00% 0.00%
Expected volatility 33.00% 27.00% 31.00%
Expected life (years) 7 months 6 days 7 months 6 days 7 months 6 days
Fair value, per share (in dollars per share) $ 16.61 $ 16.43 $ 12.18
XML 136 R106.htm IDEA: XBRL DOCUMENT v3.20.4
COMMON STOCK - Schedule of Stock Option (Details) - Stock option activity
$ / shares in Units, shares in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2020
USD ($)
$ / shares
shares
Shares  
Beginning balance (in shares) | shares 17.1
Options granted (in shares) | shares 1.8
Options exercised (in shares) | shares (4.3)
Options forfeited (in shares) | shares (0.3)
Ending balance (in shares) | shares 14.3
Exercisable as of period end (in shares) | shares 9.5
Vested and expected to vest as of period end (in shares) | shares 13.6
Weighted- Average Exercise Price  
Beginning balance (in dollars per share) | $ / shares $ 32.19
Options granted (in dollars per share) | $ / shares 73.02
Options exercised (in dollars per share) | $ / shares 18.16
Options forfeited (in dollars per share) | $ / shares 49.74
Ending balance (in dollars per share) | $ / shares 41.27
Exercisable as of period end (in dollars per share) | $ / shares 32.32
Vested and expected to vest as of period end (in dollars per share) | $ / shares $ 40.37
Weighted- Average Remaining Contractual Term  
Outstanding as of period end 3 years 4 months 24 days
Exercisable as of period end 2 years 6 months
Vested and expected to vest as of period end 3 years 3 months 18 days
Aggregate Intrinsic Value  
Outstanding as of period end | $ $ 712.5
Exercisable as of period end | $ 558.1
Vested and expected to vest as of period end | $ $ 690.4
XML 137 R107.htm IDEA: XBRL DOCUMENT v3.20.4
COMMON STOCK - Schedule of Restricted Stock Unit Activity (Details) - Nonvested restricted stock unit activity
shares in Millions
 12 Months Ended
Dec. 31, 2020
$ / shares
shares
Shares  
Beginning balance (in shares) | shares 2.7
Granted (in shares) | shares 0.9
Vested (in shares) | shares (0.9)
Forfeited (in shares) | shares (0.1)
Ending balance (in shares) | shares 2.6
Weighted- Average Grant-Date Fair Value  
Beginning balance (in dollars per share) | $ / shares $ 46.89
Granted (in dollars per share) | $ / shares 71.31
Vested (in dollars per share) | $ / shares 40.03
Forfeited (in dollars per share) | $ / shares 49.90
Ending balance (in dollars per share) | $ / shares $ 57.59
XML 138 R108.htm IDEA: XBRL DOCUMENT v3.20.4
COMMON STOCK - Schedule of Restricted Stock Unit Activity (Narrative) (Details) - MRSUs
 12 Months Ended
Dec. 31, 2020
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Granted (in shares) 100,000
Shares related to previous year's grant (in shares) 100,000
XML 139 R109.htm IDEA: XBRL DOCUMENT v3.20.4
COMMON STOCK - Additional Information (Narrative) (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Equity [Abstract]      
Intrinsic value of stock options exercised and restricted stock units vested $ 323.5 $ 382.1 $ 281.1
Cash from exercises of stock options 79.2 110.4 103.7
Realized tax benefits from exercises of stock options and vesting of restricted stock units 72.1 85.1 62.5
Total grant date fair value of stock options vested 34.0 $ 31.2 $ 29.0
Employee stock purchase subscriptions $ 140.9    
Weighted-average remaining requisite service period 30 months    
XML 140 R110.htm IDEA: XBRL DOCUMENT v3.20.4
ACCUMULATED OTHER COMPREHENSIVE LOSS - Summary of Activity for Each Component of Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Accumulated Other Comprehensive Income (Loss), Net of Tax      
Beginning balance $ 4,148.3 $ 3,140.4 $ 2,956.2
Ending balance 4,574.3 4,148.3 3,140.4
Foreign Currency Translation Adjustments      
Accumulated Other Comprehensive Income (Loss), Net of Tax      
Beginning balance (154.8) (143.6) (100.1)
Other comprehensive (loss) income before reclassifications           35.7 (1.5) (36.7)
Amounts reclassified from accumulated other comprehensive loss (6.4) (6.6) 0.0
Deferred income tax expense 3.1 (3.1) (1.9)
Ending balance (122.4) (154.8) (143.6)
Unrealized (Loss) Gain on Hedges      
Accumulated Other Comprehensive Income (Loss), Net of Tax      
Beginning balance 12.5 23.6 (13.9)
Other comprehensive (loss) income before reclassifications           (34.8) 27.9 35.1
Amounts reclassified from accumulated other comprehensive loss (19.2) (44.2) 19.1
Deferred income tax expense 13.8 5.2 (13.8)
Ending balance (27.7) 12.5 23.6
Unrealized (Loss) Gain on Available-for-sale Investments      
Accumulated Other Comprehensive Income (Loss), Net of Tax      
Beginning balance 1.7 (5.0) (4.6)
Other comprehensive (loss) income before reclassifications           8.0 7.9 (3.1)
Amounts reclassified from accumulated other comprehensive loss 0.3 0.4 2.9
Deferred income tax expense (1.4) (1.6) (0.2)
Ending balance 8.6 1.7 (5.0)
Unrealized Pension Costs      
Accumulated Other Comprehensive Income (Loss), Net of Tax      
Beginning balance (15.4) (13.5) (14.1)
Other comprehensive (loss) income before reclassifications           (5.5) (3.2) 7.6
Amounts reclassified from accumulated other comprehensive loss 0.9 0.7 (6.7)
Deferred income tax expense 0.4 0.6 (0.3)
Ending balance (19.6) (15.4) (13.5)
Total Accumulated Other Comprehensive Loss      
Accumulated Other Comprehensive Income (Loss), Net of Tax      
Beginning balance (156.0) (138.5) (132.7)
Other comprehensive (loss) income before reclassifications           3.4 31.1 2.9
Amounts reclassified from accumulated other comprehensive loss (24.4) (49.7) 15.3
Deferred income tax expense 15.9 1.1 (16.2)
Ending balance $ (161.1) $ (156.0) (138.5)
Impact to retained earnings from adoption of ASU 2016-16 and ASU 2018-02      
Accumulated Other Comprehensive Income (Loss), Net of Tax      
Beginning balance     2.6
Impact to retained earnings from adoption of ASU 2016-16 and ASU 2018-02 | Foreign Currency Translation Adjustments      
Accumulated Other Comprehensive Income (Loss), Net of Tax      
Beginning balance     (4.9)
Impact to retained earnings from adoption of ASU 2016-16 and ASU 2018-02 | Unrealized (Loss) Gain on Hedges      
Accumulated Other Comprehensive Income (Loss), Net of Tax      
Beginning balance     (2.9)
Impact to retained earnings from adoption of ASU 2016-16 and ASU 2018-02 | Unrealized (Loss) Gain on Available-for-sale Investments      
Accumulated Other Comprehensive Income (Loss), Net of Tax      
Beginning balance     0.0
Impact to retained earnings from adoption of ASU 2016-16 and ASU 2018-02 | Unrealized Pension Costs      
Accumulated Other Comprehensive Income (Loss), Net of Tax      
Beginning balance     0.0
Impact to retained earnings from adoption of ASU 2016-16 and ASU 2018-02 | Total Accumulated Other Comprehensive Loss      
Accumulated Other Comprehensive Income (Loss), Net of Tax      
Beginning balance     (7.8)
Cumulative Effect, Period of Adoption, Adjusted Balance      
Accumulated Other Comprehensive Income (Loss), Net of Tax      
Beginning balance     2,958.8
Cumulative Effect, Period of Adoption, Adjusted Balance | Foreign Currency Translation Adjustments      
Accumulated Other Comprehensive Income (Loss), Net of Tax      
Beginning balance     (105.0)
Cumulative Effect, Period of Adoption, Adjusted Balance | Unrealized (Loss) Gain on Hedges      
Accumulated Other Comprehensive Income (Loss), Net of Tax      
Beginning balance     (16.8)
Cumulative Effect, Period of Adoption, Adjusted Balance | Unrealized (Loss) Gain on Available-for-sale Investments      
Accumulated Other Comprehensive Income (Loss), Net of Tax      
Beginning balance     (4.6)
Cumulative Effect, Period of Adoption, Adjusted Balance | Unrealized Pension Costs      
Accumulated Other Comprehensive Income (Loss), Net of Tax      
Beginning balance     (14.1)
Cumulative Effect, Period of Adoption, Adjusted Balance | Total Accumulated Other Comprehensive Loss      
Accumulated Other Comprehensive Income (Loss), Net of Tax      
Beginning balance     $ (140.5)
XML 141 R111.htm IDEA: XBRL DOCUMENT v3.20.4
ACCUMULATED OTHER COMPREHENSIVE LOSS - Change in Unrealized Pension Costs (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Prior service credit      
Pre-Tax Amount      
Prior service credit arising during period $ 0.6 $ 4.6 $ 3.3
Amortization of prior service credit (0.7) (0.2) (0.1)
Other comprehensive income (loss) (0.1) 4.4 3.2
Tax (Expense) Benefit      
Prior service credit arising during period (0.2) (0.6) (0.9)
Amortization of prior service credit 0.1 0.1 0.0
Other comprehensive income (loss) (0.1) (0.5) (0.9)
Net of Tax Amount      
Prior service credit arising during period 0.4 4.0 2.4
Amortization of prior service credit (0.6) (0.1) (0.1)
Other comprehensive income (loss) (0.2) 3.9 2.3
Net actuarial gain (loss) arising during period      
Pre-Tax Amount      
Other comprehensive income (loss) (4.5) (6.9) (2.3)
Tax (Expense) Benefit      
Other comprehensive income (loss) 0.5 1.1 0.6
Net of Tax Amount      
Other comprehensive income (loss) (4.0) (5.8) (1.7)
Unrealized pension credits (cost), net      
Pre-Tax Amount      
Prior service credit arising during period (5.5) (3.2) 7.6
Other comprehensive income (loss) (4.6) (2.5) 0.9
Tax (Expense) Benefit      
Other comprehensive income (loss) 0.4 0.6 (0.3)
Net of Tax Amount      
Other comprehensive income (loss) $ (4.2) $ (1.9) $ 0.6
XML 142 R112.htm IDEA: XBRL DOCUMENT v3.20.4
ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Information About Amounts Reclassified from Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Amounts reclassified from accumulated other comprehensive loss to affected line on Consolidated Statements of Operations                      
Other income, net                 $ 11.5 $ 8.2 $ 4.0
Provision for income taxes                 (93.3) (119.6) (39.2)
Net income $ 309.5 $ 325.2 $ (121.9) $ 310.6 $ 280.2 $ 274.7 $ 242.3 $ 249.7 823.4 1,046.9 722.2
Cost of sales                 (1,080.6) (1,114.4) (939.4)
Selling, general, and administrative expenses                 (1,228.4) (1,242.2) (1,088.5)
Income before provision for income taxes                 916.7 1,166.5 761.4
Special charges (gain), net                 0.0 0.0 $ (7.1)
Amount Reclassified from Accumulated Other Comprehensive Loss | Foreign currency translation adjustments                      
Amounts reclassified from accumulated other comprehensive loss to affected line on Consolidated Statements of Operations                      
Other income, net                 6.4 6.6  
Provision for income taxes                 (1.6) (1.6)  
Net income                 4.8 5.0  
Amount Reclassified from Accumulated Other Comprehensive Loss | (Loss) gain on hedges                      
Amounts reclassified from accumulated other comprehensive loss to affected line on Consolidated Statements of Operations                      
Provision for income taxes                 (5.0) (11.0)  
Net income                 14.2 33.2  
Cost of sales                 18.4 40.9  
Selling, general, and administrative expenses                 2.2 1.9  
Other income, net                 1.4 (1.4)  
Income before provision for income taxes                 19.2 44.2  
Amount Reclassified from Accumulated Other Comprehensive Loss | (Loss) gain on available-for-sale investments                      
Amounts reclassified from accumulated other comprehensive loss to affected line on Consolidated Statements of Operations                      
Other income, net                 (0.3) (0.4)  
Provision for income taxes                 (0.6) (0.3)  
Net income                 (0.9) (0.7)  
Amount Reclassified from Accumulated Other Comprehensive Loss | Amortization of pension adjustments                      
Amounts reclassified from accumulated other comprehensive loss to affected line on Consolidated Statements of Operations                      
Other income, net                 (0.9) (0.7)  
Provision for income taxes                 0.2 0.1  
Net income                 $ (0.7) $ (0.6)  
XML 143 R113.htm IDEA: XBRL DOCUMENT v3.20.4
OTHER INCOME, NET (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Other Income and Expenses [Abstract]      
Foreign exchange gains, net $ (12.3) $ (5.9) $ (6.7)
Gain on investments (0.6) (0.5) 1.7
Non-service cost components of net periodic pension benefit cost (credit) 0.4 0.2 (0.1)
Other 1.0 (2.0) 1.1
Total other income, net $ (11.5) $ (8.2) $ (4.0)
XML 144 R114.htm IDEA: XBRL DOCUMENT v3.20.4
INCOME TAXES - Schedule of Income Before Provisions for Income Taxes (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Income Tax Disclosure [Abstract]      
United States $ 151.3 $ 383.4 $ 266.1
International, including Puerto Rico 765.4 783.1 495.3
Income before provision for income taxes $ 916.7 $ 1,166.5 $ 761.4
XML 145 R115.htm IDEA: XBRL DOCUMENT v3.20.4
INCOME TAXES - Provision for Income Taxes (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
United States:      
Federal $ 23.4 $ 31.3 $ 10.9
State and local 48.2 48.7 13.6
International, including Puerto Rico 73.9 29.1 35.9
Current income tax expense 145.5 109.1 60.4
United States:      
Federal 11.0 28.3 (16.1)
State and local (32.9) (18.3) (22.4)
International, including Puerto Rico (30.3) 0.5 17.3
Deferred income tax (benefit) expense (52.2) 10.5 (21.2)
Total income tax provision $ 93.3 $ 119.6 $ 39.2
XML 146 R116.htm IDEA: XBRL DOCUMENT v3.20.4
INCOME TAXES - Components of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Deferred tax assets    
Compensation and benefits $ 88.6 $ 90.1
Benefits from uncertain tax positions 27.0 22.5
Net tax credit carryforwards 125.5 108.4
Net operating loss carryforwards 64.1 57.6
Accrued liabilities 105.0 41.3
Inventories 16.3 12.9
Cash flow and net investment hedges 3.3 0.0
State income taxes 0.5 0.5
Investments 1.8 1.5
Lease liability obligations 7.7 18.4
Other 3.6 3.4
Total deferred tax assets 443.4 356.6
Deferred tax liabilities    
Property, plant, and equipment (53.4) (22.6)
Cash flow and net investment hedges 0.0 (6.8)
Deferred tax on foreign earnings (29.2) (35.3)
Right-of-use assets (7.0) (17.5)
Other intangible assets (76.3) (71.0)
Other (3.1) (2.2)
Total deferred tax liabilities (169.0) (155.4)
Valuation allowance (71.6) (65.8)
Net deferred tax assets $ 202.8 $ 135.4
XML 147 R117.htm IDEA: XBRL DOCUMENT v3.20.4
INCOME TAXES - Narrative (Details) - USD ($)
$ / shares in Units, $ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Operating Loss Carryforwards [Line Items]        
Net deferred tax assets increase $ 67.4      
Valuation allowance that reduces certain deferred tax assets 71.6 $ 65.8    
Carryforward Amount 170.0      
Tax benefit from remeasurement of deferred taxes       $ 3.3
Effects of mandatory deemed repatriation       297.4
Tax benefit from harvesting foreign tax credits       32.3
Adjustment to transition tax     $ 12.8  
Deferred tax asset provisional income tax expense (benefit)     3.7  
Foreign earnings to be indefinitely reinvested 1,100.0      
Foreign earnings to be repatriated 599.8      
Estimated net tax liability on permanently reinvested earnings 21.1      
Unrecognized tax benefits 281.8 203.1 150.7 $ 225.6
Estimated decrease in unrecognized tax benefits 95.1 50.1    
Net amounts favorably affecting tax rate 186.7 153.0    
Accrued interest related to unrecognized tax benefits, net of tax benefit 14.3 9.3    
Tax benefit of accrued interest 5.1 3.5    
Interest expense (benefit), net of tax benefit 5.0 4.7 (2.8)  
Non-U.S.        
Operating Loss Carryforwards [Line Items]        
Tax reductions compared to local statutory rates $ 189.2 $ 157.6 $ 144.9  
Tax reductions compared to local statutory rates per diluted share (in dollars per share) $ 0.30 $ 0.25 $ 0.23  
Research expenditure tax credits | Carryforward period indefinite | California | State and local jurisdiction        
Operating Loss Carryforwards [Line Items]        
Carryforward Amount $ 145.1      
Puerto Rico purchases credit | Carryforward period indefinite | Puerto Rico | Non-U.S.        
Operating Loss Carryforwards [Line Items]        
Carryforward Amount $ 23.4      
XML 148 R118.htm IDEA: XBRL DOCUMENT v3.20.4
INCOME TAXES - Summary of Net Operating Loss Carryforwards (Details)
$ in Millions
Dec. 31, 2020
USD ($)
Operating Loss Carryforwards [Line Items]  
Carryforward Amount $ 419.8
Tax Benefit Amount 64.3
Valuation Allowance (45.9)
Net Tax Benefit 18.4
United States federal net operating losses | United States | Carryforward Period Ends 2030-2037  
Operating Loss Carryforwards [Line Items]  
Carryforward Amount 26.6
Tax Benefit Amount 5.6
Valuation Allowance 0.0
Net Tax Benefit 5.6
United States federal net operating losses | United States | Carryforward Period Indefinite  
Operating Loss Carryforwards [Line Items]  
Carryforward Amount 11.3
Tax Benefit Amount 2.4
Valuation Allowance 0.0
Net Tax Benefit 2.4
United States federal net operating losses | United States | Carryforward Period Ends 2022  
Capital Loss Carryforward [Abstract]  
Carryforward Amount 34.1
Tax Benefit Amount 0.2
Valuation Allowance (0.2)
Net Tax Benefit 0.0
United States state net operating losses | United States | Carryforward Period Indefinite  
Operating Loss Carryforwards [Line Items]  
Carryforward Amount 1.0
Tax Benefit Amount 0.1
Valuation Allowance (0.1)
Net Tax Benefit 0.0
United States state net operating losses | United States | Carryforward Period Ends 2026-2039  
Operating Loss Carryforwards [Line Items]  
Carryforward Amount 33.5
Tax Benefit Amount 2.1
Valuation Allowance (2.1)
Net Tax Benefit 0.0
Non-United States net operating losses | International | Carryforward Period Indefinite  
Operating Loss Carryforwards [Line Items]  
Carryforward Amount 295.1
Tax Benefit Amount 49.2
Valuation Allowance (39.9)
Net Tax Benefit 9.3
Non-United States net operating losses | International | Carryforward Period Ends 2020-2027  
Operating Loss Carryforwards [Line Items]  
Carryforward Amount 18.2
Tax Benefit Amount 4.7
Valuation Allowance (3.6)
Net Tax Benefit $ 1.1
XML 149 R119.htm IDEA: XBRL DOCUMENT v3.20.4
INCOME TAXES - Summary of Tax Credit Carryforwards (Details)
$ in Millions
Dec. 31, 2020
USD ($)
Tax credit carryforwards and the related carryforward periods  
Carryforward Amount $ 170.0
Valuation Allowance (23.4)
Net Tax Benefit 146.6
California research expenditure tax credits | California | Research expenditure tax credits | Carryforward Period Indefinite  
Tax credit carryforwards and the related carryforward periods  
Carryforward Amount 145.1
Valuation Allowance 0.0
Net Tax Benefit 145.1
Federal research expenditure tax credits | United States | Research expenditure tax credits | Carryforward Period Indefinite  
Tax credit carryforwards and the related carryforward periods  
Carryforward Amount 1.5
Valuation Allowance 0.0
Net Tax Benefit 1.5
Puerto Rico purchases credit | Puerto Rico | Purchases credit | Carryforward Period Indefinite  
Tax credit carryforwards and the related carryforward periods  
Carryforward Amount 23.4
Valuation Allowance (23.4)
Net Tax Benefit $ 0.0
XML 150 R120.htm IDEA: XBRL DOCUMENT v3.20.4
INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Income Tax Disclosure [Abstract]      
Income tax expense at U.S. federal statutory rate $ 192.5 $ 245.0 $ 159.9
Foreign income taxed at different rates (80.5) (75.0) (16.2)
State and local taxes, net of federal tax benefit 5.0 11.9 6.8
Tax credits, federal and state (43.1) (42.9) (36.7)
Build (release) of reserve for prior years' uncertain tax positions 4.2 5.0 (35.5)
U.S. tax on foreign earnings, net of credits 1.5 (2.9) (12.2)
Tax on global intangible low-taxed income 49.2 32.0 0.0
Foreign-derived intangible income deduction (2.6) (7.2) (6.6)
U.S. federal deductible employee share-based compensation (48.3) (57.6) (41.8)
Nondeductible employee share-based compensation 4.2 3.2 2.8
Impact related to 2017 U.S. Tax Reform 0.0 2.8 15.8
Other 11.2 5.3 2.9
Total income tax provision $ 93.3 $ 119.6 $ 39.2
XML 151 R121.htm IDEA: XBRL DOCUMENT v3.20.4
INCOME TAXES - Reconciliation of Beginning and Ending Amount of Uncertain Tax Positions (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns      
Uncertain gross tax positions, beginning balance $ 203.1 $ 150.7 $ 225.6
Current year tax positions 86.4 55.4 37.8
Increase in prior year tax positions 6.0 0.8 13.9
Decrease in prior year tax positions (10.0) (3.8) (78.8)
Settlements (3.7) 0.0 (46.5)
Lapse of statutes of limitations 0.0 0.0 (1.3)
Uncertain gross tax positions, ending balance $ 281.8 $ 203.1 $ 150.7
XML 152 R122.htm IDEA: XBRL DOCUMENT v3.20.4
LEGAL PROCEEDINGS (Details)
$ in Millions
 1 Months Ended 12 Months Ended
Jun. 30, 2020
USD ($)
Dec. 31, 2020
USD ($)
lawsuit
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Loss Contingencies [Line Items]        
Intellectual property litigation expenses   $ 405.4 $ 33.4 $ 214.0
Number of lawsuits that if settled could have a material adverse impact on net income or cash flows | lawsuit   1    
Accrual for environmental loss contingencies, component amount   $ 1.0    
Abbott Laboratories        
Loss Contingencies [Line Items]        
Intellectual property litigation expenses $ 367.9      
XML 153 R123.htm IDEA: XBRL DOCUMENT v3.20.4
SEGMENT INFORMATION - Schedule of Information About Reportable Segments (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Segment Reporting Information [Line Items]                      
Segment Net Sales $ 1,191.7 $ 1,140.9 $ 925.0 $ 1,128.7 $ 1,174.1 $ 1,094.0 $ 1,086.9 $ 993.0 $ 4,386.3 $ 4,348.0 $ 3,722.8
Segment Operating Income                 916.7 1,166.5 761.4
Operating segments                      
Segment Reporting Information [Line Items]                      
Segment Net Sales                 4,362.1 4,333.5 3,676.0
Segment Operating Income                 2,643.1 2,614.5 2,115.5
Operating segments | United States                      
Segment Reporting Information [Line Items]                      
Segment Net Sales                 2,516.8 2,532.7 2,055.2
Segment Operating Income                 1,727.3 1,742.3 1,368.1
Operating segments | Europe                      
Segment Reporting Information [Line Items]                      
Segment Net Sales                 945.2 926.1 826.4
Segment Operating Income                 479.3 472.0 394.8
Operating segments | Japan                      
Segment Reporting Information [Line Items]                      
Segment Net Sales                 448.6 441.4 398.4
Segment Operating Income                 286.4 272.3 237.0
Operating segments | Rest of World                      
Segment Reporting Information [Line Items]                      
Segment Net Sales                 451.5 433.3 396.0
Segment Operating Income                 $ 150.1 $ 127.9 $ 115.6
XML 154 R124.htm IDEA: XBRL DOCUMENT v3.20.4
SEGMENT INFORMATION - Reconciliation of Segment Net Sales and Pre-Tax Income to Consolidated Net Sales and Pre-Tax Income (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Net Sales Reconciliation                      
Net sales $ 1,191.7 $ 1,140.9 $ 925.0 $ 1,128.7 $ 1,174.1 $ 1,094.0 $ 1,086.9 $ 993.0 $ 4,386.3 $ 4,348.0 $ 3,722.8
Pre-tax Income Reconciliation                      
Operating income                 897.6 1,146.8 748.2
Unallocated amounts:                      
Special charges                 0.0 (64.6) (116.2)
Change in fair value of contingent consideration liabilities, net                 (13.6) 6.1 5.7
Foreign currency                 12.3 5.9 6.7
Consolidated pre-tax income                 916.7 1,166.5 761.4
Operating segments                      
Net Sales Reconciliation                      
Net sales                 4,362.1 4,333.5 3,676.0
Pre-tax Income Reconciliation                      
Operating income                 2,643.1 2,614.5 2,115.5
Unallocated amounts:                      
Consolidated pre-tax income                 2,643.1 2,614.5 2,115.5
Segment reconciling items                      
Net Sales Reconciliation                      
Net sales                 24.2 14.5 46.8
Unallocated amounts:                      
Special charges                 0.0 (64.6)  
Intellectual property litigation expenses, net                 (405.4) (33.4) (214.0)
Foreign currency                 31.5 63.9 15.3
Non-operating income                 19.1 19.7 13.2
Corporate items                      
Unallocated amounts:                      
Corporate items                 $ (1,358.0) $ (1,439.7) $ (1,058.1)
XML 155 R125.htm IDEA: XBRL DOCUMENT v3.20.4
SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Net Sales by Geographic Area and by Major Product Area                      
Net sales $ 1,191.7 $ 1,140.9 $ 925.0 $ 1,128.7 $ 1,174.1 $ 1,094.0 $ 1,086.9 $ 993.0 $ 4,386.3 $ 4,348.0 $ 3,722.8
Long-lived Tangible Assets by Geographic Area                      
Long-lived tangible assets 1,608.4       1,241.7       1,608.4 1,241.7 899.8
Transcatheter Aortic Valve Replacement                      
Net Sales by Geographic Area and by Major Product Area                      
Net sales                 2,857.3 2,737.9 2,283.8
Transcatheter Mitral and Tricuspid Therapies                      
Net Sales by Geographic Area and by Major Product Area                      
Net sales                 41.8 28.2 2.9
Surgical Structural Heart                      
Net Sales by Geographic Area and by Major Product Area                      
Net sales                 761.8 841.7 761.6
Critical Care                      
Net Sales by Geographic Area and by Major Product Area                      
Net sales                 725.4 740.2 674.5
United States                      
Net Sales by Geographic Area and by Major Product Area                      
Net sales                 2,516.8 2,532.7 2,055.3
Long-lived Tangible Assets by Geographic Area                      
Long-lived tangible assets 1,084.3       849.1       1,084.3 849.1 642.1
Europe                      
Net Sales by Geographic Area and by Major Product Area                      
Net sales                 973.6 941.2 885.1
Long-lived Tangible Assets by Geographic Area                      
Long-lived tangible assets 192.7       101.5       192.7 101.5 36.6
Japan                      
Net Sales by Geographic Area and by Major Product Area                      
Net sales                 460.1 444.7 396.8
Long-lived Tangible Assets by Geographic Area                      
Long-lived tangible assets 20.4       21.7       20.4 21.7 6.7
Rest of World                      
Net Sales by Geographic Area and by Major Product Area                      
Net sales                 435.8 429.4 385.6
Long-lived Tangible Assets by Geographic Area                      
Long-lived tangible assets $ 311.0       $ 269.4       $ 311.0 $ 269.4 $ 214.4
XML 156 R126.htm IDEA: XBRL DOCUMENT v3.20.4
QUARTERLY FINANCIAL RESULTS AND MARKET FOR THE COMPANY'S STOCK (UNAUDITED) (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Class of Stock [Line Items]                      
Net sales $ 1,191.7 $ 1,140.9 $ 925.0 $ 1,128.7 $ 1,174.1 $ 1,094.0 $ 1,086.9 $ 993.0 $ 4,386.3 $ 4,348.0 $ 3,722.8
Gross profit 895.4 859.9 686.8 863.6 887.9 801.6 782.9 761.2 3,305.7 3,233.6 2,783.4
Net income $ 309.5 $ 325.2 $ (121.9) $ 310.6 $ 280.2 $ 274.7 $ 242.3 $ 249.7 $ 823.4 $ 1,046.9 $ 722.2
Earnings per common share:                      
Basic (in dollars per share) $ 0.50 $ 0.52 $ (0.20) $ 0.50 $ 0.45 $ 0.44 $ 0.39 $ 0.40 $ 1.32 $ 1.68 $ 1.15
Diluted (in dollars per share) 0.49 0.52 (0.20) 0.49 0.44 0.43 0.38 0.39 1.30 1.64 $ 1.13
High                      
Earnings per common share:                      
Market price (in dollars per share) 92.08 87.79 78.43 81.90 82.55 76.06 65.00 65.95 92.08 82.55  
Low                      
Earnings per common share:                      
Market price (in dollars per share) $ 70.92 $ 66.87 $ 56.44 $ 51.51 $ 71.08 $ 61.00 $ 55.23 $ 46.95 $ 51.51 $ 46.95  
XML 157 R127.htm IDEA: XBRL DOCUMENT v3.20.4
QUARTERLY FINANCIAL RESTULTS AND MARKET FOR THE COMPANY'S STOCK (UNAUDITED) - Narrative (Details) - USD ($)
$ in Millions
 1 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2019
Dec. 31, 2020
Jun. 30, 2020
Sep. 30, 2019
Jun. 30, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Mar. 31, 2019
Class of Stock [Line Items]                  
Gain (loss) on litigation settlement     $ 367.9            
Inventory write off       $ 26.9 $ 46.2 $ 0.0 $ 73.1 $ 0.0  
Early-stage Transcatheter Intellectual Property                  
Class of Stock [Line Items]                  
Acquisition transaction costs                 $ 24.0
Developed technology | Valtech                  
Class of Stock [Line Items]                  
Impairment of intangible assets   $ 40.6              
Rest of World | Developed technology | Valtech                  
Class of Stock [Line Items]                  
Impairment of intangible assets $ 40.6                
XML 158 R128.htm IDEA: XBRL DOCUMENT v3.20.4
VALUATION AND QUALIFYING ACCOUNTS (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Allowance for doubtful accounts      
Movement in Valuation Allowances and Reserves      
Balance at Beginning of Period $ 14.7 $ 13.6 $ 13.7
Charged to Costs and Expenses 3.1 4.7 2.2
Charged to Other Accounts 0.0 0.2 1.0
Deductions (1.4) (3.8) (3.3)
Balance at End of Period 16.4 14.7 13.6
Tax valuation allowance      
Movement in Valuation Allowances and Reserves      
Balance at Beginning of Period 64.0 44.9 41.6
Charged to Costs and Expenses 6.3 18.9 7.1
Charged to Other Accounts 0.6 0.2 (1.8)
Deductions (1.1) 0.0 (2.0)
Balance at End of Period $ 69.8 $ 64.0 $ 44.9
XML 159 R129.htm IDEA: XBRL DOCUMENT v3.20.4
SUBSEQUENT EVENT (Details) - Subsequent Event - February 2021 Stock Repurchase Program
shares in Millions
Feb. 12, 2021
USD ($)
shares
Subsequent Event [Line Items]  
Authorized amount for share repurchase | $ $ 250,000,000.0
Shares repurchased (in shares) | shares 2.4
Percentage of shares repurchased 80.00%
EXCEL 160 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

1<:T6:SKIFI6Q$-O0W/"%Z8"NA$<%=FCJXOI+$H'/+N*8_^< M#KA\%B<,#I*\]R,VNH:I2Q(AH^-_W@LW$FE.V2ESD2VGJH."ZZU9]E56Q:]LLD79+#!M4WPH_+7OQ._ M8IMEMR/\3;,?#4E>S@?$>V7:FZW>BS]O52[-\'3$^Z*J*RQE71R+#ZUG1G$O MMR,@(V*X53_&*G/'8F$JKO4O%,L:BXYN$T!Q@X)(= YA=?EG?V=3GO'1M:$[ MC2NON'U.+&V_G''Y#P^JJ(R\D-(K">QW(F]HSP%=N1XL/+J]FTI1I?!H=C:+ M>>G1B\O O"X/>3E]Z1G0F?Y?*/52GO]1[N-]G?T7B6@$GGS]12(>BT::K^'6 MTU:N;QG/K/I2.K8))KU>,2QS4F>%Y'"XW]SM*[%P#2$AP$^T.3V67W&F=AY< M%LR[T'0_C!\ZG.P+_O9U0=.,IRB1D72*0N)/?XZZ_N_=*2R&Y_UN6\/X.'%6?8O!;CI]K' (G_$)[D#S# M*=1:[;"XT#615@>QCKYFKV$ 9N![CY'T,GL.!(@>DW@7"=.!3S&/YYO$FMY' M+(Y SU%H(1;?HO@@N(=UYW< 5R8&>@)JP)9KV?2Q9*E(J2#_6HT)AG49:7GH M!D)"SF5C0T7871>.A)XSM(#EP:WPD!1"&;2%Q#9'D.?B:B7*&G/7P#XH[%!9 M]7FX5=2*HJTNQ5$F3LG#G;1NZ@4$1R47'+FT[G%-P.>^OT0KC*1*EN,!K$JT MR<)$&W'8O702FPQ)KOYS->'C86+S&84%5MWI1N6(BDBI*?)E@[/S84F%ZPR/ M.*Y)"\XX.QMFX!P)6JD,=2?V[26#&_;6>7![TX(<+@[F=J;>M^N!PU4 MH5YVFKWW3>BZY;!HR><]_(-,2H&?,5+E6O@YKM$\]MY836?:?Q97(1X91H,J M-V.RGQOBEBOMO&C5]_9B-TXI :\_D+W.' +PN'04-FSA@/WY^T+*T")? IF&"!1NS98ARZ5L&AUORV "(:\@U MO2!L(;/ --$61<<&F3,W=E M*$80'9$N31RZJ$]K=)[:0S);AYG, 3!)%H9[#=RQ77W6Z&L^U+S-M:Q_''*V M#-.V1SVOE=,B2"$O17@#-H_H!ZB8)8C@*-J$J#R1I(!/!#5?CCI>R_<(QTM: M[AGMLAG8U,VO.?_U5"*>IG (QV3XM=_ ME3=J]3+YCU&)A082AAU7?.=K::S+*Z3+1%AJ)R4')'X*4\;<&(81[$BQJF3' M[[ER+G#R^G_XL;\^G2!Y<&OWJF2K-3&""=R:S*QSI1FPA!/K1%?DMCHWIRE. M]X<,S20DZSFJON!R8I>C8=Y&,5ZY94;3$@L.M?M>KS::/$0WL"PUDN,*$RJS MDEJ^UJP00VRXD">,DF*6%445IWPX=8\D5'08*8X73]:U&*L:=$B,2GH=_EW? M^UR&ENUCM$V"G=_7+@6)ZKC0Z1V*&;Q7'T2(RB5M.&/_04HEB/93WG"B 8E, M:4M)%-MW>M(3(%C;- 4Y?>+!,;&>7J9GC0^+'IF:R.]QO3(N*;S6(=WD15#K_WQ4I$L0U5=DA02MFZ8]00:@MC^#@PKS5R-IF8X3*L::]W#/QP MCG4R V9D$*8;P*P9TVAGDHB8,L4N2!I,U(%*^IB8&:,>!D8W]Q9G,DG7.8[ M]\X6+&:1=EQGLR;;R-3(YVNA-=$2X0NV9_Z9I4S?K1O?4-'EG\@8F>\'4T.U M'QH873[OM#,U4^IF8D50!(\8&DAZE*M/[WP,%AY2$I)9GAD=+#0L$XB2'$> M>F+4I:@<'TE9B+B)ZMP7(\>=NW(N)VE46C7U8-R"A$S3QE6NJJP-A#=/-?^% M8PLR'IR3CQBIPJMK1C2F;@71F_=S4LI'9DLXPR\=28D*(YY=Z&] Q^K[\8\A M:\)"H")O3'HQ8/FL?'?/PE6+8KP;(]WH#&CF/ G2(^UUB#\2,;0%;T]'7:Q+ M>#3H6^5$+ LH(5CI0:T%ZTF+ :X M]%-GA,'R9)"KF5&Q,=8.[^-M+/T!7^\T% ]V<"Z M&Q@VN^&&E&]S2UZ)B3^03I628R=;GMD^WTM+BHR4[1RZ5:D<3/AT0]EUL'O4 MK:.9S=P7];VEVY7>F;L!B+-A7[ ?]U5UOG"5[Q0[XC:V#0K,9>[Q/?!&,BZJ MVPC> 0;9DJ6^UU'F4C2@A[MK*S^DE229@B47ZOEKSL0GM:I'Z> QIAF(2T?\OIR_H_\_IYZ/,11M,+\[YGZL7_,_LF>.%?RM$GB0#0PC-0GK;[.7T M(IO-:)?9!?WD'S[@N+&]+O#>U<75]'EV1>[4R[MXF\]_)N>_E/-?Z)=F>*J' M#46J2KZL )]PR-SE:J/"X?$'N5S7=[B&'G+2X.=Q7=U!&_Y%Y(+I.;EL+#[L MGU 4(W.^>678Q(1D".(@ Y(4&8+WIF(2P%NXGZ M.DRL\;'%6T\'[5J_?A0HDZBM\7-[5#$]OM5T@OS^A!/M@YK!J+/L "%'^6T8 MK% ZL/>B9,E'V@VS>)@Y*T,\HX1:.I!3]:T?P>*CJ[ZQ0&W!0AK\X P$ZFK: MI2EA71TX[[ZS0F/;\\B"=^ASO>XNAV#J(C+0Y=5[SYX,P8DW"OE-O@8'J 3@ MPXC.M%%?*$GX\+:TVF[E'0-. 4;39S5HRA<@E1D12N[^1@[.+/GZE"'_P55R M:&(/XWZ"X79RFWQ-#UT*C]ZZ%XDH5^09:Q7'%6,[X NTO)OH(LU6I&J>3UGQ MHNSQ$93=91BDLHH'J0R*I-T78&1IW]HPV8JWZ MP-._A.I^06HR>SXC??4N.-\NTO$8:SZA?TB]XY\+_/:PU3W;8#VR* 0G5U>D M"Q]ESV H,"7D^OTL)=TE0$G2T"GW,X9D$@!@X$0SQ.K?<:5UGYS)"(-$0QV#A=@Y.&.*K6*3E;*DZ(HT)#;1D MU'T9Q+Y\ZU3(; 1L/026._#R?=,^Q (ZP)D&A'W06&>%2_>2)#;8N3A$K/MV MN1S"[%1*HZ/QYRP3U]J^ZC.ET93JN7'?]A6*P#K D"2X(XF_:M#4DR=Y&=6? M3@*%\2.',,5M/+QT0L:[=5.%446>-@YO-W7_/'"J<7V/#3XOW(#%,(D9 ;"6 M'"NI7HPU$=>J%O[#*"X5>W%;@9VJ&Y_>]^KFNER'6F:_1(C]=95*TONK)51 M9-I5K%_H>N=1.,)!8,$*DH1FV%B^T$OBFREHI "C[[F*[YD\55@3?EX5P[PC M6EH/PKP%ODF!!P99#?G=@P;)$4?GU*\BX!$G"'Z10&ZL"W!A!$KMS,+HRTM& MINPP"?'@"R$VVO=FEV_I8DC/D6*\UOI>'NN!8%E[2B)?^]U;X[Z1 NL>_=BU M67IW!THCBI CQ5%5T4 \WZ[MBBA=!S+7Y.C?/,DFY"#1-MS\1-A>^M$T@C$$ M.6&D UZ@/[!%[;\7)!IPN&B12O2/6N!L\"4-!^O%W\_"G>P19TI[GK_":"2/ M?SWYPAMM7GX\>^)"@'&2=3"F,_E"UF2T#TXB^6'2X\>%M7 MY^,\OGAR-^HU (M"Z"B!,-@@'E0ABQ]CGB\@F\Q704OG3KSAR+>&,<*72ZL# M..*YDP<#?(97[K\Z;#Q=,OBJ((6=!\%U_JN")%1W^"5!93)3*NY&8YI,J$U M3 @K)D"Q;>X7?P>M(?$8CY%,W["(^'MGD45;A0W4@[2#*\D/J$"]YT1O@F( M=RKX2[6&#BSL&YL]?*#BY[[<\'+D'O+IOT:,/N&1VN9^,"8J#K*@;L&=5 MI8V,R8MPY5#/H\AD]@QAP=FM_A,UP,HZ*K(_1& J,"4R%O(M;X*D/HS*C(JI M=-SCQ(?@.'D"_N1MD5Z;?\G3_L8+!HE_-,MBXQ0#3E<3S\ MA;G7VA]Z':[GA@=+(VK\KLZN^Q6FUX0BJ^_]KJ.OR-=N/S[Y_OKFVY,GSD4= MZSZ-"")N1%U435]HK+Z,9JFG7_O&%.O>(MFYJEV-/YKTY=-:\R=VMLB& M0=M5^>II]_K5T]+2_Q;T7]OLZ/^L-M_F7?[ZU<:T*_.&Q^\SZ-^&ULM59M;^)&$/XK M(S>J>A*'P9"[7 Z02,*U5'E!@>N+JGY8[ &OLM[U[8Z/\.\[NS8.N5XB]4._ MP(X]\\PS+SOCT<[8!YN[@04D>347BVL).1J4A)C0L+KBH*8?<7J,QN'/6CPX-[N-!HN;<33MGU\,O7Y0^$WBSAV=P4>R-N;! M"_-L'/4\(528DD<0_/<5+U$I#\0TOC284>O2&QZ?#^B?0NP8W:_^A.OY:O[S=#6_NX79'XO9[7*V[,#M;#6*B7UZRSAM M\"]J_.0%_'X"-T93[F"F,\R> \1,MF6<'!A?)*\B7F':A4&_ TDOZ;V"-V@S M, AX@Q?P+DU12.(^(P="9W#)=*7>HDXE.KB2+E7&51;AK^G:D>4V^OL5K\/6 MZS!X'?YO>7\5W]_E*%,<17U:']BM&_]$IK'+D;!2ET'N0.JVLQ8P/Q%>( M[U0E%)26IX.E/2A)9>Q-8BMQ<"5KR+E,%VO#1%%]2(XEDY8=U*)N!%>MG&@Z8C ?42G(4\BD*RMBI#72#E$'TFD@'?"]^.,/9TG2^[ALDPS30PCA M5?_C&Z8'*0\OQX$J1LZ8#G S:Y<*AN!J<$995B$6LI)'3RDSUBZ%M+[.697R M](]_]T):;>_DMB4=( E)2K"7WH>]5KK3&4.7C>$OA.*&B MX&7#D*$8\]#3K65-M<[@1>P\_9%@2ZM^L^[VV1;O/ M[E$A,J8-1G,L##OP*\8#PI1*62\=O&SOG MU3<5^7&U1V$YS._-JOAH7Q3(B?1;T7%;59KJU=$^;1?OM-XW3^KUUK[A.DCM M^")OV+37?7\:@:TW82V0*+ M"T6J)!7'_WY'ZB5*D:3=]L46R;OGGGOC<;+7YL;FB [N"JGL-,J=*]_&L>4Y M%LP.=8F*3K;:%,S1TNQB6QID65 J9)PFR4E<,*&BV23LKK;!HEGA!*Y,XC,/J[Q25*Z8&(QK<&,^I,>L7^ M=XO^/OA.OFR8Q:667T7F\FET%D&&6U9)=Z7W'[#QY[7'XUK:\ O[6O;X- )> M6:>+1ID8%$+5_^RNB4-/X2QY0B%M%-+ NS846+YCCLTF1N_!>&E"\Q_!U:!- MY(3R2;EVADX%Z;G9]?I\N9I?PO+#_.KB_!I>7LQ7O[^:Q(ZPO43,&YQ%C9,^ M@3-*X:-6+K=PKC+,'@+$1*ICEK;,%NFSB.^0#^%X= 1IDB;/X!UWGAX'O.,G M\#ZY' VL%-<% E,9G-]195NT\.=\8YVA^OCK&3/CSLPXF!G_[X#^%QQ8%243 MAKK"@=["I5:[@:2RSF!N+3I+_@$%#HL-^9HFHS='0&[#4I.:.E 7<6TH/<" MY\SLT(.\&"?#$ZHM*>M&D\R1A--!4SRPQ]$X:G00:E :S=%:DK?(#,]#2#.\ MI38O@S@+A(["OGC(ZNQG6(U&)\/TW]%JS'LQY+G24N\.C?V?Y3N$SSE)-"O8 MHZ%O_JT2QO.S4#(33'H28=^*<+O0UA9,0"\P%-L0%'_'T^XH8H.=9I]P[V +W M,U9*IBS08*J!VY0+"D"7LJW119N9UF_$'2SR'X]MGQ]'S3U7C?)#R"\"(659D(ILB< WS2 =:WU"RGD MN6NTQD03[E]_.4M'I[]9N*)2\;GYJHW,P.+.ZPYA_K#.5Q0&Z:=J1:S6AOK- MN(._>#Z&OGKVUGF1CH=)U]1-MS_F^+TYRH$\#*RC)P+Y3QGGC*0H*Y2^'I&R M)>+C1-VKN0B@7>74(=[Y5M+F0"U"X@(5IV"MFT?&!5TBCXV N#=?"R3*_A5A M(51$/6J[W>ZA,J_G\[UX_A\J[5K%]Y ]WR;_0-02P,$% @ 6H=,4FTFXDS8!@ W@X M !D !X;"]W;W)K&ULM5=M;^.X$?XK SK4GXQ9.NB$&9_+7.]N^Q$GH80>#R*A8'9:E2QX>G] O_.^PY>5L'*A M\]]4YK:7G6F',KD6=>Z>]>X7V?@S8KQ4Y];_TZXY.^A06ENGBT88%A2J#%?Q MUL3ASPC$C4#L[0Z*O)4WPHFK"Z-W9/@TT/C&N^JE89PJ.2E+9["K(.>NGEY^ MN7VFQ=/C\NGA_F;^/\\?%_?R!EB]8^'S[^$(WMR_S^X?E1=]!)TOV MTP;_.N#'/\"/8OJL2[>U=%MF,GL/T(>QK<7QP>+K^*>(-S+M41)U*1[$@Y_@ M)6T$$H^7_"@"9B-*]6_!).G20I=6YRH3@3-E1E^,M+)T84&OZ4Z5HDR5R&F) M10F".DO_G*^L,Z#8OWYBT;"U:.@M&O[?@WM PVIC(ZE=92-!Q@-8HCG(&#"K9DO)G5*4P:Q:/>F(:#J!<#83J(>PFN M8\C,0!,T2N/V7:K@ANMZ[LC?:U5Q9+I4HL$^\-H9S29 P84-N*Y5GJER8_WY M7*+!;'6>D2J@];5AUW0:]48TCF:]*7T6Z1;Y-/OW"F@T'L**X7@,FV[;U9UR MVZ:-2&-I&,/RA)U8ZK7;<8AG0RQ-)Y!EZCM3AVX98K(Q')0D2@ :CT<+=9#;RD8NZ@_$ MD! V-039$PT^&,J56*D<7$/F;HLJUWO)+"DP@^RQ)-DKCI*/VQG%34ICP$]; M4"-7L,K2> *=^(M.4R3V!KSJGFAVX@V'AS,@C:+>D)Y1]<*D6W\DDZ\87R&D M@O&92R-.OS_[ (,WP3PKGE MK8VG/[<;\PI!+^\%8Q]_9N:+MQ+FBU7.>\@ S)C1G5"&7D5>2RZ2#&Q_%3SN MH'X&V3&,/,0%L_>K= @=R3<.JV36XTS$UAT.(?=KI![6H;[9'H7R(.9M-$ D MCS$6N=J4WMW6;J"-*.*4'(_E.@V^XM9S)=46Q$:=#5CQD)Y\$D0C<$J#Z90) MRM1'J4T&GD#CV1@Z[DM?_%W?2KCCB'(/!:DV&9.*SB8);&W: J5;83:2G*8. M#EO'@5J*'!JZ'?BK$!>5[SW9C+( P#X#[XQR'-4U+ZBFL^Q;1X#'G=_)C4H1 M^%19W^",W C#!"4%/W&@M(C 5CKV4AN'PTC7JZ0*#^AQ2GAQ(518^6=54%VB%?"V&W=(>NB0B%US9?D.]:Y#] M[F8F_ZBGXF\:L"JA4 .U.9BVAS :LSF' C@D$4P4]0P\;"\)T^2^1#1E4UJ\ M-?%[8^YF*->8&\F\T#7WN."\S ZCH4 KK$VH) 3>=\937IS3$XI9>"*G;.2: MQP2MC2Y(MSM>S/>(66@14]]Z#T7XJ,M/7ICS:KT$%^,ZC#;VEA,G?$N$QO=5 M9D$H8"MKZV VRM*;B\A02->&'WG(J!9T Q=XMB $/)="^T2C=$;Y\>X/_!<\8SB?#GE4XL=%-$V: MP1%-9B#6&4W09:)3W4T:CR0*;3VMC?%=.X00;0DMS/]&?T*ZD>* ,%=Y9KUH MCEWJ _*MK2$@YAM8-AO?2 <'ID,?WDDT0C%\C_W?RA][D^$!:SW%ZC*S_*:1 M-G2PJ7_)/#:E_/U\X4Z-4_RF1E6-N<9U$>P-6"=:&_ZV+P.][[W3]D^^.?!N ML?%?5A9R\"=\?K2K[&PO=V]R:W-H965TK4ZG^\--IHVU3IRU'0K?_MXX;2B"HCVI M2FUGWLR;G\YL;=T/7S '>BQ-Y2]Z10CU>;_OLX)+Y1-;#DWZI=-6;S^+9G9O/;!.,KOC.D6_*4KFG*S9V?=$;]K8'7_6J M"'+0G\]JM>)[#G_6=PZ[?JI?#\ZNQR$>!OS2O_>AN.A->Y3S4C4F?+7KWWGCST3T9=;X^*1U*SN$<-;X8,L-& Q*7;7_ZG$3 MAQW =+ 'D&X :>3=&HHL/ZF@YC-GU^1$&MID$5V-:)#3E23E/CB\U<"%^9>; MR_N;^UD_0)><]+,-[JK%I7MPPY1N;14*3S=5SOE+!7V0Z)BD6R97Z;L:/W&6 MT&AX1.D@';RC;]1Y-HKZ1OL\8R3+TS^7"Q\K%6&EC0Z:_1$95>5' MI&KE EHCX&2M'!>V\?+V@0N=&5E!C/AGHVN10DV% BTD32H*HVT*[$I/3E6K M:,39$B^\IU"HBH;TQ,I1L$A'7$*GMR6#**UAI"!=9:;)<5!+>WD1Y^)O1'S4Z%9P:9]<'34N0A%:T02SD1BH'+!;NN(.0Y/&O]PFI* M:W9,!Z-!,D%;& ,*1W20GB9GSUN1E:/!\Y%C7W,DG=:Y[" M\55BG,RR8[L\1EG!L&<$XH#.QDF*O^D@&;Y"&$2N*]*L<4[*KD9XQ;4#0A8$ MFDZ0KG>AQE:K-B-;\&F:G-)DBL1^LQ)!NQ\N',\@"([C9$RW2AHHOH#K[^%4 M>",R,?-[HHZ 0F8(2ZA "6*:X@&B6(UH*-:Q&M,TF(&=H?]^82WE$Z ME7WTIV53JZ?8SS0X-[V7*M)S%V1 K MNG;V0>>0V:TX_+KNW$R#5Y4#%G_'.K_94^>Q?K['RX_S8_6 (*_XS5D3 QB; MYA#A.*%),GH-?&&<)/4?\)S2A[>F=W_GWBO9K>+MCIDJ"MHKL#OM/B NVWOS M6;S]^KA5#F/0@^X24&1RTFN[8+L)MHZWZ,(&W,EQ6> CB)T(X/W2VK#=B('N MLVK^'U!+ P04 " !:ATQ25G)_9$K M[6YZ2^^+U_V^2Y7IO2*ZG%1\M?<;NZ%,NN;7MS;3GR2BZ6GB?[M=<$7XDGX+\5'BU&_ ML9+)7&@GC696S&]Z=_'K^Q')!X&O4JQ=ZS^CG:;!^^RF-Z" A!*I)PL< MCY5X$$J1(83Q>VVSU[@DQ?;_K?6?P]ZQEQEWXL&HWV3FES>]28]E8LY+Y3^9 M]2^BWL^8[*5&N?#+UI7L&![3TGF3U\H8YU)73_Y'G8>6PF1P0B&I%9(0=^4H M1/F&>WY[;=OWW_X^O;I\^/;#Y^?KOL> M!FFZG];*]Y5R_M[*?V&/8FTM-)+X=A_[V;. M6T#D?R\X'35.1\'IZ._E]+N5JX!;4;9VPZ0&^+#L=LO<,[\43&"'9LX$3Y>L M$%::C*V%%8P[-C<*7>C83]#.I5+H"_?J-?RD(I\)VV1^?R:>LE^$RBZ\N4 C MD+\-N\N-]?)/D;$'XSQ[9XUS[(L&,Z@P^PZ,X ZG?\48L?[,I65?N2K%CS-T MS_4S\Z ,9*8P3B)+9VP\B 9X_/M?DR1._M/Y5R_%@T&4G!"IUNY67"H^4^(" M+'CAN#KA*QE%\0E#]5(\/"D1EAY,G@N;2JY8P5&\9OW45N'C,3!BH$T>FVX9G1 MF?MFH'%T=73N#E7T%S.>/J.FG<"FUG=&$MOU8:IG* NEOF4A@8#_T8W/[ MSS,V3:@2J&V,>-O%G@['V-D9NYH.$-D9&X9?1)*\"K.4ZL_HY90Z@BHW)YBO M LS1V_)%(CAGLPTT=2"T$GO9]NPY<0#4#_M]CR!>-^W^V+1[IP>>J ?V&O=T M2[=6.LS#WF &$S';"&Z9L4P)UVK:;8->3J)1>$[Q)!T^]XB^5O-+:\K%DHW# M\!")XZL)*CN>7"+'[S5HOJP2IXUG&1E#AIF3>H$M->R6$98.\'IU!:S%DTYT M]6-;ZJJR=YW$$XAR#J-R/D?<N6;DC3$4$&K@J7(>.(R'8KF& E#!/):<07#"_ M""R\9Y2.G@Y$"4=4%^/$#PPNG@*_BX45"]0F(XSO;"-97BR,W81(*+=*Z(5? MDIG TL&UU)E2KP2;":%#5*$H4I>F='M!O7QHXHC\E< +1P!T@MAW5'3T).S)[EYXO&@5R1LDLH.!N/I=*XJ\+P,7Y67"]04V!2:;+ M4""Z#%4WOCW>+*Q<0555J"G*F9(I!DMP'V! EK"U:#\"H NX+KMQ\%T<'/BV M(C465V*2[Z$.>G&!PN<=4SUF])8&=H9F7'&="A:N]*#R<&SOD?,A?P?\=;FU MON3F GV8=7;^P*W=4',WYXDX*0M^ ^6=L4M0:&VQ5?5#2]IH7!'MLZB(0QRH M),3A"=UUJB[8*\GIM.*0'(?+$RP,V8=O^2$S$F?/X6FYJWJWT'CSPO9+L"Q> M;B66,T$UDSIX:+';KBA@9AQT%*>OCFI(@S*?=\BSX-(,SB1.# M7#@)%.!@;-$CT2#$' <52N=*8:-.OS1X)58NUMSB7_;_ MOPN1O^JT\1U&R5I92M,R+U6 Z$%

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

#K^CKR# MM;<'+._@57EY%#HD=F_.<[P@_7P@]9^.'_!BF"LMIY85U40>R1G,$'>A[LB[)32N5=D]ZBZU>C"*TJ=*7A M-DEM6F:$UNM"!?)-R++4M#8478L=TND*X.25+13962@?07&BF$M;IQ6DND>] M1J_K6GEM:Z$>R=_G02%/<@6UOW>:8(=17K6=AZ TXPA9Z1HG8]]M-8.LVO) M2H'KTM#ER7BRVY_2GC9MH5MLR<9U%G"TIL/%HO"4"H1'9UNI2^"5 IAP[N6; MX+!1F*Y4\ ?62XI7G$.QT8V.FY[\ ^=S;71",+I&?0]$H7^,/H/#!"I)ZD$*' M8H6!FM.-%RNA8:\,0:$SL6.5,^@S% PDJESUFBU8 [VOLW#%+VP+JNKL[3?V M:%W,&&-Q6U6*F\G+A3VD2%]X87_K[=U3%1YF!^/Q+I=P;]..2%6+G>F9V'WQ M_L4BP$B1/X!V"0)CO7N3;+)/O]/]YP>(YH@-)&5OX0) VCO(SG#V,#O<%_>=D MO63$07 M=XZ/3[+CU=(0M4"E2=B9Y9#[:RFH#/*@_".S#.+W@.$D%2N5O4&2]=V\WPPI MC8!L[3PC .7O48U&3,4>V2,FD_V4(-_ 9DC'%Q@,Z)\\6 &,#32)7/4@]>AR M]O=LJ+YB.D(=HW8\7\5ZLP*"J?4YKZ'HD97O8/J;?X'TQ#6J!V4VJSVH3E%( M!UQR6\O@Y,5<@RDQAJ#@ D$T R+P[Y2CO>H2USH6K);(@@U-FM* M0EBYS=F6Z;SNI7WF7BZLF36EGE MF35R GT=/9D([KVS)8O 2B8S-%S27TEB\34E5+;1DS8B'$V_1$C^F4H0_,213( M"* W<+#6<4;/GRL<]:+T9'SV/0:GBF>C%*)0(K3#HF&D: F3&V?I-\C WNI;AP9 M]A,*QXL^?733-7^[6A:<>US,1C_Y2%/%TR $?G@1UNQ;7PJCC0\P'F#H,S,( M;B+I6VR]NOZ2G:4/N*?CZ3/X%^EKPL:H"E?'VHFOY&PO=V]R:W-H965T -M&# MO+R/N ML4H6O*DJ+\;#X=5%)75]]N(9/WMO7SPSK2]UK=Y;X=JJDG;[4I5F\_QL=-8] M^*"7*T\/+EX\:^12?53^<_/>XNZBIU+H2M5.FUI8M7A^=CMZ^G)*ZWG!;UIM M7'(M2)*Y,?=T\[9X?C8DAE2IMU1?\.R M0Y:Y=.K.E/_6A5\]/YN=B4(M9%OZ#V;S#Q7EN21ZN2D=_Q2;L'8R/1-YZ[RI MXF9P4.DZ_)9?HAZ2#;/AB0WCN&',?(>#F,M7TLL7SZS9"$NK08TN6%3>#>9T M34;YZ"W>:NSS+][[U[_WKIX_/+CR(TY*+/!)Z M&0B-3Q :C<4[4_N5$Z_K0A7[!"[ 5<_:N&/MY?A1BJ]4GHG):"#&P_'P$7J3 M7M0)TYN<$E5J*WZ39:O$*^WRTKC6*B?^U,Z4NI%>%6.A:UKF6I7 >#^!$W@E= MYV5;J.2EKB%Y&]["O\5FI?.5\*"V(%W!2^\1%M:L,K. X^)MNJ>26U'HQ4)9 ML;"F$K(R+3V'8Y'7@1'R.['2@+'5.4[,C?/D1=IEXLU1/G .,7!GJD;66Q8+ MV^EQ+MT*#M<8I[T;P)_S<)JL<0[V6)R;*[V6\U+AO:[7RGDFFBQNY);>#T2N MK$?,HC>V!:>EEG-=:J]I+Y&<&POCZWKI1 M$6PABU=J4:SP2N56%]D(NK6+M M9L$&TMHMO>Y5!K;<*8TO5:VL+,NMD$UCS1>-& ,\LNH#@0+_O2$B>.16QOIS MKVPE:ND!W5,:E*4SO;%K0S2CU)GXJ)3X%8_$:,@67[26-:?K$-\I4.)?#X%4 MD$-:;W8+M*-(" @70CI>V\#>8'XE/<)R6T*=*IH':R 3XG()-6.Y \3 22,U MOX KUF[!ZNY,LA5D)S!F80:HBY?($-7GRF^4JCNL-M)ZG6M !ZF*;=(!"0P! M@U[_H0*#NFY:**MU@9]"D68A02(WN0RTT[4$4>6>BE_4 M6I5B]/>_S<:C\<__:@VAOV.*=,'$0@Z*SX//Z0)&8]]@53C218+%+%(>1\IO MF>U!!#ST6XO?PV&G3AD$*T@+.>842 +^E68*A895/)1*K-3=77?J))[ZN=YM M[3374P4LX*9P%G@,1Y_YMI,QM\6#%'#PQ0*4GQ.(4=A9<%' 1+ MR4(<:* L41)O?:1(-JPT',KFJRV?R>$J.9"WD7Y.[4+J]2N\/PB#D9G '[D8 MT4 ($F0XJWQ@THD5H#\G+/98*KA@*#J/ G@0D7H^('Y0(KS'Z66M%X !J >/ M_\:S,W$;8$,AZY<=;L2[L <.Z462^3@@?U!Y:RT!^26%8O:3!-QLY5"E]>X2 MW>@'=R*8!9T1'*KDX#2&U!Q NX,Y!U"P@!61Z%4U!QB[9,_"C(>C&_$CQ*UT M6<+5W4]/CZR,?M=Y28=;\90_W>(C>4S.T3,;K*QO@5\;UWQ:]N MUU*7I(AS..FYDXS[/J$\A>+J>^%1GO89J:>\0^:"%8 MJ5MV-9QEDX,[9OY\+O-[*//(GM'E*+L\N/N4+J' MC-*4"-AB-!HE)_8G\]-7RL(X%+9V!\X2-=(U+#.;0B]/Q&QVG0WW;3887H_P M+O6 E&:Z=G+#1 X>O/H*YU='.;^";>&)]9*4S;4*4E38F@3QAUMG5Q H_'P2 M"?6,=8\G$Y+R /+PB=.@'F;7M&_$OQ+YQMGTKP!Z-$DLP3=?!_1T=I,8.]Q] M%=!3XGS_[ML ?4T:@[J2W>!S)M"XH2VK4P)S4Q?)D>D67"/,5@EQOP7] M5\#"X?UCV >#U\>XOOZ3R+\>(TR%GT\"G8ZG[N'XZAKN\ TY*4?ULPPES\-B M-3_%G9F7>ADNR6*T=JNDI92*OO4O)2->M2N+!R@'EKJN20!P1:IT=H2Z\,$$/^TKA/GYTXK9H-"B@I*TC=JP )10UZ"N M(P+4,:FP8T&E&=:BJMGU*O J:QAIU1Z-W1YN1-$Q 9NHSU^U7-"0[0>/*WC'[T:Z($ZH MEI]PE=#)&84I5"FW+ MX(,GQ!+6-:8C#02RX.B*1U5[(4Y)13Z1=HDKBY)CR M#U3Y$$:ID\/>!C$S=B$1-%1,/V[V (SO1%,6$M_K)/$1F2/I+0W0:2>(A['5 MWI>,:U'*>Q64UKC%P_1V M-#\.1'6DLAL$]AXFY(#^_&2.IS@@[PGTW)CM@YQDX2O(,Z>>C\91-!Q":V6+ M<\(:-^,Y[:>>DA09-'3XE'I#:DJ!(+NE259=2%OL3H"AX"0\ZJ%A![<5Z(OI MUL2P$\QR'LS'8Q8X TFX&W=1@YFV7[$O_:Y^>4!@[0R;V)3EW3$D747V=A2/;R341WU[H-DN/9@ K /:RA#-91":]*.56N: MG_-V:(+'DKO!$%FJ'P9%<*C' ,(1B0ZR8?JB.@>$VN-5KU/.'-"0(;0DE$QK M<[7',]JQ!/.7!\$JNPW #-U 82(J3^#Z"E%@CB)!/FM5B%K MP/SY_8"KY&#\O6!8M;X%-#@F!GH'\'Q$1*$R+E&M E"?:R!]@XC*][ MD[,L*681U7=#AU1AB!4D?K_N^)BB2V?&5L1N%T!I*L$Q$P\V%&/4EY .9G3 MQX$@2&Z-<[O5;B.;9 5-L61-N>H!7?6E"9\;,G&+>%,DQ7ER@N49J4$L^F,W M-9I+6 \N$+[121_'P0=!YB!#/V#@JYKI[?2HB%0N='&N.&6U[O!>B;'(.T8Z MS('B@EW$/J@4,O'/MEBRRS$'55.:;7!(+AD:*B$ JV3L&$HH+IB2E$NJZ17U M,W\6L 1(#N&0?K>2O[K4)!6"GR(WB:/.&DZ.BH1K',H >=!J+(NZ3R \V-O_ MD$%3<(3D$L8-;AU+N \W=U#.N0LYNJR8F6)LF0^57IC"E66I& M%1W'(4P*DLB2P16(H9",R-H9,@%/%"!+V[N[O0R?=IEW<:Z[_]7F!\ I1X&& M H;Y1#PPY?J1REA:2Y(S$C/Q/F8K$)5%P33XTU&Z0[N46MM$D?C8+OZ1VJ%P M5+_TQ29RB@J*/W602_4E,K#'TV)@2WI:QE&V43F* D560_O3JG[P;&-I$V+^ MLD4(-C9^QH$679?VO]H)=.$OG9D>M4KKZ*Q8@\B]4G_#'YZQO',9DIY*9.I/ MX%*RW)*+&=I'7VAA)6E+0\4$,=[748-0/$'IH2[J.-XKCMJ''P).U#@_HG%/#MY)B_[&PO=V]R M:W-H965T X:>N# M-BV2M/MPL ^T1-M$)5)+4NMD?_V9&4JVY/B2+':Q!T]P7;I2B1Z>='H-,J).SE?.)QH79YG?"[N MA?N:?3'PU%IQB64JE)5:,2-F%XU1Y^RJA_MIPSP6%XUA M@\5BQO/$W>GE!U'HTT=^D4XL_;*EWSN S5%NG4X+8I @E/]Q]_71S^W#/1K?7[,/-]?O)[7LV&L/RY&%RMW,*R&Q6+N,Z@!;*N! Y+@:_"O1RO112P;N>8A>VPO8=?=V6 M+O'K[N1GY!\*7HK*7HD1>^?ZQAIT)B%!9%UDAE!0AAD)E7'C(C R#$"!48(L<\ MX91SLMQDVB+?E1XCTH,!C$4Z!:XEE#=G.J>L"0JF,DF T!XQ2$*08M3:NG#N MDIMXK5H$D8: M.P-ZQSWPW[0IU&W.X#1V&A;\8U=\JQ"T6VW@W;QBS:8@2GU M$E5R?)H(!AG?>E?#8J(CKQ]Z<\:E86#N7*Q\I&=5R%2!8D2F3>$[Y 0"6)W( MF/PYY0E@"]R+VX(:PL&I:,!>XLB MVJOBCJQ%29Z9?FVWSZ"%*18?AF$G_ 5&7:#; M[Z\-TG8PQ/.Z<.Q'R:EJS]FC*#(Y:@XNU,0LJ1"""*>DPB#H'<:#F,T@ MBM#MT#! J+Q5PCG^6R6[,;<+(JF4B\/@*'&P=JQ_;@Z"SE%MOG/0X:6/ MUS2;S_65BJ O1,3*YQ4JZH M3,/\Y_&$4?9=B=N\(;UP^ 72/4APM,[26]DED,GD3 +#F=$I)J<\Q2(*$\B> M2N^$Q-HKU2O84)@3:->C>L&M/U$&F($KR1F'4-*$ "% A%TLO=J2P)8GE%L[ M0P)-KQV(1+F"7:$ (/\\7I;D/\ M\Z9^K?%N*4%#S74(N=*"A^*YV0F# 1H1_OL@4]$Q%L98Q=X@&%"D1<_9057G M%%%()'TP4*>'.OTG5X)U^I3QAP$;.:A>+C?2/>&JV\YQ+>!Q46]\K[@$72&( M$_"6H055;UR1)22'[J#W2]@_ 1\6QB%O$[&!;(J^?N.;L'*=G.0#/4<+9-Q@ MDJIWJC4&5J3R+5OQ'BNQJAPY[9?+,0.OZ M'FP!RS8<5I'3&6ZVN.M6\G"0^0[(YZIC!AT'(2;H$6 (&&U S=\@5;5EQ-O MX;;QU5+W?7UM4[DZW5XY=K5D:/I+F2TJ'C,;K@,+!EM5A:\ MXD(P:X-60'@L94 M/7.V!\QGY$ST/!FH['W*_UZM"WW)=6N30Q-8')78@VMNDL=EV1)EAZ$$I&BX MNCLO>A6-@AL%L]7F;+UQAJ'3_S"E?S MK!KS;=6XP"5U#5C^2R%_M B%]/E_&Z$=N.OWR@CM@9=P/ 1G_< !&@:O?1_R M+$"!Q;\3H#THE3]:@%(_CYUY*62U14.\1E2\.;00T$6!?%#4.N";5?OFSWK" MUZDKTW#VYJ32#B;KCM0E3VL0@LR->B]/T32N7>PP(;"@@88@P#_!*9:)[=76 M1[0/6>R*ZOUN+&-JAKP #*?01 MJ79.IS1<" Y7;MP ZS.M7?F !ZR^DEW^#U!+ P04 " !:ATQ2TD>?50,. M #U* &0 'AL+W=O( M+-U+@-2Q9"=QN[9 DJ9X'=J^H.G;\# , R/1-E=)=$DIB?O7[W='ZM/.1[MA M 2++$GEWO(_?W9%^=6OL5[=4JA1W>5:XUSO+LER]/#QTR5+ETHW,2A5X,S'Q\F$M=[+QYQ<\N[9M7IBHS7:A+*UR5Y]*NSU1F M;E_O1#OU@\]ZL2SIP>&;5RNY4%>J_'UU:?'ML*&2ZEP53IM"6#5_O7,:O3R; MTG@>\#>M;EWG7M!*KHWY2E_>IZ]WQB20RE12$@6)CQMUKK*,"$&,;X'F3L.2 M)G;O:^KO>.U8R[5TZMQD?]=IN7R],]L1J9K+*BL_F]M?55C/$=%+3.;X*F[] MV DX)I4K31XFXWNN"_\I[X(>.A-FXWLFQ&%"S')[1BSE6UG*-Z^LN1661H,: MW?!2>3:$TP49Y:JT>*LQKWQS\?'RPV]_7%R(LXM/%^_>?Q&7'TX_7;TZ+$&; M1APF@*Q4=3E$LG+HI4I7T"AQ"JD2RN)3N+'Z3X5B4C,8D.1#R. MQP_0FS0KG3"]R3WT/JM26P5_*L69*M1\<\'&$P;!E-F,/VO M5?DS=,1;B%RHM!9>7&:R@+;36VE3)S[HN7*)5D6BG*!@+/'OR#]YTG68M KA MM.+)NA!_E2N)V"A2D2A+<\1%91'R>)B8JBBM5FXDWA>P0C0[$.52B7.38\X: MWDD3,E G56YP @=B\*NQMP?BZE:7WY7-B-&>4TI\,J42T_V1^$-)&YP&2TQ4 M?JUL8W;B^D+L@4RNLPR"NWUQOI3%0A'IE37_1G!WF)KK3"\DA?M+Z&FABT(7 M"V'F8@TN8E=$XZ-1C,\7)Z.IN%+V1B<*ZW2E.!Y-!+U[7Y3**CS@I^/1$?Y? MB$MI2YUH+)M>D%:N*^+B1(01$>:>)F4EK9:9R(QS(L:D&<@UGK:2&BL?CX[W MQ=YT%.^S^82$.Z;LDG_^TRR.XK_02PPYKZR%*=="W25^N59"7_[>L;D,3&&Q M("PD&HU)@=UUQL>\3K_>5F-SJ:VXD5FE:#";2#JG2K==7<<3IG),3'B!&7"X MK&PA@@N%V8(&Q"1%OLK,&G+UE12/9O@_?H(:[]?7DU5R##FB4330R,D$U,.* MWE7L;5>E+"LG+A_P(LS88UWN\QUIL[:<7[@LNSIE)LSB=W"P<\_'>3X@< 2W M8$I3*&M??$+.E3E%F8->$[,H]'>,!UL*,RC(F4RGDD638 I?9:!_*7[CE6:F M6#R'N^8BT_):9[I$L((\L<$',8'9DBJO,B;B]9,@?*U:$A#<*/;6 U% $NBJ ME'CZ)C_)\05BF8"\A0@)TBPHUVX>#X MC\474X(^J?4%69ENCD;3??$%:Y<=J;=896_G].RWG7V!FD3(+'L$Y6XE5A#% M%,CR88K!9ND.FG(U7*Q=?82F$27^T)"(DF\ M,]1DKH^O+Y^"R)0,>OCI76B78717>)"E0-P.I_ E<7&W\JK;CBA[$44(KE.^ MPN50'Y89YV\?[2'],'HN*''5$-I Z0E-/LT-0.>[MPG4-'#M"-Y8BS0<.G!P M5AYATLD^76.^1B$6GJ;X78X.4M"4'9Z(-(IHP]FKQ#N'DLF28Y/\C9SC%T$E M2PFX3KRR1)+1I_.>EBKX)Q)XBAG65(LE PEJ5+\LY.$EO/$&-F'-R?1&.V.1 MXZ\PT4(M0D+%:V*. M0)>$H9O>VZ\0%X@F#ZB6U7F5BP6L@7R@&D_@LJ0N1E##5):1C_,%1 ,]LOY2 MHS2V.H' @6P]V]P$: Q&P=)^=R3U"FB*_%%*NR"(@^\G7B<8ET ^6><14G5' MLV$UK8"0 -JA<5)S!N:'S\$ M9/WJJR*+2Y&;5&6\.FL87\HE2@ M/1!^DU3[NR\WUEE72 XW*0H.%EXOC03NQ7*\HJ97L!ZU, MTBM9KJ 4!#'5"H"5$LS##[SX4"YZ;Z>XGGJ&ZPFNY](M MFQ)!-Y#+H$/&9](Q$_73KDQ"".@4#.RKAH9NQ /\]3*X7^?EC%_2]2=5]7B: M&BK.YR/U:#X::O*(-?FBN3Z2<:*@GTES?

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

I8KJ;J6V[*;J_[)\<[']\5'TVK]'8!5G6J9R) M$&0%:1(@KL]#T =3L#% 9OK6P2&U7\?S_2 G*0AWU/._6G7?NDJV,SQN/R?\DS@\(3# 1=HIH/T,Y#3Q,[(:?,#A M2[@Y!0,='4Z$X&B?T+ %8'_A!25B9C3YJV)<(HPO$=Y=X$\"KY8P:+@7O)NBSYGAX= N^K(XCQ;;:2->$I M&VF!XR(+W#T[E-F@M>_=MQ/I:E8(,(Z _2FI1;!:B>8LW)XV9[NA'EW6CI[D M*0Z;2749Z=K-J/"+C0':M]V!#C.I[=E7ZM&#=7KTX"7JT6#QK=:CRT.Y6I?6 MS_O5DX*C('F897 WJ6Q9RWAJI8\8B8#5\98YM*@:GJ0Y6YO .T;H!0PR M -ID7MHC_BY'%HX^GWPY^GIT8GT]/#GZ>+3_J RQ<8N9;K%^XQ9KW&(;N,4> M!SUKK%$%>W:,M_W?X\^'!Z>/RM%,*&'21.P787Z=Y$.[1(L."HRRP>OC:#T@ M=]2]$6]P[%Z@+H)P 71O" N4SE!TPG%Z[*;@XR*\"I+RHBG@06:GR];6N6G M*X.$-H]3 */B1\V.F<$VD%Y:5A2"OHR+*@4VHV.Y1ARX^*35YFO&5);Z$1KV MNT5\_]C_^N7X^+/UL^31C]P$1GG$RW08=-H]?O@/K'Q/3(&-78@P(K;L)=.I M3#U6Z43-\8*.PS*\K0+$U>U @: =HEZ<%1[.Y@P*? 7<,(MD+LTLAVM(!DX7 M31J>?VG:UA_>[]>R*_:!OB-VG%& _TPY>GYMG[1+-T\8@\J=AV=Z2J68Q1?,V5?GLF8 MQIT"@BMKGIF2'V;(TN$L0^" @ #%F8Y?2Z(L>)K>Q( M+EF<9G^W\ ?LCD*_PZZ'U7T)MNEN&*YS-PP;=X/A;J@=Q(+/(07RBM'(%O@\ MOA@?+Q^E/)SX7) 645).26SZ7=^#!3J'!Q9"%NO2 MD]K6;Y(=$C4]Q]P$I9:7N]@Q?BRGRHTO*3-43%(;)+;45W3@]M] MZQ6 >Z#'UM+U5\Z@/=*_M"A8)#T._>*_T+@A$^A@_\3Z)'UV2I/&"NL$.ZUM MO=Z#:Y\.W^^]T8%GC*UX_RW"E!/Q6$%S1BT==.;[<8:[L*;JG;GTSF,X]C-6 M%I'I^'1)?3].8D"9"T$&GP%?]"JR6S7Y,0?=@VT\1003S 9\4!NHR6];=N0- M&D=>X\C;T?RV*U7A7](DRW ^>1!N5K!R$U9P'7Z^VS@-;K1.GQZMTJ?=4?]V M^G2_LTZ?OF+ACRK>,2WIC,YP1F=(NK.J=A$H?$ %1=8(K ?QMQ+]6H"2)$I9 M "G9=10K#TBRZN5P;^%QKM2K8;?ME*+6".!A?GN&OV&L,,QT.0"]\.#P\^GA MUWU\Y5DJIB2/BRA7>K2PG/;07/0L"<%.-A/_UBW[]#RL- =:ZBK-1KRA;W26 MOV%:*6:.4CTB"8H0P#^VO")-0;6?@Y;OT?1>*T4G:1!A+)O5F!:!FWRQ/B#/ MF4IR>L.+1'<".I.2+$?E-4N\D!0!\AV4FNE-,DAW4RU=$_V7@#0(DE_(EQ(Q M;/9]D'YAEBOGRNN]DU_^5TQG[_;WWEB'8$W%V14YM=OC-N-UW&;\0-QF9]C+ MHO6NSX-LVSB[@H^L3AP ZEO('6B!]9U^ET3_G!,C0#&WM5JNOK.60#1)10G8 M,DC3:""BY6A/Z!NX+'B!8/MADQ@^N>G*)97[-.R$>G9J5J6O<,PE"&7DXU*R M)(YE=&THJ-' MZ&!#QL-O-' =R"4OEK9%VSM5\\NOIU_T/1__O41W-"I1<@)Y5F'"%<[2NQ&B?,EH[ MM4.NG=YB#KXZN.H]5ZLNSR3)835S/ *.'D42[:8(71$ BGQN?0QU++MDC&10 M/7V+:#4F_D:XAU:E3WD_)41F&B)1!1%90H3]WI0A(_,\DLQU$+U@8S+%1(!( MGFE#LX4B]%6OTV_WZB[R;M?XQ2_([UQSL-?]YE@0%5O_+( N'+=E5@<([YS3 M>L19*IE;$3/:GZ!MVWIV48+3V]1;HDO,..3ME?UQA#ER1WE\&2MK6B936YR27 MEC/2+H:]W6+.H&=1SRO:Y8SQN/8>Q:-T7(AR7XAY*E:) M$GW5,2I7$Z?H%!E%BU.?+4\+FN%ON#?6J.QBVQR5)S%)IY^('=KI(SSBH MI5$@"L4D!-HD\^Z?1:@D"9P @7.A@>-5P/%JP(DJ MX-2(4;MY4#KA_,D24AV P3CD?5D?3JW=4SX!D.J=LVN0R M4]!0(%,@6FVP1"!,92F<,&VPM$YQTWCR655OSL>!5 ;@W\&K3- MHWC:I7-7N\I!ZT+1>T"B!Y257T08OWG6O.4#2'=#I*-ME2DH> H*B UG A2 M_90RU7NJNE3[496IIX]%Z^U*8BK*?GSZ^UQ7)*#VJ64?LOE73K]*>F(;S^VT MARL%ZTK[;C'T$RY^I93?E32AOF5M&F3M%EHT\[7AL/VN.NNO=QI.VNO7?7:<;OC#&_UUJNO];O=>UGK:-.W M/O3@LMT<<;)$W9N,.!EOLBG6_1YF6Z.-=O4[.FBMPQB+(W1/;MYIUVD]]ER[ MG4"/S>"X\0"8'#)MF(W]>^E2H)S_TZ;7CMKN;#YV]Z>X?>9Y3@\4O!(O[[?%30>('%E-/<(@\ MAN0L\M.4F9]KQ?\SG03>:0^>Q?#W9WL\_1TZGD;QO>[ /B3[7(W)W M[8CNE0UM;PSK+M_Y$K0[BOJ\,'W.N?$0]D:G>VB=SFUW&IUNQ7Z&G*JRR%+, MD&ROO2(N^:BG>4I-/+FH)5P18'[XV>_/VH&T#0#M.'MPG)O8?%L'S]-PI#:$ MTA#*J.T^&SK9@A3^&Z7Q['(_X9W.'%M?+H5.FV!E0%-5"^KZA:4F4V9;*=U2 M ><44$YE?K%*LM:=Y;D7N*4Q(779F).?ZL,/2H$-JMQ>!5X9Y1D6'F(9<"P MTPLU*XR2M'7I7RXIF03[B\%&O"1.IJ%'7:[46,TDHT*L)*,&_<^A-&?]H9XM MN_ZQWAY-_]\"*ZVF$L#K MMU0%JLJO7W5Z"TTHU..9!)RBS/MGWO26NJG>Q8&J.\IFJE8\R\N.S3[TXXTU-:Q=Z6'MN#M=0ZT#$P//D[GD2>'J(-%F-DU>%]_A!+*MMX82!!>A$A.G+EKG8H?U[?94;FPRXE&#YX=2[7;7'%QT_38_K ]'O2VGG(* M&E-_< _IL2-W^^FQ][-6L*WZ3P>N_>[Z;]YAK8.-U_,B\THWM#]>3MJQM5G& M\;7^W"<*$NXE\=AYH<^(-)YGZO#VH,-H/:7 MQQ8JSR+GJFXKJLK9O&8KWB)5YVYQA-USEX^[[>[M$GF>2NCH)9^NXXS;@^9X MG^OQOG8'S[AXYF6?[(W2@1[@9!\#"CNH"#W!A,?#(.#>(JC]4#.0EY;]>/-D MY>WDU^TJS32YETL(;AK ZNUEP1*Y)C'KB!SZ#MC$>W M;.#C#&[7:N?JICC=T;U$TOKC>UGKHS?PT;?HF>2,1'=U3#[ZK2^LQ.?)+;@! M0@.$!@@-$!H@-$!H@- H0%" X0&" T0&B T0&B \.AW;N"(W(6"G^,BM609 MM*HR=WA.U&+W?&JYCR&>O]!/Z,O_R_)\R]HKRW=A9A"]S!@!&^%*>+P[SP@. M,YP&JZ8$&]/'JN%6^#Y=/D2-^/-U,PO-Z9FO]:BCS.KRTIOQD;>9>/1F_5@R MCZ;.8MAY7GKHB\N#%P] M\A?_\QPJL];-P5##)@E>(9 :UKK*9+. M^7(26*[SE\7A?TQ^XDU5A"O2&,?'6GR&(E?S,-3XB\F;\OWXO0/ ?7@R#@7R MBFJ>NSDQ#T[=#W4%GO?FMF?_?$]]GZHHS8*0:GKPN;C 2:6]OC'=$0?=K( [ M#:$"2.,$4IK+RG#G(LQ+J0HD\;@+)D(UK91+/K,V#4S1#TW%' [(\D2:AEQW M>RE2FD6,A9YA3@+A9SJE8D;S6?+0"V?$V]1[80T4;].=6XPEX(K@Y$/X#J"= M%87?)0Y>/ ?88Z4HEXU&T8VV2;-98*"#@8>H\FNNK(\462*DY5SM>N7B*9G:9)E M5@&,*LVQ\AM/10\)4S/C7[DCIYJ]QO-X]:Q>/NZ<1LV;PU ODR+"@N)RPB:( MHU=CDQ"(<["LRJE(N.(J&=;])B!@\3Q)7^"2Y53/.5,LO\_OG7*S^&T;I4]IM@I2?1/!G G0/?"G/ M99KQD>)D=8*'*(#24QH9FW-G@!^PK%@-V$59Q,*'X$L#V1=GL8OE]V#+")RR MVK9^.P^!CVENC%-:"]6+H%P.RN@(1[Q2N?MJKI;HHS;FTK.H!Y8J:$@[3[]: MM2!DR#RQ"EDW7ZW&;#-'5>P4J]AEEO&7Z4HJ@XA96ZCGO!NZ:%#JHEDU?M/Z M4*38> O?2+P;%X -.;#6WPM].AKO'+BTC&GZ]YPJ[;-,T0H@-P[<9@+!9^4/ MF7HA#C3&J=YXV*1YS&921"Q[FIF%!@FXXSHXFIF%S-[ 3,,95FA>:/Y($? 0".N=602TF3;"ENT(4EV$ 7]6Z90P@#K.LT.H!_HT=AO2U2)Z%642WHXOEK(CT MTA*<$8MJD+ALHXJD90I#R ?I088>:12T,5H-M;V)B)6#B 2M=U[U/L(&*22U M)KCX&59S^2P&#(^0'E]+8$9&;LYSQT\;PH=UKB)=I^]MW#D%S-@GI9C0++[] M?)4"C*8*:K)I*4-;8#5[(N+SUZ:U 7&M-U1' Q*9>NNP7L%V1GZ>DOWB=IP^ MZLRDAJ JH3]&@AF>!.U7&?*^GZ+HU^^'T_D-Y\/'6<@S-(_ =!+&)^@XX?V= M9]+Q9O6QO>-B& I^_X%$><7I?%7;L;7__L_(]?MO-O_LD]_ M.>_>5&P _6!H!_OLP&.C\ 14MS^!X=$D=C0>8R8BA#<>.\/<[73&QMFZ'3A" MN!<_?B' %B_0SU+DW#0I@D->LDK4\=[3C'1W(YA6^/(8)XKZ8A&3$N^OA0^P M<#%%'?RD !W&(V,H+G4% M(O8,>"^2NJ;KLJ<8LH/*-P#GP7W)T#1C8W,MR3J]ENJ%1G9_M,)QH#DPD3YU M_ZM\1]H#FH/BSE."474!&9J6C7,/D--\;YB"AE=_[9C-:5PV/Q6$,O*MRR3]KM!1+=E MZ*&Q; P19,6$W)H<#T*N%TGD:==L";4A^<.3LYR_M-N"Z_FAZSX@BM+46Y;6 MSVN"RQ18E=YARWE ^6EJ-L40I(53+9 M=XLJK\$Z*_5Q4>4YLZ!3 M0ILB+AG%%=JY9,TGGMG2TQ,!L_]>I_VR^4/ M'*E-8I7/45$1M]/&3!UQ(<*H;(X=%U,)%)TAR624UZ&B$QG['$3,PD!D24RQ MJC*:=PECK5E<4?O3)^1_!%F%*I;YS_$XV6OH(I4Q(#7EN-:4]CC.4D) M,K-2&5!@0K,)\H#X'&,!7&)-ZNK )/;JMJ(D/K,!&Z=5,.5YAG )#7Z3JE4Y M BI ;Q(!#)V26I!O[N#0_%_K#:ZCO5V8*M"VK$5#K/2Z\$07^!H=0I!$47*9 MO;4,NVS8(M?,M>OYIT H7J_&..-WG)=B.H)H ?K]_";:(]PA9AA(PW_IZ^;. M;_9ECG83HB+(_1K,,\G+,.0NOWD)NIT%Z)Z>:X@JV9>AK$#>2&)2V=3.*-QVRW3(%Z_ZK2[',+J8'+KVS%5ALHT=7=[VQNVR?[C" WN#R16A__>] MZZ-J?7?O >-BJWNK?PS_6X1^J$(P!V*&Z:'65]"%BM1;T6#]:9$-)@"KG2"O M\$1V#G)3[UA-!^"?*=\"_\"4!]#150;->9+F+&^-80RM,J15*2%L7G)REQ4( M3X4"6]6+.1(U4S[2;#E@QAQ0KQ9@Z96Q"*MTCJ!FJ=A;GC_M2H#T@0=RTJ=*?.<5^BK5=S0IW2? M?R27Z%DF4:K'-"CO#%M).GJ@7T:N2?(_,U-3F1@M]=5PRJG7(2;G95)^IW^) M[R#W,"22"QY=HM.19!50I'Q2&5^$::("'+!#A@"PPN\29S+$OHX';H;6/&)B!#GY*7#R@R)7^D@RR:Q]+U>>N*'UFA+1Z4_X&;.LE6Q0AKI4F821N$3Q M7/);UVTI/2C4<4'8-,[D0'VW4JI9GU>'K(/C& Z@Q"42-?KC9:(9* $^NL+] MNJ5%B7!9;COCT0#)+\S*>1U+R<$T/R=-,-%.?27!5BF$4FCNA:7M5JK5+5*X M50Y "Y.5] >3$5ENP_]/(2V<5Q05CD00Q1I'D%Z2A3&M30F^!P.\0"59Q(I MASGF+M-@'PEZ9=NZ.KW6)X>9_C!EM9Y@&JY@ $A!(UV#%. M8E;25_PH91<6I3N3)T7S#^M5?SPVF-&ZCXDK>&A[8]?\DQ0?Q['USP* ZK@M MDP,+[US%GJ\MMZPR),C-!-(AAV.AH)*@4\&*64J[-!UW'#\*E6-%9+(>:*KE MWX#9I*O+X%R](IN%K&"%&$%(T&6B:I56+I:#GZPB%IGR!K-.6?JH04AU!\/V MN$2562JIE.@3?+V@+*.$2B5'*3R M*JM$OD]BCF_MP=M04UM:%;#<2NK])BF#'O334M-YY9B"LT]18$V5&V?-W/9GZ5A M9*%OG5V$EU@MHXS.@_V33X?O58ZQ)3,-$5WC*[[^Z*8,@:V*Q.V_H@RMQ3O52'M MJ@[0^!05U^*])1U5TXQ!;)-W4NT":(6P'CV& "P0*R WC#()D>?*RX$&61B$ MY+C@M%2JD6,WWD3?I2H3,/8@9IBM(2+E2:.JHCA]+P%SQLB4J_=_0L:9F5V)P!L1B\PCM, MB>;+Z2QGJPX'C%\7 +C@O%89E;T?U.KPJU6"MUKD)@3&UAWUSIAS44]4E+D5 MU:L(/U_UQWW3U;E&NB+7XS'KD[R2M/QMI_-4Y>UCBMOVWGT[>AZ+P)T^;._# MW:T"*K*JLR?BK32K%_-KN,)U2*=Z;+7__DEAR(>#\GV!P&J0)45 ]4 M1H[&EX'IC#AYA'%\O(C$[:.S9\J:YB663<$Z58+8TJ=-^4"Y ECL2R22HP:< MM:K6+9334O8&X?W,(H$2F0Q-3\R$Q]%(%?Q7$>O2\%P$1[L>LJAD(V_: ,8* M6"U '8.-S!S@0UV#T:K3(%YGVL9)QIU#!D[/[!Q"26A7LB$5VS1"JF4G"?1D MZ76^&KC].K]?WOZU"K]B0[W=8T-$"KO*AFAQP(;0D_A!3M("L\@PC9*3)2G9 M0F4'(%)X'HBH5)0)6R:Z5'F]=6UQYO!L8=*[;'.UMCG:MG+@RD$8) MY;6LN>[@BIRYASR%U3EOM5,X0"[[ 1-Z+9M0BQ2B6M+3=:F%ZP7S#>&&4*K# M#2$)< NG9U:6>G_?DYAL.N9CPJ^1.U&TPPH031Q[0IN,F;$>]>T1GWE0.&\*#> MPHZ8'IK+56-.3 FDOIO5'E6^7:UUKRAC@/3IFO%.D9;5=>2K>[TNO&RTX&BB M55[QTO4.DQ>9HN,T*3I-BLX&*3K/P^E0%Q-%QC[:QQ0.G#:T8\*AWW6,_J6: MDY.?A%*<*@% Y17+U0;TEEYG:+!F*M=$#X;VEN ]9H8G/C(R:H V;O7T3+!P M%2;P:8S[1KZ8%G%K3D.\67\@;K_7[E7NFA=QRQ];#T 3ZB.@-5^/#A'ZM#$;2#* MR#.".@VQ"?H]Q&.6A>7.I";\)LW2[+*Y-F9R&15)2YA(@?H?E$X&S\'Y+VAP M6*.;+3:-8]34#16,BJJG2.R/*7*,NJO=$3F]T<#(=+Q&Y-18%K:GR@H@0G:C MDQ_:[9N,;I45 0CH2>EG2QYX9GN]3KM?"J(7)89680?#Q.D;%N$U8NBZ$W(' MW7;W3B$8G='-/9EE/=ES5DSUQ(%Q=461EQ90*V%%\<.N L@? BM(Z3NZ8 M3K&9]T*=ZU41*W?V P?/LR^1AMMZXNN&GD/9@.H M$5^H!T%MFT_A$#?;['6:P/J1@4HH441REEL4&;7T>I_4@9]BILJV=MS!_5X] M;/'Y0(X2G)T&=+< '>G-OW/3*[O;@/!N(.S9_0:$MP#A/@;CK'X%R9N(N8GP MOI^E21'[MEJN!_9V$%P%@D=48I9;!2($WLM)OH@ZU^UOX_/O6$\!!*_N;__F MOFD6UDYMG(H 5FNQ6P,!7KTA**[B/->1W"+W:E#Y9: R#FYQW'<-,C?(W"!S M@\P-,N_,QAMD;I#YV2#S+FO,-[96 _K/D[)6C\LLZ0C3K-?[:=V;[7LEV>T> M^CF=4=NY(?JM/N5[998+GUSK47J>A]2].8MHSNBASZC?T-&NGY'3:X^;,]KM M,W(?51Z]!/_\D6[&G\34%>16&L^*?3\1!'-ZHQMS@=6G_)CFX3,_)+?3[C=G MM-MGU&O.:.?/J#MN]YHSVNTS GGTB'3T$GP\I_7!,DE,0T:G87[=A!KKM7CS MPAQ"-+2F,9)V_) :9\/.G]'0;;O-&>WV&3D]Y\;Z47-(3R+; ?D+CD[&%DE&*X/7DQ?G%KJQC[*QDYHC:HYHQTS9YIB:8VJ.J7$, MW4#]*2=%&,.WJLY-K[T7YP<:W#@^UAA&#VV]=ILSVO4S&C='M.M'Y#0)7KM_ M1*/&_7.ON4,\D3&IFGI1:]::-\A_T[)>RR5%Z#HPJ/H]U5:R"X?@)P4VJ=2[ M>K$UGML'T(Y3<:L[O'5MRO:@],CF:D,O#;ULGK=S4[G74$M#+2^36MS^\+:A M@89:&FIY:=0R'MXV<;>AEH9:7ABU#(:CVV90/SZUD/_B;S3CX:?%R7M; ^1B MV]C5PS3^L]W_K!V+H<"V;LKQ_4Z'OA("K\4;BQ%I^;_W-YM8[R'"^-8KJF$R M9Y>'L9=,)15_1:&8A!&/T*$IHO" &E&>X,"/<*JFD%7U8OFYR.'>K(BH7@Q' MW^#M,A9>KH>>X@]NQQE:^U[>MD[/EUX29C2G%>>=X:8M$B77GOF,)W-%#[/$RON=OM\ Y2.14A MUL35[A-3H.4\@[5&D34!,/P7WP0@'/U% R(GGYF&]!QG"]:H+/9XXYZY\JM^V3O0D>CB:G9M$ MOSP#?8'SF*^]CS++@/)@K8Z%O M_!H;$B0@A4 AP3?U=&FF8 ?,$78,;NEW("*Y[ -$S2>.O M<6FPPVEREHK9>>AE>IID,:6AEAFSDVKD)FPC+U(<<*8>AGMEGA%@X'"25)+\ M0> 5!#(\CZGXCC,Q<<1:@C_.4=*$=!7'B>*,1.)*1Q"UEZ!+:;GU\WBROET-7?D(W&Z#8N\+8L,BI11 MLN*/+YO[>6NYWS4916IZ858?7I@ :9<3#"TR##("_(I)MF=)XC-AP^(O0H]) M'V^,\6PPFE>D&9'@I,A@Z1G0L_4;:I$70*$_%$=>^4G2T(2A&B&SQ#=%R+MS MY-V:H\([/\ "]9C;V97;;EE9 30OLAHL@!R1F:&.13Q YN? (9#=*F0K)P.S M+@B\!=>D>(N>N0M< =F$6@@LZXB@ 4OQL.,E/PHX6Z3X$:2R$F \-$])(6+R M$^P7P*.^VMQ_&J#!2$+)C$@3%V(%K%&%K089@FC-!P00)R1 =840_R=%3+ L 8^)7FB,+AP7L [=_#H<._V9RX1.R7 M7H%L%L"Y_V4?CCN_E)*1X=_*[66D I(1S%,9+K%VL!6(6RQ%HE8:W%''58/9>F9+[3\'Q+ M( HOI!K5J$;?& \JET2G>D1,0 !7-8^LC23YI%PLNO6P6'^]WE:T=29M">@ MGWRW!2NB2S'/]OY6'Z$9QO8"#-=M?WD>MC%_\TH*#8)[@P8S"A_= B20 MWP(K!62%NV Y8F?68IT#?_W[WO^$@>,.W;X6H+;Y/%,O#DJ]."OUXE;I]L&K8 (4.3G"U,)B M>9;DH3()0$LH%]^V/HD8> 2I#Q.P7<"2RAC&PD>'3RY+/Q"^"R!A0@84)Q'E M!T "X7\K,JT(X:<1$,S\2Y-SC<1L MHS;W-&VR%ZU0R;4*U6]*RX3#SDQDB2LLBV8M(ER"J +- MI1K/I;H)$"-%AX"F$/5:;0I(1379#*FKTM\]6"]&$H!0@<@42B8@/6/X$K\" M0 *X!/I_RTJ3.9) JU+6@P(4[%(IS]C4#E/?ID'K^%5$##@87&(Q2QA9$L\K MTE0B^P#LU&M1[X(]Q>B+ 'T>$+]0>'2)G@EVBE\@.[0TNL(7P3R-"GH;VTWG M2-FF#[O<0KGPRQ!MEHLD]$VCHE5^H/1@,;LL]U>S(,0$F'C;^D=R"=]+JX=+ M8ZOTJO/]!BBJ%96O-BVH\C[3L8_L@0GV$HV$/)^]A&16 M8:7QQMJL=L1FF9.<,AD8G596XF'Y1GL">_+7O:WDWHI5EJ);H+4[44*7$!QS M:TEL9%DA--:#18Q]:?+$^\ZTJ;^?"?B^^C937,BV*^"5@NU"VQK\M,S.D\BO MA7^B5>UO@++ND1N'_M_WKE?Y^OV]^PM-7C^5FMUO:4@Q5&O?\Q /$-&_@-[A MAF_%&IJ'3"2OG2.@B1 MD/:EH^^:D+3DZV(V P"6>(^ZC*B@.U/0;:$6Z8>95V09ZTOLQ4+[NW'5WO@, MVWO6@>((MEU8Z5UPU MP3@Q*@D 8%)J5<"($$60?--166,5Z]5,D^!Z3X],3Y=I:_49D\;&8"K8%_RM M\,_X5-#C6GHXE:6FK3$V@@"JAO6HG\S,1S4/"&/4Q^(\FE?6BK85@H NE;94 M*9G;QL4!WR)"71@<9=&I+F21$WP'=Q(4"%XK2 *FA"EEN4 M)7PJ19Z!I"?LB[STSY42 M?I/:"B(E':,6ZZL(A'5@QD?2U,DX0&9C^B$DH*5'@R02$H\* M:;6<9)\ VT:*7(!;D@Z<3&>1_&$@(ZC4%6-\RH>R5F"N5JZ^HA%72.LKA\L1 M?^]9B^J1*_>QL/(<[.5+664'P%\,@-("1*5>RV=E-JD8E>)(9!+$R!A8!M8-WGX8PQ@V ):%HM"^R$/)FJR' ,3\[+)!C2 M)\F5E)<>2(7Z1 <,61\PQ\N5XU;]0[\4 W!?E!M#9\60+)G/<(&P13Q&$PLF MTA,HQLV[SV2LG"8JWI=Q<]EZ2G!A$DQ!8$ T,XMRBXCT@#BG@$>'[%2 M:P (]!%19N_PYJO#+S(V].%&#[%17H5$?L*+0SWC!].;^ M'W8[T12#_$[SPS4;8J)"GC"K$IDU[-K6KU5\I$P-60<:0G-S3/R3\Q*AH L0"$Z/<[LN'JXR.%]?RJ&B^H_ZXYYC4<;+CDM MEA7K0/HAHF&6HN(G^C+4UF^0LY?$I17,&KO$B$H&>S0@#OK>GVD](_5RKG M*;OU@ MR%H)2LJ<)\&MTH2AE7J>+Y/ OE?:Z>D]L"> V9)P5I1-(@F)V]#I6@=:; ^9V?-*9E(45$+4YD25'D: M"L8J+2,Y^ HFD@(6*X5@UL+-ODF O[&-K#T]%V%&?FU$Q@W?H5V/-2L?JS+ MUD+:C*4R64 GNZMJ54MRE#>R92Y@C&M[1/ MP$A3"F-5E4A^UZJ*BDP)CXCQA0IS3!@1/17YQ3]?#&1!A[F+91%?.4OK^SV(3, MS3F1DN9;49<"7MP. HWZWO^+E:."7MO]J57%*-49;0*A/XM6LG3VHN M>[(!2Z8!M(FQ(+2Y6.>H/&,M;>G1NDD'*K6O\E?.-%M\J.Y8U;_D?\4JBP!N MGWN1-$LI#,:O2)S7Y"49I^=QD"K' [=AR:0$J*4;F;5UUR%5 IV)")8DO7/* MZ4*?X!GZ'(E18;5V,@T]Y1*$3\@\9.=XF'U_WJZ*HPJ.ZY,S%=)7]+"&E,C3 MCZ:]"K:@)S5,E4##ZO:(LR_1@X;1"#+C+P@[,-) EGW- :EU @[PD*\)?>"> M=C]X(DWGA"V,TRJAC;^+X8;]4L#CIXTT#UYGMNHM["A6,::*\@$H4<5=%4S* MG7#>Y_(&C.5RRN#*K^DB5MH TNR$^0N\N:KY-:"I5U]&/;&2EZ!0Q6090_+I+#VCL-37Z2:EJ&5E MW'@H*//[5RYFHN(595EKO)"9$8#"GJ39VPW33KN#+14!7/FBASY5G.K@#LIN M0@^_A'?UW-X>:^(U-E1YA'2J(&. BE\JY:;B<.\V/X?F^.[E^-3)3+0A"K2: M%9Y.$B_3[Y5DY<0EK;29QBQ<^1O(W:F4Q%4P-5VF% *NLNO?W8!^F^.^E^.N MB%!G55!9^SL\O^9P'OEP+A*,A6DR5.J@BJXOZVT[YSNY.AJ+9G<5C021'W)* M02I+$8$>3[/6)O9+/:;J5 /W@6)A:!4EX.HT2G\VJZG2U4RWM0"\16Z_5,;'K)Y,Q(4G*<>:,TO* M-RRFH*V0#E=4"ZU%SZ>"UJ<:+#-=[5SE%RRDD)>Z\%H\U.ET]93!*A5&)RNR ML8>EP L'Q'',N6%:RLS,51:8K2^QDD[E5Y7ZO)E NGIQN@JY]+AA*3P UZ5>QTA(3Z&)R*'_=>!?GH(>&ED$$M?LO.V+*M M@UELM2HCO6668!FQ!>U>I_X18&7G5:KV0GV7KB6A[J[B$I2AKU*4,3]#]%-6 M9ZHZ=[!/M67V28)?.1T"?L; L!CDM6JSM&K"MN\%*F/81!=9%!6[NN M*#R:%4& )36HL(D?JMR)@!.6E:"EK_-;D889EJ:K1/(DK3+O9V$58BA=NVH1 M2BYA4JL((\KM2'1UOQFB7KL"A">E\HL?N&AS'5JR&OF:NM@":^I-0*\ L)&X M6<7$1:PCN[+4"NGM& ;!9RGLDU1]#K2:^[2#KMHG"#[GQJ>7#S< =/4MEI=!KZ2B*_#Q)J>^%KE6EQ[)2S_YO@4^RVGXF M.!F%RI+AZ0#,&T*Q%;WF%@*DE?(,:G%A-$0B'A)%2<62-8)AS726EUW>\(,+ MD,!&%YQB),LU54V55+ '6%.8G=DC*@EWL$Z,B)ZU?&)(:U2H571 RRW @:^K');T'&31V"AXQ&P M#!U\I'(M+OUBR3!+4,D+C<[?NA6+D?E$@*Y*-92A7G9"881F$1R)6:9= =6Q M8@)BH4-_F&R@*VQJS:S*MH5U H%30:Y"1ZQQ%1.>L-N(5CK,SB-X+9)G818) M7=U#9C]_$3T'*,) Z7CJX<8KN>"'^A&"^@=*1J93[TP*PDBNV5'8)8@:'8:; M)NRW:EOQM/6>&YI2)]CG1S7U.<#\F#@3S[XL&MLM"5GU[YD%'"+3^B^B-02 RO@MVC&)QJGZP;+$E,#*>@"M]7 MQ,2GP7SZ+O-K;@*UAC+JXVM?1S(?++ID+J6Z4K9.!D4L\])PII2'TZ7XNP2C M1ZV?M[?QZU#,5S!3_D)?E?RU6F]#3Q9;1J M>1N :B&9C[\IK$_H0K$.1!HE8$9/E1#B+^DT0.KZ,47U8D8VWJS(RPK7S'35 MRE4.MJJPB36. MZ1><>BDL[)TYIV1C]6O5LI*R&JF))QE"@+$T*<17A1[8!Q!P,*8.#9=941G, M3 @)Q8#**%=5_V&.%5 U6)C+1:TCIV0]P48+3.4JD, JUH.$CBZ7TI9I41]) M# \GZ?<9,%-I2"NB5-5TJE5VGPIC8(44$T77&]G&R/J00@RR@&^>PV6PB3U. M'J\;+56G=G(0X0P!'1?F?DHTZ86T#')\>B9^+;0"T=U0KN>'@E^FF1_ NB!? M8>E!*-T+9'+2AP''Z!C+SITE:RL[*&O(I (/'5E/Z*&;46=7HV[QRF1EL8YC':HM0G'RWLUDJ/^R+_-P.XB$@,(559K29C M^!(5I8DT;J!,;HE0H37PD*W14[7OVH]IX&W1OGN<#J'X&J,Y*( U]E%_V$(R MSR,7+%1EP)7O%+U"AGUY+\7P4.9R##4O*U]*HWXQ ;55S!?GCI98/BB M3*2OM[\M6_^A)X/\PAR^"*+"*SN4HX1+TLA\CLW-F@%H)/VH'NASK,[D(IVT MC+74K$!68+CT1ED;5%:UON.T&@E5Q7J-_5##5VKXI#L=^P"P"S[A:NTX'3,M ME&&,PI+;1V%,^[K[>5).*K16FH'YJINES8ITANU?FVRC[60;]9MLHR;;: >Z ME*PML68V]A5]CL]%2L@?LR13^2C*HXC\F-B>P=_K/'SU##/=>T)E/V/SI@!T MEZ1T$56%@+Z<;4XQ;G0,4ICV]CU MT)?$;&E 2)GX/!,S[#Q*F1]F1D!EV[-Q>T9BTWP[Y>78.)4='9_&!2# 64*9 M-TLKPE=-BY@FR4:+E]D9K+9;NKKKQ\5=,8#($4W0EZJ[UZC'%A$ ;/FVM='4 M[U?C4;^:'U +01+YVQ&Z5&EV.,2@!+G I[7 MOF1-:/PN^ZR]<^D7D?1+*+>,*2ZEDT[W]2QG(C]U=_&U8?MIDM;:JYLNS=KT MT'K<_LF&Z9^+&V?WL$DYWZDU/TEUC40&#V+9KO)"B+\9)4>;\O-!9VE^$3SU MF6:>X#P ]+:PBQX8'B7! C,)0LQKK.* M$SB\>60 >1V_:57'W#_L_VS5,II MZ=#&UY+)5W4(KF^T#+,CD7Q,8C]1['@BXN_<9%:MQWJ]]_'HY^.O>V^N T"N MYG;1#$-KDJ0I5877=UT--%Q<>=OZ62\*P;]&%)3[H>,IFT/71<]ZD1-$"5O) MJ^4VLWKDL3P:3 ]N9V5 W:I#>UE(J7M\[+#C^M+,3?L\I!9WK08K7PW)C;=S MU2Y*^;6ZRI\PSJ[4INVW1JRJ8Z#M;55?M%BK(J6::J57I4];I*B(GI[ZA)M[JFN4K9 /X?)[%=SY3' M]"LPJGE,!UE/"ZVHDR@2&/TNWW\&1EJFNB/1W*R:.FOD3W-064_77!@H#&>6 M4/D2FT'J[;@(+N\!.*&!4BYO_M?,"HK84_FO>C7F3(55:ULL&:XM$.2H+@0 MA*LCQS5WYTNX6>[B"HUV7]IQ?Y5%+C*PL]LC:Z)5 M@_T%G054%JVI_&W1!J\I(JMHQA*$C31?PP+3^$SZ)IKKYF:+KU]GWQO@J> . M"L\KI^>T^PLZSGZL:4'EC\BL5%-J[U[Y5EY:-20$4PZ" +N535:06+)4#UX? MY9 EJO-\J455:M7JD=K5\5?Y>LF:]+-&S5)JEB:&9>J\MB#@Z4;&&P7L3B-E MR7A]#NK7^^ME&^;LE:W6R4>B&#GWHV0+SGPTS+DLC)NWIJS#9.?*+@T$\**V M=4297%1[K0:"HF=&>FCD4GV5N0C20*;B6Y*N_E0UUZP<&DC3.7C1ETF:G\^! MMZ\3:"V2-->*47)N<'M<]),8VPM98:KZ.JNHS5F*];"L;I#,86T$,PV4"J+R M$BG"$A0I:7" *%@R%\PWD^X\VW5A-:;^9&I*J+W1?'0M';&@+- M/BE2QD&J$^2$@D67-+T?=64S=WS"&]%!DYKD-!>]18GT2'PAH4%[92)K\"Q8 M1!7[4W/)J3/@M7% SO34F+P<_N 2Q]7DW+86XY^*25#B:K;8#8=9TRHTITS9 M#:>D-CDHU^6@#)HLS!!SZLHRP-+1E36TF65G"U?I?(1,#T?Z^X7AFE49>CJ96PKMLK M_X4Y-9),3(E]]>1_J0F!.=Q#E0WP"VC>1BU4%9O;(_6IG)<&SZ,%KVTHY690 M/@@]DX3BW)Q'G*FIM5P6 G<\>4E^5$F>9R+"%YRLAFAEMYEA'*_O5[?*O\ > M+,)53\R$M]"Q<#F9YMH V&US8]2(7*S39$1-E]F M7<&B:@-I]!JZ_;9SQ1(PG8I:<53J.$Z(*":1ZG4R(UU75@MJ6R=L"2FVH'^O MS9BOY&+&VH#&U),;V\=ZUK!%3;1/!Z4F:P!_.?WA__/.CT& M8?'YY/CCT?O]T\/WUH>CS_N?#X[V/UHGI_##I\//IR<[OY7WAP>'GWX^_&J5 M4;#;*84&A^KK9NL+V\M5JR@E2E(@6=O#R-@LDV_U'^_\,)M%8OXVC&FQ]-"[ M.D?$#US(E&)RZB/T/;ZLV.IXW![UN\A9\Q3^W]^VJUW;;_=%@H[?^C5;,JP:X(,3_OM?=J^0-M6]_Z\Y^6$X=UMC1 M?0DTR6SO:B9U7YRZLT-2X^JU;"XU!B VOM*0:I0;1W'58_0KMB3C@/075I2- MXML/83I=%BX:$^Y^R(SZ:U6O%('P\&K#EB"^%:$0UJ^EE,?8).MDM5T]$Y1IY,N6K)+. M0IK#SYR]9YV<2\F3CM>ZF$BO=SO..N[42)H=6,O-4*'G/F])\P"V\QIQDW#! MQN]8+6@=QM@=9)WC%DFJI8EK]'8;E-6(I@?%L87GU>0KQ^Q*NC,,XHDRJ\&" MW#+<32"PCDN_>2.;GLMQ][K/7C8U?./>$6E\)=_ 5M.I/)=QAGEU/,^GX2#/ MY>![O8:#-(AT1T0:N5=S$,SJ_(#SGAN^\5R.N]=O^$:#2'=%I/Z5?(-ZO)\G M$;PX^ZMU2 E1#0=Y+@??&S0#^*5-,'W4*.6QKH=U>E6G?>75-SKI5W72 MV&*R2.,P.^<6$]2OZ3JJQ3?&3./8"2I/VB\E)OTW2KVZ:1[8B\PM'FTEMWC8 MY!8_MI38Q=SB7-!GWKVVIOE!JYF^E**B.6E;&.3DWP(45>PN" M>R98ZXJ/WSM@:1A$7F\K]F*!\1K1ZG__9^2ZG7<'C%OT+^?=FX7$KC(=_V%@ MM7JYCXXXE'CS8K%%MVO3):PU%I35G)5562(5AGJUJ"G/@FZ5HV25"$/,P/N E&@.$2JMOFT:U<)8G#^;C7:UE#BZ6=B6_)6OJ4565.UJ/G3#F+*;U+W5EX088K) M_#7C/H <3\1:IT9S5L6]SO!,1?(%FG>&DZ\SEH+7>2T:TLCTH%NC-OH M?BMUO\<4Z*U'AP"K3&6+TS!_(,-I!Q'":+NA#,H7"XIM*N@OEL]C@_&$0D-H M^E#O2V-VK.K]C6&GJNSO(HID Z[1W1O=O='=U^GNH'DO=TEZ$L[V@W+0C!$M^:+9SX[LZ_\\B"WD[.NRR(_NX.DQ6\RP9,Q;"C.073EO$X&? V1C91GB -VO! MB%1P"_'7TD,W*>* (S6SC-:E]*/RE=S-+;C)F\T1\I_*'0P;.1DC?=Y7D@)01X+PD-#Y ^T.3.M3Y31.2.*X S?98T5O]:* M)_]V?&NOZ,0,J.JY9GL'WCZFI M-&Q#!:!?UU3,-];K+P?[QS^_X5%ZJ9'DQ$WA0R,:3U]3JJ3FQ?J+J''"1U.? M0ICENFAH;2!Q2FID=I^,Q&4U.<;(M$HY+8M&"IT54=U#=E(]CW<8P&ZP!*@S@H**R PCNU3L]QFFIU51UCV>I_%@F& MCFZ_2X#G3^&(CPGUN31F&@.C*U+ZMI@D!;SC7*J)28U7[PI^@+-L4W;XEM87 M(J>^I54"TB^H^;I,4^SY"?PAA>-@8:-ON8VQAN.&*E-PK27X1'S*QQ5!*'QO M<&\=[I7*A")Q=CHDGO1IO!B%0%%Y81<@]3%>AZ4-L*\!]D9DO.89 M#YF:+9%YD9HSIUQ-S=FN.5M6F!77$>QVTZ>@FM5K"*_T[A6HTR'0S9EC<%PT M+1:9LT]37BH+IX4>MDN<>P[_N_ )Y//(P%5P2)B!GN8$KS_!&QEDU4&S/L1S M#]F<*B>@WS5DQWDLIOI/M*'^ 7J]&'B!]Z[&+"RCA2T0L M-CW*\8S76Z&U.=:\+)Q;#2NZ N$-%D9SIKB PF!0A+F$B<"#T&R()8Z]P>Z_ MFL^$J5=,$7R>&IQ4CIU"0!@JKQXI(4P]=%(Z,PS/]XK^Y4_",_-> I)4DP ^ MXH">RL9Y5KFO^ZI;?^5%N $98C-]0K(L4^C.!JG&D)5V2EWZI8!D8E(.05T9 MUU#&(O#6F4A+UKI2N:*HV ^U@7+JYPHC;45L9Z68P#&@=X 0$VBFM <:^*3M MXD5=XW7XAJMQ9FJ:@3+=R4J0,2T=MIUB<8+/SU $R0"R+^'!J(4[*5*>>4Y. M,3*<*<6+IK<#=Z/CJ&^8ECV1^![2"9(X6NE' M$04< D?,)*G)HA=85"F9 M%,B6?1R%1S4?#7^IJ/@XH+U"TJ(PA3:JM&T.MRH%)68OKH$6NK) SY>=$7 %= MJ^:F+A62I&8MX(=Q_[!85"/63R$R>"4>W/V)CIN&UC'^@$/;]\FX_"1RV,QR M>/7!MW%M9-73"V>K>,H+Q[.;%C%I;H-^J(A >Y*?"^8(3 M""G@('7;@Q:ZIHS%*6MJS>H(8UK*+",G 2O95AKR=SXO[C M8BI3'+D8)*E$)]ZW CBL'WIJD+/*>XIH\.2"CWA58D;U55@W* *Q_C:(\=JK MB;R9::M1J+J@"[[BPSNR7,U@U"O#=RK%D2>>G]);R^@T^1^L_Q;X)'Z@[GU9 M7"B^+8#308U5X_UB(1\HK]HK4XVK!HN^,+P)Q"FB**GXI@(!S77/\G*F)7YP M ;@GACM>#DQA1UF"L!RUE7"\ABD'A M"K&49D:9&K(:]TT,$4N;,=@4K+NF$RJKAW (HFSZW&EL"+(4PK& M*CRJXPZ=E][ %>BS\;IJHT:MQ2)%*.UC8 M"_!.U,F*V;F,RO18O7 DQ:C&+.9M"WA%R)P(6)(5J2*GQ643<.&P-0PI.1WL M)E9)2C6*1\:N#VJK/4JM19"#TIJ"V0QWZ&#V7>&O#31*^*M99(PB90A67(@P M(FL=7ID5,TKC(^X&W]4B"DD:T7P;V*KU2\Z94IS,1-%%,.M":""L@N=5\Z;4 M!N"5>$X@(2I%MF*]O%DZIDH;)F['AB,<32 I%4N G4GFH%*3R?V0?4=DPK=] MCY-+0(PS^30XUK[OIT8<3W&$$@*KD7,A=K> *6Q;Q\I10Z#2[R#57@5^;ZKB M:T&]*HE !Q57IJV6W@&3GZ)7_2RNN88J/6LK*$P3L?6GR8^R0+JU;Z[872U@ MV6)%@..4()W1-C1W;79N*[*J[@:8F*?2#6^T3Y,OUW(=EUCK8M\%/+O(U-PX M_E%;[6U7=0.Q NS<5)/,_50RH.8&K&<_Y]([CTE68J&2"NK4UD)44&8_Z A0 MJ>#AS1- P@!IXP?FII5>@*S(.(OM'3M&2]C40B!K%K>D&FU##&@O[<6;Q: \ M$F"A,U>KZLI*/U>*<^DA@T_"*V"M2XKVEQOS4/:I%)EN=)&%6:XQNRZMM&\W M MV$"!_?LX+@%O7W;>HO"Y"K'-R:$UU[MF4N:AW1T+D#UHL=A=]E-+=!98QM M=)TL8%,ES4HDG"48.4!&JE&1G]%3TUO5,YRKK.%9.T5,:GZBKHD/(DRM?],\ M>15)@>-!:!^8RKGUL5)@=D0PK],>=L'K83G.#=P=FL#64* 1NFSYX6)6^@25/JO92HJ%R60P*V IQ8ON\[B(A08A MICQA* 80'2A71NR"++.]5-5!DLZ1TL$D!Q9,]HRJ-[H:-J%J*:L8ZJ)'051I M@)P[85T0Q16D5\J0>!HEODPTK!GG)"=P(K="8.A:;6!*(IIC>E2"SWW"^*=U M(-((+(]PJA6':>++" 0]J$3,.]&9JM=?LQ2*.)D ^E^0^1+&LZ+2)OE?36*! M2?*]3I-8T"06[&QB@7;1OG;><,!6<1"+_"-:6=1-9Y@3<380;B^"[^TJ7R*5U ]R_%N^OQ_E' M_/SO[AA=.N:-\:[N^D2CFW7OQOO9>#^WXOUF4#WX5O[HIIZK[ M0#G#RN3B"E.OT=>M3$;,>&K\]2YNT_L&0I5><_47MVD3:>U'FV-W8$1H'5X/ MJ;459&AD@CP7>8F))!Y*1CJ5^3DF]I5%9:M=9HNH@:FBT]F2C^ZQ!=OA=:Z_ M35>C"QU6+(:D//8OJQXL.57]%,E!6\4#V N C$5GNRWZ8."#F(U@4:J7)$KQ M@%N2YI-33ADL0&A@A*EOST1*\MSD:RL^0M":F'QUNV1<;UW/P\^CG3^6_8WRA"3EYC9>)[ :1TD6!F8 M,=0^?ORR(RL]2B_@MQ;PXR@$NHM#L2,+^R G:2'2.0/,<P]5FHP\ E0OISQ^'ZZH [:_4T<-,ON0?1=V5UZ>G&*E0"5AOQ(C?>Q MYGUTMC$>:MC9QGBH;K=Q63XOE^7C8?OJNHO#][_M?WU_8GT\^G!X>K9?B*#6PB^G=@WP?'GT^./QZ]WS\]?&_]O/]Q'S9N MG?SC\/#TY+EN^34HD2JPB+U-?F#5+2CXRC1[L^UM&YQ(3=0D&BH%1 J$:.-0 M$3'+Y%O]QSNLF8O$_&T8TP[HH7=U/K="F-$:^;)BEN-Q>]3O(K]4XS;5AQ4K M;1,KU4,A:]>&;GLP=M=>[K2=M=>N>JWCM ?=X:U>>_6U?O>>%CO>Z+4;CC1= M.S%UO,D<3D:\AQG$.;J.FCK<<:(*^B]/X[P#/*I;%8THK,=YL.2CL_3>U'4J M@ENZ^*2 :78WOQX@5V^X 6P-L-58AO78Z;@5:(3W_2Q-0$VRU1(]3TK0T&Z\ M[6GH^Y'<]K;'&VU[_^3$%.0;D.7RO@/ZSU7[OG*T]R/L^D#5D')-^2;T=(M- M/^!$Y,5=;SP0^9:[W81S/%.(W9@Z5G,%&E@^9)MU)PAE-0 .,*A!^?'X!]9V M@ K,5ET=BVZR_8ZU4RQB]38:_?FXP]Z?2&_G^.4"%QW*ZS9_G2 M"Z(8ONQC_]S6.'7 M?GX@TA0GU%)*,- 7P Z>&NRQ6\GO_GL^>9]_53XWPXO_OAE_.UX M^ON/3]^\^>???NU]^O9S^/G;OR[_>/\Y_./T7]WC7W[M?_KVKS[\]N/3>Z_W ML?LY^OW/V?33Z5'WT[=_1\?OCRY___9[Y],O__KS]^FOG<]_GD?'IT>=XU/X M[72_>_QAU/UT,)YZTP_Q\;?S\\_?OGX__NW?X>_?/G\[?H_?.81W__/\T[?/ MT?%O1PZ\R_WTS0\_=K^>_S[]$1U_.W(_O?^] ^OH?H:_?__S:_@9_O^/]V?] M/[[MSX]_^5G^\_P[7?G=@'\'G@\Z/CZ>'^:>3SN5_'#_H]IW!V/:'7M?N MC2<]>](?=VQWXHKAI.^-W>%P[R>GY8RZ;??__*V.&FM$QFUXW0U(XD929>&3 MBY*IX4O/DB_UAJ/AT/='8V ^O;$S'@T[_8$S%#WI>!.GZR!?6,JQ3WQI.&X[.\27MF0=/1'] M[^0\27,;DX P@T%F.;>C>8VU)7P&PS=K#8JK;.454%G)?I\RD[J]\E3G1'0( MIW &1]41-(SG)HSGQ%"(NC*8C(9R8G>[GF/WO(EGCYR!;W<[_M 9CX-1?^#M M_>0ZXW;OKFSG"M*_+W5H4T/]I=/F[16(AC:W39N54B#Z]+OP7L-!)9S(<>N/^WD_=[K ]VB':W))+:&,]P @=JE?8>/_;@9D?]L"D MMZ][IU'K8Q/R#3N7FGSA/9'\Q]?Y'[_YLXG;&WR:_C$]/OT0P?=^?'Y_UOO\RR?8 MWUGGC_>XQP_1[Z?? 08_?__CVX?@\_OO (.SRT_?/LT_X_[W_S,9CGS'=0;V M9- 9VKT)F G %H9V!SBWXW1%T/=&>S^-VX,E5D >RYO@V;:D08-G3PW//N__ M9S3NB1YP,=OK.\+N!;V1/9&]KBU'X[X7=/R1](.]GT;MX1*>M?0LJ_!"1O.% M/*:;:%R;.J.>LL:U-5Z^1$^?9=Z0U*U(JK** .-'(V\PM('[ 1%T1EU;C- T MDIV.-QR+?M %S:OO]%:PVR?O)&YH=-MRL*'1K=&H81WYX]XXZ(SLGC.6=F_0 M!6KMCWW;#P+/$6(T&@_'0*.][D[1Z,MRF!Y3X5-E!*U/+GGI'IAMZ0,$\8K1 M--Z7&_&7N:$#>/VQUY7]P!Y[PPX87"*P1Z/1T [ZLC/P.D/A33Q0A$=WCQ,W MCM&=)\D0N\^/1B[GMUSY=">!-*SA]W)!(P+X8K> "1_QVUW=\BR:*S_W13]#4W> MGB8KL=_UO:[K]T:V'+I#NS<:^/98#H3='0;CKCL9RKZ8[/TTZ'7:XQVBR6OD MOJY9A,7*J\GXH>Y\6>Z)+SB"-E0S8;/&.W'O^HD"^"'#NW&!WIPIPEJ1(;*R MLO^?B3,,_)$O[9Y MBA$8(][H*^,!X-AKSN&4QN"JC+LWSUIM'%2["QU;DM3 M::AS*]0Y+ZFSZW4[WF#H@ODP","0Z/1MH%#'[LEQ9R3ZGL_];>0TMWX M*NX4H? VJX!]Z2;15H,4^P3KALOS <=L$T&@:VZ/<\ M0)9 CH7K"6 V6-&_A4A%XZ[86=K<:J2BH^V G":8/O6+2@ "@8;]X!Y M=ASH :KC&[YT>[YT5-,9^A)LC_[8[DLYM'O!T+=%,!G9$W_@=$=.M]_I E_J MMCICY^ZZ6%>!UW()V.8TMT0?1&HXXM1$_8 MWKC7]SK4_M!U9H] CA^3^.P^RLU?@CVT+5\%GD%3T7H7 M5O3)5#PZ0>![GSP83R+W' M_J$^IR8![*;YU '<2?=L?#]S!Q!\$PN]@CZSN MN-_49#QC$GX ST-#PMLDX4K!&/A]KS\8#^W "3!=J=NW1V/L-C4>2;_OCWLC MQT$2[@PZ=\^MWKV M$R3T87S$L_B*BSD.?LTD>40;!G0C!O2KJ4,$KC<40=>W.[[G8]S#LT=NKVN/ MN\(9#X9=;]"3>S^->TVJQ#.FTJVE2C14NDTJK=0$M]N3X]Y$V %H"W;/\WNV MD'W7]CH37XKQ>!Q(@4["Y]@*=Y=UA%^2Q+_$D;2&KV'<^!H>T=>@3Z3A-C?B M-K_7_ IB)"9=X#'!Q!EX[E""K.#>VUN8"=#X%7:67!_ MK]"0ZVW)U0A2C+M^?P(Z>]!%%;[K=^W1Q.O;$SERI1"3@?0DD>M@N*))8>-# MN/=BBC#.17P6XM!.]ALLQ2=NJ3.\!-MD>YT@]"%P%M5GF1_^\*("(==PH5MQ M(<]4&CSA>DXPZMK=;G=D]]S>Q!X/^AU[[ T"T1L.@\[0P][>A)VE MUNWUB&BH=?O46ND,CO"&3J<[L2?"[=F],?:*Q&(I(8:!TQ7CL7"(6@=-8L/# MTMI[&<@TE3XH#5XRE58N?C1M&.Y=.=!0/R*@GXH?)==IF,R-F,Q9+;6Q(P,Q MZHQMV9^,[9XS&=@C*08V'))TA'0[0]?9^\GM;J%%3>-%V%D:W99*T-#H]FBT M4@1Z(ACC,=C"E;[=F\@^J 03:7O]7M\#3< =3M#7-W1WRM/W8EP'3?^%A^Z_ M\#F)O:; ZA9LY;LI^OL]'T.5TN[W AK.,\&J!@F6AN<,^X[K^5W,:W)6C>=I MO '/A3SOH05#0YZW)\]*Z@^E+P/?&=O=SFAB]SP!\K_3'=M!!TQ^K],-1M@E MS>DX=Q^DMWOF_Q/JPK!:_&]8:J[%6GO&J@V'WF^??@\ M%T[]8*TJ&JY]$Z[]K=;;TL5VEL)S[4$'N^=-QD-[-.YV[;[O2SD9@'6&NAMCU8>V1_3,,V&:>Z,>MLPS7MFFD:%3:?7$QVW:X]=5'4GF#K; M"3S;=1UGU/4[(.&Z>S\-6KW1Z!DQS96JLG-#>W2!A7E@=,GT<6AUN+H=R-'^ MSTE] MJW:XT\C\B,.FOS#V-)W9;J.NU=HA24_X8CCIV2.)R.P/'[HUHU+HW M\CK8TV"\6XE)6PH<--SF67*;;8_-;KC-W;A-91SZXYX_[ X$5E,BC_$]>SP8 M^?9H[ 2!ZX^[OIP MQEU=BII^67-I *L3POI4X>GA)(B#-.F:?+T(/J.O'RK MCN%C!?O]V*? K/%3PY)NPY+J39W&7G\\[@$W\MP13MD>V:(#+*G?GP1NWW7\ MP5#N_308=G8J(:M)FMPME:$AV'LFV$J'"/QA7_I#:0]ZWL#N#=!B\?K"[O8' M73!=)CUG@ [F;5@LNY=!^41TB,5>3DL:1-/#Z:%[.&DF-&]8T&U84*V)4V<" MYDO@=NS>F HM^B-[% 32=H3.VR:.#UC,KV?)DX-F=Z53"M- MH=\?!X/NH&M+,?;L7M#W[-$8AU B?J@00Q&/1_(]$DUDWYR$[N?W(*?85JK M=X,8=3-SZ"%F>C06X=WX?*WN53CCL>/T.K;?<8#/#WJ.+:3CVH.1YXV]SDB. MNT#\HW%W:W6O3R4)LZ'J!QT&TE#UG:G:\/,X(ZMYOCT9.A-[ MZ':"WK#?[PPG_;V?QAWW[K&BAZ+J%U!&6TT,\^6DUG/+Z=S)Y?-RV=.V!XF] MAX-IROINR:)J5;=2C(20OFL'W<'([HV#P!;=?M<>.EX?%)*^._9[>S_UQ_VM M#5?>&<5CBUZBETO9VYY"UE#VW2C;UA)5=D_YV.5<_-6D=P!WP%+1U0%TEH4^>5:!!I?B3YDUH@07 MQ[E3$LO+95W;4DI^+C)81I8=)--)&--I5:=X8!YBZ1EO.-SM.-R?M>)6V?'< MCA@,;4]V>G;/<2?V>#ST;5^Z0@Y\,7:ZE(HWV':5UN/K+HW39(=TEX8!/"@# M,/PKGC<<^?V.[?4[';L7=*0] 39N#[U ]@,O<"9CR9W(MI5'LWLJSM/SKYQB M?U)=/:5R:9R[36%_N3QL6TH,'4J]2F _]ALV=4LV=6CJ*2-WZ'5&'=?V71P) M/?*D/?8[@>UVI3L9"6?@#(*]GURG?_=YC8V/Y1G2^+;TE(;&MTWCE2K2&8XF M79SX/NHZ8U!%1A-[% "-=X*>G(A "N$-L''Q8&O="W=/%7EZWI9[2_)]\;;5 M/6< -TSKEDSKR%1,''_8&?2'8[LS'F%WL,[ '@LQL)UNQPU UGB^!/L)S*=M MS8#:&;VD\9_LD%[2T/C6:;Q23,:![/>]8&P+K^/;O8'LX9"ED=UWQF+L!X/. MH#O:^ZD_>CJ)92_ 1?)K[,%B1!CC,!=KEF0A'DC6.$MV0RDI6=2')"V/"JRK M+_J@&M9U2]95:^S2&?5\UY\,[=,>!/P)R]X=V3PPZ]LCS?=L/>L'(=7O!H.MA-,>Y MNSG2N%"VERT+)'#&*2J9S/-(3C%W16 G 1'I3)4N9ZJ,[L>9\KRYV/:4%GU0 M7R4L^D(V7.N67*MJOO+Y_?Z?GR__TW?$T!D.^K9PQ 0'UG3@+W]LC\:^VQ]W M>L)UNNC\[=X]B?9&M/ [7K"&7:E MW84_[)[O2UM(-[#_/WO?VM36L6W[5U2<4W62*D_2[X>S+U4$<#;[!G ,22[^ MDNJGD2TDCB3LX%]_NY< "5O8""V))='G[&! (-;J7F/T'//)/8G<)$(.RN=F MN8I@\O-*@/X9N%5& _(ZM_4]\Q83/WN%5>LPO8G:P\)35!GX(3;9(=@ ME!OC4A7 !IK,$D-]Q%B9M&6Y>40-Y8?%?[*&Z*YU%E]!=YU62$*WLS8P01%H MZS PPBRH'.+QFGMI*1/6Y Y.B*Y.5MDS<)?L],[/V\/L(QE4/A%WDRCNQH4] MH]T1+UH8?==O\H#5>="VW3#D8L[^?P;ME]UVY_]L#/N7X4MZF%B2[:[?F5R0 MP@\S\<.=#F]8,JRU5,!TY ^4"]S/_7TK"*CI;=4$6;N?4R7K5E]^^.33&@Z M'O;)P%D\#^M\+^7[>'5S9'P!(?8G9X8;'PX5D .Z,'N'GF;UN/T_1_L\'WG_=O= M])[OWYP=G6R3P\]_7/V_SVFMTCJE]_]\\/Z/3X>?W_U-%5:61YDTG^+ E$%@ M@\]]Q$-D$5.?7OZVG73/ _4XEUYYH%;]@?*2LR@,AABI@/0($3!4!H@6.]?F)%W[KW:1SD)V&PG >Q>NH& MV[=756SW!CR 1[M__(V005(FRY\*1H'Y7$%E! $9))=,4"Y(_ :C37V&%G0Z MEF>HH<^0Q(X$G(Y!2P(#%IP%$Q@'GS;?(8R$E[GG$9J2A_$UB8V>J! MF&'I>42:@G!:2&JC0=;/RFESG(OE 5NW!TPJCYA.#!>,-L"D$V EP^FNU9OO,O?\>L\]X%;CT]^>$CNUET$5IJIH&Y6U(VC(4G9>$XP M QPUR4-O(N@HTY>.49%.:D$MK3M?:T53,=<:M(M-N"R@K0&TX]B0-)/8ZD<>[NVMS"HTNI;@FZT/NN_N-W/>OS@]_/?UT2O[SX>#\;?OTY/?/AR?_ M:1_L;J-D_.*#OPX^O3W?2_=^\.D+(_>?P]V]ORER,L;LFI2< T-"Y6)V 8@9 M*8*C0:)OJ:@E!$_*T[0Z3Q.+@B#O"-!(<\?[$, (FYZFX(P3- C$<]/(3?00 M']&$H_LIW$19P?O>\/H'OO%4%H]E\Y[&J^RQQ-P8@QV&Q&%)EP1L0/MDX@B) M/3.>$13-TWB(RK.UZL^65M9'%"4XHA/3(9+;.Y'TI76*:*2I)4GSXA=H)H?X M1$1O5M*KJUSDJX=O?S"X+ ]>,QZ\D]_S$4LQT@*X%PS2]AJP2"IP4ANAJ)5* MN(TM0<64PI,JXWD99VEYK%;HL?J<_OU;4V^FUE$YH&UT2"8*P*<4U36*P\FPU[=EZ][=DQ,: !022,]X5PF"CRKGO@F'O MJ5 BM[5"^ALT-A&E>]%*W[@(Z?6/H7,U1\SN.4R\7P")%R__H\ U,<8G1)$V M0H#S)%F+!C%(>X) ",X9Q9[H/*ALNK7X=$/NGZ 2>:V1N8 CL"#S4/(>NLIOM?@?CIDUE1;4OUM6=6'-+F@>#M==%YP MTVE=F+:'=K?ES$5[:#KS]%I;:ZJI)W'GF^[1\:Z\3INRW]T9;FHF7 M[@PM1EA*0R*%]!\!YKE.#(4\:$6M8T9KJT1V;#): S.59)[& KF>9)X"Y"4# M>6Q@&&<81CAW+K$)R)09T%$'P,AB+Z/'+GOT\ M!:NABTKP$GQ4Q,=Z$W/ X M^%8P_6ZZ_+F:I:TU(2W!LKC9C+WKO=AV[O+\LI/S379#;+MV::HT"R$=[MX9 M*4P\8T$REPA)<&"Y&[7VP8(7Z8!!2DM)_<86>\$%G[^7:_%&-!;(2[ L"I#K M!_)$=S0G95(!'*Q )N<,)LN"NP 66X+2$ZRP4!M;](5DN+:)?,5Y,;/S8OS, MMWI5'I5@;@W2;Z;.OQ,YX.ZJ>C3N3 MF['?37L3?DL[I.($ I)Q%& V5 B@1EE##(DA MV*1\!)[BP/BJ&V#Q7:P@>A]O8A3T/@UZQ]8%B<9X&25()EQ";Z2@6?H@+#<: MI]T+D2?TIM2D?24_;9.^L$,+OM7-_5'9IB68C!\JB36F\N9R-8I MD)P)DOO?**O_ Z7??G] _CP__.O/#V_3^AR=O&.'G_-Z;;/#D[>=TY,#>G#^ MQ^>OFB&=G/Y-*/'*).$01)# %)=@F&'@2%(23CN-E4SX)M,R=)XN^ZL\40U] MHM[O_^VT-YC$Q*\>Q?Q$&5!8IB^5YU1:$DENKZ6GG!>W?6B>>YK7!;:Q'E)<:6UCTD/&4& "!3#6$< V&5;)V"*,93WT0B,VER(J/M?F M@G8)3M<"VOE!.Q&^54BI("QP@K.9)!)HO9=@F5+4Q;K9W]:0W-)V1VKFG=WB9U-M4^%G&8BISO3P[D/E>D '#F4 MQPDKT(FL@'!BL*#!26ZK4*Z<5L33Q E]92SG&H5_"]CG!_O$['!!#38R@"*$ M .,Q@A(* Z4B()D0[[G(8,=,K0C8ZTPQ6PU#96(:9^5$>XCA\L"19:.;>TG3 M>OC>I>V$V\%"\TWW:]I"_O<3KL^Z-RCJ?I M7J5-:G7SO-N6Z:=O=UOM=&7O^E4A:W_8ZL76\"P,0J:3:H>K+-'8[IJN:U=^ MS?2-:ASGYKWW??W'J1KUP;WH#:IBKI?]T#$YD/KSI[8?GMV0VL0O7C][:/PK MQJ:+N!S>_RM-66-&O@@.3WS,EULQ8,1$$AX4058PY*D-B:=#LGJU8!A)]7>> MDW+]2V?]<2K/NP"V'\P',#'=X4O3^62N!AL_W5F(\W;WYHH8&:4@W[=FYZ;_ M+OWT]6HG*/U\_9T,[6\B*\:%+>&(*])9T^N;:NL30X5^_JET.:8QU](ZZ^<# M]K\>L)<)>)G*,J3RW-J,F7_]9+:^@LUHM;?^9?L_;4U[B)[T:?]J,FKUM._M M_K7]9O>X]=O^J[WCG?V]PYV]X];.T9O71V^V3_:/#F>FQ&EWW\#[WCDZ/#[Z M;7]W^V1OMW5\DOXYV#L\.6X=O6H=O=X;W?OQNM[\#^UN*[UM)P%B\*(5_G$A MG?,7H3]*E4GGR,AT3"__6/<23/#3*)&Q,A+&QT9EF*1UZ)B+07AY\\G/OCVX MZ)BKE^UN=3?5+_U\E_TR3WYAE%37.'KYFD*UWE2<9A:]=@U>_^%K@MVL"/8+ M.VOT&M>;A)![7T:;^-[7OO6V&&\**A_UMM]^C=-RL8G.'_2VW_$5?S<0A/E7 M/SM%G8]@LAP9JAXT%OLTF/Z@M9>.1-_:#2Z@9]U.P=SJ[6NF[X(>.VUVCAL"X+][B%4_.-*I^S=&+)FK&ZZ<.0]LQTPE?% ME@]TU33>W_O =7BLP[>Y_MP'WO@,#ET4#766>QIQ8$):+11V&''LN##<\;]W M,VDCC##4T.SB8^A>AE?]WGD6KOGJ_FH/SW8N!VFI0G_O']>YS$N\/1B$]#_? MI+*VP_:UL_?\\/WI^W?L[>Z[3Z>?#_CIR>_\[5]_IK]W\.GTKU=G!Y]/Z=O= MO<^GG]_QL;/7?3XEZ7U/?K]Z^]?OZ&#W]\\')X=GA[OOTM\[9>GZ\.E[?_8V M_=R7SM[#SX?OTSW@P]W_=-[N_O[I7K.$E_F[PZ3S\7#]K7 MCMYC].EO)Y'CCAC0)D?.C":@=1 @B=-1(420(4'"P\VZ<9G"?!KAY"5@7FA&?=6 M44L852BDKQ01IN)!=<.#JO!@LWD0W_(@DY0A3Q"0*!TP''-ACS. (Y>:8T1HE!,>7!,R,I#D82E9O:4-THK#Z' M@-ZO_=Y@T+KH]V)[.$^W]OG\.2O-0,O4!-5VO:YVJ[#1#&QTN#,A @A6D=%D M-J0=RC7 5H()R(/T*A**C$&\\E=0Q*=T(VFHO^()F@P]8\PO4SX4S#\:\V.] MX%Q"K34*A,K"GU('1O((-J+TA:6>2),Q3RBMK&@7&4 B4D2)^D2-JJC2WR0BI:V\38$I>H%Y_'H=.I9E>_ M"]W0-YT75<IDJHX!Z M$: >"Q!'F+?,*R"46&#I? ;KJ0(E'+=,1\*8&&4;J$W>(%"OR]3:!Z+S31@$ MTW=GE;3PX6/H]"YROY#Y=$4#.[$W4E=\F;@YVHM$1KOCG2A,] @FFBS903%9 MAE$J$)+D5'7+P6*'@"I#J8G1,,(WMJ1 M04\5M2_N=YPK4$Q%+@N#*X3V4V. M4L<4 YL[JC$;&&B++ 1JL+844:QB@BLG!:[K#-?:H6VO_1:L;AJT?#GO#T*)?S9XIGHJ%V?Z_W>[%<1@..Z%PTR.Y M:;+BP5HO@^,.O'(,&,,!-#(24#+Z+?*.:"\WMACB)5:PSF"MW?(O8*T-K&.[ MGS#G+;8&"%4NV?W.@W+I@\"&!2\EQI%N;-$:TA4*5IN+U=K-_H+5VK Z4=/ M*?:3G?RY:WC;AU';Y,G90L7KOS3+_Y?+0;J>P6"G=V[;W6HG M=FYW:&=R@[;[_;RC53OWT>;N=[?/TPX,C^(]OW(S]>$*%[*;@>R.)DLF9#0R M,N.!1Q. "8M (4IR(C6UVE ;2"ZWK"]WNO@CEX7[608OUZ B!NF&TV>% 5:" M 2:DB;&$**_ B, 2[@,&:S'*2D4E_N=:<[:Q)F_2V]; M12Y&5A-X.S+\GM:'@6^H>];C^XRWX_+>=^U_7.2V[E8SCI M3A6$E1['9(4(9C PQSE8XCAP(Z4U!',>;9Z$H @F/S?( 5.\I4V/;!3$UHG8 ML8((WF%,N 8K8@066-(2QD9 +!(ITM-+G$H*@I7&:^L,U]J#&P6N=<)U;/0C M8A@7F$%4TB2C/S>V5MR#%RA*YH)4(L$58]&H>J3OV/XWX]72Q89O0WR5?_(Y M-*XZNJ@$?O==JUWA?2'-J]:L"A:D"#F;W&E0B9T!$^1BY%@)4E6-8B86WTZ_X'ZU<%^_O"K@GAO MPBM+TQ8W2U\<.X\AH?U)76$=]P&;"$1:!LP2FK-6*;BT"50(;$-TR<+@\YL7 MQ1/;7(36'C@I")T3H6,-@*4*4A$#(F $#*D(VBD*G'@3$G:M0R:/H)Z__KL@ MM+D(K=V8+PB=#Z$3ACP/EBB#&'"95;J4$I1F"I+IKHQGG+M@$T+UIFX00I]9 M]<>MM3Y_B& %B6:6Y,X%6.L?T\+G1,V1W^!F*PKES$0Y!W?" 5B$2!2"(&@R M"A+/@.$" 0K>(\<9840GRIE6'5IRL-<"I@LPV0M,ZX'IV';7& <NTP=& ML <;C0','558&"MI'B\SK1E,@>E:P'0!=GN!:2TPG3#@K:5$"\U!T=Q&G1L' MB4Y9/E)=;HUB-;(53+\NWRY5#:PB61\=B"$:J4MOP# != \-D@2XP1#!="K"NBGK:(N(%XDB"<$ T+,64H]$,HM M,.0M)%A+H-$0ZA2BS)N-+3E7!X3BZW]T/4#&P+6C?Z*#ZX@[L7B<:G@>[HKZ MRP"^Y*/"08_GH#\FE8$1TD49(VC!)+ @7.(@Y, %EH=$,%SG-W$9*M(I-(5R6%/JV7ZRH' QIM MT8^>[98-L=6+#Q_8@ RY]>6WGMX;FG_FF/C_C^=C]JQ M7:;UNZX@ZG4'OU1;.?JYD[QU!^UNK]\>7MW$,[>[_NZ[[/WO97KY( S/>GX< M!"T52+,QW>FDA$#&H,B) !052DRG&1C&1#)2E A(86LXWMC26-266_Q@D*V0 MF_(9$\J4$=3J>..\!+1.X5!4VJ (6[!&L9!4*X55B(]!B)/IL6US;Q9 M.'$\L\C+ZWN5V9T0C'QN(9BGUV*)U*Y=0[^$;HCMDB\Z&U&Y2=U$B=4!$PPQ MG5# '(N@#-/@B/32L+1=*B3=1#=I&8&QODA=0 5&06HM2!VK$2F]3[R)PH+DA1%*C."]4)ZY^@&$A $JBF>:J, M=& T,L"1QCX&+H0F&UM4K^/@[$8;]8?AOJKIQ?HP&K<0_[VX^U\;IJU=OJ2G M;^QXV?YHVAUC.^&DM],[/^]UCX<]]^&LUTG+//C%#-JN,/!,#/QN4M9(;[4U M-!>7X)B,)17 (,&!$&Z(CL8CD1A83:TJ;ZC_I2;';2&Z0G1/&/HJ'+A@#IP0 MC%X:S)0#2ST"9J@')9$'XKS1/B*D3,SA*\1$;>U\"@L6%FS2C3^EL"Y4MUBJ MFQ#<,0]N08I .L(",$8T:*DI.)T.-APP9I9O;$DRK3M)0XENV=-.?/OCHB$J MI[=$.#/]/,M^9$*D';G9BJ?@B\G8'OGQY>U34:W.8QR:$\\)34^"[UTF#KCO M06DVETX'2JW>W;*@94'K7=!GUE]FS_2[Z;('K8O0;PTRL[Y\U//U?=_N2NQ^ MW1+ M;7QS3MW\N;L*&!4%_'T%_/[.4#U+B;4614 1.V HQESIIR'M.".<,I;^M[&% M-VF30LXU6;N%?=:8,4!3V60S[C$,-A&,3&9&@2)ZJS$D +1D''UC05C#J M&,GL(^J:[%?8I[#/LMAGSL! 89^%L,^$]U]8+7$(!BP+R?;!6H-RW ,- DGK MO!,49?;!M&G=-N<>VH<]&R\?JY*N0Y$WG> MG9KH542.M".*A LV70&"YNVI1*.7_>(6?D.KH5_UIQ_%BT<"_\\ MDG\F9D(JB90A!F)0"ECD G22D^ UIM1;%!UWE72L*U&W\$_AGW61CH5_'L<_ MDYT:E$M'0HC@$$OBT4@&-H3A5;W\MR&?JL7T]WG9,I1JL.@U;L<#H:F6]UC'7DUJQJ1?H(THK)D];S' ML_(+34TF>%"M]T,MI.8]>_>:$2,.6W01X@V7;H^H]+!BTJ-8F1.#HS%_EIST MV0V+N^.N""5G(CK*,5<$^"Y#POS 8$RUH'6Z3BV3C))6<:P;-0Y_*QRBN\)#S^(@-:P MZ=.3"H'KO?B*APH%S41!=^9;1<11,OLE2*(2!5E"07E,01JM!491A> 3!5$\ M?QU^\_+C"HJ?0 H4%->%X@DQH! G) EZI)S*_3180K%0$"-51F">C#Z>45S# MB(F"XD:C>%EBH*"X)A1/R('$O,KF$]@ISI.D#QJL4P80C92I0+'Q*J&8H4:= MQ94<^&F8&XC<=".X;=BP]2_;_VGK;JN"].'FNB;^D MY!,#H3[>[/GWU$JL* MYDO&'!D'828_GIR%EG&N=YZNYBHM6:O;&Z:_E_M#I,MKIXM_US>=UH7I#W/L M;W@6!B$CL^J^81)26K'=-5W73C^4L#(,U1R#S7N7YMSTW[6[,%KJEVDE?K[^ M3BZ&5WH)T?J)?]T#'#]L?P\Z>V'Y[=<-'$+UY? M&AK_BK'I;A,KW/LK7UWS$VTOHU]TSYCXF"^W(JZ(B20\*()L@IRG-C"I@B9, M"X:15']+O7'S2V?]FUNX2!P)MA_,!S QW>%+T_EDK@8;/]W=W;217RS\?6OV MO0?A_B6,<6%+.'K6TK'1&TWV>)FH)?3S3Z7+,8VYEM99/Q^*__6 O=S8.LD, MEK&;)Y=D%/^U==;*JG?6_WK^TWN\>MW_9?[1WO[.\= M[NP=MW:.WKP^>K-]LG]T^'!Z?ABC-.6^=XX.CX]^V]_=/MG;;1V?I'\.]@Y/ MCEM'K]+='[Q^L_?OON]=5V&']K=5GK;3A[ \V/=-SG!1;SB MHLH.&!\15?^6=*<=;$+^R.ZAI' M+U_3I=:;BM/,F-?^R.L_?$VFFQ69?F$,C5[C>I,0#WO8[#NIF=@6?WH'L.]E F#_DKJ[MPZ7TS5#Z[YF[W!V]-=UPP])9%NCA<.Z M+-SC%DXMHO=10\Z'VJ9&?-U;[^[&KW5IQVPWOZ*.X3(OXEZO\-'QC5?XSP\' MY[]_/OC\G\[!^T[[[?O?V<')'_SM[MGYZ?NW9P>[>Y\./Z>_14YO/;Q'YP=7 M1W^EG__\@1^0P_<'GW^G;\\/V"EY\_[M^:OWIW\=OC\D>_AP]\.G+[W"IY_W M>;JFSTI]\[2]^CIR=_I&O])1ZTKSW"Q^C3 MWU)PX3A'X F6P+P)8&5T$*U#1'I,M;FD$$920FN9"+(7=5L%;]T#\'0W/0C^7[U[TPUGH M#MH?0^N'3L+#C]=:^T6K&T9A?O//G9'K_,<'U?8^=".:35,/]FK6X8XJ2[.^ M2_/,6@:\ZO73E]V6N^SW0]==M8;]]&Z=*GFA9?S[R\'P?)1_4&H.EN3.JAA_ M9Y+PQT;0]7;M7._62=ZLT25N=_W)>.NV;WCY2; ^FV=C553(']U^ M2)?Q.?@;W\8[T^ZV$DC/@G\7'J(^UIR1:E 9CV"D'3,X>]7I??IWWH5?TY94 MCMA<2O FN(X9#-HQ+>8-0Q4>FHV'CB=$1O0:!>]-VCT>@>7@DK*2 =92*VUI M\"'9' S-8',LSK28P8)8R"R@/'IP#BVU;DFZ80D"8PHCV @0:'K3KKSXDN8CY\FTV.#D(ZS&,%()H$Y'Y*=X!Q0SS%7 M2"H;LPU?W(;K"O':NQ85B#<"XF,]H+UWU%L&EN2N* QY,,9J2(RN/5-,XRH1 M=$H2:(%X8R'>^,! @?K2H#Y6&RYHGIC; F?$ *-.@4(T N>2,D2Y=GE:)IJ_ M&VJ)#CQ<;%1A@>L004Y0NLD)AMCKPR ]Z*UV]V-X>,[2>K/5TB3'>(?^W>OD M!;WQ@QQUCX.[[+>'[3#8[K<'Z:7=]&7WW>MT\SU?6.HQ+'4U&3=P@B8+A(&6 M%N62/ S:TF20$)3CFH))XC:VQ*PL59R4JU H5L#91'".U8*/B!-C#"#'&3!- M)=BH!"3+D&$E<;(I= ;GC"/3"CC7,0.HP'2Y,!U;^D1;;YB.0+!6.DB8WS/+*+P9; L5S3EPJ9;TW]LV+>R_=\:]EKA>LSG M,XLZ-#YMZ*O YZU;XE6_=[Y]M+/_JM<_3F1U%,?45GCL$3QV-%FH@!FW#DD& M2F9S@V$+6L4 FI@\6,')Q'/98S'WA-;BH6PNXI\F(ZD@?HF('PL,E_1%TOD4 M)!$66&)P4#&Z9+F$8!VQ-'T_([Y4)JTQXI\F)E$0OT3$3^1 !26\X!ZT"PGQ M,DHPZ7C/H0F$#65(<;*Q19HWE.$9=F-XB"QY?'^!Z&UJ<43!;.V8'6N!H"V)P0M0RB7,.HG!"$9!4$2,%Y8KS+,6 M0#-J@:=LS;86C=#O@&&^ENC7 VAH6FW?N\SC;&XNO[36K&%UUH;5:T_UFD+H MQ7OSF#Z;)]N3(ZY=VACJG ,LI086 @=E< !,DN$,QXM#')%VP@/>($F.0FM^5CH*-)5K#4BA-:]60G MNNYQ%(5+"Y<6+EV80Z$09GV$.3'173A'K#,.I$DTR0)!8(E/EBB7@B+&T]:( MW.1]6H'R2M+E]&'P-U?=V.GN#1KB._V2FS9^?J/,EK]OMCRK8[:\(AM;9;9\ MF2U?9LLW\[Z_-5M^^_C?K5>_'?UUO*XWO^83Y;G CYDH+^0FHKSVN>OC MIJE_;T8[>_;72M=FG'PM<\C+-/EUV,7UG.U=ILF7:?)+7K@GF29_WO:^$Y[F MGG-;U5;L]#X-6K'?.V_U+D*6/=UWK>R2^EB5$SSD89IY .%WGHXENFJ_7*@Y MQ[L]OL2F+&=9SOJ6Q6'QY*FW:' MC7Z,GS(3:T6G(+.#]G6([/T>/_SU=W[TZ]O.V_/#3A4.^^O5V<'GMV=O3SZP M@_/]]-_IU>'N.WH;(GOOW[_]Z^#SX>>]?]Z>O^D'N^GZ[U0WK/??1EB.R0Y&L]H E9UP@:A7:V%*$SI]/ M\ U*6U12P!=_\L%) 86-5IF-EIGH5(AJH40U4:RC@@[!6'"*.F"$6S#!&S!( M^4!\0!ZQ*O6)B?D+@0M5%:I:"E75GD=4^&BA?#0N1!+6FDB(!BE"-9B%@-4, M@7#4T4 IYQKGS"(R?V91C6Q49X,UG&ZMX4)TW*"CZIW6#PE\KMT)5<."D4+- MWW?9[W;1[WULYPB&O9KJ>'M9AW]D1=T73^ -*BM6RWO4Z7@BO/&>I]UPD4#> M'G53-%W?,N>Y"O=S]8U'M4Q\J'W5N(?R*=TWD]N0/N^$ZU%PVQ.[44R/&4R/ M.W-3?>1!$D< *YFD$-,4K",1%)&16QX9IWD@"Y*-,CUJ$D(%M(OJI5Y 6S]H MQ_Z+M%U66Z9 8A&!F2A 8T%!4VDIT<$+23>VE)Z_!K9@MK&8K5WN%\S6C]FQ MQC'MTL_&]YW=_D"SJ*?PS"]F 0AH6('DM$DU-6J21: MB6# &X2 B<1&FE,/-IMZ I$H>"(BHFJK8FQ0Y7;!;-T&?\'LXC [-O@3L28= M3B5$$0(P&9)*YUB!5<9IX[Q#.B3,\C*:8(TQ6X/!/YF*\#GT>SX9.P7)BT_IM.'.EBP[>!OGH6'[\Q1 M,CY0J[R#P'.D52D*1D0&N;>7%-XKE,=1-\_%4ORE#9FW<_%2BV79/Z[],95Y*)5@A5/ M;NK?;LU1S,QT75-6*&F6ZLF[0X$D)SP&K<%3ZX%A[T'[Q$PZ[2/!!B7K3]9& M2L5%VE@$UV_Q%ZS6@]7QV!D25=2$"\ 490/"1U F#U40,7(EN99";VPQ5"*. M:PS4VF,9!:CU '5BW E"FC.6C'RITU'*A$9@HXQ)IM,$T:B0IVIC*ZF 3=4@ MI#XS5_[.F>F^RR-26S$]_ZV/IG-9C2;(:$NW4]G_O>Z@[<-HYD&KTS:VW:F: M$+RH.A>,9 '&C],%S\%+47L2TR^7@W0]@\%.[]RVN]6^[-SNU\[D=FWW^WE_ M*RX;;?5^=_L\;4"BN7M^Y;?K#;["A?QF(K^].XJ"2!4\T: E2XJ"&PD6Z9@S M+I2P/!KNC2$N"@T*.4# M,$,X6"4H>,RH9\0@Y=S&5M('S0#_,XMN[(88^OW@;]NNF7^^,_>[,BH7^1)WH]"/S/1S_ZD_+",I//&9_GA1**?8$%; MH< P9:4BCDA!-K;8M,'<#^>?XA]MK,MA<<*C0'Y1V[] 8Z"VP7@=L+B3USKF<@'K3))[DL6 MP5)+(2;U+XT,QFF^L47DE!JK)SERGUF@X_5EWYU5Y=CM+EST>R[IYU8_#()) MWZ_JL'WX&#J]BZR52RCC:5.@P=!DO+#Y M2T\+PAN+\"554Q31 */=<"B"$I58@S+U@&UL,K^/@^_7&\9.* M^8+?A>)W+/"U-D+3A%_*8\(O(1ZL"PP0R5R,E!(,;6PI-44R%(6_#M!=0FIA M@6Y]T)U0^]$B)"E5$$F&KH\:K# 1*#5$9T^ 0[&:O#9/55%#A?X*"(.;-H'M M1]82K6R.0<-JB2;VH;#-3&SC)@U]9DC$AG$0V!E@IDK\(Q*$9X%@X1!QN7\+ MF=9IJ50PKP-6EV#D%ZS.@=6Q42^0,9*) X+#DS%'+5S!)P/TE+'.-8R817Q MN0K^"E:;B]4E6/4%JX_'ZH05GRQX;XF*R78G>1B3I6"]$\!C()1I;6/$&UNB M] 9XHD*A?K@P;=\*H^CTI)O?7?;[N2/:*'CWO)S\#;/QKW?IIH;Q.I7@QM]0 M)1,7DIJ-I-[=&O^')^Z?@W=_^X@MB\2!#XPD 4"342&248$\$HHXX3@3E;NA M9.RM)XZ78/\7'"\"QU=W<$RP8]8C!D20 ,QB#"I9@""EHH+Z!&?*U? D&6@0J 0-+%11\]RN:*_?K;%1<,+Q##5W6"TC4L;GW".%2D7!"L'W*51! >WB0'MX]^!5+F : M(@',"0+F303KM8*D#9!5S#BMR7V@+5&$I144S#F=9&5]$@V.%&1?Q$3+]&L_ M1>&C1PJ!W,2$(6<]P>!D+C004H)!G $SPD=.-'&Y^2@G4RJ*2WB@J0AN7'B@ MX+96XS_AEC/'N: 2+#$6F/(.3!['+EVT7*O$P(AO;#&Z21KD2BS@;5[A03E^ MGTP.Y![ "%&J.4W;$]*AZQ1-,-8>:#J5'8F>88QR/I&<*T&P1 -*\]^&>OT? M3#_53AS=]'#;,1?MH>DMTLO:QLC&QCZ1@,><0J,0H M8*)BP(E]Q)2Q224 L"X@7N:XP@+BND \T5/(,RE95"!IA H(*X)Q!,Z0"D2C9<6 K(:&*((-/,^J7L26$0J M,"02B*=T$%B/@ !%C6\EG)[P5NZ?W;KH]SZV?? M>S795#AMQ\>YZPILK^]# M'X:]BY=Y:0:]3MNW\JVM-WW5/-JP>WGN>\/KU[\DM+2/.VD;7U_OXB]7?PRR M5^.6T+9O-[(0VDR$=F=R8= "&9P;+1!E$J%) DI2#'F(LA+8!D98(K07B+/Y MU<5,X%DAY^6]-[3VA%"#*"F$T !"&,L4(CG57%A00BE@/$I(ZD2!QH9Z+I/I M*FPF!*RFQ1IK)H3""2O(";470!3@+PSXDXU3 Z(LB@C&").+'C#8P!D$9X(4 MPMKH$_ U$?,[*)8%^YJ"(,U0.W+ZX)2L=&*G]VG0BOW>>:O=_1@&#Q4Z#UB* M!]MJC6:O.0:#/-2S-<]:EN5'E_V2(;G$ M?FROS57.Q1Z<]*XG-B?[)5DLPZO7'=,=;G?]7OIN-=:Y6"TS62U_W)FT(IU5 M%FE@)B:KA0D*UD0*CH9HD35:$KJQQ9"4Y#9R5;LQK"MS:_00%N L#[F1S!!H(B=0# MDCP TR9G- L)RGIJ<"!(LW3B$CK?A)7EI4+Z]N"B8Z[R=89O8WV5?[+.?-#F M2Y_7EWUW9G)CZEYLG86.3RH1SDV20.WAU;6/I***U@^'O6$8Z5GYU=.YWFDK MS5)'_TZ[=-([N-ZCX^#RO\6E.RM5WYE.(ZD+D2D%V&.<:\T1)#W$TY?,8!-= M\#'WL1&D5)VO*6X7+XX*;NO"[<2D&JJQ182!#S@WH]88#(D:N!1(2^\P8=7$ M>C2E:JS@=AUPNWAM5'!;$VXGI)$U*!E#CH/V4@'SQ"=5Q!Q0;D@RG@31(>&6 MX,9T>7E> 9'7_5ZZ?'\=*1VDIWPTN.9:&+27(A=6UK7SI&KA>N=>I8T[-E7' MRQOF.HJ%R6IALCO=J(TPVC@F@ :4+!!)#.C $Y-YKED0B$F%,I.14K>^QCBN M7ST4'"\#QV,E@7U@D8L A.IDD4C!P=(H(&D(+[QRW.465KR&#E8%QHV%$!:(FCS-1H%@E.3V$PZ4"1&P(]?F:R,5WM!EO"Q+-1UIV&=5H%;44D0(3% MP%!BJ]SH%IAQ'J4#*0D,O;$EU+1Z]^+#7 ?T+C[V4-!;+WK'NL%$1:ID2NP( M Q:M!FL\ 8&UTMQ1*JC.;>OD7/TF"WJ;B][%1R *>FM%[Z1<< R'Z 4$G4NY M"/>0 *T !)0S0D#K%P"?$<7!_+C43/9A"C:E]V9Q8JX+DI<;BRA(K@_) M8U6!L/$,*0F$"9^0S$E2%5R!BKEQEN=:*KZQ1;FNK;-$07+SD+S<<$1!J(KCP(@Q$;J\H!H9]9+/+I.E]^#OV>-X.S[SI)?[D#,+@UWYO M4&R6V6R6.ZTB3+)-).<"+#(>NNT][D6"I5:J%6"ZW+=!>7D M?0(,3\8C31#<:@-&90^^" HTQQP1 M_WE>(<8GS5*L!G=\@X\*%AD4RCAC'!"(TMB M-B=*N[@U16OMQG]!:]UH'1O_GC$5+$D8E4;DU&$"AAD,.FEU$G#.+_8Y8%C0 MND)H;9[M7R!<,X0G;'\6* [<,@@&>6!Y;*42. (7T4I/-/4QU&;[E^*E1V)R M?S"X-%TWRCSLYKA JQ]<:'_,D?/G%11X4M/_ZRE^59#FS>U>%"Z:C8ON]$.C MSMAD-RB0V07!!!6@,S61:(E0Z6NBV,86F:]7='$E-A>OM1O_!:_UXW5L_BMN M8[( *7#ID^T@\LA<1 )(D[XF0CKN\W"Z:8.H"E[7 :^UIPH6O-:.UPE;GU!D M:!06$G56_<\4&)_.5QQY\%9[&Q#:V$*;HAEP?5[N_?V)XJ%V-_UO:+KOVNF1 M;YFD<8>C$J1V%RYR-NT@V_^#8/KNK/J^#Q]#IU?U3B^!@*=K5[!_NVG;U9X5 MLIJ)K.ZT.!-,6)]YBAO/@5%OP% A02(KTAZB+!4R6OTITY0)!=0HD@Y7XD$;;$$E \D+CZ/F>&.+-@6MI1+BV44\JIA?B6PL7-07OPH1. >]BP#LA>RAR @NF(5"93EZM\2C!(&]IT-Y@'G*"P7RZIZ$1 MD#R-JN$V_V$8MIP9G+5^N!R$'.SXL771[WUL^_2%O1GTDNZK96[1,$^TP_;Z M/O1AV+MXF1=IT.NT?2O?Y)HS6 W:89#N-WWV)96E#=Q)^_?Z>M-^N?HC[>-^ MM[#8O"RV=Z=&0B<.(S$"&-IA$\-1884@JTH YXQ%;+$!*;)_.%:SZETV)] MP"_8;PKVGU*U%,0O#/$3@L5AJ2**"'"5$>UM[JVJZ!N>5CGJW"7[[NOXLEY_Y8)]9DFE3&MK?5 $>Q=]ZW7)G',;%\=3+I2I)*2618A".N !69 6^Y "LR],,DZIFAC"XM&MS%Y-Y*YA(Z4FP+1 P"+#8!3S8#5%PF,7<6XZ@55I4K_&F%UHD_J" MV5HP.^''""PQK#()I(SF1C$*@?5!0Y <4>*MY*::-JD:->CZ>65AU35=I\JX\+O#Z+!)$:I< ;\+%]=;<):3MKM\Q%^VA MZ92A&8\DJ=_OB &=.\QI"S3(Z_)8K;0#3AC/G>@\<=FP*.TGUA6YM0N!@MQ% M(G0+U$4$_6J#D]WCO!F%A&8B MH3M#:9P5R,M@\:DBXX -I8#XTZ#TLY!X)3BF"PAX]C&EM1\DS<#L*49Q?,+C=Q)AJH43BLM MR7.+@C0E#ZKBW-=Y_0OQSD2\=[IM8&K#$<3%#&8J*B=61C M"S,TA7C+M,UU >I"DY\*4!\/U(F$IX"ERHTFI-9)TGB/$T8U!VT%3B#F/&B; MDQ0+4-<9J O->"I ?310)Z4,CHJ'J"&(@++OP8%"4@))9$IL0BKR(I^HTS(( MRA3-I68YY9!%AE>Z@?Q5^G30]J%OGM\HS>4:]3.,^GW5Z^_<[M#.Y ;]UC:V MW6D/KU[=5-:5:M-'\M>=EMM!(J.00A!4GN>! M"J0GI$>4EB/G+(A@28(TMZ"9]3DA4KE 51 D%S+R.EI"E2!*":*4CMX-3 R[ MISG7I*-G(I9=[4>AX3EI^.1.:V^.A&,V1,!2)\N*&0L6T0#">H>U".E4U8F& MIY23ESST=0#QXCKL%1 O&,1C>80L2Q9QGH:NG<]U8 :,=!I(X#Q&2M(&)UN* MS-5DKX"XN2"N0145$#\)B"<$D4I2!4>E@$1DDR#*37+3-@)Q47).$6-(SCL^ ML*%!F%7J]'W=Z'NV'GFEMW=S>GL7VIJ7MN[T]I;IB,%*8DB6(P:&(P&=F]N$ M((-V)&K!$VTQ)>8J92V]O=<.^$OO[5V 7P/PQZ(CZ0WI/?>@/#60J#M]AE$$ M&JB4F@J+8LX=P7RNZ>REM_C,&-$LPN^_W0=5>M\(\[,]UWH=4W MP] :?5[UVCHTI?66!XP3:"D$T M@"#&\HI[922.#"R)-,DKSD&Q*$!2Z22QB#!#YQUX/RN<"D6L D4L+AI4*.+I M*6)":@D;.24<@7(R22WE'2BK-=#(*/8\&"N2#2$6:D(\F/0?JZJR02*-)9$*J(8.T-,J!"Y@F$E$>#"$2Q>6)M M]6)B.P]782TS;-GPKMWMYFS 7FQ=!?/,RH9F8<,\P=![I1/7,8VUDH@++ T+ M.%E4%/^]_Y *[6\&^HM#:GDL=V<>C1 2:V=BELX8F* 8-!<1A$"2QLBHQ*&* M_2LVI?MTZ?RT+A@7/A 2L-7:QY M)"*21$/ 16N!)0L6M.8G",.U+15_>^G6IQU M(7PE=32:,*\)9UHBS:.5C#.K7 "*2 MH1S]$LZ"$DH@EO;;C/*R":KA-*@77T_LYE[<71:6G7%]UH5HBQ-LW8AVK)TI M3]9V" Z()@98I JL]1@"1DY$QKFCNC8G6.T0*US;)$HI7%N\&%(& MF[9*@N,R O/,@4K"!"R-B&CL@M:N)F=D8^BT=)LLBS"Q"#\-37K\TK^^_7'K M7^G#S6],/%4N\4SH7]/QUK]L_Z>MV^?^H;]6&XMC]#T:)YG&3\Y"RSC7.T]_ M^RI'S[N]87IWTT_?[K;:Z]4VG=6'Z57GJ\"P,0C7Z( /.9!?9=1N>]$.# M8?I&U:!J\][[OO[CC(QZCU[T!NU,$R_[H6.&[8_AYT]M/SR[.6,F?O&:"M#X M5XQ-%W$YO/]7FK+&C-]=CLF/^7*KXRAB(@D/BB K&/+4AB11@B9,"X:15'\K MOG'S2V?]FUNX,.\"V'XP'\#$=(>3N1IL_'1G(<[;7?ABX>];LW/3?Y=^ M^GJULREP_9W,M*JR%.]9PA@7MH0CZDZF06_4$?IE.C!"/_]4NAS3F&MIG?6S MO?-?W]]+F8"7^21#*G>]SICYUT_F:[JXGTL:P"ARZM.^M_O7]IO=X]9O^Z_V MCG?V]PYW]HY;.T=O7A^]V3[9/SJV3O=W6\4GZ MYV#O\.2X=?0J?76T\W__??3;[MZ;X_]I[?W^Q_[)Z;HNPP_M;BN];2=!8_!C MW37-)S_?G.KM;G6]U2_]?)?I,B=^80]6 MUSAZ^9HNM=[D F?&O+:)KO_P-9EN5F3ZA8D[>HVH34SPO2^CS?M?^];;LDTI MZ:/>]=NO<Y<..R?U7?0I0?_F_XU>S3/>\@,>H?59NM>FW_K3="Y#O2RS/@M4GJU'+]WV>>^R.US, M\;4:"Y"N-?OT3*?UVK0]M+NM'7/1'IK.,UZ4-V%HTC=]:\_TST!VT/X;6;[W!DUZ"RL@(/NMU$BL._J>5 M0_##JSN+LE;IY=-7XI?MW[8/=_9:VR>MW;V=O8-?]MZT*'[1RN4:"^D9]*#D MFM5)(AE4I_@7>2028VJUH9I1SJ1QRG%A\X!I:[1RQC^T&F9D(NP/!I?!-R8M MY/#X-BWD\^'N[_3M;N?]XCD[=GA^04O3W91H>[;]MO=T_1X:]O M/HS30APZ)7OL\/,^._SU]T_I]_\Y?+_'W[Y_A][NGK7?_KI_=?CK/CI]_P?_ M*BWD\YOWIR?OTG7FG\WOOT<.3CKG1_GO_OJ?#Z?O\^^]:1^>=.)!^SHEY!A] M^MMY327C!JST&)AU")34 ;A/NQ"\Y,Z;C2V"R90&B>O=E6.Q(%Z7#+EGE !7 M&W%-G*RC<[70UVST]?F6OH+T"CF%(5J26S=2#CI:!&E?B,*.6Z[0\Z2O8H\\ MU!X1RB+)0O2(,"'3PY2>&B80,8X8P1YM^[I@E;LDGEIC-[2&"6. M)QE% 6N:9!6A 4SN6!8]]<@ET:6H2C3&R29>@3YEA<,*ARU"427MQ)$P,4LJ M)IS4W$LKB"->1R$]OI_"'ER^64AM7E+CMZ26A%:0"A- +D9@S*I$:EX!-E%R MY7# G%05F6+:D-)BGQ5N>T;\EB_I!N818 P-A9'BJQ2>:I. M&3:Q:M"<1=('%X@R0:G !2..*LV$,)(ZYSEWO 24GP*DUY+^BJ#2' ^3]S%3 NG M'1:2!,)&N +K,05A;9YD&J26.*>LB08= MGL^K>.<_VX=_;+\Y;8U*=U09]_VH/%GDD=#..DJ3>6"XP31$+AF+7DAC3#N?CA%H3M<6$'CM2'I/$A>I\CT-Z"#1B!=LHZ0@U! M@3R[PHYG#.P9<$V,-%A0AP0)S$=II>58"\)"Q$FME6R3)B!]7.V@%&5:AP1R M3M(I+I/,UC)*P"S($ /WQLKG6NU0 /\0P",7&4^R3BL:F<+*2F^#PY02[X1S MWSC("^"7YU*;B(-[SJV,5@')1SJ3,4%>,03$.A29D,1:5I4 2++)"^2?A6=M M%LN=2VF=MB@=],E&E%83R0CU$7L=&([?J&B.0!^DD!48L M!I6;Q42A-?4L6V$HP9NA*>"NSW9?.U"O)JYG@+4AV56NF$'",ZZL0=Q9C[!) MAGMZK1CNC0#ZY*1#Q(0E5 !R#@,SG(%F48#$!CDOK*#^.DU<34F5:>@Y_@S2 MQ _#L-7NNM[Y0_IB/^:&&\="#V\;OXRTY;)B9<7*BI45:^2*/??D3ZHXM28$ MXJ1@##-#C,5:YBP@[!ER?^_FW#:$$8:'#>).I^U^==CF?N?;'TV[DR?JG?1& MXX F+=)?S*#MBD$ZBT%Z?,>Q)(EV)L;L6/((F*8(% \!DJ8@4B+,I(H;6Y*0 M^:L6&YR^73BO<-Z,!=K:(61E8%YHQKU5U!)&%0KI*T6$*9S7,,Z;3(M7T5J" M#!B"*3 >[$B$JZB0])+30'SS.&^M$N.GXV\T\L3=&7DR4MTO6MTP&A!O_GD4 MKWU_,1K'1G.P^$.=JV7%RHJ5%2LK5E;LN:W8 \)J:VV_"^.ELI$+Y3@C0EJ% MN:'8E'"92&B0X".(5L. Y6)0+T$+T)!")#?4YJ[VN"I45#9.O-9YK MU^,%S\O%\X0^]X)%;BD&'57NYBUS-@QR$*RPZ1EF1%O4-#PO.P;NVQ]OWOOZ M+2#__$M]\Q[MKD^/X4O0%5\\ 7A'CJOT1WON0ZM=%6XE /LD\$.51M*ZZ*0W MO]VK=$//WLTXM8(N1,[S%!7DO6*8:,,H$A(CQ]-%LDAG9K;*ESBJI-N][*>E M>YWNHN?_/WOOVM1&KBT,_Q47SWEJ[ZE"[&Y)W2W-/&^JF(0])Z<&,I.0/97Y MDM(5.C$VQVV'D%__KB7US<8$2" 8Z*H]V8#;:FEIW:^QPB[\^ZNJG$7>!XQ/ MX18';G83;G;>JX;GW#*0388(4$((+ZPE<(.:L,+PQ#HAE,FVGK&-\C0.L8); M'B;R@RCX/VJ\< ,!WP8!=P7P!89'K1(D%[0@G!E--%;<)%X#82MO)!;;/&X" M'L*C \2&@/(=IW+GS&6ZL#X7G@OEM;:\2#3U>9(KY\4@)#9.2'05F0KM4YKF MA,I4$:YL1D22,%(47!?26"8S@_4;[/N3N@'U*.;D& @ Z(1UT," M4H/L(_<9?_ZVLI\A]#P$ZP>(#1!["!![Z@'D6[>_=^V'134_<9-Y=3C=!$,YP^R*0C!1.L\%9Q+W%60;I1 >:!0]XWAQP@ M-LB4>S;6!YFR63*E;]J;%*2'<(S05 K"O5-$\%P1[1)."Y\F5!0;)U6>0.N. MF-?29""5D]&I.D<*PA8X@5SA'/@K_%B5ULVBV3\NE2['0!FNVA0/\,:O\2A] MLY=W65N;K642[D"CM,Y2QTT!G)Y;YXND4)EV.;]Y+?Q7L[5V3>3JL*]JX-TW MX=UO>EW1"Y%:8?*,6$S/XM1H(O$?D\HBH9HZ;,<3M. M$2Z5)%=.%5K3(N=@P;/-*N >Z';# M/78#W=X-W7:>-UHD%JY,$J.Q?3EED@AK&,F$5(E,N0<#&2L[BD=,ML,: QN[ MMXR.@8U].QOK.WNDI&FF"D>D+D !,:DG*LLI<9E-#=R2+')40/CWSU\8TCAN M0G=_+&;F6%6P'O:*F3E5+6;GL09MR. 8(B%#).3^ZAAOW/VPV M3 B\V=#PP]UY3[2I3.4IQ1X*U'H0;0DC,E.,%/A')51B%8BV[-;&C&QB*#1)'#6Y)8YRL*P5SXER5A'# M+<]46A@PK[>>%7(=W=YX@L@FDNP#7.,A,(U!F]Q B#UY\73K/I-!/-V!>-H_ M?#N/K<9!/DDJBYPYXJW("<_SG$AG!%'*L$PRREBJ-TH^7>$LL65U.E;GN$_W M=:8V/#D\>9=//JH4KF*M:/AU]_?=@^=[H]W#T8N]YWO[O^Z]'K%T>X2\_5)! M>XVXPE,9'+?6'Z/S//6)<&EBL*(RA*LT*L/%%F!UWG7!#6#S&&P81 M>2,1^7+>G\0A-<8_$Z)XFA)N'%APUAMBE@8D+271 M29&2-,6_"P%FK0!3]OL#) -!/Q2"OI'OZIO)N1W%/@QO_H&$W\ERQU*FJ6S3'MLWK*=@#3GWU\K,-#]QM/]309.^-Q*GP/-FPP6 M,UJFS.G"&9_9+*/JGA6&\$+ /SK#Z?;:D"0O%!.I!%T,B)UMISQY.#K\D)DR M//D@GAP0=7CR03SY! HC#]Q\5(8!ED,=Y)"Y/D!L@-@ L0%BC[F>Y":&O68Z MR1CSN6)<)%2KPCGN-:.:%CJ1H9Q$-N4D\KLL?!#$W2#IW4^J',>QT7%<;M_^ M_U55I1G,_QN9_V^7W/DIXZPH4D,H-RF!F^5$.&>(+X3&'(Q,%GD(V//\^QMU M/([:R(= V0-'O'..Z%E2*&^=<"+CRBE%3>HE3D0N?2 M2,DL3W,G,Y_GV":(IJ+(A+^&9#ZK]C53[=TN)3$++NI3!)FB*!RBB,0!..% M8YM$UC\ZEF[+3\W:]1($G_]9-FN4$PLX^#.1@6W< PU'/]8H-"%NQE#!^<'8 M=R'#;W0ZAL7;NX(#/7F'Y-HZ:&I-AI52VBO-I4Q4XA@#A<49)77"KQ.EN<%H MI?#OKZMC] 96=B-69OH-3A*3.\>%(SFCE'#A04&164&$X88G+DFTU3C\89/\ MCD-$>UUF,YW8M& DDU81#G8C*","QS E.?>)+:1B MCYV$AV#J +$A_'S'(_F$I99RD2:+-FQ4X^"(J![0T0&P3%_>4I#8+B1]L3 M/>^FQ8X*U%.2*I\2GCM.)%,Y\<9H#]:$S3,)DB)/-FK\A) M:K!]Y#[CS]]6133$HX<(_@"Q 6(/ 6*/,IQ\GR;XKOVPJ.8G;C*O#J>[ #G< M@1K_H4K[>:"MSDB92Y 6EWBNQ]4RD.VR#QMD.//*^>>0 ML4&JW+.]/DB5#9,J2[E+)M&%9)9H8P7AHA!$&DI)KKDJ4L=DZNC&B96A:\WP MY(-X\@ETK?EC,3/'P+BK4/]6SVB,F71#&YLA[#*$7>YQ?)PQDB>9Y5057#&C MK,ALXC/)N>;&I#?6Y)9&L,80(:6$8)7$!&>%$X MHCSGA%JM?&:\E,IN/4LW*KXRD.LMEX;<+;$.\Y)OB6J[1$O+-$N< UI-@&!Q M> !!!5$\X(57&8"[*JM9S1G:TRG>QF7/)#LM30305/ZR^-AK(/F.$!LT+4W MOZYS$-YW+KS[?L_4:4<%CG)66A'.$T5$9BP1UN8NS2BUAFZ4]!Y\GL.3#^+) M1Y5Y5ZP5#;_N_KY[\'QOM'LX>K'W?&__U[W7(Y9NCY"W7RIHA[DM7_=6I49D M/O&..B' Y/4J*XP48!;GZ 'A:1C=*R)?]6N!".N:]M*0H)$C( MA$HBTUR03/%,\DS+U**$3,5.^E#&LMQ#JL!3(>F+.O&MT?,P;^F[J;KS6G&? M4)> MIMXI8&J"T94GB8DL:G0N78:S):!J@>J_HJ@9GD.,!#4.V=Y;JF2FM*< M<\$H3WEB!D'] TBZ%SXR/M=&:TV4-AG./!=$HQ&?Y&OM]4.$?'VW?A+0+ M4106J[V3E,M4BB+)9+2@WF169$ 8TF"SSPA7<8/(S3>KD9]!(KPP,#]-F[U(CW5_R,-E,"\:< M()Q)1]#91.#V/,G!$BV4S5)IW=8S0=D.?\35AP/3&YC>S9A>XA4S.K/,IX[G MA9:Y2$V:9*G).PD/T=(!8D-\^6[% MA*(9R[3C-BD.JT$A3;R*=\&*_]@VEP&*\]Q.\'B T0>[(0>Y31Y/LT MP8=!J!NEA[WK&^S2V]05)B5<:?@G4P48[%*25%MO4F-UH8NM9Y+>6IN53WV0*ALF5?K6?:8TYYET)->)(F#A"R*M5(0*:UUF<\9$MG%B M91@U,SSY()Y\ IUGAO':0]AE$R'VM,(NZP<699II+Y5-F>3.%T+8O&"Y23.F M.+7^QIK<,%[[MI2PH_Y\!&\930W-B4D%F/:<:J*R3)(L=[10DG$FY=8S]OT# M3S8X$O\HR?4FE2%W2ZS#A,Y;HMHNT5*EN80KXL1;90DW:4ITP5-B!*?4&VV8 M\EO//WP1.5&%^P&OQ'>234(S)L(S"^[_2K=).'>Y%:"J$B5S"89H M8H7W.I,:. !/V8[8H*#=$*??N#K=2UJ)7"M@WY+R0,DWI>3.AT0Y+YAE&7$F MSPAW4A IN JI]E;*%._S\5/RD*,T0&S(ZKICM\C]) L/4N);I40O]5?X/*-% M0HG)LIQP:2S1KC!$9X(:E0MC.&-9X ,_NQ+M[^@+DO;C:UJCH> M.-R/U8-[+F!JI',N!1W8 G?CFH)PB:TE\V2!5^5 E^ MQ5JZ_'7W]]V#YWNCW_N_[KT>L71[A)3U3:ZU&@3UV+]XM)\97("= M+O38M:/_^G,!=[*ER8"/B;VM3]U*J8-XYQCU.SKR6 M.RXL'OUQ X.Z$8/:Z[O<*:*,XX:D0B7(RSQ.Y]2QG^:T- MY+@U\KCG=)'[90.;%JWXKWM#@QM<_R9QQS6)3)D(9AT! ME'.@Q:64B%1K(@P3CO-"9BX9&.3W9NX,.M-7=":MF).**6JHX(6RDE&I39KE MB3!.>COH3#^ )?32VC.N"Y/Z@K"B2 AGN2?2II98:6QN3>X2DV\]2^FMY;4_ M%HXPJ$R#RG2[SO]O9XUMB+CO,)LL3NQT7C\XZ%6WST0[O2K1>6I3IXE4UA!N MLASKLQDIC-:646Z Q0(3W98)_Z[Q$@,+'5CHDV.A-^"@0G.?*R6]!JM342\Y MDQFE3G-8.K/N<@XZ,,X?QSA[05.:IJER24X22E/"*2V(THH257"C<:U-"[EQ5>\ MG(.6^2/Y9F^V1)XX08TCW#NL9(-_!).2Y%SXA.4Z53D/6F;!=]ACT3)#SN"_ MPO3E9_4LV=Z$W/Y W%3<_D#<-+F*[&A7DM'_=WGZ[>J.XT$-[-K-[FG+A\=N MI Q.PE"3<[BDT60ZA]75#/X\&96PLZ.9&H].U6P>>A4>N\HA PG7J^;.CGPY M41-3PD/5'/X0,G]W+CUW_7).=PK DE].IU5($/YYYL9J7GYROYR5=G[ M%VO42[JO* V;6,PO_\JFP)CG*T.0>__B=@,']"DM: :$G>B<)Y9IQPOA@#%+ M4).20KP78JOYTO&L.<*I.G)$SYSZ2)2'$_ZLQF?JO-KZUQ(@3LI)LR/)D3HO M!=F)FAW!PS6P4=C4?T'"_BIA>7]G$(RL H3+=!8Z'/\/'^Y=_!\[\WH^:O7?[QZO7OX\M7!C3GBNM-OX+D/ M7AW"00]?P5D/WKSZ_>6+W<.]%Z-_OSS8/7C^($5C:W4)>RK& >J/EBYE[Y5Z:LKS_=]>GOW]UTO^ZK?]+P''LX,OYLO!;_O\ M'?V?^I-3P3(B&:Y99PF4BB.$N)I5F-N.I<=)PZ1GG!:4LL9INC1QHZJ=(9[,%L-L70-.O7_Z! MA#QZ]>_1KV_?O#S8>_.FT3+K"[X)([M$BZ,4Y=0]"6Q$UQI.<3A80*8K8?5L MSYZIF:U&OY<>P%:ZB8$]/9_.3FMA,?KGUKI'MD;3&6I6HZWG40_;^@FOR2[, MO!I-6YP>G4UG8PN2&U4S.RJK$1P4Y#_\. E?]]/Q>'J&2MR1FX+:=GJ,ZO1H MYH[PZS^/WH(5"$^_036MVA[M+6:P^/;H?Q2\!JUQA-KHZ6P:3XY/+BT/GWR"T]N1/E^_-=1:#1SN:#J#VT:X MS*X. =<7U2G8.;!Q@'>)8'VS (4)X?ZF \%_(P@BB)_79Q\]AUWL!,+I MH]HUJ8,']?D*"7E-R<'O7W+0^Y(<;T!O*#W[%V4)BB)/H#T.!Q_V#]YEQV\.#[^^\51$M8ZW*7PWY?]%^_X_N'? M?O\+O./#Q_?:>26*E!*I*"6<*DZ4U(P (#G-O"\*858%BA(J9ZQ(9:(33G4A MG7*%S67&+"NL2U<%RINW^_N[K]^A,'GS\K>#E_]^^7SWX'"T^_SYJ[<'AR\/ M?AO] [^ MN-P?LW)BRM-Q'/NP=)T/7&&ZX$6ZTD,$LMF,%Z#*S.NO+O"/ );U@AWUG3DJ M/!] M,_/R?1L @M7"UV5ME0S8-8[HUU0)=!A-:OW,=)JK-JOSU&(1Q]H-3I6 M(..UC@O JO<[/<.#P.G@2V8>_E9U\G.$P/T405"_LMYV #_\.M5@ID<.#*N@ M^VZF1^-I%>:@S& [QI7A7G#O %H_FY[TUPGJY8G"TRV]N%;R8,L[HS#&.BBF M'8C^@1B@QN=5">H9'*B]'40JO(W)=/[5&P$HP^+5+Z-C ,$G-]L>^05:G"/X M91+0\KP!9G@0=Z17W*2E7\(![0!+W:6(<+D#]5*:?RB\XKF;S5$)A^L>JZH* MEQBI$D!]BF0V751C!"B830@Y=1*90T>T)PH91T!:#$*%'U?6"O9);1>9Q6P& MQQZ=@Q:^ MA5G>)[].W[$2JQE>>;I9Z=#U.(O)J,]H&0BM@E8;M/+J&'1?%+ M-?IU"L(!$>5%X$'3685!R;%"+J9&EX8]P8)VJQ6QCH'J!?9[EDNN@W>W3@R]O*59S>%"O5>J)3(0B<%<)4=QG M)))DNYJ"/3# T.8JUD?@) ML.63Z:1^/O;%[7M8@-L$&1T_!S(J@7#L-KHWYK-2+^91^B B4QDQ&=E3U;M_ M7&"& 83VR53$)Y<%>W_)^=ET-'%GZ#")37LOV3"\:LU;_,@IKVZK50CB.YN"+_4OM>90(Q>(&Q$E?'M^YM"=!-">'U>@QZ#WZN*[P@%1";GV M(9S=0GP)3[[?=W3^V M?@(#L@36W;T]\&-GPTE 0,">42C WX%7XRW-RN#RKTZ!4;0>==QP-+S@%9>8 MXXTVC>PKG 4WT)@U3:P!'T9.=*(^@O73($9@EJ!_+TY.H_8=+#75295&2K0Z M?2-/U^6.C';-?!$/L1C#ETRP5VT)R\T:FW!:]5Z_,QJ]G(04E=(L0!?O_O/R!4DEP!40T+H38'1HWBJ+VA>RVQ)D;Y#X=8AE M7'[$/\.1_6(6+/G59T$NJQE>. K+"':$\G0Q&^E%!5A81?B B??1S=$"#9X/ MQ =\!A3&CP!VXSHSN8OXU.L8D !@+<[@R]4BW#_^B,^W;\#3 ^K5-^X7L!F@ MN_JV(@X%4[,Y]1D&7J(A#WL':044VOQ6GVO9@F[>M-W>"VZNVRKNIKM.#%^% M+)W^<2O0:.'[[C/.JL:? *<67F&,!#[>!ANNG(30R!R1.+X)8 M;Q\4M&-OC MZ6G 0#.MYO7GLT\-_F&()_A[P#Q7Y6ST":?.C$["')J(6MN(I"#S\8#E+*X$ M6LP1?B4Z>X_BZD!:UC44TWHM:I@'CT3 ;9#0 ?A3OP*L8V>/\,3E!.-@];LC MR!T'1E@C_F$[!4Q,7P072^A:!C#>>W.V]V(CI.9\#_)Z,CX 2S2;CNWL:0 M1TXGMO$> 3@7T6J$S1Z-IZ ECD!]GDR16FK7UGG$\G#Z^X/ ]O M2*E[(BEUU[V67S8EL>R;$^H>S FOGSHW^N?S)B;[TS>?^YY.>7F.P_5CX%\] M_S6'OSD_[,7\=B$G8[!EH8GHR6((93@ M2?X,)A/82:@FUW[C^HEEORJZ6'; +LHD((V>) HT= M]+#N;>'U&!U4< )0HVVP&:--&X:E1<,W[B@8* VD6EC..VRIO:K16JI]M97K M@*J"8>;=;%9[ OJ.B[[;]Q^-PQ>=".A7!Y,";0!X_U:#=7>$3V'%G[&=?FFN M@6&[QBQ.%A':KX+-A$@UO< :2:$Y55B/'"H3#=_0R5"+RDV73<: ZG@/<^.B;K\&/5QD4[)^F2D[D)8*/$#X^';*C B,>1S[9B M/].:W:?^]+5XSL'D3I]?&7&$_TA^C1JAT]6()=9;"K+[J$/BH,^]J6$6' M>O3?JCJKM 5C<*+$6SJJ?9^S&<*\#K*,7E^Y\#)VH6=Z=#H%33%$;P 6$>%J M%2SDPJ#ZU\ORPU \_%1Y#%@M0#4"J3T&9:-+2JQ?N+J=]CCU_@/68*[=='9^ MR]N:XH>]K81X4(BTE2>GH-"&A(Y9S"?3YTLDLIRN$=70NJRER1;MP[\Y0=GF M/?AR=M(DP"YFM7>[)<"H-:ZF/8Q1H^H$T24\&P-\%]"FIJ?(&T MUH&,%HI7/8[:M](8)_I4I[)B F5SA^UC<(MOPL7-U>1+B:+:A%*W<]CE!..B)APCD$"F8!!OT5@#F]%R-P62H7]0:(&"?&53&,3 (:% '?C '.( G[ TKMF9U M2FWO^H*!5B_;8C]F1X-U@F=!>NIQA]&B:HRG]]"_P4$L[K4!X",K"V&$2:+V:3B#K;-1>;.1WK[6Q9Q33W[1YI@/6! M@O'3.KK M.(I1KVW:^$:$JYB.H$+X2TT.]ML\>5#!#2H0^3-97<';N@]Q,%J M-%IF,[595+5A=KN:Z]4SQS"SP;A&A:CC8#&W&G!*A^W%V.82R>$N9@"ER/:" M=8JF:+.YOFJ#L5,DXH"9'8ZW =)@@E=34X:=!JH,$J0L3[&,#1&?$^G4>_"K/CJI/8E M')<5"@[38T^H7,U";LIV_^,8OX-]'Y>G\78#+#'LWFZKI^(U,G6,X>,:,1L6 MW#"Y&H\C/PR0K;6%D")1IPWT>. CYQJ=+ZY6OUI74@1^5*7;"'8H; @<8'2$ M^0(-D73+K+C=NB^&?!G,<9C4.G?,@<$[![DT/W-NM8!Z;;9&ZLN6(LCE8EJO AHR:Z])U?&K+,U!+)24M1L1Z&GL)43;1%5\^[M4=0;UAVV)QK6K[UZU+I@ M_U.)I0N!.%90H.PK$+WK;"'QCU;..-NP%5CQ:*90A8*?/L0,_/ZUUVDXG=3K MA&%4;N*[D9]=AT$$C;ZSNI:VL,0%:H[49IHM155BTC?C!A"/WK@2HZJP]FCQNE#)/+WH.ARRV7Y( M-IL8LMF&;+:'ENLU9+,-V6SWE,UV97;:2H"3YH600(^69I);:F6:">H=32T3 MAC%]:9^P*P.C*UES1G(^Y5!GEF6"6)JE9(WXV0=O[6MR^$-9G MB=+.%X:SE"J7ZP)^*/(\R7--KQ^W_Z,+X;QJK947KC*S,M0:O?*'H6;@"0;N M]S_LO:^.X\2*SR;*E7KGQ&,LU0D48>AR#!\BN MBQ%%I_,L!FK1C$PIJGHLK^M9M_$W[,02JXW1C#IV)U-[#C<)&-'85SNK&N!H MQ='\:1KBT4OV9_#\3.?8:.T2+WUMC*$#_;31E?OAJ,M"7->*9>V,1KM+A<&1 MM\6*79J$M==]E,KMT7]M5O?U=5DOOSIT2E+\ MOQG9B+NU:PL1/F8F_MXE%-]G8F* 5OI+V-A&9G#^/ITA"[WUS.T8N8 M0'VAU=\1VS][;WQ&M3.&"&T*PKG. MB+"4$@K7(HQ)-./L"G$7O.#(K_IYT_WT__7<\#)="A6F$(EKT!'_<+OHZ%E2 M*&^=<"+CRBE%^K4B-&RD,0*\NZ_X9^ J,^QE$Z?(DPQ]0*BR:ZH;3X_.J#?U_ MZF+);89$ET=U.G-8-5'%P0SES(;^.N=+?4E&,C8CVEMS> M]**S-Y&#;H]^B\'XJ)_MVI-R@J>/''>O[N%SSQ6#+15=X_KQ;MJDLHM7O1V0 M(AZV[O#5!;N1?V&P.\Z#V/ +1(Z"##3DXK>LX@)/N:^8P1I>="5OV=FZ>(!& MQ0A"8K6WXK*[MF]HH(ZW'3,76L1!:-W$HLBY91J,AYS:C.?62*=R(5+)#9JU MW-VN@5O-7_G?L'IK=V+?U)51;Z;CIVL]O'JQ>P[6 RUD+C*;$V,5!6,6[ AI M&"?H2Z>YX$QIO?6LX&M&K7>>O)MC(];=K M2 [7?O':O^P?O>*H2QA)/"YZS5!:9H\ZG4DE#O7C17+X:KO_6K3_:!XE/OI2X M$9%:0Y0!7L!2=#$BQ2<[^;5]]V=NLX7Y ]+&;LD^N^,A.JHZ!JK"_\,^[)^ MG";SH1M0MO]E_WVJK32%UH2E0@)Y%9ZH-.$$P.BE=X)Y*S:GJA^O<-2[PP=> MTM]WVC2)#E73!W1?7LA=,Z;P8*Q9;ZSG/,L$TYIE/N>)5H7$ M\7";PBZZVWY,G"*2;2QA<9\-TGF@\!);+>CYJ'*FY@M]-U6HE[ NY+R'UL&"*OCZ6P>HNW;=87JY2L>8=O@IEE4 MN_;%-<=- ']Y@QX:-L!5\RZ_/U[SKV(TMF4])]PB6 MQ*G9K*R[79Q@IXT,5K[UI*+[]%82,U3#$/$U)"44F=35 ]6RR&I%0X)[.,)%H9<15DW%9 M?OWZ5XIHFTJF.CG2X?T&81[*F:S# JTVO3($XM9T]7LJH3-LM'+L8ARZ[=%^F=K5#3U;(D!L0!/Z^82JK[B)$S<_ MGH:6[=V$B5"BVL.9G='>Q1V'3=II"/R%3BC8^AU V34WP,J3[NVKQ:I1)02# M>K*H>JWTP[A @-OVZ'0&X#B)P1 X'*LZP M9&:EX5_3)04'+L4)RM.NLTQWOB9J68&N%X+D&%\J<,IAN-7)Y19FN2, M>>\SRQ632DE0[8RP>09*+^/K'1_1@]WVBDCPIC",)YY;PM#!$<)<3J:7)4ZFT%W3KV47'XO]M ML"[BDW/_6!XO]FDZK\.#YN/V]4CY<@[1T>'%6'T7U^I11-#>FC%2379%.;4M M2?4:2#0CPE8.4\8^KJAU3:M:BVN&GS6%UH]8++R^5/,)\R)6>&LHC45=+[:1 M;8>-=EV7T .)DKQF9JU,CXBP/:KOQ9>S"@&P7?\$*-4^TG4?J@N#>Q<^/S]U M78NO@"V@?FZ88G:AN>D]:V%UJ^*85(3W-+U*M^IW/]D\^+YLA@?'@VURZ]BA M(OQV*L+E4!$^5(0_M'KIH2)\J B_IXKP*RN\5[S=8!FHP@ME4^=XGA4JSR1C MP@M;Z,(F^64)3E=ZR3=.ZTTSI,R+O@/T!*(6>H7+H$[!BU$L= L&+T&OK\PL MIGU/0O] T[3=K$V:ON/CHEE3:S4XFS%V!5+UZ&$UFYV']-I@$;6NC]JX6K6C M;KH[-,XF,8NMOR2XA-8XE):, MO(WRIP:DV)B9!&$W6]>T.J^:?;R)Y/=BU=P(K9QZ;G@T04>-FAKPY@P>!=5@ M9*=GH:5;CY+FQ[/IXNAXXTI+UR/5?>)44TZZT@(OQ'%LB*-CD4FTX^/MQ &J M@2>=8))Q,S0665/H/+T:)PKM;$._K3!=UZY?5#L<@1*80=,S'3W^RP$@+(DI MZX*;"P;JUS&F[P@^0>]^\"?A.Y$3P1/X"E@*9PHO%^7%[K3PAK;]+7;T[-A@ M#^^.5>/Z;=ITUYTT&P?*K"[-P4&PV"T"F[>=J(_158)LN.V$N[R'+DFBUW.X MG4/0V\&2I%@&WG;K=6ZF@$;;O_$AMS=QC@T:XV;5Z^!/,4&^:XH4>L9W(#"%@#S*H MZDIKZO2/V&J]N8IX;1W2G#>[7(=C%Z"";6X;[]9J8\3>V(CJ. QPUIU8:T(% M$6N[4.1\&B.1:X+&YVU7=37NS^]%W.V<,#6/4Y/>5D+MT1+*+0\0V,!R^\"& MKA.XO%?96_/):]0N=:X'BQY+,G9^_C/+&Q/MND+Z;M.!#F?*NMV)#;#>K8-$ MK]MNJS%'Z(F%1?:_[)]A9J#."L&8UT2G@A&>44=DP3RAE-E,:.JS)-F<5)_F M\D;=[3W@W5,7>&IS:GQ6K*U5-S+JP?PFI_M8F;5 M>4/=[NSG-;0CLX/=]SJ73&>9(LS0G'!3 MI$2EWI&"6NU4;C,K_-8SEEQHXP7R_VNWZ5QA,P7K&>FY]KGP*9?AWD2229X, MMWG;M_EY_\_WGBB< M&#VNB^X;N'V/#(@C>0+.A*DM(5/C0M)>UT 8&"$ M>&L]$BBHPO.HV@?^%_+TKGN&>I'V#&OW?@VCJVV8=QR:R%\)_#CTH)84*_N+ M 6.0 92TZ0L* MK+'SJHRX7XM^S&W%NOBV0WHS?Z,SY*.ZH6#W=M%V:L$1-< 8IB=1CC2V-*Z, M+@FP:><7&__W[>1Z-M@Y]FZL\:V7?!'MW\6DH5#=9+S6+4( 9+7WC$R];\$; MZ2# _!NK'.[7JGG93#5Y\C4.\(ZC]S1QWC* EU2Y)[R@!5%9GI!4>282E>D\ MX:M1GY1G*J$JR:VEH,T(*1W-,H;3T3.>9VIS#)_FLGO]^!Z>P;-ZDIA.->^/ M"<>Q$+/8$19(])^7ITG]- K3&4*\:EQ^"B@Y1SMY676[N,1)\WM!H;J2 A&!)$4 M"U10@&-\[ 1$&DCU"X,]@RNO2L$)>VT MK#L(8:;ZZ)^=.0K:W]%1"/36LZK\ M7)).#%WLI-H3@+J,F$\1GFA'.4_1?"$%2QXPOO,8T[JUG\[,I M04OK M)4B]/3\?E/J_G+MU;$NHFL>7V:RI6*SDIY3&P"5S69LI%5-U9 3#I? M:E,0>^VT*=(K@;':_5@/&4+Z:U+@VUY.8;QFB=.X5)A["7!88.0L]@[M.)W #1^<[:]H-U0USO[7C MT'P-Z&[6@^0'](JOFTSL3NQRAXG0I.[EI&5*T;YZ67?7>K)M2?8/]\\./KQ[ MKY31CK*$9 !\PJ5(B*2>$JUMYJSVQA5^ZUG.=M);ZD3T WK(#ZAP MY90QKB2A'G482@W1,@%3DSI3,&F*W&9;S[+\JRUJ;MJ=*+>.4I=JB5W47&($ M*[+$:4%3GTM?J( .W]>4:$"';T"'H_KJH>K[_Y>7[3"E0]'Q.\D0 O_)@?6FM*%$%F$F)REUF!(8!=XH'-0ME M0(=O08>/[TW*K? /5B[?O92:% M5IDAN4E!KL//1";6$\8*G26)D(4#ZDB!6UXNV#>16PY8\N )7?UW,_TL&V7Y[$KBA1#> MPM,V=TQRS"%-E7 NJ#W:"J._/H/X%I)G_IA-3]UL?O['6$WFH/M@1>GIT# 4 M&X;"&N\%W)E,F 9-1R:$:U!\9&H:*#R&]:[- MZ&4_Q> M>O?4J/]PG^Y_.7K/F$[ VG4DU4H1;H %".DD 02UWF3&LX2#L7/CL@'#&2AG M'%@(A9U)(W.9)8H+0U5*E;IV3L5PF]>]S8,7?[[G>>Z%MI;XPJ/IZE(2O']) M8A)1Y$YQ'*W +]YFB(5'Q0,9A5Z48\R2CXF[Y0DF+C=U0U<3C6,W93.J9YX7,ADX+S!$B:R41AGDXJ59I+:XOA,F_],@]W@8YYZDQFB5%8 MS*4SO$S/22JIS7F1@&Z6 5?.UM-QD/4GRAR#!)^=+RL1==+K533LJ8";I-Y9 MH3GW'BM&E5:IL!IXB;?#M=_RM;/]+WOO3:)3[G-*1.$XX2QC1+@\)Y4Y4+W^;Y #E9!U^BAU=3' M /E5O=PK$VN"QKA4U30H#>IZK:T[_'Y9]]_'ILMOENR!D'Q@C!N[65@QV@=U M7^R>'8*;6E1M!GCHR3E7GUMK8V>$#CFP->I?5W5;EVB6W-4,/Q<'2 6@G'[=E,19VS<)6GV3&^8; MHU?],SWA8!3L%;A(4IC4R"PG-%,:- $.&KT3.2E2PIE+<.7I-QY11H($:GA=;.PH6SXC;G(PY775_U 3KB"LT]2Q41S* CSAHB M.06ECQ8FEX7A8$IO/1/\*ZD[-T\ZY* ,)!K4#9M+GEDM0"/@3"0.?A,T5[7^MV2R M+R7UW%;7][MUY/^.A?,NJ$%/?-;?2L>(\X,CP">1BP2]/C;)<*IF0F3N#4DD M" H*8+4JW1PW?KS$A^NNC_T.)Z/_49,%-@]-&P);*A"QT]/@#L>&=4"=)W5O M.WSF:%':T-@,R+C6QF,G!34ZF=HXX&GFYK-I0Z5QC$K=)!)GPX!]O]KHHYLZ MU#274%V7CK(*173X.Q;% R^(+\9( FCHL8/'SNAU4/:GGBRJ6MM&7;MI3K>N M9=$,OX'G"M^8Q,9#X]@O-6CKMJNYB6_LQGK%WYMY+*6[ZEU3/2Z/ZCJ?*388 M;)9L.WQ@LZ1V/$W[RO7G6K^#)LQ2=Y8#\,1GPH"U25U!'.N!%Z=UU*2+BUQH MX[>8A#X9*]OL[+06(LL#;A:AQUU,ZXZM'-5XM8M&6Y0<)T=T-5!M,[Y+=A_& M($1D:6[F>OM>VN,_OKJYB\*7:'+QG503;'9 M]?G(@(T,W/"2WJ[N,PY4K.K6.-.:0T;9%U(A]I&EO6O*3& M_Z5I;#NCY_4F+FD)5XN'YL0XD2S 9P5UVXK,KM/+$D+BOK#*$A!V4:DC%Z1! M.U H KMN=MJN$)MGN\_AT4"L2PQ@=8MU%]I:Q 2D!Z(N+;XS\I4CD)8*:-U5 M3P3IE^:4==B(: SH3EKN$CL[5:.Z_]/D:-QC/77;)UP"[J?I(%P#/7;?&GUR MQZ5IOH1A.FR%$^+OUWDK^A#C3FN?7>5.%=[WM3/^'^)%O3IU=3O@&I9J98S\ MIK647=EUX$2=G'L+O^P&.7>?4X*:QMN(; \"?K]WNM\FP*V6$:LL%A/!P>:U M0<59$B#H3'_CW.A@"@(OCXD^BUG=TJ;5":_VBM];OGPO8,^(VQV?0X0E* MP-^F4QN4-.0SB"P$4]'L"@-\>)Z%<-3V<$%;_52ZLR:4UL% 32:+H*V5D6'X M*1(]ML#!P%T82X)#(GV)CM;@(@P:'^K!(<@'I\*.D !, PIB4%M-.3.+$YQW MB3TV8E/]J%>>A>;O]2"57JO(ELV9"_7?JUMO'JJJFCAK-]Y\!HM9D#"*U/ M+%.Y'&X1JUHL6=[Y=H3-S6$7UJK5T^4EL9&D1LQ"BQE60JW5V:9#:>OD6L$G M%&W8*GB&G!_KJ #7KV[,8DO;FR@03?4.;N-^Q_U'6,7Z,UTZA MSJG3'SH=?#M7OP,>^!":#_=?IM:^KK9J0NOR>,N =*%];]WW)[04]:#:E74' MU- @5)T&!3%X]&(20\_:456P M-9WT)UHW)]T9O47G8;4P"!E,I>Y_=>G9[9K5]DX0N6U9K69^A/9Y%W.T?<>C MZC7#=^/N K<88TYX736_YE75TF B;*U:GIPX6T8+<70-G(M>U4T49=>08KN3 M_G:_8PSJTRNO3(?RRJ&\\J$5'P[EE4-YY3V55UY9+GEAFBG34DA-+95<^5P8 MDX#YGU)K59;I2Z>97FWW+[_',VE!J8*E1<8S+I2R3 GO89MI(8OLQW@&U@N9 MT#A^>1Y8,P0TJA__6#796OL#%:9.7T5-YEN5U4D=[0Y_[$USK+,R,8FU-B([ M)2R,>\ Q9SBH(AIF?C%?Q.396\O*V40K95]-5!Q%5&N%U3I-+-@/]6R]*]1+ M#.5W7J#5CUM5,>B):S3$*UT;53T[-EXR:HAH?.AVL",*POY@V&;%Z:P-W2T/ M"^RF(VQWH_Y",V-38IU5,Q\AV!% B5C3B4I]/: Q=#BN9WJ$\8NM5QN0RY=U MQF\SUG#LCD!SQO[H[@@+0J=AX&V+TE4P#Z*]WY^V$ ;_X0"(WF$0IYMD 55/ M4*F]"0T0JPZ*#?S1!50##$R2,%BJ!=MV%W!<3)JY)O![9\CT1B&VB1.=N5+; M0)&YQ4!F'+0(9+U,]HT9@M-10LO:%:/UI-=.?F>T=_F'*X ZG<&#,QREW(U# MZ=]9;_^]\V&\-F9 Q/0"[(@+OX3 A!/C9-]8NIGQ'0-^ZO&-=?%%^L] MQ*!T[Z3XCC&.Y0B&G76G+O"=QKCMWZG_ZOO7-76^_YSK^TSB4VP3BY(D%>WJYG^G!ASVZ?_8^3PK-\BPA3">4<)L* MHDS!"8<;U-1[H9C>>C:97L@D_IJ/M-_9.^:A7<-5&*XN#NNZF _9]2ZX48JZ MRVQ.F2JR7 M>>*%S)[W*:(8UDMJKVRQ(N!6,?'HI[7"6#T?O?6[2S"E/M.$I M LHTZUY6 X9T18@2W=4T-$FDA" M#7>.98IRI[&57[Y#;P MJL]//67C)4CQH_>YY9*FV+$AP?XKHO $F(LBM% B,=PP;S3B MC0M)FN5R;*\M5XY&-E+[6V2R=O1F'JS;D$>)]#%=A,1.6'3-C$9BZ;KJ$]5#:0Y&7$PI6"X<"#9L M^UB,K:W-& ##OUI4>*:V&B!43^ 1 J\,85OD.?,P1O98C<=N@C,=]7E3Q [P MPH"K^AS,W<7\.([2#EX(]=%-\-&3SK%4(,F=F\MJ:7@'OB M7'L5> 02CT#P""0F/<"7L0 _*A%UL+#G=*R192E5;PV<@Z\R&-0H6*H.[@&< M<03LT:@!GSPQ%(.&P=A? C=KZ^<-Z%DH!PX$M\/LM54.V0Z&;T<>VGQA40WX&KN>!(Q6#] MIZX@(:1I:. 3R&]-GI0L4*B=>H%FM]&#C5QJ,VI64U-.,$*W:.A MZP7@<5R];L71)]UZBVU\0$^!5GO#<+LAUJU[M0>H>H8N+M3=0)Q+7:,^[KDM M_PH<;JPF@5N'H0GNJ&S\LR9PZYCH$!E'W'K-5F)-#M;O780?\$]X17@]'-4< ME^Z3:S<7G^QOJKYPA?W'3;,QW-*2T*PWI *IAR\LQM$#NP2TT&MD/0+'!>K1 MR&5=OV)F=>'5"BPC2PFEE8AFH1)MTD 5-'2$V6JFV*TU$[E;)?MU;6+L3NR+ MSL#8BXPO*MY/3]_F!X?OWJ,KC(HT)=YCGK3TBFB6YT2G6[5O.4/-WL#!W1/ MW1+>/]O_\/:]DJ;P&05ZY$: .88[0]?+EN":!J[7MG]*(JV5NYCO?!;BK^=P>4#(=7>T^G!?>U53V^M $9N>.Q!-&JA>P9F'X26WDUU+A^S:(;OV MH>6>#MFU0W;MO0TON2);=C6[-C'&P1.YT);G(I>.,B42P1P7F<&P&C:_GO-4J< M9%0F-EMG0VR<-GX8O-'(_;7#M- ZX;).D@W:<.L,TT%S#T;TY4KT/\M)$] & MM;'N&1(:Q79Z=A=>_NGGJW@1:@:0CH8/3:>5^;G[XQ9;5Z5B= M_UQ.PF'#EWY9YFNHOIYE"ZK"6/G+V!=1+@?+U23V 8$!6A+?O7)VT.E MV75.%96?'W,N<:UCO0LM2O>66I2.6+J]=-"'<(W7.^X5M]B=J6:8R$[A2*,0 M-QXUVWM0-XP:S&T=.,'C;CT9P*5R -RW 4[+Z7/:JF[\.W0SP'.#YW?"\F8HS MPO\O@@=\HYG201L+6D6>->=*1@^!S_[7=4ZRV>CW8^>[+/NM "-BLO#OTZK: M;?*1#J?/0[SI#8;',)/2S:H@T!YZI<+QNY//XU'7PXRO[^\/)+\QUXU^)O^C;'9U_]=?#QW:$M M__YP_.'@M]+YF(LW 2 9&F:NLH[YQ6WY 5Z*+;77ZM9LXD<9303 MW)',Z(+P5&1$,>V)931G15((6NBM9SFPIXN="+[*GKZ72FY7_?EV+]Q ]U^E M^UNP< :Z_V%TWQDQ2@IG;*Y)FC@#=&\8D:G3Q&+"EV-:^2)'NN=KAN4.=#_0 M_:T;) /=WR'==^:(-HREF:0$>#/0O74)$4H;(B6(?6T*7C".=%\\%'G_.*-$ MEY4870;\[^!$&W?VRSP[USWD V6SB\HV^ M":49U5HGGB0^!9::>$]$YB1H5@FG&>,<_K?U+-UA-W3PW(O"=(6?>& TCYG1 M?*$ILWY0A#8O,CU=>&Q.;-(K2G MQ2N&Q.9'PT:&Q.;-HL*GQ4B&Q.:'Q2V&Q.9-Y!E#8O.0V#RPIU=#8O.0X#@D M-C]%NA\2FP>Z'Q*;GQ[=#XG-#\Q2:?O[=],%X@ '+U47<-(>?0,Z-8-CIE7LRC>Z1)FW'V#W6.#^_.9FH2IP-6 U>Z"5?JYP9; M;G*;,D,20\$*\4P2255&;)$ZY1AUUMNM9W*';;H[]2E2XJV; ,E_FA*[.P" M[X![>J-(412,<&,UD8D2Q'/ABX1[Z6V*\ZTW/[+Q%$GQUK7R@11_-"EVJKK- MO8'[,P3N5!*NTA1,=(89[<; S2FJO0%29/9>4&$(UY01 >H\*924 M>9IXX1RH[SF[L=;PG83R,'V)3XWR?U0(8:#\VZ+\\Y;RE4@R2KDCB< 1JXIQ MH/Q<>%8JJP RN?) Y'YCSB.L'9^V]=K#^L!:FNJBIY2Q?'W0^&!NFL-!T**.Z7A(D?!W')5^HF8?W9QHC(-?\N!H/AV= M+F;F&)X9J=/3V?0ST-W].YJ6MXY]OG%G,RGGIJKW/9KRPSOY[-CUYWDV/?^57&<;NR70QF3]T M3]O8_??K\[__LJ? 37/YT%HI!W>Y]8SN7+3)1H#6 M8_AA^X8XDA6@P2;, ]O7/#>Y$)9:IPLK9$'A?;=9>S[@R'?B2+K_XN5[61@. M=Y.3A!E*N/:.VJ*W$N-@N%B.[$.1Y 3W0Q/G+59SIRW/)%<>@9X M(@KA!7,Z99*9:SCA!SSY<7ARN/N> T'3'#M:7,S5P_=P5O.H,7NWX?'ND%_.X_&0:&AZ%&X8?PO*FNV5,;;>7>JE'VAFU M &F)WZISX<^FB[$=':M/^*F;P [F)6FP:N=Z.@4/KONMRY61)<7E%ER@RW2 M6.XF50# :S<&%< ^GU;SZH_IN#3GA_"J7\>@-3PU_/ZR?[;_8N^] UF5Y,82 MPZS%!JX66[GFQ"![D@H4'59$)E9.%L[N(N<1K'!:YUF>6GC$ MJ6J!_ 69P\R9Z=$$5JH"V3?'';G/^+,++$>-QU%/KN&BSM3,5J/X"SY;S8.B M;$=>E;/1)S5>N&IG].;B5P KJK+J%.]=4YC2*?;70E9F5\;W+FUP+@+)J :GF =.=S0#IC:R M<.(.!OCW[O1X0/Q+.';8#BS3@AK^4K7K3\%J"\_.W/\NRJJ$1>LSX]'*J1W] M\Q,"&-A__/TG?)V"8\T47C#!R\9]E'":?\-M70#(I7;1O(<4/3RHK@2)#T+NSFATN+1[554._Q??$-Y9CLOY.:[0P _>[V#YT?\N MU&P.4 O9?%'> 6=6PN7]W6QVAH.P.40,!?@U8 M$G$I4N*G,F U@'<"0KVJU PD-)";_9ASB6L=ZUVP]?>6;/T1F/G?T8SY?J[Q>L>]?NONR_(-UP1, M-ON&44VYK0-?IU_Y(P)<*@? ?1O@Q$WXQZ,8.H&J>C![U-A=Z-%QAV4 &P>( M2],VOO/P#S=;8R7FHIRCA30%,R+AF3(R\UPJEU"?IMQ(<>-BQ]J"K&L<+AB8 M>]&N>.B1DYBU\0&LP@]OT_V3E]F[#^/RX/#/Y."OO\M7AV_3@P___OCWR=\? M#S[L)7^?''QO#BS_1O6 ?^1O?_>GWR]\F?=/_P M]9)2(MP 5&86?M"+,9,Q1:M(DQY[/Q4V;N#[L,J>! MIPT\K>5I4A6%\RX7<'KNM9 )M\YEWF?:I7G!;ES&.?"TN^!I7:L7P7*3<>M) MDJ4YX58S(AWWQ(K_G[TW;6HKR=9&_XJ"<]Y[JR*X\"$E315Z:OFC15X"D&I2XTU.[$#'QZ\:AS$;NS; MSJO1P>A1N]O.)\UUMLMZ_;^T!)?7U/MP1)K F2*P&5/#7 PA*!N#8L9BG8J" MN 3 ,UU;+!I"M \:49>3=?%)P0^N(I=!11)7UH2<-ZUNR9OWX+*FHO?82ZI5 MPMR*9)QV5L)V;IR07!?%93ED;4IQ<90D1D!3L3Q+6%3(\110$"1:HX&F60FR M1AZCHDZ1M9_*FE8R&!&)5H[SH(71))HD&%9*!2)$(=1+(6L30DV5Q89)CX0Q M&'&M W*."108#TQ'&B@&6>/R"2>A7&K:_#$.HNW[PXHMA_@]=GK'V0-P'JI\ MJX%X?EB#E2"66>^Y%YPYZ00F"5X'XY1RS!8._?A8TYJI166,==X(1(1,B M'6;*8(LHPS%G7W?("LL0F]O"%6>C_>$S>?JMP^UW[XZ]Z:L89IPHNW0.7)G$2T*_-'X!-TE#J,<)1 M 7=PGB'KX56@CAFA(,]\,]B"GP.8KUPNE_$^C'$^GQ&K(6U.4@M(-#/ M@7(DPY"+TB ALM*NHK>Q#A>X>CI7Q/I9B/7"M80BUH\AUF1&K+V4G'M0(BS# M G'!(](DN5Q_W6"CA85)KXX!EF2W?LDG !<9RT"[N$L2\)<1O+2($5ANT%[^ MDY%6'&XG0.Z"S?-@\]F,)D7W9>3>ZR01)](B[KE 6BA 5:V]Y$S1P-/*FIH_ MZGP!(K(\54\*JKTX5'ND\Z2":G=#M?,95'-1B>"SL5HXE7-I8&23<\@K'DFB M4E(<5]:DO";/?4&U@FK/%]4>Z12NH-K=4(W,H)HRT;(H J*14B!L5(,>C272 MB@H"6C6C*0> JCMZM#P*JCW'BDY5DFK;.+:YWVUHP/#_S8G3A^U^S'$UKZI< M]"?=G*GZ(C7U.(/UM=G@;THLGY-RMX^.8FC7%9Y&:;1C6&UL00M"G97\5>,D M-VBF =.-J[.63]\GMRSG[+X16+I5U?/+&<>"LS2D2&P4/)FH+=&>"AZ8BD)[ M]0L]<*OU]DJ.ZXPI[DHJZW[?=@^JGOQU-KGD;WN6/UK/V>JK/_^N,X%_S#.3 MZ[OD%(;V8&++0_1I@M ]BKML_6CM;NU[IV6*G*(44K;'&8*THQ9%271T,MHH M]G"ZF,%-*S-77*C2U*<36%NYU$N5!;\RQE:Q9:?MX>%,(O:+ M^@2CQ._3%0I6&[#-P*..;#L7;YF2G=NTY2=2DDL-W**HVA4)JJLA=!L>H W: MU.A!>_N-7)NFG=K9L@8W&UPK9OWH8TY#87/:?=2OLND?]_KC,C55]OZZ<$Y5 M:J N1'/2&8Z+N+E8IZP/DQS^=IC;4#5K=(=9B+R,I_G]J+)))4\S(#H",IZM MF<>]004@K_NY?@RT>I2%>\0ZIGXUVCKPY"?6P49Q,KSY)U=RBSX26 MV:;2F M_A[V)S3[ %99/]IOH$A 8U_;SJD]&ZS\SVQV]'9W?'/#\P9T8^]G'@__Z/O9E"_&I:KF;$_?UY MPJM5N[GQ>?WCQD[C_=;;S9TW6YNM-YL[C3?;'__>_KB^N[7=>OH];&WO0I=V MMZ%7K9WM]UL;Z[N;&XVW6ZWUUINM]?>-G5WXH+G9VMUI_/&F-ZK3].>=^_U( MO:2K-3._^G?G4[.Y_G&OL?VVL;/UKK7U=NO->FNWL?[FS?8GV,1;[QI_PZC MU/^\_S]ESC=_>5'!9'JCJ-F2PMY'S*W4+G"II8F468TUBUR+Q,GELEDDEQ#% MEHI<=-;1:*DC)LB8J!#*?)UE3Z%DWY^TN72 M1*/J2\?PMY]+P^;OJYI/F2E4K:WZO7H-*7@*17 VX*[?*VI2ZMJ=YKJ-20?G MF!,YXBXA3CU0>V\B\@([JE12GN/EJ5,W-7W/J#3=2:[@%2ZZUD@@9%W?MJ!C M=T&[.,E,O:K3#$\%6@F?@B1FC3L#0Z59@/C"S4&]..GW8]>?-?KMP;$.*[6?54"$VY9[=CYCKU?MR#K:%EE.:G)?:XN!_2]*DNV(.%?QIG: M^-6PM+O?>QWXUH,RVAY60S^N*1J_9R6KKBYZDD?G"%Z0>=GLL%T6::UAZ>U-:AB_)SX[7F8B<7FJN6DQNW M^12VEL.SU9GB&1!S>^C;AS6M>\.^K'2OT?WO?'KO,]^;X=X46PV.[4,X+).'.O)V0:7 MMZ-LV\@#V^^='!SFDH1PIT[>AFL[1;L[^>Q"'&>60RXN6\_\JYH%I(H"N+.Z M>.*DR<]8J*[ WQ4$@P^J,I+QAS_,UKO)V+^"5=L;#":7#O)JF/KZ6D2$/O$XEH!5:^U%?H8G=06T_!J98\Q^[!\' [Y?7QMA[U-Z-N MO(%1>0N#\L\8LAGU91&LKTW1.O?[G 4;@C4H9Q)"W"J%#(T>8:=%B%KX0$7V M9;QL=1MS^#]"',"0UE4T!Y.%UCC,@SKX\U7C#_IGM80S9+4K0^<8B,:+:RP, MN:1F.[1M/T/SI1M?^O7H[M4:_8/]^7-YRD5 AU4QS4Z[+@QZS0.FZL2.;GZI MG.D$[.< @WJ'LZ.:WK-/S(_),'^)1?52@N;6]4@GXM@X@)&J9;+3JVJJ7A;D M\6B.>EM=.=7=Z0&9($?^IC;V0D,KJ8512"==/]K)IBX#2I?MMKGD+:AF6:/K M9.-S1IH9#*F;. ,7T[#RO-E8MNO_FHKTXTS=X>'TXKLH]]ZM3B:K^0(&56F_ M@\,8,U>H[/S5<<34LR9/&%7Z'5Q:;_;*&J]+QQY4%O]^M:[&6OO,?6<+T4]* MZF:J4-UG5&8>KN["5Y?**D\?562Z."I87^^#]6*OR67]_/ZH/?7#:BOI65YU MU9/@=L-X=*70<#8^5!OBRGB)/-#D5W=\W1Y:8+^W60ZP)1Z=5,7J&]N5F.4V M]^,A[)YY;-]#EQ^XQ3]MW\JU"^#7NMX8U"8+K)[.ZHO_/8'126>OKML/KLR< M[\!ZJFE\S;2OX%RE_(U7S7@1#F"K;U1%MO-Z&!]?77PS,A/!1Z>';7]XPU*: M93O5$KYX$#3TS81G72TD?NU^-)+LO!IK>2G+<<[E6,%4UL[&1W^C!N?65=/5 MJ16INCKXQ=%E?:SHXO2""I=73KJ\#"XSDD%V!@E9$C(3&5K0^:H]KM/^WY,: MB4?+]](!YVC3STQFLD:J,\::&.>=$;3);L7C1V!Z<2I\'8!.06Q>4:"ZPO/. MK_3HHDH]B-M%=?N)\(X:>T6@;B/A6<^J)E6_[M=$\ZH1TE]Z>%;;:P)V2]HP:=%H MR&9:M/KSH_(E-7L#?*Q?K**_^[TNO/3U&-9F\)=N#-\"7:VY3Y)B/&9C.-,2 M=+4@05<3"CG,E;+.>67;S M68#;]= [SDM\LB0:.P#& 32LIVY6W^HVUD\.8.=J9&_4FGZ_O1#VZSK<^*N7 M-4W*^Q'VOGZ<[ JP6"J^<5ZIKD?'M06RWI5];U#1\$KQ M"[6M\; W0LW)XR[T$WO1F+'"/#D(O,^#J]."*N]WWLQ[KM*+V[6)MH- AX>- M/@U!98]7.@XZ_NC)><^L[;XC,W=E\JKQ?MR42KVYIB79'CMOSR]V\WR..=[- MKKG'I2:?PDYPP1ZJ@4KM[!!8.:D-@!,=M+N5DUGEYS.I5D[$J[P(S:L1>88O MVT>C/7+U!G'FAO73;:C].^MF0G^F%]R_;/?$]L\:)#^ XD9HAXHT'-K* M3RP[?O6KO0U(1>YW]]+1PLQN.MD*)_OJ+2W/TX+^I $")/\.) M^E$O7&A?,%,#0(O*SCPC?C??[=7(/# ^JX>/>W!5=8AP<;/!>#4#D3T9G59T MLV^B'62^5YUI9&Z?8K5@AZY4?DG5^[=R?<;C%766-VK%M_C?L_'P+GPCZG*+\J?I7S^%7RXE=9_"J?FM=A\:LL?I6/Y%=Y"S_):W_W M2XWU$?TK?\FFEY,>/SD._*^3;LSC*6_'@*>'-[^?8E"5#:[V?)J8/Z^UKXVF M[N+>)\>A\J68>4"F7/7=JT50L5C8>BK^^Y/'C,YD+V*"\O')A5$WJXS9O:8? MCSO6CYGT__-?FE+\CPN=-M^V^HS\(Y-V((V5J@S#,;KRPA7CRI6KE66A:F2G M)LJ#>+5Q53B/RRZ]\'5W6+=R[<8N[3[A[9/:O7Z53O+X_=K!Y=*;VSHS/% M@.UWV^[DW1?!X**![<3: 680H>>UF;4V[.>XS?H@LYO-IKW3:D;&GDZU%;=* M) I,X.)$&YYZOBJML6B_%,$XG0,K*)_AK(H MMOM5ST8#NF 5?*)$/65%_!J?Z^M4B)^C4;4'_)*Q 5->N0)POWM39C=NR@]L M+W\?#VRG:8>[IWOG;P^;G M+U^;7S?QWGGGV_:[3=*BK4[KZQ9\![_]W&KOM0W^\I]#[(_^W;6?SOVY\_\+W=3VR/?J+-K_E^'\0>_5?[/^=[;/O#/K8J M6<,3\B(0!+3!(>>$18P0E8B1BXGX)=_?]S^>_/C[AY0[-VM=Q6I;FS^Y^_-UL[FSJM&:W/W MJEY]Z]WY6G[TZ];.]HX*:1)QV$0:>;#:P! Q+@,W1 HWCE=9.A8P[28P95$> MQFK+.0$<.N[G$[!A/I\=M@]FLK[-V*4F?K+U,2CTL#($-SI9C&J+[:L,H/_] M>Y.$33DRONZ>'(7>6+)'C(XB[_]'*YV-?/Y'?^US+NV M(<_DE@>@U*$) 9[]W79.<>+H(*)>=;! M+0E'6P MN'4 S_^T+P0C0="(B-0*\<0-W]FI]BH=2VUDA[X >05^-1F+:*:B?G75&BODX.*36 M3===-J,UWEN7C;.]RJV[.J'(\3J@&?IQWHG1FUG_[Y7ZYRM_@I+X:A2^,W95 MKAU(ZXV]=J$Y&6:'K6J_/[;9@)L/7XY/AG%RZE-[ZN1&5_>?4K(G@M18'W=A MI$'_63E+VTLZ:W6DY+.:F16ZHS:\[]2G2<#P3@;'[6P7R#IC)BF@@&;KPDZ, MC59O&!M$5SKB.)U-986HI3]'KE9JW74-&CE@3[RIIIPH1Q:(?& ]J%-KS(=? M6 3K'$]>8QN/@@"K\:V1P MHWAZE1_;0J/?.[.=X51\T-@ZT[1G^?8<;IL= M)^ZS5AU+W&ENE76):\LLX+L)6D1J,>$Z56N5C)DWL+U+>ZV<8ZU^K/M3EN?E MY?EMWXAHF&,4">HCD&W,D?&@=Q/BA#<:@S[$5]8(OJF:TFB%S@94'MF0+5,] MV(%@:<3Y,$PIHW0"HJ\WR.3&X MZRU)O[8,;4V,R+6A^G;$[Z_>8 @/V?'M[#^7VAY^TS\>G= #L[OR?47R;LOG M*O(TP8BIE7'UN7-:=3RG6&NK0E282\JN?=[5W'D JL5+"R*;8WONWGXV"!0:?G&M-<7$<@S7!"!F,>6 @L MIER 0U\'*Q-#3QW?<%KY]H^B,NK#I;&K)T!&GN51',54N+W/OIKY\DXGYD"B M::)4(5&W!V#3KY25FA)EC6-\P-8[KVL]W?ZJ9\3@DCN36,1X.-"X^]Y3E':8[DK2=:GYL_ MOGS]?O MS)).@UJ!I,8:"Z)UGH7:)0B MEX]XK#U^KG"_GWGI;4T.M&&'?-_K'J!.^WN.N:A\ 9ZO*0L(S<7Q^W6,9NQD M,%:8Y^0/-$7BI .-"'13I[PQ@A"E$M *!2Q7UNQFM;-'Z.SL'>]7LC;T!*QB=^-;IL_F@?[ROC@,6@CTCF< MTXIAY+PV*%)LA$S6*AGR2=$UF<,5%,>U[W_^Z-_ MC>&YC3>V']J]QOMA6 7]S,LC<#OU8PY^X9;S![*7']#,[KA:+5-+Z5J MIB]@=_2,T7CG$R*B_C%H?,S)#F%R/O?ZG9S#_: *TWO2)&IA3'-]5MZWIAUX M_AXY\#SID?H5W6Q6R/E3KCG/#LY Q_5*2R$PXXPZF]<@\53@I+G0],;P"Z^/I*MS2HH=G>2/25_O4R&[]_.*:%M>_O!TL"8 M !792-"8#>;(R1@1XT[K@$$-2')EC?[4WV!$ZZX#M8D0 ;YVSD!$)4N MY2#=X;C@UW:1:;B[6769RR!OF;"$FY-,GSO+=N+W^Y65?,K',-;1BX!< MX@QQ+A1H*S$A8RF31";"N%]94ZOD9MRK4I!=0CT_&>.,>G66WU$RVGJ.*BZ; M^>C.:7MX#F);(]HX3^%%CJ5Q$/;H+B ?)PE:4/MVY7L,K[._+QP$7U[,M+@Y M9GJ>4PEY<2I1(JU+I/5RQB&72.M;1EK_*ICXT0X>Q>\X>-PY.1[G"^K\5:=U MW5KWG7.MR&Y[0V0@>N8_ ;L?VY M]6WO,IW(JMKQZ>\TWLT8]?08_* M#ORD"<^!?G%XS?:3]C8&0Y$,(2!NA40FLSVF2!2>"5"MKAQ#TNBL4XY3(00' MGFJ!GX3("2C+V$1O+Q]#;N_^<_/C+U=U8V-S=WWK_&/KH/YTU#_:]PB0EBI'$22-. M$T5.&H8,,5$00Z)F5\1R*57C-Y-@?LR0C\^!+ M58RK :Z_GE#D55S3Y%S3>%)>>?3U:O75I=++]7>*KBIV\]=XE=SXW<]N2\BJ M).9.M_WY=^*!&DMOUZ"J9O1HC&$:\W+X_U;8RD33F2E+O215ZZ]@>K54KJ_+ M?=$I+ MJ2_W!.=M?E$=QKF[*[>YSPB-K][J.0TL,2]33,PS%),_@-V,++:#/^>95F?] MMX-^[Z0;T*BIWL>8TL^ZOW1[VU8WUT>KPEAO@Q5WZ'(_/^V1^GR%[LZY%_RJ MN[>!Q>75SNQ3S'4:U6)EE#>3!4<*.P$ M?QUMO_MPVOS\[Z/FQA9M??70OM!N[HQ^\Y]_';JCT-G^^N&L^;4%SSP\:N4# M7NA'\]T>_[*Q_N/+Y[W3YM<]VCK_1EMTZ\=_S@^&S1W\X_WNYK"YOL\8-00+ MB[RS%/'@)=))<\2CB43HJ%C,$9E,KJH;(C+OL]K'(#;'JI]KO[CTR,M[3L&> M9XH]7&FE0O8.P80;8K3"0A)E>23>$49JK[B"/8^!/6<7V!-E),H)AD1(#'$+ M?RSF#@67E# "XR!D]FK7-T:#/P;V+$BU>2KD[7.O7]4''SG_WTC]Z7PC<"V< M/FG,63C?R2._U?V['O<".G<'G6_3A"=1J9CU 6$<@>;X&)#QCJ,@+&9!.:TQ M!=#A-Z>@N#7H_$3P'XKPW%;)?O'2NG"&4*1U<=(ZH0C6$9=PX"@!)T!<,H., MXR"RRGO/J=.4>9!62NZOGBQ06E^8?>=MN]L>Y,POX^1V=R()M]6YGC3L+)PD MC,<^1\H6V+D'[&R>5I!3$87U?1TT+$:L4?#9A9U&#) C":@F7'.IG4X"KZP) M*JZ)"'_R9I$BK@_&$HJX+E!*0L%0%(JT.BJ^L:4Q7V8)4F=LM^4?.G1RX1D,Q-4$,9B'T3G(4PBW\%Y[A MS79;%?K%#^@+.RY]#\)V'Y/S,R4RSY.N+$K'RHNFT)3Y:,KYM&XEHU()4YW3 M?A/$,2/(FER+@M-HB8=I"6EES:C[6VN7[TRWH,LS19=%*4,%7>Z$+A,ER II M.8X)$>KS81##@"[2H""MYC)&;!T%=%F FUHY@[ZK7/UUTN[D=M?U%CK1#N)A MKQ-R\LY^[WM=BJ<<2S\4D8FGKR\F8+T;WH^'?VMJ]-_U>X-RRC4G#N%IEF.T M482:B&RD'/&D&7*>"Q0P+$[N@N,9A[0FJV*)3KG*H?22\8(BK \GK!/2H#@- M/&B-8((HXIXZ9!.QB&'EF;5:>RU7UB0QJWJ)A/6%66N:UA_"A_VS61MI<7)_ M:(O'Q< # &V.A[V SAU ATPS!&)H4)Y3Y(S1B(= $.P($3$?G4C26LO=RIJ0 M?&''-4MD""E2NFC+09'2!4KI%#5(3"0=!"))",2C),A2FA 7)#K"90#A75GC M4B[,$Z08%.86MXOU7I44 V=*D\8XO-8,D809'-Q0R0LS$>STTO#4]F.Q"3RT3>"-/:YR M19_'D+/JG@QC?SSX1>>X ]2PF8 V U/!8D#11Y^Y $4.<.J,.G M"0(%M-&)2Y0+72">*$,N"(H2I4XFHH7/=@)&V/V-DL50L+QBNC"&4,1T@6+: MG.+Q1A)L+>)4!N#QB2+C@290H8'91R5]"BMK5(IGE3/O/HS^'@&D3UJ2[[[A MWKI"ZCC2+-=&'98SPGO*N9C>CK.C'U%)(Z=RM+C (.>2Y@29CB;F4V06KZR1 M5\:PA:6^>A+QXD7T'W(3+Z+_6*(_V>*#==1ZJ1$#(8WJ$(_[($%5?<<79ASXXQ&L U-#OS$U M\O"Z$_,+0*KUHQZ,T7GU^8TH5@!L+@#;FDF>YQ2C))B(J,L IDE$EB>#) ]$ M""^"2GYE31A]39S"G\6*\!SD>5%FA"+/CR;/4TE@O(J Q0P9G +B@7IDJ =^ M$GR2.H@H* %Y)M=EKGH4>2Z)]4J.JF=I5RGIK.9&LIDY MXK0D%O0KQ@WW,3D2LFK%C%B8(\23L*H4A"L(MQ3FHX)P=T&X*><1X6T$-$,& M9@[QY 32.@DD)8LLYT%.^1B7O,(2/Y$\H[\@<^/R]M"-^'-0_%U7OH0<@Z"7 M]4]BJ,)F>\/#V&]TVM:U.^WA7:OAOHAD>"6[8,DN>*^@M*/C3N\L1NCKT7'L M#BJC1R6$.4@M)W'(21U*_L$7DB%L45;S\;+Z&"M+V_L)E+\YZ?>+^6QN2C:3 MMD?AR)W#&(7@#.**:V0=ILTPN(+- DG5"0UN+3C$T/"3-&(\^P-'&9.Q'J%64 MG#G!9S8V$@LM(I$H."D ?+A&CI&(DDI&21>D)A+ 9P&%=(OA87EE= $=:E>UA^Z!V(1G$ MX;!3E?YH_-'J#>$9K*(-1%\)X"A:S,++/U[,0P:D_O=8-)2[ %!SRM7_PRFT M:5\X;VG$'D45-.).92V%,V2U8($&V$%LSFFD[E\OJ1@;EE=,%^/.?A[[O6 ' MAT5X'TQXFS/"JY.3-)F$HM4<<05B;&+@P" XBXI9'Z7+/J&:$OJ/)9+?%V9E MF"(1F3"TNX.3ONWZV.C7XC"H"44]'W>E$R]"H5F<=\-D3D"SV1K/R B?BEXS M)S*=7:$5V&/JN$<,"T FGM.V9PNH5D*HP*0">,H.G<7^\)S%=7&.#T5<%RRN MLT3"B]P6;\\O<0$EK80_ R @6$!?6(2>412*2O!TX935=62-Z89G; MBLEA">5T@>F/BIPN2$YG28%,RMND-4HD 2D@,2"7B$$T:!^M9)1H5ITAEB(+ MCR9P;VV[W_AN.R>QT4L@)_WV=V#)WTN$Q,,3A(V+P2X!6??%GIGP'"ND4 8;@,V.B#UC9E35FBNW@.8OIHOA!$=.%BNE4RL.DN'3!(*]R M&AW,@<93EMV4HQ18>H,ET'A9O!<>/VKRR/:_Q2%TH!%_Y)P8)7SBM]D/FN.A M?],;# ONW-MK87W?..TD$QIAXH >"&.1<TT\I%:VQ<+PF^C"']/C?[;6)23^_L@K.]+*PSA1" ?L ;E!)B" MIL:CP+4(#BNNK5U94TM5-;Z8$):;(Q0Y7;3SP?H^#QQ'$B2*0!<0IPS(/%8* M!>8]%E$JDF.="2[)&!Z?)?1CU9@J F+LN5CL" ]-$C[&NDCL21_&JOA/+\@3 M87W?,"\H\Q8EP@3BUBGDJ!+(:,RHAC^8\\J,L$SZ23$C+"E%*%+Z$'X(Z_O> MY @'BU'PQ $_T QIKR,RRN8P)2T$R\:^Y^&##O#CTS.:FI5XP93Y TVM5N",95==VTEH8QSVT.82!+Y1-= M; A+1A"*B"Y<1"?L '-J#"P_9+FDB#L)[, E@S1S(D7BF/:Q.F,H/@B/)FM5 M>K$ZGQ(0@MN4P'GQ2LFB3 ?5T%\$4!7GI_LA#YDF!R$9P!A)D+ YAL$H L@3 M"/)&&)8(3H[3E36M%U8BL5@/EE!0%V4]*(*Z8$&=4 07.8_4$B#P*F=@QQ(Y M;( B6.X]24YH9T!0S;,J[G#K"C.CWXT*H-6-N*X&VLNL;;K@T7DVL+?(+ P7 M8#?.25OP[[[X1V<<(83F7N8356LTXD%K9!BF"&.B/=+R MR!:0 ID%,I>(*1;(?&C(G%!&FI@F.'H42$R(JY@-2LPB#%R16XDYS"1 II'W M/QI>#LBLZ.;_#'->"?A_:']?&_>K=7($HN'7_F_U8=TIU_^?M8L.5I_#GW$7 MJP>WNP'6X&M*5T6%J;]9-FF6S:UN(TO4JP8(2.--[PB:<-;H1Y\',C1LX[_G M$-[$L+(I1!VUX-FGF4H06N5<# 0+IO8W\J,PP03=N^K[5O<[C%VO?_:YWQ[& MC=YI]\G+\I?_'&)_].^N_6Q.H(W0AG\=-G?W2.O=)Y+;N$ED_OM 0@*-"T+T&E>C/ FY0_:XR5Z<!J0&8)$W]:K3!XG34;L[OKGA>./LE,0/]L0X,!>!C4=#N9&<8*7W54ZNE>D6 M@-N;O/%WL].*O7GU_VI:_O'[5ZVZ=M5N;GQ>_[BQTWB_]79SY\W69NO-YD[C MS?;'O[<_KN]N;;>>?@];V[O0I=UMZ%5K9_O]UL;Z[N9&X^U6:[WU9FO]?6-G M%SYH CCO-/YX,]H^PI]W[O];&QL[JYOO?])9^N_E_:$ M$;$,+ F2A/?6<$*#AG^3D4E*B2UEYD+C':D%LRP9)\N\$W /$KE4SDA-//!C MH&C2"B\R2Z9XQ)+'YL%9\KOC#V,XZ<3M],8.#M]V>J<[)\?'==)]V]D M#I M#4[Z<5")ZRX\^J].SW][<;P8WA_L!^- '64211T8D./HD!8FH*25TRQ:CQ-= M:42@7,=Y'^V?Q&MVUM^DJMU(IJY?[M.SWLA+H9'70F.K6ZM1L&"70@&=DR+^ MT>Z.%9+!+Q$HXXVX 6A$:O3@$6=9K3C+)4M'_9W"JQ+?_#5> M)3=^]]/;KFK.[W37GW\G&'OQ;96WNNNBSR35C"'PP4;M%O>XT8!XC0UQN8\::GT_L+C>_62ICQ4K9G=L8 M:!1N?5ZRW >,UY\F+=2'KPQF&UW'P_W=C^=7O'9./J4VT;WSKW8.P^'S=T/9/OSEW:+[HDO7__]%>[+O[Q[ M>]C:7<\^&R-_C"(8H9QI'>*>IM!7@Z#'@Z (X#PTXK0G#P9RS MX$1"TH2$>-08:<4(THP83J64//F5-582I3VJ2IAK$#6&N0C1?<+&GAMH7M?% M9P.:#Z 67E2RRKA90',NT/PPK1;:%(V)T: D+:B%W%'DI(C(D&@LA66)::G3@;9Q.D74W M'X@%NHT]^WO\;C>;*4??T2U0OOZUG%K$(^]E\CO"#6[(V78<A??5(MU<"FVH#"!Y\T$%F[LN%AI[_-R^MN>92P<%$(P%R'8 MF[9Y",$=Z(0&2>T,XE%$!$PM(LIX59Z0K@"W-'W+[E5<*?@SM.Q?$QG?CF/ M_5X 1EW0Z$'0Z,(L\O4;W:=.&6MY0%P+AGA0 1GE+(I1*4D3XP;K[,>L*:'_ M6")(6I!I9*G1I=7KHDJSS*ED!I4Z:;NAD=I=V_55($C.%5-/Q6*,($_5J?X1 M[21ER%[,D+TP/YVWMMW/F:=.JHPO@T/;AWNW!X.3VC)[7.^_>>=NU$DR#O); M>#EHAUCGF9FVTC:*K\\+H8,+,'_=A@[N#'O^VU:U'DDA@7.1P(,94UC4C I@ M?]*+A#CA#FD>'6).<*(83C'P9:2 12LM,/0;\Y$6&'H(&)I8QJ*,T0:M$%/< M(RY"0LZ2@)SGBAKL9=*DP%"!H:7HVV.Z!17 N0?@3/D$$:$3UU0CKWTN;2T] M,M@2)'$24FG%0F K:XROLB5"FU_HH.-L9M#8^'. >LI7OC"_J(_Y->HE=#*( M#3L8Q.&@T7-#"Q=6FGC\X0\M:-^5*MZ%9U[QD"K9%UY(;.+"/4^JM;>=/@WB M>EYXVZ-EM]7='"VZM[W^[+G,N,S&6=F;YMJ;-D^G"Q)A(ZV.1B)%G4(\,H(, M$P9%HKE6BDN=T_FS!?BGE,CI@DY/1R,OZ/1XZ#2I_<,(-A@SB@"<".(&1V1# M A(MA77*D:0]75GCYOY>+ 6="CH]'47]-O;"@EF_$[,^C3!K2VQ_V(_$^N"M M0MY&BC@S!KE$))+!>9RB$)9)K#(ZIR6, B/+.$4P:?>.ND]23D/JEZJ:--RU'SKHM_C.UQ7E>RV96-_ M5\W CW$PA"<,8\B%1=:[U?\V__>D_1W$NSLP3:>;Z] M\6&?$16M8A8IJQGB5B=DA0)ALXE)1T(B(EPI'O@[BS]>,WTON^;CU3ET7L,. M:00RFFG$"?9("T^0\H(H%KD'!/Y9 O!YE7PJNZ$.34@GA5 M!8U-I+ZZH!2&O-A"2V'(6]^U%(8LA2%+86;UUIPNVI[S]1.>,O./QL+HE8F64-Y,%1PH[ 1R2DNN#,^$J[" M_M9M@G*[)T>A-QQ]?]6F>)UFNCY\8_O],QC1?^>@\F=B4.R=[7UM0MO>0KM\ M-BJ"4MIDV[M-UCK?^I';^^7=Q]P>O'W9H/CU7^WF^1;9^[Q%6Y51\0/+QL7F MN8>V;YXUW_WKVY=WN>\?Q'_.MR8AN]#NUOH^"8D)(@T*RC/$C>/("8,1==0J M)[RA2JVLD5=$LU6Z(+/BK23> M$48RVOTZ]K>@W>]'N[,9M*.).BT XUCD%'&9)#*2.*1B(LSS7+XD5&BGS/UK M.Q6T*VBW/+V> ^UDB)1&XHRPD4?L-5,"1ZSQ M.;1A?=]C:E)(%&F1@,!1%9 %:HY@>G(Y)LY5C"MKBO G F@O(27?U#'**#/? MI%1!;W@8^XW*=:([',7IWFC^H?.-R[7X_*2AZNYJZ*5PBIGC[#?UZ!=HF@N: MIHJ$[VZ> ]LRC!-AN436VIP:-"9DL.2(&A>3)@(;GW5+^1SCNXJ(WE]W*B+Z M ")ZH1!M_FBN[R<"^I#7#F&@>8AC>&4B%L@1)2,EDFC,042+A#YG"5T4WR\2 MN@@);4UMHB"A7%F,3?*(*$415SR'PL F2AB7SF(07XVSA-Z[QN'R11H^<0Y_ M#^Y^6__Z)PT[#\/=6[VN+\AS!^3Y<)F^9YNH5-0AI:Q W%F)C-(),2U"8DY0 M[^C*VK.,P2M"^K#LO0CIW85TEL##_A^9\A@)Q3GBPB6D@1^@@+'5UE&E?4X_ MN%0A(45(GP2!+T)Z9R&]Q.&C(Y9%BA&C0M4US#94>X.O:A/TOXY]6K1JBB>J;_6#JRK(ES+4E?)HH5^>;I\V#?9Q@!XC1(">I!N5* MDAS+ZQ"+B0?F$\&!9$\4BO']_>X6*V1+GCFO &T!VN5S[2M ^]N ]FP*:-?W M$W58)J=1#"+6#LZ64XMBPBHJGI0AKG9PYO>W9!6@+4!;@/;AO0H+FOXN-+WD M;2@\%5Y9CQ2C O%H$[+!:N"NG@BN$^9&9&]#L6J>!Y;>(G/+-9E<;L[/\DA) M$GZ:$F']",9].)@YPKQD[6@<]T$@^_!L^.88OJQJ=L)L#1K''>M'%40&OM\[ MA0LZ-O]NV&ODNB$'=0W/VH22\[$.AO!UX_BD[P_M((ZL*_6]IIXZ*@@*[T^J MY;,Z.XYYT.MZH2?5_6\WLC?-2 4%B5!%1=04.\EQ8"X"-XR@@QO)"59ZG^1B M"9-?/?1D79^>0ZXVX)\'3@_S/@X&,<[FCUZBE#[?QM#9:9U_//JR<<#VCCZ< M;K^#:XXV,U1^;9Y_@>=]8P"3?.]\_:SUYG(ZF$^L]>[+M^V-T/ZRLA]P(1XY)7"B&.A07EW,@>/ M2!52%%RQE5$1VY,8UK-J8%@$C$R>>"RX!.W"N1"HH$%@YV62EU/&O-]7$L=W# MV'C3.X(GG]7%BP8-#]ANLT=&2FT?&] J'U\UX$DG"7:EDWZN?PZO1@6.7C4Z M@$4 2,>V/SRJ3;^GMA\/>R<54'V/AVW?&4-6MA ?5\6+3]O#0\"N(WA2OF%= M.&D8^T> :+9[4#VDWSN"+P:#QO 01N9G\DL"Q9(QV/Q$X)89:TT^+=!!"I!H MQJ=-?U,Z*(R:?QU.^F?1]F\CS[O0ONWT!IZ<-^@7)]-;IZV-3_O66^*H5(A: MKA ,LD6&2H:$4BE$Q0CSV;OJLD V\B#G#>YG\QB#XY@&KH5FG"KB6#0Q">]8 MDEAZ4N9Q0?.XN[G/:* IL>QE+G,8LR+(8>Z0M3%QXZW7.0HFYRRY9B)!G@>] MHZH^^2D(^(4O5Z-WG#%TD"<:9C6"S ,IR7+=[F8*,P2\J7%F=7Z2]U3(X<5B M&\&:[PV *F9VEKM?#5\CSJ37WGO\34B)D5O,9I[,?&?S]>(?"? MFNIF1>L-]'6)-,;?+EH_6N?K^]8I8;6S2+ H$6<6YP3($AF-C=?8 U[ZE36& MK_% '2=:>S77?"^XXG*9[]O.]X><#9'#Z_/FUX,?K=V]?29!OHB(B! .V JS M@8R)#A''/??1X"2!#%)UC;8_F?LL^?/,_X(KZ)3YO\O\?P/9W]PW6H5 N,FS M'A&'O11IX2*B4G+-77 ,^VK^\4_F'Y3ZXP@??H^=,U!>=PY[_2'*NVBU,K[; M?KO*I#B]O51[1+\I+]L[.W&X!=.?K_TO#5/,U'H^B#K>G=-$3I/SL3;GDTL]WC= M-MOG+WO[DH;L4M;.EQ 3=]E64)VOS9:<+TDE2^*A!X\(G-7J+I5*??(*WL@% M@(""!M=]:>^==P[SLUI?URFT"^]]_7CX9?< VORQTSS?$MMO+KL ?&+-W0]G M7X[^]76[_S+[L=VZ]U;:/O!6>O=IZP$\O^<;TX\5]?W0=71B1&. M%$W R+57R$2F$0V,6!_+IUNOUA MWYNH@\,!"9-MVL$1P#%K$)816Q&RU2M4]46?5,ZT<2O&2["Q2B;GD?C4/ MKW_ ![Y$:MV9V Q?762+.^[U\QHMQ:U?2!G'A^'+8W/TV?)E\'D*FTUSFC!+ M!QN*51X1*1/B#@-AULHA:5U2PE%*N:X.4!9%F)\0+2ZPLTQ]>W2*6V#G7K#S MX3+'C; O2,<\"BHJQ*6CR,6 D=\H\0'F@_CF4"<>(,L8PHYJVE*EC.; M_,J:HO.F&WHXUC)'\J#G+5\/O&D7^;JC?'VZO&\K8E@($;0%23@(&O?(>LV1 M8=IKJQFUP:RL"3UOA-U33.QY@S,/88_CS#.5*:AW\^Y^*5!M/@OA]7&.Y0CA MWD/S;(#\@8E2@>]YX7M"C[C @G+*D& ]QXEW]?V:I]6B(\.0G MUL& G QO_LEU3N*/X5DOU"6V/?7WL#]1?0XB?4G@U6_F?6 M#[[='=_<\#SF-_9^UJ<].X1.^=#KGVDF*3W88-1+%)"MUZ\6U&L0B=C/5T%S M[-*TI7'8SW#]7[].MZ% UZKB#GJID<.;ZYKD]N;5_ZMIN3:TX3%R>&QN?%[_ MN+'3>+_U=G/GS=9FZ\WF3N/-]L>_MS^N[VYMMYY^#UO;N]"EW6WH56MG^_W6 MQOKNYD;C[59KO?5F:_U]8V<7/FANMG9W&G^\&>>>^//._7ZD7LK51IVPXZ>= MN!FY?Y:RXU%.P9A7I>4-@VPN)6=-R51+S,&%@MXM+>PD.=+#:2'&,>R$>*HNRD?YT M4_O;GE4YHC9.8@N>O'L:.]]C$YIQN$QI)N]E+*!?-KZ=?SGZ1%J[6Z1%/^&] M\R;=^_SQZ_;&'FM]WCQM;L!OOG[YVCR[;"R /7&W=?1E]Q-I?OW$ONQ^S,\Y M_/*NR5M?/=G;73^%?;'=.FJ>_^=\?<9E+L\5RQEZ2<*(4^&1<8D@;P,W1F@G M,*WRC5S-.;"T?BO/HFHUB PME:B7!7+VHNWOGO8*TLR%-#/1;-IA'Y,3*-$D M$$\R(,U=0D9P3UW@5'*1E_W]BV>5VIKS(@TK=3.7"FD.^S$6K)D+:[:FL<8& M*VAR'E'+"& - ([FUB*K' V.1&$U6UDCBSO^**SFUEC#"ZM9)JQYVSOI%ZB9 M"VIF8HX2*$Z)!8RPT@%Q2PQRQ%.$K4XIUV# (JVLZ55=6,WO1AI16,U2(4W[ M>R$U\R'-3#A L$XJ0372F@.I(=8@PRE%5J:4XQMU4BR?DBTJBKYPFENZ*!_& M?JP\'0JS61:\6<_344#G3J!SR9A1??P "[X-0=^%9UHWUT?#*LJI_! M[AX'PWO@V=-E77\L&VQ]ZHYS7\>P^)3RUQ6$^+F#[S.*S?A.$'TQA. M0]0T8($\S 7B.#JD&8[(^2B4L20F[YY-?.HU,5CS.1#?(M[JNKN,D?]WA"7< M7 >S]J?.WMBU'_1QO_>]'>)@IN (_'M1PVY4K_)*X9#!52?L)^1;7>J!E'H@ M/XWCJ9;57E54:G.FJ%2I"O*K42M50>XP9"^P*LCGZDT,R$*K[$&\ME)R%?A3 M%7>[HB[.,RYW6B=+2[>OC=6;AU_?LJSP+-4>S]=Z/5T?Q[-U46V8/&GF?7S4 MVEW'3?KO;\"8:7.WB7/& V@7V]OM?&T=??BQ_?D#;9X?D"O,^VB/-#<^G'_Y M_/';WOE>+@J?,Q[P+[OA^O?%IQOVO]?43WOZP+SAP;Q\H MPD$ ^Y;:(ZLC1PZ'R)TV1&N13\OEC>7?%YAVI0C5G9.'%*%Z5*$ZNQ JT?RP M[[P/"2>&.-$&\20HLL)J9+&5FFIMDY8K:V*5_52HGE':V2N[[8PV]\+2S'9/ M,I5?B(&*W>8$8F,TUA]AJ"\,58@6T;Z%:#ZV$WRT56)'PAY?PV7&#K)' C97!1DOCF(E9PN?T5'_R$OY8Z<.6)K/(]3EQ?IWC9K:P[VRJ MD5>5K?M-[PCZ<]8XM*$QQZ'6G1+DS)YN758; +E.0;$:Q.Y43?AKW1KRGU9O MN!>'T/JCV/6@1CP/?X:[I]+9(JV-]?U(81EXDQ"E-B=_4JL-^.>!LTIM=;_' M03T76]V-Z(;KW="T_6^Q L?-_SUI#\]VHA^E(8(OWP"H@V:]V[=Y"ZB*)0[R MGMWI#4[ZRY-Z:G=K+"^'K?,FV:/_[C0_?^#;GW,>3G^^_7E/M(XVR?8&_'8C MY^53F;&WL@+YL4 MVK /FRVQ5!*DB %Y\<$A"XL)T1B9-(IS%N+ES&*.I*2)HLQ*P:/FL"]3EW-V M4A=4"OYRJJJMUK\W=W:KW&XWZMR_%H9K-X!?-V6VZ91HQ[G721C&N02)2DXF M#-N'\4D(^WAYM:H[OFX/@7KX>V5VS#+1F$C [;9VO$I_S@D>5J@_=?L1.GX> MPSL0U?>]P6"[.R7HRY4D[A$DM76^N1^Q@64>'3(J9D+,!3+2"60QK':MN,0N M/8DD<5,3VVAW@1/!>AU<&2[3LM@-F;E%ZP\;L!VW>^&NF>%F.LY7U:W) M[W-**4?E*JR?A7L2J%6LU0-X/0AV-U^*G[=54%':^L+7P%-JZU-: T^JK>QV M:^!)'@)=[V=RO7EL8@HF3]-/:]HWJW%+]Z-?V\6?QV#,YUBT%(OY-OW\F>[S MS]@)P-?0T2B[]'VDQO"=WU0/1L3 M;;21U=%!&B8G2$Z57@M\%?CZ&7Q-^5&]/H_]7K"#P]N"VKKW)TJQU@9%[D-VYW3(>0]OI:>41\*8QMDVK2FA_RC( M5Y"O(-^2(%_66 ORS8E\K0GA4X*()*1&SB2.N.8).6L("DIRYZWC*;B"? 7Y M"O(]I,J:C4>5[:A V;Q0-B%Q0C(EA?+(2P6Z*R4I9W>WB/HDG58I*>:*[EIP M[ 7CF'7"&>5 FU&""\X-9]$32IFR@<5T0WAA,;T]&'QM3S&Q'/!)F4'$18UR MD RS#H48]1>Q41=JE(MXVL2E1;\*OA5\.MG^%5L;TN%>\W=<3W3]7T>A,-: M&&1%#(B[B)%F (&8Y9A9*X+DNJB@!?H*]"T;]!7CVYV@KWD!?<8+J41(*!DE M$<< @AI+C+RVSF-)%)&D0%^!O@)]#ZFU%NO;W;'LTP66X4B2U3$ADIQ"G'*" M=,(642F(CBHD@+>GI+_^PG-O'"L+W8@_![]R9;GR(:\L"[5<^22N+ NU7/DD MKBP+M5SY)*XL"[5<^22N+ NU7/DDKBP+M5SY)*X<+=3Q)1>9ZRHS^FVM\)?* MUMZIU,KH'E/&N$O5$N<-"2ZM+*TLK2RM_(VM?-)1^O=-1K7^W;8[.=4G2KT^ M&MC.;;*W/&C9KG*/ G&GX+[Q3VREUS3V^?FQ!W>)^08,+$A4DNH-W[R_P M:>+C6R6$FRUR\5>$)\1=^Z. UMR@-7'T3<[AZ&Q$FED +;JV- MPG%ACKX%MPINO6C$*H"@6X M"G M1=^60/_-(I?4_: MH_66$O>F=W04^[YM.XUC>QS[-U<-GJ_?UV+IDP8"1!H% M4TF$&(EZT&.Z8H*Z)QR=3[L_ 17RTKF(C#7 B2RUR#C%$-'*\\"Q(E@N.F78 M$B4&*S*]%#)=S#8/).@3ER$7'::*<22I T&7H 99Y3RB1-H80[#,V"+H1= ? M2="+F>-^@C[QL4F@6P@K-1):@Z +G&!O5PYYT 2)5#1:5G;T(NB+%O1B+%B8 M+$]<5:+R1"1#D/:89W9ND#-1(^(PYC![ABS0S[?(\A++,O72",R(=II+@6UD M-F&+N60&/O?%O6-II'?BWB$H\48K@9@*&'&N*=)<>.292]%@84VN(,7X*BNB M6T2W*-9/2G%B.SEQ5R)Y MDF,]A#,:<2502%5:.)11A^@"[F$5. MJHBTYZ!^Q, 4 36#<'7_@M3+Y[M89/*4=5\$A[21#W%J/'/8: M*GC0;.1J@%78M3(50Y=5\:V9V2Z*\I.2\LGA.I9&D)Q6)$931><#Y\:$HP3S MK:,2R6%>-.4BZ7?>N8NFO#BQG1RN>R,I!5*-&,$6<18M=DT(; M2ATF):Y]F7&)3)^6N(HE%>:"<]P8O+Q%ED>7EE685D):-$D^BX\ 3F'V,GO((W1G%;3MB7 M1GHG)^S6QJ "28B;)!#W,B =L4;64DHY\];P[!VSJHKD%LDM>O53$O*I4_3MX?76PG)^^2F*@C)RA*"US<"8><"!)1 MBK'7S!%+Y++1\-\=U?X8 K<^&,0AREV)X;J@].+P18F2HYGX1ST5A.1')$ 'U*ZK%U%--R''U!X(>>.8Y.F27& M4N2BB_E@&T-:6 5_#'.))9*XJ(_(E+3$P6<1HP>Z\.PZ6TV1I=%:C&)G) M#"Q!K=88J1B(T)[8$+.7CI-R'+WP;K&3%Y6A)X^C&X-9;NN@C6.(:VJ1]L$A MPSQE-'(?%2W'T9\B/__VA!BZV,1W9.B)^'=TDH/9@YA@'G'.--*28B0#9S91 M["E6F:$O-F3^O?#RHO+R K!RL87GQZWCL+;>8]/?$T./0=_;0,8\](MB"1<^X028EC!BCED3%G%# T.KNWO7" MSL^1G4OH>W&9?!SZ5E)+PAQ#,A]8XT'$?.:4(6)<-O\8=;1DN1=&O[W<+N;^ MW+AVXJ0X2\1H!QHVEAQQ8CW2RL/;R##LF-9R0B![4ZV7Q.'%X%&;!@4EJ2 M>Y]P/8>.985W7SSO%COYOAQ?X]"WL9Y@)@+"1EO0H;U#AN*$O&02$ZV!X:N6 M9446/S5^GB7T_=@,76SB.S+T./2=C!C6&N)K%4!8X60>B[ MAKX++[\\V5QLX?EQZSCTS:-5A B&2$H4<9,5:F89 @/92I),--ADA7H.;^96&X3>,RWCFR['/B^2<)-#-+FXHTI,.Z9U5Y%P2+%46EA(B]1[\5 'W[F MP'<^%QJ%1Y@J >#CJ@18C2(ER<&VN6&[XD5J\U!2Y1:&[;_-HF%$8OC%XL_X=D]'$TG%C&HX@:!:D4 MXA@$N1/6(2N(5,09Y]W\VB841G^.C%X\ _$M>-H.,4XL40MZ. L -=B@@R6 M%@F!@V4!)\UXT<&?.<=&E4R(+G%M$\<&&XEIC)@'S3Q51-]K/=9B4]^=G\<1 M091M82BR*S"?B:89-$D<*%I^^7IXM=?5_.L\EJZLEX'2*R M,3@$VA9'SG"!N'T1^+T8EC?D=/'(742I6)<&\13#JFK0)#+ M?1.T8TX&)9STNG!ZX?0Y,XP9\IF/.8T2F1 $BDH%+TGP M)*I%9.:['C<_S]77_R'V4#V(UPQ&';K'0)R-$4<.+QATCU[G.?6[[5:H MOKP>!!8NV/_?LV91S&MUG@TT:F62-90'0P4W"AN1G.*".^,C 9%9$@ 6 PS% M9 * UX*3P",*-FC0;KQ$SCN-DE)<&AEU,'AI!79U;NF_<^*;1\XV+-A9L//I M86=Q"MT3H$Y4W)%KP M=-YX6AQRBXNRXTP7I@2GU#OD?0(37MB(K!8>14Z#8H$JR]*\ZSX4H"U 6X#V M@137XOF<&VJ.,XTLX3A2KU (WB#.@T,N)(LL 2N?$B1XYS5I0R>6T'!@IT%.PMV/@YV%D?I?46>QMES-%$#=KQ$V%/0 M1HW(GE*!$:7&^V"C(L8LK;""IP5/"Y[>6]V?QP;4XA.](Z!.)"FFY FU%A%) M-.)4$F0(PRAQ;V5DE%$N<]V?BW5$9J[[4[#TZED6.)UU@18;41< 4(M'='Z8 M.0[;A OCJ MJ-MOY5^_[D40_:WO\<\?K3 X&/'4Q*^&JX''/[$.)GX\N/PG$W/V$?BO]_#0 M0/.8A#Z[%I-_#WJCT1S9_8@<*#W?D$TPV->V_<.>])?^.#.GPU9G='/#E_,2 M7C;[0]O;AXN'ZZ;ARN$GF6QT)>4N68R4[FTQ:CH$4,L-H_(F O7'7KX*AF,7 M9BR-@UY&ZO]J)4(5%5%3["3'@;D(X!T-Y49R@I7>4TLKVYE-&MW4>)-!OC/H M_\\?]G+JOVY;_GQXJE53J79][WVM\7:CN=I\L['ZOO%I&S[87&]N M?VK\]J:&NAA^O_6\'VF6:KD!_VTT_UW_M'W]9"Y'\/KO.=2O]0E*M./<+/-.!)8(R%_EC-3$$RR(%](*+_;6;:ASV3".-&4"2\Y8A;DY!51B'ON0>4E,1[T',C:)I'6?3VCN,48=P" MA.T,7E.:)=/M@PCTU!\T;"S%>D;KO=_=%_/0//7427 MC"7UVE7:V5@[JC1"6,.V/>K'UZ,7?X96_ZAM3UZW.M5*5#_Z\RQ2927BG#98 M;5;]]5B_6,:UCC$\7S1\\O#KY>JK[ M[=7?"7;Y0\M@%W&PE-_HMM>RMZ=,XOQ%$CY9A.]AI(G?+3>-G'@SKZE?R@$7[C.4^Q=O]7R6^&W6Z_[->MT\,.0EKF ATL#[90\0W#_#0Q'N&N[U>WT?Y]E7V_:C&%!]-+I4; U,*1A 4B]\R?1]AK= M7J,=^Q?:(LPRZV<:&WV>T&@*G(UM#@T$>-?,S^T"NW7VMW_$ M]O>X"6,Y.)O:_%SBGS\V?WWXM;7V@3??K8OFFL?-+^N_=K[^];7Y;H/ ,^$^ MN]]@'+AY&?[&XSM ]G9;K8VWVW"<_^%^>V+W<,/,.5UP>;JWM12H5IQ,A0XA&7."+'@T<1NV MYBYXOK0B\'/LY5@@JD#4 MM1"UW=V\'41E[:]2_@H\S0I/)Z?P)%1@6&"&A,<$<4LI,I@11#7AVDOLJ:<% MG@H\/?[<%N[$[&PZU+,Z'O9@2-4<*U(N41D-"PA++1"/W"*KK$6"A*1DBL%K MO;1"I%[F!:H*5!6H*KK4@R#46)=RSDDMJ46PB0EQ;RB8>C0BS5*TC#N;.:N&R+4#.[7]H[M= M[]_;UO=8W%6WQ[ /D^XJRC1-."C$0PB 83$AAW-C=(NMRSE.B M.,,.49I(B;"7I?6*H75YV^# MW$R*%X?);?A[PF$2A!>:D%EP&^"VW" ^:)2&0H R6=*XQT8AIAX'42-*$&RWQ@4MZ]ILO#M549 MG;& P<:K<:!<>?;*EY 2M='I#WK']:&B3G?0"-F9,VC81A]FT(ZGIX@:P0XN MSU:]2@[&-[O1/X I3 XT[QX@ET7'9 WT1;QJ"@R3ALDHJ"16$FM=_.NW+U L;+"\D^"Y8LZ>&M6 M'ZN#5EG/*?!VH$(CKB1#1F.1?;:")-CEJ.;GPRFL_AQ9_796WJ5L72(Q=V'M M"?>-9S0D)PE2RG'$)6'(8JV03U@9;D5P(2VM$*6656'LPMCWSMA%7M^:J]*@=V'6)T" MD3(DVE1"1&&JFS.DB\M *;NLP*=!;H M+-#YM*#SN;=E>#C(G @<(_6ZAXU!5:OY0L7E?&E.HQIT&[!> M[5QBZJ@7C^Q)SK)J5*O97[[9_/FR&B_ 4UFX[8-<4KJJ*WTIOHUK6<\%YC:: M;\^D5<#0_>O.\>$/H/I^[)S'P'/JXCE$/-O;ZY]A0P\@9!=[6VGT?@R0^(D" MY.UKK@.@;N__:*[MD,WMS5]PW5[TC#$I+')4@'GM/4.6$(Z2T#@&I1T)<6FE MT[T =V>JF@\.[* FG%:G83.YC':BT8:M:(R:JYRK:-X8%3-?;MQS9?[;$,ZI M^^:E%^JGS:\[>\3A$ 31R#LG0#1BB1Q+ 1$.HC$ JRLGSC=DL$HF:@A3)!GN MM=<6K Y#)!5>*A/D^<+^N89^7Y%JCKD0/"-RO:&P_M^\[3UD ?F?K[>=Z M^/D,<[G_QH']'ALNQDXUJM'J=8_[YP9UIOKCZXM-DVK)\F1* M]U.]K-7\:[;#7?EM:\A?]42%G\Y8C:%EK(4&[F6L-^O=,$R+&%TPU#"'S47N M6BB[7/KD+[W74T_E2%59A')E(8 7?F4A@!=^92& %WYE(8 7?F4A@!=^92& M%WYE(8 7?F4A@!=^Y93LCDM;/T]I?S8]HV%JJ_9K(WTK)3I5(A-/*N+SE,9: M:&#&Z-1E*'I]<&-\[74=19]4?\D+"0^WZ1UZ@V[9SZM#"^LI"W6,CM[L"VY\JV,Z[VDUBEF5IXS[GY]#-8 MOG=5%MXX8;+QOLK"NY=VZ,]@N0JU%6HKU/9$EN\FU%9\:B_\RD( +_S*0@ O M_,I" "_\RI?07F 5-)\!RE,!/6A\8NE.[6F?6< ]V!-X5$E)!1$":Y)LX& MAR.S/L((D[8D'^N!M^A',[&/=/K =0FL7X=(SJ6U =M?^ M_K:SO7.R^VX'QN4Q_,MW#GMW;[S[_VES[1II?0_M8(HM!O<*:14H]33:1 MXLPJ8/3X,*=LY)@0BGH"U9&I"VD2#!A3?& MN""X62"?U5T;F3T%B'G3[1UU>T#=P#AN<$5$\W0!KNJQ.&4!GE^/1:8"\5@H M:KG,9_J,2<)088)V+&G#2PCP"0#3_F0($'LEHO: 2Y93Q &'D+7.(0 M%[__O9C=DWY_IX/222-=M0_,QK?35J'D*&')^%7WO4@VZR1 MZ=(Y]R%69['EX@QBD2NM5 C:@/3CAABML)!$61Z)=X25,VA/04*N_W@_(2$% M(S)@31&+7"#NF4>:88>8)$&F&(WS?&F%"+ZLYY2X\T1ZDA=D+HEP_AY&N'WL>8\J33$B$2!!/G"%#HP25E!A.C3&"V>?A?#W;8O!<;\"5 MBTT'I_<4K*?L>G^LG$[_RA_2Y?'O[H&AJSN^;@U@POYJ%J?X_ZD7#-@Q'R^% M2;^&/8J]?-72RD;G>^P/#F',_4:KT_C<@=6I-B"S66,UI5:[!2_[-YLUT,M" M+M<5B[.TLGT0&V^ZA_#DD\:![3=LHW-<-1KKID;\O\>MP0FLS)E5.NJUOL.B MM$\:MA,:1T#,+0]O#F([2^U\)P"UY<805YO'AS P?Q9(<;+,.Q%8(I%+Y< ( M))Y@0;P R]"+O36**<8$$Y1?U(AZ%D,_^8,8CMMQ*TULXD9GM1-6PW?;\;&_ MW1UOX-2KMS-7;,.@_FIW_;>_X(IL-#F(_@IP]PVSV=*\:MA<;OK9#[M(E M!'&##7XRO6\5759L_KU$"5F6Y&8-.F?[3MS38.G-!G3#!GN+9;Y-;WXTW8X_ MG92YR:06KZ73J*UI/3M&7MVF/^*C;M_-YGG-[CW';EU9<7OX-F>7=OM]3@M[ MN^Z_3Y]-GF-7V-] P86[MD%=Z?\^R[8^L38VTV>_7EN8AW%PT V3AN9-D.,6 M"[!X_L>;2X99O=\O:%/_YM3-9 MC"TD++70&@G%(N+!2Z0M4XA0'$-4A)A1>$994)BQ$)=6Y)1PX;U#P0LR$FY0 M$_8%:+K%."C&P27& 0 /.K2];[$.9\0;LPV=NA9/I)#+HVG;XPR>M]^;K2)? M9Y*O9^H>$^.(#98CB2U&7$F)K%([ MML]G3EV:\O)8J;E/V@WPPA.7'T'O.9MI-TZN.W;]5FC97DYF[O>[OOITM1/^ M[K8Z@W_A\N->+ Z(V=#\VZ2"9 T/WG""@A4$<>\\LH0F!-@N(J=$^Z265IB8 M%2CAJ1QF:%[C :LRE5O]0?:677JJX>Q!AL:/UN"@>SQH M]*(-,&+@[)R#W>I43TBVU:L=ZM#'Y84@.L>'H3L8?G^=.^%+ MO8D?ZSUT5P^!MP=/'GGO<%3D9&O; M[R5IL,>1(*VQ0ES*"%JH,4@Q&Y)Q3GEKEE;(E$/(HPRWAK-]H"9X<2E-5TP$ M,/FC\[S);>,4#?)QSD)G%9U]XUO;G^GFV@>0_NN\"33'@L4J,(N<$[F1<%!( M$TP1#=X'SF$O:>T2 S(W]5^)KL+!R,J M4JTH-5_WJA+OHP2GY33WMUO?XXJEY'9[]>8]'%:P#[+2<,<1M(L@(;Y$P42D=9'""+:VP MJ^1UIK=9R,4'AK7W/!#EN;!$*^9M],9+DH1/-VQT5-/6Z]M@*T M/"M, +&K ?RDQI>2SJMLQ1Q%GQ>X#9;.M3 X%,,3Z#5% M"7PF^+4VG%DARK/=V?&P\^ZLG?C7T*^+Q3ZSK=]O' M@\M_.ONSA_7S ;V)$@+Z*K=E2O>V&%<5J/D?NS!C:1ST,D#^5RL1JJB( MFF(G.0[,1:YT-)0;R0E6>@\T@ZJT2I;5N?!J?3[)7EO'X=)MN7B"\^&S.BJJ M75_[LOIQ[5/C_<;;]4]O-M:;;]8_-=YL??QGZ^/J]L96\^G/L+FU#5/:WH)9 M-3]MO=]86]U>7VN\W6BN-M]LK+YO?-J&#S;7F]N?&K^]&=51^?W6\WZD62JP MLQN-C>:_ZY^VKY_,Y3&0YQ=!F5Y"14:F@[8T:NPYL+WV1C@N))5),D\!J-8F M_6FUAV+HJ]"UKV*_U^WGR$9=V:ZQ;UN=*O+1AH]A^%6@HP^Z2Z7AVU%)/ 1* M%.M!=\Q:LM?H>=O>XMT UMCZ/M-+6YM=-MOEN MD^S"[W;7/N/==[N'.U\V02/=.=FD.S^;7SZPW;5O>.N"5KH!VJ7_L?/KWV^; MN>[@]L=ONX>[!SN_0!O]NO%K]^LZW#-\V]K^P'/=P28\>T]P)2-V!G'O014U M-($J*CSB28$RZBQ50IVO2Q4"#U)335,RG.G<.)II8L$ZB29YDLX7V5I]\^'S MQJ>-+(8^758PZX[,,!4;KA_GN7DYZKPT1%N>@)&$T=H+[K@*%K3RY)8>D7W> MK'YJ;,90A4P_G?0'\;#_JK'1\ MC>.7KF?CMR7X;G-];>GW*EI=/1$>N0^ WO"V?] X.NZ!'=4?V537N7W^B;U/ M^;'GK'DI"="7$XE+PI/%!HB42&]"H,H%)FIK'E-RQIK?:+Z]#-]6\[QK8ZMZ M7F60GYK=^,4!'#S_PYZ@ GL/\&:X4HAK9I 3QB/OJ1$)I^"2S6X:+BZ:VD= M3Q7!Y"WVW@,1QQT6V0T MIT!6&HP5QGDPJ:*H*R)?.1 [AGI4N>)BJ-*Y9HY!.(P-2!YNB/?<$Z5Y)A4E MI5;>1\?GF18PA4XFYO&QGL:;/(L73"4?3IH_]B000J($J,1@AWAP!#G8*42# MI,X1+<5U(:[:#IVL5)N;V-!QFNABU(W]%&&TG?U7C7>Q VC1KD%P-1RV.JW^ MH%>YF!OK/X]BIQ\?M9YLM7KDSU$^1(;IDVA[H)OFY1UE1#384(&]J)0_&R], MK1LW6KD<]^%0?QY$?]"!Y^^?#)-3=X5KF=C>[/D_W8&5IN=>%>U[.MH?@<&0)@ ,3]7GU3^'BHYX?)QX,U,,B M5!L++0#$@WC8#2> 1"T_^>S1A?43[!B'*E%KO<\Q*[AW90'DN;HA>N49CN K MIZ3:SGXK.Y0SX<)#3]_V^W'0'X_Q+#^>1IQA'BV@HOZ@4AK#9-)N3M$=G!M; M/IPWS(.-/WT>S3!/]KQ)\CW6:;;C^U6G\./@XL!L?SPN6+/];C?\ !"!QSQ8 MF?2/\/S]3G:^;51IP:D%!GDUSM7A,%<[X7W+NE:[;DL!1 .TMV!%TA_%@8/W ML PB41 1N#XYP+(V01,*GD2''=56B?..#D[ MM#*2&X])]X81AB8GJ %<*Z3 M4^<=.)G@Z@K9%?K5):F/#P]M#S:M?X[23HGR/*EE%FF/=S%_G[>Q<:;.Y.O; M.8AF@-*SI;FGAC>F>I.N7;0G5*Q;JV7)Z3U4U=:4S;VJMEK61,]]K&29$#6/ M4MU/[%#X)25;CL$^ZXS$PWV4]9EEM9[IL<7G>?90@4&2I)+8"<4I$P8K [:C M-H(G01D>.C*GN!BNM0\O*@89*V^@&@S)N;[RR9N3PW.)H!M\/-A\]YGN;J_^ MW*2;>'?M ]W9]O#\?"KA[W;SRP;?S$VK3LZ?2]SXU7RW_F-W>[>]N;;^:^?7 MQV_-M=V#YB^8Z]H.V3S\3':^[O_8//SX]3^_5@>;K7']F\ 8IXFBP!-&W">/ MK-48!9,23T%B[G6N+S>OT]V+LZ$GNN3Z&F%P]9X MP,RJ>IB,#+F$X:TD228%.QQ4SO.\\Z'NZ>ASK^AY%;>_!(WYW=!1.$:8,R0(S2FA_C&T MP(W3"$:QFF=#RLU)I&12*4J80EZY?+XG,:2)UBA2P2RQ/JC$JZ)H%P_X%,5O MT9'RS7$?'AY[C?H05+?3/V@=W8O+M*B!IUAI(S4Z-T"GFA.C3,2.*1L8Q@"< MT16L?$I8^6$2*Z60@(C.("V<0SP:CK1Q.5=3>DTQ#8SX?'K@8D)442H7'2K7 M8IWWUQC8GW<)+16=\@E[%D=$L&U_EGC,+=#R\R1:*NL$R?$82UW.]I "&1X2 M$H1;824/-O*<&CACOY^B6"X G[^_F!M3M,J95_&W)PZ7P]#UQ!<%+V?"RYU) MO(R4&$T81_F$5:X6%)#V)"("NZPBT8P+P$NBIECBOQ?-\F98>4E.'GF(0_33 M,:!N<7$V*?;<\?A'4C_O4+9]\:#VZ2#M*/PS%7&;L02Y9X-8?T8E%=X'+PF2 MDH'9KI1%H*,:Y*ESDKH@7+27G6FZG5*Z&!T>7KRZ"FSXNCZM.$KQ+NKJO:JK M19-W\#FC2#R;:][.'$>KR#B3(BX/XF(3BJ':8I(*Z%S^$E?N(GTI7M6IW]);4D&AG%C5;'MX\#W#C^S"5E(VSW22?V]EO# MIB?=P4'L-5SLQ)2/5$\69W*QW8K?JUY$<*.Z.U!=,>_7E1N/T>=41ZWX? MMK$^] M7%C@/'">*NFMO"SO6]\GTP]J5\>7X=!7ZY%_K@;^'L;]1.'S#@>C\>:OSZ"$ M"R.U]R@R#QBH!6QJC XQ1AWWQE)N!& @/W_>N"KLD$EH>I[//1.1Q5QK$IGS MG'&'N5.8*&*"WP)SJ9_BO*ZN>"I5\355M[8QP^:?7K?G@=$C5D[.DJ)Y^ M!!_'JJ2'K278Q,B'0[7G2K?F@8YX?R2FKA\GW&\]Y(+X_49FG+YOQ8Z_4'+] M#GK$X]2?_%\+LA7685@S\9+:D\]&-]KJC*OZU$5]U-FJE..J%E>6F9RZ;/.I M*WG.6!.*80)6F?,I<.J<$RR0%'GT22BM?24Y%,RN*N55O2@EW^ZY N4/>/:> MHYH1JRD"N8X15Y$BEQO6@ )"O51,>AU AA"S/*4&Y6F[AQ\'+7\PUM1GZOTF M$LXMU0GVH%VHY&3BE/MHC+1,*EE1AAA3!F'XUI1QP<)?!4LK#]"V-ZHZKOW! M1F>RG?#+)H^OW_; "A="BP0X)@W8ZHPBDZQ'!LB#8F\,QA+(0UY5[>W(@C$- M$NY[JWO<;Y_4^#)L\!H'!]TPV5IUV%(P_@12JDIR=8]&$FY4.GUT?8^CG@,9:*T^[E=M3;Z6QLVFU$T;4>*;/]4LFQI_-M6][,3&E ME*7(J@C$J$A"QBJ),.P=6+5>P$]FVJ@J\Y3T!=6X#I.,0.<[)W5S]N?(:'-F3QO'1L'^F/869V>B2 M2ILB#=IPQW,=S* C\40S&J5WMCY7Y9CYW3%B.!6.B:#QADZ:$RD.#UFT=0ET$$6'XPG\\%Z+?AZ/RL. MIVOK\^=5![MQGME+!F$8V_I>Y,(XAG/+P]PT1)F C(\!:8:5!X F@LO<2.VJ MWM>C2I"UMIH1=EH9U)'>X,>T?HK5IR ]9-H9?U7Y>WH@;FUN!!,:T8*!]7^/ M;0^4$+"W6H.#TS;(0X_5Q ,F@"%?"1<,W5]@_<=AP>)A@=>S/J.SGJ*QSPSF M\!;6(1WWJF!+JU/3=%ZI[H6GWV1ZKQK]&!O-[B V"%D^YX>\LN/?;9TW+ZY3 MH,2E4V#I%'C#;5F8/GJE4^ -.P4N6I^TR39:EP_\JGY8U_6W.EX-:LK;Z9UJV5+7;O3VJ%/,L\>U@0AB/7+,YJ2$,&R3#-5G1K!L% MM#K9A*^; X&*42DKN7S^\/WX1_U)$7]:(KX*#:1V]P>8K-VOT=<1MOJ968,) MK?ZH6'UVBM1AKN%-ZD'8!NBU('RJWLQP66\80.O%P7$OQ\ZRM=..M:Z1&OUC MG]14A\WJ]F-CU$]E&/"KE^#5 MY#UK1RA,[C@!A1SW1GKLJ!9_/?S:;35QT1GRY,2M4LKG$RIM'9J7^4(^=@I M>BD05L9*J#SD@"K=XW8 !L\L<=P[PZ"3D?#EF\=Y?%G=FXEX#N8_,B^&U2Y Q&&6N'C M3=:J'M^%"8XF%,[/B.(Z\%+E&/P89]J=6X3K9\M@MI^/LF X@]IG\"G?I59Z MJ^2*UDT%8IW%!_M_+JV%5K?Q?A!N MF-3P)#-VMCJ-)FQHE=5 9976(.?3;'/*.C9^6QI^.NJD>>OVB-81FE.QB'>: M&X%-L!$,MT"3P,0Q5KG6)2%4HM&+DMMPOX(*GOW+[W&:O+98(>M)R/WL)#(B M"22L,LG8Z,&R7EIA_*IHS"M0DEQ6;"LLK#6\1JVL#C7.2K^K5*MNML-SPE6F MI[L&_X1RC"CC$JT*,$;',264:ZV<)HG4.M!]$%,)_LU.;F1S>V:^QU<3%I'0._BU?'?Z;WK#U;[#X9,[MT7MGKYWVQ7PU*"8K&5JN[3PV]?,F31K>TL(5W2R3*D M5(8L$T%"YJZ>UA(1A?').9$+=EW>[W4BF_1L!LUD2^K&;V?#0[/(06YS=@^- M5BC,N7 Z4$L!9A4CV"O,:E_ _1+3>5JJ9-[J\(S02R8BUMS>V#.$Q11=IAH/ M:I:"5UHFA@*+1GH=E6"YZIN45Z20_E[[G+*Q.FMF\0.BSA4G1-_UNOV7[!H" M4OBZOY>PX\I; 2J0 CR)6B(M8D0>.)91+P3LRM**EE-.=DXTD"XY+H^4X_* M6%MR7&[+:+RYMKHG XX8=@BT2*X1IZ"Y.QH#V!HD:0ZFK0SY#+6D4TK'W5.2 MRP,FB#PKM]<_DT[L2I\?+="$HO_JU(?5/SK.7JY4NSUMKWT"J)7/<597]^-1 M+O1QV()W[;STGF^Q&W>ON]^QA%6'K#)W18V=&'D@50;N9_VUX M9NBJM/W!@1V,'EJ[SP=GXF0YO[K=CGYPG"N5C+J_W42@'TPWAM\=56G^U"A?4A1K.7C"(^5^;7U?WM*'&4:F0I!(4 M1T<],M@F9*22UE&>, N@..*[^>>.@"+OX(=;5!(ZG4U-3)_J5=CN?CR-R:X. M0[(OFLYRP)()K)T"BP0S8H#.HD*:&XDB!NW&B2 \3TLKU_CE4CZS-*2O.G1F M.],"X/D,4M?ER\;9EU?YYFY%7[?RS5U)3[5C;KN[50U]&A&]--+!F[^^[1&E M5:0J("Q=KM!K"-(>U"[+F*-*!Z6=OSQ?_[37_-BQ,!*L5;AZ:.L,967\>=2J MI>O8F8 $?&H)+,AQ>TFM*5];&2:X:!!N"TBQDUU5TG4TAR79@Z&^>T@D&=4#,X MY_3IY?#$;.X+G(AFQ@:6H@0)ZIQ2/A*M Y:2"V8K4:I'9]S@!;O]69T-&&FK ME]=Q*YVO4[,!P)JJ,C;M?-9T/1M%N?+"LVGS>7LBW__1W/ZPEQ*G3M$(I,TT MXA;DJPO)($TEX0Q0R8CLO2!7^0D;K=,=R)E2O?TSR9%#:_G_Y-,QH\T9"I+3 MW*U) C1S(4":(G$2[)CH$G?*&R,(40IFBQ7!N#Y(;D8$: H!/@(!_FQFRY.I M !9FRB?)'>)!CUZJ ,@VK^!R",CU3 MDML5GK0)EQB?HA0N8/Y:E6^U^B%SX_?8V![YGJILXF=?H>?OX_9)HP[&B_FD ML5VWG(W?EH:7C'+:YES%1Q&A&%.8.L$Y55XG#+#MB>$*)&YR=:$,#$HD&KTH ML;9[P+#\_#WOF6'8Y%[73B">#$,F>HNXDE%')B.5Z;ITH^N\9U=FG*P>[\-U MHU1-,9%P,H72JL.%M3$\OGUEB,U$@,PI%T*4S@'-::P-(9$G&T1((00S)$!= M)S)5+TJJY3T3(]W\M;KGK 9@(!9ASX$8<<@:'1;(6V)Q#)0PZW.JY57%66Y> M6.7VWEP,A)*KWWLJ+(?_:Q]DX#*JB(U0G%3&[WW0S959<2^:?+;6]O>"Q5[" MIB#N3#ZR[SS2#NQ?*T/$,;>EQN'1/+2W ITI'MI#N.E!29^\#9'4>48"$PJ" M#042)6 ,6%$Z:HV2HU&IJ$S,R25<7_#%5@M_4V=L23QYA,23QX'EDG@R$Q/" M9YM[V##M82-0I 14SQ3 AN:"(T#%&#!5TL4LZ/%5_LE9\DY:_2OS1,XQ[?@^ MU2_'E]>.R+K>+B# 02X+'RJ%M0>O>OUA*O1X9,.#?O/.:SF;UO)\[=]YQ'4F M@?K9QW7**?Y1Z)1)W!TGWC6]M;^XE)0W7,J' >4"\*BBFN$;* M*T5BB((&L$F,NJJ,V#U&XF8HF?7R2E^14OJJE+YZ:H6A2NFK%U#ZZ@&&/QT3 MIQ?=NKZ(UITS/K(J-[*E5ON-40N4JO'DT%LWU'%CYR"?0ZU# R#N0 !FC3%. MJG3#DX6Q5W4VJ9H6595+CH[:H,<-M< <,VLX4.T!7AJYQ]I1I?S!O&OU>=*S M?&#[8TE;/3$__Z;2^L_&0?='MB#/1?@J3:I*.SZ=Q+!^ROD5>S5:K#I,?,LB M*I<.]GSZP^Q%5"[J%O-,2*RH\%K0)R27NZFN@/?S[38PTLSW8WEXC=AB?^U>[Z M;X^NKN\/U?7NS^:[SP3NQ;?6/M#-M56\M;;/=[ZL8[@';7[9_+6UO<]V\F& MUCEU_>LZWMW^3)MP?7-MY\?F6K['P<'.]D<8[P[9^;4IMM;"U^:OS9/__%J' M^6SL!>)\"/E$E!$&<5A?9!C1B"<:0TB:&Y[.EQ#,?=8B(=(KZ[E1RII@+.CW M@5,:DF!+P!+>'F7"[AV#PO1N:VOMR\;[]XW5YEIC:_M_US\V-IK;J\UW&W^] M7V^L?OJTOOWIO/=YACR-J0A]_1C/S@ECN(@ 1V'+.5/&!&>L -(R8&(:HQ:T M+.)I^\4Z.>O&WJ-:F&0(K#HZG$:=W=#ZS1@Z,G_[ITVT)J+>0QRT=9FPKN(K6*9I^K\LN9[6[9_/D45Z([&=J M@1P &Z^5O0W9"=D^.?5)967WU=@75D;MTV\C9.9E'49%O'EB:5!%CJ_1$GS)B<$V6P M+EI*;^WL>.U!ADD &A [B6C)D++T[%VLTCNQP>G(K+Y8\_YI%D 7B69@'BD0$_"8P3*I-32$\=HE=UU MQ?GN&V62ZGEA]/VJP)_\00S'[;B51M#SDO7=YO;F'F->6,<4TC*H3" *N<@P M4HI9Q27HBI2?UU]G$J27]B=_R ZNYWI<>-OKG0S;&A]W*A5G)"Y!13H9=>)^ MU0B50*I^4Y_$ Z4%D'24\E^;;:SJG4GQ8V9*5%"?0;@.<=K=>O6M55_BQV[YJ90_C;]NC?GP]>O%G:/6/VO;D=:M3C:+ZT9]G78?9NWVN MDWU%)O770\>W,3NF"RQ2<\?#N]2K -30 37"BN',9YM4'1-XF&GI&\VJ+C)=:1EU MH>D9)HCS]):NO'2(D4/4@\L;50NDQFA>3VJMZE37LD"7+M#'V*\TA2_=7CN4 M=;ITG;:[ ]L^LSY/ 2=O-K=K8)*2\UN:M:LGOI^_@=(\- 7[O\^RKQL4:GW4H#Z:J_42?IX999H\;3V$-_OM.4YR<6B_?=:'F-DO%"R>D M"D201"P/5AI%F6#*A,2XS<<6-RXK!S#=Z_GD?5,[7_[N[VYWQ>[VO^W=[1W> M_/+Q6_/K*FX>?C[9V<[CVVWM?FVVMK8_?MW\NDEVWPQ_\Y^_#]QA:&]];;>; M7_YM-[_ND]UW^7D?Z.[VWP>;].]V\_#OPTVZ(9KO-D\V?_W[[3^_-@:;G_#/ M]]OK@\W5/1^<!3R;Q1.FFSM**PF9) /AW$9P2MQHRT M?97TO^Z1YS6(@C#/%&$BID&E$$W""4@Z4[3QDI/DK%78^H(P]XTP)Z<(HXES ME!J!\L%TQ+%4R#!+$-71*2$U8Y%6\9>+M44*P!2 64R L31C"W:48*P-PSP#3'*@P/F!,C(TI88<2-5DC; "C#3:(V$<:96EIA3$\Y M&5 0IB#,8B*,#)'22)P1-O*(O69*X.@T)4F:I.SE"#-SUD@!GUG!9ZS=2*HL M%M8AG5) /'",'%8@!](_"Q\_8SYV*M?D M5<95!7A];B<$O TF ",Q>E?X>/'X>,(I$5+"G"B&:!"Y^:R0R&*-D9(<2T83 MU<(7/GX!?)P8"-\4HHY:$96/]1(LF"KJ\Z-R[%CRAF"UD4(@P%<, M'$L]RLC_J:. MTB>-0G,PXF?1)MYV>S#0SFB[ML>[]%4Y^.$Z>R(T(#*B4 M4:0T!9TC:((L2PGI9!(&J/84RZ45,D7E^+TP\+-@X+M;^86!'YJ!)\Q\3R17 MN3PZ%=EH##P'\[XP\(,S\$3\'M,@C&4H M,I+]=*'*4TS("Q4\R.,08^[O-^58_Z,P\)S"]@MMY%][4L3<)5A_Z7FBIXA4 M,P"58=+$2$(P+.<3!6N]83P$(@-+6M)T2)[ %**@< MY -;'AE.'9*!.#D4 NG#GA!!(>D^-AYU*..;C ^3N^;N%C9\7&W.EE0I!&^!6;HC1"@M)E.61>$>&IX#N MUE:Z13O "N]H11(D7B1&J> MZ[G2H"B62F&;'!;I!EQ=^/>A^'G]'/-:RXRV#M0_ED9)( E?1 M<<>]\5P))Y.QD5@G9$'"^T;"R0,XSGDI B+!4I2=!LJ *$A8D?/%(J)5)UE >#!7<*&Q$Y1 MY2B3C*+D:4*V=6M2PUOYQHK-S9K(/OY8S3(UM]NMLJ[/9:Q/BP8(OME=GT+CT?MJT'R#MK/77_I, M6]1>R"&8UM9T-*931:"6P8M+27-I80MSZG5_G$_C>E*[^Z5Z$P-:A4'9_=CX MW(_IN-UXWTJQ4LQRXXS^A3HHMV$0(IYAP]]I^333W(XWF?!+6[ES15ZF0PDU M+P5*9I=)SX<8WG3[EY]$FQ<;/<>%6_7^^/"X;0'"*P-Y]; +8_M59;F6!;W% M@C;CH%K(-[;7.X%15V_^M>WC6'BW\&[AW45>T!OR[IP.@"^T"5R'2U [N]LO M^F)O0EV7K<+ M[?S="DF[SY]=NOK0O9:G^UMKY\%KM?/I"=?-W:Q\.=[0V^^_5M MN[G]=WN'KL.S]NG6]B8_UR;(6:-4;BX2E>6(*RZ1H38BPGG*'0B="CSW)N 7 MDKIN[\R80O5/.X'U>>:;*D]S\3N,J?7<.F*ECIKXY(1Q4I,;'\:\(O'N7>\9 MG:%_./:=J&HC?:(T%[VPG")N!$=&2@.O"(N&PQ82O[1"M%PFLZ6:WE\"?4&% MQ4.%69J9/ L3/@U)UV:!2AF!(J)HSM22&V"-XB1W,+$&85TN(E)P8B7A!&+!1'-."AP,"LMO5,0H2#"],(N,6+-(]=% M8DO,R>F00:("B]6]P)VG+$H$"AU&'%N/+(\.48Q!D] B4.(R4M I7H=B3!20 M6#35H1@3M\&#S5,\T#9);[5'DB6.>#)571"!E+>&P_^,MVQI99IKX=[UAA?6 MJV,M?H_M[E$,C4'T!QUXZO[)/$+73SXR*151T4BJ(@:"=,F9B"4SDA$J'3.T M1"87 %7.]#]5BD2&B4,J>)9!Q2$#@@ )R[@U7FJF(B@9;*QCS!":+-6V;RV/ M90X+,Y#*N?^%I5)K!08BIK!; 62 +6'!Q^*="?=>5 8#]R"&34)<<(5LP YI M(9*C F0SL\ [0MR] DTIC+_ ]O4#\&JQK^?#O1.QNL2P2MXQY*BUB!.:D#56 M(D$8&$$N>!=R87RRC&]L71>^?72^72RV+2;O+5AT+& 95T")"B.,940\@+%K M-%&@H485$U HX3GO!O,B8)\SH[+D-156!2H29RP9SK&+B>9:J)I17L):C\2J M$V$M%D5NTZ<0LXDB3I5'+C?V=8Y+[+TS1N>PEF +U6BFL.J\=>$'X-6B"\_) MDIV(-24..^5I1)CDJ+0/%)D4&$I42JXPZ$6F'<1V?+;H@S? MAD?'\1^1>V!IAHNQ?VL.A\ZF"-3G+3>C4 $GXA.P \?<&H:QE+#TT1$>N2IQ MFL?BA+$;R1#+C"8..8(#X@&46\U\0$E':75228L$G$ ?(W/B);+7+/;D _!7 ML2?GPW$3L143B%/.)*0PIHC+&)'QW"%*8XJ,<.ER=PXY0VBE\-IS$&7%!+P% M6TV<0P9SG!%M4%)"994N(NV50D;+R$ED1F*6V:K(L47C+0U:MZ51N\@L)YQI M4#F"XII3Y8A1IH0P'HF[)D(8#A,GE+?(<480S_+*,OBCI!LR@HJL>0FY7I3,P8*%N&H MR#Q*UCXECIQ?U[_BC7]8EO23WGBC,)4Q:90"#8A;)Y$F(B J1(+=R2=F]%D? MY**1Z9:8?9%9O;%XO5BLMZ"K\>2W$5G*0L&"<=!G%,/0IPQCU)B M3$LI54P2]&/"9O6^%N9^[LS-E58J!&V @[DA1BLL)%&61^(=8:3$5AZ)O;=@5Q)G@R HOD2=,8DNPI]IG19W,[7A(8>]%9N]9%/4'X.^BJ,_) M-)^([3@1)<<&6%X:@SAF%AEB,5+>,*XPR8<+0%-G;(;R987;GR2W+Q:S%TW] M-HP]#BZ!S:09%@9YHQDPMN; V$Z@(*Q(2?J@72Y[0O24L.TBRO+93J@LR+&4 MZ>TD-SHAIKNVE)PATG:+2Y\$8-U'%_"R &4!R@*4!7C*"_#"ZGQN=-!1K^MC MO]_HQ7ZT/7_0L)T BF=5__,P=F[44?TA4EK*R?9+*QM+G:(S4>9./(P(YZVC M)M#\7BDO;NK['^M64ZV*]9^^?9R7\5VW&WZTVNUB8\QD8WR;C.M;;ZU6AB(K MHT6<$X>,AS]:)N^3=["G;&F%@HDQ8\.U4I3BT5GW__TO30G]LVS38F]30=CG MA[ 3\58*.*JH2,@;AA%G*2$==$#8^*!R.1'I?4'89\^ZB@N*C09N99A+!9+5 M^R"3)MK)8-V-W:V%=>^9=2=CJ2P9Z[5$D;M<%3-HI)GD*'!C" M,,IL*ZSY- MUBW*T9/8IH*PSP]A)T-([ ].34T1*GTXD'L#0-9 M]Q/7N:3OUS!T5P_T-8.9A>YQ#D=5X;L[1+D7SEEX6;^PN:S LX'#>67B3LW0 M*R!X-Q!<__%^$@0YPS[2@)+(3K@4)3)61R2U$M9I$HR-2RM"T2EE?*X&P3EP MQ(,V+RP@]@) K)P=>J:(]GE\+)XS#;O&$:5.()Y?6<$]TLYKKKEARH>9#P\5 M,"M@MG!@M@ :63,.BCYV=_3RI^BE8E2,1X^"!P;H);%!V#@7K9!<2C!* M&2,SYUT6""L0]I0A;%Y)X\6HO"<0^W8*8KD.>0R2( ,6).*26&0D5DC;A*V* M7C."P:B49M8BE@7$"H@M'HB5E/>9Q)N=8XKH;CR M/]7/ZJFYWA_C0GS5Y_!G--$AC_!\G.&HVV_E7[_N11"S((/__-$*@X,1 TW\ M:K@N>/P3ZV 5C@>7_V1B#7P$9NL]/ [0/"9)SZ[%Y-^#WEAB[$?D>M%^0S;! M8%_;]@][TE_ZX\R<#EN=T-GL#VUO'RX>KIN&*X>?9!K2E5"Z9#%2 MNK?%J.D2$*S;JZCF]7$'R#I?!<.Q"S.6QD$OP_)_M1*ABHJH*7:2X\!V:713XTU&]$X^-&HOI_[KMN7/AZ?:"X=C*ZI=7_NR^G'M M4^/]QMOU3V\VUIMOUC\UWFQ]_&?KX^KVQE;SZ<^PN;4-4]K>@EDU/VV]WUA; MW5Y?:[S=:*XVWVRLOF]\VH8/-M>;VY\:O[VIH2Z&WR_,^W$&;Y9K:7+Q[[NM MK;4O&^_?-U:;:XVM[?]=_]C8:&ZO-M]M_/5^O;'ZZ=/Z-1.:$4&FP7W]]YR( MJ+4-C(U2!!@+6\Z9,B8X8P7%U'!AC5%3,+P%C-D9O*8T ]XC@?BD =B(/X]B MIQ\;E=2*H3'H-KJYQ>'% ^2YC' #OFKDVL']1H29A,9:]/'0Q5Z]7XR\:N28 M0?Y+S*OJR!R\THT?MM_X[QF4R%N5.3ZK34X4/7[=.3X,W<'P^_^?O2]M:BM) MUOXK"NZ=]W9'N)C:%_<-1] &]Z7#B+&-VX._$+6";"$QDC -O_[-.D=" @1& M($"@FI[ ()VEELPGU\J\K&A.+L=VNJQV/GL5\^N_#[ __*MCOYCC[6\;&%1* MVH3KF^N[)UOK^1D'![L['V&\NV3W;$MLKX=OS;.MTW^??>?-#WM<>:N%9R@Q M1A$7BB.= Q#)6QDY9HP3MO)&3(D\-(!TV_#+JYEV/C&L; I11RVXC=92"6:# MLL03QR#<O79+4)I)]6U-,P_'N]V+_*/IL"[5/5QMS M+VM_<3L_^8,8CMNQFVYP@[X['ASWXN3.;]3RK])\=V \O[>[_OO2;?G&W\WU M[WN!$<-@N9&G(0'61^#XQ"0R) JJ'+@7)+> 3NB177 MIO(P\WOXYN'7J]57ESPS]7=:K@*(7OLU7B77?G?38PE9E?1VCYU3.8F%=A<# M4)'[' 9XYD[Q6TWQQ7B]'R,O]*K4:L+[=TYB^T?<@L$@//P,+G\!U MI\UO&_3KE\_XZQ]_MG:_?#AM'F[]W?SR]7#WV\;)]L[:2?.*/WP+GOL9WK5) MMW:^MK_N?/R^>PCC@+]WSS;(U\.O+1BCR./X]]G:9)\6XHCF*0F$'5.@YN3> M9%$*)%.DU,/^$F*RH4.?W[F?YX CP![TVI(Z2]-@[4E09!=TK)V3;@&/FY[=H3].==$E6+W0(\EO0@\A.B MRD$OQH(K,^'*Y@5[AQ];6M\]_;U&X?N?/]O8??QX 2_*M/S[3 M[9T/].LW^/[T M IN>@79/F]^V]F )!1%6(TFB1IQ*ATQP$GFN$DF)*$_DY4!;H%$PD82U4G-O MO29))AQ($,%2:M3E0-OZQN\[5=[4VX\;ZYL[C7=K;S??;^YL;GSZ:63L>GJ? M&AK[^<@NS41I9S"G*E'.M8DVIY+$I'6DQAG&%S1M:K/3^/.X$ZN$IE=51 M3!H48J!ER]+*&YFCJ]>F-N3H=&K]'0/JV4&$?>Y'#[ &H],= -W] MDFEDI9E_7_FU$8YC33]$5$ER>K71V,PIH[$_R('L(WM:QX_C80O9#G!8NPVD MU6G87B\'P5\U3EJ#@WQ9WLU^];S6D"1SFLTH.)['5D70<^@H-7#3MHY#L&P$'5XU.O>UC_->@./QTT M7R3%S.6OS/<:M7IRWVXM%Q M#Q[4AZ&UVWDRMG&4U;]ZO\XG7$VM'F4#;K?M?/.UK L3X8)!YHGQEP ]S+0/!.E*/E$@;,UME9D/>>J/^P?0R)H]?+>=WSK M"';>5H#XJG'4/@:Z\+Z7<3R3^W'GR+:J+DH5@ZY6;#0DGW:_"U_DHT@1R *( MTV9^'!P 7;5;AZW!)*'^#USO6NW6X#13&=QUW&N,P"(+-3>(H1/[0-U5^GA^ M8;?1M^V:Z=H1J#DKQ< .(+GJF?3KM#H@R.KH# #0JP8(\GWX)R?HY@L3/&G( M _UCUP>;:-"JX*3Z,#5:@_XPJ7>U<6U>S 7!RZN>'3>D23].76 M)/?W-*/,*PRFEW($<>V=7@+O?OY[>MKY*-_S2=KB:E5H/O^D+1@0N?[6FQY[TW=T55'V M7 :+5_7S&>P#KNSMJ.M9AG>F=TW\2:6YUR=/7JP;#'F;>^ MU;2OH.S(27H7OGLYAJ88S"&/-GC/GUC7@Y M:W?A%-E\FP#/BU#+OCSUOCQV\M(C9 Q,3^=Y-XYRS18BH5103@FU23F>0&.E M21!O,!6.>T6N2>[Y:61DA&49RCX-\CG2EQ0_./9JNY M\T%L??G:VOT&[]SYL_5U_<_#K;,/ITUX;I72\W:8TO/VLB=Z_V1KQY]NK^^S MW6_ARE/OSP]]=O_FQK_<\#>(YHPCIMK6^>P1Q/ML[6 M]EB,1!IL$4F8(\XB188[A006C #3.N)@1>A(RWMM<[A<5Z([\&ZXZ[/ A/&30")+ +/?0TE M J952"8GF#9,,<\KB4S-8K#N4_# /V[C;)@5-XJV\D*U%>6H Y2*QE+!-1$V ML:"]]C:0&&2DMRUT7+25.4)><^+P$S?,$T61="(@CHU%.DF+ E94>1:28[)H M*\N@K=R-4XNV\LBL.]96F$S$!N^04(DA'H-&QG*"(O-8.2\Y8ZQH*[.X\D<) M;+!2\6:H*5=>O+(L[-,L[%563=7_GM4!X,^=897#&!JP!O[&B.9-HGK*W)^) MJ)ZE$9(5TD?OK?8J/9-P]A=K'6FF M0J H)A81I\&@7"$:,:N)2<+E8]PK;\@L/8]NR>H/JE!?>N5MPH9W0*C%X\_; M9Y:\!$#^6<;OTD.PCMB1R)55%'.63[0S31()6@FNJ#5W\VH4"+X_!$^X-H0+ MDBN&D<$L(8Y#0MI:B;R16"KIA4BY+-24LBX%@A>0/Z> TC)4Q[F@' -<5.?H M;3X9[+O]0?].(/U\75I/HR>GV.O%\*[5R>O^-B][,Q9HG@V:]R^4W-)&)ZPT M8LP9Q)7BR"8>D74Z;U?P))?<8JM7'5>WA^8%=C/^S2++8@?@)=_7VWL[\3>X?9L5*$[TS"M^I[ M/532U_9PDA93E9 *VB'N'6CHP6DDJ>#6:A(#=BMOA!'WSPN9(T,4WTMQ?S_4 M;(NL*[)N/A6=YV1S%EEW+UGW^5S6">4HE=3D\F 2<1LDXX=M'\>+ M5>9F[E?.B=%6:D)HY#PF&R4CC'A*,/&2QNN5_#M7\VWU_LKC?O;P>/<*B-]Q MSI7MOOMVDZV3O< P<);F2">7$"<\(N-B1(H%:I)T M)C"U\D;*::W6IC>F?M5PMA]#(U<)=H X/ZJ"D(>V]ST.AK6,\X5)2:Q$.-"+NB$6. M"X>4"IPY23"3.E>8^!%1;LIR6?%HO.W%T!HTUO9[,>9E;?RR4E56OO3QRJ^- MDX.6/P"VS,W=^YF3UX!QVPVJ*Z'/ZNK-5QYWU.O^: 6XX?@H,Q:0L-V'+_=S ML0M@HYGDOR3.T40=LYP+GHSGH&(GQYTFW$8R+.?/[U/._SVPP':J9_'.^JJH M]);]NW5X?/A[M]>K"N>^M4?PS>!TB<7$QEES?6TO*>^DDQH997*(+5AD=*!( M>NLT2.S 4V[(*6ZL\@^P[T8K6PF!P^/VH'4$XF%8P[Z5,?9R@?U6Q_=RW>X* MA^O@0L/^L*UV)5C A!C"]65Z?)5K=7\#L501XSF5#@&]'?.-("_*3<1JE<9("_:9 O%/.W(M:X\E40ET['^F(1#>'R[1=U;E? M9H(%P/R\9X5-P6.-B ;MAF.:D+4$2-<2'[S&CN*X\H;^E& KHAO!V&KC]S'] M[L=.[%55X!V@[5B/L'7!^O?=3J@> 1\[V_D.A)=B+E-?%?_Y9>7]YN_;'U=^ M?54W5O"9X'L515=%YCVH27WXK5>5HZ_+Z3?Z1[##^0&=_:S&5"TD9CNYIQ7! M5CMMG1="=A7L =@A6076&/8X*4-%E#/[L<,!:UN9=^ ?0XB(8S@Z;+@N]2D MINJO<61/,X*DH?AHI!CO@R-" AUQK80"G"BD!2GI#9R6N:D(,9 M'+8&E;T>7]11X'M0&&N>?=YCV.ND66YP9CU8[8&#< ,H4428Y!GAR<<,)=.Z MMLP,)51'YYBDQDC,05B "IZHQE*1:$1,=Y 99:]ON=?;ZQM[)MDH*%9(,6E! M6!! $R=!IU5ZXAU%R E59_Y$JI/#A5CQYX+ERZ?ESUG\JNV]I=/%1H*H]+I0]5 MCN+9R--X[5+TQ'G%@1NB!E,Q BSAR VWUD[MAE,DW7UI,X]W#[M@:-0!))U2 MB'.0=);QA,!P=\$2KBREUZDTV=DWN$P[LV^_RFW#N/!)6,F=Y0YDD@P.@REJ M@N)Z]NTOZ'1+"H Q['EI!?,^()+[N.:GZ+^WCYB M"2\^R3]F(3LK@DG2ZIR%@7FT(BJ>$D\N:>R2G1ZLNNSMJ1S@0'O7., G06B9 M*0S>N;N'@P';(FJ$J_;8QGMDDR!(>Q(D(8I9'V;*J[D;I<3F71$ M5E*>^TS"[BE"$ 8U5ME$06D#+;;3O8(15T%CPH7MNI:>? MM])\->RN6>%KX[ .<=S)KS#I5CBI=/O*<=ENC2>9.V*.FWC:P34HO'JI%/6T M-O$_#9'^)+0Z#&_R?'[BJ-NO_.6O>[%M<]!YW$#P'RL7[AIF6N'Q+=;UN^WC MP?6W7*GS_T0A7,DNK>K$SX/>N)#_?D0.[)GO@*(PV->V?6)/^RO_O-C8L=49 M/=SPO.;7SOYBV\;VKES4X='DC @D!DG7RBVUY/ M_3_;EJO=*1Z_:6!%M1OK7]8^KG]JO-]\M_'I[>9&\^W&I\;;[8__VOZXMK.Y MW7S^,VQN[\"4=K9A5LU/V^\WU]=V-M8;[S:;:\VWFVOO&Y]VX(.MC>;.I\8O M;VL4C.'7.\_[B69)\&J-\5=_KF_\OM-8:ZXWWG[<6-_<:;Q;>[OY?G-G<^/F M"5^/\HN;1O._ER394-U3VAG0+E6BH.B8:+V5,2:M(S7.,%ZGW]0/C@'9H6@^ M-X"JF&&ML&0!6R4^36H;L_M-M#+) KX$0P4W"NML582B6**"O$ JK 6'B/*&)84#!S8 MBES'0%SC*IMM=T%X*!6"-K"%W!"C%1:2*,LC\8XP,MU&+;M[I]W]MK%GJ,6) M4H5(X")G&S!D+*%(2T8]U5ISX?/N7O6!_.-Z'7G"4S&98+DZ15L>@N.S:;ZM MY2K1UW]]YZ[+9%72VSUV>$;[DJW ZA[F]VV ]?C'[$7C\!D1:V2 M"S\U<^#[E2L:X*-KLN1:3?:FG&B<+/-.!)9(Y%(Y(S7Q! OBA;3"BZFAJ(L" M]_Q<0J[JU^[V<_[M#KS@]W;7?W]RV>I'LA6>OR^VU_WIUOI^=<:N>?:9;W_Y MVMJB&R!;O\*]:P*>\W?SBFS=/]U>_\Z;9YLGV^OYC-T'UMS9%U\/-\]VLVP] MA'&NMV',&^S?9Y_AN^][GDNG@R/(!B$1UXDAQX1 DLFH+#9<4%.K/Y49L9:= ML\%&1EQ4.@3+B3.644M3] R4'U"YPTHC@LIRE V'WC%0[KNUS8^-O];>?]YH M;&VL??K\L3;'KIS=NKV%,MT,^.FP+DX#2] ;<,1)>,H):'(L C5YS+VWP$AI MBAMJ$6R@;,O 1*K3B+FEX(1[LI][#&9G8G_HE(P37[;.@^[][&S&U07NJ#Z78QD&K/^CVLFI3Q1WS M>956?[7Q;NHX1J[:H=V!6M>JSK]4 M/M@?H"Y7#YVX^,B>UMD5'K0M6SN-@2)#H]VR+H>>6_G>_,@)M_?0$(3G_^BV M?V2W[C!QPUYTU9Z79)D\D=>_;L7'^:SVZ*C7_1N,@GQT;^)(7SBN'>&PV: X M'71[@]KOW:D."ERW@E7^V6BSJW,THUFO-C[%^H1@#:X$5]N>CGO5\K4Z=; E ML\\P3^7J^<*+#WS!YW/>C:?>&KOJAZ>,=C:! MO5(1//P%9'U^,BSV7S_P-E^X\;'W>>+$&_E__Z4IH;]]..YF\+IRAN[2\;G, M.ZT\@PK:JJWNY[V>@)*'9I!%63DZ7+G-BNQ>#?$8^*/3^$^]F->MXJN:BW*8 M;WQ\\54CMNKF(DO*?MU6)V-CI<'D MN&\.T;;/59")&PY:(*E[_N!TM0'OK/2@B1=6MXV"N-/NJB*U\/TE_6HXF'I\ M=> 9]%88>IT=.J@'V:].A[HL!> \2R4M'P18UXBQB5B_-SBJ25B_$(BQM?[V:YQR%P_VQN\ M+C_UHESRN@@6?,2.86<#7*-L2,8$0Q2VH/XP\W1>E^J)KUL#H%!_B_5=JTV M[#UX/[8!&ENUE TY\E19E7_5!G7VC7S,66;5*8WJW,/M="Z\2F\6L0_K-/WD M#V(X;L?M=.X^K6>^U@D3\QY->[MS/LEJCA5(+K63=?W#GN:,!4D,BHQ2Q$&: M("-R,6T-7$ T.I7S;<0IE?\P>V)^GG/>^"57/:BSWON_7O5CW$I+G<#N>IV?3=B7 MBU5-S8.$?,/%:'UZ)EJ)HQO.#69]-G7>O[ M=ZHZ/ISMM95TIQ33?795:9^@XTQ9S[*>93V?2[?+Y]V Z&W.Q(G_.6Z!>5Y[ MN2_2UBS3?J%]%5YH?P1J6+2:NXASP3.FG;74>^R5-D()=]M>0)F UCHA_[,Q M)J,IR9@+=([[;G["NGE"5WQ=_RYV=W9)K07,6>]T X%-PZ=%P MZ?0&X!4A01'!T:O94DZVQ),U7L6CP!F=(^:[;^P0X^2FG\57YH;G(S?BOHC',I#%\F/3T MQL0TTSB@0)- /$B*="[:*HW1R1'"G*,OV&PIK'P>G]'!>Y^TU#)QQI-Q2CHI M351)X,#P;?7\PK0/Q;1C-=][2BT)&MG@/#"M)<@(H9%4FD?+@Q-$K[RA?$HI M]\*Q+X9CA9=&Y^9%@HGY6*C*FQ4,=F+AA.\\?6P+;\&_[?:.JH(6 M=?'=_CG9W\F0G[(2+P^ C-)>.LJ4L92;F*RQ"6SZQ+76S!-6=(D%A*7/DX8\ M$83IE# *&CO0)8S-IT(%\C$(STSP0H2YZ1(WH,-#Z1*W=<FHF>14JM8 MD*E8\D_.M&/I2XW%S#@PW046B#NBD)%@T\>HAQP**CT(*NU.&O*&*QLL M86"Y"X\X[!1R@A-DJ2*1&4' H,^: MA/:DJ!)/S;03B;?<)(NE0M@IG?5_!OH_#<@&F=.GN0G!K[PA@DQI&E98]L6P MK#72+)WV7*B;_>?73:F._"T/J5"T#:.I5LH:IU?>"+EJ%LBK6 (!<^98IW,Q>BT2P8);FAQGQ!,/1@&EV$5: M./:I.7:L/W"N;%*1(VI= OU!@=(OJ42>"!LTMLSAM/+&T/L?FRT:B@76Q2-Q';#Q3UE'-N*&*X2)\GYQI)Z+P'LM( T?.<8*X M\P092QFB1'%%HQ$A*C#>N;E_0OWC1>'OUY9]F:\L"_LT"_NR\D:V0#CD9L?M MDC1RF[!5%)X89;3@AD=&M/4\,,%=LC:"SE0TWP44HALGE0"MM-^U/48E"21( MI(RCB M+D.8A(I"L1+(D@XJBQ*V6@)<95E003W/\BB>P8G62D2=LL'/ U3?D MDA>N?22NW3KG6N?S_G8)NV5C@E%8ST"L]4BPV5 C-@H MG5,B^9(UL@R\'*DU22DE8BZ3*IRE6B:C523.$15CD;Y/SK6C6"VLQ]F'/:DH M80X[9)UVB#,MD<7"(?!FQNM#Q?_[<3:_PN6ONZ96,!^-K _G720 M6&9 *D>#HDL1<1\YLDICY+VC/C'-:8[Q$T)*D/\E<^K#-@$J_#MG_AV[2IC$ M(BFAD7.&91,K(,><0\1)SYG'4A!;8OM+P,$/VRNG2.L(WJ.I:8+!R\N!\^KI4SAU3GSJC_G5>^;8.1BZ$UR(IDO'*X1%&6@&?O;J07[IPS=XX-\(!U- %3 M)#18X9P B^KD-0H>FV2BM<+JE3=ZH%\Y\9L9WX==[\NO8W%8,K"KG@3Z% M 6D:E$"6:H4HB%.M.=A;NF0$+@//SL_<+MQY3^X<&]B,Y[J]$'MHT#UZG8?<[[9;H9%9ZT5WDYYM M\B\&I>850J^QJ?25OC=4,T MGUNIW-O1_Q/[] N"%02;N]>B(-C\$&SLOD@L>9;-H40919R;B+3C$J5H S&, M>4\E*%Q:K>*"8 7!EA+!'M:[4W!M?K@VF57ADHE!(V&T!T.2):0Y38A)&F1, MF@7"YYU549"M(-L"S/I1?&"3R-8Y/@S=P?#[ F\/!V]C/UE(V"7-&9+18% ?9:()T^0"SY[16GP5@3M8WK!)S$* M#KU0')I_WFA!G/L@SCCZH@WEK.JMBGE$G)G-9$K;YA9J$ZK M!6X*W"Q",FP!H?N T$1&K+ V@$X#A /XPQTCR!KX37FAJ/)!4BF+VE-P:"'F M]J0)O@5Q[H,X$]$+%[ ,%",<\XDVG')=0,$0%4RRX+W%."Z@##G;CV&MU[.=_5@5*!LATNG;MNWW6ZD50[/;\<=P!DX_?$+:!5.?P1. M'_LYB 61;H5%GN1>( KL#Q.Y!:LC,APTQZR<_%T*3G_(0EN%IQ^!I\>>A$@I M P,_)S[ZW%0Z'Q4&\8T4V%]*NZ <]8NGI2]9[LM;N *&G?O; Q_V6R'V:F]" M^Q;YD$M?%O!ALTC.$[,G?)M;T>8$[;#=^9@[*O1@;7^W_59_V\'"53M7W)\S M@A:_4- K$! SE",>>U[^Y-*$S\-$P\<794 M!Y\BY@BXT2 >4@X"J(!H$%$G*RG&N?6VE@O5>KNP\(*Z"0H+/Q8+C_T"*:=5 MFI@02<(B3H5&8$4II+Q3F!,%4MHN'@O?-\7@UJE-5X\7+=%9[]DF_V+@;%ZY M"1,H5DYUWQNUQ(4#*,PXF1A&..1F7$YQ9!F)N64YH1X#7.5^J?/T9BY&R8H" M8P7&'OLP2X&Q.3WEE0K*#8 MXLSZ"=Q#!<7FC&)C+Y!103)-/+*Z.A8C.3*6&*1)4$)S&H2?EPE98*S V.+, M^@E<9 7&Y@QC8T^85(8Y[26*-#NS)=?(&&>1#,P0')3!UH$RQN90X/518&SH M(QN-8D2YH@*I>?O ;_&,6Y3HN<_CRQ"?ZQ"?=4$[?8MZ=O7( -:[=3K7:YA+ M[.6K\NDQ'P]=[#48>=4 "6">NI)6><8C/6-.N8T+HA=.K^-8US2]$TG/$9#* M,Q[I&4MV\C>GL#?B?XY;/T#I[ERE\WL?'EBX&<]LY[U,:TX:RW42FJ4H.:/: M$HLMQ\YHKBG&(EMSQ/S916TVE M,%XRPCVW!+N"0$^/0.,XGV64:A\"2KGK,8@.AT!<&(2U$]1:QDWN'<1(@: " M0<\&@JQF1@IOK;&64\\LSJ$Y386CBF)FKH>@VYS)*,#T<, T#MT!%&FL54+4 MQ^J4%0 3,X!36D;&B:$^J1=\TKM@TPO%)J#+)#6-*8!=IFDRR0J%4TP@B0E- MI*A'3X]"X\@;2=P9QL VK\B/U!5;?A=7'QOMQG/(OC2O-HG'(#.A"SX/SYN^U\ M;PS@B2#/CKK]U@U1EZ4O:V-B4C'2J+$#C55L0ECZGCEN:SBM)("^S,;638V"32;37]PK4/QK5C/VC07)%@ M'!*&6.!:IW.O88I"H)PIR3@C^=@6FUNB<&'9!619BC7UU@9*&.QX% 9;JZ(1 M(@B=HKPA=E'$[Y,R\D3AAXBU%-(A&0,PLN<.N2R(J9<)1RH(#_-K&EYX>7%Y M.00IG++ P0;$KXN@6A/0K4V6P-XE5L3ODW/MR,\&ZW'V84_"/DG)*((]P8A' ME9"6'".L,+5&)"ZM63@1/$]?V\);\F^[O:.<*)PM>3=H],]IOU1^O-:@YXD2 MHY(,8,0G[US46H&"X9RVW-$;W/U%HW@Z;+K04E13K$@B' 6%%>(F).28H4@+ M+1F3Q!--2SVX)>!ED8PV G0'+D&+H%P;1D'!4#ZD:*.,1:-XIDJ- Q M=V9-$MLB?Q>5D\<6/>9".TD,(AX'Q"G!R-D4D-58*94PE>PEM_0NO#SBY<2P MEP&K$#'F1#MGC7.&"6D=S7U!BOQ]H(),ISBN&^QOQRN!2E]*#O8PXUSZ[4/$>0Q5EP1JXK\75!.GCC6(W$^#LJ0]CFA M/BF/= !)+"))5*5 3+1%_BX!+V,'N,V @:D/7&ML1<(":$-2QT&MON&,7N': M1^+:L3&ON78_KWY:;>QW84B= M?.ZE83NA8?=CQY^6./UMZJ:()$CNI*!IX,1J"Y2.A0O"2*NX*>; $\/1A>:+ M'(2$P#@@;:T"(][P7+3 (^$\CK!/F@2V\D8M5F.8$@Z8,\M&T!MD#"P%YD'] MYTYIS8/U,A"+7:*%99^<9<<6O"'8J6@#LDP#RP;ID='1 ?/J@(D(&'._\H:I M^RL0A647EV6-!H#&*@K"*/>!&E BO8[))LI%U.5XVZ(R\F0TWGF-A4;*Y+@> M$P09PA3"P1GM$FPLF9\!7WAY@7G9$2.9H32YP+V7('XM)E8I4*5!9=9%_#XY MUXX->,>,#<29S+#P Z@3.4H%8@#( ,8LI!SV(H2MZ@7BV:6*Q@/YPY^=21O> M=3NAA..O;\!#@J;>D)"8X"%*PSUU23MA<+"\A ,6$Y-HYZ$0@.6F*N++4L&4H4 8J@VMI;URTN7/M@ M7#LVYEU*RO. $;=$@C;!1.Y'XQ%UVE"3(SC9_[98P8#"L?.6OHYI(1@ST3"> M-->*"TZ$\A)L I# 1?HN*!^/;7EGM76506!RB3N:-'+!$:2CB\E;26P*1?HN M 2_3X(-V*>(0.3>#."RQ03"Z+8!^0B=0C MEK#1A-ED%%\TZ;M4H?BWW$8B4YDA776NV1P;@Z MG5<5VO$AJ)4WC*^RPK(OEV6-9Y1H9YR(E,ND-"8:9[<;-@S NYCPB\K(8Q,^ MYSQ9CC6*3%/$G=,HEYE%(26L S8R45/$[Q+P4!R)Q3)RF[RV^1@;]UX MTL-'1?P^.=>.3?BD0"]FR2(F.7"M\0H9F^ WKG"BS&FF\<*)WY_8\*'5/VK; MTSS8>#.7ERLO7ED6]FD6]J4U_=T<=SUI',1VR%H:8'V*O5[,"W!X%#O]JLU[ M Y:J4S)+'KR+[OIP\=].K/V_8.GKYN-%A,XF0B^TSL7"2\621M8ECG@*'&GG M$R(AG^$!C8=RNO)&ZU6S0&[P$KA:F&:SM[%@"_O.F7W'#BA.B8K$.*142H@+ MZY"5V*#H 65I!.ZFKH2>EX"#'[97:^'@.7/PQ$&07'0CYVHJEP3BD1!D? 23 M5@7+N< AT=)H81DX>%X=30NOSIE7Q_XFSYR&_SCRQN:>9"PA(QE'U*8H8BYD MC C#_';:PF@+"N;W<;O7#GG+ESX@B'B-A%9I&*V"+.-4$6 M-#=DA'-,ZZ"M (V X5*/X26SYD,;WX5A[\FPDVW+GV, 6VD;&2$0I5TGD.EJD?<(H4%[5Q6#: MV843I_<-CU_FT9_=Y[J]$'MHT#UZG8?<[[9;H9%YZ^<1? M#$S-*X1>@],[V^K]9=O'<;W5]^UN_[@7"U[-AE=DTC@/EBII/.!5Y 'Q0"VR M)#$4O>&,49N"RR>XI9C;*;+;T?\3._4+@A4$F[O?HB#8_!!L[, (5&GGC$!! M1X&XDPZY$!G2ED6GB6?6.XN'^UT4=!L#EEHBP(Y*BIS/>^95VK?7.7 MD%M,>6(C&*QVZ!Z[=IRZ$XN-1=/)<*Z1C+*:937+:B[B:B[9N<$;,@_OG=F\ M<).=6;5^F0KT8R523J@51:6>3:6^T+?:R2!P=@LXK#7BA!)D'56("*L$I\'P MK%*_V-,6!8=>* [-/SFT(,Y]$&<<8%&1^RBM0<(+CCAE$3EC/$HQ,2=@KV#O M5][(55[0IJ#-,T&;Q\IW+1AT'PSZ/-%W6#+)J$1:8@$8Y G2#G/D!>/2!=!A M[4L^)5YPZ(7BT/QS> OBW =Q_,2I->V3(1;YR'0N*Z.0B2*A:)T6U'@O?5HT MK6?I#LK.MZ+54IP:>,B*5F]!%W*V'\-:KV<[^[&J0#8"I-.W;=OOMU(KAF:W MXX_AYLZ@0-1L$'6Q^WD@1%&/$<7*(2ZP1SH&CW(G[*2MI!2;ZC#_(ITU*,> M%L9QZ.87-'X'-Q_X7@:.AT1!$\C$_3J1%5FL-/Q*+,3?,<+0<^%L"3G_\ M"EF%TQ^!T\=>#D:B9BX9I!7&(-!31"8H@Q37%D>IK>.E4L8R:L>/<.\2*A%SB!G%O0",)1"&P,Q61@C/%U N.MA36?AS?0F'M MQV+ML3,![$6;6/)(BERLEQN"#,4>M!/E(X'?J,2%M9> M>_N3"A,_#1,/.$G MP,J!Y1!09-PACJE$-HMK(:/'*:EH:"[:H>BJ*"S\6,X9HS'G<6(5H].*Q\'T3#&Z=UW3Q:%$]B"NGBY;SH/<\ ME^;%0.&\LAHF$+">H)C]!K1P#GB$;#/:IZ0%XHRL$:2#&FN MCM!Y<,@31T0*/A9\7*C3-04?YXR/$VD>1MH@HT")R8!@5R0R-D:4>(A..F]= M"G-)."WP6."QP..#.,,*/,X9'L<^K^B%=BZWE<-,(IX 'BVS!+$4/ -IY@$G MYV0P%X L %D \D%8""?HZN M]\\WY_.M/HDQ07UV+RYT%O-)HCNQ^1ZT7['=D$@WUMVR?V MM+_RSPMS.FQU1@\W?#4OX76S/[2]?;AXN&X:KAQ^DFE&5X+LFL5(Z<$6HZ9# MP+!NG0/V&N@^]O)5,!R[,&-I'/0R,/]7*Q%048'M*7:2X\!V^;'Q MU]K[SQN-K8VU3Y\__FRV]<]+R%\K$X(%'[%CV-G O5:">4B)3JR"TVP9XK4$.)2<"2R1RJ9P! MB](3+(@7T@HO]M8IIA@33%#^I5:=[AZ7_=SI.EC^'YG3-SM'QS *&(Z'NZH5 MV(%Q_=[N^N_/5+'Z^N\#[ __ZM@OYGC[V_[I]OIWWCS;/-E>_W#:7/_ FCO[ MXNOAYMGNSO[)UT,8YWH;QIR5I,_PG=_#EA$KDT/*Y+9,"0NDK8HH\.2( ;A4 M',RL".KG41;+O>,X15"W 'T[@]>49JGV1))ZYR V4K?=[I[ SCNXT\TL@F< M$M?@\W M1KI8I7S"KK3M43^^'OWR6VCUC]KV]'6K4ZUM==-O%W$QO^"2[EF] MK_YZJ,T8LZH%RPK-,!P^?/%0UUFM=)U+BG3]G5*K1M)KO\:KY-KO;GJL6<7X M;D^]^3O!'F:L_%9/G7=GLO-GF)6Q5GMMC=*:MA['9M>W*LX\8L,&<.!<*Y7> MJ0#LK#6W%WMM,Z#=J9;NK9>A+/*;+"SN1[@+75)]NJ/MW;D8?M5P$41-)PMO MD,A9PM[1Z[+47MFE\;N"+:]4"-H WW!#C%982*(LC\0[PF9/\1S:#_G0YY?6 MX."*V="_:#?T+UH9Y\=$JV>]%'?MZ?8?NV+K[*^#YMF6^)K=M=]VZ>[AQAF, MB31I\UOSVQ;9_N/=]ZVWE]VUF_SKM^]GS2\;;.NLW6Z>?8"KO[9V=[9H<_TS MVZ5;= O>O_OEP\F_SS:'KMJ-P=;:GO=,!1D"PF!1(FZI0=H3@:*32DL1DW'D M0<)9+R)@5NDPYT<[!?%1!_F"[_-2UY<(R[^L*W.^VZ_O]GQ[>,0 MPV9GP_:R!?AB3E ]D@SY/*E FT2#=$R# IW/0/KHD%$B(0(2) 9/-<4)9 B[ MOP@I1R ?&01^F0$%$L/*IA!UU(+;:"V58!@K!PH&8 %3&06(&:+ 0UK*A?D? MG/G'"B0'UI> ]$@H*A'\!0JDC0KI! +!>D),9#E7_FK'[U\7\-CD"U"WGKE3 M-G;"/=VQTY/@2A;MG%9GL076#/)**Y.LH3P8*KA1V(CD%!?<&1\)5R'[-*8K MJ\6GL6@BR4_JH]%P05GNS^X( 7TT*92-$^1@CT$>.6,5P"O1TX32 Z3?+MP1 MA3F,=JZG&PHT%V@NL;87#,UC:R%9S10U 25&(N(V):0Q-DA3JD-,(3#VF$?' M'AZ:;W$X8@XY>0N5$SF1]%@E)MXY^?$D]F+CJ-?*&97MTT;HM7[$3L.=5@^P MWO=B?4>"5PS@VC[L+;QAT*TN.++]OMVO7PA3K/(C;?AVW!]499;S96!O>2"9 M00/>'?NOX!;82=N&=W53ZL=!?I=M_/<,P.4E5C%H;#F7W+BL6@JNI*2*).I3 MFL43.EFWL7-\&+J#X8674>[WXSYL1+__MGOH6IVZLO3Y\KZ=7-W).M.UCWNS MLW:8EV [77/+.?:19X][=\]L=?U5==>,;X'F_[!_".U.Z>]%<; MC?7C+/ZJC.)7-W/L>, GME_/!QX,K#,+XRC,<#:]<%2$RZ0=IUS$!'\Q2J*W MMW >%L99/,;9/ &E8D]C$0/7'C'.$N+< !K.G .?_(CM[E'>FE>-DX.6/SBGP2&IGS/)=9P!Y+YST.I/ M\&*FY&G2X!(O7I5K$V7*&R" NAX4RHI51U+L!-3/F^50+:EF%&^K<\_S?TR= MHGKBZ]8 -"A_"RTC]TUH;/SGN 5+7ZUA7K&U'[;5SGH6 OY'??BFL=GY$8?+ M?+MIXE6ZD.OS4YTK=Y6PG=,&3!<(;3 \?C(FSWY%1K!2AT#ZIPV@Q>] T G4 MY7ZCZD#1 $K[SW%W2*N^)O',@S_B\.I^=1BEE>>;M=U,W?!AQ3HSO+]2Q4*L MSN6"0/+=0]""@4G:0-!'L?>J\7GUTVJUG_ VF&6GL=\%!;N3-[%F# !:?]KH M9P.M8K-7C4.0*[YU!,^8_+0:'\IV =["[I'>63G'DL;C#Q=:5>VN]9 M] '7=2^)NCR7VD $/75@82M@G+WN(V'\"M@J #L8;ZN*5^5;P;3((AH6K59GZXU!]0;:(X Z M +4\Q;Q3-10"?E6"L95@TV )6Y6UV["@68]-X%>-"*@4>P!$/5 +,N+U\M"& M?[W*F#/:V8E-79P04A:6M=(N>#4,X<[WN=S"R0@2V[-6$UL\D MEZFD#S(YO[ /JDC;]B[LE8/-/LC3;)RV8CMDB@&0;L&.'?6BS7_#OT?V])P\ MP(BTQ^W!2,.IMNJ

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â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�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�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�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

E+)RNM"VDV=L[?_U(/)I6U>QX;V^Q6.PN#G9M.=F[?+>'73W>,]8ZM9M5 MV:/GS_ )_%?)[/E_/?O3SHYX8=,Z5T4ETE+)2F6B=KJ8B/>9_=69G MRU)/II78'^P/Q7M;7NFYY.\K71GU//3S;(__?K9'@SP;V6SY_%FFYT)G?WFD M?WZ2'F4J?:Q2-7P\3@]'PZ=/#IZ,CT:':78X.'SZ?P?[,,L]>)\;N6IIU%\> MY;K8F2J

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end

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`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end XML 161 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 162 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 163 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.4 html 585 705 1 false 150 0 false 8 false false R1.htm 000010001 - Document - Cover Sheet http://www.edwards.com/role/Cover Cover Cover 1 false false R2.htm 100010002 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 100020003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 100030004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 100040005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Sheet http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Statements 5 false false R6.htm 100050006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 100060007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Sheet http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Statements 7 false false R8.htm 210011001 - Disclosure - DESCRIPTION OF BUSINESS Sheet http://www.edwards.com/role/DESCRIPTIONOFBUSINESS DESCRIPTION OF BUSINESS Notes 8 false false R9.htm 210021002 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 210171003 - Disclosure - INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET Sheet http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNET INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET Notes 10 false false R11.htm 210191004 - Disclosure - SPECIAL CHARGES (GAIN) Sheet http://www.edwards.com/role/SPECIALCHARGESGAIN SPECIAL CHARGES (GAIN) Notes 11 false false R12.htm 210231005 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS Sheet http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS Notes 12 false false R13.htm 210291006 - Disclosure - LEASES Sheet http://www.edwards.com/role/LEASES LEASES Notes 13 false false R14.htm 210341007 - Disclosure - INVESTMENTS Sheet http://www.edwards.com/role/INVESTMENTS INVESTMENTS Notes 14 false false R15.htm 210411008 - Disclosure - ACQUISITIONS Sheet http://www.edwards.com/role/ACQUISITIONS ACQUISITIONS Notes 15 false false R16.htm 210481009 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Sheet http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETS GOODWILL AND OTHER INTANGIBLE ASSETS Notes 16 false false R17.htm 210541010 - Disclosure - DEBT AND CREDIT FACILITIES Sheet http://www.edwards.com/role/DEBTANDCREDITFACILITIES DEBT AND CREDIT FACILITIES Notes 17 false false R18.htm 210581011 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://www.edwards.com/role/FAIRVALUEMEASUREMENTS FAIR VALUE MEASUREMENTS Notes 18 false false R19.htm 210631012 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES Notes 19 false false R20.htm 210711013 - Disclosure - EMPLOYEE BENEFIT PLANS Sheet http://www.edwards.com/role/EMPLOYEEBENEFITPLANS EMPLOYEE BENEFIT PLANS Notes 20 false false R21.htm 210801014 - Disclosure - COMMON STOCK Sheet http://www.edwards.com/role/COMMONSTOCK COMMON STOCK Notes 21 false false R22.htm 210901015 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS Sheet http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS ACCUMULATED OTHER COMPREHENSIVE LOSS Notes 22 false false R23.htm 210951016 - Disclosure - OTHER INCOME, NET Sheet http://www.edwards.com/role/OTHERINCOMENET OTHER INCOME, NET Notes 23 false false R24.htm 210981017 - Disclosure - INCOME TAXES Sheet http://www.edwards.com/role/INCOMETAXES INCOME TAXES Notes 24 false false R25.htm 211081018 - Disclosure - LEGAL PROCEEDINGS Sheet http://www.edwards.com/role/LEGALPROCEEDINGS LEGAL PROCEEDINGS Notes 25 false false R26.htm 211101019 - Disclosure - SEGMENT INFORMATION Sheet http://www.edwards.com/role/SEGMENTINFORMATION SEGMENT INFORMATION Notes 26 false false R27.htm 211151020 - Disclosure - QUARTERLY FINANCIAL RESULTS AND MARKET FOR THE COMPANY'S STOCK (UNAUDITED) Sheet http://www.edwards.com/role/QUARTERLYFINANCIALRESULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITED QUARTERLY FINANCIAL RESULTS AND MARKET FOR THE COMPANY'S STOCK (UNAUDITED) Notes 27 false false R28.htm 211191021 - Disclosure - VALUATION AND QUALIFYING ACCOUNTS Sheet http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTS VALUATION AND QUALIFYING ACCOUNTS Notes 28 false false R29.htm 211211022 - Disclosure - SUBSEQUENT EVENT Sheet http://www.edwards.com/role/SUBSEQUENTEVENT SUBSEQUENT EVENT Notes 29 false false R30.htm 220032001 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 30 false false R31.htm 230043001 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES 31 false false R32.htm 230243002 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables) Sheet http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables) Tables http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS 32 false false R33.htm 230303003 - Disclosure - LEASES (Tables) Sheet http://www.edwards.com/role/LEASESTables LEASES (Tables) Tables http://www.edwards.com/role/LEASES 33 false false R34.htm 230353004 - Disclosure - INVESTMENTS (Tables) Sheet http://www.edwards.com/role/INVESTMENTSTables INVESTMENTS (Tables) Tables http://www.edwards.com/role/INVESTMENTS 34 false false R35.htm 230423005 - Disclosure - ACQUISITIONS (Tables) Sheet http://www.edwards.com/role/ACQUISITIONSTables ACQUISITIONS (Tables) Tables http://www.edwards.com/role/ACQUISITIONS 35 false false R36.htm 230493006 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) Sheet http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) Tables http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETS 36 false false R37.htm 230553007 - Disclosure - DEBT AND CREDIT FACILITIES (Tables) Sheet http://www.edwards.com/role/DEBTANDCREDITFACILITIESTables DEBT AND CREDIT FACILITIES (Tables) Tables http://www.edwards.com/role/DEBTANDCREDITFACILITIES 37 false false R38.htm 230593008 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables FAIR VALUE MEASUREMENTS (Tables) Tables http://www.edwards.com/role/FAIRVALUEMEASUREMENTS 38 false false R39.htm 230643009 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables) Tables http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES 39 false false R40.htm 230723010 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables) Sheet http://www.edwards.com/role/EMPLOYEEBENEFITPLANSTables EMPLOYEE BENEFIT PLANS (Tables) Tables http://www.edwards.com/role/EMPLOYEEBENEFITPLANS 40 false false R41.htm 230813011 - Disclosure - COMMON STOCK (Tables) Sheet http://www.edwards.com/role/COMMONSTOCKTables COMMON STOCK (Tables) Tables http://www.edwards.com/role/COMMONSTOCK 41 false false R42.htm 230913012 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables) Sheet http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables) Tables http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS 42 false false R43.htm 230963013 - Disclosure - OTHER INCOME, NET (Tables) Sheet http://www.edwards.com/role/OTHERINCOMENETTables OTHER INCOME, NET (Tables) Tables http://www.edwards.com/role/OTHERINCOMENET 43 false false R44.htm 230993014 - Disclosure - INCOME TAXES (Tables) Sheet http://www.edwards.com/role/INCOMETAXESTables INCOME TAXES (Tables) Tables http://www.edwards.com/role/INCOMETAXES 44 false false R45.htm 231113015 - Disclosure - SEGMENT INFORMATION (Tables) Sheet http://www.edwards.com/role/SEGMENTINFORMATIONTables SEGMENT INFORMATION (Tables) Tables http://www.edwards.com/role/SEGMENTINFORMATION 45 false false R46.htm 231163016 - Disclosure - QUARTERLY FINANCIAL RESULTS AND MARKET FOR THE COMPANY'S STOCK (UNAUDITED) (Tables) Sheet http://www.edwards.com/role/QUARTERLYFINANCIALRESULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDTables QUARTERLY FINANCIAL RESULTS AND MARKET FOR THE COMPANY'S STOCK (UNAUDITED) (Tables) Tables http://www.edwards.com/role/QUARTERLYFINANCIALRESULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITED 46 false false R47.htm 240054001 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue (Narrative) (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueNarrativeDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue (Narrative) (Details) Details http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables 47 false false R48.htm 240064002 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Shipping and Handling Costs (Narrative) (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESShippingandHandlingCostsNarrativeDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Shipping and Handling Costs (Narrative) (Details) Details 48 false false R49.htm 240074003 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investments (Narrative) (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsNarrativeDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investments (Narrative) (Details) Details 49 false false R50.htm 240084004 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounts Receivable (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsReceivableDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounts Receivable (Details) Details 50 false false R51.htm 240094005 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Inventories (Narrative) (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInventoriesNarrativeDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Inventories (Narrative) (Details) Details 51 false false R52.htm 240104006 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property, Plant, and Equipment (Narrative) (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentNarrativeDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property, Plant, and Equipment (Narrative) (Details) Details 52 false false R53.htm 240114007 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Goodwill and Intangible Assets (Narrative) (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESGoodwillandIntangibleAssetsNarrativeDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Goodwill and Intangible Assets (Narrative) (Details) Details 53 false false R54.htm 240124008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) Details 54 false false R55.htm 240134009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per Share (Narrative) (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsperShareNarrativeDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per Share (Narrative) (Details) Details 55 false false R56.htm 240144010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Stock-Based Compensation Expense (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Stock-Based Compensation Expense (Details) Details 56 false false R57.htm 240154011 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Stock-based Compensation (Narrative) (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESStockbasedCompensationNarrativeDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Stock-based Compensation (Narrative) (Details) Details 57 false false R58.htm 240164012 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Derivatives (Narrative) (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDerivativesNarrativeDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Derivatives (Narrative) (Details) Details 58 false false R59.htm 240184013 - Disclosure - INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET (Details) Sheet http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNETDetails INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET (Details) Details http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNET 59 false false R60.htm 240204014 - Disclosure - SPECIAL CHARGES (GAIN) - Impairment of Long-lived Assets (Details) Sheet http://www.edwards.com/role/SPECIALCHARGESGAINImpairmentofLonglivedAssetsDetails SPECIAL CHARGES (GAIN) - Impairment of Long-lived Assets (Details) Details http://www.edwards.com/role/SPECIALCHARGESGAIN 60 false false R61.htm 240214015 - Disclosure - SPECIAL CHARGES (GAIN) - Acquisition of Intellectual Property (Details) Sheet http://www.edwards.com/role/SPECIALCHARGESGAINAcquisitionofIntellectualPropertyDetails SPECIAL CHARGES (GAIN) - Acquisition of Intellectual Property (Details) Details http://www.edwards.com/role/SPECIALCHARGESGAIN 61 false false R62.htm 240224016 - Disclosure - SPECIAL CHARGES (GAIN) - Realignment Expenses (Details) Sheet http://www.edwards.com/role/SPECIALCHARGESGAINRealignmentExpensesDetails SPECIAL CHARGES (GAIN) - Realignment Expenses (Details) Details http://www.edwards.com/role/SPECIALCHARGESGAIN 62 false false R63.htm 240254017 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Components of Selected Captions (Details) Sheet http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Components of Selected Captions (Details) Details 63 false false R64.htm 240264018 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Narrative (Details) Sheet http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSNarrativeDetails OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Narrative (Details) Details 64 false false R65.htm 240274019 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Supplemental Cash Flow Information (Details) Sheet http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Supplemental Cash Flow Information (Details) Details 65 false false R66.htm 240284020 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Cash, Cash Equivalents, and Restricted Cash (Details) Sheet http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Cash, Cash Equivalents, and Restricted Cash (Details) Details 66 false false R67.htm 240314021 - Disclosure - LEASES - Narrative (Details) Sheet http://www.edwards.com/role/LEASESNarrativeDetails LEASES - Narrative (Details) Details 67 false false R68.htm 240324022 - Disclosure - LEASES - Assets and Liabilities of Operating Leases (Details) Sheet http://www.edwards.com/role/LEASESAssetsandLiabilitiesofOperatingLeasesDetails LEASES - Assets and Liabilities of Operating Leases (Details) Details 68 false false R69.htm 240334023 - Disclosure - LEASES - Maturities Of Operating Lease Liabilities (Details) Sheet http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails LEASES - Maturities Of Operating Lease Liabilities (Details) Details 69 false false R70.htm 240364024 - Disclosure - INVESTMENTS - Schedule of Investments in Debt Securities (Details) Sheet http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails INVESTMENTS - Schedule of Investments in Debt Securities (Details) Details 70 false false R71.htm 240374025 - Disclosure - INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details) Sheet http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details) Details 71 false false R72.htm 240384026 - Disclosure - INVESTMENTS - Narrative (Details) Sheet http://www.edwards.com/role/INVESTMENTSNarrativeDetails INVESTMENTS - Narrative (Details) Details 72 false false R73.htm 240394027 - Disclosure - INVESTMENTS - Schedule of Unrealized Losses on Debt Securities (Details) Sheet http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails INVESTMENTS - Schedule of Unrealized Losses on Debt Securities (Details) Details 73 false false R74.htm 240404028 - Disclosure - INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details) Sheet http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details) Details 74 false false R75.htm 240434029 - Disclosure - ACQUISITIONS - CAS Medical Systems, Inc. (Narrative) (Details) Sheet http://www.edwards.com/role/ACQUISITIONSCASMedicalSystemsIncNarrativeDetails ACQUISITIONS - CAS Medical Systems, Inc. (Narrative) (Details) Details 75 false false R76.htm 240444030 - Disclosure - ACQUISITIONS - Summary of Fair Values of Assets Acquired and Liabilities Assumed (Details) Sheet http://www.edwards.com/role/ACQUISITIONSSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails ACQUISITIONS - Summary of Fair Values of Assets Acquired and Liabilities Assumed (Details) Details 76 false false R77.htm 240454031 - Disclosure - ACQUISITIONS - Harpoon Medical, Inc. (Narrative) (Details) Sheet http://www.edwards.com/role/ACQUISITIONSHarpoonMedicalIncNarrativeDetails ACQUISITIONS - Harpoon Medical, Inc. (Narrative) (Details) Details 77 false false R78.htm 240464032 - Disclosure - ACQUISITIONS - Valtech Cardio, Ltd. (Narrative) (Details) Sheet http://www.edwards.com/role/ACQUISITIONSValtechCardioLtdNarrativeDetails ACQUISITIONS - Valtech Cardio, Ltd. (Narrative) (Details) Details 78 false false R79.htm 240474033 - Disclosure - ACQUISITIONS - CardiAQ Valve Technologies, Inc. (Narrative) (Details) Sheet http://www.edwards.com/role/ACQUISITIONSCardiAQValveTechnologiesIncNarrativeDetails ACQUISITIONS - CardiAQ Valve Technologies, Inc. (Narrative) (Details) Details 79 false false R80.htm 240504034 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details) Sheet http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details) Details 80 false false R81.htm 240514035 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in the Carrying Amount of Goodwill, by Segment (Details) Sheet http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in the Carrying Amount of Goodwill, by Segment (Details) Details 81 false false R82.htm 240524036 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets (Details) Sheet http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets (Details) Details 82 false false R83.htm 240534037 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Estimated Amortization Expense (Details) Sheet http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofEstimatedAmortizationExpenseDetails GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Estimated Amortization Expense (Details) Details 83 false false R84.htm 240564038 - Disclosure - DEBT AND CREDIT FACILITIES - Narrative (Details) Sheet http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails DEBT AND CREDIT FACILITIES - Narrative (Details) Details 84 false false R85.htm 240574039 - Disclosure - DEBT AND CREDIT FACILITIES - Summary of the Notes (Details) Notes http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails DEBT AND CREDIT FACILITIES - Summary of the Notes (Details) Details 85 false false R86.htm 240604040 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on a Recurring Basis (Details) Details 86 false false R87.htm 240614041 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of Changes in Fair Value of Contingent Consideration Obligation (Details) Sheet http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinFairValueofContingentConsiderationObligationDetails FAIR VALUE MEASUREMENTS - Summary of Changes in Fair Value of Contingent Consideration Obligation (Details) Details 87 false false R88.htm 240624042 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Details) Sheet http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails FAIR VALUE MEASUREMENTS - Narrative (Details) Details 88 false false R89.htm 240654043 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Summary of Derivative Financial Instruments Used to Manage Currency Exchange and Interest Rate Risk (Details) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeandInterestRateRiskDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Summary of Derivative Financial Instruments Used to Manage Currency Exchange and Interest Rate Risk (Details) Details 89 false false R90.htm 240664044 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments (Details) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments (Details) Details 90 false false R91.htm 240674045 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset (Details) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset (Details) Details 91 false false R92.htm 240684046 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments (Details) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments (Details) Details 92 false false R93.htm 240694047 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location of Gain or Loss on Derivative Instruments (Details) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location of Gain or Loss on Derivative Instruments (Details) Details 93 false false R94.htm 240704048 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details) Details 94 false false R95.htm 240734049 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Information Regarding Defined Benefit Pension Plans (Details) Sheet http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails EMPLOYEE BENEFIT PLANS - Schedule of Information Regarding Defined Benefit Pension Plans (Details) Details 95 false false R96.htm 240744050 - Disclosure - EMPLOYEE BENEFIT PLANS - Narrative (Details) Sheet http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails EMPLOYEE BENEFIT PLANS - Narrative (Details) Details 96 false false R97.htm 240754051 - Disclosure - EMPLOYEE BENEFIT PLANS - Components of Net Periodic Benefit Cost (Details) Sheet http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails EMPLOYEE BENEFIT PLANS - Components of Net Periodic Benefit Cost (Details) Details 97 false false R98.htm 240764052 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Weighted-Average Assumptions Used to Determine Benefit Obligations (Details) Sheet http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails EMPLOYEE BENEFIT PLANS - Schedule of Weighted-Average Assumptions Used to Determine Benefit Obligations (Details) Details 98 false false R99.htm 240774053 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Target Weighted-Average Asset Allocations and Fair Value (Details) Sheet http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails EMPLOYEE BENEFIT PLANS - Schedule of Target Weighted-Average Asset Allocations and Fair Value (Details) Details 99 false false R100.htm 240784054 - Disclosure - EMPLOYEE BENEFIT PLANS - Summary of Changes in Fair Value of Defined Benefit Plan Assets Classified as Level 3 (Details) Sheet http://www.edwards.com/role/EMPLOYEEBENEFITPLANSSummaryofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details EMPLOYEE BENEFIT PLANS - Summary of Changes in Fair Value of Defined Benefit Plan Assets Classified as Level 3 (Details) Details 100 false false R101.htm 240794055 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Benefit Payments Which Reflect Expected Future Service (Details) Sheet http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofBenefitPaymentsWhichReflectExpectedFutureServiceDetails EMPLOYEE BENEFIT PLANS - Schedule of Benefit Payments Which Reflect Expected Future Service (Details) Details 101 false false R102.htm 240824056 - Disclosure - COMMON STOCK - Treasury Stock (Narrative) (Details) Sheet http://www.edwards.com/role/COMMONSTOCKTreasuryStockNarrativeDetails COMMON STOCK - Treasury Stock (Narrative) (Details) Details 102 false false R103.htm 240834057 - Disclosure - COMMON STOCK - Accelerated Share Repurchases (Details) Sheet http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails COMMON STOCK - Accelerated Share Repurchases (Details) Details 103 false false R104.htm 240844058 - Disclosure - COMMON STOCK - Employee and Director Stock Plans (Narrative) (Details) Sheet http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails COMMON STOCK - Employee and Director Stock Plans (Narrative) (Details) Details 104 false false R105.htm 240854059 - Disclosure - COMMON STOCK - Schedule of Weighted-Average Assumptions (Details) Sheet http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails COMMON STOCK - Schedule of Weighted-Average Assumptions (Details) Details 105 false false R106.htm 240864060 - Disclosure - COMMON STOCK - Schedule of Stock Option (Details) Sheet http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails COMMON STOCK - Schedule of Stock Option (Details) Details 106 false false R107.htm 240874061 - Disclosure - COMMON STOCK - Schedule of Restricted Stock Unit Activity (Details) Sheet http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails COMMON STOCK - Schedule of Restricted Stock Unit Activity (Details) Details 107 false false R108.htm 240884062 - Disclosure - COMMON STOCK - Schedule of Restricted Stock Unit Activity (Narrative) (Details) Sheet http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityNarrativeDetails COMMON STOCK - Schedule of Restricted Stock Unit Activity (Narrative) (Details) Details 108 false false R109.htm 240894063 - Disclosure - COMMON STOCK - Additional Information (Narrative) (Details) Sheet http://www.edwards.com/role/COMMONSTOCKAdditionalInformationNarrativeDetails COMMON STOCK - Additional Information (Narrative) (Details) Details 109 false false R110.htm 240924064 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Summary of Activity for Each Component of Accumulated Other Comprehensive Loss (Details) Sheet http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails ACCUMULATED OTHER COMPREHENSIVE LOSS - Summary of Activity for Each Component of Accumulated Other Comprehensive Loss (Details) Details 110 false false R111.htm 240934065 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Change in Unrealized Pension Costs (Details) Sheet http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails ACCUMULATED OTHER COMPREHENSIVE LOSS - Change in Unrealized Pension Costs (Details) Details 111 false false R112.htm 240944066 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Information About Amounts Reclassified from Accumulated Other Comprehensive Loss (Details) Sheet http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Information About Amounts Reclassified from Accumulated Other Comprehensive Loss (Details) Details 112 false false R113.htm 240974067 - Disclosure - OTHER INCOME, NET (Details) Sheet http://www.edwards.com/role/OTHERINCOMENETDetails OTHER INCOME, NET (Details) Details http://www.edwards.com/role/OTHERINCOMENETTables 113 false false R114.htm 241004068 - Disclosure - INCOME TAXES - Schedule of Income Before Provisions for Income Taxes (Details) Sheet http://www.edwards.com/role/INCOMETAXESScheduleofIncomeBeforeProvisionsforIncomeTaxesDetails INCOME TAXES - Schedule of Income Before Provisions for Income Taxes (Details) Details 114 false false R115.htm 241014069 - Disclosure - INCOME TAXES - Provision for Income Taxes (Details) Sheet http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails INCOME TAXES - Provision for Income Taxes (Details) Details 115 false false R116.htm 241024070 - Disclosure - INCOME TAXES - Components of Deferred Tax Assets and Liabilities (Details) Sheet http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails INCOME TAXES - Components of Deferred Tax Assets and Liabilities (Details) Details 116 false false R117.htm 241034071 - Disclosure - INCOME TAXES - Narrative (Details) Sheet http://www.edwards.com/role/INCOMETAXESNarrativeDetails INCOME TAXES - Narrative (Details) Details 117 false false R118.htm 241044072 - Disclosure - INCOME TAXES - Summary of Net Operating Loss Carryforwards (Details) Sheet http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails INCOME TAXES - Summary of Net Operating Loss Carryforwards (Details) Details 118 false false R119.htm 241054073 - Disclosure - INCOME TAXES - Summary of Tax Credit Carryforwards (Details) Sheet http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails INCOME TAXES - Summary of Tax Credit Carryforwards (Details) Details 119 false false R120.htm 241064074 - Disclosure - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details) Sheet http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details) Details 120 false false R121.htm 241074075 - Disclosure - INCOME TAXES - Reconciliation of Beginning and Ending Amount of Uncertain Tax Positions (Details) Sheet http://www.edwards.com/role/INCOMETAXESReconciliationofBeginningandEndingAmountofUncertainTaxPositionsDetails INCOME TAXES - Reconciliation of Beginning and Ending Amount of Uncertain Tax Positions (Details) Details 121 false false R122.htm 241094076 - Disclosure - LEGAL PROCEEDINGS (Details) Sheet http://www.edwards.com/role/LEGALPROCEEDINGSDetails LEGAL PROCEEDINGS (Details) Details http://www.edwards.com/role/LEGALPROCEEDINGS 122 false false R123.htm 241124077 - Disclosure - SEGMENT INFORMATION - Schedule of Information About Reportable Segments (Details) Sheet http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationAboutReportableSegmentsDetails SEGMENT INFORMATION - Schedule of Information About Reportable Segments (Details) Details 123 false false R124.htm 241134078 - Disclosure - SEGMENT INFORMATION - Reconciliation of Segment Net Sales and Pre-Tax Income to Consolidated Net Sales and Pre-Tax Income (Details) Sheet http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails SEGMENT INFORMATION - Reconciliation of Segment Net Sales and Pre-Tax Income to Consolidated Net Sales and Pre-Tax Income (Details) Details 124 false false R125.htm 241144079 - Disclosure - SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details) Sheet http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details) Details 125 false false R126.htm 241174080 - Disclosure - QUARTERLY FINANCIAL RESULTS AND MARKET FOR THE COMPANY'S STOCK (UNAUDITED) (Details) Sheet http://www.edwards.com/role/QUARTERLYFINANCIALRESULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDDetails QUARTERLY FINANCIAL RESULTS AND MARKET FOR THE COMPANY'S STOCK (UNAUDITED) (Details) Details http://www.edwards.com/role/QUARTERLYFINANCIALRESULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDTables 126 false false R127.htm 241184081 - Disclosure - QUARTERLY FINANCIAL RESTULTS AND MARKET FOR THE COMPANY'S STOCK (UNAUDITED) - Narrative (Details) Sheet http://www.edwards.com/role/QUARTERLYFINANCIALRESTULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDNarrativeDetails QUARTERLY FINANCIAL RESTULTS AND MARKET FOR THE COMPANY'S STOCK (UNAUDITED) - Narrative (Details) Details 127 false false R128.htm 241204082 - Disclosure - VALUATION AND QUALIFYING ACCOUNTS (Details) Sheet http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails VALUATION AND QUALIFYING ACCOUNTS (Details) Details http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTS 128 false false R129.htm 241224083 - Disclosure - SUBSEQUENT EVENT (Details) Sheet http://www.edwards.com/role/SUBSEQUENTEVENTDetails SUBSEQUENT EVENT (Details) Details http://www.edwards.com/role/SUBSEQUENTEVENT 129 false false All Reports Book All Reports ew-20201231.htm ew-20201231.xsd ew-20201231_cal.xml ew-20201231_def.xml ew-20201231_lab.xml ew-20201231_pre.xml ex-101610xkq42020.htm ex-101710xkq42020.htm ex-101810xkq42020.htm ex-21110xkq42020.htm ex-2310xkq42020.htm ex-31110xkq42020.htm ex-31210xkq42020.htm ex-3210xkq42020.htm ex-4210xkq42020.htm ew-20201231_g1.jpg ew-20201231_g10.jpg ew-20201231_g11.jpg ew-20201231_g12.jpg ew-20201231_g13.jpg ew-20201231_g2.jpg ew-20201231_g3.jpg ew-20201231_g4.jpg ew-20201231_g5.jpg ew-20201231_g6.jpg ew-20201231_g7.jpg ew-20201231_g8.jpg ew-20201231_g9.jpg http://fasb.org/us-gaap/2020-01-31 http://fasb.org/srt/2020-01-31 http://xbrl.sec.gov/country/2020-01-31 http://xbrl.sec.gov/stpr/2018-01-31 http://xbrl.sec.gov/dei/2020-01-31 true true JSON 166 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ew-20201231.htm": { "axisCustom": 0, "axisStandard": 44, "contextCount": 585, "dts": { "calculationLink": { "local": [ "ew-20201231_cal.xml" ] }, "definitionLink": { "local": [ "ew-20201231_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "ew-20201231.htm" ] }, "labelLink": { "local": [ "ew-20201231_lab.xml" ], "remote": [ "http://xbrl.fasb.org/srt/2020/elts/srt-doc-2020-01-31.xml", "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "ew-20201231_pre.xml" ] }, "referenceLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml", "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-ref-2020-01-31.xml" ] }, "schema": { "local": [ "ew-20201231.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd" ] } }, "elementCount": 1063, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2020-01-31": 2, "http://xbrl.sec.gov/dei/2020-01-31": 4, "total": 6 }, "keyCustom": 70, "keyStandard": 635, "memberCustom": 54, "memberStandard": 92, "nsprefix": "ew", "nsuri": "http://www.edwards.com/20201231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000010001 - Document - Cover", "role": "http://www.edwards.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210171003 - Disclosure - INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET", "role": "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNET", "shortName": "INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R100": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ew:DefinedBenefitPlanChangeinBenefitObligationPlanAssetsNetAmountRecognizedonBalanceSheetTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "ib8905de6ef794be8a9718b6abba3e3ef_I20191231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240784054 - Disclosure - EMPLOYEE BENEFIT PLANS - Summary of Changes in Fair Value of Defined Benefit Plan Assets Classified as Level 3 (Details)", "role": "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSSummaryofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details", "shortName": "EMPLOYEE BENEFIT PLANS - Summary of Changes in Fair Value of Defined Benefit Plan Assets Classified as Level 3 (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i68f4a438526a4d77bc61758f85271a05_D20190101-20191231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R101": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240794055 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Benefit Payments Which Reflect Expected Future Service (Details)", "role": "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofBenefitPaymentsWhichReflectExpectedFutureServiceDetails", "shortName": "EMPLOYEE BENEFIT PLANS - Schedule of Benefit Payments Which Reflect Expected Future Service (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R102": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:TreasuryStockValueAcquiredCostMethod", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240824056 - Disclosure - COMMON STOCK - Treasury Stock (Narrative) (Details)", "role": "http://www.edwards.com/role/COMMONSTOCKTreasuryStockNarrativeDetails", "shortName": "COMMON STOCK - Treasury Stock (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i9ac7c6473ee64e99863210075bd7feb3_I20190531", "decimals": "INF", "lang": "en-US", "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R103": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i3f407eaf3c5c476b98bad2f21cecaeb7_D20200529-20200529", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteStockSplitConversionRatio1", "reportCount": 1, "unitRef": "rate", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240834057 - Disclosure - COMMON STOCK - Accelerated Share Repurchases (Details)", "role": "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails", "shortName": "COMMON STOCK - Accelerated Share Repurchases (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "ia256f9a80b15422fa4ae62e26044352b_I20180430", "decimals": "INF", "lang": "en-US", "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R104": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "icaf78fc5c629411a931e78d92c62f5ed_D20200101-20201231", "decimals": "3", "first": true, "lang": "en-US", "name": "ew:EstimatedAnnualForfeitureRatePercent", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240844058 - Disclosure - COMMON STOCK - Employee and Director Stock Plans (Narrative) (Details)", "role": "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "shortName": "COMMON STOCK - Employee and Director Stock Plans (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "icaf78fc5c629411a931e78d92c62f5ed_D20200101-20201231", "decimals": "3", "first": true, "lang": "en-US", "name": "ew:EstimatedAnnualForfeitureRatePercent", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R105": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "icaf78fc5c629411a931e78d92c62f5ed_D20200101-20201231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240854059 - Disclosure - COMMON STOCK - Schedule of Weighted-Average Assumptions (Details)", "role": "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails", "shortName": "COMMON STOCK - Schedule of Weighted-Average Assumptions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "icaf78fc5c629411a931e78d92c62f5ed_D20200101-20201231", "decimals": "INF", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R106": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "ic41f1445f7254dc5b8673b0e8ecd2e04_I20191231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240864060 - Disclosure - COMMON STOCK - Schedule of Stock Option (Details)", "role": "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails", "shortName": "COMMON STOCK - Schedule of Stock Option (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "ic41f1445f7254dc5b8673b0e8ecd2e04_I20191231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R107": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "ib4d1bed0b07a471ebf5c972eb108fc3b_I20191231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240874061 - Disclosure - COMMON STOCK - Schedule of Restricted Stock Unit Activity (Details)", "role": "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails", "shortName": "COMMON STOCK - Schedule of Restricted Stock Unit Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "ib4d1bed0b07a471ebf5c972eb108fc3b_I20191231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R108": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i38aa8bce7d8c4577aadf32a6d5168927_D20200101-20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240884062 - Disclosure - COMMON STOCK - Schedule of Restricted Stock Unit Activity (Narrative) (Details)", "role": "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityNarrativeDetails", "shortName": "COMMON STOCK - Schedule of Restricted Stock Unit Activity (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i38aa8bce7d8c4577aadf32a6d5168927_D20200101-20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R109": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "ew:ShareBasedCompensationArrangementByShareBasedPaymentAwardIntrinsicValueOfStockOptionsExercisedAndVestedRestrictedStockUnits", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240894063 - Disclosure - COMMON STOCK - Additional Information (Narrative) (Details)", "role": "http://www.edwards.com/role/COMMONSTOCKAdditionalInformationNarrativeDetails", "shortName": "COMMON STOCK - Additional Information (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "ew:ShareBasedCompensationArrangementByShareBasedPaymentAwardIntrinsicValueOfStockOptionsExercisedAndVestedRestrictedStockUnits", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210191004 - Disclosure - SPECIAL CHARGES (GAIN)", "role": "http://www.edwards.com/role/SPECIALCHARGESGAIN", "shortName": "SPECIAL CHARGES (GAIN)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R110": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i47877dd8920149198705617a4e1cb131_I20191231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240924064 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Summary of Activity for Each Component of Accumulated Other Comprehensive Loss (Details)", "role": "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS - Summary of Activity for Each Component of Accumulated Other Comprehensive Loss (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i205b39cb42b745bd992748fdbc385dc2_I20171231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R111": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i918cbf382ab841b7a8061277d0442a9e_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240934065 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Change in Unrealized Pension Costs (Details)", "role": "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails", "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS - Change in Unrealized Pension Costs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i918cbf382ab841b7a8061277d0442a9e_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R112": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ew:DisclosureOfFairValueHedgingInstrumentsAndCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:OtherNonoperatingIncomeExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240944066 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Information About Amounts Reclassified from Accumulated Other Comprehensive Loss (Details)", "role": "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Information About Amounts Reclassified from Accumulated Other Comprehensive Loss (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "ifafedb620e104fcf9db9e23571152e6b_D20200101-20201231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:OtherNonoperatingIncomeExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R113": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240974067 - Disclosure - OTHER INCOME, NET (Details)", "role": "http://www.edwards.com/role/OTHERINCOMENETDetails", "shortName": "OTHER INCOME, NET (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "lang": "en-US", "name": "ew:GainLossOnInvestmentsOtherIncomeExpenseNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R114": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241004068 - Disclosure - INCOME TAXES - Schedule of Income Before Provisions for Income Taxes (Details)", "role": "http://www.edwards.com/role/INCOMETAXESScheduleofIncomeBeforeProvisionsforIncomeTaxesDetails", "shortName": "INCOME TAXES - Schedule of Income Before Provisions for Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R115": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241014069 - Disclosure - INCOME TAXES - Provision for Income Taxes (Details)", "role": "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails", "shortName": "INCOME TAXES - Provision for Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R116": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241024070 - Disclosure - INCOME TAXES - Components of Deferred Tax Assets and Liabilities (Details)", "role": "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails", "shortName": "INCOME TAXES - Components of Deferred Tax Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R117": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "ew:IncreaseDecreaseInDeferredTaxAssetsLiabilitiesNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241034071 - Disclosure - INCOME TAXES - Narrative (Details)", "role": "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "shortName": "INCOME TAXES - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "ew:IncreaseDecreaseInDeferredTaxAssetsLiabilitiesNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R118": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241044072 - Disclosure - INCOME TAXES - Summary of Net Operating Loss Carryforwards (Details)", "role": "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails", "shortName": "INCOME TAXES - Summary of Net Operating Loss Carryforwards (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R119": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SummaryOfTaxCreditCarryforwardsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:TaxCreditCarryforwardAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241054073 - Disclosure - INCOME TAXES - Summary of Tax Credit Carryforwards (Details)", "role": "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails", "shortName": "INCOME TAXES - Summary of Tax Credit Carryforwards (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SummaryOfTaxCreditCarryforwardsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:TaxCreditCarryforwardValuationAllowance", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210231005 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS", "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS", "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R120": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241064074 - Disclosure - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details)", "role": "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails", "shortName": "INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R121": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i47877dd8920149198705617a4e1cb131_I20191231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241074075 - Disclosure - INCOME TAXES - Reconciliation of Beginning and Ending Amount of Uncertain Tax Positions (Details)", "role": "http://www.edwards.com/role/INCOMETAXESReconciliationofBeginningandEndingAmountofUncertainTaxPositionsDetails", "shortName": "INCOME TAXES - Reconciliation of Beginning and Ending Amount of Uncertain Tax Positions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R122": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LitigationSettlementExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241094076 - Disclosure - LEGAL PROCEEDINGS (Details)", "role": "http://www.edwards.com/role/LEGALPROCEEDINGSDetails", "shortName": "LEGAL PROCEEDINGS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "INF", "lang": "en-US", "name": "ew:LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber", "reportCount": 1, "unique": true, "unitRef": "lawsuit", "xsiNil": "false" } }, "R123": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i592ba786c5b74a3ca749fb84dc6899fd_D20201001-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241124077 - Disclosure - SEGMENT INFORMATION - Schedule of Information About Reportable Segments (Details)", "role": "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationAboutReportableSegmentsDetails", "shortName": "SEGMENT INFORMATION - Schedule of Information About Reportable Segments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "ifc74df274b4a4e678edb188a442ade84_D20200101-20201231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R124": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i592ba786c5b74a3ca749fb84dc6899fd_D20201001-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241134078 - Disclosure - SEGMENT INFORMATION - Reconciliation of Segment Net Sales and Pre-Tax Income to Consolidated Net Sales and Pre-Tax Income (Details)", "role": "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails", "shortName": "SEGMENT INFORMATION - Reconciliation of Segment Net Sales and Pre-Tax Income to Consolidated Net Sales and Pre-Tax Income (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "idd3ed2e5a708457ab5dc372486088218_D20200101-20201231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:OperatingIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R125": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i592ba786c5b74a3ca749fb84dc6899fd_D20201001-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241144079 - Disclosure - SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details)", "role": "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails", "shortName": "SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i6de22e1b95ae4e0c83750eb821f69f7a_I20181231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:NoncurrentAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R126": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i592ba786c5b74a3ca749fb84dc6899fd_D20201001-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241174080 - Disclosure - QUARTERLY FINANCIAL RESULTS AND MARKET FOR THE COMPANY'S STOCK (UNAUDITED) (Details)", "role": "http://www.edwards.com/role/QUARTERLYFINANCIALRESULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDDetails", "shortName": "QUARTERLY FINANCIAL RESULTS AND MARKET FOR THE COMPANY'S STOCK (UNAUDITED) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i592ba786c5b74a3ca749fb84dc6899fd_D20201001-20201231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:GrossProfit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R127": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "ic3cde380158a4a9ba9dec0856246255e_D20200401-20200630", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:GainLossRelatedToLitigationSettlement", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241184081 - Disclosure - QUARTERLY FINANCIAL RESTULTS AND MARKET FOR THE COMPANY'S STOCK (UNAUDITED) - Narrative (Details)", "role": "http://www.edwards.com/role/QUARTERLYFINANCIALRESTULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDNarrativeDetails", "shortName": "QUARTERLY FINANCIAL RESTULTS AND MARKET FOR THE COMPANY'S STOCK (UNAUDITED) - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R128": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i749cf9d8fd544dc887267ae35cbcd38b_I20191231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ValuationAllowancesAndReservesBalance", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241204082 - Disclosure - VALUATION AND QUALIFYING ACCOUNTS (Details)", "role": "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails", "shortName": "VALUATION AND QUALIFYING ACCOUNTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "ia05970a3c3924b3eb4f77d4916e9b835_I20171231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:ValuationAllowancesAndReservesBalance", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R129": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i092224ac1f28474baa42932b45f43adc_I20210212", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241224083 - Disclosure - SUBSEQUENT EVENT (Details)", "role": "http://www.edwards.com/role/SUBSEQUENTEVENTDetails", "shortName": "SUBSEQUENT EVENT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i092224ac1f28474baa42932b45f43adc_I20210212", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210291006 - Disclosure - LEASES", "role": "http://www.edwards.com/role/LEASES", "shortName": "LEASES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210341007 - Disclosure - INVESTMENTS", "role": "http://www.edwards.com/role/INVESTMENTS", "shortName": "INVESTMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210411008 - Disclosure - ACQUISITIONS", "role": "http://www.edwards.com/role/ACQUISITIONS", "shortName": "ACQUISITIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210481009 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS", "role": "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETS", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210541010 - Disclosure - DEBT AND CREDIT FACILITIES", "role": "http://www.edwards.com/role/DEBTANDCREDITFACILITIES", "shortName": "DEBT AND CREDIT FACILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210581011 - Disclosure - FAIR VALUE MEASUREMENTS", "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTS", "shortName": "FAIR VALUE MEASUREMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210631012 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES", "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100010002 - Statement - CONSOLIDATED BALANCE SHEETS", "role": "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "shortName": "CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:ShortTermInvestments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210711013 - Disclosure - EMPLOYEE BENEFIT PLANS", "role": "http://www.edwards.com/role/EMPLOYEEBENEFITPLANS", "shortName": "EMPLOYEE BENEFIT PLANS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210801014 - Disclosure - COMMON STOCK", "role": "http://www.edwards.com/role/COMMONSTOCK", "shortName": "COMMON STOCK", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210901015 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS", "role": "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS", "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210951016 - Disclosure - OTHER INCOME, NET", "role": "http://www.edwards.com/role/OTHERINCOMENET", "shortName": "OTHER INCOME, NET", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210981017 - Disclosure - INCOME TAXES", "role": "http://www.edwards.com/role/INCOMETAXES", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "211081018 - Disclosure - LEGAL PROCEEDINGS", "role": "http://www.edwards.com/role/LEGALPROCEEDINGS", "shortName": "LEGAL PROCEEDINGS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "211101019 - Disclosure - SEGMENT INFORMATION", "role": "http://www.edwards.com/role/SEGMENTINFORMATION", "shortName": "SEGMENT INFORMATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:QuarterlyFinancialInformationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "211151020 - Disclosure - QUARTERLY FINANCIAL RESULTS AND MARKET FOR THE COMPANY'S STOCK (UNAUDITED)", "role": "http://www.edwards.com/role/QUARTERLYFINANCIALRESULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITED", "shortName": "QUARTERLY FINANCIAL RESULTS AND MARKET FOR THE COMPANY'S STOCK (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:QuarterlyFinancialInformationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "211191021 - Disclosure - VALUATION AND QUALIFYING ACCOUNTS", "role": "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTS", "shortName": "VALUATION AND QUALIFYING ACCOUNTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "211211022 - Disclosure - SUBSEQUENT EVENT", "role": "http://www.edwards.com/role/SUBSEQUENTEVENT", "shortName": "SUBSEQUENT EVENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100020003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "role": "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "220032001 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230043001 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "ew:ScheduleOfSelectedCaptionsBalanceSheetDisclosuresTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230243002 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables)", "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables", "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "ew:ScheduleOfSelectedCaptionsBalanceSheetDisclosuresTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "ew:AssetsAndLiabilitiesOfLesseeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230303003 - Disclosure - LEASES (Tables)", "role": "http://www.edwards.com/role/LEASESTables", "shortName": "LEASES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "ew:AssetsAndLiabilitiesOfLesseeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230353004 - Disclosure - INVESTMENTS (Tables)", "role": "http://www.edwards.com/role/INVESTMENTSTables", "shortName": "INVESTMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230423005 - Disclosure - ACQUISITIONS (Tables)", "role": "http://www.edwards.com/role/ACQUISITIONSTables", "shortName": "ACQUISITIONS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230493006 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)", "role": "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230553007 - Disclosure - DEBT AND CREDIT FACILITIES (Tables)", "role": "http://www.edwards.com/role/DEBTANDCREDITFACILITIESTables", "shortName": "DEBT AND CREDIT FACILITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230593008 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)", "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables", "shortName": "FAIR VALUE MEASUREMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230643009 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)", "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100030004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS", "role": "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:ResearchAndDevelopmentExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "ew:DefinedBenefitPlanChangeinBenefitObligationPlanAssetsNetAmountRecognizedonBalanceSheetTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230723010 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables)", "role": "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSTables", "shortName": "EMPLOYEE BENEFIT PLANS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "ew:DefinedBenefitPlanChangeinBenefitObligationPlanAssetsNetAmountRecognizedonBalanceSheetTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AcceleratedShareRepurchasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230813011 - Disclosure - COMMON STOCK (Tables)", "role": "http://www.edwards.com/role/COMMONSTOCKTables", "shortName": "COMMON STOCK (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AcceleratedShareRepurchasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230913012 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)", "role": "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables", "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230963013 - Disclosure - OTHER INCOME, NET (Tables)", "role": "http://www.edwards.com/role/OTHERINCOMENETTables", "shortName": "OTHER INCOME, NET (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230993014 - Disclosure - INCOME TAXES (Tables)", "role": "http://www.edwards.com/role/INCOMETAXESTables", "shortName": "INCOME TAXES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "231113015 - Disclosure - SEGMENT INFORMATION (Tables)", "role": "http://www.edwards.com/role/SEGMENTINFORMATIONTables", "shortName": "SEGMENT INFORMATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "231163016 - Disclosure - QUARTERLY FINANCIAL RESULTS AND MARKET FOR THE COMPANY'S STOCK (UNAUDITED) (Tables)", "role": "http://www.edwards.com/role/QUARTERLYFINANCIALRESULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDTables", "shortName": "QUARTERLY FINANCIAL RESULTS AND MARKET FOR THE COMPANY'S STOCK (UNAUDITED) (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i3f407eaf3c5c476b98bad2f21cecaeb7_D20200529-20200529", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteStockSplitConversionRatio1", "reportCount": 1, "unitRef": "rate", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240054001 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue (Narrative) (Details)", "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueNarrativeDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:ContractWithCustomerLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ew:DisclosureOfFairValueHedgingInstrumentsAndCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240064002 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Shipping and Handling Costs (Narrative) (Details)", "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESShippingandHandlingCostsNarrativeDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Shipping and Handling Costs (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i64d3bd1062d546dc9ea688194c20014e_D20200101-20201231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:InvestmentPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i1d20633fff5d4a39aa9b24c8d65f1e34_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240074003 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investments (Narrative) (Details)", "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsNarrativeDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investments (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "us-gaap:InvestmentPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i1d20633fff5d4a39aa9b24c8d65f1e34_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100040005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "role": "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME", "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:TradeAndOtherAccountsReceivablePolicy", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i077d7712262e4346ba72e7f2d62cfb93_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "ew:AccountsReceivablePaymentTerms", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240084004 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounts Receivable (Details)", "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsReceivableDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounts Receivable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "us-gaap:TradeAndOtherAccountsReceivablePolicy", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i077d7712262e4346ba72e7f2d62cfb93_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "ew:AccountsReceivablePaymentTerms", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:InventoryPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "ew:InventoryWriteDownExpirationPeriodTrigger", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240094005 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Inventories (Narrative) (Details)", "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInventoriesNarrativeDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Inventories (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "us-gaap:InventoryPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "ew:InventoryWriteDownExpirationPeriodTrigger", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240104006 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property, Plant, and Equipment (Narrative) (Details)", "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentNarrativeDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property, Plant, and Equipment (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "iacc57a987ce740eab873f5cad3719d1c_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240114007 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Goodwill and Intangible Assets (Narrative) (Details)", "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESGoodwillandIntangibleAssetsNarrativeDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Goodwill and Intangible Assets (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "iacc57a987ce740eab873f5cad3719d1c_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i592ba786c5b74a3ca749fb84dc6899fd_D20201001-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240124008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Computation of Basic and Diluted Earnings Per Share (Details)", "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Computation of Basic and Diluted Earnings Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i77378007e44f4e54a92dab796fc9e394_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240134009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per Share (Narrative) (Details)", "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsperShareNarrativeDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per Share (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i77378007e44f4e54a92dab796fc9e394_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "us-gaap:CompensationRelatedCostsPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240144010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Stock-Based Compensation Expense (Details)", "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Stock-Based Compensation Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "us-gaap:CompensationRelatedCostsPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:CompensationRelatedCostsPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "iadba2dfe1ae54f9e8a18c254d37e58c7_D20200101-20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240154011 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Stock-based Compensation (Narrative) (Details)", "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESStockbasedCompensationNarrativeDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Stock-based Compensation (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "us-gaap:CompensationRelatedCostsPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "iadba2dfe1ae54f9e8a18c254d37e58c7_D20200101-20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:DerivativesPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240164012 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Derivatives (Narrative) (Details)", "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDerivativesNarrativeDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Derivatives (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "us-gaap:DerivativesPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LitigationSettlementExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240184013 - Disclosure - INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET (Details)", "role": "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNETDetails", "shortName": "INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i077978fb0d7b40e79d1b427c8066e53f_D20200701-20200731", "decimals": "-5", "lang": "en-US", "name": "us-gaap:PaymentsForLegalSettlements", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100050006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "role": "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i75fc3e246e9c45e596209665f27a089b_D20201001-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240204014 - Disclosure - SPECIAL CHARGES (GAIN) - Impairment of Long-lived Assets (Details)", "role": "http://www.edwards.com/role/SPECIALCHARGESGAINImpairmentofLonglivedAssetsDetails", "shortName": "SPECIAL CHARGES (GAIN) - Impairment of Long-lived Assets (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R61": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i3c56c7865503432ba82171c250f84586_I20190331", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240214015 - Disclosure - SPECIAL CHARGES (GAIN) - Acquisition of Intellectual Property (Details)", "role": "http://www.edwards.com/role/SPECIALCHARGESGAINAcquisitionofIntellectualPropertyDetails", "shortName": "SPECIAL CHARGES (GAIN) - Acquisition of Intellectual Property (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R62": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "ica35a1244f5a456d892464f634003b67_D20180301-20180331", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240224016 - Disclosure - SPECIAL CHARGES (GAIN) - Realignment Expenses (Details)", "role": "http://www.edwards.com/role/SPECIALCHARGESGAINRealignmentExpensesDetails", "shortName": "SPECIAL CHARGES (GAIN) - Realignment Expenses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "ica35a1244f5a456d892464f634003b67_D20180301-20180331", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ew:ScheduleOfSelectedCaptionsBalanceSheetDisclosuresTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240254017 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Components of Selected Captions (Details)", "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails", "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Components of Selected Captions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ew:ScheduleOfSelectedCaptionsBalanceSheetDisclosuresTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "ibd7425029502442ea99ee1d7f9214ff4_D20190701-20190930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InventoryWriteDown", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240264018 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Narrative (Details)", "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSNarrativeDetails", "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R65": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InterestPaidNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240274019 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Supplemental Cash Flow Information (Details)", "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails", "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Supplemental Cash Flow Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InterestPaidNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240284020 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Cash, Cash Equivalents, and Restricted Cash (Details)", "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails", "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Cash, Cash Equivalents, and Restricted Cash (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i6de22e1b95ae4e0c83750eb821f69f7a_I20181231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240314021 - Disclosure - LEASES - Narrative (Details)", "role": "http://www.edwards.com/role/LEASESNarrativeDetails", "shortName": "LEASES - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ew:AssetsAndLiabilitiesOfLesseeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240324022 - Disclosure - LEASES - Assets and Liabilities of Operating Leases (Details)", "role": "http://www.edwards.com/role/LEASESAssetsandLiabilitiesofOperatingLeasesDetails", "shortName": "LEASES - Assets and Liabilities of Operating Leases (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R69": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240334023 - Disclosure - LEASES - Maturities Of Operating Lease Liabilities (Details)", "role": "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails", "shortName": "LEASES - Maturities Of Operating Lease Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i7113b9a3943547ac8c56b3e16ba98cad_I20171231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100060007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY", "role": "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i7113b9a3943547ac8c56b3e16ba98cad_I20171231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240364024 - Disclosure - INVESTMENTS - Schedule of Investments in Debt Securities (Details)", "role": "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails", "shortName": "INVESTMENTS - Schedule of Investments in Debt Securities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240374025 - Disclosure - INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details)", "role": "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails", "shortName": "INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions", "reportCount": 1, "unique": true, "unitRef": "investment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240384026 - Disclosure - INVESTMENTS - Narrative (Details)", "role": "http://www.edwards.com/role/INVESTMENTSNarrativeDetails", "shortName": "INVESTMENTS - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions", "reportCount": 1, "unique": true, "unitRef": "investment", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i47877dd8920149198705617a4e1cb131_I20191231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240394027 - Disclosure - INVESTMENTS - Schedule of Unrealized Losses on Debt Securities (Details)", "role": "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails", "shortName": "INVESTMENTS - Schedule of Unrealized Losses on Debt Securities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i47877dd8920149198705617a4e1cb131_I20191231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240404028 - Disclosure - INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details)", "role": "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails", "shortName": "INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i661988b5f4614fa09ff916c9dd27bd35_I20190211", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:BusinessAcquisitionSharePrice", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240434029 - Disclosure - ACQUISITIONS - CAS Medical Systems, Inc. (Narrative) (Details)", "role": "http://www.edwards.com/role/ACQUISITIONSCASMedicalSystemsIncNarrativeDetails", "shortName": "ACQUISITIONS - CAS Medical Systems, Inc. (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i661988b5f4614fa09ff916c9dd27bd35_I20190211", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:BusinessAcquisitionSharePrice", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240444030 - Disclosure - ACQUISITIONS - Summary of Fair Values of Assets Acquired and Liabilities Assumed (Details)", "role": "http://www.edwards.com/role/ACQUISITIONSSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "shortName": "ACQUISITIONS - Summary of Fair Values of Assets Acquired and Liabilities Assumed (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i7186f6760b5742359079ceb8954f5230_I20190418", "decimals": "-5", "lang": "en-US", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i57301b12bcfd42bbb53d1fe4ecf5788c_D20171201-20171201", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240454031 - Disclosure - ACQUISITIONS - Harpoon Medical, Inc. (Narrative) (Details)", "role": "http://www.edwards.com/role/ACQUISITIONSHarpoonMedicalIncNarrativeDetails", "shortName": "ACQUISITIONS - Harpoon Medical, Inc. (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i57301b12bcfd42bbb53d1fe4ecf5788c_D20171201-20171201", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:PaymentsToAcquireBusinessesGross", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240464032 - Disclosure - ACQUISITIONS - Valtech Cardio, Ltd. (Narrative) (Details)", "role": "http://www.edwards.com/role/ACQUISITIONSValtechCardioLtdNarrativeDetails", "shortName": "ACQUISITIONS - Valtech Cardio, Ltd. (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "iab12514d1cb849509dae0b6d2f501b33_D20161126-20161126", "decimals": "-5", "lang": "en-US", "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:PaymentsToAcquireBusinessesGross", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240474033 - Disclosure - ACQUISITIONS - CardiAQ Valve Technologies, Inc. (Narrative) (Details)", "role": "http://www.edwards.com/role/ACQUISITIONSCardiAQValveTechnologiesIncNarrativeDetails", "shortName": "ACQUISITIONS - CardiAQ Valve Technologies, Inc. (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i715733702b54427c8f0df9c1947e64fb_D20150703-20150703", "decimals": "-5", "lang": "en-US", "name": "us-gaap:PaymentsToAcquireBusinessesGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210011001 - Disclosure - DESCRIPTION OF BUSINESS", "role": "http://www.edwards.com/role/DESCRIPTIONOFBUSINESS", "shortName": "DESCRIPTION OF BUSINESS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "if307afde8e854aeaa26cb17bbed10537_D20190101-20191231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAcquiredDuringPeriod", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240504034 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details)", "role": "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i47877dd8920149198705617a4e1cb131_I20191231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240514035 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in the Carrying Amount of Goodwill, by Segment (Details)", "role": "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in the Carrying Amount of Goodwill, by Segment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240524036 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets (Details)", "role": "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240534037 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Estimated Amortization Expense (Details)", "role": "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofEstimatedAmortizationExpenseDetails", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Estimated Amortization Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:LongtermDebtWeightedAverageInterestRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240564038 - Disclosure - DEBT AND CREDIT FACILITIES - Narrative (Details)", "role": "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "shortName": "DEBT AND CREDIT FACILITIES - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:LongtermDebtWeightedAverageInterestRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "ia56cecca8c7e402e897ffe8de7edefc2_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentUnamortizedDiscount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240574039 - Disclosure - DEBT AND CREDIT FACILITIES - Summary of the Notes (Details)", "role": "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails", "shortName": "DEBT AND CREDIT FACILITIES - Summary of the Notes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "ia56cecca8c7e402e897ffe8de7edefc2_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentUnamortizedDiscount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240604040 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on a Recurring Basis (Details)", "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "shortName": "FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on a Recurring Basis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "ia85e6da1ce664654ab84921c254913e8_I20201231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i47877dd8920149198705617a4e1cb131_I20191231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240614041 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of Changes in Fair Value of Contingent Consideration Obligation (Details)", "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinFairValueofContingentConsiderationObligationDetails", "shortName": "FAIR VALUE MEASUREMENTS - Summary of Changes in Fair Value of Contingent Consideration Obligation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i6de22e1b95ae4e0c83750eb821f69f7a_I20181231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R88": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240624042 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Details)", "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "shortName": "FAIR VALUE MEASUREMENTS - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0191794883de4c3aa031d095aa66aac4_I20201231", "decimals": "4", "lang": "en-US", "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R89": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i7b0d06b908264e7592213286f70f3478_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240654043 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Summary of Derivative Financial Instruments Used to Manage Currency Exchange and Interest Rate Risk (Details)", "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeandInterestRateRiskDetails", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Summary of Derivative Financial Instruments Used to Manage Currency Exchange and Interest Rate Risk (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i7b0d06b908264e7592213286f70f3478_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210021002 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R90": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OffsettingAssetsTableTextBlock", "us-gaap:OffsettingLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i967d5bedf5614f02bba2b4cc46258b11_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeAssets", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240664044 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments (Details)", "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "ifec0608d5ae3461caf00b27b0f8bf676_I20201231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DerivativeAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R91": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OffsettingAssetsTableTextBlock", "us-gaap:OffsettingLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i967d5bedf5614f02bba2b4cc46258b11_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240674045 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset (Details)", "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OffsettingAssetsTableTextBlock", "us-gaap:OffsettingLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i967d5bedf5614f02bba2b4cc46258b11_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R92": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "ibbc89bfac0f9427abec1b93e2d03c674_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeGainLossOnDerivativeNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240684046 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments (Details)", "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "ibbc89bfac0f9427abec1b93e2d03c674_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeGainLossOnDerivativeNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R93": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ew:DisclosureOfFairValueHedgingInstrumentsAndCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240694047 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location of Gain or Loss on Derivative Instruments (Details)", "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location of Gain or Loss on Derivative Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ew:DisclosureOfFairValueHedgingInstrumentsAndCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "ie9135bcd7d3b4bb195bc5ddb356e169e_D20200101-20201231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R94": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240704048 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details)", "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i0fa3cb5d3f1e467b9681c1051c56a5c5_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R95": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ew:DefinedBenefitPlanChangeinBenefitObligationPlanAssetsNetAmountRecognizedonBalanceSheetTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "ib8905de6ef794be8a9718b6abba3e3ef_I20191231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanBenefitObligation", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240734049 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Information Regarding Defined Benefit Pension Plans (Details)", "role": "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails", "shortName": "EMPLOYEE BENEFIT PLANS - Schedule of Information Regarding Defined Benefit Pension Plans (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ew:DefinedBenefitPlanChangeinBenefitObligationPlanAssetsNetAmountRecognizedonBalanceSheetTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i5ffcd397b2fb46e7989a2a74e6474327_D20200101-20201231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R96": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240744050 - Disclosure - EMPLOYEE BENEFIT PLANS - Narrative (Details)", "role": "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails", "shortName": "EMPLOYEE BENEFIT PLANS - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i879fa924d925497095fb7454b9ce147d_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R97": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ew:DefinedBenefitPlanChangeinBenefitObligationPlanAssetsNetAmountRecognizedonBalanceSheetTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i5ffcd397b2fb46e7989a2a74e6474327_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240754051 - Disclosure - EMPLOYEE BENEFIT PLANS - Components of Net Periodic Benefit Cost (Details)", "role": "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails", "shortName": "EMPLOYEE BENEFIT PLANS - Components of Net Periodic Benefit Cost (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i5ffcd397b2fb46e7989a2a74e6474327_D20200101-20201231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R98": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i1c088b9bac094250a4e18b5b40c8b496_I20201231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240764052 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Weighted-Average Assumptions Used to Determine Benefit Obligations (Details)", "role": "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails", "shortName": "EMPLOYEE BENEFIT PLANS - Schedule of Weighted-Average Assumptions Used to Determine Benefit Obligations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i1c088b9bac094250a4e18b5b40c8b496_I20201231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R99": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i1c088b9bac094250a4e18b5b40c8b496_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240774053 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Target Weighted-Average Asset Allocations and Fair Value (Details)", "role": "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "shortName": "EMPLOYEE BENEFIT PLANS - Schedule of Target Weighted-Average Asset Allocations and Fair Value (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ew-20201231.htm", "contextRef": "i1c088b9bac094250a4e18b5b40c8b496_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } } }, "segmentCount": 150, "tag": { "country_JP": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "JAPAN", "terseLabel": "Japan" } } }, "localname": "JP", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "xbrltype": "domainItemType" }, "country_PR": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PUERTO RICO", "terseLabel": "Puerto Rico" } } }, "localname": "PR", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "United States" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r849", "r850", "r851" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r852" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r847" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]", "terseLabel": "Documents Incorporated by Reference" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r853" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "verboseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r853" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r853" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r854" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float", "terseLabel": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r853" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r853" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r853" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r853" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "verboseLabel": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer", "verboseLabel": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r849", "r850", "r851" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag", "terseLabel": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r846" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r848" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.edwards.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "ew_AbbottLaboratoriesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Abbott Laboratories [Member]", "label": "Abbott Laboratories [Member]", "terseLabel": "Abbott Laboratories" } } }, "localname": "AbbottLaboratoriesMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNETDetails", "http://www.edwards.com/role/LEGALPROCEEDINGSDetails" ], "xbrltype": "domainItemType" }, "ew_AcceleratedShareRepurchaseAgreementsEnteredIntoNovember2018Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accelerated Share Repurchase Agreements Entered Into November 2018", "label": "Accelerated Share Repurchase Agreements Entered Into November 2018 [Member]", "terseLabel": "November 2018" } } }, "localname": "AcceleratedShareRepurchaseAgreementsEnteredIntoNovember2018Member", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails" ], "xbrltype": "domainItemType" }, "ew_AcceleratedShareRepurchaseAgreementsEnteredIntoOctober2018Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accelerated Share Repurchase Agreements Entered Into October 2018 [Member]", "label": "Accelerated Share Repurchase Agreements Entered Into October 2018 [Member]", "terseLabel": "October 2018" } } }, "localname": "AcceleratedShareRepurchaseAgreementsEnteredIntoOctober2018Member", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails" ], "xbrltype": "domainItemType" }, "ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the value of the initial shares repurchased as a percentage of the contract amount under accelerated share repurchase agreement.", "label": "Accelerated Share Repurchases, Value of Shares Repurchased as Percentage of Contract Amount", "terseLabel": "Value of Shares as % of Contract Value", "verboseLabel": "Percentage of shares repurchased" } } }, "localname": "AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails", "http://www.edwards.com/role/SUBSEQUENTEVENTDetails" ], "xbrltype": "percentItemType" }, "ew_AccountsReceivablePaymentTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounts Receivable, Payment Terms", "label": "Accounts Receivable, Payment Terms", "terseLabel": "Accounts receivable, required payment terms" } } }, "localname": "AccountsReceivablePaymentTerms", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsReceivableDetails" ], "xbrltype": "durationItemType" }, "ew_AccrualForEnvironmentalLossContingenciesGovernmentalAuthorityThresholdForDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrual For Environmental Loss Contingencies, Governmental Authority, Threshold For Disclosure", "label": "Accrual For Environmental Loss Contingencies, Governmental Authority, Threshold For Disclosure", "terseLabel": "Accrual for environmental loss contingencies, component amount" } } }, "localname": "AccrualForEnvironmentalLossContingenciesGovernmentalAuthorityThresholdForDisclosure", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/LEGALPROCEEDINGSDetails" ], "xbrltype": "monetaryItemType" }, "ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 10.0, "parentTag": "ew_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes, payroll taxes and other taxes, excluding income taxes payable. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrual for Property Payroll and Other Taxes Other than Income Taxes Current", "terseLabel": "Property, payroll, and other taxes" } } }, "localname": "AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "ew_AccruedLiabilitiesAndOtherLiabilitiesCurrent": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the combined amount of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered and the aggregate carrying amount of current liabilities not separately disclosed in the balance sheet. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities and Other Liabilities Current", "terseLabel": "Accrued and other liabilities (Note\u00a05)", "totalLabel": "Total accrued and other liabilities" } } }, "localname": "AccruedLiabilitiesAndOtherLiabilitiesCurrent", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "ew_AccruedLitigationAndInsuranceReserves": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 11.0, "parentTag": "ew_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued Litigation And Insurance Reserves", "label": "Accrued Litigation And Insurance Reserves", "terseLabel": "Litigation and insurance reserves (Note\u00a018)" } } }, "localname": "AccruedLitigationAndInsuranceReserves", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "ew_AccruedRebates": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 6.0, "parentTag": "ew_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying amount, as of the balance sheet date, of current obligations associated with sales rebates.", "label": "Accrued Rebates", "terseLabel": "Accrued rebates" } } }, "localname": "AccruedRebates", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "ew_AccruedRelocationCostsCurrent": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 5.0, "parentTag": "ew_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued Relocation Costs, Current", "label": "Accrued Relocation Costs, Current", "terseLabel": "Accrued relocation related costs" } } }, "localname": "AccruedRelocationCostsCurrent", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "ew_AggregateIntrinsicValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value [Abstract]", "terseLabel": "Aggregate Intrinsic Value" } } }, "localname": "AggregateIntrinsicValueAbstract", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "stringItemType" }, "ew_April2018StockRepurchaseProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "April 2018 Stock Repurchase Program [Member]", "label": "April 2018 Stock Repurchase Program [Member]", "terseLabel": "April 2018" } } }, "localname": "April2018StockRepurchaseProgramMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails" ], "xbrltype": "domainItemType" }, "ew_AssetsAndLiabilitiesOfLesseeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets And Liabilities Of Lessee [Table Text Block]", "label": "Assets And Liabilities Of Lessee [Table Text Block]", "terseLabel": "Assets And Liabilities Of Lessee" } } }, "localname": "AssetsAndLiabilitiesOfLesseeTableTextBlock", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/LEASESTables" ], "xbrltype": "textBlockItemType" }, "ew_BuildingsAndLeaseholdImprovementsGross": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount, as of the balance sheet date, of long-lived, depreciable assets, that includes building structures and leasehold improvements.", "label": "Buildings and Leasehold Improvements Gross", "terseLabel": "Buildings and leasehold improvements" } } }, "localname": "BuildingsAndLeaseholdImprovementsGross", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "ew_BusinessCombinationConsiderationToBeTransferred": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Consideration To Be Transferred", "label": "Business Combination, Consideration To Be Transferred", "terseLabel": "Acquisition price, subject uncertain adjustments" } } }, "localname": "BusinessCombinationConsiderationToBeTransferred", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSCASMedicalSystemsIncNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_BusinessCombinationContingentConsiderationLiabilityPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Combination, Contingent Consideration, Liability, Period", "label": "Business Combination, Contingent Consideration, Liability, Period", "terseLabel": "Period to obtain certain European regulatory approval", "verboseLabel": "Period to make additional pre-specified milestone-driven payments" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityPeriod", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSCardiAQValveTechnologiesIncNarrativeDetails", "http://www.edwards.com/role/ACQUISITIONSHarpoonMedicalIncNarrativeDetails", "http://www.edwards.com/role/ACQUISITIONSValtechCardioLtdNarrativeDetails" ], "xbrltype": "durationItemType" }, "ew_BusinessCombinationFutureOptionToAcquireBusinessAdditionalAmountSubjectToRegulatoryApproval": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Future Option To Acquire Business, Additional Amount Subject To Regulatory Approval", "label": "Business Combination, Future Option To Acquire Business, Additional Amount Subject To Regulatory Approval", "terseLabel": "Future option to acquire business, additional amount subject to regulatory approval" } } }, "localname": "BusinessCombinationFutureOptionToAcquireBusinessAdditionalAmountSubjectToRegulatoryApproval", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSValtechCardioLtdNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_BusinessCombinationFutureOptionToAcquireBusinessAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Future Option To Acquire Business, Amount", "label": "Business Combination, Future Option To Acquire Business, Amount", "terseLabel": "Future option to acquire business, amount" } } }, "localname": "BusinessCombinationFutureOptionToAcquireBusinessAmount", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSValtechCardioLtdNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_BusinessCombinationFutureOptionToAcquireBusinessPeriodToObtainRegulatoryApproval": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Combination, Future Option To Acquire Business, Period To Obtain Regulatory Approval", "label": "Business Combination, Future Option To Acquire Business, Period To Obtain Regulatory Approval", "terseLabel": "Future option to acquire business, period to obtain regulatory approval" } } }, "localname": "BusinessCombinationFutureOptionToAcquireBusinessPeriodToObtainRegulatoryApproval", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSValtechCardioLtdNarrativeDetails" ], "xbrltype": "durationItemType" }, "ew_BusinessCombinationInprocessResearchandDevelopmentExpectedCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, In-process Research and Development, Expected Costs", "label": "Business Combination, In-process Research and Development, Expected Costs", "terseLabel": "Additional research and development expenditures to be incurred prior to product introduction" } } }, "localname": "BusinessCombinationInprocessResearchandDevelopmentExpectedCosts", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSCardiAQValveTechnologiesIncNarrativeDetails", "http://www.edwards.com/role/ACQUISITIONSHarpoonMedicalIncNarrativeDetails", "http://www.edwards.com/role/ACQUISITIONSValtechCardioLtdNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_CASMedicalSystemsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CAS Medical Systems, Inc. [Member]", "label": "CAS Medical Systems, Inc. [Member]", "terseLabel": "CAS Medical Systems, Inc." } } }, "localname": "CASMedicalSystemsInc.Member", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSCASMedicalSystemsIncNarrativeDetails", "http://www.edwards.com/role/ACQUISITIONSSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "domainItemType" }, "ew_CapitalLossCarryforwardAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Capital Loss Carryforward [Abstract]", "label": "Capital Loss Carryforward [Abstract]", "terseLabel": "Capital Loss Carryforward [Abstract]" } } }, "localname": "CapitalLossCarryforwardAbstract", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails" ], "xbrltype": "stringItemType" }, "ew_CapitalLossCarryforwardPeriodEnds2022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Capital Loss Carryforward Period Ends 2022 [Member]", "label": "Capital Loss Carryforward Period Ends 2022 [Member]", "terseLabel": "Carryforward Period Ends 2022" } } }, "localname": "CapitalLossCarryforwardPeriodEnds2022Member", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "ew_CapitalLossCarryforwards": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Capital Loss Carryforwards", "label": "Capital Loss Carryforwards", "terseLabel": "Carryforward Amount" } } }, "localname": "CapitalLossCarryforwards", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "ew_CapitalLossCarryforwardsValuationAllowance": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails": { "order": 2.0, "parentTag": "ew_DeferredTaxAssetsCapitalLossCarryforwardsNetOfValuationAllowance", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Capital Loss Carryforwards, Valuation Allowance", "label": "Capital Loss Carryforwards, Valuation Allowance", "negatedTerseLabel": "Valuation Allowance" } } }, "localname": "CapitalLossCarryforwardsValuationAllowance", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "ew_CardiAQValveTechnologiesInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CardiAQ Valve Technologies, Inc. [Member]", "label": "CardiAQ Valve Technologies, Inc. [Member]", "terseLabel": "CardiAQ" } } }, "localname": "CardiAQValveTechnologiesInc.Member", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSCardiAQValveTechnologiesIncNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_CarryforwardPeriodEnds20302037Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Carryforward Period Ends 2030-2037 [Member]", "label": "Carryforward Period Ends 2030-2037 [Member]", "terseLabel": "Carryforward Period Ends 2030-2037" } } }, "localname": "CarryforwardPeriodEnds20302037Member", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "ew_CasmedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Casmed [Member]", "label": "Casmed [Member]", "terseLabel": "Casmed" } } }, "localname": "CasmedMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_CommonStockMarketPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company during the period.", "label": "Common Stock Market Price", "terseLabel": "Market price (in dollars per share)" } } }, "localname": "CommonStockMarketPrice", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/QUARTERLYFINANCIALRESULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDDetails" ], "xbrltype": "perShareItemType" }, "ew_CreditAgreementMaturityApril2023Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Credit Agreement Maturity April 2023 [Member]", "label": "Credit Agreement Maturity April 2023 [Member]", "terseLabel": "Credit Agreement Maturity April 2023" } } }, "localname": "CreditAgreementMaturityApril2023Member", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_CreditAgreementMaturityJuly2019Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the credit agreement with a maturity of July 2019.", "label": "Credit Agreement, Maturity July 2019 [Member]", "terseLabel": "Credit agreement, maturity July 2019" } } }, "localname": "CreditAgreementMaturityJuly2019Member", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_CriticalCareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents the critical care product line.", "label": "Critical Care [Member]", "terseLabel": "Critical Care" } } }, "localname": "CriticalCareMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "xbrltype": "domainItemType" }, "ew_DeferredTaxAssetsCapitalLossCarryforwardsNetOfValuationAllowance": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Capital Loss Carryforwards, Net Of Valuation Allowance", "label": "Deferred Tax Assets, Capital Loss Carryforwards, Net Of Valuation Allowance", "totalLabel": "Net Tax Benefit" } } }, "localname": "DeferredTaxAssetsCapitalLossCarryforwardsNetOfValuationAllowance", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "ew_DeferredTaxAssetsInvestmentsInUnconsolidatedAffiliates": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 9.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from investments. Includes equity method investments; excludes investments in subsidiaries.", "label": "Deferred Tax Assets, Investments in Unconsolidated Affiliates", "terseLabel": "Investments" } } }, "localname": "DeferredTaxAssetsInvestmentsInUnconsolidatedAffiliates", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ew_DeferredTaxAssetsLeaseLiabilityObligations": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 10.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Lease Liability Obligations", "label": "Deferred Tax Assets, Lease Liability Obligations", "terseLabel": "Lease liability obligations" } } }, "localname": "DeferredTaxAssetsLeaseLiabilityObligations", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ew_DeferredTaxAssetsOperatingLossCarryforwardsNetOfReduction": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards, net of the reduction for the benefit related to windfall to be recorded to additional paid in capital when realized as a reduction to income taxes payable.", "label": "Deferred Tax Assets Operating Loss Carryforwards Net of Reduction", "verboseLabel": "Net operating loss carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNetOfReduction", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ew_DeferredTaxAssetsOperatingLossCarryforwardsNetOfValuationAllowance": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the amount after allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets Operating Loss Carryforwards Net of Valuation Allowance", "totalLabel": "Net Tax Benefit" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNetOfValuationAllowance", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "ew_DeferredTaxLiabilityOperatingLeaseRightOfUseAmortization": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Liability, Operating Lease Right Of Use Amortization", "label": "Deferred Tax Liability, Operating Lease Right Of Use Amortization", "negatedTerseLabel": "Right-of-use assets" } } }, "localname": "DeferredTaxLiabilityOperatingLeaseRightOfUseAmortization", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ew_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTaxExpenseBenefitNetofTax": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails": { "order": 3.0, "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Accumulated Other Comprehensive Income, Deferred Income Tax Expense (Benefit), Net of Tax", "label": "Defined Benefit Plan, Accumulated Other Comprehensive Income, Deferred Income Tax Expense (Benefit), Net of Tax", "negatedTerseLabel": "Deferred income tax benefit" } } }, "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTaxExpenseBenefitNetofTax", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "ew_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPensionIncrease": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents the percentage of increase in pension.", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Pension Increase", "terseLabel": "Pension increase" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPensionIncrease", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "xbrltype": "percentItemType" }, "ew_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationSocialSecuritiesIncrease": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents the percentage of increase in social security.", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Social Securities Increase", "terseLabel": "Social securities increase" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationSocialSecuritiesIncrease", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "xbrltype": "percentItemType" }, "ew_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostPensionIncrease": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents the percentage of increase in pension.", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Pension Increase", "terseLabel": "Pension increase" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostPensionIncrease", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "xbrltype": "percentItemType" }, "ew_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostSocialSecuritiesIncrease": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents the percentage of increase in social security.", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Social Securities Increase", "terseLabel": "Social securities increase" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostSocialSecuritiesIncrease", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "xbrltype": "percentItemType" }, "ew_DefinedBenefitPlanChangeinBenefitObligationPlanAssetsNetAmountRecognizedonBalanceSheetTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents the changes in benefit obligations, plan assets and the net amount recognized in the balance sheet for defined benefit plans.", "label": "Defined Benefit Plan, Change in Benefit Obligation Plan Assets, Net Amount Recognized on Balance Sheet [Table Text Block]", "terseLabel": "Schedule of Information Regarding Defined Benefit Pension Plans" } } }, "localname": "DefinedBenefitPlanChangeinBenefitObligationPlanAssetsNetAmountRecognizedonBalanceSheetTableTextBlock", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSTables" ], "xbrltype": "textBlockItemType" }, "ew_DefinedContributionPlanEmployerMatchingContributionPercentFirstLevel": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of the first level of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.", "label": "Defined Contribution Plan Employer Matching Contribution Percent, First Level", "terseLabel": "Dollar-for-dollar match of employee's annual eligible compensation (as a percent)" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionPercentFirstLevel", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "percentItemType" }, "ew_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchFirstLevel": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage employer matches for the first level of the employee's percentage contribution matched.", "label": "Defined Contribution Plan, Employer Matching Contribution Percent of Match First Level", "terseLabel": "Company match, first level (as a percent)" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatchFirstLevel", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "percentItemType" }, "ew_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchSecondLevel": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage employer matches for the second level of the employee's percentage contribution matched.", "label": "Defined Contribution Plan, Employer Matching Contribution Percent of Match, Second Level", "terseLabel": "Company match, second level (as a percent)" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatchSecondLevel", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "percentItemType" }, "ew_DefinedContributionPlanEmployerMatchingContributionPercentSecondLevel": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of the second level of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.", "label": "Defined Contribution Plan, Employer Matching Contribution Percent, Second Level", "terseLabel": "Company match of eligible compensation after dollar-for-dollar basis (as a percent)" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionPercentSecondLevel", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "percentItemType" }, "ew_DefinedContributionPlanProfitSharingContributionRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For a defined contribution plan, the percent of the participant's eligible compensation that the employer will contribute to the profit sharing plan.", "label": "Defined Contribution Plan Profit Sharing Contribution Rate", "terseLabel": "Profit sharing contribution calculated on eligible earnings (as a percent)" } } }, "localname": "DefinedContributionPlanProfitSharingContributionRate", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "percentItemType" }, "ew_DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Fair Value of Derivative Asset Gross Amounts Not Offset [Abstract]", "terseLabel": "Gross Amounts Not Offset in the Consolidated Balance Sheet" } } }, "localname": "DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "stringItemType" }, "ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Fair Value of Derivative Liability Gross Amounts Not Offset [Abstract]", "terseLabel": "Gross Amounts Not Offset in the Consolidated Balance Sheet" } } }, "localname": "DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "stringItemType" }, "ew_DevelopedTechnologyAndInProcessResearchAndDevelopmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Developed Technology And In-Process Research And Development [Member]", "label": "Developed Technology And In-Process Research And Development [Member]", "terseLabel": "Developed Technology and In-process Research and Development" } } }, "localname": "DevelopedTechnologyAndInProcessResearchAndDevelopmentMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSValtechCardioLtdNarrativeDetails", "http://www.edwards.com/role/SPECIALCHARGESGAINImpairmentofLonglivedAssetsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESGoodwillandIntangibleAssetsNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_DisclosureOfFairValueHedgingInstrumentsAndCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure Of Fair Value Hedging Instruments And Cash Flow Hedging Instruments, Statements Of Financial Performance And Financial Position, Location [Table Text Block]", "label": "Disclosure Of Fair Value Hedging Instruments And Cash Flow Hedging Instruments, Statements Of Financial Performance And Financial Position, Location [Table Text Block]", "terseLabel": "Schedule of the Effect of Fair Value and Cash Flow Hedge" } } }, "localname": "DisclosureOfFairValueHedgingInstrumentsAndCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "xbrltype": "textBlockItemType" }, "ew_EarlystageTranscatheterIntellectualPropertyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Early-stage Transcatheter Intellectual Property [Member]", "label": "Early-stage Transcatheter Intellectual Property [Member]", "terseLabel": "Early-stage Transcatheter Intellectual Property" } } }, "localname": "EarlystageTranscatheterIntellectualPropertyMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/QUARTERLYFINANCIALRESTULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDNarrativeDetails", "http://www.edwards.com/role/SPECIALCHARGESGAINAcquisitionofIntellectualPropertyDetails" ], "xbrltype": "domainItemType" }, "ew_EffectiveIncomeTaxRateReconciliationDeductionSharebasedCompensationCostAmount": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 9.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Deduction, Share-based Compensation Cost, Amount", "label": "Effective Income Tax Rate Reconciliation, Deduction, Share-based Compensation Cost, Amount", "negatedTerseLabel": "U.S. federal deductible employee share-based compensation" } } }, "localname": "EffectiveIncomeTaxRateReconciliationDeductionSharebasedCompensationCostAmount", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "ew_EffectiveIncomeTaxRateReconciliationImpactsRelatedTo2017U.S.TaxReformAmount": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 11.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Impacts Related To 2017 U.S. Tax Reform, Amount", "label": "Effective Income Tax Rate Reconciliation, Impacts Related To 2017 U.S. Tax Reform, Amount", "terseLabel": "Impact related to 2017 U.S. Tax Reform" } } }, "localname": "EffectiveIncomeTaxRateReconciliationImpactsRelatedTo2017U.S.TaxReformAmount", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "ew_EffectiveIncomeTaxRateReconciliationTaxOnGlobalIntangibleLowTaxedIncomeAmount": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 7.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Tax On Global Intangible Low-Taxed Income, Amount", "label": "Effective Income Tax Rate Reconciliation, Tax On Global Intangible Low-Taxed Income, Amount", "terseLabel": "Tax on global intangible low-taxed income" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxOnGlobalIntangibleLowTaxedIncomeAmount", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "ew_EffectiveIncomeTaxRateReconciliationU.S.TaxOnForeignEarningsNetOfCreditsAmount": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 6.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, U.S. Tax On Foreign Earnings, Net Of Credits, Amount", "label": "Effective Income Tax Rate Reconciliation, U.S. Tax On Foreign Earnings, Net Of Credits, Amount", "terseLabel": "U.S. tax on foreign earnings, net of credits" } } }, "localname": "EffectiveIncomeTaxRateReconciliationU.S.TaxOnForeignEarningsNetOfCreditsAmount", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "ew_EmployeeAndNonemployeeStockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An arrangement whereby an employee or nonemployee (including a member of the entity's Board of Directors) is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement.", "label": "Employee and Nonemployee Stock Options [Member]", "terseLabel": "Option Awards", "verboseLabel": "Stock option activity" } } }, "localname": "EmployeeAndNonemployeeStockOptionsMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails" ], "xbrltype": "domainItemType" }, "ew_EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndVestingOfRestrictedStockUnits": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Disclosure of aggregate tax benefit realized from the exercise of stock options and vesting of restricted stock units during the period.", "label": "Employee Service Share Based Compensation, Tax Benefit Realized from Exercise of Stock Options and Vesting of Restricted Stock Units", "terseLabel": "Realized tax benefits from exercises of stock options and vesting of restricted stock units" } } }, "localname": "EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndVestingOfRestrictedStockUnits", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAdditionalInformationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_EmployeeStockPurchasePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employee Stock Purchase Plan [Member]", "label": "Employee Stock Purchase Plan [Member]", "terseLabel": "ESPP" } } }, "localname": "EmployeeStockPurchasePlanMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_EquipmentWithCustomers": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 4.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The gross amount, as of the balance sheet date, of long-lived, depreciable equipment at customer locations.", "label": "Equipment with Customers", "terseLabel": "Equipment with customers" } } }, "localname": "EquipmentWithCustomers", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "ew_EstimatedAnnualForfeitureRatePercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents the estimated annual forfeiture rate of the entity's stock-based compensation plans, percentage.", "label": "Estimated Annual Forfeiture Rate Percent", "terseLabel": "Estimated annual forfeiture rate" } } }, "localname": "EstimatedAnnualForfeitureRatePercent", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "percentItemType" }, "ew_EuropeSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the Europe reportable segment of the entity.", "label": "Europe Segment [Member]", "terseLabel": "Europe" } } }, "localname": "EuropeSegmentMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationAboutReportableSegmentsDetails" ], "xbrltype": "domainItemType" }, "ew_February2021StockRepurchaseProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "February 2021 Stock Repurchase Program", "label": "February 2021 Stock Repurchase Program [Member]", "terseLabel": "February 2021 Stock Repurchase Program" } } }, "localname": "February2021StockRepurchaseProgramMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/SUBSEQUENTEVENTDetails" ], "xbrltype": "domainItemType" }, "ew_FixedRate4.3002018NotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fixed Rate 4.300% 2018 Notes [Member]", "label": "Fixed Rate 4.300% 2018 Notes [Member]", "terseLabel": "Fixed-rate 4.300% 2018 Notes" } } }, "localname": "FixedRate4.3002018NotesMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails" ], "xbrltype": "domainItemType" }, "ew_ForeignEarningsToBeRepatriated": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Foreign Earnings To Be Repatriated", "label": "Foreign Earnings To Be Repatriated", "terseLabel": "Foreign earnings to be repatriated" } } }, "localname": "ForeignEarningsToBeRepatriated", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_GainLossOnInvestmentsOtherIncomeExpenseNet": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/OTHERINCOMENETDetails": { "order": 2.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This item represents the portion of gain (loss) on investments categorized by the entity as other income (expense). Includes, but is not limited to, (1) the net realized and unrealized gain (loss) included in earnings for the period as a result of selling or holding marketable securities categorized as trading, available-for-sale, or held-to-maturity, including those trading securities held for investment under deferred compensation agreements net of the gain (loss) of the related deferred compensation liability; (2) the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied; (3) gains (losses) realized during the period from the sale of investments accounted for under the cost method of accounting; (4) losses recognized for other than temporary impairments (OTTI) of the subject investments; and (5) the amount of recovery of investments which had previously been fully or partially written-off.", "label": "Gain (Loss) on Investments, Other Income Expense, Net", "negatedLabel": "Gain on investments" } } }, "localname": "GainLossOnInvestmentsOtherIncomeExpenseNet", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/OTHERINCOMENETDetails" ], "xbrltype": "monetaryItemType" }, "ew_HarpoonMedicalInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Harpoon Medical, Inc. [Member]", "label": "Harpoon Medical, Inc. [Member]", "terseLabel": "Harpoon Medical" } } }, "localname": "HarpoonMedicalInc.Member", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSHarpoonMedicalIncNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_HemodynamicMonitorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hemodynamic Monitors [Member]", "label": "Hemodynamic Monitors [Member]", "terseLabel": "Hemodynamic Monitors" } } }, "localname": "HemodynamicMonitorsMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_IncreaseDecreaseInDeferredTaxAssetsLiabilitiesNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase or decrease during the year in net deferred tax assets. Includes items recorded to stockholders' equity and which did not impact the income tax provision.", "label": "Increase (Decrease) in Deferred Tax Assets (Liabilities), Net", "terseLabel": "Net deferred tax assets increase" } } }, "localname": "IncreaseDecreaseInDeferredTaxAssetsLiabilitiesNet", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_IncreaseDecreaseInLegalSettlementAccrual": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) In Legal Settlement Accrual", "label": "Increase (Decrease) In Legal Settlement Accrual", "terseLabel": "Litigation settlement accrual" } } }, "localname": "IncreaseDecreaseInLegalSettlementAccrual", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "ew_InitialDeliveryOfSharesSettledJune2019Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Initial Delivery Of Shares Settled June 2019 [Member]", "label": "Initial Delivery Of Shares Settled June 2019 [Member]", "terseLabel": "Initial Delivery of Shares Settled June 2019" } } }, "localname": "InitialDeliveryOfSharesSettledJune2019Member", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails" ], "xbrltype": "domainItemType" }, "ew_InitialDeliveryofSharesSettledMay2019Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Initial Delivery of Shares Settled May 2019 [Member]", "label": "Initial Delivery of Shares Settled May 2019 [Member]", "terseLabel": "Initial Delivery of Shares Settled May 2019" } } }, "localname": "InitialDeliveryofSharesSettledMay2019Member", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails" ], "xbrltype": "domainItemType" }, "ew_InsuranceContractsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents the information about insurance contracts.", "label": "Insurance Contracts [Member]", "terseLabel": "Insurance contracts", "verboseLabel": "Insurance Contracts" } } }, "localname": "InsuranceContractsMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSSummaryofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details" ], "xbrltype": "domainItemType" }, "ew_IntellectualPropertyLitigationExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the net amount of judgment or settlement awarded to (against) the entity and legal, forensic, accounting, investigative fees and other expenses related to intellectual property litigation.", "label": "Intellectual Property Litigation Expense", "negatedLabel": "Intellectual property litigation expenses, net" } } }, "localname": "IntellectualPropertyLitigationExpense", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails" ], "xbrltype": "monetaryItemType" }, "ew_InventoryWriteDownExpirationPeriodTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period prior to the expiration date which triggers the write down of inventory, expressed in months.", "label": "Inventory Write Down Expiration Period Trigger", "terseLabel": "Period prior to expiration date which triggers write-down of inventory" } } }, "localname": "InventoryWriteDownExpirationPeriodTrigger", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInventoriesNarrativeDetails" ], "xbrltype": "durationItemType" }, "ew_InventoryWriteDownSlowMovingPeriodTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The time period used to identify slow-moving inventory which triggers an inventory write-down.", "label": "Inventory Write Down Slow Moving Period Trigger", "terseLabel": "Period used to evaluate slow-moving inventory levels" } } }, "localname": "InventoryWriteDownSlowMovingPeriodTrigger", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInventoriesNarrativeDetails" ], "xbrltype": "durationItemType" }, "ew_JapanSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the Japan reportable segment of the entity.", "label": "Japan Segment [Member]", "terseLabel": "Japan" } } }, "localname": "JapanSegmentMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationAboutReportableSegmentsDetails" ], "xbrltype": "domainItemType" }, "ew_July2018StockRepurchaseProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "July 2018 Stock Repurchase Program", "label": "July 2018 Stock Repurchase Program [Member]", "terseLabel": "July 2018" } } }, "localname": "July2018StockRepurchaseProgramMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails" ], "xbrltype": "domainItemType" }, "ew_LesseeOperatingLeaseLeaseNotYetCommencedAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Amount", "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Amount", "terseLabel": "Lease commitments for leases not yet commenced" } } }, "localname": "LesseeOperatingLeaseLeaseNotYetCommencedAmount", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/LEASESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_LineOfCreditFacilityAdditionalCapacityIncreaseOption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount by which the borrowing capacity of the line of credit may be increased at the entity's option, subject to certain conditions, under the terms of the credit agreement.", "label": "Line of Credit Facility, Additional Capacity Increase Option", "terseLabel": "Additional amount available, subject to lender approval" } } }, "localname": "LineOfCreditFacilityAdditionalCapacityIncreaseOption", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_LongTermStockIncentiveCompensationProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents details pertaining to the Long-Term Stock Incentive Compensation Program of the entity.", "label": "Long Term Stock Incentive Compensation Program [Member]", "terseLabel": "The Program" } } }, "localname": "LongTermStockIncentiveCompensationProgramMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loss Contingency, Claims That If Settled Could Have A Material Adverse Impact, Number", "label": "Loss Contingency, Claims That If Settled Could Have A Material Adverse Impact, Number", "terseLabel": "Number of lawsuits that if settled could have a material adverse impact on net income or cash flows" } } }, "localname": "LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/LEGALPROCEEDINGSDetails" ], "xbrltype": "integerItemType" }, "ew_MarketBasedRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Market Based Restricted Stock Units [Member]", "label": "Market Based Restricted Stock Units [Member]", "terseLabel": "MRSUs" } } }, "localname": "MarketBasedRestrictedStockUnitsMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_May2019StockRepurchaseProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "May 2019 Stock Repurchase Program", "label": "May 2019 Stock Repurchase Program [Member]", "terseLabel": "May 2019" } } }, "localname": "May2019StockRepurchaseProgramMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTreasuryStockNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_May2019StockRepurchaseProgramSharesPurchasedAndSoldInMay2019Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "May 2019 Stock Repurchase Program, Shares Purchased And Sold In May 2019 [Member]", "label": "May 2019 Stock Repurchase Program, Shares Purchased And Sold In May 2019 [Member]", "terseLabel": "Purchased and sold in May 2019" } } }, "localname": "May2019StockRepurchaseProgramSharesPurchasedAndSoldInMay2019Member", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails" ], "xbrltype": "domainItemType" }, "ew_May2019StockRepurchaseProgramSharesSoldInJune2019Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "May 2019 Stock Repurchase Program, Shares Sold In June 2019 [Member]", "label": "May 2019 Stock Repurchase Program, Shares Sold In June 2019 [Member]", "terseLabel": "Purchased in May 2019 and sold in June 2019" } } }, "localname": "May2019StockRepurchaseProgramSharesSoldInJune2019Member", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails" ], "xbrltype": "domainItemType" }, "ew_MeasurementInputProbabilityOfMilestoneAchievementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement Input, Probability Of Milestone Achievement [Member]", "label": "Measurement Input, Probability Of Milestone Achievement [Member]", "terseLabel": "Measurement Input, Probability of Milestone Achievement" } } }, "localname": "MeasurementInputProbabilityOfMilestoneAchievementMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_MeasurementInputVolatilityOfFutureRevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement Input, Volatility Of Future Revenue [Member]", "label": "Measurement Input, Volatility Of Future Revenue [Member]", "terseLabel": "Measurement Input, Volatility of Future Revenue" } } }, "localname": "MeasurementInputVolatilityOfFutureRevenueMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_NonemployeeDirectorsStockIncentiveCompensationProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents details pertaining to the Nonemployee Directors Stock Incentive Compensation Program of the entity.", "label": "Nonemployee Directors Stock Incentive Compensation Program [Member]", "terseLabel": "Nonemployee Directors Program" } } }, "localname": "NonemployeeDirectorsStockIncentiveCompensationProgramMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_NonqualifiedDeferredCompensationPlanSelectEmployeeGroupMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents a nonqualified deferred compensation plan for a select group of employees.", "label": "Nonqualified Deferred Compensation Plan Select Employee Group [Member]", "terseLabel": "Nonqualified deferred compensation plans" } } }, "localname": "NonqualifiedDeferredCompensationPlanSelectEmployeeGroupMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_OperatingLeaseRightOfUseAssetAmortization": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating Lease, Right Of Use Asset Amortization", "label": "Operating Lease, Right Of Use Asset Amortization", "terseLabel": "Non-cash operating lease cost" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortization", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "ew_OtherIncomeExpenseItems": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/OTHERINCOMENETDetails": { "order": 4.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reflects all other income and expense recognized by the entity in the period not otherwise specified in the income statement.", "label": "Other Income Expense Items", "negatedLabel": "Other" } } }, "localname": "OtherIncomeExpenseItems", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/OTHERINCOMENETDetails" ], "xbrltype": "monetaryItemType" }, "ew_OtherNonoperatingNonrecurringIncomeExpense": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other Nonoperating Nonrecurring (Income) Expense", "label": "Other Nonoperating Nonrecurring (Income) Expense", "terseLabel": "Special gain (Note\u00a04)", "verboseLabel": "Special charges (gain), net" } } }, "localname": "OtherNonoperatingNonrecurringIncomeExpense", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "ew_PuertoRicoPurchasesCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Puerto Rico Purchases Credit [Member]", "label": "Puerto Rico Purchases Credit [Member]", "terseLabel": "Puerto Rico purchases credit" } } }, "localname": "PuertoRicoPurchasesCreditMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_PurchaseCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to purchase credit carryforward.", "label": "Purchase Credit [Member]", "terseLabel": "Purchases credit" } } }, "localname": "PurchaseCreditMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "ew_ResearchAndDevelopmentAccruals": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 9.0, "parentTag": "ew_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying amount, as of the balance sheet date, of current obligations associated with research and development and clinical trials.", "label": "Research And Development Accruals", "terseLabel": "Research and development accruals" } } }, "localname": "ResearchAndDevelopmentAccruals", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "ew_RestOfWorldMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the geographic areas of the world other than the United States, Europe and Japan.", "label": "Rest of World [Member]", "terseLabel": "Rest of World" } } }, "localname": "RestOfWorldMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "xbrltype": "domainItemType" }, "ew_RestOfWorldSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the reportable segment of the entity comprised of regions other than the United States, Europe and Japan (Rest of World).", "label": "Rest of World Segment [Member]", "terseLabel": "Rest of World" } } }, "localname": "RestOfWorldSegmentMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSValtechCardioLtdNarrativeDetails", "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails", "http://www.edwards.com/role/QUARTERLYFINANCIALRESTULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDNarrativeDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationAboutReportableSegmentsDetails", "http://www.edwards.com/role/SPECIALCHARGESGAINImpairmentofLonglivedAssetsDetails" ], "xbrltype": "domainItemType" }, "ew_RestrictedStockAndRestrictedStockUnitAwardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted stock and restricted stock units awarded by a company to their employees as a form of incentive compensation.", "label": "Restricted Stock and Restricted Stock Unit Awards [Member]", "terseLabel": "Restricted stock or restricted stock units" } } }, "localname": "RestrictedStockAndRestrictedStockUnitAwardsMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_ScheduleOfSelectedCaptionsBalanceSheetDisclosuresTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of the aggregate supplemental balance sheet disclosures, including descriptions and amounts, related to assets and liabilities.", "label": "Schedule of Selected Captions Balance Sheet Disclosures [Table Text Block]", "terseLabel": "Schedule of Components of Selected Captions in the Consolidated Balance Sheets" } } }, "localname": "ScheduleOfSelectedCaptionsBalanceSheetDisclosuresTableTextBlock", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables" ], "xbrltype": "textBlockItemType" }, "ew_SeniorNotesDue2018Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to senior notes which are due in 2018.", "label": "Senior Notes Due 2018 [Member]", "terseLabel": "2013 Notes" } } }, "localname": "SeniorNotesDue2018Member", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPreviousPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Grants In Previous Period", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Grants In Previous Period", "terseLabel": "Shares related to previous year's grant (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPreviousPeriod", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityNarrativeDetails" ], "xbrltype": "sharesItemType" }, "ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardIntrinsicValueOfStockOptionsExercisedAndVestedRestrictedStockUnits": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the intrinsic value of stock options exercised and restricted stock units that vested during the period.", "label": "Share Based Compensation Arrangement by Share Based Payment Award, Intrinsic Value of Stock Options Exercised and Vested Restricted Stock Units", "terseLabel": "Intrinsic value of stock options exercised and restricted stock units vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardIntrinsicValueOfStockOptionsExercisedAndVestedRestrictedStockUnits", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAdditionalInformationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGrantDateFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the total grant-date fair value of options that vested during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options Vested in Period, Grant Date Fair Value", "terseLabel": "Total grant date fair value of stock options vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGrantDateFairValue", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAdditionalInformationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_ShareBasedCompensationArrangementsAwardGrantedAnnuallyToNonemployeeDirectorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents details pertaining to an award granted annually to a nonemployee director.", "label": "Share-based Compensation Arrangements Award Granted Annually to Nonemployee Director [Member]", "terseLabel": "Annual award to nonemployee director" } } }, "localname": "ShareBasedCompensationArrangementsAwardGrantedAnnuallyToNonemployeeDirectorMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_ShareBasedCompensationArrangementsAwardsGranted2012AndAfterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents details pertaining to awards granted in 2012 and years after.", "label": "Share Based Compensation Arrangements Awards Granted 2012 and after [Member]", "terseLabel": "Awards granted in 2012 and later" } } }, "localname": "ShareBasedCompensationArrangementsAwardsGranted2012AndAfterMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_ShareBasedGoodsAndNonemployeeServicesTransactionNonemployeeAwardValueMaximum": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the maximum total grant date fair value of stock-based awards that can be granted to nonemployee directors.", "label": "Share Based Goods and Nonemployee Services Transaction Nonemployee Award Value Maximum", "terseLabel": "Limit on total value of the award" } } }, "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionNonemployeeAwardValueMaximum", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_ShareInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Information [Abstract]", "terseLabel": "Share information (Note\u00a02):" } } }, "localname": "ShareInformationAbstract", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "ew_SurgicalHeartValveTherapyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents the surgical heart valve therapy product line.", "label": "Surgical Heart Valve Therapy [Member]", "terseLabel": "Surgical Structural Heart" } } }, "localname": "SurgicalHeartValveTherapyMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "xbrltype": "domainItemType" }, "ew_TaxCarryforwardsExpirationPeriodYears20202027Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax Carryforwards Expiration Period Years 2020-2027 [Member]", "label": "Tax Carryforwards Expiration Period Years 2020-2027 [Member]", "terseLabel": "Carryforward Period Ends 2020-2027" } } }, "localname": "TaxCarryforwardsExpirationPeriodYears20202027Member", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "ew_TaxCarryforwardsExpirationPeriodYears20262039Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax Carryforwards Expiration Period Years 2026-2039 [Member]", "label": "Tax Carryforwards Expiration Period Years 2026-2039 [Member]", "terseLabel": "Carryforward Period Ends 2026-2039" } } }, "localname": "TaxCarryforwardsExpirationPeriodYears20262039Member", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "ew_TaxCarryforwardsNoExpirationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents tax carryforwards with no expiration.", "label": "Tax Carryforwards, No Expiration [Member]", "terseLabel": "Carryforward Period Indefinite", "verboseLabel": "Carryforward period indefinite" } } }, "localname": "TaxCarryforwardsNoExpirationMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "ew_TaxCreditCarryforwardDeferredTaxAssetNetOfValuationAllowance": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the amount after allocation of valuation allowances of deferred tax asset attributable to tax credit carryforwards.", "label": "Tax Credit Carryforward Deferred Tax Asset Net of Valuation Allowance", "totalLabel": "Net Tax Benefit" } } }, "localname": "TaxCreditCarryforwardDeferredTaxAssetNetOfValuationAllowance", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "ew_TaxCutsAndJobsActMeasurementPeriodAdjustmentTransitionTaxForAccumulatedForeignEarningsIncomeTaxExpenseBenefits": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Tax Cuts And Jobs Act, Measurement Period Adjustment, Transition Tax For Accumulated Foreign Earnings, Income Tax Expense (Benefits)", "label": "Tax Cuts And Jobs Act, Measurement Period Adjustment, Transition Tax For Accumulated Foreign Earnings, Income Tax Expense (Benefits)", "negatedLabel": "Adjustment to transition tax" } } }, "localname": "TaxCutsAndJobsActMeasurementPeriodAdjustmentTransitionTaxForAccumulatedForeignEarningsIncomeTaxExpenseBenefits", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpenseBenefit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Change In Tax Rate, Deferred Tax Asset, Provisional Income Tax Expense (Benefit)", "label": "Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Change In Tax Rate, Deferred Tax Asset, Provisional Income Tax Expense (Benefit)", "negatedTerseLabel": "Tax benefit from remeasurement of deferred taxes" } } }, "localname": "TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpenseBenefit", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_TaxCutsAndJobsActOf2017IncompleteAccountingForeignTaxCreditsProvisionalIncomeTaxExpenseBenefit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Foreign Tax Credits, Provisional Income Tax Expense (Benefit)", "label": "Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Foreign Tax Credits, Provisional Income Tax Expense (Benefit)", "negatedTerseLabel": "Tax benefit from harvesting foreign tax credits" } } }, "localname": "TaxCutsAndJobsActOf2017IncompleteAccountingForeignTaxCreditsProvisionalIncomeTaxExpenseBenefit", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Transition Tax For Accumulated Foreign Earnings, Provisional Income Tax Expense (Benefit)", "label": "Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Transition Tax For Accumulated Foreign Earnings, Provisional Income Tax Expense (Benefit)", "terseLabel": "Effects of mandatory deemed repatriation" } } }, "localname": "TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentsChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpenseBenefit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Tax Cuts And Jobs Act Of 2017, Measurement Period Adjustments, Change In Tax Rate, Deferred Tax Asset, Provisional Income Tax Expense (Benefit)", "label": "Tax Cuts And Jobs Act Of 2017, Measurement Period Adjustments, Change In Tax Rate, Deferred Tax Asset, Provisional Income Tax Expense (Benefit)", "terseLabel": "Deferred tax asset provisional income tax expense (benefit)" } } }, "localname": "TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentsChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpenseBenefit", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_TranscatheterAorticValveReplacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transcatheter Aortic Valve Replacement [Member]", "label": "Transcatheter Aortic Valve Replacement [Member]", "terseLabel": "Transcatheter Aortic Valve Replacement" } } }, "localname": "TranscatheterAorticValveReplacementMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "xbrltype": "domainItemType" }, "ew_TranscatheterMitralAndTricuspidTherapiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transcatheter Mitral And Tricuspid Therapies [Member]", "label": "Transcatheter Mitral And Tricuspid Therapies [Member]", "terseLabel": "Transcatheter Mitral and Tricuspid Therapies" } } }, "localname": "TranscatheterMitralAndTricuspidTherapiesMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "xbrltype": "domainItemType" }, "ew_TranscatheterMitralValveReplacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transcatheter Mitral Valve Replacement [Member]", "label": "Transcatheter Mitral Valve Replacement [Member]", "terseLabel": "Transcatheter Mitral Valve Replacement" } } }, "localname": "TranscatheterMitralValveReplacementMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNETDetails" ], "xbrltype": "domainItemType" }, "ew_TwoPreviousAcquisitionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Previous Acquisitions [Member]", "label": "Two Previous Acquisitions [Member]", "terseLabel": "Two Previous Acquisitions" } } }, "localname": "TwoPreviousAcquisitionsMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_UnitedStatesSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the United States reportable segment of the entity.", "label": "United States Segment [Member]", "terseLabel": "United States" } } }, "localname": "UnitedStatesSegmentMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationAboutReportableSegmentsDetails" ], "xbrltype": "domainItemType" }, "ew_UnrecognizedTaxBenefitsAccruedInterestTaxBenefit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The tax benefits pertaining to the amount of interest expense accrued on unrecognized tax benefits.", "label": "Unrecognized Tax Benefits, Accrued Interest, Tax Benefit", "terseLabel": "Tax benefit of accrued interest" } } }, "localname": "UnrecognizedTaxBenefitsAccruedInterestTaxBenefit", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ew_ValtechCardioLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Valtech Cardio, Ltd [Member]", "label": "Valtech Cardio, Ltd [Member]", "terseLabel": "Valtech" } } }, "localname": "ValtechCardioLtdMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSValtechCardioLtdNarrativeDetails", "http://www.edwards.com/role/QUARTERLYFINANCIALRESTULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDNarrativeDetails", "http://www.edwards.com/role/SPECIALCHARGESGAINImpairmentofLonglivedAssetsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESGoodwillandIntangibleAssetsNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_ValtechSpinoffMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Valtech Spin-off [Member]", "label": "Valtech Spin-off [Member]", "terseLabel": "Valtech spin off" } } }, "localname": "ValtechSpinoffMember", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSValtechCardioLtdNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_WeightedAverageRemainingContractualTermYearsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining Contractual Term Years [Abstract]", "terseLabel": "Weighted- Average Remaining Contractual Term" } } }, "localname": "WeightedAverageRemainingContractualTermYearsAbstract", "nsuri": "http://www.edwards.com/20201231", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r218", "r231", "r232", "r233", "r234", "r236", "r238", "r242" ], "lang": { "en-us": { "role": { "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.", "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationAboutReportableSegmentsDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r218", "r231", "r232", "r233", "r234", "r236", "r238", "r242" ], "lang": { "en-us": { "role": { "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.", "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationAboutReportableSegmentsDetails" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember": { "auth_ref": [ "r174", "r178", "r299", "r556", "r557", "r558", "r601", "r602" ], "lang": { "en-us": { "role": { "documentation": "Represents amount after cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.", "label": "Cumulative Effect, Period of Adoption, Adjusted Balance [Member]", "terseLabel": "Cumulative Effect, Period of Adoption, Adjusted Balance" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": { "auth_ref": [ "r174", "r178", "r299", "r556", "r557", "r558", "r601", "r602" ], "lang": { "en-us": { "role": { "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.", "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]", "terseLabel": "Impact to retained earnings from adoption of ASU 2016-16 and ASU 2018-02" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAxis": { "auth_ref": [ "r174", "r178", "r299", "r556", "r557", "r558", "r601", "r602" ], "lang": { "en-us": { "role": { "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.", "label": "Cumulative Effect, Period of Adoption [Axis]", "terseLabel": "Cumulative Effect, Period of Adoption [Axis]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionDomain": { "auth_ref": [ "r174", "r178", "r299", "r556", "r557", "r558", "r601", "r602" ], "lang": { "en-us": { "role": { "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.", "label": "Cumulative Effect, Period of Adoption [Domain]", "terseLabel": "Cumulative Effect, Period of Adoption [Domain]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "srt_EuropeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Continent of Europe.", "label": "Europe [Member]", "terseLabel": "Europe" } } }, "localname": "EuropeMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "xbrltype": "domainItemType" }, "srt_LitigationCaseAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim.", "label": "Litigation Case [Axis]", "terseLabel": "Litigation Case [Axis]" } } }, "localname": "LitigationCaseAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNETDetails", "http://www.edwards.com/role/LEGALPROCEEDINGSDetails" ], "xbrltype": "stringItemType" }, "srt_LitigationCaseTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information.", "label": "Litigation Case [Domain]", "terseLabel": "Litigation Case [Domain]" } } }, "localname": "LitigationCaseTypeDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNETDetails", "http://www.edwards.com/role/LEGALPROCEEDINGSDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r508", "r518", "r745", "r746", "r747", "r748", "r749", "r750", "r770", "r818", "r821" ], "lang": { "en-us": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]", "terseLabel": "High", "verboseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/LEASESNarrativeDetails", "http://www.edwards.com/role/QUARTERLYFINANCIALRESULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsReceivableDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r508", "r518", "r745", "r746", "r747", "r748", "r749", "r750", "r770", "r818", "r821" ], "lang": { "en-us": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]", "terseLabel": "Low", "verboseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/LEASESNarrativeDetails", "http://www.edwards.com/role/QUARTERLYFINANCIALRESULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsReceivableDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsNarrativeDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r245", "r408", "r411", "r771", "r817", "r819" ], "lang": { "en-us": { "role": { "documentation": "Information by product and service, or group of similar products and similar services.", "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueNarrativeDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESShippingandHandlingCostsNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r245", "r408", "r411", "r771", "r817", "r819" ], "lang": { "en-us": { "role": { "documentation": "Product or service, or a group of similar products or similar services.", "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueNarrativeDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESShippingandHandlingCostsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r444", "r508", "r518", "r745", "r746", "r747", "r748", "r749", "r750", "r770", "r818", "r821" ], "lang": { "en-us": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/LEASESNarrativeDetails", "http://www.edwards.com/role/QUARTERLYFINANCIALRESULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsReceivableDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsNarrativeDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r444", "r508", "r518", "r745", "r746", "r747", "r748", "r749", "r750", "r770", "r818", "r821" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/LEASESNarrativeDetails", "http://www.edwards.com/role/QUARTERLYFINANCIALRESULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsReceivableDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsNarrativeDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r513", "r855" ], "lang": { "en-us": { "role": { "documentation": "Information reported for future period.", "label": "Forecast [Member]", "terseLabel": "Forecast" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNETDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r513" ], "lang": { "en-us": { "role": { "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario [Domain]", "terseLabel": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNETDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": { "auth_ref": [ "r169", "r858" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]", "terseLabel": "VALUATION AND QUALIFYING ACCOUNTS" } } }, "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTS" ], "xbrltype": "textBlockItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r246", "r247", "r408", "r412", "r820", "r836", "r837", "r838", "r839", "r840", "r841", "r842", "r843" ], "lang": { "en-us": { "role": { "documentation": "Geographical area.", "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r246", "r247", "r408", "r412", "r820", "r831", "r836", "r837", "r838", "r839", "r840", "r841", "r842", "r843", "r844", "r856", "r857" ], "lang": { "en-us": { "role": { "documentation": "Information by geographical components.", "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r362", "r513", "r737" ], "lang": { "en-us": { "role": { "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNETDetails" ], "xbrltype": "stringItemType" }, "srt_ValuationAndQualifyingAccountsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]", "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]" } } }, "localname": "ValuationAndQualifyingAccountsAbstract", "nsuri": "http://fasb.org/srt/2020-01-31", "xbrltype": "stringItemType" }, "srt_ValuationAndQualifyingAccountsDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]", "terseLabel": "Valuation and Qualifying Accounts Disclosure" } } }, "localname": "ValuationAndQualifyingAccountsDisclosureLineItems", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "xbrltype": "stringItemType" }, "srt_ValuationAndQualifyingAccountsDisclosureTable": { "auth_ref": [ "r169", "r858" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]", "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]" } } }, "localname": "ValuationAndQualifyingAccountsDisclosureTable", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "xbrltype": "stringItemType" }, "srt_WeightedAverageMember": { "auth_ref": [ "r745", "r747", "r750" ], "lang": { "en-us": { "role": { "documentation": "Average of a range of values, calculated with consideration of proportional relevance.", "label": "Weighted Average [Member]", "terseLabel": "Weighted Average" } } }, "localname": "WeightedAverageMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "stpr_CA": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CALIFORNIA", "terseLabel": "California" } } }, "localname": "CA", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax" } } }, "localname": "AOCIAttributableToParentNetOfTaxRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AcceleratedShareRepurchasesDateAxis": { "auth_ref": [ "r390" ], "lang": { "en-us": { "role": { "documentation": "Information by date of execution of accelerated share repurchases.", "label": "Accelerated Share Repurchases, Date [Axis]", "terseLabel": "Accelerated Share Repurchases, Date [Axis]" } } }, "localname": "AcceleratedShareRepurchasesDateAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails", "http://www.edwards.com/role/SUBSEQUENTEVENTDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AcceleratedShareRepurchasesDateDomain": { "auth_ref": [ "r390" ], "lang": { "en-us": { "role": { "documentation": "Date upon which the accelerated share repurchase agreement was executed.", "label": "Accelerated Share Repurchases, Date [Domain]", "terseLabel": "Accelerated Share Repurchases, Date [Domain]" } } }, "localname": "AcceleratedShareRepurchasesDateDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails", "http://www.edwards.com/role/SUBSEQUENTEVENTDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare": { "auth_ref": [ "r390" ], "lang": { "en-us": { "role": { "documentation": "Final price paid per share for the purchase of the targeted number of shares, determined by an average market price over a fixed period of time.", "label": "Accelerated Share Repurchases, Final Price Paid Per Share", "terseLabel": "Final settlement per share price (in dollars per share)" } } }, "localname": "AcceleratedShareRepurchasesFinalPricePaidPerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare": { "auth_ref": [ "r390" ], "lang": { "en-us": { "role": { "documentation": "The price paid per share to immediately purchase the targeted number of shares on the date of executing the accelerated share repurchase agreement.", "label": "Accelerated Share Repurchases, Initial Price Paid Per Share", "terseLabel": "Initial delivery, price per share (in dollars per share)" } } }, "localname": "AcceleratedShareRepurchasesInitialPricePaidPerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_AcceleratedShareRepurchasesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accelerated Share Repurchases [Line Items]", "terseLabel": "Accelerated Share Repurchase" } } }, "localname": "AcceleratedShareRepurchasesLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AcceleratedShareRepurchasesTable": { "auth_ref": [ "r390" ], "lang": { "en-us": { "role": { "documentation": "A table reflecting activity in an accelerated share repurchase (ASR) program.", "label": "Accelerated Share Repurchases [Table]", "terseLabel": "Accelerated Share Repurchases [Table]" } } }, "localname": "AcceleratedShareRepurchasesTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AcceleratedShareRepurchasesTextBlock": { "auth_ref": [ "r390" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of accelerated share repurchase (ASR) programs. An ASR is a combination of transactions that permits an entity to purchase a targeted number of shares immediately with the final purchase price of those shares determined by an average market price over a fixed period of time. An accelerated share repurchase program is intended to combine the immediate share retirement benefits of a tender offer with the market impact and pricing benefits of a disciplined daily open market stock repurchase program. ASRs can be disclosed as part of stockholders' equity.", "label": "Accelerated Share Repurchases [Table Text Block]", "terseLabel": "Accelerated Share Repurchases" } } }, "localname": "AcceleratedShareRepurchasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsNotesAndLoansReceivableLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]", "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]" } } }, "localname": "AccountsNotesAndLoansReceivableLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsReceivableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing accounts payable and accrued liabilities.", "label": "Accounts Payable and Accrued Liabilities [Member]", "terseLabel": "Accrued and other liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r47" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r4", "r29", "r251", "r252" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable, net of allowances of $9.6 and $8.7, respectively" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r22", "r779", "r803" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 1.0, "parentTag": "ew_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes, Current", "terseLabel": "Taxes payable" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accrued Liabilities and Other Liabilities [Abstract]", "terseLabel": "Accrued and other liabilities" } } }, "localname": "AccruedLiabilitiesAndOtherLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccruedMarketingCostsCurrent": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 3.0, "parentTag": "ew_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Marketing Costs, Current", "terseLabel": "Accrued marketing expenses" } } }, "localname": "AccruedMarketingCostsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r12", "r13", "r49" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 7.0, "parentTag": "ew_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Professional Fees, Current", "terseLabel": "Accrued professional services" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "auth_ref": [ "r84", "r91", "r94", "r645" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "netLabel": "Unrealized Pension Costs", "terseLabel": "Unrealized pension credits (cost), net", "verboseLabel": "Amortization of pension adjustments" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember": { "auth_ref": [ "r86", "r91", "r94", "r645" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to prior service cost (credit) component of defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member]", "terseLabel": "Prior service credit" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember": { "auth_ref": [ "r83", "r91", "r94", "r645" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]", "terseLabel": "Net actuarial gain (loss) arising during period" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r45", "r347" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "auth_ref": [ "r91", "r100", "r644" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.", "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]", "terseLabel": "Unrealized (Loss) Gain on Hedges", "verboseLabel": "(Loss) gain on hedges" } } }, "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": { "auth_ref": [ "r80", "r81", "r82", "r91", "r94" ], "lang": { "en-us": { "role": { "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.", "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]", "terseLabel": "Unrealized (Loss) Gain on Available-for-sale Investments", "verboseLabel": "(Loss) gain on available-for-sale investments" } } }, "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": { "auth_ref": [ "r85", "r91", "r465" ], "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).", "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax", "negatedTotalLabel": "Total" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "verboseLabel": "Accumulated Other Comprehensive Loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r32", "r88", "r90", "r91", "r807", "r826", "r827" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r707", "r708", "r709", "r710", "r711", "r713" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r87", "r91", "r94", "r171", "r172", "r173", "r645", "r822", "r823" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Loss", "verboseLabel": "Total Accumulated Other Comprehensive Loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r77", "r91", "r94", "r645", "r708", "r709", "r710", "r711", "r713" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "terseLabel": "Foreign Currency Translation Adjustments", "verboseLabel": "Foreign currency translation adjustments" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r331" ], "lang": { "en-us": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life", "terseLabel": "Weighted average useful life" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSCASMedicalSystemsIncNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]", "terseLabel": "Amounts included in the measurement of lease liabilities:" } } }, "localname": "AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r30" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid in Capital, Common Stock", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r171", "r172", "r173", "r556", "r557", "r558" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income to cash provided by operating activities:" } } }, "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r520", "r522", "r562", "r563" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Stock-based compensation expense" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockSplit": { "auth_ref": [ "r381", "r388" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from a stock split in which per-share par value or stated value is not changed proportionately.", "label": "Adjustments to Additional Paid in Capital, Stock Split", "negatedTerseLabel": "Stock issued to effect stock split" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalStockSplit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r522", "r552", "r561" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Total stock-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Expense, after Tax", "terseLabel": "Total stock-based compensation expense, net of tax" } } }, "localname": "AllocatedShareBasedCompensationExpenseNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForCreditLossMember": { "auth_ref": [ "r168" ], "lang": { "en-us": { "role": { "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]", "terseLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForCreditLossMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r36", "r257", "r300" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "terseLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r140", "r329", "r338" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization expense related to other intangible assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r195" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Anti-dilutive securities excluded from the computation of earnings per share (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsperShareNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r195" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsperShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsperShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r195" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsperShareNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AssetBackedSecuritiesMember": { "auth_ref": [ "r275", "r445" ], "lang": { "en-us": { "role": { "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.", "label": "Asset-backed Securities [Member]", "terseLabel": "Asset-backed securities" } } }, "localname": "AssetBackedSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r154", "r226", "r233", "r240", "r298", "r641", "r646", "r701", "r777", "r802" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r6", "r8", "r62", "r154", "r298", "r641", "r646", "r701" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r686" ], "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "totalLabel": "Total assets" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": { "auth_ref": [ "r266" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": { "order": 1.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax", "terseLabel": "Gross Unrealized Gains" } } }, "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": { "auth_ref": [ "r267" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": { "order": 2.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax", "negatedLabel": "Gross Unrealized Losses" } } }, "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": { "auth_ref": [ "r264", "r306" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale, Amortized Cost", "totalLabel": "Amortized Cost" } } }, "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Available-for-sale [Abstract]", "terseLabel": "Available-for-sale" } } }, "localname": "AvailableForSaleSecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Available-for-sale Securities, Debt Maturities [Abstract]", "terseLabel": "Available-for-Sale" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Available-for-sale, Maturity, Amortized Cost, Rolling Maturity [Abstract]", "terseLabel": "Amortized Cost" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Available-for-sale, Maturity, Fair Value, Rolling Maturity [Abstract]", "terseLabel": "Fair Value" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 1.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost", "terseLabel": "Due in 1\u00a0year or less" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 1.0, "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value", "terseLabel": "Due in 1\u00a0year or less" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 2.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost", "terseLabel": "Due after 1\u00a0year through 5\u00a0years" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 2.0, "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value", "terseLabel": "Due after 1\u00a0year through 5\u00a0years" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost": { "auth_ref": [ "r269" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 3.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.", "label": "Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Amortized Cost", "terseLabel": "Instruments not due at a single maturity date" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": { "auth_ref": [ "r269" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 3.0, "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.", "label": "Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value", "terseLabel": "Instruments not due at a single maturity date" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtSecurities": { "auth_ref": [ "r261", "r265", "r306", "r785" ], "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "order": 2.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 }, "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": { "order": 3.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale", "terseLabel": "Fair Value", "totalLabel": "Total", "verboseLabel": "Available-for-sale investments" } } }, "localname": "AvailableForSaleSecuritiesDebtSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r524", "r554" ], "lang": { "en-us": { "role": { "documentation": "Information by date or year award under share-based payment arrangement is granted.", "label": "Award Date [Axis]", "terseLabel": "Award Date [Axis]" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted.", "label": "Award Date [Domain]", "terseLabel": "Award Date [Domain]" } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r524", "r554" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityNarrativeDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESStockbasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r657", "r663" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BankTimeDepositsMember": { "auth_ref": [ "r791" ], "lang": { "en-us": { "role": { "documentation": "Certificates of deposit (CD) or savings accounts with a fixed term or understanding the customer can only withdraw by giving advanced notice with a bank or other financial institution. A CD is a short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest.", "label": "Bank Time Deposits [Member]", "terseLabel": "Bank time deposits" } } }, "localname": "BankTimeDepositsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BuildingAndBuildingImprovementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.", "label": "Building and Building Improvements [Member]", "terseLabel": "Buildings and improvements" } } }, "localname": "BuildingAndBuildingImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r501", "r514" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSCASMedicalSystemsIncNarrativeDetails", "http://www.edwards.com/role/ACQUISITIONSCardiAQValveTechnologiesIncNarrativeDetails", "http://www.edwards.com/role/ACQUISITIONSHarpoonMedicalIncNarrativeDetails", "http://www.edwards.com/role/ACQUISITIONSSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.edwards.com/role/ACQUISITIONSValtechCardioLtdNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails", "http://www.edwards.com/role/QUARTERLYFINANCIALRESTULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDNarrativeDetails", "http://www.edwards.com/role/SPECIALCHARGESGAINAcquisitionofIntellectualPropertyDetails", "http://www.edwards.com/role/SPECIALCHARGESGAINImpairmentofLonglivedAssetsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESGoodwillandIntangibleAssetsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r501", "r514", "r619", "r620" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSCASMedicalSystemsIncNarrativeDetails", "http://www.edwards.com/role/ACQUISITIONSCardiAQValveTechnologiesIncNarrativeDetails", "http://www.edwards.com/role/ACQUISITIONSHarpoonMedicalIncNarrativeDetails", "http://www.edwards.com/role/ACQUISITIONSSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.edwards.com/role/ACQUISITIONSValtechCardioLtdNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails", "http://www.edwards.com/role/QUARTERLYFINANCIALRESTULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDNarrativeDetails", "http://www.edwards.com/role/SPECIALCHARGESGAINAcquisitionofIntellectualPropertyDetails", "http://www.edwards.com/role/SPECIALCHARGESGAINImpairmentofLonglivedAssetsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESGoodwillandIntangibleAssetsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.", "label": "Business Acquisition, Transaction Costs", "terseLabel": "Acquisition transaction costs" } } }, "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/QUARTERLYFINANCIALRESTULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDNarrativeDetails", "http://www.edwards.com/role/SPECIALCHARGESGAINAcquisitionofIntellectualPropertyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": { "auth_ref": [ "r634" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.", "label": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned", "terseLabel": "Fair value of shares issued in connection with business combinations (Note 8)" } } }, "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSValtechCardioLtdNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "auth_ref": [ "r634" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of equity interests issued or issuable to acquire entity.", "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares", "terseLabel": "Issuance of shares of common stock (in shares)" } } }, "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSValtechCardioLtdNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSCASMedicalSystemsIncNarrativeDetails", "http://www.edwards.com/role/ACQUISITIONSCardiAQValveTechnologiesIncNarrativeDetails", "http://www.edwards.com/role/ACQUISITIONSHarpoonMedicalIncNarrativeDetails", "http://www.edwards.com/role/ACQUISITIONSSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.edwards.com/role/ACQUISITIONSValtechCardioLtdNarrativeDetails", "http://www.edwards.com/role/SPECIALCHARGESGAINAcquisitionofIntellectualPropertyDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.", "label": "Business Acquisition, Share Price", "terseLabel": "Consideration per share to be transferred (in dollars per share)" } } }, "localname": "BusinessAcquisitionSharePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSCASMedicalSystemsIncNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r618" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Combination, Acquisition Related Costs", "terseLabel": "Acquisition-related costs" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSCASMedicalSystemsIncNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r628", "r629", "r632" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "terseLabel": "Cash purchase price", "verboseLabel": "Purchase price subject to certain adjustments" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSCASMedicalSystemsIncNarrativeDetails", "http://www.edwards.com/role/ACQUISITIONSCardiAQValveTechnologiesIncNarrativeDetails", "http://www.edwards.com/role/ACQUISITIONSHarpoonMedicalIncNarrativeDetails", "http://www.edwards.com/role/ACQUISITIONSValtechCardioLtdNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": { "auth_ref": [ "r139", "r637" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 5.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.", "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability", "negatedTerseLabel": "Change in fair value of contingent consideration liabilities, net", "terseLabel": "Change in fair value of contingent consideration liabilities", "verboseLabel": "Change in fair value of contingent consideration liabilities, net (Note 11)" } } }, "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": { "auth_ref": [ "r636" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.", "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High", "terseLabel": "Potential milestone-driven payments" } } }, "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSHarpoonMedicalIncNarrativeDetails", "http://www.edwards.com/role/ACQUISITIONSValtechCardioLtdNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "auth_ref": [ "r627", "r630", "r635" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.", "label": "Business Combination, Contingent Consideration, Liability", "verboseLabel": "Additional payments if certain European regulatory approval is obtained" } } }, "localname": "BusinessCombinationContingentConsiderationLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSCardiAQValveTechnologiesIncNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": { "auth_ref": [ "r691" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure contingent consideration liability from business combination.", "label": "Business Combination, Contingent Consideration, Liability, Measurement Input", "verboseLabel": "Contingent consideration liability measurement input" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "decimalItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": { "auth_ref": [ "r627", "r631" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.", "label": "Business Combination, Contingent Consideration, Liability, Noncurrent", "terseLabel": "Contingent consideration liabilities (Notes 8 and 11)" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r638" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "ACQUISITIONS" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONS" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized": { "auth_ref": [ "r623" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount, measured at acquisition-date fair value, of all liabilities assumed that arise from contingencies and were recognized by the entity.", "label": "Business Combination, Liabilities Arising from Contingencies, Amount Recognized", "terseLabel": "Liability for estimated fair value of contingent milestone payment" } } }, "localname": "BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSCardiAQValveTechnologiesIncNarrativeDetails", "http://www.edwards.com/role/ACQUISITIONSHarpoonMedicalIncNarrativeDetails", "http://www.edwards.com/role/ACQUISITIONSValtechCardioLtdNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": { "auth_ref": [ "r622" ], "calculation": { "http://www.edwards.com/role/ACQUISITIONSSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets", "terseLabel": "Current assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": { "auth_ref": [ "r622" ], "calculation": { "http://www.edwards.com/role/ACQUISITIONSSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities", "negatedTerseLabel": "Liabilities assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": { "auth_ref": [ "r622" ], "calculation": { "http://www.edwards.com/role/ACQUISITIONSSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets", "terseLabel": "Deferred tax assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": { "auth_ref": [ "r621", "r622" ], "calculation": { "http://www.edwards.com/role/ACQUISITIONSSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 6.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles", "terseLabel": "Finite lived intangible assets", "verboseLabel": "Increase to intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r621", "r622" ], "calculation": { "http://www.edwards.com/role/ACQUISITIONSSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "terseLabel": "Property and equipment, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "auth_ref": [ "r622" ], "calculation": { "http://www.edwards.com/role/ACQUISITIONSSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net", "totalLabel": "Total purchase price" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combinations [Abstract]", "terseLabel": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "auth_ref": [ "r145", "r146", "r147" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.", "label": "Capital Expenditures Incurred but Not yet Paid", "verboseLabel": "Capital expenditures accruals" } } }, "localname": "CapitalExpendituresIncurredButNotYetPaid", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedComputerSoftwareGross": { "auth_ref": [ "r845" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 5.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.", "label": "Capitalized Computer Software, Gross", "terseLabel": "Software" } } }, "localname": "CapitalizedComputerSoftwareGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAcquiredFromAcquisition": { "auth_ref": [ "r120" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).", "label": "Cash Acquired from Acquisition", "negatedTerseLabel": "Less: cash acquired" } } }, "localname": "CashAcquiredFromAcquisition", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r41", "r142" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "order": 1.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "terseLabel": "Cash equivalents" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r16", "r143", "r150" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r134", "r142", "r148" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of year", "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of year", "totalLabel": "Total cash, cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r134", "r706" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase (decrease) in cash, cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": { "auth_ref": [ "r681" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.", "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months", "negatedTerseLabel": "Cash flow hedge loss to be reclassified" } } }, "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgingMember": { "auth_ref": [ "r653" ], "lang": { "en-us": { "role": { "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.", "label": "Cash Flow Hedging [Member]", "terseLabel": "Cash flow hedges" } } }, "localname": "CashFlowHedgingMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "verboseLabel": "Non-cash investing and financing transactions:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1": { "auth_ref": [ "r679" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement.", "label": "Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments", "terseLabel": "Derivatives designated as hedging instruments" } } }, "localname": "ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1": { "auth_ref": [ "r679" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement.", "label": "Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge", "terseLabel": "Hedged items" } } }, "localname": "ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]", "terseLabel": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/QUARTERLYFINANCIALRESTULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDNarrativeDetails", "http://www.edwards.com/role/QUARTERLYFINANCIALRESULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfTreasuryStockTable": { "auth_ref": [ "r391", "r392", "r393", "r394" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.", "label": "Class of Treasury Stock [Table]", "terseLabel": "Class of Treasury Stock [Table]" } } }, "localname": "ClassOfTreasuryStockTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTreasuryStockNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommercialPaperMember": { "auth_ref": [ "r372" ], "lang": { "en-us": { "role": { "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.", "label": "Commercial Paper [Member]", "terseLabel": "Commercial paper" } } }, "localname": "CommercialPaperMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r54", "r361", "r786", "r811" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 9.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (Notes\u00a06, 10 and 18)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r358", "r359", "r360", "r369" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "LEGAL PROCEEDINGS" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/LEGALPROCEEDINGS" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r171", "r172" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r28", "r381" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r28" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "verboseLabel": "Common stock, $1.00 par value, 1,050.0 shares authorized, 636.4 and 218.1 shares issued, and 624.3 and 209.1 shares outstanding, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Retirement Benefits [Abstract]", "terseLabel": "Retirement Benefits [Abstract]" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CompensationRelatedCostsPolicyTextBlock": { "auth_ref": [ "r149", "r529" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.", "label": "Compensation Related Costs, Policy [Policy Text Block]", "terseLabel": "Stock-based Compensation" } } }, "localname": "CompensationRelatedCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Components of Deferred Tax Assets [Abstract]", "terseLabel": "Deferred tax assets" } } }, "localname": "ComponentsOfDeferredTaxAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Components of Deferred Tax Liabilities [Abstract]", "terseLabel": "Deferred tax liabilities" } } }, "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r96", "r97", "r98", "r104", "r788", "r813" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive income" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "auth_ref": [ "r103", "r117", "r787", "r812" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.", "label": "Comprehensive Income (Loss) Note [Text Block]", "terseLabel": "ACCUMULATED OTHER COMPREHENSIVE LOSS" } } }, "localname": "ComprehensiveIncomeNoteTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r150", "r643" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConstructionInProgressGross": { "auth_ref": [ "r346" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 6.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction in Progress, Gross", "terseLabel": "Construction in progress" } } }, "localname": "ConstructionInProgressGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r396", "r397", "r409" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "terseLabel": "Deferred revenue" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r410" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized", "terseLabel": "Revenue recognized that was previously deferred" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CorporateDebtSecuritiesMember": { "auth_ref": [ "r445", "r494", "r829" ], "lang": { "en-us": { "role": { "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.", "label": "Corporate Debt Securities [Member]", "terseLabel": "Corporate debt securities" } } }, "localname": "CorporateDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CorporateNonSegmentMember": { "auth_ref": [ "r231", "r232", "r233", "r234", "r236", "r242", "r244" ], "lang": { "en-us": { "role": { "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.", "label": "Corporate, Non-Segment [Member]", "verboseLabel": "Corporate items" } } }, "localname": "CorporateNonSegmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r109", "r771" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "negatedLabel": "Cost of sales", "terseLabel": "Cost of sales" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESShippingandHandlingCostsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of sales", "verboseLabel": "Cost of sales" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r106" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "negatedTerseLabel": "Corporate items" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CurrencySwapMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.", "label": "Currency Swap [Member]", "terseLabel": "Cross currency swap contracts" } } }, "localname": "CurrencySwapMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeandInterestRateRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Federal, State and Local, Tax Expense (Benefit) [Abstract]", "terseLabel": "United States:" } } }, "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r155", "r598", "r605" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Federal Tax Expense (Benefit)", "terseLabel": "Federal" } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [ "r158", "r598" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails": { "order": 3.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Foreign Tax Expense (Benefit)", "terseLabel": "International, including Puerto Rico" } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r155", "r598", "r605", "r607" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current Income Tax Expense (Benefit)", "totalLabel": "Current income tax expense" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Current" } } }, "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r155", "r598", "r605" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current State and Local Tax Expense (Benefit)", "terseLabel": "State and local" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r625" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer Relationships" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSCASMedicalSystemsIncNarrativeDetails", "http://www.edwards.com/role/ACQUISITIONSSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r377" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "DEBT AND CREDIT FACILITIES" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r20", "r22", "r23", "r778", "r781", "r800" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Basis spread on variable rate (as a percent)" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r23", "r374", "r781", "r800" ], "calculation": { "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-term Debt, Gross", "terseLabel": "Amount" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r718", "r720" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Fixed-rate unsecured senior notes" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r700" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Debt Instrument, Fair Value Disclosure", "terseLabel": "Fair value of the notes, based on Level 2 inputs" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r51", "r376", "r718" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument, Interest Rate, Effective Percentage", "terseLabel": "Effective Interest Rate" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Fixed interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r52" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "auth_ref": [ "r796" ], "lang": { "en-us": { "role": { "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.", "label": "Debt Instrument, Redemption Price, Percentage", "terseLabel": "Price equal to principal amount, plus accrued and unpaid interest (as a percent)" } } }, "localname": "DebtInstrumentRedemptionPricePercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r52", "r156", "r382", "r385", "r386", "r387", "r717", "r718", "r720", "r797" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term", "terseLabel": "Term of the credit agreement" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r717", "r720" ], "calculation": { "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount", "negatedLabel": "Unamortized discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": { "auth_ref": [ "r286", "r311", "r314" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails": { "order": 2.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer", "terseLabel": "Fair value, 12 months or greater" } } }, "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": { "auth_ref": [ "r286", "r311" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails": { "order": 2.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss", "negatedTerseLabel": "Gross unrealized losses, 12 months or greater" } } }, "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": { "auth_ref": [ "r286", "r311", "r314" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails": { "order": 1.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months", "terseLabel": "Fair value, less than 12 months" } } }, "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": { "auth_ref": [ "r286", "r311" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails": { "order": 1.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss", "negatedTerseLabel": "Gross unrealized losses, less than 12 months" } } }, "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleTable": { "auth_ref": [ "r290" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale [Table]", "terseLabel": "Debt Securities, Available-for-sale [Table]" } } }, "localname": "DebtSecuritiesAvailableForSaleTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": { "auth_ref": [ "r282", "r307", "r314" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.", "label": "Debt Securities, Available-for-sale, Unrealized Loss Position", "totalLabel": "Total fair value" } } }, "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": { "auth_ref": [ "r283", "r308" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss", "negatedTotalLabel": "Total gross unrealized losses" } } }, "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": { "auth_ref": [ "r281", "r310", "r314" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value [Table Text Block]", "terseLabel": "Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position" } } }, "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": { "auth_ref": [ "r284", "r309" ], "lang": { "en-us": { "role": { "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions", "terseLabel": "Number of Investments" } } }, "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": { "auth_ref": [ "r577" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESNarrativeDetails": { "order": 2.0, "parentTag": "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.", "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible", "terseLabel": "Estimated decrease in unrecognized tax benefits" } } }, "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationCashbasedArrangementsLiabilityClassifiedNoncurrent": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for deferred compensation arrangements payable after one year (or the normal operating cycle, if longer). Represents currently earned compensation under cash arrangements (such as a profit-sharing plan, rabbi trust, and employee contract--excluding equity-based arrangements) that is not actually paid until a later date.", "label": "Deferred Compensation Cash-based Arrangements, Liability, Classified, Noncurrent", "terseLabel": "Deferred compensation plans" } } }, "localname": "DeferredCompensationCashbasedArrangementsLiabilityClassifiedNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements. Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.", "label": "Deferred Compensation Liability, Current and Noncurrent", "terseLabel": "Amount accrued under nonqualified plans" } } }, "localname": "DeferredCompensationLiabilityCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationPlanAssets": { "auth_ref": [ "r46" ], "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "order": 3.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.", "label": "Deferred Compensation Plan Assets", "terseLabel": "Investments held for deferred compensation plans" } } }, "localname": "DeferredCompensationPlanAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r155", "r599", "r605" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Federal Income Tax Expense (Benefit)", "terseLabel": "Federal" } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract]", "terseLabel": "United States:" } } }, "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r46", "r719" ], "calculation": { "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails": { "order": 3.0, "parentTag": "us-gaap_LongTermDebt", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Net", "negatedTerseLabel": "Unamortized debt issuance costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNoncurrentGross": { "auth_ref": [ "r46", "r719" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Cost, Gross, Noncurrent", "verboseLabel": "Issuance costs" } } }, "localname": "DeferredFinanceCostsNoncurrentGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "auth_ref": [ "r155", "r599", "r605" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Foreign Income Tax Expense (Benefit)", "terseLabel": "International, including Puerto Rico" } } }, "localname": "DeferredForeignIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r570", "r571" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets, Net", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r140", "r155", "r599", "r605", "r606", "r607" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "totalLabel": "Deferred income tax (benefit) expense" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Deferred" } } }, "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r25", "r26", "r588", "r780", "r799" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred Tax Liabilities, Gross", "negatedTotalLabel": "Total deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r155", "r599", "r605" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred State and Local Income Tax Expense (Benefit)", "terseLabel": "State and local" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsCapitalLossCarryforwards": { "auth_ref": [ "r596", "r597" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails": { "order": 1.0, "parentTag": "ew_DeferredTaxAssetsCapitalLossCarryforwardsNetOfValuationAllowance", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards.", "label": "Deferred Tax Assets, Capital Loss Carryforwards", "terseLabel": "Tax Benefit Amount" } } }, "localname": "DeferredTaxAssetsCapitalLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r589" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "totalLabel": "Total deferred tax assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsHedgingTransactions": { "auth_ref": [ "r596", "r597" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from hedging transactions.", "label": "Deferred Tax Assets, Hedging Transactions", "terseLabel": "Cash flow and net investment hedges" } } }, "localname": "DeferredTaxAssetsHedgingTransactions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsInventory": { "auth_ref": [ "r596", "r597" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.", "label": "Deferred Tax Assets, Inventory", "terseLabel": "Inventories" } } }, "localname": "DeferredTaxAssetsInventory", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "auth_ref": [ "r591" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.", "label": "Deferred Tax Assets, Net", "totalLabel": "Net deferred tax assets" } } }, "localname": "DeferredTaxAssetsLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r596", "r597" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails": { "order": 1.0, "parentTag": "ew_DeferredTaxAssetsOperatingLossCarryforwardsNetOfValuationAllowance", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "terseLabel": "Tax Benefit Amount" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r596", "r597" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 11.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Deferred Tax Assets, Other", "terseLabel": "Other" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsStateTaxes": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 8.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from state taxes.", "label": "Deferred Tax Assets, State Taxes", "verboseLabel": "State income taxes" } } }, "localname": "DeferredTaxAssetsStateTaxes", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": { "auth_ref": [ "r594", "r596", "r597" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.", "label": "Deferred Tax Assets, Tax Credit Carryforwards", "terseLabel": "Net tax credit carryforwards" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwards", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": { "auth_ref": [ "r596", "r597" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits", "terseLabel": "Compensation and benefits" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": { "auth_ref": [ "r596", "r597" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities", "terseLabel": "Accrued liabilities" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves": { "auth_ref": [ "r596", "r597" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves, classified as other.", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves", "terseLabel": "Benefits from uncertain tax positions" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r590" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation allowance", "terseLabel": "Valuation allowance that reduces certain deferred tax assets" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails", "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesDerivatives": { "auth_ref": [ "r596", "r597" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from derivatives.", "label": "Deferred Tax Liabilities, Derivatives", "negatedLabel": "Cash flow and net investment hedges" } } }, "localname": "DeferredTaxLiabilitiesDerivatives", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets": { "auth_ref": [ "r596", "r597" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.", "label": "Deferred Tax Liabilities, Goodwill and Intangible Assets", "negatedLabel": "Other intangible assets" } } }, "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesOther": { "auth_ref": [ "r596", "r597" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.", "label": "Deferred Tax Liabilities, Other", "negatedLabel": "Other" } } }, "localname": "DeferredTaxLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": { "auth_ref": [ "r596", "r597" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.", "label": "Deferred Tax Liabilities, Property, Plant and Equipment", "negatedLabel": "Property, plant, and equipment" } } }, "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings": { "auth_ref": [ "r596" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.", "label": "Deferred Tax Liabilities, Undistributed Foreign Earnings", "negatedLabel": "Deferred tax on foreign earnings" } } }, "localname": "DeferredTaxLiabilitiesUndistributedForeignEarnings", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESComponentsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries": { "auth_ref": [ "r616" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability not recognized because of the exceptions to comprehensive recognition of deferred taxes related to undistributed earnings of foreign subsidiaries.", "label": "Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Undistributed Earnings of Foreign Subsidiaries", "terseLabel": "Estimated net tax liability on permanently reinvested earnings" } } }, "localname": "DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent": { "auth_ref": [ "r24", "r418", "r419", "r442" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.", "label": "Liability, Defined Benefit Pension Plan, Noncurrent", "terseLabel": "Other long-term liabilities" } } }, "localname": "DefinedBenefitPensionPlanLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": { "auth_ref": [ "r453" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.", "label": "Defined Benefit Plan, Accumulated Benefit Obligation", "terseLabel": "Accumulated benefit obligation" } } }, "localname": "DefinedBenefitPlanAccumulatedBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax [Abstract]", "terseLabel": "Accumulated other comprehensive loss, net of tax:" } } }, "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax": { "auth_ref": [ "r91", "r465" ], "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails": { "order": 1.0, "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.", "label": "Accumulated Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Tax", "terseLabel": "Net actuarial loss" } } }, "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax": { "auth_ref": [ "r91", "r465" ], "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails": { "order": 2.0, "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).", "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax", "negatedLabel": "Net prior service cost" } } }, "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": { "auth_ref": [ "r434", "r494" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.", "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)", "terseLabel": "Actual return on plan assets" } } }, "localname": "DefinedBenefitPlanActualReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanActuarialGainLoss": { "auth_ref": [ "r427" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.", "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)", "negatedLabel": "Actuarial loss" } } }, "localname": "DefinedBenefitPlanActuarialGainLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": { "auth_ref": [ "r420", "r460", "r488", "r494", "r495" ], "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails": { "order": 5.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Gain (Loss)", "negatedTerseLabel": "Amortization of actuarial loss" } } }, "localname": "DefinedBenefitPlanAmortizationOfGainsLosses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": { "auth_ref": [ "r420", "r461", "r489", "r494", "r495" ], "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails": { "order": 6.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)", "terseLabel": "Amortization of prior service credit" } } }, "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position [Abstract]", "terseLabel": "Net amounts recognized on the consolidated balance sheet:" } } }, "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": { "auth_ref": [ "r467" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate", "terseLabel": "Discount rate" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease": { "auth_ref": [ "r468" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase", "terseLabel": "Rate of compensation increase" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate": { "auth_ref": [ "r470" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average interest crediting rate used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, cash balance and other defined benefit plans with promised interest crediting rate.", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Weighted-Average Interest Crediting Rate", "terseLabel": "Cash balance interest crediting rate" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": { "auth_ref": [ "r467" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate", "terseLabel": "Discount rate" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": { "auth_ref": [ "r469", "r493" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets", "terseLabel": "Expected return on plan assets" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": { "auth_ref": [ "r468" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase", "terseLabel": "Rate of compensation increase" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate": { "auth_ref": [ "r470" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average interest crediting rate used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, cash balance and other defined benefit plans with promised interest crediting rate.", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate", "terseLabel": "Cash balance interest crediting rate" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligation": { "auth_ref": [ "r422" ], "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails": { "order": 1.0, "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan, Benefit Obligation", "negatedLabel": "Projected benefit obligation", "periodEndLabel": "End of year", "periodStartLabel": "Beginning of year" } } }, "localname": "DefinedBenefitPlanBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": { "auth_ref": [ "r429", "r498" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.", "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid", "negatedLabel": "Benefits paid" } } }, "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant": { "auth_ref": [ "r426" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contributions received by defined benefit plan from participant which increase benefit obligation.", "label": "Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant", "terseLabel": "Participant contributions" } } }, "localname": "DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": { "auth_ref": [ "r444", "r445", "r447", "r448", "r449", "r450", "r451", "r452", "r472", "r494" ], "lang": { "en-us": { "role": { "documentation": "Information by defined benefit plan asset investment.", "label": "Defined Benefit Plan, Plan Assets, Category [Axis]", "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]" } } }, "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSSummaryofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember": { "auth_ref": [ "r445" ], "lang": { "en-us": { "role": { "documentation": "Cash and cash equivalent in which defined benefit plan asset is invested.", "label": "Defined Benefit Plan, Cash and Cash Equivalents [Member]", "terseLabel": "Cash" } } }, "localname": "DefinedBenefitPlanCashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]", "terseLabel": "Change in projected benefit obligation:" } } }, "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]", "terseLabel": "Change in fair value of plan assets:" } } }, "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "auth_ref": [ "r436", "r445", "r447", "r492", "r494", "r495" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.", "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer", "terseLabel": "Employer contributions" } } }, "localname": "DefinedBenefitPlanContributionsByEmployer", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanDebtSecurityMember": { "auth_ref": [ "r445" ], "lang": { "en-us": { "role": { "documentation": "Debt instrument issued by corporation, government and governmental agency, municipality, and other institution; in which defined benefit plan asset is invested.", "label": "Defined Benefit Plan, Debt Security [Member]", "terseLabel": "Debt securities" } } }, "localname": "DefinedBenefitPlanDebtSecurityMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]", "terseLabel": "Defined Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSSummaryofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanEquitySecuritiesMember": { "auth_ref": [ "r445", "r494" ], "lang": { "en-us": { "role": { "documentation": "Security representing ownership in corporation or other legal entity for which ownership is represented by share of stock, in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.", "label": "Defined Benefit Plan, Equity Securities [Member]", "terseLabel": "Equity securities" } } }, "localname": "DefinedBenefitPlanEquitySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember": { "auth_ref": [ "r445", "r447", "r494" ], "lang": { "en-us": { "role": { "documentation": "Security representing ownership in corporation or other legal entity, not domiciled in United States of America (US), for which ownership is represented by share of stock; in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.", "label": "Defined Benefit Plan, Equity Securities, Non-US [Member]", "terseLabel": "International equities" } } }, "localname": "DefinedBenefitPlanEquitySecuritiesNonUsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember": { "auth_ref": [ "r445", "r447", "r494" ], "lang": { "en-us": { "role": { "documentation": "Security representing ownership in corporation or other legal entity, domiciled in United States of America (US), for which ownership is represented by share of stock; in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.", "label": "Defined Benefit Plan, Equity Securities, US [Member]", "terseLabel": "United States equities" } } }, "localname": "DefinedBenefitPlanEquitySecuritiesUsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": { "auth_ref": [ "r454" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years", "terseLabel": "2024-2026" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofBenefitPaymentsWhichReflectExpectedFutureServiceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": { "auth_ref": [ "r454" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One", "terseLabel": "2021" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofBenefitPaymentsWhichReflectExpectedFutureServiceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": { "auth_ref": [ "r454" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five", "terseLabel": "2025" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofBenefitPaymentsWhichReflectExpectedFutureServiceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": { "auth_ref": [ "r454" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four", "terseLabel": "2024" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofBenefitPaymentsWhichReflectExpectedFutureServiceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": { "auth_ref": [ "r454" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three", "terseLabel": "2023" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofBenefitPaymentsWhichReflectExpectedFutureServiceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": { "auth_ref": [ "r454" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two", "terseLabel": "2022" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofBenefitPaymentsWhichReflectExpectedFutureServiceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": { "auth_ref": [ "r455", "r495" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year", "terseLabel": "Expected employer contributions" } } }, "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "auth_ref": [ "r420", "r459", "r487", "r494", "r495" ], "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails": { "order": 3.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.", "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets", "negatedTerseLabel": "Expected return on plan assets" } } }, "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": { "auth_ref": [ "r433", "r445", "r447", "r448", "r494" ], "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails": { "order": 2.0, "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.", "label": "Defined Benefit Plan, Plan Assets, Amount", "periodEndLabel": "End of year", "periodStartLabel": "Beginning of year", "terseLabel": "Plan assets at fair value" } } }, "localname": "DefinedBenefitPlanFairValueOfPlanAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSSummaryofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": { "auth_ref": [ "r428" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.", "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)", "negatedTerseLabel": "Currency exchange rate changes and other" } } }, "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": { "auth_ref": [ "r418", "r442", "r494" ], "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.", "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan", "totalLabel": "Underfunded status" } } }, "localname": "DefinedBenefitPlanFundedStatusOfPlan", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]", "terseLabel": "Funded Status" } } }, "localname": "DefinedBenefitPlanFundedStatusOfPlanAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanInterestCost": { "auth_ref": [ "r420", "r425", "r458", "r486", "r494", "r495" ], "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails": { "order": 2.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.", "label": "Defined Benefit Plan, Interest Cost", "terseLabel": "Interest cost", "verboseLabel": "Interest cost" } } }, "localname": "DefinedBenefitPlanInterestCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "auth_ref": [ "r456", "r484", "r494", "r495" ], "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "totalLabel": "Net periodic pension benefit cost (credit)" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAmendments": { "auth_ref": [ "r430" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in benefit obligation of defined benefit plan from change in terms of existing plan or initiation of new plan.", "label": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment", "negatedTerseLabel": "Plan amendment" } } }, "localname": "DefinedBenefitPlanPlanAmendments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": { "auth_ref": [ "r438", "r498" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.", "label": "Defined Benefit Plan, Plan Assets, Benefits Paid", "negatedLabel": "Benefits paid" } } }, "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant": { "auth_ref": [ "r437" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contributions received by defined benefit plan from participant which increases plan assets.", "label": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant", "terseLabel": "Participant contributions" } } }, "localname": "DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r435" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.", "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)", "terseLabel": "Currency exchange rate impact", "verboseLabel": "Currency exchange rate changes and other" } } }, "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSSummaryofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage": { "auth_ref": [ "r444", "r494" ], "lang": { "en-us": { "role": { "documentation": "Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.", "label": "Defined Benefit Plan, Plan Assets, Target Allocation, Percentage", "terseLabel": "Target asset allocations (as a percent)" } } }, "localname": "DefinedBenefitPlanPlanAssetsTargetAllocationPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements": { "auth_ref": [ "r450", "r494" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, measured using unobservable input, of increase (decrease) in plan asset of defined benefit plan from purchase, sale and settlement of trade associated with underlying investment.", "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Purchase, Sale, and Settlement", "terseLabel": "Purchases, sales and settlements" } } }, "localname": "DefinedBenefitPlanPurchasesSalesAndSettlements", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSSummaryofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanRealEstateMember": { "auth_ref": [ "r445", "r494" ], "lang": { "en-us": { "role": { "documentation": "Property composed of building, land and land improvement; in which defined benefit plan asset is invested.", "label": "Defined Benefit Plan, Real Estate [Member]", "terseLabel": "Real estate" } } }, "localname": "DefinedBenefitPlanRealEstateMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments": { "auth_ref": [ "r421", "r463", "r491" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from event reducing expected years of future service of present employees or eliminating accrual of defined benefits for some or all future services of present employees.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment", "terseLabel": "Gain due to curtailment" } } }, "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SPECIALCHARGESGAINRealignmentExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": { "auth_ref": [ "r421", "r463", "r491" ], "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails": { "order": 4.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement", "negatedTerseLabel": "Settlements and curtailment gain" } } }, "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanServiceCost": { "auth_ref": [ "r423", "r457", "r485", "r494", "r495" ], "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails": { "order": 1.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan, Service Cost", "terseLabel": "Service cost", "verboseLabel": "Service cost, net" } } }, "localname": "DefinedBenefitPlanServiceCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]", "terseLabel": "Weighted-average assumptions used to determine the benefit obligations" } } }, "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]", "terseLabel": "Weighted-average assumptions used to determine the net periodic benefit cost" } } }, "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedContributionPlanCostRecognized": { "auth_ref": [ "r499" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for defined contribution plan.", "label": "Defined Contribution Plan, Cost", "terseLabel": "Matching contributions relating to entity's employees" } } }, "localname": "DefinedContributionPlanCostRecognized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Contribution Plan Disclosure [Line Items]", "terseLabel": "Defined Contribution Plans" } } }, "localname": "DefinedContributionPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.", "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent", "terseLabel": "Maximum contributions of a participant's eligible compensation (as a percent)" } } }, "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedContributionPlanTable": { "auth_ref": [ "r499" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans.", "label": "Defined Contribution Plan [Table]", "terseLabel": "Defined Contribution Plan [Table]" } } }, "localname": "DefinedContributionPlanTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r140", "r345" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation expense for property, plant and equipment" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r140", "r221" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetFairValueGrossLiability": { "auth_ref": [ "r64", "r74", "r661" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails": { "order": 2.0, "parentTag": "us-gaap_DerivativeAssets", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of liability associated with financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Asset, Fair Value, Gross Liability", "negatedTerseLabel": "Gross Amounts Offset in the Consolidated Balance Sheet" } } }, "localname": "DerivativeAssetFairValueGrossLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection": { "auth_ref": [ "r68", "r72" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after effects of master netting arrangements, deduction of assets not subject to a master netting arrangement and elected not to be offset, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, offset against an obligation to return collateral.", "label": "Derivative Asset, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election", "totalLabel": "Net Amount" } } }, "localname": "DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction": { "auth_ref": [ "r66", "r72" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails": { "order": 2.0, "parentTag": "us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be offset, deducted from derivative assets.", "label": "Derivative Asset, Not Offset, Policy Election Deduction", "negatedLabel": "Financial Instruments" } } }, "localname": "DerivativeAssetNotOffsetPolicyElectionDeduction", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r65", "r71", "r700" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails": { "order": 1.0, "parentTag": "us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection", "weight": 1.0 }, "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "order": 4.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset", "terseLabel": "Derivatives", "totalLabel": "Net Amounts Presented in the Consolidated Balance Sheet", "verboseLabel": "Fair Value" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Asset [Abstract]", "terseLabel": "Assets" } } }, "localname": "DerivativeAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeCollateralObligationToReturnCash": { "auth_ref": [ "r67", "r72", "r675" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails": { "order": 3.0, "parentTag": "us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to return cash collateral under master netting arrangements that have not been offset against derivative assets.", "label": "Derivative, Collateral, Obligation to Return Cash", "negatedTerseLabel": "Cash Collateral Received" } } }, "localname": "DerivativeCollateralObligationToReturnCash", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeCollateralRightToReclaimCash": { "auth_ref": [ "r67", "r72", "r675" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails": { "order": 3.0, "parentTag": "us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of right to receive cash collateral under master netting arrangements that have not been offset against derivative liabilities.", "label": "Derivative, Collateral, Right to Reclaim Cash", "negatedTerseLabel": "Cash Collateral Received" } } }, "localname": "DerivativeCollateralRightToReclaimCash", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeandInterestRateRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeFairValueOfDerivativeAsset": { "auth_ref": [ "r63", "r73", "r661", "r752" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails": { "order": 1.0, "parentTag": "us-gaap_DerivativeAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.", "label": "Derivative Asset, Fair Value, Gross Asset", "terseLabel": "Gross Amounts" } } }, "localname": "DerivativeFairValueOfDerivativeAsset", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeLiability": { "auth_ref": [ "r63", "r73", "r661", "r752" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails": { "order": 1.0, "parentTag": "us-gaap_DerivativeLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.", "label": "Derivative Liability, Fair Value, Gross Liability", "terseLabel": "Gross Amounts" } } }, "localname": "DerivativeFairValueOfDerivativeLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r659" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "Derivative, Gain (Loss) on Derivative, Net", "terseLabel": "Amount of Gain or (Loss) Recognized in Income on Derivative" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r658", "r662", "r668", "r671" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeandInterestRateRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r684" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "terseLabel": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r655", "r658", "r668" ], "lang": { "en-us": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r655", "r658", "r668", "r671", "r672", "r677", "r680" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table]", "terseLabel": "Derivative Instruments, Gain (Loss) [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "terseLabel": "Derivative Instruments, Gain (Loss)" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred": { "auth_ref": [ "r683" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The estimated value of gains (losses), net anticipated to be transferred in the future from accumulated other comprehensive income into earnings.", "label": "Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred", "terseLabel": "Amount of Gain or (Loss) Recognized in\u00a0Income on Derivative (Amount Excluded from Effectiveness Testing)" } } }, "localname": "DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r65", "r71", "r700" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails": { "order": 1.0, "parentTag": "us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection", "weight": 1.0 }, "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "terseLabel": "Derivatives", "totalLabel": "Net Amounts Presented in the Consolidated Balance Sheet", "verboseLabel": "Fair Value" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Liability [Abstract]", "terseLabel": "Liabilities" } } }, "localname": "DerivativeLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r65" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 2.0, "parentTag": "ew_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Current", "terseLabel": "Fair value of derivatives" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityFairValueGrossAsset": { "auth_ref": [ "r64", "r74", "r661" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails": { "order": 2.0, "parentTag": "us-gaap_DerivativeLiabilities", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of asset associated with financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Liability, Fair Value, Gross Asset", "negatedTerseLabel": "Gross Amounts Offset in the Consolidated Balance Sheet" } } }, "localname": "DerivativeLiabilityFairValueGrossAsset", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection": { "auth_ref": [ "r68", "r72" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after effects of master netting arrangements, deduction of liabilities not subject to a master netting arrangement and elected not to be offset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, offset against the right to receive collateral.", "label": "Derivative Liability, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election", "totalLabel": "Net Amount" } } }, "localname": "DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction": { "auth_ref": [ "r66", "r72" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails": { "order": 2.0, "parentTag": "us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be offset, deducted from derivative liabilities.", "label": "Derivative Liability, Not Offset, Policy Election Deduction", "negatedLabel": "Financial Instruments" } } }, "localname": "DerivativeLiabilityNotOffsetPolicyElectionDeduction", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]", "terseLabel": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeandInterestRateRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r649", "r651" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative, Notional Amount", "terseLabel": "Notional Amount" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeandInterestRateRiskDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r648", "r650", "r651", "r655", "r656", "r664", "r668", "r673", "r676", "r680" ], "lang": { "en-us": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]", "terseLabel": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeandInterestRateRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativesFairValueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivatives, Fair Value [Line Items]", "terseLabel": "Derivatives designated as hedging instruments" } } }, "localname": "DerivativesFairValueLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r150", "r159", "r648", "r650", "r655", "r656", "r674" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives, Policy [Policy Text Block]", "terseLabel": "Derivatives" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "auth_ref": [ "r655" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Designated as Hedging Instrument [Member]", "terseLabel": "Derivatives designated as hedging instruments" } } }, "localname": "DesignatedAsHedgingInstrumentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeandInterestRateRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DevelopedTechnologyRightsMember": { "auth_ref": [ "r626" ], "lang": { "en-us": { "role": { "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.", "label": "Developed Technology Rights [Member]", "verboseLabel": "Developed technology" } } }, "localname": "DevelopedTechnologyRightsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSCASMedicalSystemsIncNarrativeDetails", "http://www.edwards.com/role/ACQUISITIONSSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.edwards.com/role/ACQUISITIONSValtechCardioLtdNarrativeDetails", "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails", "http://www.edwards.com/role/QUARTERLYFINANCIALRESTULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDNarrativeDetails", "http://www.edwards.com/role/SPECIALCHARGESGAINImpairmentofLonglivedAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DomesticCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.", "label": "Domestic Tax Authority [Member]", "terseLabel": "Federal research expenditure tax credits", "verboseLabel": "United States federal net operating losses" } } }, "localname": "DomesticCountryMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DomesticPlanMember": { "auth_ref": [ "r500", "r504", "r517" ], "lang": { "en-us": { "role": { "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Domestic Plan [Member]", "terseLabel": "Domestic Plan" } } }, "localname": "DomesticPlanMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings per share:", "verboseLabel": "Earnings per common share:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/QUARTERLYFINANCIALRESULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r105", "r176", "r177", "r178", "r179", "r180", "r184", "r187", "r192", "r193", "r194", "r197", "r198", "r789", "r814" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic (in dollars per share)", "verboseLabel": "Basic earnings per share (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/QUARTERLYFINANCIALRESULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic [Abstract]", "terseLabel": "Basic:" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r105", "r176", "r177", "r178", "r179", "r180", "r187", "r192", "r193", "r194", "r197", "r198", "r789", "r814" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted (in dollars per share)", "verboseLabel": "Diluted earnings per share (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/QUARTERLYFINANCIALRESULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted [Abstract]", "terseLabel": "Diluted:" } } }, "localname": "EarningsPerShareDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r150", "r195", "r196" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Earnings per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Effect of Cash Flow Hedges on Results of Operations [Abstract]", "terseLabel": "Gain (loss) on cash flow hedging relationships:" } } }, "localname": "EffectOfCashFlowHedgesOnResultsOfOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r706" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "terseLabel": "Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Effect of Fair Value Hedges on Results of Operations [Abstract]", "terseLabel": "Gain (loss) on fair value hedging relationships:" } } }, "localname": "EffectOfFairValueHedgesOnResultsOfOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r49" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 13.0, "parentTag": "ew_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Employee compensation and withholdings" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "terseLabel": "Allocation of stock-based compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r553" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Employee stock purchase subscriptions" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAdditionalInformationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r553" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Weighted-average remaining requisite service period" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAdditionalInformationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": { "auth_ref": [ "r552" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Expense, Tax Benefit", "negatedTerseLabel": "Income tax benefit" } } }, "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.", "label": "Employee Stock [Member]", "terseLabel": "ESPP" } } }, "localname": "EmployeeStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]", "terseLabel": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityClassOfTreasuryStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Equity, Class of Treasury Stock [Line Items]", "terseLabel": "Treasury Stock" } } }, "localname": "EquityClassOfTreasuryStockLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTreasuryStockNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r171", "r172", "r173", "r175", "r181", "r183", "r202", "r299", "r381", "r388", "r556", "r557", "r558", "r601", "r602", "r707", "r708", "r709", "r710", "r711", "r713", "r822", "r823", "r824" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/COMMONSTOCKTreasuryStockNarrativeDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Method Investment, Financial Statement, Reported Amounts [Abstract]", "terseLabel": "Equity method investments" } } }, "localname": "EquityMethodInvestmentFinancialStatementReportedAmountsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r295" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Equity method investment, ownership percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r42", "r227", "r293" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails": { "order": 1.0, "parentTag": "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "terseLabel": "Carrying value of equity method investments" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesFvNi": { "auth_ref": [ "r698" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails": { "order": 2.0, "parentTag": "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Equity Securities, FV-NI", "terseLabel": "Carrying value of non-marketable equity securities" } } }, "localname": "EquitySecuritiesFvNi", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount": { "auth_ref": [ "r291" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cumulative loss from downward price adjustment on investment in equity security without readily determinable fair value.", "label": "Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount", "terseLabel": "Decrease in non-marketable equity securities due to observable price changes" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount": { "auth_ref": [ "r291" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of impairment loss on investment in equity security without readily determinable fair value.", "label": "Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount", "terseLabel": "Impairment of equity securities" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount": { "auth_ref": [ "r292" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain from upward price adjustment on investment in equity security without readily determinable fair value.", "label": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount", "terseLabel": "Upward price adjustments" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount": { "auth_ref": [ "r292" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cumulative gain from upward price adjustment on investment in equity security without readily determinable fair value.", "label": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount", "terseLabel": "Increase in non-marketable equity securities due to observable price changes" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "auth_ref": [ "r700" ], "lang": { "en-us": { "role": { "documentation": "Measured as an estimate of fair value.", "label": "Estimate of Fair Value Measurement [Member]", "terseLabel": "Estimate of Fair Value Measurement" } } }, "localname": "EstimateOfFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r686", "r687", "r688", "r695" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r445", "r447", "r448", "r449", "r450", "r451", "r452", "r494", "r687", "r742", "r743", "r744" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSSummaryofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r694", "r695" ], "lang": { "en-us": { "role": { "documentation": "Information by class of liability.", "label": "Liability Class [Axis]", "terseLabel": "Liability Class [Axis]" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementBasisAxis": { "auth_ref": [ "r686", "r696" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement basis.", "label": "Measurement Basis [Axis]", "terseLabel": "Measurement Basis [Axis]" } } }, "localname": "FairValueByMeasurementBasisAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r686", "r687", "r690", "r691", "r697" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosureItemAmountsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.", "label": "Fair Value Measurement [Domain]", "terseLabel": "Fair Value Measurement [Domain]" } } }, "localname": "FairValueDisclosureItemAmountsDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r694" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "FAIR VALUE MEASUREMENTS" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTS" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueHedgingMember": { "auth_ref": [ "r652" ], "lang": { "en-us": { "role": { "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.", "label": "Fair Value Hedging [Member]", "terseLabel": "Fair value hedges" } } }, "localname": "FairValueHedgingMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel12And3Member": { "auth_ref": [ "r447" ], "lang": { "en-us": { "role": { "documentation": "Fair value measurement input including quoted price in active market for identical asset or liability reporting entity can access at measurement date (level 1), input other than quoted price included within level 1 either directly or indirectly observable for asset or liability (level 2) and unobservable input reflecting entity's own assumption (level 3).", "label": "Fair Value, Inputs, Level 1, 2 and 3 [Member]", "terseLabel": "Total plan assets measured at fair value" } } }, "localname": "FairValueInputsLevel12And3Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r445", "r447", "r452", "r494", "r687", "r742" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level\u00a01" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r445", "r447", "r452", "r494", "r687", "r743" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level\u00a02" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r445", "r447", "r448", "r449", "r450", "r451", "r452", "r494", "r687", "r744" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level\u00a03" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSSummaryofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations": { "auth_ref": [ "r686", "r687" ], "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of obligations measured on a recurring basis.", "label": "Obligations, Fair Value Disclosure", "terseLabel": "Contingent consideration liabilities" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisObligations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r692" ], "lang": { "en-us": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value.", "label": "Fair Value by Liability Class [Domain]", "terseLabel": "Fair Value by Liability Class [Domain]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinFairValueofContingentConsiderationObligationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r692", "r695" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r692", "r695" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Summary of Changes in Fair Value of Contingent Consideration Obligation" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember": { "auth_ref": [ "r447", "r685", "r697" ], "lang": { "en-us": { "role": { "documentation": "Fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Measured at Net Asset Value Per Share [Member]", "terseLabel": "Alternative investments measured at net asset value" } } }, "localname": "FairValueMeasuredAtNetAssetValuePerShareMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "auth_ref": [ "r693" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "negatedLabel": "Changes in fair value" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinFairValueofContingentConsiderationObligationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r692" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Fair value, end of year", "periodStartLabel": "Fair value, beginning of year" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofChangesinFairValueofContingentConsiderationObligationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r445", "r447", "r448", "r449", "r450", "r451", "r452", "r494", "r742", "r743", "r744" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSSummaryofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r694", "r697" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair Value on a Recurring Basis" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "auth_ref": [ "r657", "r664", "r677" ], "lang": { "en-us": { "role": { "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]" } } }, "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r275", "r279", "r301", "r302", "r303", "r304", "r305", "r310", "r312", "r313", "r314", "r739", "r740", "r741", "r742", "r743", "r744", "r745", "r746", "r747", "r748", "r749", "r750", "r751", "r753", "r754", "r755", "r756", "r757", "r758", "r759", "r760", "r761", "r762", "r763", "r764", "r765", "r766", "r767", "r768", "r769" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]", "terseLabel": "Financial Instrument [Axis]", "verboseLabel": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life", "terseLabel": "Weighted-Average Useful Life (in years)" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r337" ], "calculation": { "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r339" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "2021" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofEstimatedAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r339" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "terseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofEstimatedAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r339" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofEstimatedAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r339" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofEstimatedAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r339" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofEstimatedAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r330", "r334", "r337", "r341", "r772", "r773" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSCASMedicalSystemsIncNarrativeDetails", "http://www.edwards.com/role/ACQUISITIONSSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.edwards.com/role/ACQUISITIONSValtechCardioLtdNarrativeDetails", "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails", "http://www.edwards.com/role/QUARTERLYFINANCIALRESTULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDNarrativeDetails", "http://www.edwards.com/role/SPECIALCHARGESGAINImpairmentofLonglivedAssetsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESGoodwillandIntangibleAssetsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r337", "r773" ], "calculation": { "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Cost" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails", "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r330", "r336" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSCASMedicalSystemsIncNarrativeDetails", "http://www.edwards.com/role/ACQUISITIONSSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.edwards.com/role/ACQUISITIONSValtechCardioLtdNarrativeDetails", "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails", "http://www.edwards.com/role/QUARTERLYFINANCIALRESTULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDNarrativeDetails", "http://www.edwards.com/role/SPECIALCHARGESGAINImpairmentofLonglivedAssetsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESGoodwillandIntangibleAssetsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r337", "r772" ], "calculation": { "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Net Carrying Value" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Net [Abstract]", "terseLabel": "Finite-lived intangible assets" } } }, "localname": "FiniteLivedIntangibleAssetsNetAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ForeignCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.", "label": "Foreign Tax Authority [Member]", "netLabel": "Non-U.S.", "terseLabel": "Non-United States net operating losses", "verboseLabel": "Puerto Rico purchases credit" } } }, "localname": "ForeignCountryMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r702", "r703", "r704", "r705" ], "calculation": { "http://www.edwards.com/role/OTHERINCOMENETDetails": { "order": 1.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), before Tax", "negatedLabel": "Foreign exchange gains, net", "terseLabel": "Foreign currency" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERINCOMENETDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r150", "r715" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "terseLabel": "Foreign Currency Translation" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ForeignExchangeContractMember": { "auth_ref": [ "r445", "r670" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.", "label": "Foreign Exchange Contract [Member]", "terseLabel": "Foreign currency contracts" } } }, "localname": "ForeignExchangeContractMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignExchangeForwardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.", "label": "Foreign Exchange Forward [Member]", "terseLabel": "Foreign currency forward exchange contracts" } } }, "localname": "ForeignExchangeForwardMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeandInterestRateRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignGovernmentDebtSecuritiesMember": { "auth_ref": [ "r445", "r829" ], "lang": { "en-us": { "role": { "documentation": "Debt security issued by government not domiciled in United States of America (US).", "label": "Debt Security, Government, Non-US [Member]", "terseLabel": "Foreign government bonds" } } }, "localname": "ForeignGovernmentDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignPlanMember": { "auth_ref": [ "r500", "r504", "r517" ], "lang": { "en-us": { "role": { "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Foreign Plan [Member]", "terseLabel": "Foreign Plan" } } }, "localname": "ForeignPlanMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossRelatedToLitigationSettlement": { "auth_ref": [ "r361" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.", "label": "Gain (Loss) Related to Litigation Settlement", "terseLabel": "Gain (loss) on litigation settlement" } } }, "localname": "GainLossRelatedToLitigationSettlement", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNETDetails", "http://www.edwards.com/role/QUARTERLYFINANCIALRESTULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeCostsInInventoryAmountIncurred": { "auth_ref": [ "r60" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregate amount of general and administrative costs incurred in each period and charged to inventory.", "label": "General and Administrative Costs in Inventory, Amount Incurred", "terseLabel": "General and administrative costs allocated to inventory" } } }, "localname": "GeneralAndAdministrativeCostsInInventoryAmountIncurred", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInventoriesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeCostsInInventoryAmountRemaining": { "auth_ref": [ "r60" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Actual or estimated amount of general and administrative costs remaining in inventory.", "label": "General and Administrative Costs in Inventory, Amount Remaining", "terseLabel": "General and administrative costs included in inventory" } } }, "localname": "GeneralAndAdministrativeCostsInInventoryAmountRemaining", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInventoriesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeographicAreasLongLivedAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Geographic Areas, Long-Lived Assets [Abstract]", "terseLabel": "Long-lived Tangible Assets by Geographic Area" } } }, "localname": "GeographicAreasLongLivedAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r322", "r323", "r776" ], "calculation": { "http://www.edwards.com/role/ACQUISITIONSSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 }, "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "terseLabel": "Goodwill (Note\u00a09)", "verboseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAcquiredDuringPeriod": { "auth_ref": [ "r324" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.", "label": "Goodwill, Acquired During Period", "terseLabel": "Goodwill acquired during the year", "verboseLabel": "Increase to goodwill" } } }, "localname": "GoodwillAcquiredDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails", "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]", "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r344" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "terseLabel": "GOODWILL AND OTHER INTANGIBLE ASSETS" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r325" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "terseLabel": "Currency translation adjustment" } } }, "localname": "GoodwillForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]", "terseLabel": "Carrying amount of goodwill" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill [Roll Forward]", "terseLabel": "Goodwill" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r108", "r154", "r226", "r232", "r236", "r239", "r242", "r298", "r701" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "terseLabel": "Gross profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/QUARTERLYFINANCIALRESULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingDesignationAxis": { "auth_ref": [ "r655", "r672" ], "lang": { "en-us": { "role": { "documentation": "Information by designation of purpose of derivative instrument.", "label": "Hedging Designation [Axis]", "terseLabel": "Hedging Designation [Axis]" } } }, "localname": "HedgingDesignationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeandInterestRateRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationDomain": { "auth_ref": [ "r655" ], "lang": { "en-us": { "role": { "documentation": "Designation of purpose of derivative instrument.", "label": "Hedging Designation [Domain]", "terseLabel": "Hedging Designation [Domain]" } } }, "localname": "HedgingDesignationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeandInterestRateRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r655" ], "lang": { "en-us": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HeldToMaturitySecurities": { "auth_ref": [ "r261", "r270", "r785" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-maturity", "totalLabel": "Amortized Cost" } } }, "localname": "HeldToMaturitySecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]", "terseLabel": "Held-to-maturity" } } }, "localname": "HeldToMaturitySecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain": { "auth_ref": [ "r272", "r277" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": { "order": 1.0, "parentTag": "us-gaap_HeldToMaturitySecurities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrecognized gain on investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain", "terseLabel": "Gross Unrealized Gains" } } }, "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss": { "auth_ref": [ "r273", "r278" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": { "order": 2.0, "parentTag": "us-gaap_HeldToMaturitySecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss", "negatedLabel": "Gross Unrealized Losses" } } }, "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Held-to-maturity, Maturity [Abstract]", "terseLabel": "Held-to-Maturity" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Held-to-maturity, Maturity, Fair Value, Rolling Maturity [Abstract]", "terseLabel": "Fair Value" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Held-to-maturity, Maturity, Amortized Cost, Net [Abstract]", "terseLabel": "Amortized Cost" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 1.0, "parentTag": "us-gaap_HeldToMaturitySecuritiesFairValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value", "terseLabel": "Due in 1\u00a0year or less" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 2.0, "parentTag": "us-gaap_HeldToMaturitySecuritiesFairValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in second through fifth rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value", "terseLabel": "Due after 1\u00a0year through 5\u00a0years" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": { "auth_ref": [ "r274", "r280" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 3.0, "parentTag": "us-gaap_HeldToMaturitySecuritiesFairValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), without single maturity date and not allocated over maturity grouping.", "label": "Debt Securities, Held-to-maturity, Maturity, without Single Maturity Date, Fair Value", "terseLabel": "Instruments not due at a single maturity date" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount": { "auth_ref": [ "r274" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 3.0, "parentTag": "us-gaap_HeldToMaturitySecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at amortized cost (held-to-maturity), without single maturity date and not allocated over maturity grouping.", "label": "Debt Securities, Held-to-maturity, Maturity, without Single Maturity Date, Amortized Cost", "terseLabel": "Instruments not due at a single maturity date" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesFairValue": { "auth_ref": [ "r271", "r276", "r785" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": { "order": 3.0, "parentTag": "us-gaap_HeldToMaturitySecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-maturity, Fair Value", "terseLabel": "Fair Value", "totalLabel": "Total" } } }, "localname": "HeldToMaturitySecuritiesFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 1.0, "parentTag": "us-gaap_HeldToMaturitySecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost", "terseLabel": "Due in 1\u00a0year or less" } } }, "localname": "HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 2.0, "parentTag": "us-gaap_HeldToMaturitySecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in second through fifth rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost", "terseLabel": "Due after 1\u00a0year through 5\u00a0years" } } }, "localname": "HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": { "auth_ref": [ "r140", "r342" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.", "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)", "terseLabel": "Impairment of intangible assets" } } }, "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSValtechCardioLtdNarrativeDetails", "http://www.edwards.com/role/QUARTERLYFINANCIALRESTULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDNarrativeDetails", "http://www.edwards.com/role/SPECIALCHARGESGAINImpairmentofLonglivedAssetsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESGoodwillandIntangibleAssetsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfInvestments": { "auth_ref": [ "r263" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.", "label": "Other than Temporary Impairment Losses, Investments", "terseLabel": "Impairment charges (Note 4)" } } }, "localname": "ImpairmentOfInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.", "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Impairment of Goodwill and Long-lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InProcessResearchAndDevelopmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.", "label": "In Process Research and Development [Member]", "verboseLabel": "In-process research and development" } } }, "localname": "InProcessResearchAndDevelopmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESGoodwillandIntangibleAssetsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "auth_ref": [ "r157", "r608" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofIncomeBeforeProvisionsforIncomeTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic", "terseLabel": "United States" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofIncomeBeforeProvisionsforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "auth_ref": [ "r157", "r608" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofIncomeBeforeProvisionsforIncomeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign", "terseLabel": "International, including Puerto Rico" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofIncomeBeforeProvisionsforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r157", "r226", "r232", "r236", "r239", "r242" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 }, "http://www.edwards.com/role/INCOMETAXESScheduleofIncomeBeforeProvisionsforIncomeTaxesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest", "terseLabel": "Segment Operating Income", "totalLabel": "Income before provision for income taxes", "verboseLabel": "Consolidated pre-tax income" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/INCOMETAXESScheduleofIncomeBeforeProvisionsforIncomeTaxesDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationAboutReportableSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]", "terseLabel": "Pre-tax Income Reconciliation" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r349" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails", "http://www.edwards.com/role/INVESTMENTSNarrativeDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails", "http://www.edwards.com/role/INVESTMENTSNarrativeDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r578" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]", "terseLabel": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r574", "r586", "r593", "r603", "r609", "r613", "r614", "r617" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXES" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r155", "r182", "r183", "r224", "r572", "r604", "r611", "r816" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 }, "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Provision for income taxes", "terseLabel": "Provision for income taxes (Note\u00a017)", "totalLabel": "Total income tax provision" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/INCOMETAXESProvisionforIncomeTaxesDetails", "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxHolidayAggregateDollarAmount": { "auth_ref": [ "r609" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of income taxes from which a reporting entity is exempt or for which it will receive a reduction in income taxes as a result of the income tax holiday granted by the taxing jurisdiction.", "label": "Income Tax Holiday, Aggregate Dollar Amount", "terseLabel": "Tax reductions compared to local statutory rates" } } }, "localname": "IncomeTaxHolidayAggregateDollarAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare": { "auth_ref": [ "r609" ], "lang": { "en-us": { "role": { "documentation": "Per share amount effect of the income tax benefit resulting from the income tax holidays granted by taxing jurisdictions.", "label": "Income Tax Holiday, Income Tax Benefits Per Share", "terseLabel": "Tax reductions compared to local statutory rates per diluted share (in dollars per share)" } } }, "localname": "IncomeTaxHolidayIncomeTaxBenefitsPerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r99", "r150", "r568", "r569", "r586", "r587", "r592", "r600", "r833" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationDeductions": { "auth_ref": [ "r573" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 8.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations attributable to deduction. Includes, but is not limited to, dividend deduction, deduction for dividend paid to employee stock ownership plan (ESOP), Medicare prescription drug benefit subsidy deduction, and other deductions.", "label": "Effective Income Tax Rate Reconciliation, Deduction, Amount", "negatedTerseLabel": "Foreign-derived intangible income deduction" } } }, "localname": "IncomeTaxReconciliationDeductions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": { "auth_ref": [ "r573" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount", "terseLabel": "Foreign income taxed at different rates" } } }, "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r573" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount", "terseLabel": "Income tax expense at U.S. federal statutory rate" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": { "auth_ref": [ "r573" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 10.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount", "terseLabel": "Nondeductible employee share-based compensation" } } }, "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationOtherAdjustments": { "auth_ref": [ "r573" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 12.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount", "terseLabel": "Other" } } }, "localname": "IncomeTaxReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes": { "auth_ref": [ "r573" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 5.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount", "terseLabel": "Build (release) of reserve for prior years' uncertain tax positions" } } }, "localname": "IncomeTaxReconciliationPriorYearIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r573" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 3.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount", "terseLabel": "State and local taxes, net of federal tax benefit" } } }, "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationTaxCredits": { "auth_ref": [ "r573" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 4.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Amount", "negatedLabel": "Tax credits, federal and state" } } }, "localname": "IncomeTaxReconciliationTaxCredits", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r136", "r144" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "verboseLabel": "Income taxes" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables": { "auth_ref": [ "r139" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.", "label": "Increase (Decrease) in Accounts and Other Receivables", "negatedLabel": "Accounts and other receivables, net" } } }, "localname": "IncreaseDecreaseInAccountsAndOtherReceivables", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r139" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "auth_ref": [ "r139" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.", "label": "Increase (Decrease) in Income Taxes Payable", "terseLabel": "Income taxes" } } }, "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": { "auth_ref": [ "r139" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.", "label": "Increase (Decrease) in Deferred Income Taxes", "negatedLabel": "Deferred income taxes" } } }, "localname": "IncreaseDecreaseInDeferredIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r139" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInNotesReceivables": { "auth_ref": [ "r139" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period of the amounts due from borrowers for outstanding secured or unsecured loans evidenced by a note.", "label": "Increase (Decrease) in Notes Receivables", "negatedTerseLabel": "Issuances of notes receivable" } } }, "localname": "IncreaseDecreaseInNotesReceivables", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": { "auth_ref": [ "r139" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net", "negatedLabel": "Other" } } }, "localname": "IncreaseDecreaseInOtherOperatingCapitalNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r139" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r188", "r189", "r190", "r194" ], "calculation": { "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements", "terseLabel": "Dilutive effect of stock plans (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r332", "r340" ], "lang": { "en-us": { "role": { "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets [Axis]", "terseLabel": "Indefinite-lived Intangible Assets [Axis]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Indefinite-lived Intangible Assets [Line Items]", "terseLabel": "Indefinite-lived Intangible Assets [Line Items]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails", "http://www.edwards.com/role/SPECIALCHARGESGAINImpairmentofLonglivedAssetsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESGoodwillandIntangibleAssetsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r340" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)", "terseLabel": "In-process research and development" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Indefinite-lived Intangible Assets (Excluding Goodwill) [Abstract]", "terseLabel": "Indefinite-lived intangible assets" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r332", "r340" ], "lang": { "en-us": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.", "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.", "label": "Intangible Assets, Gross (Excluding Goodwill)", "terseLabel": "Cost" } } }, "localname": "IntangibleAssetsGrossExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r328", "r335" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Other intangible assets, net (Note\u00a09)", "totalLabel": "Net Carrying Value" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r101", "r220", "r716", "r719", "r790" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "verboseLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which reported facts about interest income have been included.", "label": "Interest Income [Member]", "terseLabel": "Interest expense" } } }, "localname": "InterestIncomeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r133", "r135", "r144" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "verboseLabel": "Interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r37", "r318" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Finished products" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r3", "r59" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories (Note\u00a05)", "totalLabel": "Total inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory, Net [Abstract]", "verboseLabel": "Inventories" } } }, "localname": "InventoryNetAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r15", "r60", "r150", "r199", "r315", "r317", "r319" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "auth_ref": [ "r39", "r318" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.", "label": "Inventory, Raw Materials, Net of Reserves", "terseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterialsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r38", "r318" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Inventory, Work in Process, Net of Reserves", "terseLabel": "Work in process" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWriteDown": { "auth_ref": [ "r316" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.", "label": "Inventory Write-down", "terseLabel": "Inventory write off" } } }, "localname": "InventoryWriteDown", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSNarrativeDetails", "http://www.edwards.com/role/QUARTERLYFINANCIALRESTULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r112", "r219" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "negatedLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentPolicyTextBlock": { "auth_ref": [ "r296", "r815" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment in financial asset.", "label": "Investment, Policy [Policy Text Block]", "terseLabel": "Investments" } } }, "localname": "InvestmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentsAllOtherInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments, All Other Investments [Abstract]", "terseLabel": "Equity securities" } } }, "localname": "InvestmentsAllOtherInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.", "label": "Investments Classified by Contractual Maturity Date [Table Text Block]", "terseLabel": "Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity" } } }, "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments, Debt and Equity Securities [Abstract]", "terseLabel": "Investments, Debt and Equity Securities [Abstract]" } } }, "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": { "auth_ref": [ "r42" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.", "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures", "totalLabel": "Total investments in unconsolidated affiliates" } } }, "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": { "auth_ref": [ "r290", "r774", "r795", "r830" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for investments in certain debt and equity securities.", "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]", "verboseLabel": "INVESTMENTS" } } }, "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTS" ], "xbrltype": "textBlockItemType" }, "us-gaap_Land": { "auth_ref": [ "r10", "r44" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.", "label": "Land", "terseLabel": "Land" } } }, "localname": "Land", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]", "terseLabel": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_LegalMattersAndContingenciesTextBlock": { "auth_ref": [ "r369" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.", "label": "Legal Matters and Contingencies [Text Block]", "verboseLabel": "INTELLECTUAL PROPERTY LITIGATION EXPENSES, NET" } } }, "localname": "LegalMattersAndContingenciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNET" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]", "terseLabel": "Lessee, Lease, Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/LEASESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r727" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]", "terseLabel": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/LEASESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r724" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee, Leases [Policy Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseDiscountRate": { "auth_ref": [ "r726" ], "lang": { "en-us": { "role": { "documentation": "Discount rate used by lessee to determine present value of operating lease payments.", "label": "Lessee, Operating Lease, Discount Rate", "terseLabel": "Weighted-average discount rate" } } }, "localname": "LesseeOperatingLeaseDiscountRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r732" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Lessee, Operating Lease, Liability, Maturity" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/LEASESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r732" ], "calculation": { "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r732" ], "calculation": { "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r732" ], "calculation": { "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2021" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r732" ], "calculation": { "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r732" ], "calculation": { "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r732" ], "calculation": { "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r732" ], "calculation": { "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r732" ], "calculation": { "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails_1": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less: imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "auth_ref": [ "r725" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Term of Contract", "terseLabel": "Lease term" } } }, "localname": "LesseeOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/LEASESNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r734" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "LEASES" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/LEASES" ], "xbrltype": "textBlockItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r35", "r154", "r298", "r701", "r782", "r809" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders' equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r50", "r154", "r298", "r642", "r646", "r647", "r701" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [ "r686" ], "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial and nonfinancial obligations.", "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure", "totalLabel": "Total liabilities" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Fair Value Disclosure [Abstract]", "terseLabel": "Liabilities" } } }, "localname": "LiabilitiesFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent": { "auth_ref": [ "r53" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for uncertainty in income taxes classified as noncurrent.", "label": "Liability for Uncertainty in Income Taxes, Noncurrent", "terseLabel": "Uncertain tax positions (Note 17)" } } }, "localname": "LiabilityForUncertainTaxPositionsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r23", "r781", "r800" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-term Line of Credit", "terseLabel": "Borrowings outstanding" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.", "label": "Line of Credit Facility, Commitment Fee Percentage", "terseLabel": "Facility fee (as a percent)" } } }, "localname": "LineOfCreditFacilityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r48" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "verboseLabel": "Aggregate borrowings in multiple currencies" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]", "terseLabel": "Credit Facility" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LitigationReserveCurrent": { "auth_ref": [ "r54", "r361", "r368" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 4.0, "parentTag": "ew_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.", "label": "Estimated Litigation Liability, Current", "terseLabel": "Litigation settlement (Notes 3 and 18)" } } }, "localname": "LitigationReserveCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LitigationReserveNoncurrent": { "auth_ref": [ "r54", "r361" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.", "label": "Estimated Litigation Liability, Noncurrent", "terseLabel": "Litigation settlement (Notes 3 and 18)" } } }, "localname": "LitigationReserveNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LitigationSettlementExpense": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 4.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.", "label": "Litigation Settlement, Expense", "terseLabel": "Intellectual property litigation expenses, net (Note 3)", "verboseLabel": "Intellectual property litigation expenses" } } }, "localname": "LitigationSettlementExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNETDetails", "http://www.edwards.com/role/LEGALPROCEEDINGSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LondonInterbankOfferedRateLIBORMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.", "label": "London Interbank Offered Rate (LIBOR) [Member]", "terseLabel": "LIBOR" } } }, "localname": "LondonInterbankOfferedRateLIBORMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r23", "r375", "r781", "r805" ], "calculation": { "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt", "totalLabel": "Total carrying amount" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r52" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Excluding Current Maturities", "terseLabel": "Long-term debt (Note\u00a010)" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermInvestments": { "auth_ref": [ "r42" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).", "label": "Long-term Investments", "terseLabel": "Long-term investments (Note\u00a07)" } } }, "localname": "LongTermInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r52" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r52", "r373" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongtermDebtWeightedAverageInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.", "label": "Long-term Debt, Weighted Average Interest Rate, at Point in Time", "terseLabel": "Weighted-average interest rate under all debt obligations (as a percent)" } } }, "localname": "LongtermDebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]", "terseLabel": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNETDetails", "http://www.edwards.com/role/LEGALPROCEEDINGSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r370", "r371" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]", "terseLabel": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNETDetails", "http://www.edwards.com/role/LEGALPROCEEDINGSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MachineryAndEquipmentGross": { "auth_ref": [ "r11", "r346" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 3.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment, Gross", "terseLabel": "Machinery and equipment" } } }, "localname": "MachineryAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]", "terseLabel": "Machinery and equipment" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MaterialReconcilingItemsMember": { "auth_ref": [ "r236" ], "lang": { "en-us": { "role": { "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.", "label": "Segment Reconciling Items [Member]", "terseLabel": "Segment reconciling items" } } }, "localname": "MaterialReconcilingItemsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge": { "auth_ref": [ "r682" ], "lang": { "en-us": { "role": { "documentation": "Maximum period of time the entity is hedging its exposure to variability in future cash flows for forecasted transactions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Excludes forecasted transactions related to payment of variable interest on existing financial instruments.", "label": "Maximum Length of Time, Foreign Currency Cash Flow Hedge", "terseLabel": "Period when cash flows associated with future transactions and certain local currency expenses are expected to occur" } } }, "localname": "MaximumLengthOfTimeForeignCurrencyCashFlowHedge", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDerivativesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_MeasurementInputDiscountRateMember": { "auth_ref": [ "r689" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate to determine present value of future cash flows.", "label": "Measurement Input, Discount Rate [Member]", "terseLabel": "Measurement Input, Discount Rate" } } }, "localname": "MeasurementInputDiscountRateMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r689" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]", "terseLabel": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]", "terseLabel": "Measurement Input Type [Domain]" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MortgagesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A loan to finance the purchase of real estate where the lender has a lien on the property as collateral for the loan.", "label": "Mortgages [Member]", "terseLabel": "Mortgages" } } }, "localname": "MortgagesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MovementInValuationAllowancesAndReservesRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]", "terseLabel": "Movement in Valuation Allowances and Reserves" } } }, "localname": "MovementInValuationAllowancesAndReservesRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MunicipalBondsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long-term debt securities issued by state, city or local governments or the agencies operated by state, city or local governments.", "label": "Municipal Bonds [Member]", "terseLabel": "Municipal securities" } } }, "localname": "MunicipalBondsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r205", "r213" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "Nature of Operations [Text Block]", "terseLabel": "DESCRIPTION OF BUSINESS" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DESCRIPTIONOFBUSINESS" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r134" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash used in financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]", "terseLabel": "Cash flows from financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r134" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash (used in) provided by investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]", "terseLabel": "Cash flows from investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r134", "r138", "r141" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]", "terseLabel": "Cash flows from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r176", "r177", "r178", "r179", "r184", "r185", "r191", "r194", "r226", "r232", "r236", "r239", "r242" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 }, "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "terseLabel": "Net income", "totalLabel": "Net income" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.edwards.com/role/QUARTERLYFINANCIALRESULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentHedgingMember": { "auth_ref": [ "r654" ], "lang": { "en-us": { "role": { "documentation": "Hedges of a net investment in a foreign operation.", "label": "Net Investment Hedging [Member]", "terseLabel": "Net investment hedges" } } }, "localname": "NetInvestmentHedgingMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent": { "auth_ref": [ "r420" ], "calculation": { "http://www.edwards.com/role/OTHERINCOMENETDetails": { "order": 3.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits.", "label": "Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component", "terseLabel": "Non-service cost components of net periodic pension benefit cost (credit)" } } }, "localname": "NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERINCOMENETDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recently Adopted Accounting Standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonUsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Countries excluding the United States of America (US).", "label": "Non-US [Member]", "terseLabel": "International" } } }, "localname": "NonUsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NoncurrentAssets": { "auth_ref": [ "r247" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.", "label": "Long-Lived Assets", "terseLabel": "Long-lived tangible assets" } } }, "localname": "NoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NondesignatedMember": { "auth_ref": [ "r655" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Not Designated as Hedging Instrument [Member]", "verboseLabel": "Derivatives not designated as hedging instruments" } } }, "localname": "NondesignatedMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r113" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "terseLabel": "Non-operating income" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ObligationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The carrying values as of the balance sheet date of all debt, including all short-term borrowings, long-term debt, and capital lease obligations.", "label": "Obligations [Member]", "terseLabel": "Obligations" } } }, "localname": "ObligationsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent": { "auth_ref": [ "r91" ], "calculation": { "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent.", "label": "OCI, before Reclassifications, before Tax, Attributable to Parent", "terseLabel": "Other comprehensive (loss) income before reclassifications", "verboseLabel": "Prior service credit arising during period" } } }, "localname": "OciBeforeReclassificationsBeforeTaxAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OffsettingAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Offsetting Assets [Line Items]", "terseLabel": "Offsetting Assets [Line Items]" } } }, "localname": "OffsettingAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OffsettingAssetsTable": { "auth_ref": [ "r69", "r70" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements.", "label": "Offsetting Assets [Table]", "terseLabel": "Offsetting Assets [Table]" } } }, "localname": "OffsettingAssetsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OffsettingAssetsTableTextBlock": { "auth_ref": [ "r69", "r70" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of derivative and other financial assets that are subject to offsetting, including master netting arrangements.", "label": "Offsetting Assets [Table Text Block]", "terseLabel": "Schedule of Effect of Master-Netting Agreements and Rights of Offset, Assets" } } }, "localname": "OffsettingAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OffsettingDerivativeAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Offsetting Derivative Assets [Abstract]", "terseLabel": "Derivative Assets" } } }, "localname": "OffsettingDerivativeAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OffsettingDerivativeLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Offsetting Derivative Liabilities [Abstract]", "terseLabel": "Derivative Liabilities" } } }, "localname": "OffsettingDerivativeLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OffsettingLiabilitiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Offsetting Liabilities [Line Items]", "terseLabel": "Offsetting Liabilities [Line Items]" } } }, "localname": "OffsettingLiabilitiesLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OffsettingLiabilitiesTable": { "auth_ref": [ "r69", "r70" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about derivative and financial liabilities that are subject to offsetting, including enforceable master netting arrangements.", "label": "Offsetting Liabilities [Table]", "terseLabel": "Offsetting Liabilities [Table]" } } }, "localname": "OffsettingLiabilitiesTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OffsettingLiabilitiesTableTextBlock": { "auth_ref": [ "r69", "r70" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of derivative and other financial liabilities that are subject to offsetting, including master netting arrangements.", "label": "Offsetting Liabilities [Table Text Block]", "terseLabel": "Schedule of Effect of Master-Netting Agreements and Rights of Offset, Liabilities" } } }, "localname": "OffsettingLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r226", "r232", "r236", "r239", "r242" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "terseLabel": "Operating income", "totalLabel": "Operating income" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r728", "r733" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "terseLabel": "Operating lease cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/LEASESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r722" ], "calculation": { "http://www.edwards.com/role/LEASESAssetsandLiabilitiesofOperatingLeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails_1": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "totalLabel": "Total operating lease liabilities", "verboseLabel": "Total lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/LEASESAssetsandLiabilitiesofOperatingLeasesDetails", "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r722" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.edwards.com/role/LEASESAssetsandLiabilitiesofOperatingLeasesDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Operating lease liabilities, current portion", "verboseLabel": "Operating lease liabilities (Note 6)" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.edwards.com/role/LEASESAssetsandLiabilitiesofOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r722" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 }, "http://www.edwards.com/role/LEASESAssetsandLiabilitiesofOperatingLeasesDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease liabilities, long-term portion", "verboseLabel": "Operating lease liabilities (Note 6)" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.edwards.com/role/LEASESAssetsandLiabilitiesofOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r723", "r729" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Operating cash flows from operating leases" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r721" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use assets", "verboseLabel": "Operating lease right-of-use assets (Note 6)" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.edwards.com/role/LEASESAssetsandLiabilitiesofOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r731", "r733" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted-average remaining lease term (in years)" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r594" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards", "terseLabel": "Carryforward Amount" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Operating Loss Carryforwards [Line Items]", "terseLabel": "Operating Loss Carryforwards [Line Items]" } } }, "localname": "OperatingLossCarryforwardsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsTable": { "auth_ref": [ "r595" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "Operating Loss Carryforwards [Table]", "terseLabel": "Operating Loss Carryforwards [Table]" } } }, "localname": "OperatingLossCarryforwardsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsValuationAllowance": { "auth_ref": [ "r590" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails": { "order": 2.0, "parentTag": "ew_DeferredTaxAssetsOperatingLossCarryforwardsNetOfValuationAllowance", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.", "label": "Operating Loss Carryforwards, Valuation Allowance", "negatedLabel": "Valuation Allowance" } } }, "localname": "OperatingLossCarryforwardsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r231", "r232", "r233", "r234", "r236", "r242" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationAboutReportableSegmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r12", "r13", "r14", "r49" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 12.0, "parentTag": "ew_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Other accrued liabilities" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r61" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 7.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r46" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": { "auth_ref": [ "r91", "r100", "r707", "r709", "r713" ], "calculation": { "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeOtherNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax", "totalLabel": "Prior service credit arising during period" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": { "auth_ref": [ "r89" ], "calculation": { "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax", "negatedLabel": "Prior service credit arising during period" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeTax": { "auth_ref": [ "r103", "r294", "r707", "r712", "r713", "r787", "r812" ], "calculation": { "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails_1": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeOtherNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Tax", "totalLabel": "Other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), before Tax [Abstract]", "terseLabel": "Pre-Tax Amount" } } }, "localname": "OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": { "auth_ref": [ "r78", "r88" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax", "terseLabel": "Unrealized (loss) gain on hedges" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": { "auth_ref": [ "r78", "r88", "r660", "r665", "r678" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax", "terseLabel": "Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": { "auth_ref": [ "r88", "r92" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax", "terseLabel": "Amount of gain (loss) reclassified from accumulated OCI into income" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": { "auth_ref": [ "r88", "r92", "r666" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax", "terseLabel": "Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax": { "auth_ref": [ "r79", "r88", "r92", "r667" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.", "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax", "terseLabel": "Amount excluded from effectiveness testing recognized in earnings based on an amortization approach" } } }, "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r76" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Foreign currency translation adjustments" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": { "auth_ref": [ "r669" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.", "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax", "terseLabel": "Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)" } } }, "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "verboseLabel": "Net of Tax Amount" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r95", "r97", "r639", "r640", "r644" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "terseLabel": "Other comprehensive income (loss), net of tax", "totalLabel": "Other comprehensive (loss) income, net of tax" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]", "terseLabel": "Other comprehensive (loss) income, net of tax (Note\u00a015):" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "auth_ref": [ "r85", "r88" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "negatedLabel": "Unrealized pension costs" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax": { "auth_ref": [ "r88", "r92", "r93", "r289" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 5.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.", "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax", "negatedTerseLabel": "Reclassification of net realized investment loss to earnings" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossTax": { "auth_ref": [ "r89", "r103", "r572", "r610", "r612", "r707", "r710", "r713", "r787", "r812" ], "calculation": { "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails_1": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeOtherNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Tax", "negatedTotalLabel": "Other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeLossTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Tax [Abstract]", "terseLabel": "Tax (Expense) Benefit" } } }, "localname": "OtherComprehensiveIncomeLossTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1": { "auth_ref": [ "r639", "r640", "r644" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent", "negatedLabel": "Deferred income tax expense" } } }, "localname": "OtherComprehensiveIncomeLossTaxPortionAttributableToParent1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeOtherNetOfTax": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in other comprehensive income, after tax, from changes classified as other.", "label": "Other Comprehensive Income, Other, Net of Tax", "totalLabel": "Other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeOtherNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "auth_ref": [ "r80", "r88" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 4.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax", "terseLabel": "Unrealized gain (loss) on available-for-sale investments" } } }, "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCurrentAssetsMember": { "auth_ref": [ "r657", "r677" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other current assets.", "label": "Other Current Assets [Member]", "terseLabel": "Other current assets" } } }, "localname": "OtherCurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherIncomeAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Income and Expenses [Abstract]", "terseLabel": "Other Income and Expenses [Abstract]" } } }, "localname": "OtherIncomeAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": { "auth_ref": [ "r415", "r564" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.", "label": "Other Income and Other Expense Disclosure [Text Block]", "terseLabel": "OTHER INCOME, NET" } } }, "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERINCOMENET" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intangible assets classified as other.", "label": "Other Intangible Assets [Member]", "terseLabel": "Other" } } }, "localname": "OtherIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment": { "auth_ref": [ "r40" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount of inventory owned by the entity but in the hands of a customer, typically a reseller.", "label": "Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross", "terseLabel": "Finished goods inventories held on consignment" } } }, "localname": "OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInventoriesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherInvestmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other investments.", "label": "Other Investments [Member]", "verboseLabel": "Other" } } }, "localname": "OtherInvestmentsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r53" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 8.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other long-term liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r141" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income (Expense)", "negatedLabel": "Other" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncurrentAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent assets.", "label": "Other Noncurrent Assets [Member]", "terseLabel": "Other assets" } } }, "localname": "OtherNoncurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNoncurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.", "label": "Other Noncurrent Liabilities [Member]", "terseLabel": "Other long-term liabilities" } } }, "localname": "OtherNoncurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r114" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 5.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 }, "http://www.edwards.com/role/OTHERINCOMENETDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "negatedLabel": "Other income, net (Note\u00a016)", "negatedTotalLabel": "Total other income, net", "terseLabel": "Other income, net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails", "http://www.edwards.com/role/OTHERINCOMENETDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).", "label": "Other Nonoperating Income (Expense) [Member]", "terseLabel": "Other income, net" } } }, "localname": "OtherNonoperatingIncomeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails", "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNonrecurringIncomeExpense": { "auth_ref": [ "r115" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 6.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other expense (income) that is infrequent in occurrence or unusual in nature.", "label": "Other Nonrecurring (Income) Expense", "negatedLabel": "Special charges", "terseLabel": "Special charges (Note\u00a04)" } } }, "localname": "OtherNonrecurringIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherOperatingIncomeExpenseNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.", "label": "Other Operating Income (Expense), Net", "terseLabel": "Other income, net" } } }, "localname": "OtherOperatingIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherPaymentsToAcquireBusinesses": { "auth_ref": [ "r123" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with other payments to acquire businesses including deposit on pending acquisitions and preacquisition costs.", "label": "Other Payments to Acquire Businesses", "negatedTerseLabel": "Payment for acquisition option" } } }, "localname": "OtherPaymentsToAcquireBusinesses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherReceivables": { "auth_ref": [ "r61" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from parties in nontrade transactions, classified as other.", "label": "Other Receivables", "terseLabel": "Other receivables" } } }, "localname": "OtherReceivables", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PatentsMember": { "auth_ref": [ "r626" ], "lang": { "en-us": { "role": { "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.", "label": "Patents [Member]", "verboseLabel": "Patents" } } }, "localname": "PatentsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": { "auth_ref": [ "r131" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.", "label": "Payment for Contingent Consideration Liability, Financing Activities", "negatedTerseLabel": "Payment of contingent consideration" } } }, "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForLegalSettlements": { "auth_ref": [ "r137" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.", "label": "Payments for Legal Settlements", "terseLabel": "Payments for Legal Settlements" } } }, "localname": "PaymentsForLegalSettlements", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNETDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "auth_ref": [ "r121", "r125", "r160" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.", "label": "Payments for (Proceeds from) Other Investing Activities", "negatedLabel": "Other" } } }, "localname": "PaymentsForProceedsFromOtherInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r129" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Purchases of treasury stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries": { "auth_ref": [ "r123" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of noncontrolling interest during the period.", "label": "Payments to Acquire Additional Interest in Subsidiaries", "terseLabel": "Cash previously paid for cost method investment" } } }, "localname": "PaymentsToAcquireAdditionalInterestInSubsidiaries", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSHarpoonMedicalIncNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": { "auth_ref": [ "r118", "r122", "r262" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Payments to Acquire Debt Securities, Available-for-sale", "negatedLabel": "Purchases of available-for-sale investments (Note\u00a07)" } } }, "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r123", "r633" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "negatedLabel": "Acquisition (Notes\u00a08 and 9)", "terseLabel": "Cash paid to acquire business", "verboseLabel": "Cash purchase price subject to certain adjustments" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSCardiAQValveTechnologiesIncNarrativeDetails", "http://www.edwards.com/role/ACQUISITIONSValtechCardioLtdNarrativeDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r123" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "terseLabel": "Total purchase price, net of cash acquired" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireHeldToMaturitySecurities": { "auth_ref": [ "r122", "r262" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow through purchase of long-term held-to-maturity securities.", "label": "Payments to Acquire Held-to-maturity Securities", "negatedLabel": "Purchases of held-to-maturity investments (Note\u00a07)" } } }, "localname": "PaymentsToAcquireHeldToMaturitySecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r124" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedTerseLabel": "Investments in intangible assets and in-process research and development" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r124" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Capital expenditures" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "auth_ref": [ "r444", "r446", "r452", "r471", "r473", "r474", "r475", "r476", "r477", "r494", "r496", "r497", "r499", "r519" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for retirement benefits.", "label": "Retirement Benefits [Text Block]", "terseLabel": "EMPLOYEE BENEFIT PLANS" } } }, "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANS" ], "xbrltype": "textBlockItemType" }, "us-gaap_PensionPlansDefinedBenefitMember": { "auth_ref": [ "r416", "r418", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r444", "r445", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r467", "r469", "r470", "r472", "r475", "r479", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r499", "r500", "r514", "r515", "r516", "r517" ], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.", "label": "Pension Plan [Member]", "terseLabel": "Defined benefit pension plans" } } }, "localname": "PensionPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSSummaryofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details", "http://www.edwards.com/role/SPECIALCHARGESGAINRealignmentExpensesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PlanAssetCategoriesDomain": { "auth_ref": [ "r444", "r445", "r447", "r448", "r449", "r450", "r451", "r452", "r472", "r494" ], "lang": { "en-us": { "role": { "documentation": "Defined benefit plan asset investment.", "label": "Defined Benefit Plan, Plan Assets, Category [Domain]", "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]" } } }, "localname": "PlanAssetCategoriesDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSSummaryofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details" ], "xbrltype": "domainItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r524", "r554" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "auth_ref": [ "r699" ], "lang": { "en-us": { "role": { "documentation": "Measured at fair value for financial reporting purposes.", "label": "Portion at Fair Value Measurement [Member]", "terseLabel": "Portion at Fair Value Measurement" } } }, "localname": "PortionAtFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, authorized shares (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r27" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "verboseLabel": "Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r5", "r7", "r320", "r321" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates": { "auth_ref": [ "r120" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from the sale of a business segment or subsidiary or sale of an entity that is related to it but not strictly controlled during the period (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).", "label": "Proceeds from Divestiture of Businesses and Interests in Affiliates", "terseLabel": "Net proceeds from sale of previous ownership" } } }, "localname": "ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSHarpoonMedicalIncNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r127" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds from Issuance of Long-term Debt", "verboseLabel": "Proceeds from issuance of debt" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "auth_ref": [ "r128", "r132", "r160" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.", "label": "Proceeds from (Payments for) Other Financing Activities", "terseLabel": "Other" } } }, "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": { "auth_ref": [ "r118", "r119", "r262" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Proceeds from Sale and Maturity of Debt Securities, Available-for-sale", "terseLabel": "Proceeds from sales and maturities of available-for-sale investments (Note\u00a07)" } } }, "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities": { "auth_ref": [ "r119", "r262" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from the sale or maturity of long-term held-to-maturity securities.", "label": "Proceeds from Sale and Maturity of Held-to-maturity Securities", "terseLabel": "Proceeds from sales and maturities of held-to-maturity investments (Note\u00a07)" } } }, "localname": "ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r126", "r555" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Cash from exercises of stock options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAdditionalInformationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockPlans": { "auth_ref": [ "r126" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from the stock plan during the period.", "label": "Proceeds from Stock Plans", "terseLabel": "Proceeds from stock plans" } } }, "localname": "ProceedsFromStockPlans", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]", "terseLabel": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESShippingandHandlingCostsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r45", "r348" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r44", "r346" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "totalLabel": "Total property, plant and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r17", "r18", "r348", "r810" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property, plant, and equipment, net (Note\u00a05)", "totalLabel": "Total property, plant and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Net [Abstract]", "terseLabel": "Property, plant, and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNetAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r43", "r150", "r348", "r834", "r835" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r17", "r346" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Long-Lived Tangible Asset [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Estimated useful life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Quarterly Financial Information Disclosure [Abstract]", "terseLabel": "Quarterly Financial Information Disclosure [Abstract]" } } }, "localname": "QuarterlyFinancialInformationDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_QuarterlyFinancialInformationTextBlock": { "auth_ref": [ "r201" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.", "label": "Quarterly Financial Information [Text Block]", "terseLabel": "QUARTERLY FINANCIAL RESULTS AND MARKET FOR THE COMPANY'S STOCK (UNAUDITED)" } } }, "localname": "QuarterlyFinancialInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/QUARTERLYFINANCIALRESULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITED" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]", "terseLabel": "Amounts reclassified from accumulated other comprehensive loss to affected line on Consolidated Statements of Operations" } } }, "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": { "auth_ref": [ "r91", "r94", "r707", "r711", "r713" ], "calculation": { "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax", "negatedLabel": "Amortization of prior service credit" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": { "auth_ref": [ "r91", "r94", "r100", "r707", "r711", "r713" ], "calculation": { "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeOtherNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax", "negatedTotalLabel": "Amortization of prior service credit" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent": { "auth_ref": [ "r91" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.", "label": "Reclassification from AOCI, Current Period, before Tax, Attributable to Parent", "negatedLabel": "Amounts reclassified from accumulated other comprehensive loss" } } }, "localname": "ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAociCurrentPeriodTax": { "auth_ref": [ "r89", "r93" ], "calculation": { "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails": { "order": 2.0, "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).", "label": "Reclassification from AOCI, Current Period, Tax", "terseLabel": "Amortization of prior service credit" } } }, "localname": "ReclassificationFromAociCurrentPeriodTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]", "terseLabel": "Amount Reclassified from Accumulated Other Comprehensive Loss" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]", "terseLabel": "Schedule of Information About Amounts Reclassified from Accumulated Other Comprehensive Loss" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]", "terseLabel": "Unallocated amounts:" } } }, "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]", "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns" } } }, "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofBeginningandEndingAmountofUncertainTaxPositionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities": { "auth_ref": [ "r130" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation.", "label": "Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security", "negatedTerseLabel": "Payments on debt and finance lease obligations" } } }, "localname": "RepaymentsOfLongTermDebtAndCapitalSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff": { "auth_ref": [ "r333" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of the write-off for research and development assets that were acquired in a transaction other than a business combination.", "label": "Research and Development Asset Acquired Other than Through Business Combination, Written-off", "netLabel": "Purchased in-process research and development" } } }, "localname": "ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r565", "r845" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development expenses" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research and Development Expense [Member]", "terseLabel": "Research and development expenses" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r150", "r565" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development Expense, Policy [Policy Text Block]", "terseLabel": "Research and Development Costs" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchMember": { "auth_ref": [ "r595" ], "lang": { "en-us": { "role": { "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.", "label": "Research Tax Credit Carryforward [Member]", "terseLabel": "Research expenditure tax credits" } } }, "localname": "ResearchMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCashCurrent": { "auth_ref": [ "r2", "r16", "r148" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash, Current", "terseLabel": "Restricted cash included in other current assets" } } }, "localname": "RestrictedCashCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashNoncurrent": { "auth_ref": [ "r9", "r19", "r148", "r832" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash, Noncurrent", "terseLabel": "Restricted cash included in other assets" } } }, "localname": "RestrictedCashNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted stock units", "verboseLabel": "Nonvested restricted stock unit activity" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESStockbasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost and Reserve [Line Items]", "terseLabel": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SPECIALCHARGESGAINRealignmentExpensesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringReserveCurrent": { "auth_ref": [ "r351", "r356" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "order": 8.0, "parentTag": "ew_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.", "label": "Restructuring Reserve, Current", "terseLabel": "Accrued realignment reserves" } } }, "localname": "RestructuringReserveCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r31", "r388", "r559", "r808", "r825", "r827" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r171", "r172", "r173", "r175", "r181", "r183", "r299", "r556", "r557", "r558", "r601", "r602", "r822", "r824" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanNameAxis": { "auth_ref": [ "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r444", "r445", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r467", "r468", "r469", "r470", "r472", "r475", "r479", "r480", "r481", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r518" ], "lang": { "en-us": { "role": { "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.", "label": "Retirement Plan Name [Axis]", "terseLabel": "Retirement Plan Name [Axis]" } } }, "localname": "RetirementPlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanNameDomain": { "auth_ref": [ "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r444", "r445", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r467", "r468", "r469", "r470", "r472", "r475", "r479", "r480", "r481", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r518" ], "lang": { "en-us": { "role": { "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.", "label": "Retirement Plan Name [Domain]", "terseLabel": "Retirement Plan Name [Domain]" } } }, "localname": "RetirementPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanSponsorLocationAxis": { "auth_ref": [ "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r444", "r445", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r467", "r468", "r469", "r470", "r472", "r475", "r480", "r481", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r500", "r504", "r517" ], "lang": { "en-us": { "role": { "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Sponsor Location [Axis]", "terseLabel": "Retirement Plan Sponsor Location [Axis]" } } }, "localname": "RetirementPlanSponsorLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanSponsorLocationDomain": { "auth_ref": [ "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r444", "r445", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r467", "r468", "r469", "r470", "r472", "r475", "r480", "r481", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r500", "r504", "r517" ], "lang": { "en-us": { "role": { "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Sponsor Location [Domain]", "terseLabel": "Retirement Plan Sponsor Location [Domain]" } } }, "localname": "RetirementPlanSponsorLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanTypeAxis": { "auth_ref": [ "r416", "r417", "r418", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r444", "r445", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r467", "r469", "r470", "r472", "r475", "r479", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r499", "r500", "r501", "r502", "r503", "r504", "r514", "r515", "r516", "r517" ], "lang": { "en-us": { "role": { "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Axis]", "terseLabel": "Retirement Plan Type [Axis]" } } }, "localname": "RetirementPlanTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSSummaryofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details", "http://www.edwards.com/role/SPECIALCHARGESGAINRealignmentExpensesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanTypeDomain": { "auth_ref": [ "r416", "r417", "r418", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r444", "r445", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r467", "r469", "r470", "r472", "r475", "r479", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r499", "r500", "r501", "r502", "r503", "r504", "r514", "r515", "r516", "r517" ], "lang": { "en-us": { "role": { "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Domain]", "terseLabel": "Retirement Plan Type [Domain]" } } }, "localname": "RetirementPlanTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSSummaryofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details", "http://www.edwards.com/role/SPECIALCHARGESGAINRealignmentExpensesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r217", "r218", "r231", "r237", "r238", "r245", "r246", "r249", "r407", "r408", "r771" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Net sales", "verboseLabel": "Segment Net Sales" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/QUARTERLYFINANCIALRESULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationAboutReportableSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r151", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r414" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue from Contract with Customer [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue, Initial Application Period Cumulative Effect Transition [Line Items]", "terseLabel": "Revenue, Initial Application Period Cumulative Effect Transition [Line Items]" } } }, "localname": "RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable": { "auth_ref": [ "r413" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information when using transition method for cumulative effect in initial period of application for revenue from contract with customer.", "label": "Revenue, Initial Application Period Cumulative Effect Transition [Table]", "terseLabel": "Revenue, Initial Application Period Cumulative Effect Transition [Table]" } } }, "localname": "RevenueInitialApplicationPeriodCumulativeEffectTransitionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenuePerformanceObligationDescriptionOfTiming": { "auth_ref": [ "r398" ], "lang": { "en-us": { "role": { "documentation": "Description of timing for satisfying performance obligation in contract with customer. Includes, but is not limited to, as services are rendered, and upon shipment, delivery or completion of service.", "label": "Revenue, Performance Obligation, Description of Timing", "terseLabel": "Contract length" } } }, "localname": "RevenuePerformanceObligationDescriptionOfTiming", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "terseLabel": "Net Sales Reconciliation", "verboseLabel": "Net Sales by Geographic Area and by Major Product Area" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenues from External Customers and Long-Lived Assets [Line Items]", "terseLabel": "Enterprise-Wide Information" } } }, "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r730", "r733" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Right-of-use assets obtained in exchange for new lease liabilities" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RoyaltyExpense": { "auth_ref": [ "r110" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.", "label": "Royalty Expense", "terseLabel": "Royalty Expense" } } }, "localname": "RoyaltyExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNETDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": { "auth_ref": [ "r58" ], "lang": { "en-us": { "role": { "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]", "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsReceivableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r91", "r712", "r713" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Summary of Activity for Each Component of Accumulated Other Comprehensive Loss" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": { "auth_ref": [ "r443" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.", "label": "Schedule of Allocation of Plan Assets [Table Text Block]", "terseLabel": "Schedule of Target Weighted-Average Asset Allocations and Fair Value" } } }, "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r464" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.", "label": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Change in Unrealized Pension Costs" } } }, "localname": "ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r195" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsperShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": { "auth_ref": [ "r466" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.", "label": "Defined Benefit Plan, Assumptions [Table Text Block]", "terseLabel": "Schedule of Weighted-Average Assumptions Used to Determine Benefit Obligations" } } }, "localname": "ScheduleOfAssumptionsUsedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Securities, Available-for-sale [Line Items]", "terseLabel": "Debt Securities, Available-for-sale [Line Items]" } } }, "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": { "auth_ref": [ "r268", "r269", "r285", "r286", "r287", "r288", "r793", "r794" ], "lang": { "en-us": { "role": { "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.", "label": "Schedule of Available-for-sale Securities [Table]", "terseLabel": "Schedule of Available-for-sale Securities [Table]" } } }, "localname": "ScheduleOfAvailableForSaleSecuritiesTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r619", "r620" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSCASMedicalSystemsIncNarrativeDetails", "http://www.edwards.com/role/ACQUISITIONSCardiAQValveTechnologiesIncNarrativeDetails", "http://www.edwards.com/role/ACQUISITIONSHarpoonMedicalIncNarrativeDetails", "http://www.edwards.com/role/ACQUISITIONSSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.edwards.com/role/ACQUISITIONSValtechCardioLtdNarrativeDetails", "http://www.edwards.com/role/SPECIALCHARGESGAINAcquisitionofIntellectualPropertyDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of cash and cash equivalents.", "label": "Schedule of Cash and Cash Equivalents [Table Text Block]", "terseLabel": "Schedule of Cash and Cash Equivalents" } } }, "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.", "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]", "terseLabel": "Supplemental Cash Flow Information" } } }, "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r600" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Schedule of Provision for Income Taxes" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r52", "r156", "r382", "r385", "r386", "r387", "r717", "r718", "r720", "r797" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-term Debt Instruments [Table Text Block]", "terseLabel": "Summary of the Notes" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r591" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "terseLabel": "Components of Deferred Tax Assets and Liabilities" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r478", "r479", "r482", "r483", "r494" ], "lang": { "en-us": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Defined Benefit Plans Disclosures [Table]", "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSComponentsofNetPeriodicBenefitCostDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSSummaryofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "auth_ref": [ "r658", "r668", "r672" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table Text Block]", "terseLabel": "Schedule of Effect of Derivative Instruments" } } }, "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r194" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Computation of Basic and Diluted Earnings Per Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock": { "auth_ref": [ "r448" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the effect of fair value measurements using significant unobservable inputs (Level 3) on changes in plan assets of pension plans and/or other employee benefit plans for the period.", "label": "Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets [Table Text Block]", "terseLabel": "Summary of Changes in Fair Value of Defined Benefit Plan Assets Classified as Level 3" } } }, "localname": "ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r573" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r522", "r551", "r561" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r522", "r551", "r561" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "terseLabel": "Schedule of Stock-Based Compensation Expense" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Equity Method Investments [Line Items]", "terseLabel": "Schedule of Equity Method Investments [Line Items]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsTable": { "auth_ref": [ "r1", "r154", "r297", "r298", "r701" ], "lang": { "en-us": { "role": { "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.", "label": "Schedule of Equity Method Investments [Table]", "terseLabel": "Schedule of Equity Method Investments [Table]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": { "auth_ref": [ "r454" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.", "label": "Schedule of Expected Benefit Payments [Table Text Block]", "terseLabel": "Schedule of Benefit Payments Which Reflect Expected Future Service" } } }, "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r686", "r687" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Summary of Financial Instruments Measured at Fair Value on a Recurring Basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r330", "r336", "r772" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails", "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r330", "r336" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Finite-Lived Other Intangible Assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock": { "auth_ref": [ "r662" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the presentation of foreign exchange contracts on the statement of financial position, including the fair value amounts and location of such amounts.", "label": "Schedule of Foreign Exchange Contracts, Statement of Financial Position [Table Text Block]", "terseLabel": "Schedule of Location and Fair Value Amounts of Derivative Instruments" } } }, "localname": "ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r326", "r327" ], "lang": { "en-us": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]", "terseLabel": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r326", "r327" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Schedule of Changes in the Carrying Amount of Goodwill, by Segment" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Held-to-maturity Securities [Line Items]", "terseLabel": "Schedule of Held-to-maturity Securities [Line Items]" } } }, "localname": "ScheduleOfHeldToMaturitySecuritiesLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfHeldToMaturitySecuritiesTable": { "auth_ref": [ "r275", "r279", "r280" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-maturity [Table]", "terseLabel": "Debt Securities, Held-to-maturity [Table]" } } }, "localname": "ScheduleOfHeldToMaturitySecuritiesTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [ "r157" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.", "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]", "terseLabel": "Schedule of Income Before Provisions for Income Taxes" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r340", "r343" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.", "label": "Schedule of Indefinite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails", "http://www.edwards.com/role/SPECIALCHARGESGAINImpairmentofLonglivedAssetsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESGoodwillandIntangibleAssetsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r340", "r343" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.", "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Indefinite-Lived Other Intangible Assets" } } }, "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A tabular presentation of the information summarizing investments in and advances to majority-owned subsidiaries, other controlled companies, and other affiliates, as prescribed by the SEC. It reflects specified information about ownership, financial results from, and financial position in such entities. Includes the tabular presentations that disaggregate investments in and advances to majority-owned subsidiaries, other controlled companies, and other affiliates.", "label": "Schedule of Investments in and Advances to Affiliates, Schedule of Investments [Table Text Block]", "terseLabel": "Schedule of Investments in Unconsolidated Affiliates" } } }, "localname": "ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": { "auth_ref": [ "r456" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.", "label": "Schedule of Net Benefit Costs [Table Text Block]", "terseLabel": "Components of Net Periodic Benefit Cost" } } }, "localname": "ScheduleOfNetBenefitCostsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [ "r537" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.", "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]", "terseLabel": "Schedule of Restricted Stock Unit Activity" } } }, "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": { "auth_ref": [ "r649" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.", "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]", "terseLabel": "Summary of Derivative Financial Instruments Used to Manage Currency Exchange and Interest Rate Risk" } } }, "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.", "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]", "terseLabel": "Schedule of Other Expense, Net" } } }, "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERINCOMENETTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]", "terseLabel": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESShippingandHandlingCostsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r45", "r348" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": { "auth_ref": [ "r200" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.", "label": "Quarterly Financial Information [Table Text Block]", "terseLabel": "Schedule of Quarterly Financial Results and Market for the Company's Stock" } } }, "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/QUARTERLYFINANCIALRESULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r624" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Summary of Fair Values of Assets Acquired and Liabilities Assumed" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": { "auth_ref": [ "r16", "r148", "r775", "r806" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.", "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]", "terseLabel": "Schedule of Restricted Cash" } } }, "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r353", "r354", "r355" ], "lang": { "en-us": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]", "terseLabel": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SPECIALCHARGESGAINRealignmentExpensesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": { "auth_ref": [ "r107", "r248" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]", "terseLabel": "Schedule of Enterprise-Wide Information" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": { "auth_ref": [ "r102", "r248" ], "lang": { "en-us": { "role": { "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]", "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r226", "r229", "r235", "r326" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationAboutReportableSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r226", "r229", "r235", "r326" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of Information About Reportable Segments and Reconciliation of Segment Net Sales and Pre-Tax Income" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r524", "r554" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityNarrativeDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESStockbasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r530", "r542", "r544" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Schedule of Stock Option Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": { "auth_ref": [ "r546" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]", "terseLabel": "Schedule of Weighted-Average Assumptions for ESPP Subscriptions" } } }, "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r546" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Schedule of Weighted-Average Assumptions for Options Granted" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r55", "r152", "r203", "r204", "r378", "r379", "r380", "r382", "r383", "r384", "r385", "r386", "r387", "r388" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]", "terseLabel": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/QUARTERLYFINANCIALRESTULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDNarrativeDetails", "http://www.edwards.com/role/QUARTERLYFINANCIALRESULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt and Equity Securities, FV-NI [Line Items]", "terseLabel": "Debt and Equity Securities, FV-NI [Line Items]" } } }, "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security with change in fair value recognized in net income (FV-NI).", "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]", "terseLabel": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]" } } }, "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r336" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Schedule of Estimated Amortization Expense" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r214", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r231", "r232", "r233", "r234", "r236", "r237", "r238", "r239", "r240", "r242", "r249", "r817" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSValtechCardioLtdNarrativeDetails", "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails", "http://www.edwards.com/role/QUARTERLYFINANCIALRESTULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDNarrativeDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationAboutReportableSegmentsDetails", "http://www.edwards.com/role/SPECIALCHARGESGAINImpairmentofLonglivedAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r214", "r215", "r216", "r226", "r230", "r236", "r240", "r241", "r242", "r243", "r245", "r248", "r249", "r250" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "SEGMENT INFORMATION" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATION" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationofSegmentNetSalesandPreTaxIncometoConsolidatedNetSalesandPreTaxIncomeDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationAboutReportableSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r111" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "negatedLabel": "Selling, general, and administrative expenses", "terseLabel": "Selling, general, and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]", "terseLabel": "Selling, general, and administrative expenses", "verboseLabel": "Selling, general, and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationofGainorLossonDerivativeInstrumentsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SeniorNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.", "label": "Senior Notes [Member]", "terseLabel": "Senior Notes" } } }, "localname": "SeniorNotesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESSummaryoftheNotesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r139" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation (Notes\u00a02 and 14)" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r525" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r536" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedTerseLabel": "Forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r541" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r539" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r539" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r538" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r538" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Ending balance (in dollars per share)", "periodStartLabel": "Beginning balance (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted- Average Grant-Date Fair Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r540" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedLabel": "Vested (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r540" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Vested (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r549" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Expected dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r548" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Expected volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r550" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Average risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityNarrativeDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESStockbasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": { "auth_ref": [ "r554" ], "lang": { "en-us": { "role": { "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate", "terseLabel": "Maximum percentage of compensation employees can authorize to be withheld for common stock purchases" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r527" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized", "terseLabel": "Common stock available for issuance (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r533" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number", "terseLabel": "Exercisable as of period end (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r533" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Exercisable as of period end (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r536" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period", "negatedTerseLabel": "Options forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "auth_ref": [ "r534" ], "lang": { "en-us": { "role": { "documentation": "Net number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures", "terseLabel": "Options granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r543" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Fair value, per share (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r554" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Outstanding as of period end" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r532", "r554" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r531" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Ending balance (in dollars per share)", "periodStartLabel": "Beginning balance (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]", "terseLabel": "Weighted- Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": { "auth_ref": [ "r544" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value", "terseLabel": "Vested and expected to vest as of period end" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": { "auth_ref": [ "r545" ], "lang": { "en-us": { "role": { "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number", "terseLabel": "Vested and expected to vest as of period end (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r545" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price", "terseLabel": "Vested and expected to vest as of period end (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r521", "r528" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityNarrativeDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESStockbasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Options exercised (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "terseLabel": "Options forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Options granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareRepurchaseProgramAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by share repurchase program.", "label": "Share Repurchase Program [Axis]", "terseLabel": "Share Repurchase Program [Axis]" } } }, "localname": "ShareRepurchaseProgramAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTreasuryStockNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareRepurchaseProgramDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the share repurchase program.", "label": "Share Repurchase Program [Domain]", "terseLabel": "Share Repurchase Program [Domain]" } } }, "localname": "ShareRepurchaseProgramDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTreasuryStockNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "auth_ref": [ "r525" ], "lang": { "en-us": { "role": { "documentation": "Percentage of vesting of award under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage", "terseLabel": "Percentage vesting upon retirement for each full year of employment subsequent to the grant date" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESStockbasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r526" ], "lang": { "en-us": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period", "terseLabel": "Expiration date" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r547", "r560" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected life (years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r554" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value", "terseLabel": "Exercisable as of period end" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r554" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Exercisable as of period end" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r545" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Outstanding as of period end" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r545" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Vested and expected to vest as of period end" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase price of common stock expressed as a percentage of its fair value.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent", "terseLabel": "Percentage of lower of fair market value of common stock on effective date of subscription or date of purchase" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r381" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_ShippingAndHandlingMember": { "auth_ref": [ "r411" ], "lang": { "en-us": { "role": { "documentation": "Packing and transport of product.", "label": "Shipping and Handling [Member]", "terseLabel": "Shipping and Handling" } } }, "localname": "ShippingAndHandlingMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESShippingandHandlingCostsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShortTermInvestments": { "auth_ref": [ "r21", "r783", "r784", "r801" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.", "label": "Short-term Investments", "terseLabel": "Short-term investments (Note\u00a07)" } } }, "localname": "ShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r170" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.", "label": "Software and Software Development Costs [Member]", "terseLabel": "Software" } } }, "localname": "SoftwareAndSoftwareDevelopmentCostsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StateAndLocalJurisdictionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.", "label": "State and Local Jurisdiction [Member]", "netLabel": "California research expenditure tax credits", "terseLabel": "State and local jurisdiction", "verboseLabel": "United States state net operating losses" } } }, "localname": "StateAndLocalJurisdictionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r0", "r214", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r231", "r232", "r233", "r234", "r236", "r237", "r238", "r239", "r240", "r242", "r249", "r326", "r350", "r352", "r357", "r817" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACQUISITIONSValtechCardioLtdNarrativeDetails", "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails", "http://www.edwards.com/role/QUARTERLYFINANCIALRESTULTSANDMARKETFORTHECOMPANYSSTOCKUNAUDITEDNarrativeDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationAboutReportableSegmentsDetails", "http://www.edwards.com/role/SPECIALCHARGESGAINImpairmentofLonglivedAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r57", "r171", "r172", "r173", "r175", "r181", "r183", "r202", "r299", "r381", "r388", "r556", "r557", "r558", "r601", "r602", "r707", "r708", "r709", "r710", "r711", "r713", "r822", "r823", "r824" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSChangeinUnrealizedPensionCostsDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofInformationAboutAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/COMMONSTOCKTreasuryStockNarrativeDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]", "terseLabel": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r171", "r172", "r173", "r202", "r771" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_StockCompensationPlanMember": { "auth_ref": [ "r195" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.", "label": "Share-based Payment Arrangement [Member]", "terseLabel": "Stock compensation plan" } } }, "localname": "StockCompensationPlanMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsperShareNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StockIssued1": { "auth_ref": [ "r145", "r146", "r147" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of stock issued in noncash financing activities.", "label": "Stock Issued", "verboseLabel": "Fair value of shares issued in payment for contingent consideration liabilities" } } }, "localname": "StockIssued1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r27", "r28", "r388" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Stock Issued During Period, Shares, Acquisitions", "negatedTerseLabel": "Stock issued in payment for contingent consideration liabilities (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r27", "r28", "r381", "r388" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Common stock issued under equity plans, including tax benefits (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r27", "r28", "r381", "r388", "r535" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "negatedLabel": "Options exercised (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockSplits": { "auth_ref": [ "r27", "r28", "r381", "r388" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of a stock split.", "label": "Stock Issued During Period, Shares, Stock Splits", "terseLabel": "Stock issued to effect stock split (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockSplits", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r57", "r381", "r388" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Stock Issued During Period, Value, Acquisitions", "terseLabel": "Shares issued in payment for contingent consideration liabilities" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r27", "r28", "r388", "r523", "r543" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Common stock issued under equity plans" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program, Authorized Amount", "terseLabel": "Amount Paid", "verboseLabel": "Authorized amount for share repurchase" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails", "http://www.edwards.com/role/COMMONSTOCKTreasuryStockNarrativeDetails", "http://www.edwards.com/role/SUBSEQUENTEVENTDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r28", "r33", "r34", "r154", "r259", "r298", "r701" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 10.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total stockholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSSummaryofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders' equity (Note\u00a014)" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r153", "r388", "r395" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "COMMON STOCK" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCK" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.", "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio", "terseLabel": "Stock split, conversion ratio" } } }, "localname": "StockholdersEquityNoteStockSplitConversionRatio1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueNarrativeDetails" ], "xbrltype": "pureItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]", "terseLabel": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUBSEQUENTEVENTDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r714", "r736" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNETDetails", "http://www.edwards.com/role/SUBSEQUENTEVENTDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r714", "r736" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]", "terseLabel": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUBSEQUENTEVENTDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r714", "r736" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNETDetails", "http://www.edwards.com/role/SUBSEQUENTEVENTDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r714", "r736" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansNarrativeDetails", "http://www.edwards.com/role/INTELLECTUALPROPERTYLITIGATIONEXPENSESNETDetails", "http://www.edwards.com/role/SUBSEQUENTEVENTDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]", "terseLabel": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r735", "r738" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "SUBSEQUENT EVENT" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUBSEQUENTEVENT" ], "xbrltype": "textBlockItemType" }, "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": { "auth_ref": [ "r576", "r585", "r587" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.", "label": "Summary of Income Tax Contingencies [Table Text Block]", "terseLabel": "Reconciliation of Beginning and Ending Amount of Uncertain Tax Positions" } } }, "localname": "SummaryOfIncomeTaxContingenciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock": { "auth_ref": [ "r595" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "Summary of Operating Loss Carryforwards [Table Text Block]", "terseLabel": "Summary of Net Operating Loss Carryforwards" } } }, "localname": "SummaryOfOperatingLossCarryforwardsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock": { "auth_ref": [ "r595" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of tax credit carryforwards available to reduce future taxable income, including amounts, expiration dates, limitations on use and the related deferred tax assets and valuation allowances.", "label": "Summary of Tax Credit Carryforwards [Table Text Block]", "terseLabel": "Summary of Tax Credit Carryforwards" } } }, "localname": "SummaryOfTaxCreditCarryforwardsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": { "auth_ref": [ "r75" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.", "label": "Supplemental Balance Sheet Disclosures [Text Block]", "terseLabel": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS" } } }, "localname": "SupplementalBalanceSheetDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "verboseLabel": "Cash paid during the year for:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardAmount": { "auth_ref": [ "r594" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails": { "order": 2.0, "parentTag": "ew_TaxCreditCarryforwardDeferredTaxAssetNetOfValuationAllowance", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Tax Credit Carryforward, Amount", "verboseLabel": "Carryforward Amount" } } }, "localname": "TaxCreditCarryforwardAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxCreditCarryforwardAxis": { "auth_ref": [ "r595" ], "lang": { "en-us": { "role": { "documentation": "Information by specific tax credit related to an unused tax credit.", "label": "Tax Credit Carryforward [Axis]", "terseLabel": "Tax Credit Carryforward [Axis]" } } }, "localname": "TaxCreditCarryforwardAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Tax Credit Carryforward [Line Items]", "terseLabel": "Tax credit carryforwards and the related carryforward periods" } } }, "localname": "TaxCreditCarryforwardLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardNameDomain": { "auth_ref": [ "r595" ], "lang": { "en-us": { "role": { "documentation": "The name of the tax credit carryforward.", "label": "Tax Credit Carryforward, Name [Domain]", "terseLabel": "Tax Credit Carryforward, Name [Domain]" } } }, "localname": "TaxCreditCarryforwardNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TaxCreditCarryforwardTable": { "auth_ref": [ "r595" ], "lang": { "en-us": { "role": { "documentation": "A listing of tax credit carryforwards available to reduce future taxable income including descriptions, amounts, expiration dates, limitations on use and the related deferred tax assets and valuation allowances.", "label": "Tax Credit Carryforward [Table]", "terseLabel": "Tax Credit Carryforward [Table]" } } }, "localname": "TaxCreditCarryforwardTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardValuationAllowance": { "auth_ref": [ "r590" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails": { "order": 1.0, "parentTag": "ew_TaxCreditCarryforwardDeferredTaxAssetNetOfValuationAllowance", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from tax credit carryforwards for which it is more likely than not that a tax benefit will not be realized.", "label": "Tax Credit Carryforward, Valuation Allowance", "negatedLabel": "Valuation Allowance" } } }, "localname": "TaxCreditCarryforwardValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxPeriodAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information about the period subject to enacted tax laws.", "label": "Tax Period [Axis]", "terseLabel": "Tax Period [Axis]" } } }, "localname": "TaxPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxPeriodDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identified tax period.", "label": "Tax Period [Domain]", "terseLabel": "Tax Period [Domain]" } } }, "localname": "TaxPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESSummaryofTaxCreditCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TaxesPayableCurrentAndNoncurrent": { "auth_ref": [ "r22", "r779", "r804" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.", "label": "Taxes Payable", "terseLabel": "Taxes payable (Note 17)" } } }, "localname": "TaxesPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "auth_ref": [ "r253", "r254", "r255", "r256", "r258", "r260" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for accounts receivable.", "label": "Accounts Receivable [Policy Text Block]", "terseLabel": "Accounts Receivable" } } }, "localname": "TradeAndOtherAccountsReceivablePolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r275", "r279", "r739", "r740", "r741", "r742", "r743", "r744", "r745", "r746", "r747", "r748", "r749", "r750", "r751", "r753", "r754", "r755", "r756", "r757", "r758", "r759", "r760", "r761", "r762", "r763", "r764", "r765", "r766", "r767", "r768", "r769" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]", "terseLabel": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r56", "r391" ], "lang": { "en-us": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]", "terseLabel": "Treasury Stock" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTreasuryStockNarrativeDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockShares": { "auth_ref": [ "r56", "r391" ], "lang": { "en-us": { "role": { "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.", "label": "Treasury Stock, Shares", "terseLabel": "Treasury stock, shares (in shares)" } } }, "localname": "TreasuryStockShares", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockSharesAcquired": { "auth_ref": [ "r28", "r381", "r388" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.", "label": "Treasury Stock, Shares, Acquired", "terseLabel": "Shares repurchased (in shares)", "verboseLabel": "Purchases of treasury stock (in shares)" } } }, "localname": "TreasuryStockSharesAcquired", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKAcceleratedShareRepurchasesDetails", "http://www.edwards.com/role/COMMONSTOCKTreasuryStockNarrativeDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.edwards.com/role/SUBSEQUENTEVENTDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r56", "r391", "r394" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedLabel": "Treasury stock, at cost, 12.1 and 9.0 shares, respectively" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "auth_ref": [ "r381", "r388", "r391" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.", "label": "Treasury Stock, Value, Acquired, Cost Method", "negatedLabel": "Purchases of treasury stock", "verboseLabel": "Aggregate cost of stock repurchases" } } }, "localname": "TreasuryStockValueAcquiredCostMethod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTreasuryStockNarrativeDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_USGovernmentDebtSecuritiesMember": { "auth_ref": [ "r792" ], "lang": { "en-us": { "role": { "documentation": "Debt securities issued by the United States government.", "label": "US Government Debt Securities [Member]", "terseLabel": "United States government bonds" } } }, "localname": "USGovernmentDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_USTreasuryAndGovernmentMember": { "auth_ref": [ "r445", "r792", "r829" ], "lang": { "en-us": { "role": { "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).", "label": "US Treasury and Government [Member]", "terseLabel": "U.S. government and agency securities" } } }, "localname": "USTreasuryAndGovernmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UndistributedEarningsOfForeignSubsidiaries": { "auth_ref": [ "r566", "r615", "r798", "r828" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.", "label": "Undistributed Earnings of Foreign Subsidiaries", "terseLabel": "Foreign earnings to be indefinitely reinvested" } } }, "localname": "UndistributedEarningsOfForeignSubsidiaries", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of unrealized gains and losses on investments.", "label": "Unrealized Gain (Loss) on Investments [Table Text Block]", "terseLabel": "Schedule of Investments in Debt Securities" } } }, "localname": "UnrealizedGainLossOnInvestmentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INVESTMENTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r567", "r579" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESNarrativeDetails": { "order": 1.0, "parentTag": "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "periodEndLabel": "Uncertain gross tax positions, ending balance", "periodStartLabel": "Uncertain gross tax positions, beginning balance", "terseLabel": "Unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESReconciliationofBeginningandEndingAmountofUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r580" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions", "negatedLabel": "Decrease in prior year tax positions" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofBeginningandEndingAmountofUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": { "auth_ref": [ "r582" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.", "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities", "negatedLabel": "Settlements" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofBeginningandEndingAmountofUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": { "auth_ref": [ "r581" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.", "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions", "terseLabel": "Current year tax positions" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofBeginningandEndingAmountofUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r580" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions", "terseLabel": "Increase in prior year tax positions" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofBeginningandEndingAmountofUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued": { "auth_ref": [ "r575" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense accrued for an underpayment of income taxes.", "label": "Unrecognized Tax Benefits, Interest on Income Taxes Accrued", "terseLabel": "Accrued interest related to unrecognized tax benefits, net of tax benefit" } } }, "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense": { "auth_ref": [ "r575" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense for an underpayment of income taxes.", "label": "Unrecognized Tax Benefits, Interest on Income Taxes Expense", "terseLabel": "Interest expense (benefit), net of tax benefit" } } }, "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": { "auth_ref": [ "r583" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.", "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations", "negatedLabel": "Lapse of statutes of limitations" } } }, "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESReconciliationofBeginningandEndingAmountofUncertainTaxPositionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": { "auth_ref": [ "r584" ], "calculation": { "http://www.edwards.com/role/INCOMETAXESNarrativeDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.", "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate", "totalLabel": "Net amounts favorably affecting tax rate" } } }, "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock": { "auth_ref": [ "r116" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for an event or transaction that is unusual in nature or infrequent in occurrence, or both.", "label": "Unusual or Infrequent Items, or Both, Disclosure [Text Block]", "terseLabel": "SPECIAL CHARGES (GAIN)" } } }, "localname": "UnusualOrInfrequentItemsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SPECIALCHARGESGAIN" ], "xbrltype": "textBlockItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r206", "r207", "r208", "r209", "r210", "r211", "r212" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": { "auth_ref": [ "r168" ], "lang": { "en-us": { "role": { "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward.", "label": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]", "terseLabel": "Tax valuation allowance" } } }, "localname": "ValuationAllowanceOfDeferredTaxAssetsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationAllowancesAndReservesBalance": { "auth_ref": [ "r161", "r167" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount", "periodEndLabel": "Balance at End of Period", "periodStartLabel": "Balance at Beginning of Period" } } }, "localname": "ValuationAllowancesAndReservesBalance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": { "auth_ref": [ "r164" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense", "terseLabel": "Charged to Costs and Expenses" } } }, "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts": { "auth_ref": [ "r165" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account", "terseLabel": "Charged to Other Accounts" } } }, "localname": "ValuationAllowancesAndReservesChargedToOtherAccounts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesDeductions": { "auth_ref": [ "r166" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction", "negatedLabel": "Deductions" } } }, "localname": "ValuationAllowancesAndReservesDeductions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesDomain": { "auth_ref": [ "r161", "r162", "r163", "r166", "r167" ], "lang": { "en-us": { "role": { "documentation": "Valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]", "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]" } } }, "localname": "ValuationAllowancesAndReservesDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationAllowancesAndReservesTypeAxis": { "auth_ref": [ "r161", "r162", "r163", "r166", "r167" ], "lang": { "en-us": { "role": { "documentation": "Information by valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]", "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]" } } }, "localname": "ValuationAllowancesAndReservesTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r186", "r194" ], "calculation": { "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted (in shares)", "totalLabel": "Dilutive weighted-average shares outstanding (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Weighted-average number of common shares outstanding:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r184", "r194" ], "calculation": { "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic (in shares)", "verboseLabel": "Weighted-average shares outstanding (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 8 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233" }, "r116": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "220", "URI": "http://asc.fasb.org/subtopic&trid=114868817" }, "r117": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "220", "URI": "http://asc.fasb.org/topic&trid=2134417" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3151-108585" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18726-107790" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(1)(i))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(n))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column B))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(1)))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(2)))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column D))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column E))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(ColumnA))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1377-109256" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=121640914&loc=d3e1280-108306" }, "r201": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "270", "URI": "http://asc.fasb.org/topic&trid=2126967" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r213": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8475-108599" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e4975-111524" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953423-111524" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5212-111524" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5033-111524" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5093-111524" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "8A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=SL6284422-111562" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269825-111563" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27337-111563" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27340-111563" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)-(d)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27357-111563" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27357-111563" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "http://asc.fasb.org/topic&trid=2196928" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117539-209714" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117539-209714" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33775-111570" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(b)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922890-210455" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r319": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b),(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r344": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=116646759&loc=d3e15243-108350" }, "r369": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870" }, "r377": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 4.C)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656" }, "r395": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130561-203045" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130564-203045" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(i)(1)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048" }, "r414": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r415": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "610", "URI": "http://asc.fasb.org/topic&trid=49130413" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1731-114919" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(10)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(8)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(9)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(8)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(l)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(o)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(p)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(q)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2919-114920" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4587-114921" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(e)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(e)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r519": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "http://asc.fasb.org/topic&trid=2235017" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f(1))", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.28,29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907" }, "r564": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "720", "URI": "http://asc.fasb.org/topic&trid=2122503" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121573983&loc=d3e28200-109314" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e39076-109324" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r617": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e1043-128460" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "b", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)(3)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479" }, "r638": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(i)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(ii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(iii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(1)(i)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "4CCC", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998896-113959" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(2)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41641-113959" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41675-113959" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80845-113994" }, "r684": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "http://asc.fasb.org/topic&trid=2229140" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "54B", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117332851&loc=SL7495116-110257" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=99377092&loc=SL75136599-209740" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=d3e13220-108610" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225877-175312" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30226-110892" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r715": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "http://asc.fasb.org/topic&trid=2175825" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226016-175313" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918666-209980" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971" }, "r734": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/subtopic&trid=77888251" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r738": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226003-175313" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r745": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r746": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r747": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r748": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r749": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r75": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "210", "URI": "http://asc.fasb.org/topic&trid=2122208" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r754": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r755": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r756": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r758": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r759": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r760": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r762": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r763": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r764": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r765": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r766": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r767": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r768": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r769": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r770": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733" }, "r771": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r772": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r773": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r774": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "940", "URI": "http://asc.fasb.org/subtopic&trid=2176304" }, "r775": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r776": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r777": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r778": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r779": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r780": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r781": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r782": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r783": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(4))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r784": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r785": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(6))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r786": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r787": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r788": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r789": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(dd)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r790": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r791": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Subparagraph": "b.", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=121551529&loc=d3e60009-112784" }, "r792": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62557-112803" }, "r793": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62557-112803" }, "r794": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62586-112803" }, "r795": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "942", "URI": "http://asc.fasb.org/subtopic&trid=2209399" }, "r796": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r797": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r798": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Subparagraph": "(b)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6479915&loc=d3e66715-112838" }, "r799": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r800": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r801": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(g))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r802": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r803": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r804": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r805": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r806": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r807": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r808": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r809": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r810": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r811": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r812": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r813": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r814": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r815": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(b))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r816": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r817": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r818": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439" }, "r819": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r820": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r821": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441" }, "r822": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r823": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r824": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r825": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r826": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r827": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r828": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6487024&loc=d3e29054-158556" }, "r829": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121641442&loc=d3e19393-158473" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r830": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "946", "URI": "http://asc.fasb.org/subtopic&trid=2324412" }, "r831": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r832": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580" }, "r833": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650" }, "r834": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r835": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r836": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r837": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r838": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r839": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i),(j),(k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r840": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r841": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r842": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r843": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r844": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r845": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r846": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r847": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r848": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r849": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r850": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r851": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r852": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r853": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r854": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r855": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "11", "Subsection": "03" }, "r856": { "Footnote": "2", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r857": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29" }, "r858": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "09" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e640-108580" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e689-108580" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "17A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724391-108580" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067" } }, "version": "2.1" } ZIP 167 0001099800-21-000007-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001099800-21-000007-xbrl.zip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�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